assays_assay_id,assays_assay_organism,assays_chembl_id,assays_curated_by,assays_assay_tissue,assays_description,assays_assay_category,assays_relationship_type,assays_assay_tax_id,assays_doc_id,assays_tid,assays_src_id,assays_src_assay_id,assays_cell_id,assays_bao_format,assays_tissue_id,assays_variant_id
7524,Rattus norvegicus,CHEMBL618647,Intermediate,Kidney,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7525,Rattus norvegicus,CHEMBL618648,Intermediate,Kidney,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7526,Rattus norvegicus,CHEMBL618649,Intermediate,Kidney,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7527,Rattus norvegicus,CHEMBL618650,Intermediate,Liver,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7528,Rattus norvegicus,CHEMBL618651,Intermediate,Liver,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7529,Rattus norvegicus,CHEMBL876497,Intermediate,Liver,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7530,Rattus norvegicus,CHEMBL618652,Intermediate,Lung,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2048.0,
7531,Rattus norvegicus,CHEMBL618653,Intermediate,Lung,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,2048.0,
7532,Rattus norvegicus,CHEMBL618654,Intermediate,Lung,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2048.0,
7533,Rattus norvegicus,CHEMBL618655,Intermediate,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,N,10116.0,6351,50597,1,,,BAO_0000218,,
7534,Rattus norvegicus,CHEMBL618656,Intermediate,,Compound was tested for solubility in water,,N,10116.0,1465,50597,1,,,BAO_0000218,,
7535,,CHEMBL618657,Intermediate,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,U,,5182,22229,1,,,BAO_0000100,,
7536,Rattus norvegicus,CHEMBL618658,Intermediate,,Solubility was determined,,N,10116.0,17847,50597,1,,,BAO_0000218,,
7537,Rattus norvegicus,CHEMBL618659,Intermediate,,solubility in water (ug/mL) at 37 degree C.,,N,10116.0,15339,50597,1,,,BAO_0000218,,
7538,Rattus norvegicus,CHEMBL618660,Intermediate,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,N,10116.0,5202,50597,1,,,BAO_0000218,,
7539,Rattus norvegicus,CHEMBL618661,Intermediate,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,N,10116.0,1088,50597,1,,,BAO_0000218,,
7540,Rattus norvegicus,CHEMBL873807,Intermediate,,Half life in rats,,N,10116.0,3169,50597,1,,,BAO_0000218,,
7541,Rattus norvegicus,CHEMBL618662,Intermediate,,Half life in Dawley rat,,N,10116.0,5353,50597,1,,,BAO_0000218,,
7542,Rattus norvegicus,CHEMBL618663,Intermediate,,Half life period after 3 mg/kg iv administration,,N,10116.0,2864,50597,1,,,BAO_0000218,,
7543,Rattus norvegicus,CHEMBL618664,Intermediate,,Half life period after 3 mg/kg iv administration in rat,,N,10116.0,2864,50597,1,,,BAO_0000218,,
7544,Rattus norvegicus,CHEMBL618665,Intermediate,,Half life period after 3 mg/kg iv administration in the rat,,N,10116.0,2864,50597,1,,,BAO_0000218,,
7545,Rattus norvegicus,CHEMBL876498,Intermediate,,Half life period in female Sprague-Dawley rats,,N,10116.0,6362,50597,1,,,BAO_0000218,,
7546,Rattus norvegicus,CHEMBL618666,Intermediate,,Half life period in rat,,N,10116.0,6249,50597,1,,,BAO_0000218,,
7547,Rattus norvegicus,CHEMBL620440,Intermediate,,Half-life in rats was determined,,N,10116.0,3169,50597,1,,,BAO_0000218,,
7548,Rattus norvegicus,CHEMBL620441,Intermediate,,Half-life in rats with metabolic oxidation,,N,10116.0,3169,50597,1,,,BAO_0000218,,
7549,Rattus norvegicus,CHEMBL620442,Intermediate,,Half-life in rats,,N,10116.0,3169,50597,1,,,BAO_0000218,,
7550,Rattus norvegicus,CHEMBL620443,Intermediate,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,10116.0,17260,50597,1,,,BAO_0000218,,
7551,Rattus norvegicus,CHEMBL620444,Intermediate,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,10116.0,17260,50597,1,,,BAO_0000218,,
7552,Rattus norvegicus,CHEMBL620445,Intermediate,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,10116.0,17260,50597,1,,,BAO_0000218,,
7553,Rattus norvegicus,CHEMBL620446,Intermediate,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,10116.0,17260,50597,1,,,BAO_0000218,,
7554,Rattus norvegicus,CHEMBL620447,Intermediate,Plasma,Biological half-life measured in plasma of rat,,N,10116.0,2879,50597,1,,,BAO_0000218,1969.0,
7555,Rattus norvegicus,CHEMBL621129,Intermediate,Plasma,Biological half-life measured in plasma of rat; 22-25,,N,10116.0,2879,50597,1,,,BAO_0000218,1969.0,
7556,Rattus norvegicus,CHEMBL621130,Intermediate,Plasma,Biological half-life measured in plasma of rat; 9-16,,N,10116.0,2879,50597,1,,,BAO_0000218,1969.0,
7557,Rattus norvegicus,CHEMBL873808,Intermediate,,Compound was evaluated for its half life when administered intravenously in rat,,N,10116.0,3184,50597,1,,,BAO_0000218,,
7558,Rattus norvegicus,CHEMBL876598,Intermediate,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,N,10116.0,4891,50597,1,,,BAO_0000218,,
7559,Rattus norvegicus,CHEMBL621131,Intermediate,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,N,10116.0,429,50597,1,,,BAO_0000218,,
7560,Rattus norvegicus,CHEMBL621132,Intermediate,,Half life (T1/2) after oral administration in rat,,N,10116.0,5656,50597,1,,,BAO_0000218,,
7561,Rattus norvegicus,CHEMBL621133,Intermediate,,Half life of compound after iv administration of 20 mg/kg dose in rat,,N,10116.0,4413,50597,1,,,BAO_0000218,,
7562,Rattus norvegicus,CHEMBL621312,Expert,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,10116.0,3598,50597,1,,,BAO_0000218,,
7563,Rattus norvegicus,CHEMBL621313,Intermediate,,Half life of compound was determined in rat,,N,10116.0,17267,50597,1,,,BAO_0000218,,
7564,Rattus norvegicus,CHEMBL621314,Intermediate,Blood,Half life of compound was determined in rat blood,,N,10116.0,4727,50597,1,,,BAO_0000218,178.0,
7565,Rattus norvegicus,CHEMBL621315,Intermediate,,Half life at 1 mg/kg was determined in rat,,N,10116.0,17651,50597,1,,,BAO_0000218,,
7566,Rattus norvegicus,CHEMBL621316,Intermediate,,Half life at 10 mg/kg was determined in rat,,N,10116.0,17651,50597,1,,,BAO_0000218,,
7567,Rattus norvegicus,CHEMBL621317,Intermediate,,Half life in rats,,N,10116.0,401,50597,1,,,BAO_0000218,,
7568,Rattus norvegicus,CHEMBL621318,Intermediate,,Half life in rats in hours,,N,10116.0,4942,50597,1,,,BAO_0000218,,
7569,Rattus norvegicus,CHEMBL621319,Intermediate,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,N,10116.0,17735,50597,1,,,BAO_0000218,,
7570,Rattus norvegicus,CHEMBL621377,Intermediate,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,N,10116.0,6056,50597,1,,,BAO_0000218,,
7571,Rattus norvegicus,CHEMBL621378,Intermediate,,Half life was determined,,N,10116.0,5213,50597,1,,,BAO_0000218,,
7572,Rattus norvegicus,CHEMBL876599,Intermediate,,Half life after i.v. administration,,N,10116.0,6616,50597,1,,,BAO_0000218,,
7573,Rattus norvegicus,CHEMBL621379,Intermediate,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,N,10116.0,5937,50597,1,,,BAO_0000218,,
7574,Rattus norvegicus,CHEMBL621380,Intermediate,Plasma,Half life in rat plasma,,N,10116.0,5819,50597,1,,,BAO_0000218,1969.0,
7575,Rattus norvegicus,CHEMBL621381,Intermediate,Plasma,Half life in rat plasma; Not detected,,N,10116.0,5819,50597,1,,,BAO_0000218,1969.0,
7576,Rattus norvegicus,CHEMBL618515,Intermediate,,Half life in rats,,N,10116.0,6803,50597,1,,,BAO_0000218,,
7577,Rattus norvegicus,CHEMBL618516,Intermediate,,Half life period of compound was determined after peroral administration,,N,10116.0,17804,50597,1,,,BAO_0000218,,
7578,Rattus norvegicus,CHEMBL618517,Intermediate,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,N,10116.0,17804,50597,1,,,BAO_0000218,,
7579,Rattus norvegicus,CHEMBL618518,Intermediate,,Half life period in rat,,N,10116.0,5948,50597,1,,,BAO_0000218,,
7580,Rattus norvegicus,CHEMBL618519,Intermediate,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,N,10116.0,1916,50597,1,,,BAO_0000218,,
7581,Rattus norvegicus,CHEMBL618698,Intermediate,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,N,10116.0,1916,50597,1,,,BAO_0000218,,
7582,Rattus norvegicus,CHEMBL618862,Intermediate,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,N,10116.0,1916,50597,1,,,BAO_0000218,,
7583,Rattus norvegicus,CHEMBL618863,Intermediate,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,N,10116.0,4890,50597,1,,,BAO_0000218,,
7584,Rattus norvegicus,CHEMBL618864,Intermediate,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,N,10116.0,17764,50597,1,,,BAO_0000218,,
7585,Rattus norvegicus,CHEMBL618865,Intermediate,,Half life time in rat the dose of 2 mg/kg,,N,10116.0,4727,50597,1,,,BAO_0000218,,
7586,Rattus norvegicus,CHEMBL618866,Intermediate,,Half-life 24 hr after 10 mg/kg iv administration in rats,,N,10116.0,17509,50597,1,,,BAO_0000218,,
7587,Rattus norvegicus,CHEMBL618867,Intermediate,,Half-life 24 hr after 2 mg/kg iv administration in rats,,N,10116.0,17509,50597,1,,,BAO_0000218,,
7588,Rattus norvegicus,CHEMBL875828,Intermediate,,Half-life consistent with the observed metabolic steady state in rats,,N,10116.0,6597,50597,1,,,BAO_0000218,,
7589,Rattus norvegicus,CHEMBL618868,Intermediate,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,N,10116.0,17735,50597,1,,,BAO_0000218,,
7590,Rattus norvegicus,CHEMBL618869,Intermediate,,Half-life for oxidative metabolic stability was determined using male human,,N,10116.0,6597,50597,1,,,BAO_0000218,,
7591,Rattus norvegicus,CHEMBL618870,Intermediate,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,N,10116.0,17670,50597,1,,,BAO_0000218,,
7592,Rattus norvegicus,CHEMBL618871,Intermediate,Plasma,Half-life in rat plasma,,N,10116.0,1696,50597,1,,,BAO_0000218,1969.0,
7593,Rattus norvegicus,CHEMBL618872,Intermediate,Plasma,Half-life in rat plasma was determined,,N,10116.0,1742,50597,1,,,BAO_0000218,1969.0,
7594,Rattus norvegicus,CHEMBL873816,Intermediate,,Half-life in rats was determined,,N,10116.0,17800,50597,1,,,BAO_0000218,,
7595,,CHEMBL618873,Autocuration,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,U,,12923,22224,1,,,BAO_0000218,,
7596,,CHEMBL621602,Autocuration,,Area under curve after oral dose of 0.1 mg//kg,,U,,11954,22224,1,,,BAO_0000019,,
7597,,CHEMBL621603,Autocuration,,Area under curve after oral dose of 0.3 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
7598,,CHEMBL621604,Autocuration,,Area under curve after oral dose of 1 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
7599,,CHEMBL621605,Autocuration,,Area under curve after oral dose of 10 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
7600,,CHEMBL621606,Autocuration,,Area under curve after oral dose of 23.4 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
7601,,CHEMBL621607,Autocuration,,Area under curve after oral dose of 3 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
7602,,CHEMBL621608,Autocuration,,Area under curve after oral dose of 3.87 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
7603,,CHEMBL621609,Autocuration,,Area under curve was determined,,U,,5237,22224,1,,,BAO_0000019,,
7604,,CHEMBL621610,Autocuration,,Area under curve at a dose of 10 mg/kg,,U,,4026,22224,1,,,BAO_0000218,,
7605,Rattus norvegicus,CHEMBL621611,Intermediate,,Area under curve was determined; ND=No data,,N,10116.0,5237,50597,1,,,BAO_0000218,,
7606,Rattus norvegicus,CHEMBL621612,Intermediate,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,N,10116.0,14793,50597,1,,,BAO_0000218,,
7607,Rattus norvegicus,CHEMBL622308,Intermediate,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,N,10116.0,14793,50597,1,,,BAO_0000218,,
7608,Rattus norvegicus,CHEMBL622309,Intermediate,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,N,10116.0,14793,50597,1,,,BAO_0000218,,
7609,Rattus norvegicus,CHEMBL622310,Intermediate,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,N,10116.0,14793,50597,1,,,BAO_0000218,,
7610,Rattus norvegicus,CHEMBL622311,Intermediate,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,N,10116.0,14793,50597,1,,,BAO_0000218,,
7611,Rattus norvegicus,CHEMBL622312,Intermediate,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,N,10116.0,14793,50597,1,,,BAO_0000218,,
7612,Rattus norvegicus,CHEMBL622931,Intermediate,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,N,10116.0,14793,50597,1,,,BAO_0000218,,
7613,Rattus norvegicus,CHEMBL622932,Intermediate,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,N,10116.0,14793,50597,1,,,BAO_0000218,,
7614,Rattus norvegicus,CHEMBL622736,Intermediate,Plasma,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,N,10116.0,14793,50597,1,,,BAO_0000218,1969.0,
7615,Rattus norvegicus,CHEMBL622737,Intermediate,Plasma,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,N,10116.0,14793,50597,1,,,BAO_0000218,1969.0,
7616,Rattus norvegicus,CHEMBL622738,Intermediate,Plasma,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,N,10116.0,14793,50597,1,,,BAO_0000218,1969.0,
7617,Rattus norvegicus,CHEMBL622739,Intermediate,Plasma,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,N,10116.0,14793,50597,1,,,BAO_0000218,1969.0,
7618,Rattus norvegicus,CHEMBL622740,Intermediate,Plasma,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,N,10116.0,14793,50597,1,,,BAO_0000218,1969.0,
7619,Rattus norvegicus,CHEMBL622741,Intermediate,Plasma,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,N,10116.0,14793,50597,1,,,BAO_0000218,1969.0,
7620,Rattus norvegicus,CHEMBL622742,Intermediate,Plasma,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,N,10116.0,14793,50597,1,,,BAO_0000218,1969.0,
7621,Rattus norvegicus,CHEMBL622743,Intermediate,Plasma,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,N,10116.0,14793,50597,1,,,BAO_0000218,1969.0,
7622,Mus musculus,CHEMBL622744,Intermediate,Plasma,AUC in mice,,N,10090.0,11637,50594,1,,,BAO_0000218,1969.0,
7623,,CHEMBL624134,Autocuration,,Area under curve was measured from the graph obtained from concentration Vs time,,U,,11149,22224,1,,,BAO_0000019,,
7624,,CHEMBL624135,Autocuration,,Area under curve value of compound per hour after oral administration,,U,,10016,22224,1,,,BAO_0000019,,
7625,Rattus norvegicus,CHEMBL624136,Intermediate,,Area under curve was determined after oral administration in rats,,N,10116.0,17796,50597,1,,,BAO_0000218,,
7626,Rattus norvegicus,CHEMBL624137,Intermediate,,Area under curve was determined after oral administration in rats; No data,,N,10116.0,17796,50597,1,,,BAO_0000218,,
7627,Rattus norvegicus,CHEMBL624320,Intermediate,,Area under curve was determined after oral administration in rats;No data,,N,10116.0,17796,50597,1,,,BAO_0000218,,
7628,Canis lupus familiaris,CHEMBL624321,Intermediate,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,N,9615.0,12923,50588,1,,,BAO_0000218,,
7629,Rattus norvegicus,CHEMBL624322,Intermediate,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,,
7630,Rattus norvegicus,CHEMBL624323,Intermediate,,Area under curve was determined for the compound after iv dose of 5.06 in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,,
7631,Rattus norvegicus,CHEMBL624324,Intermediate,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,,
7632,Rattus norvegicus,CHEMBL624325,Intermediate,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,,
7633,Rattus norvegicus,CHEMBL624326,Intermediate,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,,
7634,Rattus norvegicus,CHEMBL624327,Intermediate,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,,
7635,Rattus norvegicus,CHEMBL624328,Intermediate,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,,
7636,Canis lupus familiaris,CHEMBL627848,Intermediate,,Area under curve was determined in Dogs after peroral administration,,N,9615.0,14169,50588,1,,,BAO_0000218,,
7637,Rattus norvegicus,CHEMBL627849,Intermediate,,Area under curve was determined in Rats after peroral administration,,N,10116.0,14169,50597,1,,,BAO_0000218,,
7638,Rattus norvegicus,CHEMBL627850,Intermediate,,Area under curve was determined in carotid blood of rat when administered intradermally,,N,10116.0,14258,50597,1,,,BAO_0000218,,
7639,Rattus norvegicus,CHEMBL627851,Intermediate,,Area under curve was determined in portal blood of rat when administered intradermally,,N,10116.0,14258,50597,1,,,BAO_0000218,,
7640,Mus musculus,CHEMBL627852,Intermediate,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,10090.0,15011,50594,1,,,BAO_0000218,,
7641,Mus musculus,CHEMBL627853,Intermediate,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,N,10090.0,15011,50594,1,,,BAO_0000218,,
7642,Mus musculus,CHEMBL627854,Intermediate,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,N,10090.0,15011,50594,1,,,BAO_0000218,,
7643,Mus musculus,CHEMBL627855,Intermediate,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,10090.0,15011,50594,1,,,BAO_0000218,,
7644,Mus musculus,CHEMBL627856,Intermediate,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,N,10090.0,15011,50594,1,,,BAO_0000218,,
7645,Mus musculus,CHEMBL875339,Intermediate,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,N,10090.0,15011,50594,1,,,BAO_0000218,,
7646,Mus musculus,CHEMBL627857,Intermediate,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,N,10090.0,15011,50594,1,,,BAO_0000218,,
7647,Rattus norvegicus,CHEMBL627858,Intermediate,Spleen,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2106.0,
7648,Rattus norvegicus,CHEMBL627859,Intermediate,Blood,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,178.0,
7649,Rattus norvegicus,CHEMBL627860,Intermediate,Brain,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,955.0,
7650,Rattus norvegicus,CHEMBL627019,Intermediate,Heart,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,948.0,
7651,Rattus norvegicus,CHEMBL627020,Intermediate,Liver,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2107.0,
7652,Rattus norvegicus,CHEMBL627021,Intermediate,Lung,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2048.0,
7653,Rattus norvegicus,CHEMBL627022,Intermediate,Muscle tissue,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2385.0,
7654,Rattus norvegicus,CHEMBL627023,Intermediate,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,,
7655,Rattus norvegicus,CHEMBL627024,Intermediate,Spleen,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2106.0,
7656,Rattus norvegicus,CHEMBL627025,Intermediate,Thyroid gland,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2046.0,
7657,Rattus norvegicus,CHEMBL627026,Intermediate,Kidney,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2113.0,
7658,Rattus norvegicus,CHEMBL627027,Intermediate,Blood,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,178.0,
7659,Rattus norvegicus,CHEMBL627028,Intermediate,Brain,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,955.0,
7660,Rattus norvegicus,CHEMBL627029,Intermediate,Heart,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,948.0,
7661,Rattus norvegicus,CHEMBL627030,Intermediate,Kidney,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2113.0,
7662,Rattus norvegicus,CHEMBL627031,Intermediate,Liver,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2107.0,
7663,Rattus norvegicus,CHEMBL627032,Intermediate,Lung,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2048.0,
7664,Rattus norvegicus,CHEMBL627033,Intermediate,Muscle tissue,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2385.0,
7665,Rattus norvegicus,CHEMBL627034,Intermediate,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,,
7666,Rattus norvegicus,CHEMBL627035,Intermediate,Spleen,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2106.0,
7667,Rattus norvegicus,CHEMBL627036,Intermediate,Thyroid gland,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2046.0,
7668,Rattus norvegicus,CHEMBL875340,Intermediate,Blood,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,178.0,
7669,Rattus norvegicus,CHEMBL627037,Intermediate,Heart,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,948.0,
7670,Rattus norvegicus,CHEMBL627038,Intermediate,Kidney,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2113.0,
7671,Rattus norvegicus,CHEMBL627039,Intermediate,Liver,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2107.0,
7672,Rattus norvegicus,CHEMBL627040,Intermediate,Muscle tissue,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2385.0,
7673,Rattus norvegicus,CHEMBL624663,Intermediate,Spleen,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2106.0,
7674,Rattus norvegicus,CHEMBL625963,Intermediate,Thyroid gland,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2046.0,
7675,Rattus norvegicus,CHEMBL876799,Intermediate,Brain,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,955.0,
7676,Rattus norvegicus,CHEMBL626133,Intermediate,Lung,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,2048.0,
7677,Rattus norvegicus,CHEMBL626134,Intermediate,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,N,10116.0,10130,50597,1,,,BAO_0000218,,
7678,Rattus norvegicus,CHEMBL626135,Intermediate,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,N,10116.0,6295,50597,1,,,BAO_0000218,,
7679,Rattus norvegicus,CHEMBL626136,Intermediate,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,N,10116.0,6296,50597,1,,,BAO_0000218,,
7680,Rattus norvegicus,CHEMBL626137,Intermediate,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,N,10116.0,6296,50597,1,,,BAO_0000218,,
7681,Rattus norvegicus,CHEMBL626138,Intermediate,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,N,10116.0,6295,50597,1,,,BAO_0000218,,
7682,Rattus norvegicus,CHEMBL626139,Intermediate,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,N,10116.0,6296,50597,1,,,BAO_0000218,,
7683,Rattus norvegicus,CHEMBL626140,Intermediate,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,10116.0,17260,50597,1,,,BAO_0000218,,
7684,Rattus norvegicus,CHEMBL626141,Intermediate,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,10116.0,17260,50597,1,,,BAO_0000218,,
7685,Rattus norvegicus,CHEMBL626142,Intermediate,,C24h in rat p.o. at 20 mg/kg concentration,,N,10116.0,17686,50597,1,,,BAO_0000218,,
7686,Rattus norvegicus,CHEMBL627930,Intermediate,Muscle tissue,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
7687,Rattus norvegicus,CHEMBL627931,Intermediate,Muscle tissue,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
7688,Rattus norvegicus,CHEMBL627932,Intermediate,Muscle tissue,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
7689,Rattus norvegicus,CHEMBL627933,Intermediate,Spleen,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2106.0,
7690,Rattus norvegicus,CHEMBL627934,Intermediate,Spleen,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,2106.0,
7691,Rattus norvegicus,CHEMBL627935,Intermediate,Spleen,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2106.0,
7692,Rattus norvegicus,CHEMBL627936,Intermediate,Blood,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7693,Rattus norvegicus,CHEMBL627937,Intermediate,Blood,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7694,Rattus norvegicus,CHEMBL627938,Intermediate,Blood,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7695,Rattus norvegicus,CHEMBL627939,Intermediate,Blood,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7696,Rattus norvegicus,CHEMBL627940,Intermediate,Blood,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7697,Rattus norvegicus,CHEMBL627941,Intermediate,Blood,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7698,Rattus norvegicus,CHEMBL876800,Intermediate,Blood,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7699,Rattus norvegicus,CHEMBL627942,Intermediate,Blood,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7700,Rattus norvegicus,CHEMBL627943,Intermediate,Blood,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7701,Rattus norvegicus,CHEMBL627944,Intermediate,Blood,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7702,Rattus norvegicus,CHEMBL627945,Intermediate,Blood,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7703,Rattus norvegicus,CHEMBL628584,Intermediate,Blood,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7704,Rattus norvegicus,CHEMBL628585,Intermediate,Blood,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7705,Rattus norvegicus,CHEMBL628586,Intermediate,Blood,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7706,Rattus norvegicus,CHEMBL628587,Intermediate,Blood,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7707,Rattus norvegicus,CHEMBL628588,Intermediate,Blood,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7708,Rattus norvegicus,CHEMBL628589,Intermediate,Blood,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7709,Rattus norvegicus,CHEMBL625304,Intermediate,Blood,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7710,Rattus norvegicus,CHEMBL625305,Intermediate,Blood,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7711,Rattus norvegicus,CHEMBL625306,Intermediate,Blood,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7712,Rattus norvegicus,CHEMBL625307,Intermediate,Blood,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7713,Rattus norvegicus,CHEMBL625308,Intermediate,Blood,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7714,Rattus norvegicus,CHEMBL627740,Intermediate,Blood,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7715,Rattus norvegicus,CHEMBL627741,Intermediate,Blood,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7716,Rattus norvegicus,CHEMBL627742,Intermediate,Blood,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7717,Rattus norvegicus,CHEMBL627743,Intermediate,Blood,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7718,Rattus norvegicus,CHEMBL627744,Intermediate,Blood,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,178.0,
7719,Rattus norvegicus,CHEMBL627745,Intermediate,Bone,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7720,Rattus norvegicus,CHEMBL627746,Intermediate,Bone,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7721,Rattus norvegicus,CHEMBL627747,Intermediate,Bone,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7722,Rattus norvegicus,CHEMBL876810,Intermediate,Bone,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7723,Rattus norvegicus,CHEMBL627748,Intermediate,Bone,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7724,Rattus norvegicus,CHEMBL627749,Intermediate,Bone,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7725,Rattus norvegicus,CHEMBL627750,Intermediate,Bone,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7726,Rattus norvegicus,CHEMBL618728,Intermediate,Bone,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7727,Rattus norvegicus,CHEMBL618729,Intermediate,Bone,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7728,Rattus norvegicus,CHEMBL618730,Intermediate,Bone,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7729,Rattus norvegicus,CHEMBL618731,Intermediate,Bone,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7730,Rattus norvegicus,CHEMBL618732,Intermediate,Bone,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7731,Rattus norvegicus,CHEMBL618733,Intermediate,Bone,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7732,Rattus norvegicus,CHEMBL618734,Intermediate,Bone,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7733,Rattus norvegicus,CHEMBL618735,Intermediate,Bone,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7734,Rattus norvegicus,CHEMBL876602,Intermediate,Bone,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7735,Rattus norvegicus,CHEMBL618736,Intermediate,Bone,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7736,Rattus norvegicus,CHEMBL618737,Intermediate,Bone,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7737,Rattus norvegicus,CHEMBL618738,Intermediate,Bone,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7738,Rattus norvegicus,CHEMBL618739,Intermediate,Bone,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7739,Rattus norvegicus,CHEMBL618740,Intermediate,Bone,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7740,Rattus norvegicus,CHEMBL618741,Intermediate,Bone,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7741,Rattus norvegicus,CHEMBL618742,Intermediate,Bone,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7742,Rattus norvegicus,CHEMBL618743,Intermediate,Bone,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,10000001.0,
7743,Rattus norvegicus,CHEMBL618744,Intermediate,Plasma,Half-life from rat plasma at a single oral dose of 25 mg/kg,,N,10116.0,17752,50597,1,,,BAO_0000218,1969.0,
7744,Rattus norvegicus,CHEMBL618745,Intermediate,,Half-life in male rat,,N,10116.0,5610,50597,1,,,BAO_0000218,,
7745,Rattus norvegicus,CHEMBL620479,Intermediate,,Half-life in rat after peroral administration at 10 mg/kg concentration,,N,10116.0,5939,50597,1,,,BAO_0000218,,
7746,Rattus norvegicus,CHEMBL620480,Intermediate,,Half-life in rat after peroral administration at 5 mg/kg concentration,,N,10116.0,5939,50597,1,,,BAO_0000218,,
7747,Rattus norvegicus,CHEMBL620481,Intermediate,,Half-life in rat at a dose of 3 mg/kg,,N,10116.0,17771,50597,1,,,BAO_0000218,,
7748,Rattus norvegicus,CHEMBL620482,Intermediate,,Half-life was evaluated in rats,,N,10116.0,1974,50597,1,,,BAO_0000218,,
7749,Rattus norvegicus,CHEMBL876603,Intermediate,,Half-life was measured in rat,,N,10116.0,4239,50597,1,,,BAO_0000218,,
7750,Rattus norvegicus,CHEMBL620483,Intermediate,,Half-life period for the compound was determined in rats at 50 mg/kg dose,,N,10116.0,6681,50597,1,,,BAO_0000218,,
7751,Rattus norvegicus,CHEMBL620484,Intermediate,,Half-life period in rats after intravenous administration at 5 mg/kg,,N,10116.0,17752,50597,1,,,BAO_0000218,,
7752,Rattus norvegicus,CHEMBL620485,Intermediate,,Half-life period in rat at 10 mg/kg,,N,10116.0,6046,50597,1,,,BAO_0000218,,
7753,Rattus norvegicus,CHEMBL620486,Intermediate,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,N,10116.0,6685,50597,1,,,BAO_0000218,,
7754,Rattus norvegicus,CHEMBL620487,Intermediate,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,N,10116.0,6685,50597,1,,,BAO_0000218,,
7755,Rattus norvegicus,CHEMBL620488,Intermediate,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,N,10116.0,6685,50597,1,,,BAO_0000218,,
7756,Rattus norvegicus,CHEMBL620489,Intermediate,,Half-life time in rat the dose of 2 mg/kg,,N,10116.0,4727,50597,1,,,BAO_0000218,,
7757,Rattus norvegicus,CHEMBL620490,Intermediate,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,N,10116.0,1088,50597,1,,,BAO_0000218,,
7758,Rattus norvegicus,CHEMBL620491,Intermediate,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,N,10116.0,5610,50597,1,,,BAO_0000218,,
7759,Rattus norvegicus,CHEMBL876604,Intermediate,Plasma,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,N,10116.0,3032,50597,1,,,BAO_0000218,1969.0,
7760,Rattus norvegicus,CHEMBL620492,Intermediate,,Oral half life was determined,,N,10116.0,5199,50597,1,,,BAO_0000218,,
7761,Rattus norvegicus,CHEMBL620493,Intermediate,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,N,10116.0,14941,50597,1,,,BAO_0000218,,
7762,Rattus norvegicus,CHEMBL620494,Intermediate,,Pharmacokinetic property (t1/2) in rat,,N,10116.0,4408,50597,1,,,BAO_0000218,,
7763,Rattus norvegicus,CHEMBL620495,Intermediate,Plasma,Plasma elimination half-life was determined,,N,10116.0,2552,50597,1,,,BAO_0000218,1969.0,
7764,Rattus norvegicus,CHEMBL620496,Intermediate,Plasma,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,N,10116.0,5199,50597,1,,,BAO_0000218,1969.0,
7765,Rattus norvegicus,CHEMBL620497,Intermediate,Plasma,Plasma half life was observed after intravenous administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,1969.0,
7766,Rattus norvegicus,CHEMBL620498,Intermediate,Plasma,Plasma half-life was determined,,N,10116.0,1465,50597,1,,,BAO_0000218,1969.0,
7767,Rattus norvegicus,CHEMBL620499,Intermediate,Plasma,Plasma half-life following oral administration in Fisher rats,,N,10116.0,1446,50597,1,,,BAO_0000218,1969.0,
7768,Rattus norvegicus,CHEMBL620500,Intermediate,Plasma,Plasma half-life in rat,,N,10116.0,6824,50597,1,,,BAO_0000218,1969.0,
7769,Rattus norvegicus,CHEMBL873809,Intermediate,Plasma,Plasmatic Half-life after intravenous administration to rat,,N,10116.0,17533,50597,1,,,BAO_0000218,1969.0,
7770,Rattus norvegicus,CHEMBL620501,Intermediate,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,N,10116.0,5979,50597,1,,,BAO_0000218,,
7771,Rattus norvegicus,CHEMBL620502,Intermediate,,Terminal half life after intravenous administration (1 mg/kg) in rat,,N,10116.0,4689,50597,1,,,BAO_0000218,,
7772,Rattus norvegicus,CHEMBL620503,Intermediate,,Terminal half life in Rat at a oral dose of 5 mg/kg,,N,10116.0,4689,50597,1,,,BAO_0000218,,
7773,Rattus norvegicus,CHEMBL620504,Intermediate,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,N,10116.0,2463,50597,1,,,BAO_0000218,,
7774,Rattus norvegicus,CHEMBL876605,Intermediate,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,N,10116.0,4883,50597,1,,,BAO_0000218,,
7775,Rattus norvegicus,CHEMBL620505,Intermediate,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,N,10116.0,4883,50597,1,,,BAO_0000218,,
7776,Rattus norvegicus,CHEMBL873811,Intermediate,Plasma,plasma half life was observed after intravenous administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,1969.0,
7777,Rattus norvegicus,CHEMBL624016,Expert,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,10116.0,3598,50597,1,,,BAO_0000218,,
7778,Rattus norvegicus,CHEMBL624017,Intermediate,,Half life of compound determined in rat,,N,10116.0,4576,50597,1,,,BAO_0000218,,
7779,Rattus norvegicus,CHEMBL624018,Intermediate,,Mean residence time determined in rat,,N,10116.0,4576,50597,1,,,BAO_0000218,,
7780,Rattus norvegicus,CHEMBL624019,Intermediate,,Plasma half life determined in rat,,N,10116.0,4576,50597,1,,,BAO_0000218,,
7781,Rattus norvegicus,CHEMBL624020,Intermediate,Brain,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,955.0,
7782,Rattus norvegicus,CHEMBL624201,Intermediate,,Compound was evaluated for pharmacokinetic parameter maximum time period,,N,10116.0,4891,50597,1,,,BAO_0000218,,
7783,Rattus norvegicus,CHEMBL872528,Intermediate,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,N,10116.0,429,50597,1,,,BAO_0000218,,
7784,Rattus norvegicus,CHEMBL624202,Intermediate,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
7785,Rattus norvegicus,CHEMBL624203,Intermediate,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
7786,Rattus norvegicus,CHEMBL624350,Intermediate,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
7787,Rattus norvegicus,CHEMBL621320,Intermediate,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
7788,Rattus norvegicus,CHEMBL621321,Intermediate,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,N,10116.0,17582,50597,1,,,BAO_0000218,,
7789,Rattus norvegicus,CHEMBL621322,Intermediate,,Maximum time (Tmax) required to reach Cmax in rats,,N,10116.0,4026,50597,1,,,BAO_0000218,,
7790,Rattus norvegicus,CHEMBL621323,Intermediate,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,N,10116.0,4890,50597,1,,,BAO_0000218,,
7791,Rattus norvegicus,CHEMBL621324,Intermediate,,Maximum time of clearance of compound in rats after peroral administration,,N,10116.0,6571,50597,1,,,BAO_0000218,,
7792,Rattus norvegicus,CHEMBL621325,Intermediate,,Maximum time at the dose of 2 mg/kg in rat,,N,10116.0,4727,50597,1,,,BAO_0000218,,
7793,Rattus norvegicus,CHEMBL875837,Intermediate,Plasma,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,N,10116.0,17651,50597,1,,,BAO_0000218,1969.0,
7794,Rattus norvegicus,CHEMBL621326,Intermediate,Plasma,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,N,10116.0,17651,50597,1,,,BAO_0000218,1969.0,
7795,Rattus norvegicus,CHEMBL621327,Intermediate,,Tmax in Guinea pig (PO dose),,N,10116.0,14465,50597,1,,,BAO_0000218,,
7796,Rattus norvegicus,CHEMBL621328,Intermediate,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,N,10116.0,14941,50597,1,,,BAO_0000218,,
7797,Rattus norvegicus,CHEMBL621329,Intermediate,,Pharmacokinetic parameter (Tmax) in rat,,N,10116.0,5960,50597,1,,,BAO_0000218,,
7798,Rattus norvegicus,CHEMBL621330,Intermediate,,Pharmacokinetic parameter (Tmax) was estimated,,N,10116.0,5022,50597,1,,,BAO_0000218,,
7799,Rattus norvegicus,CHEMBL621331,Intermediate,,Pharmacokinetic property (Tmax) in rat,,N,10116.0,4408,50597,1,,,BAO_0000218,,
7800,Rattus norvegicus,CHEMBL621332,Intermediate,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,N,10116.0,5983,50597,1,,,BAO_0000218,,
7801,Rattus norvegicus,CHEMBL621333,Intermediate,,T max in Rat at a oral dose of 5 mg/kg,,N,10116.0,4689,50597,1,,,BAO_0000218,,
7802,Rattus norvegicus,CHEMBL621334,Intermediate,,T max was determined at 10 mg/kg po dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
7803,Mus musculus,CHEMBL621335,Intermediate,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,N,10090.0,15011,50594,1,,,BAO_0000218,,
7804,Canis lupus familiaris,CHEMBL621336,Intermediate,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,N,9615.0,14180,50588,1,,,BAO_0000218,,
7805,Rattus norvegicus,CHEMBL621337,Intermediate,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,N,10116.0,14180,50597,1,,,BAO_0000218,,
7806,Canis lupus familiaris,CHEMBL621338,Intermediate,,Area under curve was measured after i.v. administration into Beagle dog.,,N,9615.0,14599,50588,1,,,BAO_0000218,,
7807,Canis lupus familiaris,CHEMBL875838,Intermediate,,Area under curve was measured after iv administration into Beagle dog,,N,9615.0,14599,50588,1,,,BAO_0000218,,
7808,Canis lupus familiaris,CHEMBL621339,Intermediate,,Area under curve was measured after po administration into Beagle dog,,N,9615.0,14599,50588,1,,,BAO_0000218,,
7809,Canis lupus familiaris,CHEMBL621340,Intermediate,,Area under curve was measured after po administration into Beagle dog.,,N,9615.0,14599,50588,1,,,BAO_0000218,,
7810,,CHEMBL621341,Autocuration,,Area under curve was measured at peroral dose of 3 mg/kg,,U,,15675,22224,1,,,BAO_0000218,,
7811,,CHEMBL621342,Autocuration,,Area under curve was measured by using concentration Vs time,,U,,12706,22224,1,,,BAO_0000019,,
7812,,CHEMBL621343,Autocuration,,Area under curve was measured by using concentration Vs time; not tested,,U,,12706,22224,1,,,BAO_0000019,,
7813,Mus musculus,CHEMBL621344,Intermediate,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,N,10090.0,9750,50594,1,,,BAO_0000218,,
7814,Mus musculus,CHEMBL621345,Intermediate,,Area under curve(AUC) was measured in mice after oral administration.,,N,10090.0,9750,50594,1,,,BAO_0000218,,
7815,,CHEMBL621346,Autocuration,,Area under curve(AUC) value of the compound,,U,,14691,22224,1,,,BAO_0000019,,
7816,,CHEMBL621347,Autocuration,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,U,,14691,22224,1,,,BAO_0000218,,
7817,Canis lupus familiaris,CHEMBL621348,Intermediate,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,N,9615.0,14691,50588,1,,,BAO_0000218,,
7818,,CHEMBL621349,Autocuration,Blood,Area under curve(carotid artery) was determined by the availability in blood,,U,,2939,22224,1,,,BAO_0000019,178.0,
7819,,CHEMBL621350,Autocuration,Blood,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,U,,2939,22224,1,,,BAO_0000019,178.0,
7820,,CHEMBL875839,Autocuration,Blood,Area under curve(carotid artery) was determined by the availability in blood; No data,,U,,2939,22224,1,,,BAO_0000019,178.0,
7821,,CHEMBL620211,Autocuration,Blood,Area under curve(portal vein) was determined by the availability in blood,,U,,2939,22224,1,,,BAO_0000019,178.0,
7822,,CHEMBL620212,Autocuration,Blood,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,U,,2939,22224,1,,,BAO_0000019,178.0,
7823,,CHEMBL620213,Autocuration,Blood,Area under curve(portal vein) was determined by the availability in blood; No data,,U,,2939,22224,1,,,BAO_0000019,178.0,
7824,Macaca mulatta,CHEMBL620214,Intermediate,Plasma,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,N,9544.0,9552,50797,1,,,BAO_0000218,1969.0,
7825,Macaca mulatta,CHEMBL620215,Intermediate,Plasma,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,N,9544.0,9552,50797,1,,,BAO_0000218,1969.0,
7826,Macaca mulatta,CHEMBL620216,Intermediate,Plasma,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,N,9544.0,9552,50797,1,,,BAO_0000218,1969.0,
7827,Canis lupus familiaris,CHEMBL620888,Intermediate,Plasma,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,N,9615.0,9552,50588,1,,,BAO_0000218,1969.0,
7828,Canis lupus familiaris,CHEMBL620889,Intermediate,Plasma,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,N,9615.0,9552,50588,1,,,BAO_0000218,1969.0,
7829,,CHEMBL620890,Autocuration,Plasma,Area under plasma concentration vs time curve observed in rats for 0-3 h,,U,,9552,22224,1,,,BAO_0000019,1969.0,
7830,Rattus norvegicus,CHEMBL620891,Intermediate,Plasma,Area under plasma time curve determined in male rat,,N,10116.0,11911,50597,1,,,BAO_0000218,1969.0,
7831,,CHEMBL620892,Autocuration,,Area under the MAP curve measured over 5 min.,,U,,16618,22224,1,,,BAO_0000019,,
7832,Mus musculus,CHEMBL621079,Intermediate,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,N,10090.0,14387,50594,1,,,BAO_0000218,,
7833,Mus musculus,CHEMBL621080,Intermediate,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,N,10090.0,14387,50594,1,,,BAO_0000218,,
7834,Canis lupus familiaris,CHEMBL621081,Intermediate,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,N,9615.0,12836,50588,1,,,BAO_0000218,,
7835,Cricetinae,CHEMBL621082,Intermediate,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,N,10026.0,12836,100712,1,,,BAO_0000218,,
7836,Rattus norvegicus,CHEMBL621083,Intermediate,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,N,10116.0,12836,50597,1,,,BAO_0000218,,
7837,Canis lupus familiaris,CHEMBL621084,Intermediate,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,N,9615.0,14339,50588,1,,,BAO_0000218,,
7838,Canis lupus familiaris,CHEMBL621085,Intermediate,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,N,9615.0,14339,50588,1,,,BAO_0000218,,
7839,Canis lupus familiaris,CHEMBL621086,Intermediate,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,N,9615.0,14339,50588,1,,,BAO_0000218,,
7840,Canis lupus familiaris,CHEMBL621087,Intermediate,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,N,9615.0,10524,50588,1,,,BAO_0000218,,
7841,Canis lupus familiaris,CHEMBL622607,Intermediate,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,N,9615.0,9994,50588,1,,,BAO_0000218,,
7842,Canis lupus familiaris,CHEMBL622608,Intermediate,,Serum AUC in marmosets (IV dose),,N,9615.0,11325,50588,1,,,BAO_0000218,,
7843,,CHEMBL624481,Autocuration,,Area under the curve after intravenous administration at a dose of 10 umol/kg,,U,,12536,22224,1,,,BAO_0000019,,
7844,,CHEMBL624482,Autocuration,,Area under the curve after intravenous administration at a dose of 2 umol/kg,,U,,12536,22224,1,,,BAO_0000019,,
7845,,CHEMBL624483,Autocuration,,Area under the curve after intravenous administration at a dose of 4 umol/kg,,U,,12536,22224,1,,,BAO_0000019,,
7846,,CHEMBL624484,Autocuration,,Area under the curve after intravenous administration at a dose of 40 umol/kg,,U,,12536,22224,1,,,BAO_0000019,,
7847,,CHEMBL624485,Autocuration,,Area under the curve after intravenous administration at a dose of 5 umol/kg,,U,,12536,22224,1,,,BAO_0000019,,
7848,Rattus norvegicus,CHEMBL624486,Intermediate,,Area under the curve for fumarate salt was evaluated in F344 Rats.,,N,10116.0,15556,50597,1,,,BAO_0000218,,
7849,,CHEMBL624487,Autocuration,,Area under the curve for the compound was calculated.,,U,,2809,22224,1,,,BAO_0000019,,
7850,,CHEMBL624488,Autocuration,,Area under the curve in concentration/ time,,U,,9511,22224,1,,,BAO_0000019,,
7851,Rattus norvegicus,CHEMBL624489,Intermediate,,Area under the curve administered intraintestinal in rats.,,N,10116.0,12818,50597,1,,,BAO_0000218,,
7852,Rattus norvegicus,CHEMBL625184,Intermediate,,Area under the curve administered intravenously in rats.,,N,10116.0,12818,50597,1,,,BAO_0000218,,
7853,,CHEMBL625185,Autocuration,,Area under the curve during intravenous administration,,U,,15118,22224,1,,,BAO_0000019,,
7854,,CHEMBL875954,Autocuration,,Area under the curve during intravenous administration; Not determined,,U,,15118,22224,1,,,BAO_0000019,,
7855,,CHEMBL625186,Autocuration,,Area under the curve during systemic administration,,U,,15118,22224,1,,,BAO_0000019,,
7856,,CHEMBL625187,Autocuration,,Area under the curve during systemic administration; Not determined,,U,,15118,22224,1,,,BAO_0000019,,
7857,,CHEMBL625188,Autocuration,,Area under the curve was calculated for the compound.,,U,,2632,22224,1,,,BAO_0000019,,
7858,Canis lupus familiaris,CHEMBL625189,Intermediate,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,N,9615.0,14346,50588,1,,,BAO_0000218,,
7859,Canis lupus familiaris,CHEMBL625190,Intermediate,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,N,9615.0,14346,50588,1,,,BAO_0000218,,
7860,Rattus norvegicus,CHEMBL621733,Intermediate,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,,
7861,Rattus norvegicus,CHEMBL621734,Intermediate,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,,
7862,Rattus norvegicus,CHEMBL621735,Intermediate,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,N,10116.0,11149,50597,1,,,BAO_0000218,,
7863,Rattus norvegicus,CHEMBL621736,Intermediate,Plasma,Clearance of the drug was measured in the plasma of rat; No data,,N,10116.0,17796,50597,1,,,BAO_0000218,1969.0,
7864,Rattus norvegicus,CHEMBL621737,Intermediate,Plasma,The pharmacokinetic parameter plasma clearance in vivo in rats,,N,10116.0,5247,50597,1,,,BAO_0000218,1969.0,
7865,Rattus norvegicus,CHEMBL621738,Intermediate,,Plasma clearance at the dose of 2 mg/kg in rat,,N,10116.0,4727,50597,1,,,BAO_0000218,,
7866,Rattus norvegicus,CHEMBL622806,Intermediate,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,N,10116.0,5654,50597,1,,,BAO_0000218,,
7867,Rattus norvegicus,CHEMBL623519,Intermediate,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,N,10116.0,5654,50597,1,,,BAO_0000218,,
7868,Rattus norvegicus,CHEMBL623520,Intermediate,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,10116.0,17260,50597,1,,,BAO_0000218,,
7869,Rattus norvegicus,CHEMBL623521,Intermediate,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,10116.0,17065,50597,1,,,BAO_0000218,,
7870,Rattus norvegicus,CHEMBL623522,Intermediate,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,10116.0,17671,50597,1,,,BAO_0000218,,
7871,Rattus norvegicus,CHEMBL623523,Intermediate,,Clearance rate in rat,,N,10116.0,6672,50597,1,,,BAO_0000218,,
7872,Rattus norvegicus,CHEMBL623690,Intermediate,,Clearance rate in rat,,N,10116.0,6673,50597,1,,,BAO_0000218,,
7873,Rattus norvegicus,CHEMBL623691,Intermediate,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
7874,Rattus norvegicus,CHEMBL623692,Intermediate,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
7875,Rattus norvegicus,CHEMBL623693,Intermediate,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
7876,Rattus norvegicus,CHEMBL623694,Intermediate,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
7877,Rattus norvegicus,CHEMBL623695,Intermediate,,Clearance of compound after iv administration of 20 mg/kg dose in rat,,N,10116.0,4413,50597,1,,,BAO_0000218,,
7878,Rattus norvegicus,CHEMBL623696,Intermediate,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
7879,Rattus norvegicus,CHEMBL623697,Intermediate,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
7880,Macaca mulatta,CHEMBL623698,Intermediate,Plasma,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,U,9544.0,5005,22224,1,,,BAO_0000218,1969.0,
7881,Rattus norvegicus,CHEMBL623699,Intermediate,Plasma,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,U,10116.0,5005,22224,1,,,BAO_0000218,1969.0,
7882,Rattus norvegicus,CHEMBL623700,Intermediate,,Mean (%CV) PK parameters for CL(mL/min/kg).,,N,10116.0,15765,50597,1,,,BAO_0000218,,
7883,Rattus norvegicus,CHEMBL623701,Intermediate,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,N,10116.0,3747,50597,1,,,BAO_0000218,,
7884,Rattus norvegicus,CHEMBL623702,Intermediate,Plasma,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,N,10116.0,16366,50597,1,,,BAO_0000218,1969.0,
7885,Rattus norvegicus,CHEMBL623703,Intermediate,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,N,10116.0,4199,50597,1,,,BAO_0000218,,
7886,Rattus norvegicus,CHEMBL623704,Intermediate,,Plasma clearance in rat was determined,,N,10116.0,17267,50597,1,,,BAO_0000218,,
7887,Rattus norvegicus,CHEMBL623705,Intermediate,,Plasma clearance in rat after administration of 2 mg/kg iv,,N,10116.0,6535,50597,1,,,BAO_0000218,,
7888,Rattus norvegicus,CHEMBL623706,Intermediate,,Plasma clearance in rat after administration of 2 mg/kg iv,,N,10116.0,6535,50597,1,,,BAO_0000218,,
7889,Rattus norvegicus,CHEMBL623707,Intermediate,,Plasma clearance was determined,,N,10116.0,5041,50597,1,,,BAO_0000218,,
7890,Rattus norvegicus,CHEMBL623708,Intermediate,,Plasma clearance in rat,,N,10116.0,5960,50597,1,,,BAO_0000218,,
7891,Rattus norvegicus,CHEMBL623709,Intermediate,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,N,10116.0,5937,50597,1,,,BAO_0000218,,
7892,Rattus norvegicus,CHEMBL623710,Intermediate,,Plasma clearance in rat by iv administration,,N,10116.0,5871,50597,1,,,BAO_0000218,,
7893,Rattus norvegicus,CHEMBL623711,Intermediate,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,N,10116.0,5874,50597,1,,,BAO_0000218,,
7894,Rattus norvegicus,CHEMBL623712,Intermediate,,Plasma clearance in rat p.o.,,N,10116.0,6504,50597,1,,,BAO_0000218,,
7895,Rattus norvegicus,CHEMBL623713,Intermediate,,Plasma clearance in rats,,N,10116.0,6803,50597,1,,,BAO_0000218,,
7896,Rattus norvegicus,CHEMBL623714,Intermediate,,Plasma clearance was determined; ND denotes no data,,N,10116.0,5041,50597,1,,,BAO_0000218,,
7897,Rattus norvegicus,CHEMBL623715,Intermediate,,Plasma clearance was determined; ND denotes not determined,,N,10116.0,5041,50597,1,,,BAO_0000218,,
7898,Rattus norvegicus,CHEMBL623716,Intermediate,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,N,10116.0,1916,50597,1,,,BAO_0000218,,
7899,Rattus norvegicus,CHEMBL622980,Intermediate,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,N,10116.0,5199,50597,1,,,BAO_0000218,,
7900,Rattus norvegicus,CHEMBL622981,Intermediate,,Plasma administration to rats,,N,10116.0,16367,50597,1,,,BAO_0000218,,
7901,Rattus norvegicus,CHEMBL622982,Intermediate,,Plasma clearance of the compound in female Sprague-Dawley rats,,N,10116.0,6362,50597,1,,,BAO_0000218,,
7902,Rattus norvegicus,CHEMBL622983,Intermediate,,Plasma clearance was observed after intravenous administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,,
7903,Rattus norvegicus,CHEMBL622984,Intermediate,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,N,10116.0,6215,50597,1,,,BAO_0000218,,
7904,Rattus norvegicus,CHEMBL622985,Intermediate,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,N,10116.0,1466,50597,1,,,BAO_0000218,,
7905,Rattus norvegicus,CHEMBL623631,Intermediate,Plasma,plasma clearance was observed after intravenous administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,1969.0,
7906,Rattus norvegicus,CHEMBL623632,Intermediate,,In vivo CL/F determined,,N,10116.0,4723,50597,1,,,BAO_0000218,,
7907,Rattus norvegicus,CHEMBL623633,Intermediate,Plasma,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,1969.0,
7908,Rattus norvegicus,CHEMBL623634,Intermediate,Plasma,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,1969.0,
7909,Rattus norvegicus,CHEMBL623635,Intermediate,,Compound was tested for the lower blood clearance in rat,,N,10116.0,5213,50597,1,,,BAO_0000218,,
7910,Rattus norvegicus,CHEMBL621195,Intermediate,,Evaluated for the low clearance in rat (in vivo),,N,10116.0,4687,50597,1,,,BAO_0000218,,
7911,Rattus norvegicus,CHEMBL621196,Intermediate,,Pharmacokinetic property (CLb)of the compound was determined in rat,,N,10116.0,3371,50597,1,,,BAO_0000218,,
7912,Rattus norvegicus,CHEMBL875287,Intermediate,,Rapid clearance after intravenous administration in rat was determined,,N,10116.0,4690,50597,1,,,BAO_0000218,,
7913,Rattus norvegicus,CHEMBL621197,Intermediate,,Clearance measured in rat,,N,10116.0,5702,50597,1,,,BAO_0000218,,
7914,Rattus norvegicus,CHEMBL621198,Intermediate,Plasma,Compound was evaluated for plasma clearance in rat,,N,10116.0,740,50597,1,,,BAO_0000218,1969.0,
7915,Rattus norvegicus,CHEMBL621199,Intermediate,Plasma,Low plasma clearance was calculated in rat,,N,10116.0,4853,50597,1,,,BAO_0000218,1969.0,
7916,Rattus norvegicus,CHEMBL621200,Intermediate,,Pharmacokinetic property (Clp) in rat,,N,10116.0,5789,50597,1,,,BAO_0000218,,
7917,Rattus norvegicus,CHEMBL621201,Intermediate,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,N,10116.0,4527,50597,1,,,BAO_0000218,,
7918,Rattus norvegicus,CHEMBL621202,Intermediate,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,N,10116.0,4527,50597,1,,,BAO_0000218,,
7919,Rattus norvegicus,CHEMBL621203,Intermediate,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,N,10116.0,6518,50597,1,,,BAO_0000218,,
7920,Rattus norvegicus,CHEMBL621204,Intermediate,,Plasma clearance after IV dosing at 1 mg/kg in rat,,N,10116.0,6518,50597,1,,,BAO_0000218,,
7921,Rattus norvegicus,CHEMBL621205,Intermediate,Heart,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7922,Rattus norvegicus,CHEMBL621206,Intermediate,Heart,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7923,Rattus norvegicus,CHEMBL621207,Intermediate,Heart,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7924,Rattus norvegicus,CHEMBL621208,Intermediate,Heart,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7925,Rattus norvegicus,CHEMBL621209,Intermediate,Heart,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7926,Rattus norvegicus,CHEMBL876484,Intermediate,Heart,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7927,Rattus norvegicus,CHEMBL621210,Intermediate,Heart,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7928,Rattus norvegicus,CHEMBL621211,Intermediate,Heart,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7929,Rattus norvegicus,CHEMBL621212,Intermediate,Heart,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7930,Rattus norvegicus,CHEMBL621213,Intermediate,Heart,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7931,Rattus norvegicus,CHEMBL621214,Intermediate,Heart,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7932,Rattus norvegicus,CHEMBL621215,Intermediate,Heart,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7933,Rattus norvegicus,CHEMBL621216,Intermediate,Heart,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7934,Rattus norvegicus,CHEMBL621217,Intermediate,Heart,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7935,Rattus norvegicus,CHEMBL621218,Intermediate,Heart,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7936,Rattus norvegicus,CHEMBL621219,Intermediate,Heart,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7937,Rattus norvegicus,CHEMBL621220,Intermediate,Heart,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7938,Rattus norvegicus,CHEMBL621221,Intermediate,Heart,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7939,Rattus norvegicus,CHEMBL621222,Intermediate,Heart,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7940,Rattus norvegicus,CHEMBL621223,Intermediate,Heart,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7941,Rattus norvegicus,CHEMBL876485,Intermediate,Heart,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7942,Rattus norvegicus,CHEMBL621224,Intermediate,Heart,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7943,Rattus norvegicus,CHEMBL621225,Intermediate,Heart,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7944,Rattus norvegicus,CHEMBL621226,Intermediate,Heart,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,948.0,
7945,Rattus norvegicus,CHEMBL621227,Intermediate,Kidney,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7946,Rattus norvegicus,CHEMBL621228,Intermediate,Kidney,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7947,Rattus norvegicus,CHEMBL621229,Intermediate,Kidney,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7948,Rattus norvegicus,CHEMBL621230,Intermediate,Kidney,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7949,Rattus norvegicus,CHEMBL621231,Intermediate,Kidney,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7950,Rattus norvegicus,CHEMBL621232,Intermediate,Kidney,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7951,Rattus norvegicus,CHEMBL621233,Intermediate,Kidney,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7952,Rattus norvegicus,CHEMBL621234,Intermediate,Kidney,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7953,Rattus norvegicus,CHEMBL621235,Intermediate,Kidney,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7954,Rattus norvegicus,CHEMBL621236,Intermediate,Kidney,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7955,Rattus norvegicus,CHEMBL621237,Intermediate,Kidney,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7956,Rattus norvegicus,CHEMBL876486,Intermediate,Kidney,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,2113.0,
7957,Rattus norvegicus,CHEMBL622436,Intermediate,Intestine,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,160.0,
7958,Rattus norvegicus,CHEMBL622437,Intermediate,Intestine,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,160.0,
7959,Rattus norvegicus,CHEMBL622438,Intermediate,Intestine,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,160.0,
7960,Rattus norvegicus,CHEMBL622439,Intermediate,Liver,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7961,Rattus norvegicus,CHEMBL622440,Intermediate,Liver,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7962,Rattus norvegicus,CHEMBL622441,Intermediate,Liver,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7963,Rattus norvegicus,CHEMBL622442,Intermediate,Liver,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7964,Rattus norvegicus,CHEMBL622443,Intermediate,Liver,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7965,Rattus norvegicus,CHEMBL622444,Intermediate,Liver,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7966,Rattus norvegicus,CHEMBL622445,Intermediate,Liver,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7967,Rattus norvegicus,CHEMBL622446,Intermediate,Liver,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7968,Rattus norvegicus,CHEMBL622447,Intermediate,Liver,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7969,Rattus norvegicus,CHEMBL622448,Intermediate,Liver,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7970,Rattus norvegicus,CHEMBL622449,Intermediate,Liver,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7971,Rattus norvegicus,CHEMBL622450,Intermediate,Liver,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7972,Rattus norvegicus,CHEMBL622451,Intermediate,Liver,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7973,Rattus norvegicus,CHEMBL622452,Intermediate,Liver,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7974,Rattus norvegicus,CHEMBL622453,Intermediate,Liver,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7975,Rattus norvegicus,CHEMBL622454,Intermediate,Liver,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7976,Rattus norvegicus,CHEMBL622455,Intermediate,Liver,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7977,Rattus norvegicus,CHEMBL876024,Intermediate,Liver,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
7978,Rattus norvegicus,CHEMBL622456,Intermediate,,T max was determined at 3 mg/kg po dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
7979,Rattus norvegicus,CHEMBL622457,Intermediate,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
7980,Rattus norvegicus,CHEMBL622458,Intermediate,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
7981,Rattus norvegicus,CHEMBL622459,Intermediate,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,N,10116.0,15022,50597,1,,,BAO_0000218,,
7982,Rattus norvegicus,CHEMBL873343,Intermediate,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,N,10116.0,15022,50597,1,,,BAO_0000218,,
7983,Rattus norvegicus,CHEMBL622460,Intermediate,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,N,10116.0,15022,50597,1,,,BAO_0000218,,
7984,Rattus norvegicus,CHEMBL622461,Intermediate,Plasma,Time for maximum plasma concentration determined in rat,,N,10116.0,4576,50597,1,,,BAO_0000218,1969.0,
7985,Rattus norvegicus,CHEMBL622462,Intermediate,Plasma,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,N,10116.0,6681,50597,1,,,BAO_0000218,1969.0,
7986,Rattus norvegicus,CHEMBL622463,Intermediate,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,N,10116.0,16365,50597,1,,,BAO_0000218,,
7987,Rattus norvegicus,CHEMBL622464,Intermediate,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,N,10116.0,16365,50597,1,,,BAO_0000218,,
7988,Rattus norvegicus,CHEMBL622465,Intermediate,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,N,10116.0,16365,50597,1,,,BAO_0000218,,
7989,Rattus norvegicus,CHEMBL622466,Intermediate,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,N,10116.0,16365,50597,1,,,BAO_0000218,,
7990,Rattus norvegicus,CHEMBL622467,Intermediate,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,N,10116.0,16365,50597,1,,,BAO_0000218,,
7991,Rattus norvegicus,CHEMBL622468,Intermediate,Plasma,Time of maximum plasma concentration in rat,,N,10116.0,6824,50597,1,,,BAO_0000218,1969.0,
7992,Rattus norvegicus,CHEMBL876025,Intermediate,Plasma,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,N,10116.0,6685,50597,1,,,BAO_0000218,1969.0,
7993,Rattus norvegicus,CHEMBL622469,Intermediate,Plasma,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,N,10116.0,6685,50597,1,,,BAO_0000218,1969.0,
7994,Rattus norvegicus,CHEMBL622470,Intermediate,Plasma,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,N,10116.0,6685,50597,1,,,BAO_0000218,1969.0,
7995,Rattus norvegicus,CHEMBL622471,Intermediate,,Time required to reach maximum concentration (Cmax) after oral administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,,
7996,Rattus norvegicus,CHEMBL622472,Intermediate,Plasma,Time required to reach maximum concentration in rat plasma,,N,10116.0,1742,50597,1,,,BAO_0000218,1969.0,
7997,Rattus norvegicus,CHEMBL622473,Intermediate,Plasma,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,N,10116.0,2774,50597,1,,,BAO_0000218,1969.0,
7998,Rattus norvegicus,CHEMBL624282,Intermediate,Plasma,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,N,10116.0,5199,50597,1,,,BAO_0000218,1969.0,
7999,Rattus norvegicus,CHEMBL624283,Intermediate,Plasma,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,N,10116.0,12873,50597,1,,,BAO_0000218,1969.0,
8000,Rattus norvegicus,CHEMBL624284,Intermediate,Plasma,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,N,10116.0,12873,50597,1,,,BAO_0000218,1969.0,
8001,Rattus norvegicus,CHEMBL624285,Intermediate,Plasma,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,N,10116.0,1916,50597,1,,,BAO_0000218,1969.0,
8002,Rattus norvegicus,CHEMBL624286,Intermediate,,Time to reach Cmax after oral administration to rats,,N,10116.0,16367,50597,1,,,BAO_0000218,,
8003,Rattus norvegicus,CHEMBL624287,Intermediate,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,N,10116.0,16366,50597,1,,,BAO_0000218,,
8004,Rattus norvegicus,CHEMBL624288,Intermediate,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,N,10116.0,216,50597,1,,,BAO_0000218,,
8005,Rattus norvegicus,CHEMBL624289,Intermediate,Plasma,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,N,10116.0,6410,50597,1,,,BAO_0000218,1969.0,
8006,Rattus norvegicus,CHEMBL873344,Intermediate,Plasma,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,N,10116.0,6410,50597,1,,,BAO_0000218,1969.0,
8007,Rattus norvegicus,CHEMBL619623,Intermediate,,Tmax after peroral administration (10 mg/kg) was determined in rat,,N,10116.0,6215,50597,1,,,BAO_0000218,,
8008,Rattus norvegicus,CHEMBL621399,Expert,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,10116.0,3598,50597,1,,,BAO_0000218,,
8009,Rattus norvegicus,CHEMBL621400,Intermediate,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,N,10116.0,4527,50597,1,,,BAO_0000218,,
8010,Rattus norvegicus,CHEMBL621401,Intermediate,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,N,10116.0,17670,50597,1,,,BAO_0000218,,
8011,Rattus norvegicus,CHEMBL621402,Intermediate,,Tmax was determined,,N,10116.0,1465,50597,1,,,BAO_0000218,,
8012,Rattus norvegicus,CHEMBL621403,Intermediate,,Tmax was determined,,N,10116.0,2552,50597,1,,,BAO_0000218,,
8013,Rattus norvegicus,CHEMBL621121,Intermediate,,Tmax after oral administration in rat,,N,10116.0,5656,50597,1,,,BAO_0000218,,
8014,Rattus norvegicus,CHEMBL872525,Intermediate,,Tmax after peroral administration in rats at 2.4 uM/kg,,N,10116.0,17764,50597,1,,,BAO_0000218,,
8015,Rattus norvegicus,CHEMBL621122,Intermediate,,Tmax in male rat,,N,10116.0,5610,50597,1,,,BAO_0000218,,
8016,Rattus norvegicus,CHEMBL621123,Intermediate,,Tmax in rat at 10 mg/kg,,N,10116.0,6046,50597,1,,,BAO_0000218,,
8017,Rattus norvegicus,CHEMBL621124,Intermediate,,Tmax in rat by po administration at a dose of 40 mg/kg,,N,10116.0,5874,50597,1,,,BAO_0000218,,
8018,Rattus norvegicus,CHEMBL621125,Intermediate,,Tmax in rats,,N,10116.0,17596,50597,1,,,BAO_0000218,,
8019,Rattus norvegicus,CHEMBL621126,Intermediate,,Tmax was measured in rats after peroral administration at 5 mg/kg,,N,10116.0,17804,50597,1,,,BAO_0000218,,
8020,Rattus norvegicus,CHEMBL621127,Intermediate,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,N,10116.0,1908,50597,1,,,BAO_0000218,,
8021,Rattus norvegicus,CHEMBL621128,Intermediate,,Tmax value after administration of 20 mg/Kg oral dose in rat,,N,10116.0,2959,50597,1,,,BAO_0000218,,
8022,Rattus norvegicus,CHEMBL618263,Intermediate,,Tmax value at a dose of 10 mg/kg in male SD rats,,N,10116.0,6757,50597,1,,,BAO_0000218,,
8023,Rattus norvegicus,CHEMBL618264,Intermediate,,Tmax value at a dose of 100 mg/kg in male SD rats,,N,10116.0,6757,50597,1,,,BAO_0000218,,
8024,Rattus norvegicus,CHEMBL618265,Intermediate,,Tmax value at a dose of 50 mg/kg in male SD rats,,N,10116.0,6757,50597,1,,,BAO_0000218,,
8025,Rattus norvegicus,CHEMBL618266,Intermediate,Plasma,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,N,10116.0,4186,50597,1,,,BAO_0000218,1969.0,
8026,Rattus norvegicus,CHEMBL618267,Intermediate,,time required to reach maximum concentration (Cmax) after oral administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,,
8027,Rattus norvegicus,CHEMBL618450,Intermediate,Urine,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,N,10116.0,429,50597,1,,,BAO_0000218,1088.0,
8028,Rattus norvegicus,CHEMBL618451,Intermediate,Urine,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,N,10116.0,429,50597,1,,,BAO_0000218,1088.0,
8029,Rattus norvegicus,CHEMBL618452,Intermediate,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,N,10116.0,5546,50597,1,,,BAO_0000218,,
8030,Rattus norvegicus,CHEMBL618453,Intermediate,Urine,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,N,10116.0,3173,50597,1,,,BAO_0000218,1088.0,
8031,Rattus norvegicus,CHEMBL618454,Intermediate,Urine,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,N,10116.0,3173,50597,1,,,BAO_0000218,1088.0,
8032,Rattus norvegicus,CHEMBL618455,Intermediate,Urine,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,N,10116.0,3173,50597,1,,,BAO_0000218,1088.0,
8033,Rattus norvegicus,CHEMBL618456,Intermediate,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,N,10116.0,4257,50597,1,,,BAO_0000218,,
8034,Rattus norvegicus,CHEMBL618457,Intermediate,,Compound distribution in rat tissues was determined,,N,10116.0,6011,50597,1,,,BAO_0000218,,
8035,Rattus norvegicus,CHEMBL618458,Intermediate,,Volume of distribution was evaluated in rat,,N,10116.0,5472,50597,1,,,BAO_0000218,,
8036,Rattus norvegicus,CHEMBL618459,Intermediate,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,,
8037,Rattus norvegicus,CHEMBL876733,Intermediate,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,,
8038,Canis lupus familiaris,CHEMBL618460,Intermediate,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,N,9615.0,14346,50588,1,,,BAO_0000218,,
8039,Rattus norvegicus,CHEMBL618461,Intermediate,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,,
8040,,CHEMBL618462,Autocuration,,Area under the curve was determined after oral administration (300 uM/Kg),,U,,15469,22224,1,,,BAO_0000019,,
8041,Rattus norvegicus,CHEMBL618463,Intermediate,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,,
8042,Rattus norvegicus,CHEMBL618464,Intermediate,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,,
8043,Rattus norvegicus,CHEMBL618465,Intermediate,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,,
8044,Rattus norvegicus,CHEMBL618466,Intermediate,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,,
8045,Rattus norvegicus,CHEMBL618467,Intermediate,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,,
8046,Rattus norvegicus,CHEMBL618468,Intermediate,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,,
8047,Canis lupus familiaris,CHEMBL618469,Intermediate,Plasma,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,N,9615.0,12935,50588,1,,,BAO_0000218,1969.0,
8048,Canis lupus familiaris,CHEMBL618470,Intermediate,Plasma,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,N,9615.0,12935,50588,1,,,BAO_0000218,1969.0,
8049,,CHEMBL618471,Autocuration,,Plasma drug AUC in rat (PO dose),,U,,14813,22224,1,,,BAO_0000218,,
8050,Mus musculus,CHEMBL618472,Intermediate,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,N,10090.0,15792,50594,1,,,BAO_0000218,,
8051,,CHEMBL618473,Autocuration,,Area under was determined at a dose of 30 mg/kg,,U,,3579,22224,1,,,BAO_0000218,,
8052,Mustela putorius furo,CHEMBL621699,Intermediate,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,N,9669.0,12487,50506,1,,,BAO_0000218,,
8053,Rattus norvegicus,CHEMBL621700,Intermediate,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,N,10116.0,12487,50597,1,,,BAO_0000218,,
8054,Rattus norvegicus,CHEMBL621701,Intermediate,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,N,10116.0,12487,50597,1,,,BAO_0000218,,
8055,Mustela putorius furo,CHEMBL621702,Intermediate,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,N,9669.0,12487,50506,1,,,BAO_0000218,,
8056,Canis lupus familiaris,CHEMBL621703,Intermediate,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,N,9615.0,12487,50588,1,,,BAO_0000218,,
8057,Canis lupus familiaris,CHEMBL621704,Intermediate,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,N,9615.0,12487,50588,1,,,BAO_0000218,,
8058,Rattus norvegicus,CHEMBL624259,Intermediate,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,N,10116.0,12902,50597,1,,,BAO_0000218,,
8059,Rattus norvegicus,CHEMBL624260,Intermediate,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,N,10116.0,12902,50597,1,,,BAO_0000218,,
8060,Rattus norvegicus,CHEMBL624430,Intermediate,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,N,10116.0,12902,50597,1,,,BAO_0000218,,
8061,Rattus norvegicus,CHEMBL624431,Intermediate,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,N,10116.0,12902,50597,1,,,BAO_0000218,,
8062,Rattus norvegicus,CHEMBL624432,Intermediate,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,N,10116.0,12902,50597,1,,,BAO_0000218,,
8063,Rattus norvegicus,CHEMBL624433,Intermediate,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,N,10116.0,12902,50597,1,,,BAO_0000218,,
8064,Rattus norvegicus,CHEMBL624434,Intermediate,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,N,10116.0,12902,50597,1,,,BAO_0000218,,
8065,Rattus norvegicus,CHEMBL624435,Intermediate,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,N,10116.0,12902,50597,1,,,BAO_0000218,,
8066,Mus musculus,CHEMBL618570,Intermediate,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,N,10090.0,12745,50594,1,,,BAO_0000218,,
8067,Mus musculus,CHEMBL618571,Intermediate,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,10090.0,12745,50594,1,,,BAO_0000218,,
8068,Mus musculus,CHEMBL618572,Intermediate,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,N,10090.0,12745,50594,1,,,BAO_0000218,,
8069,Mus musculus,CHEMBL618573,Intermediate,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,10090.0,12745,50594,1,,,BAO_0000218,,
8070,Mus musculus,CHEMBL619267,Intermediate,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,N,10090.0,12745,50594,1,,,BAO_0000218,,
8071,Mus musculus,CHEMBL619431,Intermediate,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,10090.0,12745,50594,1,,,BAO_0000218,,
8072,Mus musculus,CHEMBL619432,Intermediate,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,N,10090.0,12745,50594,1,,,BAO_0000218,,
8073,Mus musculus,CHEMBL619433,Intermediate,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,10090.0,12745,50594,1,,,BAO_0000218,,
8074,,CHEMBL619434,Autocuration,Plasma,AUC in mice after oral dose (50 mg/kg),,U,,13298,22224,1,,,BAO_0000218,1969.0,
8075,Mus musculus,CHEMBL619435,Intermediate,Serum,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,N,10090.0,12226,50594,1,,,BAO_0000218,1977.0,
8076,,CHEMBL619436,Autocuration,Plasma,AUC (0-4 hr) ug/ml/h,,U,,12634,22224,1,,,BAO_0000019,1969.0,
8077,Rattus norvegicus,CHEMBL619437,Intermediate,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,N,10116.0,14810,50597,1,,,BAO_0000218,,
8078,,CHEMBL619438,Autocuration,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,U,,13889,22224,1,,,BAO_0000218,,
8079,Mus musculus,CHEMBL619439,Intermediate,,Compound was evaluated for Area under curve in mice,,N,10090.0,10018,50594,1,,,BAO_0000218,,
8080,Rattus norvegicus,CHEMBL619440,Intermediate,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,N,10116.0,8758,50597,1,,,BAO_0000218,,
8081,,CHEMBL619441,Autocuration,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,U,,8758,22224,1,,,BAO_0000218,,
8082,Rattus norvegicus,CHEMBL619442,Intermediate,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,N,10116.0,8758,50597,1,,,BAO_0000218,,
8083,,CHEMBL875156,Autocuration,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,U,,2249,22224,1,,,BAO_0000019,,
8084,,CHEMBL619443,Autocuration,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,U,,2249,22224,1,,,BAO_0000019,,
8085,,CHEMBL619444,Autocuration,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,U,,2249,22224,1,,,BAO_0000019,,
8086,,CHEMBL623464,Autocuration,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,U,,2249,22224,1,,,BAO_0000019,,
8087,Mus musculus,CHEMBL623465,Intermediate,,Compound was evaluated for area under curve when administered through oral route in mouse,,N,10090.0,15115,50594,1,,,BAO_0000218,,
8088,Rattus norvegicus,CHEMBL623466,Intermediate,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,N,10116.0,6518,50597,1,,,BAO_0000218,,
8089,Rattus norvegicus,CHEMBL623467,Intermediate,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,N,10116.0,6518,50597,1,,,BAO_0000218,,
8090,Rattus norvegicus,CHEMBL623468,Intermediate,,Plasma clearance in rat,,N,10116.0,6249,50597,1,,,BAO_0000218,,
8091,Rattus norvegicus,CHEMBL622660,Intermediate,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,N,10116.0,2463,50597,1,,,BAO_0000218,,
8092,Rattus norvegicus,CHEMBL622661,Intermediate,,Plasma clearance rate in Sprague-Dawley rats,,N,10116.0,4969,50597,1,,,BAO_0000218,,
8093,Rattus norvegicus,CHEMBL622662,Intermediate,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,10116.0,17720,50597,1,,,BAO_0000218,,
8094,Rattus norvegicus,CHEMBL622663,Intermediate,,Pharmacokinetic property (total body clearance) in rat,,N,10116.0,3457,50597,1,,,BAO_0000218,,
8095,Rattus norvegicus,CHEMBL622664,Intermediate,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,N,10116.0,5983,50597,1,,,BAO_0000218,,
8096,Rattus norvegicus,CHEMBL622665,Intermediate,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,N,10116.0,6295,50597,1,,,BAO_0000218,,
8097,Rattus norvegicus,CHEMBL622666,Intermediate,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,N,10116.0,6296,50597,1,,,BAO_0000218,,
8098,Rattus norvegicus,CHEMBL621615,Intermediate,,Cl in rat i.v. at 2 mg/kg concentration,,N,10116.0,17686,50597,1,,,BAO_0000218,,
8099,Rattus norvegicus,CHEMBL621616,Intermediate,,Clearance of compound after intravenous administration in rats at 24 uM/kg,,N,10116.0,17764,50597,1,,,BAO_0000218,,
8100,Rattus norvegicus,CHEMBL621617,Intermediate,,Clearance was determined,,N,10116.0,5503,50597,1,,,BAO_0000218,,
8101,Rattus norvegicus,CHEMBL621618,Intermediate,,Clearance by intravenous administration of 3.4 mg/kg in rat,,N,10116.0,4368,50597,1,,,BAO_0000218,,
8102,Rattus norvegicus,CHEMBL621619,Intermediate,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,N,10116.0,6005,50597,1,,,BAO_0000218,,
8103,Rattus norvegicus,CHEMBL621620,Intermediate,,Clearance rate after i.v. administration in rats,,N,10116.0,5031,50597,1,,,BAO_0000218,,
8104,Rattus norvegicus,CHEMBL621786,Intermediate,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,N,10116.0,4890,50597,1,,,BAO_0000218,,
8105,Rattus norvegicus,CHEMBL621787,Intermediate,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,N,10116.0,5182,50597,1,,,BAO_0000218,,
8106,Rattus norvegicus,CHEMBL621788,Intermediate,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,N,10116.0,5979,50597,1,,,BAO_0000218,,
8107,Rattus norvegicus,CHEMBL621789,Intermediate,,Clearance (Cl) after oral administration in rat,,N,10116.0,5656,50597,1,,,BAO_0000218,,
8108,Rattus norvegicus,CHEMBL621790,Intermediate,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,N,10116.0,17804,50597,1,,,BAO_0000218,,
8109,Rattus norvegicus,CHEMBL621791,Intermediate,Plasma,Compound was tested for plasma clearance in rat,,N,10116.0,4839,50597,1,,,BAO_0000218,1969.0,
8110,Rattus norvegicus,CHEMBL621792,Intermediate,,In vitro microsome metabolism clearance in rat was determined,,N,10116.0,5041,50597,1,,,BAO_0000218,,
8111,Rattus norvegicus,CHEMBL621793,Intermediate,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,,N,10116.0,5041,50597,1,,,BAO_0000218,,
8112,Rattus norvegicus,CHEMBL621794,Intermediate,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
8113,Rattus norvegicus,CHEMBL621795,Intermediate,Plasma,In vivo plasma clearance was determined,,N,10116.0,5496,50597,1,,,BAO_0000218,1969.0,
8114,Rattus norvegicus,CHEMBL621796,Intermediate,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,N,10116.0,5739,50597,1,,,BAO_0000218,,
8115,Rattus norvegicus,CHEMBL621797,Intermediate,Liver,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,,N,10116.0,5676,50597,1,,401.0,BAO_0000218,2107.0,
8116,Rattus norvegicus,CHEMBL621798,Intermediate,,Pharmacokinetic property (Plasma clearance) was measured in rat,,N,10116.0,4239,50597,1,,,BAO_0000218,,
8117,Rattus norvegicus,CHEMBL621799,Intermediate,,Pharmacokinetic property (clearance) in rat i.v.,,N,10116.0,5676,50597,1,,,BAO_0000218,,
8118,Rattus norvegicus,CHEMBL621800,Intermediate,,"Plasma Clearance was evaluated in rats, iv",,N,10116.0,1918,50597,1,,,BAO_0000218,,
8119,Rattus norvegicus,CHEMBL621801,Intermediate,,Plasma clearance (in vivo) in rats was determined,,N,10116.0,17800,50597,1,,,BAO_0000218,,
8120,Rattus norvegicus,CHEMBL621802,Intermediate,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,N,10116.0,6056,50597,1,,,BAO_0000218,,
8121,Rattus norvegicus,CHEMBL618596,Intermediate,,Plasma clearance was determined,,N,10116.0,5496,50597,1,,,BAO_0000218,,
8122,Rattus norvegicus,CHEMBL618597,Intermediate,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,N,10116.0,5939,50597,1,,,BAO_0000218,,
8123,Rattus norvegicus,CHEMBL618598,Intermediate,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,N,10116.0,5939,50597,1,,,BAO_0000218,,
8124,Rattus norvegicus,CHEMBL618599,Intermediate,,Plasma clearance in rats,,N,10116.0,17752,50597,1,,,BAO_0000218,,
8125,Rattus norvegicus,CHEMBL618600,Intermediate,,Plasma clearance rate determined in rat,,N,10116.0,4576,50597,1,,,BAO_0000218,,
8126,Rattus norvegicus,CHEMBL618601,Intermediate,,Plasma clearance was determined in rat,,N,10116.0,6011,50597,1,,,BAO_0000218,,
8127,Rattus norvegicus,CHEMBL618602,Intermediate,,Plasma clearance was determined,,N,10116.0,5510,50597,1,,,BAO_0000218,,
8128,Rattus norvegicus,CHEMBL618603,Intermediate,,Plasma clearance value in rat,,N,10116.0,5948,50597,1,,,BAO_0000218,,
8129,Rattus norvegicus,CHEMBL618604,Intermediate,Liver,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,N,10116.0,6125,50597,1,,,BAO_0000218,2107.0,
8130,Rattus norvegicus,CHEMBL618605,Intermediate,,Clearance in rat,,N,10116.0,4839,50597,1,,,BAO_0000218,,
8131,Rattus norvegicus,CHEMBL618606,Intermediate,,Total body clearance in rat i.v. at 2 mg/kg concentration,,N,10116.0,17686,50597,1,,,BAO_0000218,,
8132,Rattus norvegicus,CHEMBL618607,Intermediate,,Clearance of compound in rats after intravenous administration,,N,10116.0,6571,50597,1,,,BAO_0000218,,
8133,Rattus norvegicus,CHEMBL618608,Intermediate,,Clearance after iv administration to rats,,N,10116.0,3364,50597,1,,,BAO_0000218,,
8134,Rattus norvegicus,CHEMBL618609,Intermediate,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8135,Rattus norvegicus,CHEMBL618610,Intermediate,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8136,Rattus norvegicus,CHEMBL618611,Intermediate,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8137,Rattus norvegicus,CHEMBL618612,Intermediate,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8138,Rattus norvegicus,CHEMBL618613,Intermediate,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8139,Rattus norvegicus,CHEMBL621076,Intermediate,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8140,Rattus norvegicus,CHEMBL621077,Intermediate,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8141,Rattus norvegicus,CHEMBL621078,Intermediate,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,N,10116.0,17670,50597,1,,,BAO_0000218,,
8142,Rattus norvegicus,CHEMBL621251,Intermediate,,Clearance in rat,,N,10116.0,5970,50597,1,,,BAO_0000218,,
8143,Rattus norvegicus,CHEMBL621252,Intermediate,,Clearance in rat after oral administration at 10 mg/kg,,N,10116.0,6495,50597,1,,,BAO_0000218,,
8144,Rattus norvegicus,CHEMBL621253,Intermediate,,Clearance in rat.,,N,10116.0,4590,50597,1,,,BAO_0000218,,
8145,Rattus norvegicus,CHEMBL621254,Intermediate,,Clearance rate following an oral dose of 20 mg/kg in rats,,N,10116.0,6193,50597,1,,,BAO_0000218,,
8146,Rattus norvegicus,CHEMBL621255,Intermediate,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,N,10116.0,2832,50597,1,,,BAO_0000218,,
8147,Rattus norvegicus,CHEMBL621256,Intermediate,Plasma,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,N,10116.0,1052,50597,1,,,BAO_0000218,1969.0,
8148,Rattus norvegicus,CHEMBL621257,Intermediate,Liver,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
8149,Rattus norvegicus,CHEMBL621258,Intermediate,Liver,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
8150,Rattus norvegicus,CHEMBL621259,Intermediate,Liver,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
8151,Rattus norvegicus,CHEMBL621260,Intermediate,Liver,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
8152,Rattus norvegicus,CHEMBL876494,Intermediate,Liver,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
8153,Rattus norvegicus,CHEMBL621261,Intermediate,Liver,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
8154,Rattus norvegicus,CHEMBL621262,Intermediate,Liver,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
8155,Rattus norvegicus,CHEMBL621263,Intermediate,Liver,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
8156,Rattus norvegicus,CHEMBL621264,Intermediate,Liver,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,N,10116.0,9866,50597,1,,,BAO_0000218,2107.0,
8157,Rattus norvegicus,CHEMBL621265,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8158,Rattus norvegicus,CHEMBL621266,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8159,Rattus norvegicus,CHEMBL621267,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8160,Rattus norvegicus,CHEMBL621268,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8161,Rattus norvegicus,CHEMBL621269,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8162,Rattus norvegicus,CHEMBL621270,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8163,Rattus norvegicus,CHEMBL621271,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8164,Rattus norvegicus,CHEMBL621272,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8165,Rattus norvegicus,CHEMBL621273,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8166,Rattus norvegicus,CHEMBL621274,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8167,Rattus norvegicus,CHEMBL876495,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8168,Rattus norvegicus,CHEMBL621275,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8169,Rattus norvegicus,CHEMBL621276,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8170,Rattus norvegicus,CHEMBL621277,Intermediate,Muscle tissue,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,2385.0,
8171,Rattus norvegicus,CHEMBL621278,Intermediate,Intestine,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,160.0,
8172,Rattus norvegicus,CHEMBL621279,Intermediate,Intestine,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,160.0,
8173,Rattus norvegicus,CHEMBL621280,Intermediate,Intestine,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,N,10116.0,9866,50597,1,,,BAO_0000218,160.0,
8174,Rattus norvegicus,CHEMBL621281,Intermediate,Spleen,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2106.0,
8175,Rattus norvegicus,CHEMBL621282,Intermediate,Spleen,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,N,10116.0,9866,50597,1,,,BAO_0000218,2106.0,
8176,Rattus norvegicus,CHEMBL621283,Intermediate,Spleen,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,N,10116.0,9866,50597,1,,,BAO_0000218,2106.0,
8177,Rattus norvegicus,CHEMBL621284,Intermediate,Spleen,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,N,10116.0,9866,50597,1,,,BAO_0000218,2106.0,
8178,Rattus norvegicus,CHEMBL621285,Intermediate,Spleen,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,2106.0,
8179,Rattus norvegicus,CHEMBL621286,Intermediate,Spleen,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2106.0,
8180,Rattus norvegicus,CHEMBL623220,Intermediate,Spleen,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,2106.0,
8181,Rattus norvegicus,CHEMBL623221,Intermediate,Spleen,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,N,10116.0,9866,50597,1,,,BAO_0000218,2106.0,
8182,Rattus norvegicus,CHEMBL876029,Intermediate,Spleen,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,N,10116.0,9866,50597,1,,,BAO_0000218,2106.0,
8183,Rattus norvegicus,CHEMBL623222,Intermediate,Stomach,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,N,10116.0,9866,50597,1,,,BAO_0000218,945.0,
8184,Rattus norvegicus,CHEMBL623223,Intermediate,Stomach,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,N,10116.0,9866,50597,1,,,BAO_0000218,945.0,
8185,Rattus norvegicus,CHEMBL621445,Intermediate,Stomach,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,N,10116.0,9866,50597,1,,,BAO_0000218,945.0,
8186,Rattus norvegicus,CHEMBL621446,Intermediate,Blood,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,178.0,
8187,Rattus norvegicus,CHEMBL621447,Intermediate,Blood,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,178.0,
8188,Rattus norvegicus,CHEMBL619681,Intermediate,Blood,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,178.0,
8189,Rattus norvegicus,CHEMBL619682,Intermediate,Blood,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,178.0,
8190,Rattus norvegicus,CHEMBL619683,Intermediate,Blood,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,178.0,
8191,Rattus norvegicus,CHEMBL619684,Intermediate,Brain,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,955.0,
8192,Rattus norvegicus,CHEMBL619685,Intermediate,Brain,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,955.0,
8193,Rattus norvegicus,CHEMBL619686,Intermediate,Brain,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,955.0,
8194,Rattus norvegicus,CHEMBL619687,Intermediate,Brain,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,955.0,
8195,Rattus norvegicus,CHEMBL619688,Intermediate,Brain,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,955.0,
8196,Rattus norvegicus,CHEMBL619689,Intermediate,Heart,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,948.0,
8197,Rattus norvegicus,CHEMBL619690,Intermediate,Heart,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,948.0,
8198,Rattus norvegicus,CHEMBL619691,Intermediate,Heart,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,948.0,
8199,Rattus norvegicus,CHEMBL619692,Intermediate,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,N,10116.0,6062,50597,1,,,BAO_0000218,,
8200,Rattus norvegicus,CHEMBL619693,Expert,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,10116.0,3598,50597,1,,,BAO_0000218,,
8201,Rattus norvegicus,CHEMBL619694,Intermediate,,Vc value after IV dose at a dose of 5 mg/kg in rats.,,N,10116.0,1908,50597,1,,,BAO_0000218,,
8202,Rattus norvegicus,CHEMBL619695,Intermediate,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,N,10116.0,17596,50597,1,,,BAO_0000218,,
8203,Rattus norvegicus,CHEMBL619696,Intermediate,,Compound was evaluated for pharmacokinetic parameter volume of distribution,,N,10116.0,4891,50597,1,,,BAO_0000218,,
8204,Rattus norvegicus,CHEMBL619697,Intermediate,,Compound was evaluated for volume of distribution in rat,,N,10116.0,740,50597,1,,,BAO_0000218,,
8205,Rattus norvegicus,CHEMBL619698,Intermediate,,Steady state volume distribution was determined; steady state(ss),,N,10116.0,16366,50597,1,,,BAO_0000218,,
8206,Rattus norvegicus,CHEMBL619699,Intermediate,,Steady state volume of distribution after iv administration to rats,,N,10116.0,3364,50597,1,,,BAO_0000218,,
8207,Rattus norvegicus,CHEMBL619700,Intermediate,,Steady state volume of distribution dosing at 3 mg/kg iv,,N,10116.0,2552,50597,1,,,BAO_0000218,,
8208,Rattus norvegicus,CHEMBL619701,Intermediate,,The compound was evaluated for volume of distribution in rat,,N,10116.0,406,50597,1,,,BAO_0000218,,
8209,Rattus norvegicus,CHEMBL619702,Intermediate,,The compound was tested for volume of distribution in rat,,N,10116.0,12500,50597,1,,,BAO_0000218,,
8210,Rattus norvegicus,CHEMBL620335,Intermediate,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,N,10116.0,12500,50597,1,,,BAO_0000218,,
8211,Rattus norvegicus,CHEMBL620336,Intermediate,,Volume distribution (VD) after oral administration in rat,,N,10116.0,5656,50597,1,,,BAO_0000218,,
8212,Rattus norvegicus,CHEMBL620337,Intermediate,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,10116.0,17671,50597,1,,,BAO_0000218,,
8213,Rattus norvegicus,CHEMBL620520,Intermediate,,Volume distribution in rat,,N,10116.0,1094,50597,1,,,BAO_0000218,,
8214,Rattus norvegicus,CHEMBL620521,Intermediate,,Volume distribution in rat,,N,10116.0,5833,50597,1,,,BAO_0000218,,
8215,Rattus norvegicus,CHEMBL875825,Intermediate,,Volume distribution in rat after peroral administration at 10 mg/kg,,N,10116.0,5939,50597,1,,,BAO_0000218,,
8216,Rattus norvegicus,CHEMBL620522,Intermediate,,Volume distribution in rat after peroral administration at 5 mg/kg,,N,10116.0,5939,50597,1,,,BAO_0000218,,
8217,Rattus norvegicus,CHEMBL620523,Intermediate,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,N,10116.0,6005,50597,1,,,BAO_0000218,,
8218,Rattus norvegicus,CHEMBL620524,Intermediate,,Volume of distribution in rat.,,N,10116.0,1696,50597,1,,,BAO_0000218,,
8219,Rattus norvegicus,CHEMBL620525,Intermediate,,Volume of distribution in rat,,N,10116.0,6672,50597,1,,,BAO_0000218,,
8220,Rattus norvegicus,CHEMBL620526,Intermediate,,Volume of distribution in rat,,N,10116.0,6673,50597,1,,,BAO_0000218,,
8221,Rattus norvegicus,CHEMBL620527,Intermediate,,Volume of distribution in rat by iv administration,,N,10116.0,5871,50597,1,,,BAO_0000218,,
8222,Rattus norvegicus,CHEMBL620528,Intermediate,,Volume of distribution in rats,,N,10116.0,6803,50597,1,,,BAO_0000218,,
8223,Rattus norvegicus,CHEMBL620529,Intermediate,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,N,10116.0,5199,50597,1,,,BAO_0000218,,
8224,Rattus norvegicus,CHEMBL620530,Intermediate,,Volume distribution at the dose of 2 mg/kg in rat,,N,10116.0,4727,50597,1,,,BAO_0000218,,
8225,Rattus norvegicus,CHEMBL620531,Intermediate,,Steady state volume of distribution was determined,,N,10116.0,16367,50597,1,,,BAO_0000218,,
8226,Macaca mulatta,CHEMBL620532,Intermediate,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,U,9544.0,5005,22224,1,,,BAO_0000218,,
8227,Rattus norvegicus,CHEMBL620533,Intermediate,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,U,10116.0,5005,22224,1,,,BAO_0000218,,
8228,Rattus norvegicus,CHEMBL620534,Intermediate,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,U,10116.0,5005,22224,1,,,BAO_0000218,,
8229,Rattus norvegicus,CHEMBL620535,Intermediate,,Mean (%CV) PK parameters for Vdss(mL/kg).,,N,10116.0,15765,50597,1,,,BAO_0000218,,
8230,Rattus norvegicus,CHEMBL875826,Intermediate,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
8231,Rattus norvegicus,CHEMBL620536,Intermediate,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
8232,Rattus norvegicus,CHEMBL620537,Intermediate,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,N,10116.0,5334,50597,1,,,BAO_0000218,,
8233,Rattus norvegicus,CHEMBL618526,Intermediate,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,N,10116.0,5334,50597,1,,,BAO_0000218,,
8234,Rattus norvegicus,CHEMBL618527,Intermediate,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,N,10116.0,5739,50597,1,,,BAO_0000218,,
8235,Rattus norvegicus,CHEMBL618528,Intermediate,,Pharmacokinetic property (Vdss) in rat,,N,10116.0,5789,50597,1,,,BAO_0000218,,
8236,Rattus norvegicus,CHEMBL618529,Intermediate,,Pharmacokinetic property (vdss) was measured in rat,,N,10116.0,4239,50597,1,,,BAO_0000218,,
8237,Rattus norvegicus,CHEMBL618530,Intermediate,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,N,10116.0,4709,50597,1,,,BAO_0000218,,
8238,Rattus norvegicus,CHEMBL618531,Intermediate,,Volume of distribution in rat,,N,10116.0,6642,50597,1,,,BAO_0000218,,
8239,Rattus norvegicus,CHEMBL618532,Intermediate,,The pharmacokinetic parameter volume of distribution in vivo in rats,,N,10116.0,5247,50597,1,,,BAO_0000218,,
8240,Rattus norvegicus,CHEMBL618533,Intermediate,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,10116.0,17720,50597,1,,,BAO_0000218,,
8241,Rattus norvegicus,CHEMBL618534,Intermediate,,Vdss in rat i.v. at 2 mg/kg concentration,,N,10116.0,17686,50597,1,,,BAO_0000218,,
8242,Rattus norvegicus,CHEMBL618535,Intermediate,,Volume distribution after intravenous administration (1 mg/kg) in rat,,N,10116.0,4689,50597,1,,,BAO_0000218,,
8243,Rattus norvegicus,CHEMBL618536,Intermediate,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,N,10116.0,5654,50597,1,,,BAO_0000218,,
8244,Rattus norvegicus,CHEMBL618537,Intermediate,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,N,10116.0,5654,50597,1,,,BAO_0000218,,
8245,Rattus norvegicus,CHEMBL618538,Intermediate,,Volume distribution at a dose of 10 uM/kg in rat was determined,,N,10116.0,4527,50597,1,,,BAO_0000218,,
8246,Rattus norvegicus,CHEMBL618539,Intermediate,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,N,10116.0,4521,50597,1,,,BAO_0000218,,
8247,Rattus norvegicus,CHEMBL618540,Intermediate,,Volume distribution was calculated in rat,,N,10116.0,6057,50597,1,,,BAO_0000218,,
8248,Rattus norvegicus,CHEMBL618541,Intermediate,,Volume distribution was determined,,N,10116.0,5510,50597,1,,,BAO_0000218,,
8249,Rattus norvegicus,CHEMBL618542,Intermediate,,Volume of distribution after intravenous administration was evaluated in rat,,N,10116.0,2938,50597,1,,,BAO_0000218,,
8250,Rattus norvegicus,CHEMBL622544,Intermediate,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,N,10116.0,6679,50597,1,,,BAO_0000218,,
8251,Rattus norvegicus,CHEMBL622545,Intermediate,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,N,10116.0,6685,50597,1,,,BAO_0000218,,
8252,Rattus norvegicus,CHEMBL622546,Intermediate,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,N,10116.0,6685,50597,1,,,BAO_0000218,,
8253,Rattus norvegicus,CHEMBL622547,Intermediate,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,N,10116.0,6685,50597,1,,,BAO_0000218,,
8254,Rattus norvegicus,CHEMBL622548,Intermediate,,Volume of distribution in steady state was determined in rat,,N,10116.0,5145,50597,1,,,BAO_0000218,,
8255,Rattus norvegicus,CHEMBL622549,Intermediate,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,N,10116.0,6467,50597,1,,,BAO_0000218,,
8256,Rattus norvegicus,CHEMBL622550,Intermediate,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,N,10116.0,6467,50597,1,,,BAO_0000218,,
8257,Mus musculus,CHEMBL622551,Intermediate,,Compound was evaluated for area under curve when administered through oral route to mouse,,N,10090.0,15115,50594,1,,,BAO_0000218,,
8258,Rattus norvegicus,CHEMBL622552,Intermediate,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,N,10116.0,8758,50597,1,,,BAO_0000218,,
8259,Rattus norvegicus,CHEMBL622553,Intermediate,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,N,10116.0,8758,50597,1,,,BAO_0000218,,
8260,,CHEMBL622554,Autocuration,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,U,,8267,22224,1,,,BAO_0000218,,
8261,Canis lupus familiaris,CHEMBL622555,Intermediate,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,N,9615.0,8267,50588,1,,,BAO_0000218,,
8262,Mus musculus,CHEMBL622556,Intermediate,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,N,10090.0,14239,50594,1,,,BAO_0000218,,
8263,Mus musculus,CHEMBL622557,Intermediate,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,N,10090.0,14239,50594,1,,,BAO_0000218,,
8264,Mus musculus,CHEMBL622558,Intermediate,Blood,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,N,10090.0,10754,50594,1,,,BAO_0000218,178.0,
8265,Mus musculus,CHEMBL622559,Intermediate,Blood,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,N,10090.0,10754,50594,1,,,BAO_0000218,178.0,
8266,Canis lupus familiaris,CHEMBL622560,Intermediate,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,N,9615.0,10754,50588,1,,,BAO_0000218,,
8267,Rattus norvegicus,CHEMBL622561,Intermediate,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,N,10116.0,14681,50597,1,,,BAO_0000218,,
8268,Rattus norvegicus,CHEMBL622562,Intermediate,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,N,10116.0,14681,50597,1,,,BAO_0000218,,
8269,Rattus norvegicus,CHEMBL622563,Intermediate,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,N,10116.0,14681,50597,1,,,BAO_0000218,,
8270,,CHEMBL622564,Autocuration,,Concentration of compound in Central nervous system,,U,,13118,22224,1,,,BAO_0000019,,
8271,,CHEMBL622565,Autocuration,,Concentration of compound in Central nervous system; Not detectable,,U,,13118,22224,1,,,BAO_0000019,,
8272,Mus musculus,CHEMBL622566,Intermediate,,"Concentration of diester in the blood, following oral administration in mice",,N,10090.0,13318,50594,1,,,BAO_0000218,,
8273,Mus musculus,CHEMBL624515,Intermediate,,"Concentration of monoester in the blood, following oral administration in mice",,N,10090.0,13318,50594,1,,,BAO_0000218,,
8274,Mus musculus,CHEMBL624516,Intermediate,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,N,10090.0,13318,50594,1,,,BAO_0000218,,
8275,,CHEMBL624517,Autocuration,,Evaluated for Pharmacokinetic property: Area under the curve,,U,,15692,22224,1,,,BAO_0000019,,
8276,Mus musculus,CHEMBL624518,Intermediate,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,N,10090.0,14839,50594,1,,,BAO_0000218,,
8277,Macaca fascicularis,CHEMBL624519,Intermediate,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,N,9541.0,14839,100710,1,,,BAO_0000218,,
8278,Macaca fascicularis,CHEMBL624520,Intermediate,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,N,9541.0,14839,100710,1,,,BAO_0000218,,
8279,Macaca fascicularis,CHEMBL624521,Intermediate,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,N,9541.0,14839,100710,1,,,BAO_0000218,,
8280,Macaca fascicularis,CHEMBL624522,Intermediate,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,N,9541.0,14839,100710,1,,,BAO_0000218,,
8281,Macaca fascicularis,CHEMBL624523,Intermediate,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,N,9541.0,14839,100710,1,,,BAO_0000218,,
8282,Macaca fascicularis,CHEMBL624409,Intermediate,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,N,9541.0,14839,100710,1,,,BAO_0000218,,
8283,Macaca fascicularis,CHEMBL624410,Intermediate,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,N,9541.0,14839,100710,1,,,BAO_0000218,,
8284,Macaca fascicularis,CHEMBL624411,Intermediate,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,N,9541.0,14839,100710,1,,,BAO_0000218,,
8285,Macaca fascicularis,CHEMBL623531,Intermediate,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,N,9541.0,14839,100710,1,,,BAO_0000218,,
8286,Macaca fascicularis,CHEMBL623532,Intermediate,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,N,9541.0,14839,100710,1,,,BAO_0000218,,
8287,Macaca fascicularis,CHEMBL623533,Intermediate,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,N,9541.0,14839,100710,1,,,BAO_0000218,,
8288,Macaca fascicularis,CHEMBL623534,Intermediate,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,N,9541.0,14839,100710,1,,,BAO_0000218,,
8289,Mus musculus,CHEMBL623535,Intermediate,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,N,10090.0,14839,50594,1,,,BAO_0000218,,
8290,Mus musculus,CHEMBL623536,Intermediate,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,N,10090.0,14839,50594,1,,,BAO_0000218,,
8291,Mus musculus,CHEMBL623537,Intermediate,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,N,10090.0,14839,50594,1,,,BAO_0000218,,
8292,Mus musculus,CHEMBL623538,Intermediate,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,N,10090.0,14839,50594,1,,,BAO_0000218,,
8293,Mus musculus,CHEMBL623539,Intermediate,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,N,10090.0,14839,50594,1,,,BAO_0000218,,
8294,Mus musculus,CHEMBL623540,Intermediate,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,N,10090.0,14839,50594,1,,,BAO_0000218,,
8295,Mus musculus,CHEMBL623541,Intermediate,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,N,10090.0,14839,50594,1,,,BAO_0000218,,
8296,Mus musculus,CHEMBL623542,Intermediate,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,N,10090.0,14839,50594,1,,,BAO_0000218,,
8297,Mus musculus,CHEMBL623543,Intermediate,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,N,10090.0,14839,50594,1,,,BAO_0000218,,
8298,Mus musculus,CHEMBL623544,Intermediate,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,N,10090.0,14839,50594,1,,,BAO_0000218,,
8299,Mus musculus,CHEMBL623545,Intermediate,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,N,10090.0,14839,50594,1,,,BAO_0000218,,
8300,Mus musculus,CHEMBL623546,Intermediate,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,N,10090.0,14839,50594,1,,,BAO_0000218,,
8301,Rattus norvegicus,CHEMBL623547,Intermediate,Plasma,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,N,10116.0,5408,50597,1,,,BAO_0000218,1969.0,
8302,Rattus norvegicus,CHEMBL623548,Intermediate,,High i.v. clearance in Dawley rats,,N,10116.0,6827,50597,1,,,BAO_0000218,,
8303,Rattus norvegicus,CHEMBL623549,Intermediate,Liver,In vitro clearance in rat liver microsomes,,N,10116.0,17538,50597,1,,,BAO_0000218,2107.0,
8304,Rattus norvegicus,CHEMBL623550,Intermediate,Liver,Intrinsic clearance in rat liver microsomes was determined,,N,10116.0,6331,50597,1,,,BAO_0000218,2107.0,
8305,Rattus norvegicus,CHEMBL875276,Intermediate,Liver,Intrinsic clearance in rat hepatocytes was determined,,N,10116.0,5948,50597,1,,401.0,BAO_0000218,2107.0,
8306,Rattus norvegicus,CHEMBL621872,Intermediate,,Plasma Clearance was determined,,N,10116.0,4026,50597,1,,,BAO_0000218,,
8307,Rattus norvegicus,CHEMBL621873,Intermediate,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,N,10116.0,6647,50597,1,,,BAO_0000218,,
8308,Rattus norvegicus,CHEMBL621874,Intermediate,,Plasma clearance in rat.,,N,10116.0,1696,50597,1,,,BAO_0000218,,
8309,Rattus norvegicus,CHEMBL621875,Intermediate,,Plasma clearance in rats,,N,10116.0,6597,50597,1,,,BAO_0000218,,
8310,Rattus norvegicus,CHEMBL621876,Intermediate,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,N,10116.0,347,50597,1,,,BAO_0000218,,
8311,Rattus norvegicus,CHEMBL621877,Intermediate,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,N,10116.0,16423,50597,1,,,BAO_0000218,,
8312,Rattus norvegicus,CHEMBL621878,Intermediate,,Plasma clearance was measured in rat,,N,10116.0,2879,50597,1,,,BAO_0000218,,
8313,Rattus norvegicus,CHEMBL621879,Intermediate,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,N,10116.0,4883,50597,1,,,BAO_0000218,,
8314,Rattus norvegicus,CHEMBL621880,Intermediate,Plasma,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,N,10116.0,5328,50597,1,,,BAO_0000218,1969.0,
8315,Rattus norvegicus,CHEMBL621881,Intermediate,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,N,10116.0,5160,50597,1,,,BAO_0000218,,
8316,Rattus norvegicus,CHEMBL621882,Intermediate,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,N,10116.0,17582,50597,1,,,BAO_0000218,,
8317,Rattus norvegicus,CHEMBL875283,Intermediate,,Total clearance at 1 mg/kg was determined in rat,,N,10116.0,17651,50597,1,,,BAO_0000218,,
8318,Rattus norvegicus,CHEMBL621883,Intermediate,,Total clearance at 10 mg/kg was determined in rat,,N,10116.0,17651,50597,1,,,BAO_0000218,,
8319,Rattus norvegicus,CHEMBL621884,Intermediate,,Clearance in rat,,N,10116.0,6596,50597,1,,,BAO_0000218,,
8320,Rattus norvegicus,CHEMBL621885,Intermediate,,Plasma clearance rate determined in rats,,N,10116.0,4796,50597,1,,,BAO_0000218,,
8321,Rattus norvegicus,CHEMBL621886,Intermediate,,Clearance of compound in rat was evaluated,,N,10116.0,6850,50597,1,,,BAO_0000218,,
8322,Rattus norvegicus,CHEMBL621887,Intermediate,Plasma,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,N,10116.0,5932,50597,1,,,BAO_0000218,1969.0,
8323,Rattus norvegicus,CHEMBL621888,Intermediate,,Pharmacokinetic property (blood clearance) in rat,,N,10116.0,3371,50597,1,,,BAO_0000218,,
8324,Rattus norvegicus,CHEMBL621889,Intermediate,,Plasma clearance in rat,,N,10116.0,2083,50597,1,,,BAO_0000218,,
8325,Rattus norvegicus,CHEMBL621890,Intermediate,,Plasma clearance in rats,,N,10116.0,4942,50597,1,,,BAO_0000218,,
8326,Rattus norvegicus,CHEMBL621891,Intermediate,Liver,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,,N,10116.0,6838,50597,1,,,BAO_0000218,2107.0,
8327,Rattus norvegicus,CHEMBL621892,Intermediate,,Clearance in Dawley rat,,N,10116.0,5353,50597,1,,,BAO_0000218,,
8328,Rattus norvegicus,CHEMBL621893,Intermediate,,Clearance rat,,N,10116.0,6641,50597,1,,,BAO_0000218,,
8329,Rattus norvegicus,CHEMBL621894,Intermediate,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,N,10116.0,6641,50597,1,,,BAO_0000218,,
8330,Rattus norvegicus,CHEMBL621895,Intermediate,,Clearance rat; Not determined,,N,10116.0,6641,50597,1,,,BAO_0000218,,
8331,Rattus norvegicus,CHEMBL875284,Intermediate,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,N,10116.0,6444,50597,1,,,BAO_0000218,,
8332,Rattus norvegicus,CHEMBL618699,Intermediate,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,N,10116.0,6444,50597,1,,,BAO_0000218,,
8333,Rattus norvegicus,CHEMBL618700,Intermediate,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,N,10116.0,6444,50597,1,,,BAO_0000218,,
8334,Rattus norvegicus,CHEMBL618701,Intermediate,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,N,10116.0,6211,50597,1,,,BAO_0000218,,
8335,Rattus norvegicus,CHEMBL876600,Intermediate,Plasma,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,N,10116.0,12873,50597,1,,,BAO_0000218,1969.0,
8336,Rattus norvegicus,CHEMBL618702,Intermediate,,Clearance of compound in rat after 1 mg/kg i.v. administration,,N,10116.0,6570,50597,1,,,BAO_0000218,,
8337,Rattus norvegicus,CHEMBL618703,Intermediate,,Compound was evaluated for Hepatic clearance in rat,,N,10116.0,3341,50597,1,,,BAO_0000218,,
8338,Rattus norvegicus,CHEMBL618704,Intermediate,,In vivo clearance after 5 mg/kg dose,,N,10116.0,4891,50597,1,,,BAO_0000218,,
8339,Rattus norvegicus,CHEMBL618705,Intermediate,Plasma,Compound was tested for plasma clearance in rats,,N,10116.0,1094,50597,1,,,BAO_0000218,1969.0,
8340,Rattus norvegicus,CHEMBL618706,Intermediate,,Hepatic clearance after intravenous administration was evaluated in rat,,N,10116.0,2938,50597,1,,,BAO_0000218,,
8341,Rattus norvegicus,CHEMBL618707,Intermediate,,Lower clearance in rat (i.v.) at 0.5 mpk,,N,10116.0,17853,50597,1,,,BAO_0000218,,
8342,Rattus norvegicus,CHEMBL618708,Intermediate,Plasma,Pharmacokinetic parameter expressed as plasma clearance in rat,,N,10116.0,6049,50597,1,,,BAO_0000218,1969.0,
8343,Rattus norvegicus,CHEMBL618709,Intermediate,,Pharmacokinetic property (Clp) in rat,,N,10116.0,5789,50597,1,,,BAO_0000218,,
8344,Rattus norvegicus,CHEMBL618710,Intermediate,,Plasma clearance in Sprague-Dawley rats,,N,10116.0,4514,50597,1,,,BAO_0000218,,
8345,Rattus norvegicus,CHEMBL618711,Intermediate,,Plasma clearance (Clp) in rat,,N,10116.0,6448,50597,1,,,BAO_0000218,,
8346,Rattus norvegicus,CHEMBL618712,Intermediate,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,N,10116.0,6062,50597,1,,,BAO_0000218,,
8347,Rattus norvegicus,CHEMBL618713,Intermediate,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,N,10116.0,5710,50597,1,,,BAO_0000218,,
8348,Rattus norvegicus,CHEMBL618714,Intermediate,,Plasma clearance after intravenous administration of 1 mg/kg in rat,,N,10116.0,4709,50597,1,,,BAO_0000218,,
8349,Rattus norvegicus,CHEMBL618715,Intermediate,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,N,10116.0,4521,50597,1,,,BAO_0000218,,
8350,Rattus norvegicus,CHEMBL618716,Intermediate,,Plasma clearance in rat was determined,,N,10116.0,1742,50597,1,,,BAO_0000218,,
8351,Rattus norvegicus,CHEMBL876601,Intermediate,,Plasma clearance measured in rat,,N,10116.0,6057,50597,1,,,BAO_0000218,,
8352,Rattus norvegicus,CHEMBL618717,Intermediate,,Plasma clearance was calculated in rat,,N,10116.0,6057,50597,1,,,BAO_0000218,,
8353,Rattus norvegicus,CHEMBL618718,Intermediate,,Plasma clearance in rat,,N,10116.0,5145,50597,1,,,BAO_0000218,,
8354,Rattus norvegicus,CHEMBL618719,Intermediate,,Plasma clearance in rat,,N,10116.0,5833,50597,1,,,BAO_0000218,,
8355,Rattus norvegicus,CHEMBL618720,Intermediate,,Plasma clearance in rat,,N,10116.0,6453,50597,1,,,BAO_0000218,,
8356,Rattus norvegicus,CHEMBL618721,Intermediate,,Plasma clearance in rat,,N,10116.0,6640,50597,1,,,BAO_0000218,,
8357,Rattus norvegicus,CHEMBL621477,Intermediate,,Plasma clearance in rats,,N,10116.0,6305,50597,1,,,BAO_0000218,,
8358,Rattus norvegicus,CHEMBL621478,Intermediate,,Plasma clearance in rat,,N,10116.0,6642,50597,1,,,BAO_0000218,,
8359,Rattus norvegicus,CHEMBL621479,Intermediate,,Plasma clearance was evaluated in rat,,N,10116.0,5472,50597,1,,,BAO_0000218,,
8360,Rattus norvegicus,CHEMBL621480,Intermediate,,Plasma clearance was evaluated in rat; Not tested,,N,10116.0,5472,50597,1,,,BAO_0000218,,
8361,Rattus norvegicus,CHEMBL621481,Intermediate,,Plasma clearance rate was determined for the compound in rat,,N,10116.0,5144,50597,1,,,BAO_0000218,,
8362,Rattus norvegicus,CHEMBL621482,Intermediate,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,N,10116.0,6685,50597,1,,,BAO_0000218,,
8363,Rattus norvegicus,CHEMBL621483,Intermediate,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,N,10116.0,6685,50597,1,,,BAO_0000218,,
8364,Rattus norvegicus,CHEMBL621484,Intermediate,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,N,10116.0,6685,50597,1,,,BAO_0000218,,
8365,Rattus norvegicus,CHEMBL621485,Intermediate,Heart,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,948.0,
8366,Rattus norvegicus,CHEMBL621486,Intermediate,Heart,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,948.0,
8367,Rattus norvegicus,CHEMBL621487,Intermediate,Intestine,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,160.0,
8368,Rattus norvegicus,CHEMBL621488,Intermediate,Intestine,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,160.0,
8369,Rattus norvegicus,CHEMBL621489,Intermediate,Intestine,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,160.0,
8370,Rattus norvegicus,CHEMBL621490,Intermediate,Intestine,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,160.0,
8371,Rattus norvegicus,CHEMBL621491,Intermediate,Intestine,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,160.0,
8372,Rattus norvegicus,CHEMBL621492,Intermediate,Kidney,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2113.0,
8373,Rattus norvegicus,CHEMBL621493,Intermediate,Kidney,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2113.0,
8374,Rattus norvegicus,CHEMBL621494,Intermediate,Kidney,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2113.0,
8375,Rattus norvegicus,CHEMBL621495,Intermediate,Kidney,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2113.0,
8376,Rattus norvegicus,CHEMBL621496,Intermediate,Kidney,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2113.0,
8377,Rattus norvegicus,CHEMBL621497,Intermediate,Liver,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2107.0,
8378,Rattus norvegicus,CHEMBL621498,Intermediate,Liver,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2107.0,
8379,Rattus norvegicus,CHEMBL621499,Intermediate,Liver,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2107.0,
8380,Rattus norvegicus,CHEMBL618634,Intermediate,Liver,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2107.0,
8381,Rattus norvegicus,CHEMBL618635,Intermediate,Liver,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2107.0,
8382,Rattus norvegicus,CHEMBL618636,Intermediate,Lung,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2048.0,
8383,Rattus norvegicus,CHEMBL619737,Intermediate,Lung,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2048.0,
8384,Rattus norvegicus,CHEMBL619738,Intermediate,Lung,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2048.0,
8385,Rattus norvegicus,CHEMBL624329,Intermediate,Lung,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2048.0,
8386,Rattus norvegicus,CHEMBL624330,Intermediate,Lung,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2048.0,
8387,Rattus norvegicus,CHEMBL624331,Intermediate,Muscle tissue,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2385.0,
8388,Rattus norvegicus,CHEMBL624332,Intermediate,Muscle tissue,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2385.0,
8389,Rattus norvegicus,CHEMBL624333,Intermediate,Muscle tissue,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2385.0,
8390,Rattus norvegicus,CHEMBL624334,Intermediate,Muscle tissue,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2385.0,
8391,Rattus norvegicus,CHEMBL624335,Intermediate,Muscle tissue,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2385.0,
8392,Rattus norvegicus,CHEMBL620016,Intermediate,Spleen,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2106.0,
8393,Rattus norvegicus,CHEMBL620169,Intermediate,Spleen,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2106.0,
8394,Rattus norvegicus,CHEMBL620170,Intermediate,Spleen,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2106.0,
8395,Rattus norvegicus,CHEMBL620171,Intermediate,Spleen,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2106.0,
8396,Rattus norvegicus,CHEMBL620172,Intermediate,Spleen,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2106.0,
8397,Rattus norvegicus,CHEMBL620173,Intermediate,Stomach,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,945.0,
8398,Rattus norvegicus,CHEMBL620174,Intermediate,Stomach,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,945.0,
8399,Rattus norvegicus,CHEMBL620175,Intermediate,Stomach,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,945.0,
8400,Rattus norvegicus,CHEMBL620176,Intermediate,Stomach,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,945.0,
8401,Rattus norvegicus,CHEMBL620177,Intermediate,Stomach,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,945.0,
8402,Rattus norvegicus,CHEMBL620178,Intermediate,Cerebellum,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2037.0,
8403,Rattus norvegicus,CHEMBL620179,Intermediate,Cerebellum,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2037.0,
8404,Rattus norvegicus,CHEMBL620180,Intermediate,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,,
8405,Rattus norvegicus,CHEMBL620181,Intermediate,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,N,10116.0,6570,50597,1,,,BAO_0000218,,
8406,Rattus norvegicus,CHEMBL620182,Intermediate,,Volume of distribution of compound in rats after intravenous administration,,N,10116.0,6571,50597,1,,,BAO_0000218,,
8407,Rattus norvegicus,CHEMBL620183,Intermediate,,Volume of distribution in rat,,N,10116.0,6453,50597,1,,,BAO_0000218,,
8408,Rattus norvegicus,CHEMBL620184,Intermediate,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,N,10116.0,6444,50597,1,,,BAO_0000218,,
8409,Rattus norvegicus,CHEMBL620185,Intermediate,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,N,10116.0,6444,50597,1,,,BAO_0000218,,
8410,Rattus norvegicus,CHEMBL620186,Intermediate,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,N,10116.0,6444,50597,1,,,BAO_0000218,,
8411,Rattus norvegicus,CHEMBL620187,Intermediate,,Volume of distribution was determined in Dawley rat,,N,10116.0,5353,50597,1,,,BAO_0000218,,
8412,Rattus norvegicus,CHEMBL620188,Intermediate,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,N,10116.0,5334,50597,1,,,BAO_0000218,,
8413,Rattus norvegicus,CHEMBL620189,Intermediate,,Volume of distribution was reported in Sprague-Dawley rat,,N,10116.0,5334,50597,1,,,BAO_0000218,,
8414,Rattus norvegicus,CHEMBL620190,Intermediate,,Volumes of distribution in rat after peroral administration,,N,10116.0,6641,50597,1,,,BAO_0000218,,
8415,Rattus norvegicus,CHEMBL620191,Intermediate,,Volumes of distribution in rat after po administration,,N,10116.0,6641,50597,1,,,BAO_0000218,,
8416,Rattus norvegicus,CHEMBL620192,Intermediate,,Volumes of distribution in rat after po administration; Not determined,,N,10116.0,6641,50597,1,,,BAO_0000218,,
8417,Rattus norvegicus,CHEMBL620193,Intermediate,,Pharmacokinetic property (Volume) in rat i.v.,,N,10116.0,5676,50597,1,,,BAO_0000218,,
8418,Rattus norvegicus,CHEMBL620194,Intermediate,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,N,10116.0,6410,50597,1,,,BAO_0000218,,
8419,Rattus norvegicus,CHEMBL876730,Intermediate,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,N,10116.0,17670,50597,1,,,BAO_0000218,,
8420,Rattus norvegicus,CHEMBL620195,Intermediate,,Volume distribution in rat after oral administration at 10 mg/kg,,N,10116.0,6495,50597,1,,,BAO_0000218,,
8421,Rattus norvegicus,CHEMBL620196,Intermediate,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,N,10116.0,5408,50597,1,,,BAO_0000218,,
8422,Rattus norvegicus,CHEMBL620197,Intermediate,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,N,10116.0,4883,50597,1,,,BAO_0000218,,
8423,Rattus norvegicus,CHEMBL620198,Intermediate,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,N,10116.0,6647,50597,1,,,BAO_0000218,,
8424,Rattus norvegicus,CHEMBL620199,Intermediate,,Volume of distribution in rats,,N,10116.0,6495,50597,1,,,BAO_0000218,,
8425,Rattus norvegicus,CHEMBL620200,Intermediate,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
8426,Rattus norvegicus,CHEMBL620201,Intermediate,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
8427,Rattus norvegicus,CHEMBL620202,Intermediate,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
8428,Rattus norvegicus,CHEMBL620203,Intermediate,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
8429,Rattus norvegicus,CHEMBL620204,Intermediate,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,N,10116.0,5974,50597,1,,,BAO_0000218,,
8430,Rattus norvegicus,CHEMBL620205,Intermediate,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
8431,Rattus norvegicus,CHEMBL624664,Intermediate,,Pharmacokinetic parameter (Vss) in rat,,N,10116.0,5960,50597,1,,,BAO_0000218,,
8432,Rattus norvegicus,CHEMBL624665,Intermediate,,Pharmacokinetic property (Volume) in rat i.v.,,N,10116.0,5676,50597,1,,,BAO_0000218,,
8433,Rattus norvegicus,CHEMBL624666,Intermediate,,Pharmacokinetic property (Vss) in rat,,N,10116.0,5948,50597,1,,,BAO_0000218,,
8434,Rattus norvegicus,CHEMBL624667,Intermediate,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,N,10116.0,5979,50597,1,,,BAO_0000218,,
8435,Rattus norvegicus,CHEMBL624668,Intermediate,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
8436,Rattus norvegicus,CHEMBL624669,Intermediate,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
8437,Rattus norvegicus,CHEMBL624670,Intermediate,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
8438,Rattus norvegicus,CHEMBL624671,Intermediate,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
8439,Rattus norvegicus,CHEMBL624672,Intermediate,,Steady state volume distribution in rat,,N,10116.0,6448,50597,1,,,BAO_0000218,,
8440,Rattus norvegicus,CHEMBL624673,Intermediate,Plasma,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,N,10116.0,12873,50597,1,,,BAO_0000218,1969.0,
8441,Rattus norvegicus,CHEMBL624674,Intermediate,,Steady state volume of distribution determined in rat,,N,10116.0,4576,50597,1,,,BAO_0000218,,
8442,Rattus norvegicus,CHEMBL624675,Intermediate,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,N,10116.0,17582,50597,1,,,BAO_0000218,,
8443,Rattus norvegicus,CHEMBL621728,Intermediate,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,N,10116.0,1466,50597,1,,,BAO_0000218,,
8444,Rattus norvegicus,CHEMBL621729,Intermediate,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,N,10116.0,5182,50597,1,,,BAO_0000218,,
8445,Rattus norvegicus,CHEMBL621730,Intermediate,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,N,10116.0,5182,50597,1,,,BAO_0000218,,
8446,Rattus norvegicus,CHEMBL621731,Intermediate,,Volume distribution in rat after administration of 2 mg/kg iv,,N,10116.0,6535,50597,1,,,BAO_0000218,,
8447,Rattus norvegicus,CHEMBL621732,Intermediate,,Volume distribution in rat after administration of 2 mg/kg iv,,N,10116.0,6535,50597,1,,,BAO_0000218,,
8448,Rattus norvegicus,CHEMBL621908,Intermediate,,Volume in steady state distribution value was determined,,N,10116.0,5041,50597,1,,,BAO_0000218,,
8449,Rattus norvegicus,CHEMBL875347,Intermediate,,Volume in steady state distribution value was determined; ND denotes no data,,N,10116.0,5041,50597,1,,,BAO_0000218,,
8450,Rattus norvegicus,CHEMBL621909,Intermediate,,Volume in steady state distribution value was determined; ND denotes not determined,,N,10116.0,5041,50597,1,,,BAO_0000218,,
8451,Rattus norvegicus,CHEMBL621910,Intermediate,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,10116.0,17065,50597,1,,,BAO_0000218,,
8452,Rattus norvegicus,CHEMBL621911,Intermediate,,Volume of distribution at steady state was evaluated in rats,,N,10116.0,6597,50597,1,,,BAO_0000218,,
8453,Rattus norvegicus,CHEMBL621912,Intermediate,,Volume of distribution at steady state was observed after intravenous administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,,
8454,Rattus norvegicus,CHEMBL621913,Intermediate,,Volume of distribution in steady state was determined in rat,,N,10116.0,6485,50597,1,,,BAO_0000218,,
8455,Rattus norvegicus,CHEMBL621914,Intermediate,,Volume of distribution in steady state was determined in rat,,N,10116.0,17655,50597,1,,,BAO_0000218,,
8456,Rattus norvegicus,CHEMBL621915,Intermediate,,Volume of distribution after i.v. administration,,N,10116.0,6616,50597,1,,,BAO_0000218,,
8457,Rattus norvegicus,CHEMBL621916,Intermediate,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,N,10116.0,1916,50597,1,,,BAO_0000218,,
8458,Mus musculus,CHEMBL621917,Intermediate,Liver,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,N,10090.0,16438,50594,1,,,BAO_0000218,2107.0,
8459,Mus musculus,CHEMBL621918,Intermediate,Liver,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,N,10090.0,16438,50594,1,,,BAO_0000218,2107.0,
8460,Mus musculus,CHEMBL621919,Intermediate,Spleen,Biodistribution of compound (oxidized form) in spleen tissue,,N,10090.0,16438,50594,1,,,BAO_0000218,2106.0,
8461,Mus musculus,CHEMBL621920,Intermediate,Spleen,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,N,10090.0,16438,50594,1,,,BAO_0000218,2106.0,
8462,Mus musculus,CHEMBL621921,Intermediate,Spleen,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,N,10090.0,16438,50594,1,,,BAO_0000218,2106.0,
8463,Mus musculus,CHEMBL622401,Intermediate,Spleen,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,10090.0,16438,50594,1,,,BAO_0000218,2106.0,
8464,Mus musculus,CHEMBL875348,Intermediate,Spleen,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,N,10090.0,16438,50594,1,,,BAO_0000218,2106.0,
8465,Mus musculus,CHEMBL622402,Intermediate,Spleen,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,N,10090.0,16438,50594,1,,,BAO_0000218,2106.0,
8466,Mus musculus,CHEMBL622403,Intermediate,Blood,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,N,10090.0,16438,50594,1,,,BAO_0000218,178.0,
8467,Mus musculus,CHEMBL622404,Intermediate,Blood,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,10090.0,16438,50594,1,,,BAO_0000218,178.0,
8468,Mus musculus,CHEMBL622405,Intermediate,Brain,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,N,10090.0,16438,50594,1,,,BAO_0000218,955.0,
8469,Mus musculus,CHEMBL622406,Intermediate,Brain,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,N,10090.0,16438,50594,1,,,BAO_0000218,955.0,
8470,Mus musculus,CHEMBL622407,Intermediate,Brain,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,10090.0,16438,50594,1,,,BAO_0000218,955.0,
8471,Mus musculus,CHEMBL622408,Intermediate,Heart,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,N,10090.0,16438,50594,1,,,BAO_0000218,948.0,
8472,Mus musculus,CHEMBL622409,Intermediate,Heart,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,N,10090.0,16438,50594,1,,,BAO_0000218,948.0,
8473,Mus musculus,CHEMBL622410,Intermediate,Heart,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,10090.0,16438,50594,1,,,BAO_0000218,948.0,
8474,Mus musculus,CHEMBL622411,Intermediate,Kidney,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,N,10090.0,16438,50594,1,,,BAO_0000218,2113.0,
8475,Mus musculus,CHEMBL627864,Intermediate,Kidney,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,N,10090.0,16438,50594,1,,,BAO_0000218,2113.0,
8476,Mus musculus,CHEMBL627865,Intermediate,Kidney,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,10090.0,16438,50594,1,,,BAO_0000218,2113.0,
8477,Mus musculus,CHEMBL627866,Intermediate,Liver,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,N,10090.0,16438,50594,1,,,BAO_0000218,2107.0,
8478,Mus musculus,CHEMBL627751,Intermediate,Liver,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,10090.0,16438,50594,1,,,BAO_0000218,2107.0,
8479,Mus musculus,CHEMBL627752,Intermediate,Spleen,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,N,10090.0,16438,50594,1,,,BAO_0000218,2106.0,
8480,Mus musculus,CHEMBL627753,Intermediate,Spleen,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,N,10090.0,16438,50594,1,,,BAO_0000218,2106.0,
8481,Mus musculus,CHEMBL627754,Intermediate,Spleen,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,10090.0,16438,50594,1,,,BAO_0000218,2106.0,
8482,Mus musculus,CHEMBL627755,Intermediate,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,N,10090.0,12467,50594,1,,,BAO_0000218,,
8483,Mus musculus,CHEMBL627756,Intermediate,Brain,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,955.0,
8484,Mus musculus,CHEMBL627757,Intermediate,Brain,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,955.0,
8485,Mus musculus,CHEMBL627758,Intermediate,Brain,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,955.0,
8486,Mus musculus,CHEMBL627759,Intermediate,Brain,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,955.0,
8487,Mus musculus,CHEMBL627760,Intermediate,Brain,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,955.0,
8488,Mus musculus,CHEMBL627761,Intermediate,Brain,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,955.0,
8489,Mus musculus,CHEMBL876811,Intermediate,Heart,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,948.0,
8490,Mus musculus,CHEMBL627762,Intermediate,Heart,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,948.0,
8491,Mus musculus,CHEMBL627763,Intermediate,Heart,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,948.0,
8492,Mus musculus,CHEMBL627764,Intermediate,Heart,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,948.0,
8493,Mus musculus,CHEMBL627765,Intermediate,Heart,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,948.0,
8494,Mus musculus,CHEMBL627766,Intermediate,Heart,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,948.0,
8495,Mus musculus,CHEMBL627767,Intermediate,Kidney,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2113.0,
8496,Mus musculus,CHEMBL627768,Intermediate,Kidney,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2113.0,
8497,Mus musculus,CHEMBL628422,Intermediate,Kidney,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2113.0,
8498,Mus musculus,CHEMBL628423,Intermediate,Kidney,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2113.0,
8499,Rattus norvegicus,CHEMBL628424,Intermediate,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,N,10116.0,5089,50597,1,,,BAO_0000218,,
8500,Rattus norvegicus,CHEMBL628425,Intermediate,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,N,10116.0,5089,50597,1,,,BAO_0000218,,
8501,Rattus norvegicus,CHEMBL628426,Intermediate,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,N,10116.0,4257,50597,1,,,BAO_0000218,,
8502,Rattus norvegicus,CHEMBL628427,Intermediate,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,N,10116.0,6679,50597,1,,,BAO_0000218,,
8503,Rattus norvegicus,CHEMBL626938,Intermediate,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,N,10116.0,5546,50597,1,,,BAO_0000218,,
8504,Rattus norvegicus,CHEMBL626939,Intermediate,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,N,10116.0,6141,50597,1,,,BAO_0000218,,
8505,Rattus norvegicus,CHEMBL626940,Intermediate,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,N,10116.0,5334,50597,1,,,BAO_0000218,,
8506,Rattus norvegicus,CHEMBL626941,Intermediate,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,N,10116.0,5334,50597,1,,,BAO_0000218,,
8507,Rattus norvegicus,CHEMBL626942,Intermediate,,Plasma clearance was reported in Sprague-Dawley rat,,N,10116.0,5334,50597,1,,,BAO_0000218,,
8508,Rattus norvegicus,CHEMBL876812,Intermediate,,Plasma clearance after intravenous administration (1 mg/kg) in rat,,N,10116.0,4689,50597,1,,,BAO_0000218,,
8509,Rattus norvegicus,CHEMBL626943,Intermediate,,Plasma clearance of compound in rats was evaluated,,N,10116.0,6848,50597,1,,,BAO_0000218,,
8510,Rattus norvegicus,CHEMBL626944,Intermediate,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,N,10116.0,6848,50597,1,,,BAO_0000218,,
8511,Rattus norvegicus,CHEMBL626945,Intermediate,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,N,10116.0,6467,50597,1,,,BAO_0000218,,
8512,Rattus norvegicus,CHEMBL626946,Intermediate,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,N,10116.0,6467,50597,1,,,BAO_0000218,,
8513,Rattus norvegicus,CHEMBL626856,Intermediate,,Plasma clearance rate in Sprague-Dawley rats,,N,10116.0,4956,50597,1,,,BAO_0000218,,
8514,Rattus norvegicus,CHEMBL626857,Intermediate,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,N,10116.0,5529,50597,1,,,BAO_0000218,,
8515,Rattus norvegicus,CHEMBL626858,Intermediate,Plasma,The compound was evaluated for plasma clearance in rat,,N,10116.0,406,50597,1,,,BAO_0000218,1969.0,
8516,Rattus norvegicus,CHEMBL627018,Intermediate,Plasma,Total plasma clearance in rat,,N,10116.0,17655,50597,1,,,BAO_0000218,1969.0,
8517,Rattus norvegicus,CHEMBL625331,Intermediate,Blood,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,N,10116.0,3293,50597,1,,,BAO_0000218,178.0,
8518,Rattus norvegicus,CHEMBL625332,Intermediate,Blood,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,N,10116.0,4075,50597,1,,,BAO_0000218,178.0,
8519,Rattus norvegicus,CHEMBL877590,Intermediate,,C max was determined at 10 mg/kg po dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
8520,Rattus norvegicus,CHEMBL625333,Intermediate,,C max was determined at 3 mg/kg po dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
8521,Rattus norvegicus,CHEMBL625334,Intermediate,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,N,10116.0,17594,50597,1,,,BAO_0000218,,
8522,Rattus norvegicus,CHEMBL625335,Intermediate,,Cmax after single intravenous bolus of 1 mg/kg in rats,,N,10116.0,17594,50597,1,,,BAO_0000218,,
8523,Rattus norvegicus,CHEMBL625336,Intermediate,,Cmax of compound at 5 mg/kg after po administration was determined in rat,,N,10116.0,4762,50597,1,,,BAO_0000218,,
8524,Rattus norvegicus,CHEMBL625337,Intermediate,,Cmax 24 hr after 10 mg/kg oral administration in rats,,N,10116.0,17509,50597,1,,,BAO_0000218,,
8525,Rattus norvegicus,CHEMBL625338,Intermediate,,Cmax 24 hr after 2 mg/kg oral administration in rats,,N,10116.0,17509,50597,1,,,BAO_0000218,,
8526,Rattus norvegicus,CHEMBL625339,Intermediate,Plasma,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,N,10116.0,1466,50597,1,,,BAO_0000218,1969.0,
8527,Rattus norvegicus,CHEMBL625340,Intermediate,,Cmax in rat after administration of 2 mg/kg iv,,N,10116.0,6535,50597,1,,,BAO_0000218,,
8528,Rattus norvegicus,CHEMBL625341,Intermediate,,Cmax in rat after administration of 2 mg/kg iv,,N,10116.0,6535,50597,1,,,BAO_0000218,,
8529,Rattus norvegicus,CHEMBL622687,Intermediate,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,N,10116.0,3169,50597,1,,,BAO_0000218,,
8530,Rattus norvegicus,CHEMBL622688,Intermediate,Plasma,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,N,10116.0,6515,50597,1,,,BAO_0000218,1969.0,
8531,Rattus norvegicus,CHEMBL622689,Intermediate,Blood,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,N,10116.0,11149,50597,1,,,BAO_0000218,178.0,
8532,Rattus norvegicus,CHEMBL620295,Intermediate,Blood,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,N,10116.0,11149,50597,1,,,BAO_0000218,178.0,
8533,Rattus norvegicus,CHEMBL620296,Intermediate,,Cmax after 10 mg/kg oral administration in rat,,N,10116.0,17858,50597,1,,,BAO_0000218,,
8534,Rattus norvegicus,CHEMBL620297,Intermediate,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,N,10116.0,6518,50597,1,,,BAO_0000218,,
8535,Rattus norvegicus,CHEMBL620298,Intermediate,,Cmax after IV dosing at 1 mg/kg in rat; no data,,N,10116.0,6518,50597,1,,,BAO_0000218,,
8536,Rattus norvegicus,CHEMBL620299,Intermediate,,Cmax after oral administration at 20 mpk in rats,,N,10116.0,4426,50597,1,,,BAO_0000218,,
8537,Rattus norvegicus,CHEMBL620300,Intermediate,,Cmax after oral administration at 20 mpk in rats; Not performed.,,N,10116.0,4426,50597,1,,,BAO_0000218,,
8538,Rattus norvegicus,CHEMBL620301,Intermediate,,Cmax after oral administration at 20 mpk in rats d; Not performed.,,N,10116.0,4426,50597,1,,,BAO_0000218,,
8539,Rattus norvegicus,CHEMBL620302,Intermediate,,Cmax after oral administration in rat,,N,10116.0,5656,50597,1,,,BAO_0000218,,
8540,Rattus norvegicus,CHEMBL620303,Intermediate,,Cmax after oral administration at a dose of 2 mg/kg in rat,,N,10116.0,6518,50597,1,,,BAO_0000218,,
8541,Rattus norvegicus,CHEMBL620304,Intermediate,,Cmax after oral administration at a dose of 4 mg/kg in rat,,N,10116.0,6518,50597,1,,,BAO_0000218,,
8542,Rattus norvegicus,CHEMBL620305,Intermediate,,Cmax in rats after 20 mg/kg oral dose,,N,10116.0,6113,50597,1,,,BAO_0000218,,
8543,Rattus norvegicus,CHEMBL620306,Intermediate,,Cmax after peroral administration in rats at 2.4 uM/kg,,N,10116.0,17764,50597,1,,,BAO_0000218,,
8544,Rattus norvegicus,CHEMBL620307,Intermediate,,Cmax at the dose of 2 mg/Kg administered perorally in rats,,N,10116.0,4756,50597,1,,,BAO_0000218,,
8545,Rattus norvegicus,CHEMBL620308,Intermediate,,Cmax at the dose of 5 mg/Kg administered perorally in rats,,N,10116.0,4756,50597,1,,,BAO_0000218,,
8546,Rattus norvegicus,CHEMBL620309,Intermediate,,Cmax by administering at 20 mg/kg p.o. in rats,,N,10116.0,6402,50597,1,,,BAO_0000218,,
8547,Rattus norvegicus,CHEMBL620310,Intermediate,,Cmax in male rat,,N,10116.0,5610,50597,1,,,BAO_0000218,,
8548,Rattus norvegicus,CHEMBL620311,Intermediate,,Cmax in rat,,N,10116.0,5207,50597,1,,,BAO_0000218,,
8549,Rattus norvegicus,CHEMBL620312,Intermediate,,Cmax in rat,,N,10116.0,6011,50597,1,,,BAO_0000218,,
8550,Rattus norvegicus,CHEMBL620313,Intermediate,,Cmax in rat,,N,10116.0,6504,50597,1,,,BAO_0000218,,
8551,Rattus norvegicus,CHEMBL620314,Intermediate,,Cmax in rat at 10 mg/kg,,N,10116.0,6046,50597,1,,,BAO_0000218,,
8552,Rattus norvegicus,CHEMBL620315,Intermediate,,Cmax in rat at the dose of 1 mg/kg i.v.,,N,10116.0,6504,50597,1,,,BAO_0000218,,
8553,Rattus norvegicus,CHEMBL620316,Intermediate,,Cmax in rat by po administration at a dose of 40 mg/kg,,N,10116.0,5874,50597,1,,,BAO_0000218,,
8554,Rattus norvegicus,CHEMBL620317,Intermediate,,Cmax in rat p.o. at 20 mg/kg concentration,,N,10116.0,17686,50597,1,,,BAO_0000218,,
8555,Rattus norvegicus,CHEMBL620318,Intermediate,,Cmax in rats,,N,10116.0,5836,50597,1,,,BAO_0000218,,
8556,Rattus norvegicus,CHEMBL620319,Intermediate,,Cmax in rats,,N,10116.0,17596,50597,1,,,BAO_0000218,,
8557,Rattus norvegicus,CHEMBL620320,Intermediate,,Cmax was evaluated after 20 uM/kg of peroral administration,,N,10116.0,16423,50597,1,,,BAO_0000218,,
8558,Rattus norvegicus,CHEMBL620321,Intermediate,,Cmax was measured in rats after peroral administration at 3 mg/kg,,N,10116.0,17804,50597,1,,,BAO_0000218,,
8559,Rattus norvegicus,CHEMBL620322,Intermediate,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,N,10116.0,1908,50597,1,,,BAO_0000218,,
8560,Rattus norvegicus,CHEMBL620323,Intermediate,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,,
8561,Rattus norvegicus,CHEMBL620324,Intermediate,Frontal cortex,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,1870.0,
8562,Rattus norvegicus,CHEMBL620325,Intermediate,Frontal cortex,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,1870.0,
8563,Rattus norvegicus,CHEMBL620326,Intermediate,Hippocampus,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,10000000.0,
8564,Rattus norvegicus,CHEMBL620327,Intermediate,Hippocampus,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,10000000.0,
8565,Rattus norvegicus,CHEMBL620328,Intermediate,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,,
8566,Rattus norvegicus,CHEMBL620329,Intermediate,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,,
8567,Rattus norvegicus,CHEMBL620330,Intermediate,Midbrain,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,1891.0,
8568,Rattus norvegicus,CHEMBL875286,Intermediate,Midbrain,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,1891.0,
8569,Rattus norvegicus,CHEMBL620331,Intermediate,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,,
8570,Rattus norvegicus,CHEMBL620332,Intermediate,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,,
8571,Rattus norvegicus,CHEMBL620333,Intermediate,Striatum,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2435.0,
8572,Rattus norvegicus,CHEMBL620334,Intermediate,Striatum,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,10116.0,13950,50597,1,,,BAO_0000218,2435.0,
8573,Rattus norvegicus,CHEMBL621015,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,178.0,
8574,Rattus norvegicus,CHEMBL621016,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,178.0,
8575,Rattus norvegicus,CHEMBL621191,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,178.0,
8576,Rattus norvegicus,CHEMBL621192,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,178.0,
8577,Rattus norvegicus,CHEMBL621193,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,178.0,
8578,Rattus norvegicus,CHEMBL621194,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,178.0,
8579,Rattus norvegicus,CHEMBL624204,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,178.0,
8580,Rattus norvegicus,CHEMBL624205,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,178.0,
8581,Rattus norvegicus,CHEMBL624206,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8582,Rattus norvegicus,CHEMBL624207,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8583,Rattus norvegicus,CHEMBL624208,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8584,Rattus norvegicus,CHEMBL624209,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8585,Rattus norvegicus,CHEMBL624210,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8586,Rattus norvegicus,CHEMBL624211,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8587,Rattus norvegicus,CHEMBL624212,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8588,Rattus norvegicus,CHEMBL624213,Intermediate,Blood,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8589,Rattus norvegicus,CHEMBL876611,Intermediate,Blood,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,10116.0,16434,50597,1,,,BAO_0000218,178.0,
8590,Rattus norvegicus,CHEMBL624214,Intermediate,Blood,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,10116.0,16434,50597,1,,,BAO_0000218,178.0,
8591,Rattus norvegicus,CHEMBL624215,Intermediate,Blood,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,10116.0,16434,50597,1,,,BAO_0000218,178.0,
8592,Rattus norvegicus,CHEMBL624216,Intermediate,Blood,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8593,Rattus norvegicus,CHEMBL624217,Intermediate,Blood,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8594,Rattus norvegicus,CHEMBL624218,Intermediate,Blood,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8595,Rattus norvegicus,CHEMBL624219,Intermediate,Blood,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8596,Rattus norvegicus,CHEMBL624220,Intermediate,Blood,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8597,Rattus norvegicus,CHEMBL624221,Intermediate,Blood,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,178.0,
8598,Rattus norvegicus,CHEMBL624222,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
8599,Rattus norvegicus,CHEMBL624223,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
8600,Rattus norvegicus,CHEMBL624224,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
8601,Rattus norvegicus,CHEMBL624225,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
8602,Rattus norvegicus,CHEMBL622420,Intermediate,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,N,10116.0,17764,50597,1,,,BAO_0000218,,
8603,Rattus norvegicus,CHEMBL622421,Intermediate,,Volume of steady state distribution after i.v. administration in rats,,N,10116.0,5031,50597,1,,,BAO_0000218,,
8604,Rattus norvegicus,CHEMBL622422,Intermediate,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,N,10116.0,6215,50597,1,,,BAO_0000218,,
8605,Rattus norvegicus,CHEMBL622423,Intermediate,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,10116.0,17671,50597,1,,,BAO_0000218,,
8606,Rattus norvegicus,CHEMBL622424,Intermediate,,Vss was determined,,N,10116.0,17752,50597,1,,,BAO_0000218,,
8607,Rattus norvegicus,CHEMBL622425,Intermediate,,Vss in rat,,N,10116.0,6596,50597,1,,,BAO_0000218,,
8608,Rattus norvegicus,CHEMBL876612,Intermediate,,Vss was evaluated after 10 uM/kg of intra arterial administration,,N,10116.0,16423,50597,1,,,BAO_0000218,,
8609,Rattus norvegicus,CHEMBL622426,Intermediate,,volume of distribution at steady state was observed after intravenous administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,,
8610,Rattus norvegicus,CHEMBL622427,Intermediate,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,N,10116.0,6062,50597,1,,,BAO_0000218,,
8611,Rattus norvegicus,CHEMBL622428,Intermediate,,Pharmacokinetic (PK) parameter Vz in rat,,N,10116.0,5874,50597,1,,,BAO_0000218,,
8612,Rattus norvegicus,CHEMBL622429,Intermediate,,Volume distribution in rats,,N,10116.0,4942,50597,1,,,BAO_0000218,,
8613,Rattus norvegicus,CHEMBL622430,Intermediate,,Volume of distribution in rat; No data,,N,10116.0,17796,50597,1,,,BAO_0000218,,
8614,Rattus norvegicus,CHEMBL622431,Intermediate,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,N,10116.0,4890,50597,1,,,BAO_0000218,,
8615,Rattus norvegicus,CHEMBL622432,Intermediate,Ileum,% absorption predicted from in vitro rat ileum transport studies,,N,10116.0,15765,50597,1,,,BAO_0000218,2116.0,
8616,Rattus norvegicus,CHEMBL622433,Intermediate,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8617,Rattus norvegicus,CHEMBL622434,Intermediate,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8618,Rattus norvegicus,CHEMBL622435,Intermediate,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8619,Rattus norvegicus,CHEMBL618748,Intermediate,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,N,10116.0,13569,50597,1,,,BAO_0000218,,
8620,Rattus norvegicus,CHEMBL618749,Intermediate,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8621,Rattus norvegicus,CHEMBL618750,Intermediate,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8622,Rattus norvegicus,CHEMBL618751,Intermediate,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8623,Rattus norvegicus,CHEMBL618752,Intermediate,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,N,10116.0,13569,50597,1,,,BAO_0000218,,
8624,Rattus norvegicus,CHEMBL618753,Intermediate,,Oral bioavailability in rat,,N,10116.0,4576,50597,1,,,BAO_0000218,,
8625,Rattus norvegicus,CHEMBL618754,Intermediate,Plasma,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,N,10116.0,750,50597,1,,,BAO_0000218,1969.0,
8626,Rattus norvegicus,CHEMBL618755,Intermediate,,Oral bioavailability in rat,,N,10116.0,750,50597,1,,,BAO_0000218,,
8627,Rattus norvegicus,CHEMBL618756,Intermediate,,Oral bioavailability in rat,,N,10116.0,4590,50597,1,,,BAO_0000218,,
8628,Rattus norvegicus,CHEMBL618757,Intermediate,,Oral bioavailability in rat,,N,10116.0,1716,50597,1,,,BAO_0000218,,
8629,Rattus norvegicus,CHEMBL618758,Intermediate,,Bioavailability in rat,,N,10116.0,1974,50597,1,,,BAO_0000218,,
8630,Rattus norvegicus,CHEMBL621088,Intermediate,,Oral bioavailability in rat (dose 30 mg/kg),,N,10116.0,4502,50597,1,,,BAO_0000218,,
8631,Rattus norvegicus,CHEMBL621089,Intermediate,,Pharmacokinetic property (cLogP) in rat,,N,10116.0,3371,50597,1,,,BAO_0000218,,
8632,Rattus norvegicus,CHEMBL621090,Intermediate,Blood,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,N,10116.0,9099,50597,1,,,BAO_0000218,178.0,
8633,Rattus norvegicus,CHEMBL621091,Intermediate,Blood,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,N,10116.0,9099,50597,1,,,BAO_0000218,178.0,
8634,Rattus norvegicus,CHEMBL876731,Intermediate,,Clearance in rat.,,N,10116.0,4590,50597,1,,,BAO_0000218,,
8635,Rattus norvegicus,CHEMBL621092,Intermediate,,Compound was evaluated for its clearance when administered intravenously in rat,,N,10116.0,3184,50597,1,,,BAO_0000218,,
8636,Rattus norvegicus,CHEMBL621093,Intermediate,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,N,10116.0,16456,50597,1,,,BAO_0000218,,
8637,Rattus norvegicus,CHEMBL621094,Intermediate,,Blood: Brain distribution ratio is determined in rat,,N,10116.0,4199,50597,1,,,BAO_0000218,,
8638,Rattus norvegicus,CHEMBL621095,Intermediate,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,N,10116.0,4199,50597,1,,,BAO_0000218,,
8639,Rattus norvegicus,CHEMBL621096,Intermediate,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,N,10116.0,4199,50597,1,,,BAO_0000218,,
8640,Rattus norvegicus,CHEMBL621097,Intermediate,Kidney,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2113.0,
8641,Rattus norvegicus,CHEMBL621098,Intermediate,,Percent dose excreted in 0-48 hours administered ip to male rat,,N,10116.0,7449,50597,1,,,BAO_0000218,,
8642,Rattus norvegicus,CHEMBL621099,Intermediate,Cerebellum,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2037.0,
8643,Rattus norvegicus,CHEMBL621100,Intermediate,Cerebellum,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2037.0,
8644,Rattus norvegicus,CHEMBL621101,Intermediate,Cerebellum,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2037.0,
8645,Rattus norvegicus,CHEMBL621102,Intermediate,Cerebellum,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2037.0,
8646,Rattus norvegicus,CHEMBL876732,Intermediate,Cerebellum,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2037.0,
8647,Rattus norvegicus,CHEMBL621103,Intermediate,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,,
8648,Rattus norvegicus,CHEMBL621104,Intermediate,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,,
8649,Rattus norvegicus,CHEMBL621105,Intermediate,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,,
8650,Rattus norvegicus,CHEMBL621106,Intermediate,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,,
8651,Rattus norvegicus,CHEMBL621107,Intermediate,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,,
8652,Rattus norvegicus,CHEMBL621108,Intermediate,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,,
8653,Rattus norvegicus,CHEMBL621109,Intermediate,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,,
8654,Mus musculus,CHEMBL621110,Intermediate,Kidney,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2113.0,
8655,Mus musculus,CHEMBL621111,Intermediate,Kidney,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2113.0,
8656,Mus musculus,CHEMBL622541,Intermediate,Liver,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2107.0,
8657,Mus musculus,CHEMBL622542,Intermediate,Liver,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2107.0,
8658,Mus musculus,CHEMBL622543,Intermediate,Liver,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2107.0,
8659,Mus musculus,CHEMBL624412,Intermediate,Liver,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2107.0,
8660,Mus musculus,CHEMBL624413,Intermediate,Liver,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2107.0,
8661,Mus musculus,CHEMBL624414,Intermediate,Liver,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2107.0,
8662,Mus musculus,CHEMBL624415,Intermediate,Lung,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2048.0,
8663,Mus musculus,CHEMBL624416,Intermediate,Lung,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2048.0,
8664,Mus musculus,CHEMBL624417,Intermediate,Lung,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2048.0,
8665,Mus musculus,CHEMBL624418,Intermediate,Lung,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2048.0,
8666,Mus musculus,CHEMBL624419,Intermediate,Lung,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2048.0,
8667,Mus musculus,CHEMBL624420,Intermediate,Lung,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2048.0,
8668,Mus musculus,CHEMBL624421,Intermediate,Muscle tissue,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2385.0,
8669,Mus musculus,CHEMBL624422,Intermediate,Muscle tissue,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2385.0,
8670,Mus musculus,CHEMBL624423,Intermediate,Muscle tissue,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2385.0,
8671,Mus musculus,CHEMBL625123,Intermediate,Muscle tissue,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2385.0,
8672,Mus musculus,CHEMBL625124,Intermediate,Muscle tissue,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2385.0,
8673,Mus musculus,CHEMBL625125,Intermediate,Muscle tissue,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2385.0,
8674,Mus musculus,CHEMBL625126,Intermediate,Zone of skin,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,14.0,
8675,Mus musculus,CHEMBL626947,Intermediate,Zone of skin,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,14.0,
8676,Mus musculus,CHEMBL626948,Intermediate,Zone of skin,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,14.0,
8677,Mus musculus,CHEMBL626949,Intermediate,Zone of skin,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,14.0,
8678,Mus musculus,CHEMBL626950,Intermediate,Zone of skin,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,14.0,
8679,Mus musculus,CHEMBL626951,Intermediate,Zone of skin,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,14.0,
8680,Mus musculus,CHEMBL626952,Intermediate,Spleen,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2106.0,
8681,Mus musculus,CHEMBL626953,Intermediate,Spleen,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2106.0,
8682,Mus musculus,CHEMBL626954,Intermediate,Spleen,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2106.0,
8683,Mus musculus,CHEMBL626955,Intermediate,Spleen,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2106.0,
8684,Mus musculus,CHEMBL626956,Intermediate,Spleen,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2106.0,
8685,Mus musculus,CHEMBL626957,Intermediate,Spleen,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,2106.0,
8686,Mus musculus,CHEMBL626958,Intermediate,Blood,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,178.0,
8687,Mus musculus,CHEMBL626959,Intermediate,Blood,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,178.0,
8688,Mus musculus,CHEMBL626960,Intermediate,Blood,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,178.0,
8689,Mus musculus,CHEMBL626961,Intermediate,Blood,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,178.0,
8690,Mus musculus,CHEMBL627589,Intermediate,Blood,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,178.0,
8691,Mus musculus,CHEMBL627590,Intermediate,Blood,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,N,10090.0,17208,50594,1,,,BAO_0000218,178.0,
8692,Mus musculus,CHEMBL627591,Intermediate,,Time taken for EC90 was determined when tested in mouse,,N,10090.0,3132,50594,1,,,BAO_0000218,,
8693,Mus musculus,CHEMBL627592,Intermediate,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,N,10090.0,3132,50594,1,,,BAO_0000218,,
8694,Mus musculus,CHEMBL627593,Intermediate,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,N,10090.0,16597,50594,1,,,BAO_0000218,,
8695,Mus musculus,CHEMBL627594,Intermediate,,Half life in mice,,N,10090.0,5727,50594,1,,,BAO_0000218,,
8696,Mus musculus,CHEMBL876813,Intermediate,,Half life period in mouse after 10 mg/Kg dose,,N,10090.0,5302,50594,1,,,BAO_0000218,,
8697,Mus musculus,CHEMBL627595,Intermediate,,Half life period in mouse after 10 mg/kg dose,,N,10090.0,5302,50594,1,,,BAO_0000218,,
8698,Mus musculus,CHEMBL627596,Intermediate,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,N,10090.0,6348,50594,1,,,BAO_0000218,,
8699,Rattus norvegicus,CHEMBL627597,Intermediate,,Cmax value at 5 mg/kg po was determined in rat,,N,10116.0,5964,50597,1,,,BAO_0000218,,
8700,Rattus norvegicus,CHEMBL627598,Intermediate,,Cmax value evaluated in rat,,N,10116.0,6078,50597,1,,,BAO_0000218,,
8701,Rattus norvegicus,CHEMBL627599,Intermediate,Brain,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,N,10116.0,5206,50597,1,,,BAO_0000218,955.0,
8702,Rattus norvegicus,CHEMBL627600,Intermediate,,Cmax value after administration of 20 mg/Kg oral dose in rat,,N,10116.0,2959,50597,1,,,BAO_0000218,,
8703,Rattus norvegicus,CHEMBL627601,Intermediate,,Cmax value at 1 mg/kg po in rat,,N,10116.0,5964,50597,1,,,BAO_0000218,,
8704,Rattus norvegicus,CHEMBL627776,Intermediate,,Cmax value at 5 mg/kg po in rat,,N,10116.0,5964,50597,1,,,BAO_0000218,,
8705,Rattus norvegicus,CHEMBL627777,Intermediate,,Cmax value at a dose of 10 mg/kg in male SD rats,,N,10116.0,6757,50597,1,,,BAO_0000218,,
8706,Rattus norvegicus,CHEMBL627778,Intermediate,,Cmax value at a dose of 100 mg/kg in male SD rats,,N,10116.0,6757,50597,1,,,BAO_0000218,,
8707,Rattus norvegicus,CHEMBL627779,Intermediate,,Cmax value at a dose of 50 mg/kg in male SD rats,,N,10116.0,6757,50597,1,,,BAO_0000218,,
8708,Rattus norvegicus,CHEMBL876814,Intermediate,,Cmax value in rats at 10 mg/kg,,N,10116.0,17617,50597,1,,,BAO_0000218,,
8709,Rattus norvegicus,CHEMBL627780,Intermediate,,Cmax value was evaluated in rats at a dose of 20 mg/kg,,N,10116.0,1445,50597,1,,,BAO_0000218,,
8710,Rattus norvegicus,CHEMBL627781,Intermediate,,Cmax value was determined after peroral administration of 20 mg/kg in rat,,N,10116.0,6082,50597,1,,,BAO_0000218,,
8711,Rattus norvegicus,CHEMBL627782,Intermediate,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,N,10116.0,1446,50597,1,,,BAO_0000218,,
8712,Rattus norvegicus,CHEMBL627783,Intermediate,Plasma,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,N,10116.0,5407,50597,1,,,BAO_0000218,1969.0,
8713,Rattus norvegicus,CHEMBL627784,Intermediate,Plasma,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,N,10116.0,2690,50597,1,,,BAO_0000218,1969.0,
8714,Rattus norvegicus,CHEMBL627785,Intermediate,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
8715,Rattus norvegicus,CHEMBL627786,Intermediate,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
8716,Rattus norvegicus,CHEMBL627787,Intermediate,Plasma,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,N,10116.0,4891,50597,1,,,BAO_0000218,1969.0,
8717,Rattus norvegicus,CHEMBL627788,Intermediate,Plasma,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,N,10116.0,2807,50597,1,,,BAO_0000218,1969.0,
8718,Rattus norvegicus,CHEMBL626579,Intermediate,Plasma,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,N,10116.0,2807,50597,1,,,BAO_0000218,1969.0,
8719,Rattus norvegicus,CHEMBL626580,Intermediate,Plasma,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,N,10116.0,2807,50597,1,,,BAO_0000218,1969.0,
8720,Rattus norvegicus,CHEMBL876815,Intermediate,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,N,10116.0,3634,50597,1,,,BAO_0000218,,
8721,Rattus norvegicus,CHEMBL626581,Intermediate,Plasma,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,N,10116.0,1881,50597,1,,,BAO_0000218,1969.0,
8722,Rattus norvegicus,CHEMBL626582,Intermediate,Plasma,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,N,10116.0,1881,50597,1,,,BAO_0000218,1969.0,
8723,Rattus norvegicus,CHEMBL626583,Intermediate,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,N,10116.0,429,50597,1,,,BAO_0000218,,
8724,Rattus norvegicus,CHEMBL626205,Intermediate,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
8725,Rattus norvegicus,CHEMBL626206,Intermediate,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
8726,Rattus norvegicus,CHEMBL626207,Intermediate,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
8727,Rattus norvegicus,CHEMBL623882,Intermediate,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
8728,Rattus norvegicus,CHEMBL623883,Intermediate,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,N,10116.0,17582,50597,1,,,BAO_0000218,,
8729,Rattus norvegicus,CHEMBL623884,Intermediate,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,N,10116.0,17582,50597,1,,,BAO_0000218,,
8730,Rattus norvegicus,CHEMBL623885,Intermediate,Plasma,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,N,10116.0,3032,50597,1,,,BAO_0000218,1969.0,
8731,Rattus norvegicus,CHEMBL623886,Intermediate,Plasma,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,N,10116.0,6295,50597,1,,,BAO_0000218,1969.0,
8732,Rattus norvegicus,CHEMBL623887,Intermediate,,Maximal concentration in rat was determined,,N,10116.0,6619,50597,1,,,BAO_0000218,,
8733,Rattus norvegicus,CHEMBL623888,Intermediate,,Maximal concentration after i.v. administration,,N,10116.0,6616,50597,1,,,BAO_0000218,,
8734,Rattus norvegicus,CHEMBL623889,Intermediate,Plasma,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,N,10116.0,3249,50597,1,,,BAO_0000218,1969.0,
8735,Rattus norvegicus,CHEMBL623890,Intermediate,Plasma,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,N,10116.0,17791,50597,1,,,BAO_0000218,1969.0,
8736,Rattus norvegicus,CHEMBL623891,Intermediate,Plasma,Cmax in rat plasma after oral dose (50 mg/Kg),,N,10116.0,17791,50597,1,,,BAO_0000218,1969.0,
8737,Rattus norvegicus,CHEMBL623892,Intermediate,Plasma,Maximal plasma concentration was determined.,,N,10116.0,1360,50597,1,,,BAO_0000218,1969.0,
8738,Rattus norvegicus,CHEMBL623893,Intermediate,Plasma,Maximal plasma drug concentration was determined,,N,10116.0,2552,50597,1,,,BAO_0000218,1969.0,
8739,Rattus norvegicus,CHEMBL877616,Intermediate,,Maximal concentration in rats after peroral administration,,N,10116.0,6571,50597,1,,,BAO_0000218,,
8740,Rattus norvegicus,CHEMBL623894,Intermediate,,Maximum concentration in rat after 2 mg/kg peroral administration,,N,10116.0,6570,50597,1,,,BAO_0000218,,
8741,Rattus norvegicus,CHEMBL623895,Intermediate,Plasma,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,N,10116.0,6567,50597,1,,,BAO_0000218,1969.0,
8742,Rattus norvegicus,CHEMBL623896,Intermediate,,Maximum concentration of compound in rat was evaluated.,,N,10116.0,3031,50597,1,,,BAO_0000218,,
8743,Rattus norvegicus,CHEMBL623897,Intermediate,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,N,10116.0,3436,50597,1,,,BAO_0000218,,
8744,Rattus norvegicus,CHEMBL623898,Intermediate,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,N,10116.0,3436,50597,1,,,BAO_0000218,,
8745,Rattus norvegicus,CHEMBL623899,Intermediate,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,N,10116.0,2083,50597,1,,,BAO_0000218,,
8746,Rattus norvegicus,CHEMBL623900,Intermediate,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,N,10116.0,3436,50597,1,,,BAO_0000218,,
8747,Rattus norvegicus,CHEMBL623901,Intermediate,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,N,10116.0,4527,50597,1,,,BAO_0000218,,
8748,Rattus norvegicus,CHEMBL623902,Intermediate,,Maximum concentration was evaluated in rats,,N,10116.0,1974,50597,1,,,BAO_0000218,,
8749,Rattus norvegicus,CHEMBL623903,Intermediate,Cerebrospinal fluid,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,N,10116.0,3307,50597,1,,,BAO_0000218,1359.0,
8750,Rattus norvegicus,CHEMBL623904,Intermediate,Plasma,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,N,10116.0,3307,50597,1,,,BAO_0000218,1969.0,
8751,Rattus norvegicus,CHEMBL877617,Intermediate,Plasma,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,N,10116.0,1916,50597,1,,,BAO_0000218,1969.0,
8752,Rattus norvegicus,CHEMBL623905,Intermediate,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,N,10116.0,1500,50597,1,,,BAO_0000218,,
8753,Rattus norvegicus,CHEMBL623906,Intermediate,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,N,10116.0,1500,50597,1,,,BAO_0000218,,
8754,Rattus norvegicus,CHEMBL623907,Intermediate,Plasma,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,N,10116.0,4186,50597,1,,,BAO_0000218,1969.0,
8755,Rattus norvegicus,CHEMBL623908,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
8756,Rattus norvegicus,CHEMBL623909,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
8757,Rattus norvegicus,CHEMBL623910,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
8758,Rattus norvegicus,CHEMBL623911,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
8759,Rattus norvegicus,CHEMBL623912,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8760,Rattus norvegicus,CHEMBL624616,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8761,Rattus norvegicus,CHEMBL624617,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8762,Rattus norvegicus,CHEMBL624618,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8763,Rattus norvegicus,CHEMBL624619,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8764,Rattus norvegicus,CHEMBL624794,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8765,Rattus norvegicus,CHEMBL624795,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8766,Rattus norvegicus,CHEMBL623921,Intermediate,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8767,Rattus norvegicus,CHEMBL623922,Intermediate,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,10116.0,16434,50597,1,,,BAO_0000218,,
8768,Rattus norvegicus,CHEMBL623923,Intermediate,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,10116.0,16434,50597,1,,,BAO_0000218,,
8769,Rattus norvegicus,CHEMBL623924,Intermediate,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,10116.0,16434,50597,1,,,BAO_0000218,,
8770,Rattus norvegicus,CHEMBL623925,Intermediate,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8771,Rattus norvegicus,CHEMBL623926,Intermediate,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8772,Rattus norvegicus,CHEMBL623927,Intermediate,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8773,Rattus norvegicus,CHEMBL623928,Intermediate,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8774,Rattus norvegicus,CHEMBL623929,Intermediate,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8775,Rattus norvegicus,CHEMBL623930,Intermediate,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
8776,Rattus norvegicus,CHEMBL623931,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,955.0,
8777,Rattus norvegicus,CHEMBL622165,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,955.0,
8778,Rattus norvegicus,CHEMBL621249,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,955.0,
8779,Rattus norvegicus,CHEMBL621250,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,955.0,
8780,Rattus norvegicus,CHEMBL621448,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,955.0,
8781,Rattus norvegicus,CHEMBL621449,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,955.0,
8782,Rattus norvegicus,CHEMBL621450,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,955.0,
8783,Rattus norvegicus,CHEMBL621451,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,955.0,
8784,Rattus norvegicus,CHEMBL621452,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8785,Rattus norvegicus,CHEMBL621453,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8786,Rattus norvegicus,CHEMBL621454,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8787,Rattus norvegicus,CHEMBL621455,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8788,Rattus norvegicus,CHEMBL621456,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8789,Rattus norvegicus,CHEMBL625145,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8790,Rattus norvegicus,CHEMBL875847,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8791,Rattus norvegicus,CHEMBL625146,Intermediate,Brain,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8792,Rattus norvegicus,CHEMBL625147,Intermediate,Brain,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,10116.0,16434,50597,1,,,BAO_0000218,955.0,
8793,Rattus norvegicus,CHEMBL625148,Intermediate,Brain,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,10116.0,16434,50597,1,,,BAO_0000218,955.0,
8794,Rattus norvegicus,CHEMBL625149,Intermediate,Brain,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,10116.0,16434,50597,1,,,BAO_0000218,955.0,
8795,Rattus norvegicus,CHEMBL625150,Intermediate,Brain,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8796,Rattus norvegicus,CHEMBL625151,Intermediate,Brain,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8797,Rattus norvegicus,CHEMBL625152,Intermediate,Brain,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8798,Rattus norvegicus,CHEMBL625153,Intermediate,Brain,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8799,Rattus norvegicus,CHEMBL625154,Intermediate,Brain,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8800,Rattus norvegicus,CHEMBL625155,Intermediate,Brain,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,955.0,
8801,Rattus norvegicus,CHEMBL625156,Intermediate,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,,
8802,Rattus norvegicus,CHEMBL624354,Intermediate,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,,
8803,Rattus norvegicus,CHEMBL624355,Intermediate,Hippocampus,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,10000000.0,
8804,Rattus norvegicus,CHEMBL624356,Intermediate,Hippocampus,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,10000000.0,
8805,Rattus norvegicus,CHEMBL624357,Intermediate,Hippocampus,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,10000000.0,
8806,Rattus norvegicus,CHEMBL624358,Intermediate,Hippocampus,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,10000000.0,
8807,Rattus norvegicus,CHEMBL624359,Intermediate,Striatum,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2435.0,
8808,Rattus norvegicus,CHEMBL624360,Intermediate,Striatum,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2435.0,
8809,Rattus norvegicus,CHEMBL624361,Intermediate,Striatum,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2435.0,
8810,Rattus norvegicus,CHEMBL624362,Intermediate,Striatum,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2435.0,
8811,Rattus norvegicus,CHEMBL624363,Intermediate,Striatum,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2435.0,
8812,Rattus norvegicus,CHEMBL624364,Intermediate,Blood,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,178.0,
8813,Rattus norvegicus,CHEMBL624365,Intermediate,Blood,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,178.0,
8814,Rattus norvegicus,CHEMBL624366,Intermediate,Blood,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,178.0,
8815,Rattus norvegicus,CHEMBL624367,Intermediate,Blood,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,178.0,
8816,Rattus norvegicus,CHEMBL624368,Intermediate,Brain,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,955.0,
8817,Rattus norvegicus,CHEMBL624369,Intermediate,Brain,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,955.0,
8818,Rattus norvegicus,CHEMBL624370,Intermediate,Brain,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,955.0,
8819,Rattus norvegicus,CHEMBL625069,Intermediate,Brain,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,955.0,
8820,Rattus norvegicus,CHEMBL625070,Intermediate,Brain,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,955.0,
8821,Rattus norvegicus,CHEMBL626051,Intermediate,Heart,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,948.0,
8822,Rattus norvegicus,CHEMBL626052,Intermediate,Heart,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,948.0,
8823,Rattus norvegicus,CHEMBL626053,Intermediate,Heart,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,948.0,
8824,Rattus norvegicus,CHEMBL626054,Intermediate,Heart,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,948.0,
8825,Rattus norvegicus,CHEMBL626055,Intermediate,Heart,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,948.0,
8826,Rattus norvegicus,CHEMBL626056,Intermediate,Kidney,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2113.0,
8827,Rattus norvegicus,CHEMBL626057,Intermediate,Kidney,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2113.0,
8828,Rattus norvegicus,CHEMBL625193,Intermediate,Kidney,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2113.0,
8829,Rattus norvegicus,CHEMBL625194,Intermediate,Kidney,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2113.0,
8830,Rattus norvegicus,CHEMBL625195,Intermediate,Liver,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2107.0,
8831,Rattus norvegicus,CHEMBL625196,Intermediate,Liver,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2107.0,
8832,Rattus norvegicus,CHEMBL625197,Intermediate,Liver,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2107.0,
8833,Rattus norvegicus,CHEMBL625198,Intermediate,Liver,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2107.0,
8834,Rattus norvegicus,CHEMBL627929,Intermediate,Liver,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2107.0,
8835,Rattus norvegicus,CHEMBL627074,Intermediate,Lung,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2048.0,
8836,Rattus norvegicus,CHEMBL627075,Intermediate,Lung,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2048.0,
8837,Rattus norvegicus,CHEMBL627076,Intermediate,Lung,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2048.0,
8838,Rattus norvegicus,CHEMBL627077,Intermediate,Lung,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2048.0,
8839,Rattus norvegicus,CHEMBL627078,Intermediate,Lung,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2048.0,
8840,Rattus norvegicus,CHEMBL627079,Intermediate,Muscle tissue,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2385.0,
8841,Mus musculus,CHEMBL873824,Intermediate,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,N,10090.0,4573,50594,1,,,BAO_0000218,,
8842,Mus musculus,CHEMBL627080,Intermediate,Plasma,Half life in mouse plasma was determined at dose 25 mg/kg,,N,10090.0,3132,50594,1,,,BAO_0000218,1969.0,
8843,Mus musculus,CHEMBL627081,Intermediate,,Half life was determined,,N,10090.0,17718,50594,1,,,BAO_0000218,,
8844,Mus musculus,CHEMBL627082,Intermediate,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,N,10090.0,17728,50594,1,,,BAO_0000218,,
8845,Mus musculus,CHEMBL627083,Intermediate,,Half-life in male mice after 1 mg/kg intravenous dose,,N,10090.0,5961,50594,1,,,BAO_0000218,,
8847,Mus musculus,CHEMBL627085,Intermediate,Plasma,Half life in mice plasma,,N,10090.0,17731,50594,1,,,BAO_0000218,1969.0,
8848,Mus musculus,CHEMBL627086,Intermediate,,Half life in mouse,,N,10090.0,17592,50594,1,,,BAO_0000218,,
8849,Mus musculus,CHEMBL627087,Intermediate,Plasma,Half life in mouse plasma at dose 25 mg/kg,,N,10090.0,3132,50594,1,,,BAO_0000218,1969.0,
8850,Mus musculus,CHEMBL627088,Intermediate,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,N,10090.0,17729,50594,1,,,BAO_0000218,,
8851,Mus musculus,CHEMBL627089,Intermediate,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,N,10090.0,17729,50594,1,,,BAO_0000218,,
8852,Mus musculus,CHEMBL627090,Intermediate,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,N,10090.0,17729,50594,1,,,BAO_0000218,,
8853,Mus musculus,CHEMBL627091,Intermediate,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,N,10090.0,3277,50594,1,,,BAO_0000218,,
8854,Mus musculus,CHEMBL627092,Intermediate,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,N,10090.0,3760,50594,1,,,BAO_0000218,,
8855,Mus musculus,CHEMBL876785,Intermediate,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,N,10090.0,3760,50594,1,,,BAO_0000218,,
8856,Mus musculus,CHEMBL627093,Intermediate,,Half-life by iv administration in mouse,,N,10090.0,2862,50594,1,,,BAO_0000218,,
8857,Mus musculus,CHEMBL627094,Intermediate,,Half-life by oral administration in mouse,,N,10090.0,2862,50594,1,,,BAO_0000218,,
8858,Mus musculus,CHEMBL627095,Intermediate,,Half-life in mice,,N,10090.0,5980,50594,1,,,BAO_0000218,,
8859,Mus musculus,CHEMBL627096,Intermediate,Brain,Half-life using mouse brain homogenate,,N,10090.0,6159,50594,1,,,BAO_0000218,955.0,
8860,Mus musculus,CHEMBL627097,Intermediate,,Half-life was measured in mice,,N,10090.0,6254,50594,1,,,BAO_0000218,,
8861,Mus musculus,CHEMBL627098,Intermediate,,Half-life was measured in mouse after an iv dose of 1 mg/kg,,N,10090.0,6062,50594,1,,,BAO_0000218,,
8862,Mus musculus,CHEMBL627099,Intermediate,Blood,Half-life period was determined in mouse blood,,N,10090.0,1574,50594,1,,,BAO_0000218,178.0,
8863,Mus musculus,CHEMBL627100,Intermediate,Brain,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,N,10090.0,56,50594,1,,,BAO_0000218,955.0,
8864,Mus musculus,CHEMBL627101,Intermediate,Plasma,Plasma half life in mouse,,N,10090.0,993,50594,1,,,BAO_0000218,1969.0,
8865,Mus musculus,CHEMBL627102,Intermediate,,Stability of the peptide in the presence of mouse serum,,N,10090.0,6652,50594,1,,,BAO_0000218,,
8866,Mus musculus,CHEMBL627103,Intermediate,,Terminal half life of compound was determined in mouse,,N,10090.0,17852,50594,1,,,BAO_0000218,,
8867,Mus musculus,CHEMBL627104,Intermediate,,Terminal half life was evaluated in mice after intravenous administration,,N,10090.0,2675,50594,1,,,BAO_0000218,,
8868,Mus musculus,CHEMBL627105,Intermediate,,Terminal half life was evaluated in mice after oral administration,,N,10090.0,2675,50594,1,,,BAO_0000218,,
8869,Mus musculus,CHEMBL876786,Intermediate,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,N,10090.0,499,50594,1,,,BAO_0000218,,
8870,Mus musculus,CHEMBL873825,Intermediate,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,N,10090.0,499,50594,1,,,BAO_0000218,,
8871,Mus musculus,CHEMBL627106,Intermediate,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,N,10090.0,499,50594,1,,,BAO_0000218,,
8872,Mus musculus,CHEMBL626336,Intermediate,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,N,10090.0,14239,50594,1,,,BAO_0000218,,
8873,Mus musculus,CHEMBL877462,Intermediate,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,N,10090.0,5506,50594,1,,,BAO_0000218,,
8874,Mus musculus,CHEMBL626337,Intermediate,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,N,10090.0,5506,50594,1,,,BAO_0000218,,
8875,Mus musculus,CHEMBL626338,Intermediate,,Half life after intraperitoneal administration of 100 mg/kg in mice,,N,10090.0,17734,50594,1,,,BAO_0000218,,
8876,Mus musculus,CHEMBL626339,Intermediate,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,N,10090.0,17728,50594,1,,,BAO_0000218,,
8877,Mus musculus,CHEMBL626340,Intermediate,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,N,10090.0,17728,50594,1,,,BAO_0000218,,
8878,Mus musculus,CHEMBL625377,Intermediate,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,N,10090.0,17728,50594,1,,,BAO_0000218,,
8879,Mus musculus,CHEMBL625378,Intermediate,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,N,10090.0,17728,50594,1,,,BAO_0000218,,
8880,Mus musculus,CHEMBL625379,Intermediate,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,N,10090.0,17728,50594,1,,,BAO_0000218,,
8881,Sus scrofa,CHEMBL625380,Autocuration,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,U,9823.0,14294,22224,1,,,BAO_0000251,,
8882,Sus scrofa,CHEMBL625381,Autocuration,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,U,9823.0,14294,22224,1,,,BAO_0000251,,
8883,Sus scrofa,CHEMBL625382,Autocuration,,Stability to porcine renal DHP-I,,U,9823.0,6056,22224,1,,,BAO_0000019,,
8884,Sus scrofa,CHEMBL873828,Autocuration,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,U,9823.0,1317,22224,1,,,BAO_0000218,,
8885,Sus scrofa,CHEMBL625383,Autocuration,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,U,9823.0,1317,22224,1,,,BAO_0000218,,
8886,Sus scrofa,CHEMBL625384,Autocuration,,Half-life of the parent prodrug in porcine esterase solution,,U,9823.0,5229,22224,1,,,BAO_0000019,,
8887,Sus scrofa,CHEMBL625385,Autocuration,,"First order rate constant, k was determined in in pig liver Esterase",,U,9823.0,4231,22224,1,,,BAO_0000019,,
8888,Sus scrofa,CHEMBL625386,Autocuration,Liver,Half life of the in pig liver Esterase,,U,9823.0,4231,22224,1,,,BAO_0000221,2107.0,
8889,Sus scrofa,CHEMBL623571,Autocuration,Liver,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,U,9823.0,5318,22224,1,,,BAO_0000221,2107.0,
8890,Sus scrofa,CHEMBL623572,Autocuration,Liver,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,U,9823.0,5318,22224,1,,,BAO_0000221,2107.0,
8891,Sus scrofa,CHEMBL623573,Autocuration,Liver,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,U,9823.0,5318,22224,1,,,BAO_0000221,2107.0,
8892,Sus scrofa,CHEMBL623574,Autocuration,Liver,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,U,9823.0,3305,22224,1,,,BAO_0000221,2107.0,
8893,Sus scrofa,CHEMBL623575,Autocuration,Liver,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,U,9823.0,3305,22224,1,,,BAO_0000221,2107.0,
8894,Sus scrofa,CHEMBL623749,Autocuration,Liver,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,U,9823.0,2842,22224,1,,,BAO_0000221,2107.0,
8895,Sus scrofa,CHEMBL623750,Autocuration,Liver,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,U,9823.0,2842,22224,1,,,BAO_0000221,2107.0,
8896,Sus scrofa,CHEMBL623751,Autocuration,Liver,Half-life in vitro in pig liver,,U,9823.0,889,22224,1,,,BAO_0000221,2107.0,
8897,Sus scrofa,CHEMBL623752,Autocuration,Liver,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,U,9823.0,1904,22224,1,,,BAO_0000221,2107.0,
8898,Rattus norvegicus,CHEMBL623753,Intermediate,Plasma,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,N,10116.0,4186,50597,1,,,BAO_0000218,1969.0,
8899,Rattus norvegicus,CHEMBL623754,Intermediate,Plasma,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,N,10116.0,2774,50597,1,,,BAO_0000218,1969.0,
8900,Rattus norvegicus,CHEMBL623755,Intermediate,Plasma,Maximum concentration in rat plasma was determined,,N,10116.0,1742,50597,1,,,BAO_0000218,1969.0,
8901,Rattus norvegicus,CHEMBL623756,Intermediate,,Maximum concentration in rats,,N,10116.0,3169,50597,1,,,BAO_0000218,,
8902,Rattus norvegicus,CHEMBL623757,Intermediate,,Maximum concentration in rats at 1-2 hours,,N,10116.0,3169,50597,1,,,BAO_0000218,,
8903,Rattus norvegicus,CHEMBL623758,Intermediate,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,N,10116.0,2081,50597,1,,,BAO_0000218,,
8904,Rattus norvegicus,CHEMBL623759,Intermediate,Brain,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,N,10116.0,3307,50597,1,,,BAO_0000218,955.0,
8905,Rattus norvegicus,CHEMBL623760,Intermediate,,Maximum concentration at the dose of 2 mg/kg in rat,,N,10116.0,4727,50597,1,,,BAO_0000218,,
8906,Rattus norvegicus,CHEMBL623761,Intermediate,,Maximum concentration was evaluated in rats,,N,10116.0,6597,50597,1,,,BAO_0000218,,
8907,Rattus norvegicus,CHEMBL623762,Intermediate,Plasma,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,N,10116.0,16365,50597,1,,,BAO_0000218,1969.0,
8908,Rattus norvegicus,CHEMBL877594,Intermediate,Plasma,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,N,10116.0,16365,50597,1,,,BAO_0000218,1969.0,
8909,Rattus norvegicus,CHEMBL623763,Intermediate,Plasma,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,N,10116.0,16365,50597,1,,,BAO_0000218,1969.0,
8910,Rattus norvegicus,CHEMBL623764,Intermediate,Plasma,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,N,10116.0,16365,50597,1,,,BAO_0000218,1969.0,
8911,Rattus norvegicus,CHEMBL623765,Intermediate,Plasma,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,N,10116.0,16365,50597,1,,,BAO_0000218,1969.0,
8912,Rattus norvegicus,CHEMBL623766,Intermediate,Blood,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,N,10116.0,2591,50597,1,,,BAO_0000218,178.0,
8913,Rattus norvegicus,CHEMBL623767,Intermediate,Blood,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,N,10116.0,2591,50597,1,,,BAO_0000218,178.0,
8914,Rattus norvegicus,CHEMBL623768,Intermediate,Blood,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,N,10116.0,2591,50597,1,,,BAO_0000218,178.0,
8915,Rattus norvegicus,CHEMBL623769,Intermediate,Plasma,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,1969.0,
8916,Rattus norvegicus,CHEMBL623770,Intermediate,Plasma,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,1969.0,
8917,Rattus norvegicus,CHEMBL623771,Intermediate,Plasma,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,1969.0,
8918,Rattus norvegicus,CHEMBL623772,Intermediate,Plasma,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,1969.0,
8919,Rattus norvegicus,CHEMBL623773,Intermediate,Plasma,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,1969.0,
8920,Rattus norvegicus,CHEMBL623774,Intermediate,Plasma,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,1969.0,
8921,Rattus norvegicus,CHEMBL623775,Intermediate,Plasma,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,1969.0,
8922,Rattus norvegicus,CHEMBL623776,Intermediate,,Cmax in rat (PO dose),,N,10116.0,14465,50597,1,,,BAO_0000218,,
8923,Rattus norvegicus,CHEMBL622191,Intermediate,Plasma,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,10116.0,4723,50597,1,,,BAO_0000218,1969.0,
8924,Rattus norvegicus,CHEMBL622192,Intermediate,Plasma,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,10116.0,4723,50597,1,,,BAO_0000218,1969.0,
8925,Rattus norvegicus,CHEMBL622193,Intermediate,Plasma,Maximum plasma concentration determined in rat,,N,10116.0,4576,50597,1,,,BAO_0000218,1969.0,
8926,Rattus norvegicus,CHEMBL622194,Intermediate,Plasma,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,N,10116.0,12873,50597,1,,,BAO_0000218,1969.0,
8927,Rattus norvegicus,CHEMBL622195,Intermediate,Plasma,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,N,10116.0,12873,50597,1,,,BAO_0000218,1969.0,
8928,Rattus norvegicus,CHEMBL622196,Intermediate,Plasma,Maximum plasma concentration in rat,,N,10116.0,6824,50597,1,,,BAO_0000218,1969.0,
8929,Rattus norvegicus,CHEMBL622197,Intermediate,Plasma,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,10116.0,17065,50597,1,,,BAO_0000218,1969.0,
8930,Rattus norvegicus,CHEMBL622198,Intermediate,Plasma,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,N,10116.0,2932,50597,1,,,BAO_0000218,1969.0,
8931,Rattus norvegicus,CHEMBL622199,Intermediate,Plasma,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,N,10116.0,2932,50597,1,,,BAO_0000218,1969.0,
8932,Rattus norvegicus,CHEMBL622200,Intermediate,Plasma,Maximum plasma concentration of compound was measured in rat,,N,10116.0,2879,50597,1,,,BAO_0000218,1969.0,
8933,Rattus norvegicus,CHEMBL622201,Intermediate,Plasma,Maximum plasma concentration after 20 mg/kg oral administration in rat,,N,10116.0,2864,50597,1,,,BAO_0000218,1969.0,
8934,Rattus norvegicus,CHEMBL623990,Intermediate,Plasma,Maximum plasma concentration after oral administration to rats,,N,10116.0,16367,50597,1,,,BAO_0000218,1969.0,
8935,Rattus norvegicus,CHEMBL623991,Intermediate,Plasma,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,10116.0,17717,50597,1,,,BAO_0000218,1969.0,
8936,Rattus norvegicus,CHEMBL623992,Intermediate,Plasma,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,N,10116.0,17717,50597,1,,,BAO_0000218,1969.0,
8937,Rattus norvegicus,CHEMBL623993,Intermediate,Plasma,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,10116.0,17717,50597,1,,,BAO_0000218,1969.0,
8938,Rattus norvegicus,CHEMBL623994,Intermediate,Plasma,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,N,10116.0,17717,50597,1,,,BAO_0000218,1969.0,
8939,Rattus norvegicus,CHEMBL623995,Intermediate,Plasma,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,N,10116.0,17720,50597,1,,,BAO_0000218,1969.0,
8940,Rattus norvegicus,CHEMBL623996,Intermediate,Plasma,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,10116.0,17720,50597,1,,,BAO_0000218,1969.0,
8941,Rattus norvegicus,CHEMBL623997,Intermediate,Plasma,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,N,10116.0,17720,50597,1,,,BAO_0000218,1969.0,
8942,Rattus norvegicus,CHEMBL623998,Intermediate,Plasma,Maximum plasma concentration dosed orally in rats,,N,10116.0,4516,50597,1,,,BAO_0000218,1969.0,
8943,Rattus norvegicus,CHEMBL623999,Intermediate,Plasma,Maximum plasma concentration dosed orally in rats after 6 hours,,N,10116.0,4516,50597,1,,,BAO_0000218,1969.0,
8944,Rattus norvegicus,CHEMBL624000,Intermediate,Plasma,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,N,10116.0,4516,50597,1,,,BAO_0000218,1969.0,
8945,Rattus norvegicus,CHEMBL624001,Intermediate,Plasma,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,N,10116.0,5199,50597,1,,,BAO_0000218,1969.0,
8946,Rattus norvegicus,CHEMBL624002,Intermediate,Plasma,Maximum plasma concentration in rat after po administration,,N,10116.0,17538,50597,1,,,BAO_0000218,1969.0,
8947,Rattus norvegicus,CHEMBL624003,Intermediate,Plasma,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,N,10116.0,6685,50597,1,,,BAO_0000218,1969.0,
8948,Rattus norvegicus,CHEMBL624004,Intermediate,Plasma,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,N,10116.0,6685,50597,1,,,BAO_0000218,1969.0,
8949,Rattus norvegicus,CHEMBL624005,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,948.0,
8950,Rattus norvegicus,CHEMBL624006,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,948.0,
8951,Rattus norvegicus,CHEMBL624007,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,948.0,
8952,Rattus norvegicus,CHEMBL624008,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,948.0,
8953,Rattus norvegicus,CHEMBL624009,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,948.0,
8954,Rattus norvegicus,CHEMBL874387,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,948.0,
8955,Rattus norvegicus,CHEMBL624010,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,948.0,
8956,Rattus norvegicus,CHEMBL624011,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,948.0,
8957,Rattus norvegicus,CHEMBL624012,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8958,Rattus norvegicus,CHEMBL624013,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8959,Rattus norvegicus,CHEMBL624736,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8960,Rattus norvegicus,CHEMBL624737,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8961,Rattus norvegicus,CHEMBL624738,Intermediate,Heart,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,10116.0,16434,50597,1,,,BAO_0000218,948.0,
8962,Rattus norvegicus,CHEMBL624739,Intermediate,Heart,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,10116.0,16434,50597,1,,,BAO_0000218,948.0,
8963,Rattus norvegicus,CHEMBL624740,Intermediate,Heart,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,10116.0,16434,50597,1,,,BAO_0000218,948.0,
8964,Rattus norvegicus,CHEMBL624896,Intermediate,Heart,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8965,Rattus norvegicus,CHEMBL624897,Intermediate,Heart,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8966,Rattus norvegicus,CHEMBL624108,Intermediate,Heart,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8967,Rattus norvegicus,CHEMBL624109,Intermediate,Heart,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8968,Rattus norvegicus,CHEMBL624110,Intermediate,Heart,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8969,Rattus norvegicus,CHEMBL624111,Intermediate,Heart,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8970,Rattus norvegicus,CHEMBL624112,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8971,Rattus norvegicus,CHEMBL624113,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8972,Rattus norvegicus,CHEMBL619709,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8973,Rattus norvegicus,CHEMBL619710,Intermediate,Heart,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,948.0,
8974,Rattus norvegicus,CHEMBL619711,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2113.0,
8975,Rattus norvegicus,CHEMBL619712,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2113.0,
8976,Rattus norvegicus,CHEMBL619713,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2113.0,
8977,Rattus norvegicus,CHEMBL619714,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2113.0,
8978,Rattus norvegicus,CHEMBL619715,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2113.0,
8979,Rattus norvegicus,CHEMBL619716,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2113.0,
8980,Rattus norvegicus,CHEMBL619717,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2113.0,
8981,Rattus norvegicus,CHEMBL619718,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2113.0,
8982,Rattus norvegicus,CHEMBL619719,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
8983,Rattus norvegicus,CHEMBL875329,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
8984,Rattus norvegicus,CHEMBL619720,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
8985,Rattus norvegicus,CHEMBL619721,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
8986,Rattus norvegicus,CHEMBL619722,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
8987,Rattus norvegicus,CHEMBL619723,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
8988,Rattus norvegicus,CHEMBL619724,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
8989,Rattus norvegicus,CHEMBL619725,Intermediate,Kidney,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
8990,Rattus norvegicus,CHEMBL619726,Intermediate,Kidney,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2113.0,
8991,Rattus norvegicus,CHEMBL619727,Intermediate,Kidney,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2113.0,
8992,Rattus norvegicus,CHEMBL619728,Intermediate,Kidney,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2113.0,
8993,Rattus norvegicus,CHEMBL619729,Intermediate,Kidney,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
8994,Rattus norvegicus,CHEMBL619730,Intermediate,Muscle tissue,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2385.0,
8995,Rattus norvegicus,CHEMBL619731,Intermediate,Muscle tissue,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2385.0,
8996,Rattus norvegicus,CHEMBL619732,Intermediate,Muscle tissue,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2385.0,
8997,Rattus norvegicus,CHEMBL619733,Intermediate,Muscle tissue,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2385.0,
8998,Rattus norvegicus,CHEMBL619734,Intermediate,Muscle tissue,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2385.0,
8999,Rattus norvegicus,CHEMBL619735,Intermediate,Zone of skin,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,14.0,
9000,Rattus norvegicus,CHEMBL875330,Intermediate,Zone of skin,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,14.0,
9001,Rattus norvegicus,CHEMBL628465,Intermediate,Zone of skin,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,14.0,
9002,Rattus norvegicus,CHEMBL628466,Intermediate,Zone of skin,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,14.0,
9003,Rattus norvegicus,CHEMBL628467,Intermediate,Zone of skin,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,14.0,
9004,Rattus norvegicus,CHEMBL628468,Intermediate,Spleen,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2106.0,
9005,Rattus norvegicus,CHEMBL628469,Intermediate,Spleen,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2106.0,
9006,Rattus norvegicus,CHEMBL628470,Intermediate,Spleen,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2106.0,
9007,Rattus norvegicus,CHEMBL628471,Intermediate,Spleen,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2106.0,
9008,Rattus norvegicus,CHEMBL628472,Intermediate,Spleen,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2106.0,
9009,Rattus norvegicus,CHEMBL625191,Intermediate,Thyroid gland,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2046.0,
9010,Rattus norvegicus,CHEMBL625192,Intermediate,Thyroid gland,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2046.0,
9011,Rattus norvegicus,CHEMBL875337,Intermediate,Thyroid gland,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2046.0,
9012,Rattus norvegicus,CHEMBL626341,Intermediate,Thyroid gland,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2046.0,
9013,Rattus norvegicus,CHEMBL626342,Intermediate,Thyroid gland,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2046.0,
9014,Rattus norvegicus,CHEMBL621943,Intermediate,Liver,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10116.0,11977,50597,1,,,BAO_0000218,2107.0,
9015,Rattus norvegicus,CHEMBL621944,Intermediate,,Half life in rats,,N,10116.0,3748,50597,1,,,BAO_0000218,,
9016,Rattus norvegicus,CHEMBL621945,Intermediate,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,N,10116.0,15765,50597,1,,,BAO_0000218,,
9017,Rattus norvegicus,CHEMBL621946,Intermediate,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,N,10116.0,4871,50597,1,,,BAO_0000218,,
9018,Rattus norvegicus,CHEMBL621947,Intermediate,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,N,10116.0,4871,50597,1,,,BAO_0000218,,
9019,Rattus norvegicus,CHEMBL621948,Intermediate,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,N,10116.0,4872,50597,1,,,BAO_0000218,,
9020,Rattus norvegicus,CHEMBL621949,Intermediate,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,N,10116.0,4872,50597,1,,,BAO_0000218,,
9021,Rattus norvegicus,CHEMBL621950,Intermediate,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,N,10116.0,5413,50597,1,,,BAO_0000218,,
9022,Rattus norvegicus,CHEMBL621951,Intermediate,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,N,10116.0,5413,50597,1,,,BAO_0000218,,
9023,Rattus norvegicus,CHEMBL621952,Intermediate,Blood,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,N,10116.0,15272,50597,1,,,BAO_0000218,178.0,
9024,Rattus norvegicus,CHEMBL621953,Intermediate,Liver,Stability (%) in rat liver microsomes,,N,10116.0,4689,50597,1,,,BAO_0000218,2107.0,
9025,Rattus norvegicus,CHEMBL621954,Intermediate,,Area under curve was calculated after intravenous administration,,N,10116.0,6057,50597,1,,,BAO_0000218,,
9026,Rattus norvegicus,CHEMBL621955,Intermediate,,Area under the curve was calculated after iv administration in rat,,N,10116.0,6057,50597,1,,,BAO_0000218,,
9027,Rattus norvegicus,CHEMBL621956,Intermediate,,Area under the curve was calculated in rat after peroral administration,,N,10116.0,6057,50597,1,,,BAO_0000218,,
9028,Rattus norvegicus,CHEMBL621957,Intermediate,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,N,10116.0,6211,50597,1,,,BAO_0000218,,
9029,Rattus norvegicus,CHEMBL621958,Intermediate,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,N,10116.0,5710,50597,1,,,BAO_0000218,,
9030,Rattus norvegicus,CHEMBL621959,Intermediate,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,N,10116.0,5710,50597,1,,,BAO_0000218,,
9031,Rattus norvegicus,CHEMBL621960,Intermediate,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,N,10116.0,17853,50597,1,,,BAO_0000218,,
9032,Rattus norvegicus,CHEMBL621961,Intermediate,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,N,10116.0,17853,50597,1,,,BAO_0000218,,
9033,Rattus norvegicus,CHEMBL621962,Intermediate,,p value of the compound,,N,10116.0,15765,50597,1,,,BAO_0000218,,
9034,Rattus norvegicus,CHEMBL876787,Intermediate,,p value of the compound,,N,10116.0,15765,50597,1,,,BAO_0000218,,
9035,Rattus norvegicus,CHEMBL621963,Intermediate,,p value of the compound,,N,10116.0,15765,50597,1,,,BAO_0000218,,
9036,Rattus norvegicus,CHEMBL622637,Intermediate,Stomach,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,10116.0,6175,50597,1,,,BAO_0000218,945.0,
9037,Rattus norvegicus,CHEMBL622638,Intermediate,Stomach,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,10116.0,6175,50597,1,,,BAO_0000218,945.0,
9038,Rattus norvegicus,CHEMBL626561,Intermediate,Stomach,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,10116.0,6175,50597,1,,,BAO_0000218,945.0,
9039,Oryctolagus cuniculus,CHEMBL626562,Autocuration,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,U,9986.0,7991,22224,1,,,BAO_0000019,,
9040,Oryctolagus cuniculus,CHEMBL626563,Autocuration,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,U,9986.0,429,22224,1,,,BAO_0000218,,
9041,Oryctolagus cuniculus,CHEMBL626564,Autocuration,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,U,9986.0,429,22224,1,,,BAO_0000218,,
9042,Oryctolagus cuniculus,CHEMBL626565,Autocuration,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,U,9986.0,6253,22224,1,,,BAO_0000218,,
9043,Oryctolagus cuniculus,CHEMBL626566,Autocuration,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,U,9986.0,6253,22224,1,,,BAO_0000218,,
9044,Oryctolagus cuniculus,CHEMBL626567,Autocuration,,Clearance rate in rabbits,,U,9986.0,3615,22224,1,,,BAO_0000218,,
9045,Oryctolagus cuniculus,CHEMBL626568,Autocuration,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,U,9986.0,4059,22224,1,,,BAO_0000218,,
9046,Oryctolagus cuniculus,CHEMBL626569,Autocuration,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,U,9986.0,5124,22224,1,,,BAO_0000218,,
9047,Oryctolagus cuniculus,CHEMBL626570,Autocuration,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,U,9986.0,5124,22224,1,,,BAO_0000218,,
9048,Oryctolagus cuniculus,CHEMBL626571,Autocuration,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,U,9986.0,5124,22224,1,,,BAO_0000218,,
9049,Oryctolagus cuniculus,CHEMBL626572,Autocuration,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,U,9986.0,429,22224,1,,,BAO_0000218,,
9050,Oryctolagus cuniculus,CHEMBL626573,Autocuration,Plasma,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,U,9986.0,4059,22224,1,,,BAO_0000218,1969.0,
9051,Oryctolagus cuniculus,CHEMBL626574,Autocuration,Liver,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,U,9986.0,9659,22224,1,,,BAO_0000251,2107.0,
9052,Oryctolagus cuniculus,CHEMBL626575,Autocuration,Liver,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,U,9986.0,9659,22224,1,,,BAO_0000251,2107.0,
9053,Oryctolagus cuniculus,CHEMBL626576,Autocuration,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,U,9986.0,3639,22224,1,,,BAO_0000218,,
9054,Oryctolagus cuniculus,CHEMBL626577,Autocuration,,Dose at which bioavailability of perorally administered compound was tested in rabbit,,U,9986.0,3639,22224,1,,,BAO_0000218,,
9055,Oryctolagus cuniculus,CHEMBL626578,Autocuration,,The compound was tested for its bioavailability in rabbit (by oral dosage).,,U,9986.0,3639,22224,1,,,BAO_0000218,,
9056,Oryctolagus cuniculus,CHEMBL625263,Autocuration,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,U,9986.0,5124,22224,1,,,BAO_0000218,,
9057,Oryctolagus cuniculus,CHEMBL625264,Autocuration,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,U,9986.0,5124,22224,1,,,BAO_0000218,,
9058,Oryctolagus cuniculus,CHEMBL625265,Autocuration,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,U,9986.0,5124,22224,1,,,BAO_0000218,,
9059,Oryctolagus cuniculus,CHEMBL625266,Autocuration,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,U,9986.0,14294,22224,1,,,BAO_0000251,,
9060,Oryctolagus cuniculus,CHEMBL876796,Autocuration,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,U,9986.0,14294,22224,1,,,BAO_0000251,,
9061,Oryctolagus cuniculus,CHEMBL625267,Autocuration,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,U,9986.0,429,22224,1,,,BAO_0000218,,
9062,Oryctolagus cuniculus,CHEMBL625268,Autocuration,Plasma,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,U,9986.0,5124,22224,1,,,BAO_0000218,1969.0,
9063,Oryctolagus cuniculus,CHEMBL625269,Autocuration,Plasma,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,U,9986.0,5124,22224,1,,,BAO_0000218,1969.0,
9064,Oryctolagus cuniculus,CHEMBL624689,Autocuration,Plasma,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,U,9986.0,5124,22224,1,,,BAO_0000218,1969.0,
9065,Oryctolagus cuniculus,CHEMBL624690,Autocuration,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,U,9986.0,429,22224,1,,,BAO_0000218,,
9066,Oryctolagus cuniculus,CHEMBL624691,Autocuration,Urine,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,U,9986.0,429,22224,1,,,BAO_0000218,1088.0,
9067,Oryctolagus cuniculus,CHEMBL624692,Autocuration,Urine,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,U,9986.0,429,22224,1,,,BAO_0000218,1088.0,
9068,Oryctolagus cuniculus,CHEMBL624693,Autocuration,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,U,9986.0,4059,22224,1,,,BAO_0000218,,
9069,Oryctolagus cuniculus,CHEMBL624694,Autocuration,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,U,9986.0,4137,22224,1,,,BAO_0000218,,
9070,Oryctolagus cuniculus,CHEMBL877596,Autocuration,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,U,9986.0,11672,22224,1,,,BAO_0000221,,
9071,Oryctolagus cuniculus,CHEMBL624695,Autocuration,,Time within which only 10% of the drug was degraded,,U,9986.0,12886,22224,1,,,BAO_0000019,,
9072,Oryctolagus cuniculus,CHEMBL624696,Autocuration,Liver,Half life period in rabbit liver homogenate,,U,9986.0,3853,22224,1,,,BAO_0000221,2107.0,
9073,Oryctolagus cuniculus,CHEMBL624697,Autocuration,,Half life value in rabbits,,U,9986.0,3615,22224,1,,,BAO_0000019,,
9074,Oryctolagus cuniculus,CHEMBL624698,Autocuration,Blood,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,U,9986.0,6253,22224,1,,,BAO_0000218,178.0,
9075,Oryctolagus cuniculus,CHEMBL624699,Autocuration,Blood,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,U,9986.0,6253,22224,1,,,BAO_0000218,178.0,
9076,Oryctolagus cuniculus,CHEMBL624700,Autocuration,,Half-life period in rabbits following intravenous administration at 2 mg/kg,,U,9986.0,6077,22224,1,,,BAO_0000218,,
9077,Rattus norvegicus,CHEMBL622903,Intermediate,Plasma,AUC 0-8 hr value in rats at 10 mg/kg,,N,10116.0,17617,50597,1,,,BAO_0000218,1969.0,
9078,Rattus norvegicus,CHEMBL622904,Intermediate,Plasma,AUC after administration at 2000 mg/kg/day in rats,,N,10116.0,17594,50597,1,,,BAO_0000218,1969.0,
9079,Rattus norvegicus,CHEMBL622905,Intermediate,Plasma,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,N,10116.0,6149,50597,1,,,BAO_0000218,1969.0,
9080,Rattus norvegicus,CHEMBL622906,Intermediate,Plasma,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,10116.0,17260,50597,1,,,BAO_0000218,1969.0,
9081,Rattus norvegicus,CHEMBL622907,Intermediate,Plasma,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,10116.0,17260,50597,1,,,BAO_0000218,1969.0,
9082,Rattus norvegicus,CHEMBL622908,Intermediate,Plasma,AUC in rat after oral administration at 10.5 mg/kg dose,,N,10116.0,6644,50597,1,,,BAO_0000218,1969.0,
9083,Rattus norvegicus,CHEMBL622909,Intermediate,Plasma,AUC in rat after oral administration at 11.2 mg/kg dose,,N,10116.0,6644,50597,1,,,BAO_0000218,1969.0,
9084,Rattus norvegicus,CHEMBL622910,Intermediate,Plasma,AUC in rat after oral administration at 9.7 mg/kg dose,,N,10116.0,6644,50597,1,,,BAO_0000218,1969.0,
9085,Rattus norvegicus,CHEMBL622911,Intermediate,Brain,AUC in rat brain after oral administration at 10 mg/kg,,N,10116.0,6495,50597,1,,,BAO_0000218,955.0,
9086,Rattus norvegicus,CHEMBL622912,Intermediate,Plasma,AUC in rat p.o.,,N,10116.0,6504,50597,1,,,BAO_0000218,1969.0,
9087,Rattus norvegicus,CHEMBL622913,Intermediate,Plasma,AUC in rat p.o. at 20 mg/kg concentration,,N,10116.0,17686,50597,1,,,BAO_0000218,1969.0,
9088,Rattus norvegicus,CHEMBL622914,Intermediate,Plasma,AUC in rat plasma after oral administration at 10 mg/kg,,N,10116.0,6495,50597,1,,,BAO_0000218,1969.0,
9089,Rattus norvegicus,CHEMBL622915,Intermediate,Plasma,AUC in rats,,N,10116.0,216,50597,1,,,BAO_0000218,1969.0,
9090,Rattus norvegicus,CHEMBL622916,Intermediate,Plasma,AUC value after IV dose at a dose of 5 mg/kg in rats.,,N,10116.0,1908,50597,1,,,BAO_0000218,1969.0,
9091,Rattus norvegicus,CHEMBL622917,Intermediate,Plasma,AUC value after oral dose at a dose of 10 mg/kg in rats.,,N,10116.0,1908,50597,1,,,BAO_0000218,1969.0,
9092,Rattus norvegicus,CHEMBL622918,Intermediate,Plasma,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,N,10116.0,6685,50597,1,,,BAO_0000218,1969.0,
9093,Rattus norvegicus,CHEMBL622919,Intermediate,Plasma,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,N,10116.0,216,50597,1,,,BAO_0000218,1969.0,
9094,Rattus norvegicus,CHEMBL622920,Intermediate,Plasma,Maximum plasma concentration was evaluated in rat,,N,10116.0,6049,50597,1,,,BAO_0000218,1969.0,
9095,Rattus norvegicus,CHEMBL622921,Intermediate,Plasma,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,N,10116.0,2463,50597,1,,,BAO_0000218,1969.0,
9096,Rattus norvegicus,CHEMBL622922,Intermediate,Plasma,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,N,10116.0,6679,50597,1,,,BAO_0000218,1969.0,
9097,Rattus norvegicus,CHEMBL622923,Intermediate,Plasma,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,N,10116.0,6681,50597,1,,,BAO_0000218,1969.0,
9098,Rattus norvegicus,CHEMBL877604,Intermediate,Plasma,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,N,10116.0,4890,50597,1,,,BAO_0000218,1969.0,
9099,Rattus norvegicus,CHEMBL622924,Intermediate,Plasma,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,N,10116.0,6410,50597,1,,,BAO_0000218,1969.0,
9100,Rattus norvegicus,CHEMBL622925,Intermediate,Plasma,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,N,10116.0,6410,50597,1,,,BAO_0000218,1969.0,
9101,Rattus norvegicus,CHEMBL622926,Intermediate,Plasma,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,N,10116.0,16366,50597,1,,,BAO_0000218,1969.0,
9102,Rattus norvegicus,CHEMBL623625,Intermediate,Plasma,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,N,10116.0,6227,50597,1,,,BAO_0000218,1969.0,
9103,Rattus norvegicus,CHEMBL623626,Expert,Plasma,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,10116.0,3598,50597,1,,,BAO_0000218,1969.0,
9104,Rattus norvegicus,CHEMBL623627,Intermediate,Plasma,Maximum plasma drug concentration was determined,,N,10116.0,1465,50597,1,,,BAO_0000218,1969.0,
9105,Rattus norvegicus,CHEMBL623628,Intermediate,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,N,10116.0,4368,50597,1,,,BAO_0000218,,
9106,Rattus norvegicus,CHEMBL623629,Intermediate,Plasma,Mean peak plasma concentration was observed after intravenous administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,1969.0,
9107,Rattus norvegicus,CHEMBL623630,Intermediate,Plasma,Mean peak plasma concentration was observed after oral administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,1969.0,
9108,Rattus norvegicus,CHEMBL623804,Intermediate,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,N,10116.0,5355,50597,1,,,BAO_0000218,,
9109,Rattus norvegicus,CHEMBL623805,Intermediate,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,N,10116.0,5355,50597,1,,,BAO_0000218,,
9110,Rattus norvegicus,CHEMBL623806,Intermediate,Plasma,Peak oral plasma concentration was determined in rats by oral administration,,N,10116.0,1567,50597,1,,,BAO_0000218,1969.0,
9111,Rattus norvegicus,CHEMBL623807,Intermediate,Plasma,Peak plasma concentration (Cmax) was determined,,N,10116.0,4026,50597,1,,,BAO_0000218,1969.0,
9112,Rattus norvegicus,CHEMBL623808,Intermediate,Plasma,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,N,10116.0,6193,50597,1,,,BAO_0000218,1969.0,
9113,Rattus norvegicus,CHEMBL623809,Intermediate,Plasma,Peak plasma concentration (Cmax) in rats,,N,10116.0,4026,50597,1,,,BAO_0000218,1969.0,
9114,Rattus norvegicus,CHEMBL623810,Intermediate,Plasma,Peak plasma concentration at 1 mg/kg peroral administration,,N,10116.0,6485,50597,1,,,BAO_0000218,1969.0,
9115,Rattus norvegicus,CHEMBL623811,Intermediate,Plasma,Peak plasma concentration in rat,,N,10116.0,17655,50597,1,,,BAO_0000218,1969.0,
9116,Rattus norvegicus,CHEMBL623812,Intermediate,Plasma,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,N,10116.0,14941,50597,1,,,BAO_0000218,1969.0,
9117,Rattus norvegicus,CHEMBL877605,Intermediate,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,N,10116.0,5394,50597,1,,,BAO_0000218,,
9118,Rattus norvegicus,CHEMBL623813,Intermediate,,Pharmacokinetic property (Cmax) in rat,,N,10116.0,4408,50597,1,,,BAO_0000218,,
9119,Rattus norvegicus,CHEMBL623814,Intermediate,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,N,10116.0,5983,50597,1,,,BAO_0000218,,
9120,Rattus norvegicus,CHEMBL623815,Intermediate,,Cmax in rat after 3mg/kg oral dose,,N,10116.0,4878,50597,1,,,BAO_0000218,,
9121,Rattus norvegicus,CHEMBL623816,Intermediate,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,N,10116.0,5862,50597,1,,,BAO_0000218,,
9122,Rattus norvegicus,CHEMBL623145,Intermediate,,Cmax in rats after 20 mg/kg oral dose,,N,10116.0,4517,50597,1,,,BAO_0000218,,
9123,Rattus norvegicus,CHEMBL623146,Intermediate,Plasma,Cmax in rat plasma after 30mg/kg oral dose,,N,10116.0,5932,50597,1,,,BAO_0000218,1969.0,
9124,Rattus norvegicus,CHEMBL623147,Intermediate,Plasma,Plasma concentration after oral administration of 100 mg/kg to rats,,N,10116.0,5436,50597,1,,,BAO_0000218,1969.0,
9125,Rattus norvegicus,CHEMBL623042,Intermediate,Brain,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,955.0,
9126,Rattus norvegicus,CHEMBL623043,Intermediate,,Tested for the Cmax in rat at 10 mg/kg per orally,,N,10116.0,4950,50597,1,,,BAO_0000218,,
9127,Rattus norvegicus,CHEMBL623044,Intermediate,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
9128,Rattus norvegicus,CHEMBL623045,Intermediate,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
9129,Rattus norvegicus,CHEMBL623046,Intermediate,,Bioavailability as oral Cmax in rats at 30 mins,,N,10116.0,3360,50597,1,,,BAO_0000218,,
9130,Rattus norvegicus,CHEMBL623226,Intermediate,,Bioavailability as oral Cmax in rats at 6hr,,N,10116.0,3360,50597,1,,,BAO_0000218,,
9131,Rattus norvegicus,CHEMBL623227,Intermediate,,The maximum concentration of compound was measured at the dose of 100 umol/kg,,N,10116.0,15022,50597,1,,,BAO_0000218,,
9132,Rattus norvegicus,CHEMBL623228,Intermediate,,The maximum concentration of compound was measured at the dose of 300 umol/kg,,N,10116.0,15022,50597,1,,,BAO_0000218,,
9133,Rattus norvegicus,CHEMBL623229,Intermediate,,The maximum concentration of compound was measured at the dose of 30 umol/kg,,N,10116.0,15022,50597,1,,,BAO_0000218,,
9134,Rattus norvegicus,CHEMBL623230,Intermediate,Plasma,The maximum plasma levels for the compounds were determined by LC-MS.,,N,10116.0,5160,50597,1,,,BAO_0000218,1969.0,
9135,Rattus norvegicus,CHEMBL623231,Intermediate,Plasma,mean peak plasma concentration was observed after intravenous administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,1969.0,
9136,Rattus norvegicus,CHEMBL623232,Intermediate,Plasma,mean peak plasma concentration was observed after oral administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,1969.0,
9137,Rattus norvegicus,CHEMBL623233,Intermediate,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,N,10116.0,4709,50597,1,,,BAO_0000218,,
9138,Rattus norvegicus,CHEMBL623234,Intermediate,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,N,10116.0,3535,50597,1,,,BAO_0000218,,
9139,Rattus norvegicus,CHEMBL623235,Intermediate,,Concentration in plasma (portal) following oral dose in rats at 1 hr,,N,10116.0,3535,50597,1,,,BAO_0000218,,
9140,Rattus norvegicus,CHEMBL623236,Intermediate,,Concentration in plasma (portal) following oral dose in rats at 2 hr,,N,10116.0,3535,50597,1,,,BAO_0000218,,
9141,Rattus norvegicus,CHEMBL623237,Intermediate,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,N,10116.0,3535,50597,1,,,BAO_0000218,,
9142,Rattus norvegicus,CHEMBL623238,Intermediate,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,N,10116.0,3535,50597,1,,,BAO_0000218,,
9143,Rattus norvegicus,CHEMBL623239,Intermediate,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,N,10116.0,3535,50597,1,,,BAO_0000218,,
9144,Rattus norvegicus,CHEMBL623240,Intermediate,Plasma,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,U,10116.0,5005,22224,1,,,BAO_0000218,1969.0,
9145,Rattus norvegicus,CHEMBL623241,Intermediate,Hypothalamus,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,N,10116.0,6326,50597,1,,,BAO_0000218,1898.0,
9146,Rattus norvegicus,CHEMBL623242,Intermediate,Hypothalamus,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,N,10116.0,6326,50597,1,,,BAO_0000218,1898.0,
9147,Rattus norvegicus,CHEMBL874394,Intermediate,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,N,10116.0,6326,50597,1,,,BAO_0000218,,
9148,Rattus norvegicus,CHEMBL623243,Intermediate,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,N,10116.0,6326,50597,1,,,BAO_0000218,,
9149,Rattus norvegicus,CHEMBL623244,Intermediate,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,10116.0,17411,50597,1,,,BAO_0000218,,
9150,Rattus norvegicus,CHEMBL623245,Intermediate,Kidney,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
9151,Rattus norvegicus,CHEMBL623246,Intermediate,Kidney,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
9152,Rattus norvegicus,CHEMBL623247,Intermediate,Kidney,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
9153,Rattus norvegicus,CHEMBL623248,Intermediate,Kidney,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
9154,Rattus norvegicus,CHEMBL623249,Intermediate,Kidney,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2113.0,
9155,Rattus norvegicus,CHEMBL625072,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2107.0,
9156,Rattus norvegicus,CHEMBL625073,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2107.0,
9157,Rattus norvegicus,CHEMBL625074,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2107.0,
9158,Rattus norvegicus,CHEMBL625075,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2107.0,
9159,Rattus norvegicus,CHEMBL625076,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2107.0,
9160,Rattus norvegicus,CHEMBL625077,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2107.0,
9161,Rattus norvegicus,CHEMBL625078,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2107.0,
9162,Rattus norvegicus,CHEMBL874395,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2107.0,
9163,Rattus norvegicus,CHEMBL625079,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9164,Rattus norvegicus,CHEMBL625080,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9165,Rattus norvegicus,CHEMBL625081,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9166,Rattus norvegicus,CHEMBL625082,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9167,Rattus norvegicus,CHEMBL625083,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9168,Rattus norvegicus,CHEMBL625084,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9169,Rattus norvegicus,CHEMBL625085,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9170,Rattus norvegicus,CHEMBL625086,Intermediate,Liver,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9171,Rattus norvegicus,CHEMBL625087,Intermediate,Liver,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2107.0,
9172,Rattus norvegicus,CHEMBL625088,Intermediate,Liver,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2107.0,
9173,Rattus norvegicus,CHEMBL622205,Intermediate,Liver,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2107.0,
9174,Rattus norvegicus,CHEMBL622206,Intermediate,Liver,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9175,Rattus norvegicus,CHEMBL622207,Intermediate,Liver,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9176,Rattus norvegicus,CHEMBL622366,Intermediate,Liver,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9177,Rattus norvegicus,CHEMBL622367,Intermediate,Liver,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9178,Rattus norvegicus,CHEMBL875331,Intermediate,Liver,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9179,Rattus norvegicus,CHEMBL622368,Intermediate,Liver,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2107.0,
9180,Rattus norvegicus,CHEMBL622369,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2048.0,
9181,Rattus norvegicus,CHEMBL622370,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2048.0,
9182,Rattus norvegicus,CHEMBL622371,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2048.0,
9183,Rattus norvegicus,CHEMBL622372,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2048.0,
9184,Rattus norvegicus,CHEMBL622373,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2048.0,
9185,Rattus norvegicus,CHEMBL622374,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2048.0,
9186,Rattus norvegicus,CHEMBL622375,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2048.0,
9187,Rattus norvegicus,CHEMBL622376,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2048.0,
9188,Rattus norvegicus,CHEMBL622377,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9189,Rattus norvegicus,CHEMBL622378,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9190,Rattus norvegicus,CHEMBL622379,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9191,Rattus norvegicus,CHEMBL622380,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9192,Rattus norvegicus,CHEMBL622381,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9193,Rattus norvegicus,CHEMBL622382,Intermediate,Lung,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9194,Rattus norvegicus,CHEMBL622383,Intermediate,Lung,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2048.0,
9195,Rattus norvegicus,CHEMBL875332,Intermediate,Stomach,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,10116.0,6175,50597,1,,,BAO_0000218,945.0,
9196,Rattus norvegicus,CHEMBL622384,Intermediate,Stomach,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,10116.0,6175,50597,1,,,BAO_0000218,945.0,
9197,Rattus norvegicus,CHEMBL622385,Intermediate,Stomach,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,10116.0,6175,50597,1,,,BAO_0000218,945.0,
9198,Rattus norvegicus,CHEMBL622386,Intermediate,Stomach,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,10116.0,6175,50597,1,,,BAO_0000218,945.0,
9199,Rattus norvegicus,CHEMBL622387,Intermediate,,The compound was tested for the plasma binding in rat,,N,10116.0,10839,50597,1,,,BAO_0000218,,
9200,Rattus norvegicus,CHEMBL622388,Intermediate,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,N,10116.0,16459,50597,1,,,BAO_0000218,,
9201,Rattus norvegicus,CHEMBL622389,Intermediate,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,N,10116.0,16459,50597,1,,,BAO_0000218,,
9202,Rattus norvegicus,CHEMBL622390,Intermediate,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,N,10116.0,16459,50597,1,,,BAO_0000218,,
9203,Rattus norvegicus,CHEMBL622391,Intermediate,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,N,10116.0,16459,50597,1,,,BAO_0000218,,
9204,Rattus norvegicus,CHEMBL622392,Intermediate,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,N,10116.0,16459,50597,1,,,BAO_0000218,,
9205,Rattus norvegicus,CHEMBL622393,Intermediate,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,N,10116.0,16459,50597,1,,,BAO_0000218,,
9206,Rattus norvegicus,CHEMBL622394,Intermediate,,Plasma level at 2 hr after administration of the compound,,N,10116.0,3278,50597,1,,,BAO_0000218,,
9207,Rattus norvegicus,CHEMBL622395,Intermediate,,plasma level at 2 hr after administration of the compound,,N,10116.0,3278,50597,1,,,BAO_0000218,,
9208,Rattus norvegicus,CHEMBL622396,Intermediate,Serum,Stability in rat serum measured as % recovery at 1 min,,N,10116.0,4684,50597,1,,,BAO_0000218,1977.0,
9209,Rattus norvegicus,CHEMBL624894,Intermediate,Serum,Stability in rat serum measured as % recovery at 10 min,,N,10116.0,4684,50597,1,,,BAO_0000218,1977.0,
9210,Rattus norvegicus,CHEMBL624895,Intermediate,Serum,Stability in rat serum measured as % recovery at 10 mins,,N,10116.0,4684,50597,1,,,BAO_0000218,1977.0,
9211,Rattus norvegicus,CHEMBL624058,Intermediate,Serum,Stability in rat serum measured as % recovery at 2 hr,,N,10116.0,4684,50597,1,,,BAO_0000218,1977.0,
9212,Rattus norvegicus,CHEMBL624059,Intermediate,Serum,Stability in rat serum measured as % recovery at 3 min,,N,10116.0,4684,50597,1,,,BAO_0000218,1977.0,
9213,Rattus norvegicus,CHEMBL624060,Intermediate,Serum,Stability in rat serum measured as % recovery at 3 mins,,N,10116.0,4684,50597,1,,,BAO_0000218,1977.0,
9214,Rattus norvegicus,CHEMBL624061,Intermediate,Serum,Stability in rat serum measured as % recovery at 5 min,,N,10116.0,4684,50597,1,,,BAO_0000218,1977.0,
9215,Rattus norvegicus,CHEMBL624062,Intermediate,Serum,Stability in rat serum measured as % recovery at 5 mins,,N,10116.0,4684,50597,1,,,BAO_0000218,1977.0,
9216,Rattus norvegicus,CHEMBL624063,Intermediate,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,N,10116.0,16456,50597,1,,,BAO_0000218,,
9217,Rattus norvegicus,CHEMBL624064,Intermediate,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,N,10116.0,16456,50597,1,,,BAO_0000218,,
9218,Rattus norvegicus,CHEMBL624065,Intermediate,Plasma,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,N,10116.0,723,50597,1,,,BAO_0000218,1969.0,
9219,Rattus norvegicus,CHEMBL624066,Intermediate,Plasma,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,N,10116.0,723,50597,1,,,BAO_0000218,1969.0,
9220,Rattus norvegicus,CHEMBL877490,Intermediate,,Half life tested in mature male rat at a dose of 30 mg/kg,,N,10116.0,5160,50597,1,,,BAO_0000218,,
9221,Rattus norvegicus,CHEMBL874442,Intermediate,,Half life after intravenous administration of 1 mg/kg in rat,,N,10116.0,4709,50597,1,,,BAO_0000218,,
9222,Rattus norvegicus,CHEMBL626890,Intermediate,,Half life period after administration (30 mg/kg) in rat,,N,10116.0,5633,50597,1,,,BAO_0000218,,
9223,Rattus norvegicus,CHEMBL626891,Intermediate,,Half life period in rat after 5 mg/Kg dose,,N,10116.0,5302,50597,1,,,BAO_0000218,,
9224,Rattus norvegicus,CHEMBL626892,Intermediate,,Half life period in rat after 5 mg/kg dose,,N,10116.0,5302,50597,1,,,BAO_0000218,,
9225,Rattus norvegicus,CHEMBL626893,Intermediate,,Half life period was determined,,N,10116.0,17791,50597,1,,,BAO_0000218,,
9226,Rattus norvegicus,CHEMBL626894,Intermediate,,Half life period was evaluated in rat,,N,10116.0,17791,50597,1,,,BAO_0000218,,
9227,Rattus norvegicus,CHEMBL626895,Intermediate,,Half life period was evaluated in rat; 0.5-1.0,,N,10116.0,17791,50597,1,,,BAO_0000218,,
9228,Rattus norvegicus,CHEMBL626896,Intermediate,,Half life period was evaluated in rat; 5.9-7.5,,N,10116.0,17791,50597,1,,,BAO_0000218,,
9229,Rattus norvegicus,CHEMBL626897,Intermediate,Plasma,Half-life in rat plasma,,N,10116.0,14512,50597,1,,,BAO_0000218,1969.0,
9230,Rattus norvegicus,CHEMBL626898,Intermediate,,Half-life time in rat was determined,,N,10116.0,6230,50597,1,,,BAO_0000218,,
9231,Rattus norvegicus,CHEMBL626899,Intermediate,,Terminal half-life after iv administration to rats,,N,10116.0,3364,50597,1,,,BAO_0000218,,
9232,Rattus norvegicus,CHEMBL626900,Intermediate,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,N,10116.0,6874,50597,1,,,BAO_0000218,,
9233,Rattus norvegicus,CHEMBL626901,Intermediate,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,N,10116.0,857,50597,1,,,BAO_0000218,,
9234,Rattus norvegicus,CHEMBL626902,Intermediate,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,N,10116.0,858,50597,1,,,BAO_0000218,,
9235,Rattus norvegicus,CHEMBL626903,Intermediate,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,N,10116.0,858,50597,1,,,BAO_0000218,,
9236,Rattus norvegicus,CHEMBL874443,Intermediate,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,N,10116.0,5355,50597,1,,,BAO_0000218,,
9237,Rattus norvegicus,CHEMBL626904,Intermediate,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,N,10116.0,5355,50597,1,,,BAO_0000218,,
9238,Rattus norvegicus,CHEMBL626905,Intermediate,,Half life in rats,,N,10116.0,6305,50597,1,,,BAO_0000218,,
9239,Rattus norvegicus,CHEMBL873830,Intermediate,Plasma,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,N,10116.0,13501,50597,1,,,BAO_0000218,1969.0,
9240,Rattus norvegicus,CHEMBL626906,Intermediate,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,N,10116.0,17594,50597,1,,,BAO_0000218,,
9241,Rattus norvegicus,CHEMBL631076,Intermediate,Plasma,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,N,10116.0,4186,50597,1,,,BAO_0000218,1969.0,
9242,Rattus norvegicus,CHEMBL631077,Intermediate,Plasma,Biological half-life was measured in plasma of rats,,N,10116.0,2932,50597,1,,,BAO_0000218,1969.0,
9243,Rattus norvegicus,CHEMBL631078,Intermediate,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,10116.0,17065,50597,1,,,BAO_0000218,,
9244,Rattus norvegicus,CHEMBL631079,Intermediate,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,N,10116.0,15765,50597,1,,,BAO_0000218,,
9245,Rattus norvegicus,CHEMBL631080,Intermediate,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,N,10116.0,2713,50597,1,,,BAO_0000218,,
9246,Rattus norvegicus,CHEMBL631081,Intermediate,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
9247,Rattus norvegicus,CHEMBL631239,Intermediate,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
9248,Rattus norvegicus,CHEMBL631240,Intermediate,Plasma,Compound was evaluated for plasma half life in rat,,N,10116.0,740,50597,1,,,BAO_0000218,1969.0,
9249,Rattus norvegicus,CHEMBL631241,Intermediate,Plasma,AUC value at a dose of 5 mg/kg (p.o.) in rats,,N,10116.0,6597,50597,1,,,BAO_0000218,1969.0,
9250,Rattus norvegicus,CHEMBL631242,Intermediate,Plasma,AUC value after administration of 20 mg/Kg oral dose in rat,,N,10116.0,2959,50597,1,,,BAO_0000218,1969.0,
9251,Rattus norvegicus,CHEMBL631243,Intermediate,Plasma,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,N,10116.0,17594,50597,1,,,BAO_0000218,1969.0,
9252,Rattus norvegicus,CHEMBL874444,Intermediate,Plasma,AUC0-96 after administration at 50 mg/kg,,N,10116.0,17596,50597,1,,,BAO_0000218,1969.0,
9253,Rattus norvegicus,CHEMBL631244,Intermediate,Plasma,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,N,10116.0,17594,50597,1,,,BAO_0000218,1969.0,
9254,Rattus norvegicus,CHEMBL631245,Intermediate,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,N,10116.0,3293,50597,1,,,BAO_0000218,,
9255,Rattus norvegicus,CHEMBL627162,Intermediate,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,N,10116.0,6757,50597,1,,,BAO_0000218,,
9256,Rattus norvegicus,CHEMBL627163,Intermediate,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,N,10116.0,6757,50597,1,,,BAO_0000218,,
9257,Rattus norvegicus,CHEMBL627164,Intermediate,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,N,10116.0,6757,50597,1,,,BAO_0000218,,
9258,Rattus norvegicus,CHEMBL627165,Intermediate,Kidney,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,N,10116.0,5979,50597,1,,,BAO_0000218,2113.0,
9259,Rattus norvegicus,CHEMBL627166,Intermediate,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,N,10116.0,5979,50597,1,,,BAO_0000218,,
9260,Rattus norvegicus,CHEMBL627167,Intermediate,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,N,10116.0,5979,50597,1,,,BAO_0000218,,
9261,Rattus norvegicus,CHEMBL627822,Intermediate,,Area under curve (AUC) at a dose of 30 mg/kg in rats,,N,10116.0,4026,50597,1,,,BAO_0000218,,
9262,Rattus norvegicus,CHEMBL627823,Intermediate,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,N,10116.0,5355,50597,1,,,BAO_0000218,,
9263,Rattus norvegicus,CHEMBL627824,Intermediate,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,N,10116.0,5355,50597,1,,,BAO_0000218,,
9264,Rattus norvegicus,CHEMBL627825,Intermediate,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,N,10116.0,5355,50597,1,,,BAO_0000218,,
9265,Rattus norvegicus,CHEMBL627826,Intermediate,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,N,10116.0,5633,50597,1,,,BAO_0000218,,
9266,Rattus norvegicus,CHEMBL627827,Intermediate,,Area under curve (Pharmacokinetic property) was determined,,N,10116.0,1716,50597,1,,,BAO_0000218,,
9267,Rattus norvegicus,CHEMBL627828,Intermediate,,Area under curve (Pharmacokinetic property) of the compound; Not determined,,N,10116.0,1716,50597,1,,,BAO_0000218,,
9268,Rattus norvegicus,CHEMBL627829,Intermediate,,Area under curve after intravenous administration (1 mg/kg) in rat,,N,10116.0,4689,50597,1,,,BAO_0000218,,
9269,Rattus norvegicus,CHEMBL627830,Intermediate,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,N,10116.0,4527,50597,1,,,BAO_0000218,,
9270,Rattus norvegicus,CHEMBL627831,Intermediate,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,N,10116.0,4527,50597,1,,,BAO_0000218,,
9271,Rattus norvegicus,CHEMBL627832,Intermediate,,Area under curve in male SD rats was observed after oral administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,,
9272,Rattus norvegicus,CHEMBL627833,Intermediate,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,N,10116.0,4413,50597,1,,,BAO_0000218,,
9273,Rattus norvegicus,CHEMBL627834,Expert,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,10116.0,3598,50597,1,,,BAO_0000218,,
9274,Rattus norvegicus,CHEMBL628004,Expert,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,N,10116.0,3598,50597,1,,,BAO_0000218,,
9275,Rattus norvegicus,CHEMBL628005,Intermediate,,Area under curve at 5 mg/kg po was determined in rat,,N,10116.0,5964,50597,1,,,BAO_0000218,,
9276,Rattus norvegicus,CHEMBL628006,Intermediate,,Area under curve in Rat at a oral dose of 5 mg/kg,,N,10116.0,4689,50597,1,,,BAO_0000218,,
9277,Rattus norvegicus,CHEMBL628007,Intermediate,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,N,10116.0,4186,50597,1,,,BAO_0000218,,
9278,Rattus norvegicus,CHEMBL625676,Intermediate,,Area under curve was determined,,N,10116.0,5510,50597,1,,,BAO_0000218,,
9279,Rattus norvegicus,CHEMBL631309,Intermediate,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,N,10116.0,17858,50597,1,,,BAO_0000218,,
9280,Rattus norvegicus,CHEMBL631310,Intermediate,,Area under curve after intravenous administration at 3 mg/kg,,N,10116.0,17804,50597,1,,,BAO_0000218,,
9281,Rattus norvegicus,CHEMBL631311,Intermediate,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,N,10116.0,6106,50597,1,,,BAO_0000218,,
9282,Rattus norvegicus,CHEMBL631312,Intermediate,,Area under curve at 4 hr in rat,,N,10116.0,5964,50597,1,,,BAO_0000218,,
9283,Rattus norvegicus,CHEMBL631313,Intermediate,,Area under curve at a dose of 30 mg/kg,,N,10116.0,4026,50597,1,,,BAO_0000218,,
9284,Rattus norvegicus,CHEMBL631314,Intermediate,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,N,10116.0,4756,50597,1,,,BAO_0000218,,
9285,Rattus norvegicus,CHEMBL631315,Intermediate,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,N,10116.0,4756,50597,1,,,BAO_0000218,,
9286,Rattus norvegicus,CHEMBL631316,Intermediate,,Area under curve for a 2-mpk po dose in SD rats,,N,10116.0,5862,50597,1,,,BAO_0000218,,
9287,Rattus norvegicus,CHEMBL631317,Intermediate,,Area under curve in SD rats,,N,10116.0,5862,50597,1,,,BAO_0000218,,
9288,Rattus norvegicus,CHEMBL874471,Intermediate,,Area under curve in rat after oral administration at 13 mg/kg dose,,N,10116.0,6644,50597,1,,,BAO_0000218,,
9289,Rattus norvegicus,CHEMBL631318,Intermediate,,Area under curve in rat by po administration at 0-24 hr,,N,10116.0,5871,50597,1,,,BAO_0000218,,
9290,Rattus norvegicus,CHEMBL631319,Intermediate,Plasma,Area under curve in rat plasma,,N,10116.0,5919,50597,1,,,BAO_0000218,1969.0,
9291,Rattus norvegicus,CHEMBL631320,Intermediate,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,N,10116.0,5939,50597,1,,,BAO_0000218,,
9292,Rattus norvegicus,CHEMBL631321,Intermediate,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,N,10116.0,5939,50597,1,,,BAO_0000218,,
9293,Rattus norvegicus,CHEMBL631322,Intermediate,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,N,10116.0,10,50597,1,,,BAO_0000218,,
9294,Rattus norvegicus,CHEMBL631323,Intermediate,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,N,10116.0,11149,50597,1,,,BAO_0000218,,
9295,Rattus norvegicus,CHEMBL631324,Intermediate,,Area under curve value in rat at a dose of 5 mg/kg,,N,10116.0,5302,50597,1,,,BAO_0000218,,
9296,Rattus norvegicus,CHEMBL631325,Intermediate,,Area under curve was determined after oral administration in rats,,N,10116.0,17796,50597,1,,,BAO_0000218,,
9297,Rattus norvegicus,CHEMBL631326,Intermediate,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,N,10116.0,4890,50597,1,,,BAO_0000218,,
9298,Rattus norvegicus,CHEMBL631327,Intermediate,,Area under curve was determined after peroral administration in rat,,N,10116.0,6011,50597,1,,,BAO_0000218,,
9299,Rattus norvegicus,CHEMBL631328,Intermediate,,Area under curve was determined at a dose 30 mpk administered orally.,,N,10116.0,5375,50597,1,,,BAO_0000218,,
9300,Rattus norvegicus,CHEMBL631329,Intermediate,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,N,10116.0,17764,50597,1,,,BAO_0000218,,
9301,Rattus norvegicus,CHEMBL627217,Intermediate,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,N,10116.0,4368,50597,1,,,BAO_0000218,,
9302,Rattus norvegicus,CHEMBL626352,Intermediate,,Area under curve was determined in male rat,,N,10116.0,5610,50597,1,,,BAO_0000218,,
9303,Rattus norvegicus,CHEMBL626353,Intermediate,,Area under curve was determined in rat after PO administration,,N,10116.0,5833,50597,1,,,BAO_0000218,,
9304,Rattus norvegicus,CHEMBL626354,Intermediate,,Area under curve was determined in rat after a 3 mg/kg of oral dose,,N,10116.0,4257,50597,1,,,BAO_0000218,,
9305,Rattus norvegicus,CHEMBL626355,Intermediate,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,N,10116.0,5937,50597,1,,,BAO_0000218,,
9306,Rattus norvegicus,CHEMBL626356,Intermediate,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,N,10116.0,5932,50597,1,,,BAO_0000218,,
9307,Rattus norvegicus,CHEMBL626357,Intermediate,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,N,10116.0,5932,50597,1,,,BAO_0000218,,
9308,Rattus norvegicus,CHEMBL626358,Intermediate,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,10116.0,17411,50597,1,,,BAO_0000218,,
9309,Rattus norvegicus,CHEMBL626359,Intermediate,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,10116.0,17411,50597,1,,,BAO_0000218,,
9310,Rattus norvegicus,CHEMBL626360,Intermediate,Plasma,Peak plasma concentration in rat at a dose of 3 mg/kg,,N,10116.0,17771,50597,1,,,BAO_0000218,1969.0,
9311,Rattus norvegicus,CHEMBL626361,Intermediate,,Plasma concentration at 2 hr in rats was evaluated.,,N,10116.0,1628,50597,1,,,BAO_0000218,,
9312,Rattus norvegicus,CHEMBL626362,Intermediate,,Plasma concentration at 2 hr in rats was evaluated; Not available,,N,10116.0,1628,50597,1,,,BAO_0000218,,
9313,Rattus norvegicus,CHEMBL626363,Intermediate,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,10116.0,17411,50597,1,,,BAO_0000218,,
9314,Rattus norvegicus,CHEMBL626970,Intermediate,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,,
9315,Rattus norvegicus,CHEMBL626971,Intermediate,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,,
9316,Rattus norvegicus,CHEMBL626972,Intermediate,Plasma,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,1969.0,
9317,Rattus norvegicus,CHEMBL626973,Intermediate,Plasma,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,1969.0,
9318,Rattus norvegicus,CHEMBL626974,Intermediate,Plasma,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,1969.0,
9319,Rattus norvegicus,CHEMBL874592,Intermediate,Plasma,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,1969.0,
9320,Rattus norvegicus,CHEMBL626975,Intermediate,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,N,10116.0,5510,50597,1,,,BAO_0000218,,
9321,Rattus norvegicus,CHEMBL626976,Intermediate,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,N,10116.0,5510,50597,1,,,BAO_0000218,,
9322,Rattus norvegicus,CHEMBL626977,Intermediate,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,N,10116.0,5510,50597,1,,,BAO_0000218,,
9323,Rattus norvegicus,CHEMBL626978,Intermediate,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,N,10116.0,5510,50597,1,,,BAO_0000218,,
9324,Rattus norvegicus,CHEMBL626979,Intermediate,,PK study was carried to determine the relative absorption ranking in rat.,,N,10116.0,16427,50597,1,,,BAO_0000218,,
9325,Rattus norvegicus,CHEMBL626980,Intermediate,Plasma,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,N,10116.0,4689,50597,1,,,BAO_0000218,1969.0,
9326,Rattus norvegicus,CHEMBL626981,Intermediate,Blood,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,178.0,
9327,Rattus norvegicus,CHEMBL626982,Intermediate,Blood,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,178.0,
9328,Rattus norvegicus,CHEMBL626983,Intermediate,Blood,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,178.0,
9329,Rattus norvegicus,CHEMBL622522,Intermediate,Blood,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,178.0,
9330,Rattus norvegicus,CHEMBL622523,Intermediate,Blood,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,178.0,
9331,Rattus norvegicus,CHEMBL622524,Intermediate,Blood,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,178.0,
9332,Rattus norvegicus,CHEMBL622525,Intermediate,Brain,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,955.0,
9333,Rattus norvegicus,CHEMBL622526,Intermediate,Brain,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,955.0,
9334,Rattus norvegicus,CHEMBL619849,Intermediate,Brain,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,955.0,
9335,Rattus norvegicus,CHEMBL619850,Intermediate,Brain,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,955.0,
9336,Rattus norvegicus,CHEMBL623864,Intermediate,Brain,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,955.0,
9337,Rattus norvegicus,CHEMBL623865,Intermediate,Brain,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,955.0,
9338,Rattus norvegicus,CHEMBL623866,Intermediate,Heart,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,948.0,
9339,Rattus norvegicus,CHEMBL623867,Intermediate,Heart,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,948.0,
9340,Rattus norvegicus,CHEMBL877615,Intermediate,Heart,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,948.0,
9341,Rattus norvegicus,CHEMBL623868,Intermediate,Heart,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,948.0,
9342,Rattus norvegicus,CHEMBL623869,Intermediate,Heart,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,948.0,
9343,Rattus norvegicus,CHEMBL623870,Intermediate,Heart,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,948.0,
9344,Rattus norvegicus,CHEMBL623871,Intermediate,Lung,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2048.0,
9345,Rattus norvegicus,CHEMBL623872,Intermediate,Lung,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2048.0,
9346,Rattus norvegicus,CHEMBL622129,Intermediate,Lung,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9347,Rattus norvegicus,CHEMBL622130,Intermediate,Lung,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9348,Rattus norvegicus,CHEMBL622131,Intermediate,Lung,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9349,Rattus norvegicus,CHEMBL622132,Intermediate,Lung,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9350,Rattus norvegicus,CHEMBL622133,Intermediate,Lung,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9351,Rattus norvegicus,CHEMBL622134,Intermediate,Lung,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9352,Rattus norvegicus,CHEMBL622135,Intermediate,Lung,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9353,Rattus norvegicus,CHEMBL622136,Intermediate,Lung,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2048.0,
9354,Rattus norvegicus,CHEMBL622137,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2385.0,
9355,Rattus norvegicus,CHEMBL622138,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2385.0,
9356,Rattus norvegicus,CHEMBL623017,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2385.0,
9357,Rattus norvegicus,CHEMBL623018,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2385.0,
9358,Rattus norvegicus,CHEMBL623019,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2385.0,
9359,Rattus norvegicus,CHEMBL623020,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2385.0,
9360,Rattus norvegicus,CHEMBL623021,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2385.0,
9361,Rattus norvegicus,CHEMBL623022,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2385.0,
9362,Rattus norvegicus,CHEMBL623023,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9363,Rattus norvegicus,CHEMBL623024,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9364,Rattus norvegicus,CHEMBL623025,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9365,Rattus norvegicus,CHEMBL620545,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9366,Rattus norvegicus,CHEMBL620546,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9367,Rattus norvegicus,CHEMBL620547,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9368,Rattus norvegicus,CHEMBL620548,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9369,Rattus norvegicus,CHEMBL620549,Intermediate,Muscle tissue,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9370,Rattus norvegicus,CHEMBL620550,Intermediate,Muscle tissue,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2385.0,
9371,Rattus norvegicus,CHEMBL620551,Intermediate,Muscle tissue,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2385.0,
9372,Rattus norvegicus,CHEMBL620552,Intermediate,Muscle tissue,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2385.0,
9373,Rattus norvegicus,CHEMBL620553,Intermediate,Muscle tissue,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9374,Rattus norvegicus,CHEMBL620554,Intermediate,Muscle tissue,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9375,Rattus norvegicus,CHEMBL875845,Intermediate,Muscle tissue,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9376,Rattus norvegicus,CHEMBL620555,Intermediate,Muscle tissue,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9377,Rattus norvegicus,CHEMBL620556,Intermediate,Muscle tissue,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9378,Rattus norvegicus,CHEMBL620557,Intermediate,Muscle tissue,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2385.0,
9379,Rattus norvegicus,CHEMBL620558,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9380,Rattus norvegicus,CHEMBL620559,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9381,Rattus norvegicus,CHEMBL622939,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9382,Rattus norvegicus,CHEMBL622940,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9383,Rattus norvegicus,CHEMBL622941,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9384,Rattus norvegicus,CHEMBL622942,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9385,Rattus norvegicus,CHEMBL622943,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9386,Rattus norvegicus,CHEMBL622944,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9387,Rattus norvegicus,CHEMBL622945,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9388,Rattus norvegicus,CHEMBL622946,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9389,Rattus norvegicus,CHEMBL622947,Intermediate,,Compound was evaluated for terminal half life in rat,,N,10116.0,3341,50597,1,,,BAO_0000218,,
9390,Rattus norvegicus,CHEMBL622948,Intermediate,Plasma,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,N,10116.0,3634,50597,1,,,BAO_0000218,1969.0,
9391,Rattus norvegicus,CHEMBL622949,Intermediate,Plasma,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,N,10116.0,3634,50597,1,,,BAO_0000218,1969.0,
9392,Rattus norvegicus,CHEMBL622950,Intermediate,,Compound was tested for its half life in rat,,N,10116.0,4839,50597,1,,,BAO_0000218,,
9393,Macaca mulatta,CHEMBL622951,Intermediate,Plasma,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,U,9544.0,5005,22224,1,,,BAO_0000218,1969.0,
9394,Rattus norvegicus,CHEMBL622952,Intermediate,Plasma,Compound was tested for its plasma half life in Sprague Dawley rats,,U,10116.0,5005,22224,1,,,BAO_0000366,1969.0,
9395,Rattus norvegicus,CHEMBL622953,Intermediate,Plasma,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,U,10116.0,5005,22224,1,,,BAO_0000366,1969.0,
9396,Rattus norvegicus,CHEMBL873818,Intermediate,Plasma,Compound was tested for plasma half-life period in rat,,N,10116.0,1094,50597,1,,,BAO_0000218,1969.0,
9397,Rattus norvegicus,CHEMBL622954,Intermediate,,Elimination half life after i.v. administration of compound in rats,,N,10116.0,5031,50597,1,,,BAO_0000218,,
9398,Rattus norvegicus,CHEMBL622955,Intermediate,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,N,10116.0,6518,50597,1,,,BAO_0000218,,
9399,Rattus norvegicus,CHEMBL875229,Intermediate,,Elimination half-life after IV dosing at 1 mg/kg in rat,,N,10116.0,6518,50597,1,,,BAO_0000218,,
9400,Rattus norvegicus,CHEMBL622956,Intermediate,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,N,10116.0,6518,50597,1,,,BAO_0000218,,
9401,Rattus norvegicus,CHEMBL622957,Intermediate,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,N,10116.0,6518,50597,1,,,BAO_0000218,,
9402,Rattus norvegicus,CHEMBL622958,Intermediate,Brain,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,N,10116.0,5408,50597,1,,,BAO_0000218,955.0,
9403,Rattus norvegicus,CHEMBL622959,Intermediate,Plasma,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,N,10116.0,5408,50597,1,,,BAO_0000218,1969.0,
9404,Rattus norvegicus,CHEMBL622960,Intermediate,Brain,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,N,10116.0,5408,50597,1,,,BAO_0000218,955.0,
9405,Rattus norvegicus,CHEMBL622961,Intermediate,Plasma,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,N,10116.0,5408,50597,1,,,BAO_0000218,1969.0,
9406,Rattus norvegicus,CHEMBL622962,Intermediate,,Evaluated for the half life in rat (in vivo),,N,10116.0,4687,50597,1,,,BAO_0000218,,
9407,Rattus norvegicus,CHEMBL622963,Intermediate,,Hafl life in rat,,N,10116.0,6640,50597,1,,,BAO_0000218,,
9408,Rattus norvegicus,CHEMBL622964,Intermediate,,Hafl life rat,,N,10116.0,6640,50597,1,,,BAO_0000218,,
9409,Rattus norvegicus,CHEMBL622965,Intermediate,,Hafl life rat,,N,10116.0,6641,50597,1,,,BAO_0000218,,
9410,Rattus norvegicus,CHEMBL622966,Intermediate,,Hafl life rat; Not determined,,N,10116.0,6640,50597,1,,,BAO_0000218,,
9411,Rattus norvegicus,CHEMBL622967,Intermediate,,Hafl life rat; Not determined,,N,10116.0,6641,50597,1,,,BAO_0000218,,
9412,Rattus norvegicus,CHEMBL622968,Intermediate,Kidney,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,10116.0,17411,50597,1,,,BAO_0000218,2113.0,
9413,Rattus norvegicus,CHEMBL622969,Intermediate,Liver,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,10116.0,17411,50597,1,,,BAO_0000218,2107.0,
9414,Rattus norvegicus,CHEMBL875327,Intermediate,Lung,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,10116.0,17411,50597,1,,,BAO_0000218,2048.0,
9415,Rattus norvegicus,CHEMBL628638,Intermediate,,Half life in rat after 1 mg/kg i.v. administration,,N,10116.0,6570,50597,1,,,BAO_0000218,,
9416,Rattus norvegicus,CHEMBL628639,Intermediate,,Half life in rat after 2 mg/kg peroral administration,,N,10116.0,6570,50597,1,,,BAO_0000218,,
9417,Rattus norvegicus,CHEMBL625840,Intermediate,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,10116.0,17411,50597,1,,,BAO_0000218,,
9418,Rattus norvegicus,CHEMBL625841,Intermediate,,Half life of 10 mg/kg oral dose determined in rats,,N,10116.0,4722,50597,1,,,BAO_0000218,,
9419,Rattus norvegicus,CHEMBL625842,Intermediate,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
9420,Rattus norvegicus,CHEMBL625843,Intermediate,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
9421,Rattus norvegicus,CHEMBL625844,Intermediate,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
9422,Rattus norvegicus,CHEMBL873822,Intermediate,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
9423,Rattus norvegicus,CHEMBL625845,Intermediate,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
9424,Rattus norvegicus,CHEMBL627059,Intermediate,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
9425,Rattus norvegicus,CHEMBL627060,Intermediate,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
9426,Rattus norvegicus,CHEMBL627061,Intermediate,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
9427,Rattus norvegicus,CHEMBL627709,Intermediate,,Half life of compound at 5 mg/kg after po administration was determined in rat,,N,10116.0,4762,50597,1,,,BAO_0000218,,
9428,Rattus norvegicus,CHEMBL627710,Intermediate,,Half life of compound determined after intravenous administration to rat,,N,10116.0,5327,50597,1,,,BAO_0000218,,
9429,Rattus norvegicus,CHEMBL627711,Intermediate,,Half life of compound was determined in rat,,N,10116.0,4847,50597,1,,,BAO_0000218,,
9430,Rattus norvegicus,CHEMBL627712,Intermediate,Plasma,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,10116.0,17720,50597,1,,,BAO_0000218,1969.0,
9431,Rattus norvegicus,CHEMBL627713,Intermediate,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,10116.0,4723,50597,1,,,BAO_0000218,,
9432,Rattus norvegicus,CHEMBL627714,Intermediate,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,10116.0,4723,50597,1,,,BAO_0000218,,
9433,Macaca fascicularis,CHEMBL627889,Intermediate,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,U,9541.0,4256,22224,1,,,BAO_0000218,,
9434,Rattus norvegicus,CHEMBL627890,Intermediate,,Half life determined in rat by intravenous administration,,U,10116.0,4256,22224,1,,,BAO_0000218,,
9435,Rattus norvegicus,CHEMBL627891,Intermediate,,Half life determined in rats after iv administration,,N,10116.0,4722,50597,1,,,BAO_0000218,,
9436,Rattus norvegicus,CHEMBL627892,Intermediate,Plasma,Half life in rat plasma after administration of 2 mg/kg iv,,N,10116.0,6535,50597,1,,,BAO_0000218,1969.0,
9437,Rattus norvegicus,CHEMBL627893,Intermediate,Plasma,Half life in rat plasma after administration of 2 mg/kg iv,,N,10116.0,6535,50597,1,,,BAO_0000218,1969.0,
9438,Rattus norvegicus,CHEMBL627894,Intermediate,Plasma,Half life in rat plasma was determined,,N,10116.0,1435,50597,1,,,BAO_0000218,1969.0,
9439,Rattus norvegicus,CHEMBL627895,Intermediate,Plasma,Half life in rat plasma was determined; NA means not applicable,,N,10116.0,1435,50597,1,,,BAO_0000218,1969.0,
9440,Rattus norvegicus,CHEMBL627896,Intermediate,,Half life in rat was tested,,N,10116.0,5206,50597,1,,,BAO_0000218,,
9441,Rattus norvegicus,CHEMBL627897,Intermediate,Plasma,Half life measured in rat plasma,,N,10116.0,6080,50597,1,,,BAO_0000218,1969.0,
9442,Rattus norvegicus,CHEMBL627898,Intermediate,,Half life recorded in rats,,N,10116.0,4449,50597,1,,,BAO_0000218,,
9443,Rattus norvegicus,CHEMBL627899,Intermediate,,Half life was calculated,,N,10116.0,6057,50597,1,,,BAO_0000218,,
9444,Rattus norvegicus,CHEMBL873823,Intermediate,,Half life was calculated in rat,,N,10116.0,6057,50597,1,,,BAO_0000218,,
9445,Rattus norvegicus,CHEMBL627900,Intermediate,,Half life was determined,,N,10116.0,3747,50597,1,,,BAO_0000218,,
9446,Rattus norvegicus,CHEMBL627901,Intermediate,,Half life after 10 mg/kg oral administration in rat,,N,10116.0,17858,50597,1,,,BAO_0000218,,
9447,Rattus norvegicus,CHEMBL627902,Intermediate,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,N,10116.0,16365,50597,1,,,BAO_0000218,,
9448,Rattus norvegicus,CHEMBL627903,Intermediate,,Half life after administering orally a dose of 30 mg/kg,,N,10116.0,16365,50597,1,,,BAO_0000218,,
9449,Rattus norvegicus,CHEMBL627904,Intermediate,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,N,10116.0,5031,50597,1,,,BAO_0000218,,
9450,Rattus norvegicus,CHEMBL627905,Intermediate,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,N,10116.0,4722,50597,1,,,BAO_0000218,,
9451,Rattus norvegicus,CHEMBL627906,Intermediate,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,N,10116.0,6078,50597,1,,,BAO_0000218,,
9452,Rattus norvegicus,CHEMBL627907,Intermediate,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,N,10116.0,6078,50597,1,,,BAO_0000218,,
9453,Rattus norvegicus,CHEMBL876783,Intermediate,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,N,10116.0,6078,50597,1,,,BAO_0000218,,
9454,Rattus norvegicus,CHEMBL627908,Intermediate,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,N,10116.0,6078,50597,1,,,BAO_0000218,,
9455,Rattus norvegicus,CHEMBL627909,Intermediate,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,10116.0,17065,50597,1,,,BAO_0000218,,
9456,Rattus norvegicus,CHEMBL627910,Intermediate,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,N,10116.0,1353,50597,1,,,BAO_0000218,,
9457,Rattus norvegicus,CHEMBL627911,Intermediate,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,N,10116.0,1353,50597,1,,,BAO_0000218,,
9458,Rattus norvegicus,CHEMBL627912,Intermediate,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,N,10116.0,1353,50597,1,,,BAO_0000218,,
9459,Rattus norvegicus,CHEMBL627913,Intermediate,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,N,10116.0,1353,50597,1,,,BAO_0000218,,
9460,Rattus norvegicus,CHEMBL627914,Intermediate,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,N,10116.0,1353,50597,1,,,BAO_0000218,,
9461,Rattus norvegicus,CHEMBL627915,Intermediate,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,N,10116.0,16423,50597,1,,,BAO_0000218,,
9462,Rattus norvegicus,CHEMBL627916,Intermediate,,Area under the curve was evaluated after 20 uM/kg of peroral administration,,N,10116.0,16423,50597,1,,,BAO_0000218,,
9463,Rattus norvegicus,CHEMBL627917,Intermediate,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,N,10116.0,6062,50597,1,,,BAO_0000218,,
9464,Rattus norvegicus,CHEMBL627918,Intermediate,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,N,10116.0,6056,50597,1,,,BAO_0000218,,
9465,Rattus norvegicus,CHEMBL627919,Intermediate,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,N,10116.0,5182,50597,1,,,BAO_0000218,,
9466,Rattus norvegicus,CHEMBL627920,Intermediate,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,N,10116.0,6410,50597,1,,,BAO_0000218,,
9467,Rattus norvegicus,CHEMBL627921,Intermediate,,Area under the curve was evaluated at an oral dose of 30 mg/kg,,N,10116.0,6410,50597,1,,,BAO_0000218,,
9468,Rattus norvegicus,CHEMBL627922,Intermediate,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,10116.0,4723,50597,1,,,BAO_0000218,,
9469,Rattus norvegicus,CHEMBL876784,Intermediate,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,10116.0,4723,50597,1,,,BAO_0000218,,
9470,Rattus norvegicus,CHEMBL627923,Intermediate,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,10116.0,4723,50597,1,,,BAO_0000218,,
9471,Rattus norvegicus,CHEMBL626208,Intermediate,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,10116.0,4723,50597,1,,,BAO_0000218,,
9472,Rattus norvegicus,CHEMBL626209,Intermediate,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,10116.0,4723,50597,1,,,BAO_0000218,,
9473,Rattus norvegicus,CHEMBL626210,Intermediate,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,10116.0,4723,50597,1,,,BAO_0000218,,
9474,Rattus norvegicus,CHEMBL627994,Intermediate,Plasma,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,N,10116.0,2463,50597,1,,,BAO_0000218,1969.0,
9475,Rattus norvegicus,CHEMBL627995,Intermediate,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,N,10116.0,4709,50597,1,,,BAO_0000218,,
9476,Rattus norvegicus,CHEMBL627996,Intermediate,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,N,10116.0,4075,50597,1,,,BAO_0000218,,
9477,Rattus norvegicus,CHEMBL627997,Intermediate,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,N,10116.0,5394,50597,1,,,BAO_0000218,,
9478,Rattus norvegicus,CHEMBL627998,Intermediate,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
9479,Rattus norvegicus,CHEMBL628640,Intermediate,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
9480,Rattus norvegicus,CHEMBL628641,Intermediate,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
9481,Rattus norvegicus,CHEMBL628642,Intermediate,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
9482,Rattus norvegicus,CHEMBL628643,Intermediate,,Compound was evaluated for area under the curve expressed as (h*ug/ml),,N,10116.0,17791,50597,1,,,BAO_0000218,,
9483,Rattus norvegicus,CHEMBL628644,Intermediate,,Compound was tested for area under curve in rat,,N,10116.0,2591,50597,1,,,BAO_0000218,,
9484,Rattus norvegicus,CHEMBL628645,Intermediate,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,N,10116.0,6567,50597,1,,,BAO_0000218,,
9485,Rattus norvegicus,CHEMBL628646,Intermediate,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,N,10116.0,6211,50597,1,,,BAO_0000218,,
9486,Rattus norvegicus,CHEMBL628647,Intermediate,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,N,10116.0,5529,50597,1,,,BAO_0000218,,
9487,Rattus norvegicus,CHEMBL628648,Intermediate,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,N,10116.0,5408,50597,1,,,BAO_0000218,,
9488,Rattus norvegicus,CHEMBL625358,Intermediate,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,N,10116.0,5408,50597,1,,,BAO_0000218,,
9489,Rattus norvegicus,CHEMBL625359,Intermediate,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,N,10116.0,5408,50597,1,,,BAO_0000218,,
9490,Rattus norvegicus,CHEMBL625360,Intermediate,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,N,10116.0,5408,50597,1,,,BAO_0000218,,
9491,Rattus norvegicus,CHEMBL625361,Intermediate,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,N,10116.0,429,50597,1,,,BAO_0000218,,
9492,Rattus norvegicus,CHEMBL625362,Intermediate,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,N,10116.0,429,50597,1,,,BAO_0000218,,
9493,Rattus norvegicus,CHEMBL625363,Intermediate,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,N,10116.0,429,50597,1,,,BAO_0000218,,
9494,Rattus norvegicus,CHEMBL625364,Intermediate,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,N,10116.0,4796,50597,1,,,BAO_0000218,,
9495,Rattus norvegicus,CHEMBL625365,Intermediate,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
9496,Rattus norvegicus,CHEMBL625366,Intermediate,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
9497,Rattus norvegicus,CHEMBL625367,Intermediate,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
9498,Rattus norvegicus,CHEMBL625368,Intermediate,Kidney,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2113.0,
9499,Rattus norvegicus,CHEMBL625369,Intermediate,Kidney,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2113.0,
9500,Rattus norvegicus,CHEMBL625370,Intermediate,Kidney,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2113.0,
9501,Rattus norvegicus,CHEMBL625371,Intermediate,Kidney,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2113.0,
9502,Rattus norvegicus,CHEMBL625372,Intermediate,Kidney,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2113.0,
9503,Rattus norvegicus,CHEMBL625373,Intermediate,Kidney,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2113.0,
9504,Rattus norvegicus,CHEMBL625374,Intermediate,Liver,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2107.0,
9505,Rattus norvegicus,CHEMBL877593,Intermediate,Liver,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2107.0,
9506,Rattus norvegicus,CHEMBL625375,Intermediate,Liver,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2107.0,
9507,Rattus norvegicus,CHEMBL625376,Intermediate,Liver,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2107.0,
9508,Rattus norvegicus,CHEMBL621973,Intermediate,Liver,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2107.0,
9509,Rattus norvegicus,CHEMBL621974,Intermediate,Liver,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2107.0,
9510,Rattus norvegicus,CHEMBL621975,Intermediate,Lung,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2048.0,
9511,Rattus norvegicus,CHEMBL622166,Intermediate,Lung,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2048.0,
9512,Rattus norvegicus,CHEMBL622167,Intermediate,Lung,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2048.0,
9513,Rattus norvegicus,CHEMBL622168,Intermediate,Lung,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2048.0,
9514,Rattus norvegicus,CHEMBL622169,Intermediate,Lung,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2048.0,
9515,Rattus norvegicus,CHEMBL622170,Intermediate,Lung,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2048.0,
9516,Rattus norvegicus,CHEMBL622171,Intermediate,Thyroid gland,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2046.0,
9517,Rattus norvegicus,CHEMBL622172,Intermediate,Thyroid gland,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2046.0,
9518,Rattus norvegicus,CHEMBL622173,Intermediate,Thyroid gland,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2046.0,
9519,Rattus norvegicus,CHEMBL622174,Intermediate,Thyroid gland,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2046.0,
9520,Rattus norvegicus,CHEMBL622175,Intermediate,Thyroid gland,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2046.0,
9521,Rattus norvegicus,CHEMBL622176,Intermediate,Thyroid gland,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2046.0,
9522,Rattus norvegicus,CHEMBL622177,Intermediate,Thyroid gland,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2046.0,
9523,Rattus norvegicus,CHEMBL622178,Intermediate,Thyroid gland,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2046.0,
9524,Rattus norvegicus,CHEMBL622179,Intermediate,Thyroid gland,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2046.0,
9525,Rattus norvegicus,CHEMBL622180,Intermediate,Thyroid gland,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2046.0,
9526,Rattus norvegicus,CHEMBL622181,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9527,Rattus norvegicus,CHEMBL622182,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9528,Rattus norvegicus,CHEMBL622183,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9529,Rattus norvegicus,CHEMBL622184,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9530,Rattus norvegicus,CHEMBL622185,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9531,Rattus norvegicus,CHEMBL622186,Intermediate,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9532,Rattus norvegicus,CHEMBL622187,Intermediate,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9533,Rattus norvegicus,CHEMBL625002,Intermediate,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9534,Rattus norvegicus,CHEMBL622090,Intermediate,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9535,Rattus norvegicus,CHEMBL622091,Intermediate,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9536,Rattus norvegicus,CHEMBL622092,Intermediate,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9537,Rattus norvegicus,CHEMBL622093,Intermediate,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9538,Rattus norvegicus,CHEMBL622094,Intermediate,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9539,Rattus norvegicus,CHEMBL622095,Intermediate,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9540,Rattus norvegicus,CHEMBL622264,Intermediate,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9541,Rattus norvegicus,CHEMBL622265,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2106.0,
9542,Rattus norvegicus,CHEMBL622266,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2106.0,
9543,Rattus norvegicus,CHEMBL622267,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2106.0,
9544,Rattus norvegicus,CHEMBL622268,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2106.0,
9545,Rattus norvegicus,CHEMBL622269,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2106.0,
9546,Rattus norvegicus,CHEMBL625071,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2106.0,
9547,Rattus norvegicus,CHEMBL621621,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2106.0,
9548,Rattus norvegicus,CHEMBL621622,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,2106.0,
9549,Rattus norvegicus,CHEMBL621623,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9550,Rattus norvegicus,CHEMBL621624,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9551,Rattus norvegicus,CHEMBL621625,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9552,Rattus norvegicus,CHEMBL621626,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9553,Rattus norvegicus,CHEMBL621627,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9554,Rattus norvegicus,CHEMBL621628,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9555,Rattus norvegicus,CHEMBL875328,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9556,Rattus norvegicus,CHEMBL621629,Intermediate,Spleen,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9557,Rattus norvegicus,CHEMBL621630,Intermediate,Spleen,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2106.0,
9558,Rattus norvegicus,CHEMBL621631,Intermediate,Spleen,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2106.0,
9559,Rattus norvegicus,CHEMBL621632,Intermediate,Spleen,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,10116.0,16434,50597,1,,,BAO_0000218,2106.0,
9560,Rattus norvegicus,CHEMBL621633,Intermediate,Spleen,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9561,Rattus norvegicus,CHEMBL621634,Intermediate,Spleen,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9562,Rattus norvegicus,CHEMBL621635,Intermediate,Spleen,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9563,Rattus norvegicus,CHEMBL621636,Intermediate,Spleen,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9564,Rattus norvegicus,CHEMBL621637,Intermediate,Spleen,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9565,Rattus norvegicus,CHEMBL621638,Intermediate,Spleen,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,2106.0,
9566,Rattus norvegicus,CHEMBL618883,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9567,Rattus norvegicus,CHEMBL618884,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9568,Rattus norvegicus,CHEMBL628627,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9569,Rattus norvegicus,CHEMBL628628,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9570,Rattus norvegicus,CHEMBL628629,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9571,Rattus norvegicus,CHEMBL628630,Intermediate,,Half life after administering orally a dose of 3 mg/kg,,N,10116.0,16365,50597,1,,,BAO_0000218,,
9572,Rattus norvegicus,CHEMBL628631,Intermediate,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,N,10116.0,16365,50597,1,,,BAO_0000218,,
9573,Rattus norvegicus,CHEMBL628632,Intermediate,,Half life after administering intravenously a dose of 1 mg/kg,,N,10116.0,16365,50597,1,,,BAO_0000218,,
9574,Rattus norvegicus,CHEMBL628633,Intermediate,,Half life after oral dosing in rats,,N,10116.0,526,50597,1,,,BAO_0000218,,
9575,Rattus norvegicus,CHEMBL628634,Intermediate,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,N,10116.0,16365,50597,1,,,BAO_0000218,,
9576,Rattus norvegicus,CHEMBL627789,Intermediate,,Half life by intravenous administration of 3.4 mg/kg in rat,,N,10116.0,4368,50597,1,,,BAO_0000218,,
9577,Rattus norvegicus,CHEMBL627790,Intermediate,,Half life in rat,,N,10116.0,3371,50597,1,,,BAO_0000218,,
9578,Rattus norvegicus,CHEMBL627791,Intermediate,,Half life in rat,,N,10116.0,6448,50597,1,,,BAO_0000218,,
9579,Rattus norvegicus,CHEMBL627792,Intermediate,,Half life in rat,,N,10116.0,6453,50597,1,,,BAO_0000218,,
9580,Rattus norvegicus,CHEMBL627793,Intermediate,,Half life in rat after intravenous administration of the compound,,N,10116.0,4353,50597,1,,,BAO_0000218,,
9581,Rattus norvegicus,CHEMBL627794,Intermediate,Plasma,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,N,10116.0,4353,50597,1,,,BAO_0000218,1969.0,
9582,Rattus norvegicus,CHEMBL627795,Intermediate,,Half life in rat after po administration of the compound,,N,10116.0,4353,50597,1,,,BAO_0000218,,
9583,Rattus norvegicus,CHEMBL627796,Intermediate,,Half life in rat after po administration of the compound; ND means Not determined,,N,10116.0,4353,50597,1,,,BAO_0000218,,
9584,Rattus norvegicus,CHEMBL875335,Intermediate,Plasma,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,N,10116.0,4353,50597,1,,,BAO_0000218,1969.0,
9585,Rattus norvegicus,CHEMBL627797,Intermediate,Plasma,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,N,10116.0,4353,50597,1,,,BAO_0000218,1969.0,
9586,Rattus norvegicus,CHEMBL627798,Intermediate,,Half life in rat i.v.,,N,10116.0,5789,50597,1,,,BAO_0000218,,
9587,Rattus norvegicus,CHEMBL627799,Intermediate,,Half life in rat i.v. at 2 mg/kg concentration,,N,10116.0,17686,50597,1,,,BAO_0000218,,
9588,Rattus norvegicus,CHEMBL627800,Intermediate,,Half life in rats,,N,10116.0,6495,50597,1,,,BAO_0000218,,
9589,Rattus norvegicus,CHEMBL627801,Intermediate,,Half life in rats after intravenous administration,,N,10116.0,484,50597,1,,,BAO_0000218,,
9590,Rattus norvegicus,CHEMBL627802,Intermediate,,Half life in rats at the dose of 1.0 mpk by i.v. administration,,N,10116.0,6467,50597,1,,,BAO_0000218,,
9591,Rattus norvegicus,CHEMBL627803,Expert,,Half life in rat,,N,10116.0,6642,50597,1,,,BAO_0000218,,
9592,Rattus norvegicus,CHEMBL873820,Intermediate,,Half life was evaluated after intravenous administration to rats,,N,10116.0,16367,50597,1,,,BAO_0000218,,
9593,Rattus norvegicus,CHEMBL627804,Intermediate,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,N,10116.0,1369,50597,1,,,BAO_0000218,,
9594,Rattus norvegicus,CHEMBL627805,Intermediate,,Half life was evaluated in rat,,N,10116.0,5472,50597,1,,,BAO_0000218,,
9595,Rattus norvegicus,CHEMBL627806,Intermediate,,Half life was evaluated in rat,,N,10116.0,6049,50597,1,,,BAO_0000218,,
9596,Rattus norvegicus,CHEMBL627107,Intermediate,,Half life was evaluated in rat; Not tested,,N,10116.0,5472,50597,1,,,BAO_0000218,,
9597,Rattus norvegicus,CHEMBL627108,Intermediate,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,N,10116.0,16366,50597,1,,,BAO_0000218,,
9598,Rattus norvegicus,CHEMBL627109,Intermediate,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,N,10116.0,11149,50597,1,,,BAO_0000218,,
9599,Rattus norvegicus,CHEMBL627110,Intermediate,Blood,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,N,10116.0,11149,50597,1,,,BAO_0000218,178.0,
9600,Primates,CHEMBL627111,Intermediate,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,U,9443.0,2891,22224,1,,,BAO_0000218,,
9601,Primates,CHEMBL627112,Intermediate,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,U,9443.0,2891,22224,1,,,BAO_0000218,,
9602,Rattus norvegicus,CHEMBL627113,Intermediate,,Half life was measured in rat at dose of 30 mg/kg by iv administration,,U,10116.0,2891,22224,1,,,BAO_0000218,,
9603,Rattus norvegicus,CHEMBL627114,Intermediate,,Half life was measured in rat at dose of 30 mg/kg by po administration,,U,10116.0,2891,22224,1,,,BAO_0000218,,
9604,Rattus norvegicus,CHEMBL627115,Intermediate,,Half life (t1/2) was determined,,N,10116.0,4026,50597,1,,,BAO_0000218,,
9605,Rattus norvegicus,CHEMBL627116,Intermediate,,Half life period at a dose of 10 uM/kg in rat was determined,,N,10116.0,4527,50597,1,,,BAO_0000218,,
9606,Rattus norvegicus,CHEMBL627117,Intermediate,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,N,10116.0,4527,50597,1,,,BAO_0000218,,
9607,Rattus norvegicus,CHEMBL627118,Intermediate,,Half life period was determined,,N,10116.0,5503,50597,1,,,BAO_0000218,,
9608,Rattus norvegicus,CHEMBL627119,Intermediate,,Half life period after intravenous administration at 20 mpk in rats,,N,10116.0,4426,50597,1,,,BAO_0000218,,
9609,Rattus norvegicus,CHEMBL627120,Intermediate,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,N,10116.0,4426,50597,1,,,BAO_0000218,,
9610,Rattus norvegicus,CHEMBL626922,Intermediate,,Half life period after intravenous administration in rat,,N,10116.0,6109,50597,1,,,BAO_0000218,,
9611,Rattus norvegicus,CHEMBL626923,Intermediate,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,N,10116.0,5654,50597,1,,,BAO_0000218,,
9612,Rattus norvegicus,CHEMBL626924,Intermediate,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,N,10116.0,5654,50597,1,,,BAO_0000218,,
9613,Rattus norvegicus,CHEMBL626925,Intermediate,Plasma,Half life period in 80% rat plasma at 37 degree Centigrade,,N,10116.0,4755,50597,1,,,BAO_0000218,1969.0,
9614,Rattus norvegicus,CHEMBL626926,Intermediate,,Half life period in SD rats,,N,10116.0,5862,50597,1,,,BAO_0000218,,
9615,Rattus norvegicus,CHEMBL626927,Intermediate,Plasma,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,N,10116.0,1515,50597,1,,,BAO_0000218,1969.0,
9616,Rattus norvegicus,CHEMBL626928,Intermediate,Plasma,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,N,10116.0,1515,50597,1,,,BAO_0000218,1969.0,
9617,Rattus norvegicus,CHEMBL626929,Intermediate,Plasma,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,10116.0,1515,50597,1,,,BAO_0000218,1969.0,
9618,Rattus norvegicus,CHEMBL626930,Intermediate,Plasma,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,10116.0,1515,50597,1,,,BAO_0000218,1969.0,
9619,Rattus norvegicus,CHEMBL626931,Intermediate,,Half life period in rat,,N,10116.0,5960,50597,1,,,BAO_0000218,,
9620,Rattus norvegicus,CHEMBL626932,Intermediate,,Half life period in rat,,N,10116.0,6103,50597,1,,,BAO_0000218,,
9621,Rattus norvegicus,CHEMBL626933,Intermediate,,Half life period in rat,,N,10116.0,6317,50597,1,,,BAO_0000218,,
9622,Rattus norvegicus,CHEMBL873826,Intermediate,,Half life period in rat after oral administration at 10.5 mg/kg dose,,N,10116.0,6644,50597,1,,,BAO_0000218,,
9623,Rattus norvegicus,CHEMBL626934,Intermediate,,Half life period in rat after oral administration at 11.2 mg/kg dose,,N,10116.0,6644,50597,1,,,BAO_0000218,,
9624,Rattus norvegicus,CHEMBL626935,Intermediate,,Half life period in rat after oral administration at 13 mg/kg dose,,N,10116.0,6644,50597,1,,,BAO_0000218,,
9625,Rattus norvegicus,CHEMBL626936,Intermediate,,Half life period in rat after oral administration at 9.7 mg/kg dose,,N,10116.0,6644,50597,1,,,BAO_0000218,,
9626,Rattus norvegicus,CHEMBL626937,Intermediate,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
9627,Rattus norvegicus,CHEMBL625906,Intermediate,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,N,10116.0,6295,50597,1,,,BAO_0000218,,
9628,Rattus norvegicus,CHEMBL625907,Intermediate,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,N,10116.0,6296,50597,1,,,BAO_0000218,,
9629,Rattus norvegicus,CHEMBL625908,Intermediate,,PK study was carried to determine AUC (area under curve) value in rat,,N,10116.0,16427,50597,1,,,BAO_0000218,,
9630,Rattus norvegicus,CHEMBL625909,Intermediate,,Pharmacokinetic parameter AUC after intravenous administration to rats,,N,10116.0,16367,50597,1,,,BAO_0000218,,
9631,Rattus norvegicus,CHEMBL625910,Intermediate,,Pharmacokinetic parameter AUC after oral administration to rats,,N,10116.0,16367,50597,1,,,BAO_0000218,,
9632,Rattus norvegicus,CHEMBL625911,Intermediate,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,N,10116.0,16365,50597,1,,,BAO_0000218,,
9633,Rattus norvegicus,CHEMBL625912,Intermediate,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,N,10116.0,16365,50597,1,,,BAO_0000218,,
9634,Rattus norvegicus,CHEMBL626538,Intermediate,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,N,10116.0,16365,50597,1,,,BAO_0000218,,
9635,Rattus norvegicus,CHEMBL876794,Intermediate,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,N,10116.0,16365,50597,1,,,BAO_0000218,,
9636,Rattus norvegicus,CHEMBL626539,Intermediate,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,N,10116.0,16365,50597,1,,,BAO_0000218,,
9637,Rattus norvegicus,CHEMBL626540,Intermediate,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,N,10116.0,16365,50597,1,,,BAO_0000218,,
9638,Rattus norvegicus,CHEMBL626541,Intermediate,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,N,10116.0,5394,50597,1,,,BAO_0000218,,
9639,Rattus norvegicus,CHEMBL626542,Intermediate,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,N,10116.0,5394,50597,1,,,BAO_0000218,,
9640,Rattus norvegicus,CHEMBL626543,Intermediate,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
9641,Rattus norvegicus,CHEMBL626544,Intermediate,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
9642,Rattus norvegicus,CHEMBL626545,Intermediate,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
9643,Rattus norvegicus,CHEMBL626546,Intermediate,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
9644,Rattus norvegicus,CHEMBL626547,Intermediate,,Pharmacokinetic parameter area under curve was reported,,N,10116.0,5334,50597,1,,,BAO_0000218,,
9645,Rattus norvegicus,CHEMBL626548,Intermediate,,Pharmacokinetic property (AUC) in rat,,N,10116.0,4408,50597,1,,,BAO_0000218,,
9646,Rattus norvegicus,CHEMBL626549,Intermediate,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,N,10116.0,5983,50597,1,,,BAO_0000218,,
9647,Rattus norvegicus,CHEMBL626550,Intermediate,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,N,10116.0,4397,50597,1,,,BAO_0000218,,
9648,Rattus norvegicus,CHEMBL626551,Intermediate,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,N,10116.0,4397,50597,1,,,BAO_0000218,,
9649,Rattus norvegicus,CHEMBL623777,Intermediate,,Pharmacokinetic property was determined,,N,10116.0,5491,50597,1,,,BAO_0000218,,
9650,Rattus norvegicus,CHEMBL623778,Intermediate,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,N,10116.0,5491,50597,1,,,BAO_0000218,,
9651,Rattus norvegicus,CHEMBL623779,Intermediate,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,N,10116.0,5491,50597,1,,,BAO_0000218,,
9652,Rattus norvegicus,CHEMBL623780,Intermediate,Plasma,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,N,10116.0,4199,50597,1,,,BAO_0000218,1969.0,
9653,Rattus norvegicus,CHEMBL622015,Intermediate,Plasma,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,N,10116.0,4199,50597,1,,,BAO_0000218,1969.0,
9654,Rattus norvegicus,CHEMBL622016,Intermediate,Plasma,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,N,10116.0,4199,50597,1,,,BAO_0000218,1969.0,
9655,Rattus norvegicus,CHEMBL622017,Intermediate,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,N,10116.0,5173,50597,1,,,BAO_0000218,,
9656,Rattus norvegicus,CHEMBL622018,Intermediate,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,N,10116.0,5173,50597,1,,,BAO_0000218,,
9657,Rattus norvegicus,CHEMBL622019,Intermediate,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,N,10116.0,5173,50597,1,,,BAO_0000218,,
9658,Rattus norvegicus,CHEMBL622020,Intermediate,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,N,10116.0,5173,50597,1,,,BAO_0000218,,
9659,Rattus norvegicus,CHEMBL622021,Intermediate,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,N,10116.0,16366,50597,1,,,BAO_0000218,,
9660,Rattus norvegicus,CHEMBL622022,Intermediate,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,N,10116.0,16366,50597,1,,,BAO_0000218,,
9661,Rattus norvegicus,CHEMBL622023,Intermediate,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,N,10116.0,5327,50597,1,,,BAO_0000218,,
9662,Rattus norvegicus,CHEMBL622024,Intermediate,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,N,10116.0,6681,50597,1,,,BAO_0000218,,
9663,Rattus norvegicus,CHEMBL622693,Intermediate,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,N,10116.0,12873,50597,1,,,BAO_0000218,,
9664,Rattus norvegicus,CHEMBL622694,Intermediate,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,N,10116.0,12873,50597,1,,,BAO_0000218,,
9665,Rattus norvegicus,CHEMBL622695,Intermediate,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,N,10116.0,6685,50597,1,,,BAO_0000218,,
9666,Rattus norvegicus,CHEMBL622696,Intermediate,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,N,10116.0,6685,50597,1,,,BAO_0000218,,
9667,Rattus norvegicus,CHEMBL622697,Intermediate,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,N,10116.0,6685,50597,1,,,BAO_0000218,,
9668,Rattus norvegicus,CHEMBL622874,Intermediate,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,N,10116.0,6619,50597,1,,,BAO_0000218,,
9669,Rattus norvegicus,CHEMBL622875,Intermediate,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,N,10116.0,6619,50597,1,,,BAO_0000218,,
9670,Rattus norvegicus,CHEMBL622876,Intermediate,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,N,10116.0,10363,50597,1,,,BAO_0000218,,
9671,Rattus norvegicus,CHEMBL622877,Intermediate,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,N,10116.0,4796,50597,1,,,BAO_0000218,,
9672,Rattus norvegicus,CHEMBL622878,Intermediate,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,,
9673,Rattus norvegicus,CHEMBL622879,Intermediate,Plasma,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,1969.0,
9674,Rattus norvegicus,CHEMBL877602,Intermediate,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,N,10116.0,4839,50597,1,,,BAO_0000218,,
9675,Rattus norvegicus,CHEMBL622880,Intermediate,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
9676,Rattus norvegicus,CHEMBL622881,Intermediate,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
9677,Rattus norvegicus,CHEMBL622882,Intermediate,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
9678,Rattus norvegicus,CHEMBL622883,Intermediate,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
9679,Rattus norvegicus,CHEMBL622884,Intermediate,Thyroid gland,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2046.0,
9680,Rattus norvegicus,CHEMBL622885,Intermediate,Thyroid gland,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,N,10116.0,11450,50597,1,,,BAO_0000218,2046.0,
9681,Rattus norvegicus,CHEMBL622886,Intermediate,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,N,10116.0,8151,50597,1,,,BAO_0000218,,
9682,Rattus norvegicus,CHEMBL622887,Intermediate,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,N,10116.0,8151,50597,1,,,BAO_0000218,,
9683,Rattus norvegicus,CHEMBL622888,Intermediate,Urine,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,N,10116.0,8151,50597,1,,,BAO_0000218,1088.0,
9684,Rattus norvegicus,CHEMBL622889,Intermediate,Blood,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,178.0,
9685,Rattus norvegicus,CHEMBL622890,Intermediate,Blood,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,178.0,
9686,Rattus norvegicus,CHEMBL622891,Intermediate,Blood,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,178.0,
9687,Rattus norvegicus,CHEMBL877603,Intermediate,Blood,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,178.0,
9688,Rattus norvegicus,CHEMBL622892,Intermediate,Brain,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,955.0,
9689,Rattus norvegicus,CHEMBL622893,Intermediate,Brain,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,955.0,
9690,Rattus norvegicus,CHEMBL622894,Intermediate,Brain,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,955.0,
9691,Rattus norvegicus,CHEMBL622895,Intermediate,Brain,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,955.0,
9692,Rattus norvegicus,CHEMBL622896,Intermediate,Brain,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,N,10116.0,8677,50597,1,,,BAO_0000218,955.0,
9693,Rattus norvegicus,CHEMBL622897,Intermediate,Heart,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,948.0,
9694,Rattus norvegicus,CHEMBL622898,Intermediate,Heart,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,948.0,
9695,Rattus norvegicus,CHEMBL622899,Intermediate,Heart,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,948.0,
9696,Rattus norvegicus,CHEMBL622900,Intermediate,Kidney,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2113.0,
9697,Rattus norvegicus,CHEMBL624114,Intermediate,Kidney,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2113.0,
9698,Rattus norvegicus,CHEMBL624115,Intermediate,Kidney,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2113.0,
9699,Rattus norvegicus,CHEMBL624116,Intermediate,Kidney,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2113.0,
9700,Rattus norvegicus,CHEMBL624117,Intermediate,Liver,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2107.0,
9701,Rattus norvegicus,CHEMBL624118,Intermediate,Liver,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2107.0,
9702,Rattus norvegicus,CHEMBL624119,Intermediate,Liver,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2107.0,
9703,Rattus norvegicus,CHEMBL624120,Intermediate,Liver,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2107.0,
9704,Rattus norvegicus,CHEMBL624121,Intermediate,Lung,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2048.0,
9705,Rattus norvegicus,CHEMBL624122,Intermediate,Lung,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2048.0,
9706,Rattus norvegicus,CHEMBL624123,Intermediate,Lung,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2048.0,
9707,Rattus norvegicus,CHEMBL624124,Intermediate,Lung,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2048.0,
9708,Rattus norvegicus,CHEMBL624125,Intermediate,Muscle tissue,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2385.0,
9709,Rattus norvegicus,CHEMBL624126,Intermediate,Muscle tissue,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2385.0,
9710,Rattus norvegicus,CHEMBL624127,Intermediate,Muscle tissue,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2385.0,
9711,Rattus norvegicus,CHEMBL624128,Intermediate,Muscle tissue,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2385.0,
9712,Rattus norvegicus,CHEMBL624129,Intermediate,Zone of skin,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,14.0,
9713,Rattus norvegicus,CHEMBL624130,Intermediate,Zone of skin,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,14.0,
9714,Rattus norvegicus,CHEMBL622340,Intermediate,Zone of skin,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,14.0,
9715,Rattus norvegicus,CHEMBL622341,Intermediate,Zone of skin,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,14.0,
9716,Rattus norvegicus,CHEMBL622342,Intermediate,Intestine,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,160.0,
9717,Rattus norvegicus,CHEMBL622343,Intermediate,Intestine,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,160.0,
9718,Rattus norvegicus,CHEMBL622344,Intermediate,Intestine,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,160.0,
9719,Rattus norvegicus,CHEMBL622345,Intermediate,Intestine,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,160.0,
9720,Rattus norvegicus,CHEMBL622346,Intermediate,Spleen,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2106.0,
9721,Rattus norvegicus,CHEMBL622347,Intermediate,Spleen,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2106.0,
9722,Rattus norvegicus,CHEMBL622348,Intermediate,Spleen,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2106.0,
9723,Rattus norvegicus,CHEMBL622349,Intermediate,Spleen,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2106.0,
9724,Rattus norvegicus,CHEMBL622350,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9725,Rattus norvegicus,CHEMBL622351,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9726,Rattus norvegicus,CHEMBL622352,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9727,Rattus norvegicus,CHEMBL622353,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9728,Rattus norvegicus,CHEMBL622354,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9729,Rattus norvegicus,CHEMBL622355,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9730,Rattus norvegicus,CHEMBL622356,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9731,Rattus norvegicus,CHEMBL622357,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9732,Rattus norvegicus,CHEMBL622358,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9733,Rattus norvegicus,CHEMBL622359,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9734,Rattus norvegicus,CHEMBL874393,Intermediate,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9735,Rattus norvegicus,CHEMBL622872,Intermediate,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9736,Rattus norvegicus,CHEMBL622873,Intermediate,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9737,Rattus norvegicus,CHEMBL623047,Intermediate,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9738,Rattus norvegicus,CHEMBL623048,Intermediate,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9739,Rattus norvegicus,CHEMBL623049,Intermediate,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9740,Rattus norvegicus,CHEMBL623050,Intermediate,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9741,Rattus norvegicus,CHEMBL623051,Intermediate,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9742,Rattus norvegicus,CHEMBL623052,Intermediate,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9743,Rattus norvegicus,CHEMBL626343,Intermediate,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9744,Rattus norvegicus,CHEMBL626344,Intermediate,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9745,Rattus norvegicus,CHEMBL626345,Intermediate,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9746,Rattus norvegicus,CHEMBL626346,Intermediate,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9747,Rattus norvegicus,CHEMBL626347,Intermediate,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9748,Rattus norvegicus,CHEMBL626348,Intermediate,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9749,Rattus norvegicus,CHEMBL626349,Intermediate,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,10116.0,16434,50597,1,,,BAO_0000218,,
9750,Rattus norvegicus,CHEMBL626350,Intermediate,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9751,Rattus norvegicus,CHEMBL626351,Intermediate,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9752,Rattus norvegicus,CHEMBL627650,Intermediate,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9753,Rattus norvegicus,CHEMBL627651,Intermediate,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9754,Rattus norvegicus,CHEMBL627652,Intermediate,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9755,Rattus norvegicus,CHEMBL627653,Intermediate,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,10116.0,16435,50597,1,,,BAO_0000218,,
9756,Rattus norvegicus,CHEMBL627654,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9757,Rattus norvegicus,CHEMBL627835,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9758,Rattus norvegicus,CHEMBL627836,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9759,Rattus norvegicus,CHEMBL627837,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9760,Rattus norvegicus,CHEMBL627838,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9761,Rattus norvegicus,CHEMBL875338,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9762,Rattus norvegicus,CHEMBL627839,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9763,Rattus norvegicus,CHEMBL627840,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9764,Rattus norvegicus,CHEMBL627841,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9765,Rattus norvegicus,CHEMBL627842,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9766,Rattus norvegicus,CHEMBL627843,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9767,Rattus norvegicus,CHEMBL627844,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9768,Rattus norvegicus,CHEMBL627845,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9769,Rattus norvegicus,CHEMBL627846,Intermediate,,Half life period in rat by iv administration at a dose of 3 mg/kg,,N,10116.0,5874,50597,1,,,BAO_0000218,,
9770,Rattus norvegicus,CHEMBL627847,Intermediate,Plasma,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,N,10116.0,1515,50597,1,,,BAO_0000218,1969.0,
9771,Rattus norvegicus,CHEMBL873821,Intermediate,Plasma,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,N,10116.0,1515,50597,1,,,BAO_0000218,1969.0,
9772,Rattus norvegicus,CHEMBL626079,Intermediate,Plasma,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,10116.0,1515,50597,1,,,BAO_0000218,1969.0,
9773,Rattus norvegicus,CHEMBL626080,Intermediate,Plasma,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,10116.0,1515,50597,1,,,BAO_0000218,1969.0,
9774,Rattus norvegicus,CHEMBL626081,Intermediate,Plasma,Half life period was evaluated in rat plasma,,N,10116.0,5491,50597,1,,,BAO_0000218,1969.0,
9775,Rattus norvegicus,CHEMBL875344,Intermediate,Plasma,Half life period was evaluated in rat plasma; Not tested,,N,10116.0,5491,50597,1,,,BAO_0000218,1969.0,
9776,Rattus norvegicus,CHEMBL626082,Intermediate,,Half life period was evaluated in rats,,N,10116.0,1918,50597,1,,,BAO_0000218,,
9777,Rattus norvegicus,CHEMBL626250,Intermediate,,"Half life period was evaluated in rats, iv",,N,10116.0,1918,50597,1,,,BAO_0000218,,
9778,Rattus norvegicus,CHEMBL626251,Intermediate,,Half life period after intravenous administration at 5 mg/kg in rat,,N,10116.0,6113,50597,1,,,BAO_0000218,,
9779,Rattus norvegicus,CHEMBL626252,Intermediate,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,N,10116.0,5546,50597,1,,,BAO_0000218,,
9780,Rattus norvegicus,CHEMBL626253,Intermediate,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,N,10116.0,5553,50597,1,,,BAO_0000218,,
9781,Rattus norvegicus,CHEMBL626254,Intermediate,Plasma,Half life stability of compound was evaluated in rat plasma,,N,10116.0,4188,50597,1,,,BAO_0000218,1969.0,
9782,Rattus norvegicus,CHEMBL626255,Intermediate,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,N,10116.0,6215,50597,1,,,BAO_0000218,,
9783,Rattus norvegicus,CHEMBL626256,Intermediate,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,N,10116.0,6141,50597,1,,,BAO_0000218,,
9784,Rattus norvegicus,CHEMBL626257,Intermediate,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,N,10116.0,5182,50597,1,,,BAO_0000218,,
9785,Rattus norvegicus,CHEMBL626258,Intermediate,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,N,10116.0,5182,50597,1,,,BAO_0000218,,
9786,Rattus norvegicus,CHEMBL626259,Intermediate,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,N,10116.0,5710,50597,1,,,BAO_0000218,,
9787,Rattus norvegicus,CHEMBL626260,Intermediate,,Half in rat i.v.,,N,10116.0,5789,50597,1,,,BAO_0000218,,
9788,Rattus norvegicus,CHEMBL875345,Intermediate,,Half period in rat after intravenous administration,,N,10116.0,6011,50597,1,,,BAO_0000218,,
9789,Rattus norvegicus,CHEMBL626261,Intermediate,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,N,10116.0,17594,50597,1,,,BAO_0000218,,
9790,Rattus norvegicus,CHEMBL626262,Intermediate,Liver,Half-life measured in in vitro Cathepsin B assay in rat liver,,N,10116.0,12357,50597,1,,,BAO_0000218,2107.0,
9791,Rattus norvegicus,CHEMBL626263,Intermediate,,Half-life of compound was determined in rats,,N,10116.0,5210,50597,1,,,BAO_0000218,,
9792,Rattus norvegicus,CHEMBL625270,Intermediate,,Half-life at 10 mg/kg in rat upon intravenous administration,,N,10116.0,17596,50597,1,,,BAO_0000218,,
9793,Rattus norvegicus,CHEMBL625271,Intermediate,,Half-life determined in rat,,N,10116.0,6672,50597,1,,,BAO_0000218,,
9794,Rattus norvegicus,CHEMBL625272,Intermediate,,Half-life determined in rat,,N,10116.0,6673,50597,1,,,BAO_0000218,,
9795,Rattus norvegicus,CHEMBL625273,Intermediate,Brain,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,955.0,
9796,Rattus norvegicus,CHEMBL625274,Intermediate,Plasma,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,N,10116.0,3741,50597,1,,,BAO_0000218,1969.0,
9797,Rattus norvegicus,CHEMBL625275,Intermediate,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,10116.0,17671,50597,1,,,BAO_0000218,,
9798,Rattus norvegicus,CHEMBL625276,Intermediate,Plasma,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,1969.0,
9799,Rattus norvegicus,CHEMBL625277,Intermediate,Plasma,Half-life in rat plasma,,N,10116.0,17537,50597,1,,,BAO_0000218,1969.0,
9800,Rattus norvegicus,CHEMBL625278,Intermediate,Plasma,Half-life in rat plasma was determined,,N,10116.0,4965,50597,1,,,BAO_0000218,1969.0,
9801,Rattus norvegicus,CHEMBL625279,Intermediate,Plasma,Half-life in rat plasma; Not tested,,N,10116.0,17537,50597,1,,,BAO_0000218,1969.0,
9802,Rattus norvegicus,CHEMBL625280,Intermediate,Serum,Half-life in rat serum,,N,10116.0,6124,50597,1,,,BAO_0000218,1977.0,
9803,Rattus norvegicus,CHEMBL876797,Intermediate,Serum,Half-life in rat serum; na is not available,,N,10116.0,6124,50597,1,,,BAO_0000218,1977.0,
9804,Rattus norvegicus,CHEMBL625281,Intermediate,,Half-life was calculated in rat,,N,10116.0,6078,50597,1,,,BAO_0000218,,
9805,Rattus norvegicus,CHEMBL873827,Intermediate,Plasma,Half-life was calculated in rat plasma,,N,10116.0,17668,50597,1,,,BAO_0000218,1969.0,
9806,Rattus norvegicus,CHEMBL625282,Intermediate,,Half-life was determined,,N,10116.0,3185,50597,1,,,BAO_0000218,,
9807,Rattus norvegicus,CHEMBL625283,Intermediate,,Half-life was determined,,N,10116.0,4883,50597,1,,,BAO_0000218,,
9808,Rattus norvegicus,CHEMBL625284,Intermediate,,Half-life after administration of 20 mg/Kg oral dose in rat,,N,10116.0,2959,50597,1,,,BAO_0000218,,
9809,Rattus norvegicus,CHEMBL625285,Intermediate,,Half-life after administration of 3.2 mg/kg intravenously in male rat,,N,10116.0,4029,50597,1,,,BAO_0000218,,
9810,Rattus norvegicus,CHEMBL625286,Intermediate,,Half-life after intravenous administration in female rat,,N,10116.0,4029,50597,1,,,BAO_0000218,,
9811,Rattus norvegicus,CHEMBL625287,Intermediate,,Half-life after intravenous administration in male rat,,N,10116.0,4029,50597,1,,,BAO_0000218,,
9812,Rattus norvegicus,CHEMBL625288,Intermediate,,Half-life after intravenous dose in rat,,N,10116.0,6180,50597,1,,,BAO_0000218,,
9813,Rattus norvegicus,CHEMBL625289,Intermediate,Liver,Half-life in a rat liver homogenate preparation,,N,10116.0,1557,50597,1,,,BAO_0000218,2107.0,
9814,Rattus norvegicus,CHEMBL625290,Intermediate,Plasma,Half-life in plasma of rat,,N,10116.0,12500,50597,1,,,BAO_0000218,1969.0,
9815,Rattus norvegicus,CHEMBL876798,Intermediate,Plasma,Half-life in plasma of rat at dose of 3-10 mgkg,,N,10116.0,12500,50597,1,,,BAO_0000218,1969.0,
9816,Rattus norvegicus,CHEMBL625291,Intermediate,,Half-life in rat,,N,10116.0,5064,50597,1,,,BAO_0000218,,
9817,Rattus norvegicus,CHEMBL625292,Intermediate,,Half-life in rat,,N,10116.0,5145,50597,1,,,BAO_0000218,,
9818,Rattus norvegicus,CHEMBL625293,Intermediate,,Half-life in rat,,N,10116.0,5147,50597,1,,,BAO_0000218,,
9819,Rattus norvegicus,CHEMBL622832,Intermediate,,Half-life in rat,,N,10116.0,5833,50597,1,,,BAO_0000218,,
9820,Rattus norvegicus,CHEMBL622833,Intermediate,,Half-life in rat,,N,10116.0,6596,50597,1,,,BAO_0000218,,
9821,Rattus norvegicus,CHEMBL622834,Intermediate,,Half-life in rat,,N,10116.0,17655,50597,1,,,BAO_0000218,,
9822,Rattus norvegicus,CHEMBL622835,Intermediate,,Half-life in rat after oral administration at 10 mg/kg,,N,10116.0,6495,50597,1,,,BAO_0000218,,
9823,Rattus norvegicus,CHEMBL622836,Intermediate,,Half-life in rat after po administration at a dose of 10 mg/kg,,N,10116.0,17538,50597,1,,,BAO_0000218,,
9824,Rattus norvegicus,CHEMBL622837,Intermediate,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,N,10116.0,17538,50597,1,,,BAO_0000218,,
9825,Rattus norvegicus,CHEMBL622838,Intermediate,,Half-life in rat at 3 mg/kg dose administered intravenously,,N,10116.0,10,50597,1,,,BAO_0000218,,
9826,Rattus norvegicus,CHEMBL622839,Intermediate,Brain,Half-life in rat brain homogenate,,N,10116.0,17669,50597,1,,,BAO_0000218,955.0,
9827,Rattus norvegicus,CHEMBL622840,Intermediate,Plasma,Half-life in rat plasma,,N,10116.0,17065,50597,1,,,BAO_0000218,1969.0,
9828,Rattus norvegicus,CHEMBL622841,Intermediate,,Half-life in rats,,N,10116.0,4333,50597,1,,,BAO_0000218,,
9829,Rattus norvegicus,CHEMBL622842,Intermediate,,Half-life in Dawley rats,,N,10116.0,6827,50597,1,,,BAO_0000218,,
9830,Rattus norvegicus,CHEMBL622843,Intermediate,Plasma,Half-life in vitro in rat plasma,,N,10116.0,889,50597,1,,,BAO_0000218,1969.0,
9831,Rattus norvegicus,CHEMBL622844,Intermediate,Plasma,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,N,10116.0,889,50597,1,,,BAO_0000218,1969.0,
9832,Rattus norvegicus,CHEMBL622845,Intermediate,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,N,10116.0,3747,50597,1,,,BAO_0000218,,
9833,Rattus norvegicus,CHEMBL622846,Intermediate,,The area under the curve of compound was measured at the dose of 100 umol/kg,,N,10116.0,15022,50597,1,,,BAO_0000218,,
9834,Rattus norvegicus,CHEMBL622847,Intermediate,,The area under the curve of compound was measured at the dose of 300 umol/kg,,N,10116.0,15022,50597,1,,,BAO_0000218,,
9835,Rattus norvegicus,CHEMBL622848,Intermediate,,The area under the curve of compound was measured at the dose of 30 umol/kg,,N,10116.0,15022,50597,1,,,BAO_0000218,,
9836,Rattus norvegicus,CHEMBL622849,Intermediate,,Bioavailability as oral AUC in rats,,N,10116.0,3360,50597,1,,,BAO_0000218,,
9837,Rattus norvegicus,CHEMBL622850,Intermediate,Plasma,The plasma concentration versus time curve (AUC) was determined,,N,10116.0,5334,50597,1,,,BAO_0000218,1969.0,
9838,Rattus norvegicus,CHEMBL876807,Intermediate,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,10116.0,17411,50597,1,,,BAO_0000218,,
9839,Rattus norvegicus,CHEMBL622851,Intermediate,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,10116.0,17411,50597,1,,,BAO_0000218,,
9840,Rattus norvegicus,CHEMBL622852,Intermediate,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,10116.0,17411,50597,1,,,BAO_0000218,,
9841,Rattus norvegicus,CHEMBL622853,Intermediate,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,N,10116.0,6570,50597,1,,,BAO_0000218,,
9842,Rattus norvegicus,CHEMBL622854,Intermediate,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,N,10116.0,6570,50597,1,,,BAO_0000218,,
9843,Rattus norvegicus,CHEMBL622855,Intermediate,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,10116.0,17411,50597,1,,,BAO_0000218,,
9844,Rattus norvegicus,CHEMBL622856,Intermediate,Plasma,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,N,10116.0,14941,50597,1,,,BAO_0000218,1969.0,
9845,Rattus norvegicus,CHEMBL622857,Intermediate,Plasma,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,N,10116.0,14941,50597,1,,,BAO_0000218,1969.0,
9846,Rattus norvegicus,CHEMBL622858,Intermediate,Plasma,AUC in rat after po administration at a dose of 10 mg/kg,,N,10116.0,17538,50597,1,,,BAO_0000218,1969.0,
9847,Rattus norvegicus,CHEMBL622859,Intermediate,Plasma,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,N,10116.0,17752,50597,1,,,BAO_0000218,1969.0,
9848,Rattus norvegicus,CHEMBL622860,Intermediate,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,N,10116.0,17509,50597,1,,,BAO_0000218,,
9849,Rattus norvegicus,CHEMBL622861,Intermediate,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,N,10116.0,17509,50597,1,,,BAO_0000218,,
9850,Rattus norvegicus,CHEMBL622862,Intermediate,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,N,10116.0,17509,50597,1,,,BAO_0000218,,
9851,Rattus norvegicus,CHEMBL622863,Intermediate,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,N,10116.0,17509,50597,1,,,BAO_0000218,,
9852,Rattus norvegicus,CHEMBL623817,Intermediate,,Area under curve value 6 hr after po administration in rat,,N,10116.0,17509,50597,1,,,BAO_0000218,,
9853,Rattus norvegicus,CHEMBL623818,Intermediate,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,10116.0,17717,50597,1,,,BAO_0000218,,
9854,Rattus norvegicus,CHEMBL623819,Intermediate,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,N,10116.0,17717,50597,1,,,BAO_0000218,,
9855,Rattus norvegicus,CHEMBL623820,Intermediate,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,10116.0,17717,50597,1,,,BAO_0000218,,
9856,Rattus norvegicus,CHEMBL623821,Intermediate,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,N,10116.0,17717,50597,1,,,BAO_0000218,,
9857,Rattus norvegicus,CHEMBL623822,Intermediate,Plasma,AUC normalized for dose (AUCN) in rat,,N,10116.0,6642,50597,1,,,BAO_0000218,1969.0,
9858,Rattus norvegicus,CHEMBL623823,Intermediate,,Area under curve in rat after p.o. administration,,N,10116.0,6640,50597,1,,,BAO_0000218,,
9859,Rattus norvegicus,CHEMBL623824,Intermediate,,Area under curve in rat after p.o. administration,,N,10116.0,6641,50597,1,,,BAO_0000218,,
9860,Rattus norvegicus,CHEMBL623825,Intermediate,,Area under curve in rat after p.o. administration; Not determined,,N,10116.0,6641,50597,1,,,BAO_0000218,,
9861,Rattus norvegicus,CHEMBL622070,Intermediate,,Area under curve in rat after peroral administration,,N,10116.0,6641,50597,1,,,BAO_0000218,,
9862,Rattus norvegicus,CHEMBL622071,Intermediate,,Area under curve (carotid artery) value of the compound,,N,10116.0,3603,50597,1,,,BAO_0000218,,
9863,Rattus norvegicus,CHEMBL622072,Intermediate,,Bioavailability expressed as the area under curve of rat carotid artery,,N,10116.0,3550,50597,1,,,BAO_0000218,,
9864,Rattus norvegicus,CHEMBL622073,Intermediate,,Area under curve in male SD rats was observed after intravenous administration in rat,,N,10116.0,15662,50597,1,,,BAO_0000218,,
9865,Rattus norvegicus,CHEMBL622074,Intermediate,,Area under curve of the compound was determined,,N,10116.0,17720,50597,1,,,BAO_0000218,,
9866,Rattus norvegicus,CHEMBL622075,Intermediate,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,N,10116.0,5407,50597,1,,,BAO_0000218,,
9867,Rattus norvegicus,CHEMBL622076,Intermediate,Plasma,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,N,10116.0,17752,50597,1,,,BAO_0000218,1969.0,
9868,Rattus norvegicus,CHEMBL622077,Intermediate,Plasma,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,N,10116.0,17752,50597,1,,,BAO_0000218,1969.0,
9869,Rattus norvegicus,CHEMBL622078,Intermediate,,Area under curve (portal vein) value of the compound,,N,10116.0,3603,50597,1,,,BAO_0000218,,
9870,Rattus norvegicus,CHEMBL622079,Intermediate,,Bioavailability expressed as the area under curve of rat portal vein,,N,10116.0,3550,50597,1,,,BAO_0000218,,
9871,Rattus norvegicus,CHEMBL622080,Intermediate,Plasma,Area Under plasma concentration time curve in rat upon peroral administration,,N,10116.0,17655,50597,1,,,BAO_0000218,1969.0,
9872,Rattus norvegicus,CHEMBL877612,Intermediate,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,N,10116.0,17582,50597,1,,,BAO_0000218,,
9873,Rattus norvegicus,CHEMBL622081,Intermediate,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,N,10116.0,17582,50597,1,,,BAO_0000218,,
9874,Rattus norvegicus,CHEMBL622082,Intermediate,,Compound was evaluated for oral bioavailability in rats,,N,10116.0,17791,50597,1,,,BAO_0000218,,
9875,Rattus norvegicus,CHEMBL622083,Intermediate,,Compound was evaluated for oral bioavailability in rats after iv administration,,N,10116.0,17791,50597,1,,,BAO_0000218,,
9876,Rattus norvegicus,CHEMBL622084,Intermediate,,Compound was evaluated for oral bioavailability in rats; 30-80,,N,10116.0,17791,50597,1,,,BAO_0000218,,
9877,Rattus norvegicus,CHEMBL622085,Intermediate,,Compound was evaluated for oral bioavailability in rats; 50-60,,N,10116.0,17791,50597,1,,,BAO_0000218,,
9878,Rattus norvegicus,CHEMBL622086,Intermediate,,Compound was evaluated for oral bioavailability in rats; no data,,N,10116.0,17791,50597,1,,,BAO_0000218,,
9879,Rattus norvegicus,CHEMBL622087,Intermediate,,Compound was evaluated for oral bioavailability in rats; peptide,,N,10116.0,17791,50597,1,,,BAO_0000218,,
9880,Rattus norvegicus,CHEMBL622088,Intermediate,Blood,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,N,10116.0,7768,50597,1,,,BAO_0000218,178.0,
9881,Rattus norvegicus,CHEMBL622089,Intermediate,Blood,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,N,10116.0,7768,50597,1,,,BAO_0000218,178.0,
9882,Rattus norvegicus,CHEMBL623685,Intermediate,Blood,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,N,10116.0,7768,50597,1,,,BAO_0000218,178.0,
9883,Rattus norvegicus,CHEMBL623686,Intermediate,Blood,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,N,10116.0,7768,50597,1,,,BAO_0000218,178.0,
9884,Rattus norvegicus,CHEMBL623687,Intermediate,Stomach,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,945.0,
9885,Rattus norvegicus,CHEMBL623688,Intermediate,Stomach,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,945.0,
9886,Rattus norvegicus,CHEMBL623689,Intermediate,Stomach,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,945.0,
9887,Rattus norvegicus,CHEMBL622485,Intermediate,Stomach,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,945.0,
9888,Rattus norvegicus,CHEMBL622486,Intermediate,Thyroid gland,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2046.0,
9889,Rattus norvegicus,CHEMBL877613,Intermediate,Thyroid gland,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2046.0,
9890,Rattus norvegicus,CHEMBL622487,Intermediate,Thyroid gland,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2046.0,
9891,Rattus norvegicus,CHEMBL622488,Intermediate,Thyroid gland,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2046.0,
9892,Rattus norvegicus,CHEMBL622489,Intermediate,Heart,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,948.0,
9893,Rattus norvegicus,CHEMBL622490,Intermediate,Urine,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,N,10116.0,6899,50597,1,,,BAO_0000218,1088.0,
9894,Rattus norvegicus,CHEMBL622491,Intermediate,Urine,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,N,10116.0,6899,50597,1,,,BAO_0000218,1088.0,
9895,Rattus norvegicus,CHEMBL622492,Intermediate,Liver,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,N,10116.0,6899,50597,1,,,BAO_0000218,2107.0,
9896,Rattus norvegicus,CHEMBL622493,Intermediate,Urine,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,N,10116.0,6899,50597,1,,,BAO_0000218,1088.0,
9897,Rattus norvegicus,CHEMBL622494,Intermediate,Urine,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,N,10116.0,6899,50597,1,,,BAO_0000218,1088.0,
9898,Rattus norvegicus,CHEMBL622495,Intermediate,Muscle tissue,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,10116.0,8677,50597,1,,,BAO_0000218,2385.0,
9899,Rattus norvegicus,CHEMBL622496,Intermediate,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,N,10116.0,6899,50597,1,,,BAO_0000218,,
9900,Rattus norvegicus,CHEMBL622497,Intermediate,Urine,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,N,10116.0,6899,50597,1,,,BAO_0000218,1088.0,
9901,Rattus norvegicus,CHEMBL622498,Intermediate,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,N,10116.0,2189,50597,1,,,BAO_0000218,,
9902,Rattus norvegicus,CHEMBL624918,Intermediate,Urine,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,N,10116.0,2189,50597,1,,,BAO_0000218,1088.0,
9903,Rattus norvegicus,CHEMBL624919,Intermediate,Urine,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,N,10116.0,2189,50597,1,,,BAO_0000218,1088.0,
9904,Rattus norvegicus,CHEMBL624920,Intermediate,Blood,Biodistribution of compound in rat blood after 5 min of administration,,N,10116.0,10839,50597,1,,,BAO_0000218,178.0,
9905,Rattus norvegicus,CHEMBL624921,Intermediate,Blood,Biodistribution of compound in rat blood after 5 min of administration.,,N,10116.0,10839,50597,1,,,BAO_0000218,178.0,
9906,Rattus norvegicus,CHEMBL624922,Intermediate,Brain,Biodistribution of compound in rat brain after 5 min of administration,,N,10116.0,10839,50597,1,,,BAO_0000218,955.0,
9907,Rattus norvegicus,CHEMBL624923,Intermediate,Heart,Biodistribution of compound in rat heart after 5 min of administration,,N,10116.0,10839,50597,1,,,BAO_0000218,948.0,
9908,Rattus norvegicus,CHEMBL624924,Intermediate,Heart,Biodistribution of compound in rat heart after 5 min of administration.,,N,10116.0,10839,50597,1,,,BAO_0000218,948.0,
9909,Rattus norvegicus,CHEMBL624925,Intermediate,Kidney,Biodistribution of compound in rat kidney after 5 min of administration,,N,10116.0,10839,50597,1,,,BAO_0000218,2113.0,
9910,Rattus norvegicus,CHEMBL624926,Intermediate,Kidney,Biodistribution of compound in rat kidney after 5 min of administration.,,N,10116.0,10839,50597,1,,,BAO_0000218,2113.0,
9911,Rattus norvegicus,CHEMBL624927,Intermediate,Liver,Biodistribution of compound in rat liver after 5 min of administration,,N,10116.0,10839,50597,1,,,BAO_0000218,2107.0,
9912,Rattus norvegicus,CHEMBL874402,Intermediate,Liver,Biodistribution of compound in rat liver after 5 min of administration.,,N,10116.0,10839,50597,1,,,BAO_0000218,2107.0,
9913,Rattus norvegicus,CHEMBL624928,Intermediate,Lung,Biodistribution of compound in rat lung after 5 min of administration,,N,10116.0,10839,50597,1,,,BAO_0000218,2048.0,
9914,Rattus norvegicus,CHEMBL624929,Intermediate,Lung,Biodistribution of compound in rat lung after 5 min of administration.,,N,10116.0,10839,50597,1,,,BAO_0000218,2048.0,
9915,Rattus norvegicus,CHEMBL624930,Intermediate,Muscle tissue,Biodistribution of compound in rat muscle after 5 min of administration,,N,10116.0,10839,50597,1,,,BAO_0000218,2385.0,
9916,Rattus norvegicus,CHEMBL624931,Intermediate,Muscle tissue,Biodistribution of compound in rat muscle after 5 min of administration.,,N,10116.0,10839,50597,1,,,BAO_0000218,2385.0,
9917,Rattus norvegicus,CHEMBL624932,Intermediate,Heart,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,10116.0,4043,50597,1,,,BAO_0000218,948.0,
9918,Rattus norvegicus,CHEMBL624933,Intermediate,Heart,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,10116.0,4043,50597,1,,,BAO_0000218,948.0,
9919,Rattus norvegicus,CHEMBL624934,Intermediate,Liver,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,10116.0,4043,50597,1,,,BAO_0000218,2107.0,
9920,Rattus norvegicus,CHEMBL624935,Intermediate,Liver,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,10116.0,4043,50597,1,,,BAO_0000218,2107.0,
9921,Rattus norvegicus,CHEMBL624936,Intermediate,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,10116.0,4043,50597,1,,,BAO_0000218,,
9922,Rattus norvegicus,CHEMBL624937,Intermediate,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,10116.0,4043,50597,1,,,BAO_0000218,,
9923,Rattus norvegicus,CHEMBL624938,Intermediate,Spleen,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,10116.0,4043,50597,1,,,BAO_0000218,2106.0,
9924,Rattus norvegicus,CHEMBL624939,Intermediate,Spleen,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,10116.0,4043,50597,1,,,BAO_0000218,2106.0,
9925,Rattus norvegicus,CHEMBL624940,Intermediate,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,10116.0,4043,50597,1,,,BAO_0000218,,
9926,Rattus norvegicus,CHEMBL874403,Intermediate,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,10116.0,4043,50597,1,,,BAO_0000218,,
9927,Rattus norvegicus,CHEMBL624941,Intermediate,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,N,10116.0,1446,50597,1,,,BAO_0000218,,
9928,Rattus norvegicus,CHEMBL624942,Intermediate,Urine,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,N,10116.0,9971,50597,1,,,BAO_0000218,1088.0,
9929,Rattus norvegicus,CHEMBL624943,Intermediate,Urine,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,N,10116.0,9971,50597,1,,,BAO_0000218,1088.0,
9930,Rattus norvegicus,CHEMBL624944,Intermediate,,% Bioavailability after 1 day of the drug administration in rats,,N,10116.0,5765,50597,1,,,BAO_0000218,,
9931,Rattus norvegicus,CHEMBL624945,Intermediate,,% Bioavailability after 4 day of the drug administration in rats,,N,10116.0,5765,50597,1,,,BAO_0000218,,
9932,Rattus norvegicus,CHEMBL624946,Intermediate,,Absolute bioavailability was evaluated in rat,,N,10116.0,4257,50597,1,,,BAO_0000218,,
9933,Rattus norvegicus,CHEMBL624947,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9934,Rattus norvegicus,CHEMBL624948,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9935,Rattus norvegicus,CHEMBL624949,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9936,Rattus norvegicus,CHEMBL622025,Intermediate,Kidney,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2113.0,
9937,Rattus norvegicus,CHEMBL622026,Intermediate,Kidney,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2113.0,
9938,Rattus norvegicus,CHEMBL622027,Intermediate,Kidney,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2113.0,
9939,Rattus norvegicus,CHEMBL622028,Intermediate,Kidney,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2113.0,
9940,Rattus norvegicus,CHEMBL622029,Intermediate,Liver,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2107.0,
9941,Rattus norvegicus,CHEMBL622208,Intermediate,Liver,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2107.0,
9942,Rattus norvegicus,CHEMBL622209,Intermediate,Liver,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2107.0,
9943,Rattus norvegicus,CHEMBL622210,Intermediate,Liver,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2107.0,
9944,Rattus norvegicus,CHEMBL622211,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9945,Rattus norvegicus,CHEMBL622212,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9946,Rattus norvegicus,CHEMBL622213,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9947,Rattus norvegicus,CHEMBL874404,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9948,Rattus norvegicus,CHEMBL620452,Intermediate,Muscle tissue,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2385.0,
9949,Rattus norvegicus,CHEMBL620453,Intermediate,Muscle tissue,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2385.0,
9950,Rattus norvegicus,CHEMBL620454,Intermediate,Muscle tissue,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2385.0,
9951,Rattus norvegicus,CHEMBL624067,Intermediate,Muscle tissue,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2385.0,
9952,Rattus norvegicus,CHEMBL624068,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9953,Rattus norvegicus,CHEMBL624069,Intermediate,Female gonad,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,992.0,
9954,Rattus norvegicus,CHEMBL624070,Intermediate,Female gonad,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,992.0,
9955,Rattus norvegicus,CHEMBL624071,Intermediate,Female gonad,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,992.0,
9956,Rattus norvegicus,CHEMBL624072,Intermediate,Uterus,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,995.0,
9957,Rattus norvegicus,CHEMBL624073,Intermediate,Uterus,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,995.0,
9958,Rattus norvegicus,CHEMBL624788,Intermediate,Uterus,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,995.0,
9959,Rattus norvegicus,CHEMBL624789,Intermediate,Uterus,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,995.0,
9960,Rattus norvegicus,CHEMBL624790,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9961,Rattus norvegicus,CHEMBL624791,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9962,Rattus norvegicus,CHEMBL624792,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9963,Rattus norvegicus,CHEMBL624793,Intermediate,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,,
9964,Rattus norvegicus,CHEMBL877491,Intermediate,Muscle tissue,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2385.0,
9965,Rattus norvegicus,CHEMBL624957,Intermediate,Muscle tissue,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2385.0,
9966,Rattus norvegicus,CHEMBL624958,Intermediate,Muscle tissue,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2385.0,
9967,Rattus norvegicus,CHEMBL624959,Intermediate,Muscle tissue,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,N,10116.0,13091,50597,1,,,BAO_0000218,2385.0,
9968,Rattus norvegicus,CHEMBL624960,Intermediate,,Dissociation constant was determined,,N,10116.0,11977,50597,1,,,BAO_0000218,,
9969,Rattus norvegicus,CHEMBL624961,Intermediate,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,N,10116.0,14941,50597,1,,,BAO_0000218,,
9970,Rattus norvegicus,CHEMBL624962,Intermediate,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
9971,Rattus norvegicus,CHEMBL624963,Intermediate,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
9972,Rattus norvegicus,CHEMBL624964,Intermediate,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,N,10116.0,4755,50597,1,,,BAO_0000218,,
9973,Rattus norvegicus,CHEMBL624965,Intermediate,,LogP value was evaluated in the in situ rat gut perfusion assay,,N,10116.0,589,50597,1,,,BAO_0000218,,
9974,Rattus norvegicus,CHEMBL624966,Intermediate,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,N,10116.0,17582,50597,1,,,BAO_0000218,,
9975,Rattus norvegicus,CHEMBL624967,Intermediate,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,N,10116.0,5031,50597,1,,,BAO_0000218,,
9976,Rattus norvegicus,CHEMBL624968,Intermediate,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,N,10116.0,17764,50597,1,,,BAO_0000218,,
9977,Rattus norvegicus,CHEMBL624969,Intermediate,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,10116.0,17720,50597,1,,,BAO_0000218,,
9978,Rattus norvegicus,CHEMBL624970,Expert,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,N,10116.0,2862,50597,1,,,BAO_0000218,,
9979,Rattus norvegicus,CHEMBL624971,Intermediate,,Half-life was evaluated after 10 uM/kg of intra arterial administration,,N,10116.0,16423,50597,1,,,BAO_0000218,,
9980,Rattus norvegicus,CHEMBL624972,Intermediate,,Half-life was evaluated after 20 uM/kg of peroral administration,,N,10116.0,16423,50597,1,,,BAO_0000218,,
9981,Rattus norvegicus,CHEMBL624973,Intermediate,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,N,10116.0,6005,50597,1,,,BAO_0000218,,
9982,Rattus norvegicus,CHEMBL624974,Intermediate,Plasma,Half-life was evaluated in plasma of rat,,N,10116.0,2938,50597,1,,,BAO_0000218,1969.0,
9983,Rattus norvegicus,CHEMBL624975,Intermediate,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,N,10116.0,6410,50597,1,,,BAO_0000218,,
9984,Rattus norvegicus,CHEMBL877492,Intermediate,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,N,10116.0,6410,50597,1,,,BAO_0000218,,
9985,Rattus norvegicus,CHEMBL624976,Intermediate,,Half-life was measured in rat after an iv dose of 1 mg/kg,,N,10116.0,6062,50597,1,,,BAO_0000218,,
9986,Rattus norvegicus,CHEMBL624977,Intermediate,,Half-life period of compound in rats after peroral administration,,N,10116.0,6571,50597,1,,,BAO_0000218,,
9987,Rattus norvegicus,CHEMBL626848,Intermediate,Plasma,Half-life period of compound was measured in rat plasma.,,N,10116.0,3136,50597,1,,,BAO_0000218,1969.0,
9988,Rattus norvegicus,CHEMBL626849,Intermediate,Plasma,Half-life period of compound was measured in rat plasma; ND is not determined,,N,10116.0,3136,50597,1,,,BAO_0000218,1969.0,
9989,Rattus norvegicus,CHEMBL626850,Intermediate,Plasma,Half-life period of compound was measured in rat plasma; not determined,,N,10116.0,3136,50597,1,,,BAO_0000218,1969.0,
9990,Rattus norvegicus,CHEMBL626851,Intermediate,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,N,10116.0,4521,50597,1,,,BAO_0000218,,
9991,Rattus norvegicus,CHEMBL626852,Intermediate,,Half-life period in rat by iv administration,,N,10116.0,5871,50597,1,,,BAO_0000218,,
9992,Rattus norvegicus,CHEMBL626853,Intermediate,,Half-life period in rats following intravenous administration at 2 mg/kg,,N,10116.0,6077,50597,1,,,BAO_0000218,,
9993,Rattus norvegicus,CHEMBL626854,Intermediate,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,N,10116.0,6679,50597,1,,,BAO_0000218,,
9994,Rattus norvegicus,CHEMBL627486,Intermediate,,Half-life period was determined for the compound in rat,,N,10116.0,5144,50597,1,,,BAO_0000218,,
9995,Rattus norvegicus,CHEMBL627487,Intermediate,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,N,10116.0,4498,50597,1,,,BAO_0000218,,
9996,Rattus norvegicus,CHEMBL627488,Intermediate,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,N,10116.0,4498,50597,1,,,BAO_0000218,,
9997,Rattus norvegicus,CHEMBL627489,Intermediate,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,N,10116.0,1908,50597,1,,,BAO_0000218,,
9998,Rattus norvegicus,CHEMBL627490,Intermediate,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,N,10116.0,6211,50597,1,,,BAO_0000218,,
9999,Rattus norvegicus,CHEMBL873829,Intermediate,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,N,10116.0,5529,50597,1,,,BAO_0000218,,
10000,Rattus norvegicus,CHEMBL627655,Intermediate,,Half-life was determined in rat at a dose of 1 mpk i.v.,,N,10116.0,6444,50597,1,,,BAO_0000218,,
10001,Rattus norvegicus,CHEMBL625994,Intermediate,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,N,10116.0,6444,50597,1,,,BAO_0000218,,
10002,Rattus norvegicus,CHEMBL625995,Intermediate,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,N,10116.0,6444,50597,1,,,BAO_0000218,,
10003,Rattus norvegicus,CHEMBL625996,Intermediate,,Half-life in rat,,N,10116.0,5207,50597,1,,,BAO_0000218,,
10004,Rattus norvegicus,CHEMBL625850,Intermediate,Plasma,In vitro half life in rat plasma,,N,10116.0,530,50597,1,,,BAO_0000218,1969.0,
10005,Rattus norvegicus,CHEMBL625851,Intermediate,Plasma,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,N,10116.0,1116,50597,1,,,BAO_0000218,1969.0,
10006,Rattus norvegicus,CHEMBL625852,Intermediate,,In vitro half life in rat,,N,10116.0,3219,50597,1,,,BAO_0000218,,
10007,Rattus norvegicus,CHEMBL625853,Intermediate,,In vivo half life period after intravenous administration in rat,,N,10116.0,6109,50597,1,,,BAO_0000218,,
10008,Rattus norvegicus,CHEMBL625854,Intermediate,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,N,10116.0,17582,50597,1,,,BAO_0000218,,
10009,Rattus norvegicus,CHEMBL874450,Intermediate,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,N,10116.0,17582,50597,1,,,BAO_0000218,,
10010,Rattus norvegicus,CHEMBL625855,Intermediate,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
10011,Rattus norvegicus,CHEMBL625856,Intermediate,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
10012,Rattus norvegicus,CHEMBL625857,Intermediate,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
10013,Rattus norvegicus,CHEMBL873831,Intermediate,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
10014,Rattus norvegicus,CHEMBL625858,Intermediate,,Longer half-life in rat (i.v.) at 0.5 mpk,,N,10116.0,17853,50597,1,,,BAO_0000218,,
10015,Rattus norvegicus,CHEMBL625859,Intermediate,,Longer half-life in rat (p.o.) at 2.0 mpk,,N,10116.0,17853,50597,1,,,BAO_0000218,,
10016,Rattus norvegicus,CHEMBL625860,Intermediate,,Pharmacokinetic property (half life) in rat,,N,10116.0,3457,50597,1,,,BAO_0000218,,
10017,Rattus norvegicus,CHEMBL625861,Intermediate,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
10018,Rattus norvegicus,CHEMBL625862,Intermediate,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
10019,Rattus norvegicus,CHEMBL625863,Intermediate,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
10020,Rattus norvegicus,CHEMBL625864,Intermediate,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
10021,Rattus norvegicus,CHEMBL625865,Intermediate,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,N,10116.0,5739,50597,1,,,BAO_0000218,,
10022,Rattus norvegicus,CHEMBL625866,Intermediate,,Pharmacokinetic half time was determined intravenously in rats.,,N,10116.0,15765,50597,1,,,BAO_0000218,,
10023,Rattus norvegicus,CHEMBL625867,Intermediate,Plasma,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,N,10116.0,6567,50597,1,,,BAO_0000218,1969.0,
10024,Rattus norvegicus,CHEMBL625868,Intermediate,Plasma,Plasma half life of hydrolysis of the compound,,N,10116.0,2448,50597,1,,,BAO_0000218,1969.0,
10025,Rattus norvegicus,CHEMBL625869,Intermediate,Plasma,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,N,10116.0,5423,50597,1,,,BAO_0000218,1969.0,
10026,Rattus norvegicus,CHEMBL874451,Intermediate,Plasma,Plasma half life period was calculated in rat,,N,10116.0,4853,50597,1,,,BAO_0000218,1969.0,
10027,Rattus norvegicus,CHEMBL625870,Intermediate,Plasma,Plasma half-life in Sprague-Dawley rats,,N,10116.0,4514,50597,1,,,BAO_0000218,1969.0,
10028,Rattus norvegicus,CHEMBL625871,Intermediate,Plasma,Plasma half-life in Sprague-Dawley rats; Not determined,,N,10116.0,4514,50597,1,,,BAO_0000218,1969.0,
10029,Rattus norvegicus,CHEMBL625872,Intermediate,Plasma,Plasma half-life in rats,,N,10116.0,1500,50597,1,,,BAO_0000218,1969.0,
10030,Rattus norvegicus,CHEMBL625873,Intermediate,Plasma,Plasma half-life in rats; <MQL,,N,10116.0,1500,50597,1,,,BAO_0000218,1969.0,
10031,Rattus norvegicus,CHEMBL625874,Intermediate,Plasma,Plasma half-life period (0-8 h) was determined,,N,10116.0,5334,50597,1,,,BAO_0000218,1969.0,
10032,Rattus norvegicus,CHEMBL625875,Intermediate,Plasma,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,N,10116.0,5334,50597,1,,,BAO_0000218,1969.0,
10033,Rattus norvegicus,CHEMBL625876,Intermediate,Plasma,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,N,10116.0,5334,50597,1,,,BAO_0000218,1969.0,
10034,Rattus norvegicus,CHEMBL631258,Intermediate,Plasma,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,N,10116.0,5334,50597,1,,,BAO_0000218,1969.0,
10035,Rattus norvegicus,CHEMBL631259,Intermediate,Plasma,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,N,10116.0,4956,50597,1,,,BAO_0000218,1969.0,
10036,Rattus norvegicus,CHEMBL631260,Intermediate,Plasma,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,N,10116.0,4956,50597,1,,,BAO_0000218,1969.0,
10037,Rattus norvegicus,CHEMBL631261,Intermediate,Blood,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,N,10116.0,7768,50597,1,,,BAO_0000218,178.0,
10038,Rattus norvegicus,CHEMBL631262,Intermediate,Blood,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,N,10116.0,7768,50597,1,,,BAO_0000218,178.0,
10039,Rattus norvegicus,CHEMBL631263,Intermediate,Blood,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,N,10116.0,7768,50597,1,,,BAO_0000218,178.0,
10040,Rattus norvegicus,CHEMBL631264,Intermediate,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,N,10116.0,7768,50597,1,,,BAO_0000218,,
10041,Rattus norvegicus,CHEMBL631265,Intermediate,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,N,10116.0,7768,50597,1,,,BAO_0000218,,
10042,Rattus norvegicus,CHEMBL631266,Intermediate,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,N,10116.0,7768,50597,1,,,BAO_0000218,,
10043,Rattus norvegicus,CHEMBL631267,Intermediate,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,N,10116.0,7768,50597,1,,,BAO_0000218,,
10044,Rattus norvegicus,CHEMBL631268,Intermediate,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,N,10116.0,7768,50597,1,,,BAO_0000218,,
10045,Rattus norvegicus,CHEMBL631269,Intermediate,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,N,10116.0,7768,50597,1,,,BAO_0000218,,
10046,Rattus norvegicus,CHEMBL631270,Intermediate,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,N,10116.0,7768,50597,1,,,BAO_0000218,,
10047,Rattus norvegicus,CHEMBL631271,Intermediate,Heart,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,N,10116.0,7768,50597,1,,,BAO_0000218,948.0,
10048,Rattus norvegicus,CHEMBL631272,Intermediate,Heart,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,N,10116.0,7768,50597,1,,,BAO_0000218,948.0,
10049,Rattus norvegicus,CHEMBL631273,Intermediate,Heart,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,N,10116.0,7768,50597,1,,,BAO_0000218,948.0,
10050,Rattus norvegicus,CHEMBL631274,Intermediate,Heart,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,N,10116.0,7768,50597,1,,,BAO_0000218,948.0,
10051,Rattus norvegicus,CHEMBL631275,Intermediate,Heart,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,N,10116.0,7768,50597,1,,,BAO_0000218,948.0,
10052,Rattus norvegicus,CHEMBL626984,Intermediate,Heart,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,N,10116.0,7768,50597,1,,,BAO_0000218,948.0,
10053,Rattus norvegicus,CHEMBL626985,Intermediate,Heart,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,N,10116.0,7768,50597,1,,,BAO_0000218,948.0,
10054,Rattus norvegicus,CHEMBL626986,Intermediate,Liver,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,N,10116.0,7768,50597,1,,,BAO_0000218,2107.0,
10055,Rattus norvegicus,CHEMBL626987,Intermediate,Liver,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,N,10116.0,7768,50597,1,,,BAO_0000218,2107.0,
10056,Rattus norvegicus,CHEMBL626988,Intermediate,Liver,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,N,10116.0,7768,50597,1,,,BAO_0000218,2107.0,
10057,Rattus norvegicus,CHEMBL626989,Intermediate,Liver,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,N,10116.0,7768,50597,1,,,BAO_0000218,2107.0,
10058,Rattus norvegicus,CHEMBL626990,Intermediate,Liver,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,N,10116.0,7768,50597,1,,,BAO_0000218,2107.0,
10059,Rattus norvegicus,CHEMBL626991,Intermediate,Liver,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,N,10116.0,7768,50597,1,,,BAO_0000218,2107.0,
10060,Rattus norvegicus,CHEMBL626992,Intermediate,Liver,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,N,10116.0,7768,50597,1,,,BAO_0000218,2107.0,
10061,Rattus norvegicus,CHEMBL626993,Intermediate,Lung,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,N,10116.0,7768,50597,1,,,BAO_0000218,2048.0,
10062,Rattus norvegicus,CHEMBL874593,Intermediate,Lung,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,N,10116.0,7768,50597,1,,,BAO_0000218,2048.0,
10063,Rattus norvegicus,CHEMBL626994,Intermediate,Lung,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,N,10116.0,7768,50597,1,,,BAO_0000218,2048.0,
10064,Rattus norvegicus,CHEMBL626995,Intermediate,Lung,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,N,10116.0,7768,50597,1,,,BAO_0000218,2048.0,
10065,Rattus norvegicus,CHEMBL626190,Intermediate,Lung,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,N,10116.0,7768,50597,1,,,BAO_0000218,2048.0,
10066,Rattus norvegicus,CHEMBL626191,Intermediate,Lung,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,N,10116.0,7768,50597,1,,,BAO_0000218,2048.0,
10067,Rattus norvegicus,CHEMBL626364,Intermediate,Lung,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,N,10116.0,7768,50597,1,,,BAO_0000218,2048.0,
10068,Rattus norvegicus,CHEMBL626365,Intermediate,Thyroid gland,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,N,10116.0,7768,50597,1,,,BAO_0000218,2046.0,
10069,Rattus norvegicus,CHEMBL626366,Intermediate,Thyroid gland,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,N,10116.0,7768,50597,1,,,BAO_0000218,2046.0,
10070,Rattus norvegicus,CHEMBL626367,Intermediate,Thyroid gland,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,N,10116.0,7768,50597,1,,,BAO_0000218,2046.0,
10071,Rattus norvegicus,CHEMBL626368,Intermediate,Thyroid gland,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,N,10116.0,7768,50597,1,,,BAO_0000218,2046.0,
10072,Rattus norvegicus,CHEMBL626369,Intermediate,Thyroid gland,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,N,10116.0,7768,50597,1,,,BAO_0000218,2046.0,
10073,Rattus norvegicus,CHEMBL626370,Intermediate,Thyroid gland,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,N,10116.0,7768,50597,1,,,BAO_0000218,2046.0,
10074,Rattus norvegicus,CHEMBL626371,Intermediate,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,N,10116.0,4498,50597,1,,,BAO_0000218,,
10075,Rattus norvegicus,CHEMBL626372,Intermediate,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,N,10116.0,4498,50597,1,,,BAO_0000218,,
10076,Rattus norvegicus,CHEMBL626373,Intermediate,,Bioavailability after a dose of 10 mg/kg p.o.,,N,10116.0,3603,50597,1,,,BAO_0000218,,
10077,Rattus norvegicus,CHEMBL626374,Intermediate,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,N,10116.0,6215,50597,1,,,BAO_0000218,,
10078,Rattus norvegicus,CHEMBL626375,Intermediate,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,N,10116.0,5710,50597,1,,,BAO_0000218,,
10079,Rattus norvegicus,CHEMBL626376,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,N,10116.0,5710,50597,1,,,BAO_0000218,,
10080,Rattus norvegicus,CHEMBL626377,Intermediate,,Bioavailability in rat po was determined,,N,10116.0,5676,50597,1,,,BAO_0000218,,
10081,Rattus norvegicus,CHEMBL626378,Intermediate,,Bioavailability of compound at 10 mg/kg in rat after oral administration,,N,10116.0,17667,50597,1,,,BAO_0000218,,
10082,Rattus norvegicus,CHEMBL626379,Intermediate,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,N,10116.0,17667,50597,1,,,BAO_0000218,,
10083,Rattus norvegicus,CHEMBL626380,Intermediate,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,N,10116.0,6848,50597,1,,,BAO_0000218,,
10084,Rattus norvegicus,CHEMBL626381,Intermediate,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,N,10116.0,6848,50597,1,,,BAO_0000218,,
10085,Rattus norvegicus,CHEMBL626382,Intermediate,,Bioavailability in rat,,N,10116.0,17267,50597,1,,,BAO_0000218,,
10086,Rattus norvegicus,CHEMBL626383,Intermediate,,Bioavailability in rat (Sprague-Dawley) (female),,N,10116.0,6362,50597,1,,,BAO_0000218,,
10087,Rattus norvegicus,CHEMBL874652,Intermediate,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,10116.0,17671,50597,1,,,BAO_0000218,,
10088,Rattus norvegicus,CHEMBL626384,Intermediate,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,N,10116.0,17671,50597,1,,,BAO_0000218,,
10089,Rattus norvegicus,CHEMBL626385,Intermediate,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,N,10116.0,4333,50597,1,,,BAO_0000218,,
10090,Rattus norvegicus,CHEMBL626386,Intermediate,,Bioavailability in rat at an oral dose of 2 mg/kg,,N,10116.0,6077,50597,1,,,BAO_0000218,,
10091,Rattus norvegicus,CHEMBL626387,Intermediate,,Bioavailability in rat,,N,10116.0,3278,50597,1,,,BAO_0000218,,
10092,Rattus norvegicus,CHEMBL626388,Intermediate,,Bioavailability in rat,,N,10116.0,5964,50597,1,,,BAO_0000218,,
10093,Rattus norvegicus,CHEMBL626389,Intermediate,,Bioavailability in rat,,N,10116.0,4884,50597,1,,,BAO_0000218,,
10094,Rattus norvegicus,CHEMBL626390,Intermediate,,Bioavailability in rat,,N,10116.0,4905,50597,1,,,BAO_0000218,,
10095,Rattus norvegicus,CHEMBL626391,Intermediate,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,N,10116.0,4884,50597,1,,,BAO_0000218,,
10096,Rattus norvegicus,CHEMBL626392,Intermediate,,Bioavailability in rat,,N,10116.0,6850,50597,1,,,BAO_0000218,,
10097,Rattus norvegicus,CHEMBL626393,Intermediate,,Oral bioavailability in rat,,N,10116.0,2864,50597,1,,,BAO_0000218,,
10098,Rattus norvegicus,CHEMBL623026,Intermediate,,Bioavailability was determined in rat,,N,10116.0,5780,50597,1,,,BAO_0000218,,
10099,Rattus norvegicus,CHEMBL623027,Intermediate,,Bioavailability,,N,10116.0,1465,50597,1,,,BAO_0000218,,
10100,Rattus norvegicus,CHEMBL623028,Intermediate,,Bioavailability,,N,10116.0,5199,50597,1,,,BAO_0000218,,
10101,Rattus norvegicus,CHEMBL623029,Intermediate,,Bioavailability in rat after 1 day dosing,,N,10116.0,5765,50597,1,,,BAO_0000218,,
10102,Rattus norvegicus,CHEMBL623030,Intermediate,,Bioavailability in rat after 4 day dosing,,N,10116.0,5765,50597,1,,,BAO_0000218,,
10103,Rattus norvegicus,CHEMBL623031,Intermediate,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,N,10116.0,6518,50597,1,,,BAO_0000218,,
10104,Rattus norvegicus,CHEMBL623032,Intermediate,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,N,10116.0,6518,50597,1,,,BAO_0000218,,
10105,Rattus norvegicus,CHEMBL623033,Intermediate,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,N,10116.0,6518,50597,1,,,BAO_0000218,,
10106,Rattus norvegicus,CHEMBL623034,Intermediate,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,N,10116.0,6518,50597,1,,,BAO_0000218,,
10107,Rattus norvegicus,CHEMBL623035,Intermediate,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,N,10116.0,2083,50597,1,,,BAO_0000218,,
10108,Rattus norvegicus,CHEMBL623036,Intermediate,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,10116.0,17260,50597,1,,,BAO_0000218,,
10109,Rattus norvegicus,CHEMBL623037,Intermediate,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,N,10116.0,4956,50597,1,,,BAO_0000218,,
10110,Rattus norvegicus,CHEMBL623038,Intermediate,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,N,10116.0,4368,50597,1,,,BAO_0000218,,
10111,Rattus norvegicus,CHEMBL874385,Intermediate,Plasma,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,N,10116.0,17752,50597,1,,,BAO_0000218,1969.0,
10112,Rattus norvegicus,CHEMBL623039,Intermediate,,Bioavailability in rat (Fisher) (fasted),,N,10116.0,1446,50597,1,,,BAO_0000218,,
10113,Primates,CHEMBL623040,Intermediate,,Bioavailability in monkey after po administration of 10 mg/kg dose,,U,9443.0,2891,22224,1,,,BAO_0000218,,
10114,Primates,CHEMBL623041,Intermediate,,Oral bioavailability in monkey (dose 10 mg/kg),,U,9443.0,2891,22224,1,,,BAO_0000218,,
10115,Rattus norvegicus,CHEMBL623741,Intermediate,,Bioavailability in rat,,N,10116.0,6672,50597,1,,,BAO_0000218,,
10116,Rattus norvegicus,CHEMBL623742,Intermediate,,Bioavailability in rat,,N,10116.0,6673,50597,1,,,BAO_0000218,,
10117,Rattus norvegicus,CHEMBL623743,Intermediate,,Bioavailability in rat,,N,10116.0,17655,50597,1,,,BAO_0000218,,
10118,Rattus norvegicus,CHEMBL623744,Intermediate,,Bioavailability in rat,,N,10116.0,17796,50597,1,,,BAO_0000218,,
10119,Rattus norvegicus,CHEMBL623745,Intermediate,,Bioavailability in rat (dose 2.0 mg/kg p.o.),,N,10116.0,17853,50597,1,,,BAO_0000218,,
10120,Rattus norvegicus,CHEMBL623746,Intermediate,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,N,10116.0,4521,50597,1,,,BAO_0000218,,
10121,Rattus norvegicus,CHEMBL623747,Intermediate,,Oral bioavailability in rat (dose 5 mg/kg p.o.),,N,10116.0,4940,50597,1,,,BAO_0000218,,
10122,Rattus norvegicus,CHEMBL623748,Intermediate,,Bioavailability in rat after po administration of 30 mg/kg dose,,U,10116.0,2891,22224,1,,,BAO_0000218,,
10123,Rattus norvegicus,CHEMBL623916,Intermediate,,Bioavailability in rat after po administration of 30 mg/kg dose,,U,10116.0,2891,22224,1,,,BAO_0000218,,
10124,Rattus norvegicus,CHEMBL623917,Intermediate,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,N,10116.0,4521,50597,1,,,BAO_0000218,,
10125,Rattus norvegicus,CHEMBL623918,Intermediate,,Bioavailability in rat (dose 2 mg/kg i.v.),,N,10116.0,17686,50597,1,,,BAO_0000218,,
10126,Rattus norvegicus,CHEMBL874386,Intermediate,,Bioavailability in rat,,N,10116.0,17796,50597,1,,,BAO_0000218,,
10127,Rattus norvegicus,CHEMBL623919,Intermediate,Plasma,Bioavailability in rat; Only traces detected in rat plasma,,N,10116.0,17796,50597,1,,,BAO_0000218,1969.0,
10128,Rattus norvegicus,CHEMBL623920,Intermediate,,Bioavailability in rat,,N,10116.0,5064,50597,1,,,BAO_0000218,,
10129,Rattus norvegicus,CHEMBL623148,Intermediate,,Bioavailability upon oral administration of compound,,N,10116.0,5147,50597,1,,,BAO_0000218,,
10130,Rattus norvegicus,CHEMBL623149,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,N,10116.0,1916,50597,1,,,BAO_0000218,,
10131,Rattus norvegicus,CHEMBL623150,Intermediate,,Bioavailability in rat,,N,10116.0,6049,50597,1,,,BAO_0000218,,
10132,Rattus norvegicus,CHEMBL623151,Intermediate,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,N,10116.0,1445,50597,1,,,BAO_0000218,,
10133,Rattus norvegicus,CHEMBL623152,Intermediate,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,N,10116.0,1445,50597,1,,,BAO_0000218,,
10134,Rattus norvegicus,CHEMBL623153,Expert,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,N,10116.0,2862,50597,1,,,BAO_0000218,,
10135,Rattus norvegicus,CHEMBL623154,Expert,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,N,10116.0,2862,50597,1,,,BAO_0000218,,
10136,Rattus norvegicus,CHEMBL623155,Intermediate,,In vitro and metabolic stability was determined,,N,10116.0,4194,50597,1,,,BAO_0000218,,
10137,Rattus norvegicus,CHEMBL623156,Intermediate,,In vitro metabolic stability in rat hepatocytes,,N,10116.0,4194,50597,1,,,BAO_0000218,,
10138,Rattus norvegicus,CHEMBL623157,Intermediate,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,N,10116.0,5486,50597,1,,,BAO_0000218,,
10139,Rattus norvegicus,CHEMBL623158,Intermediate,Liver,Metabolic rate for compound was observed in rat hepatocytes,,N,10116.0,17582,50597,1,,401.0,BAO_0000218,2107.0,
10140,Rattus norvegicus,CHEMBL623159,Intermediate,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,N,10116.0,5600,50597,1,,,BAO_0000218,,
10141,Rattus norvegicus,CHEMBL874390,Intermediate,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,N,10116.0,14294,50597,1,,,BAO_0000218,,
10142,Rattus norvegicus,CHEMBL623160,Intermediate,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,N,10116.0,14294,50597,1,,,BAO_0000218,,
10143,Rattus norvegicus,CHEMBL623161,Intermediate,,Metabolism of compound in rat S9 microsomes; Trace,,N,10116.0,14294,50597,1,,,BAO_0000218,,
10144,Rattus norvegicus,CHEMBL623162,Intermediate,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,N,10116.0,17847,50597,1,,,BAO_0000218,,
10145,Rattus norvegicus,CHEMBL623163,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10146,Rattus norvegicus,CHEMBL623164,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10147,Rattus norvegicus,CHEMBL623165,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10148,Rattus norvegicus,CHEMBL623166,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10149,Rattus norvegicus,CHEMBL624983,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10150,Rattus norvegicus,CHEMBL624984,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10151,Rattus norvegicus,CHEMBL624985,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10152,Rattus norvegicus,CHEMBL622970,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10153,Rattus norvegicus,CHEMBL622971,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10154,Rattus norvegicus,CHEMBL622972,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10155,Rattus norvegicus,CHEMBL622973,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10156,Rattus norvegicus,CHEMBL622974,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10157,Rattus norvegicus,CHEMBL622975,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10158,Rattus norvegicus,CHEMBL622976,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10159,Rattus norvegicus,CHEMBL622977,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10160,Rattus norvegicus,CHEMBL624351,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10161,Rattus norvegicus,CHEMBL624352,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10162,Rattus norvegicus,CHEMBL624353,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10163,Rattus norvegicus,CHEMBL622397,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10164,Rattus norvegicus,CHEMBL622398,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10165,Rattus norvegicus,CHEMBL622399,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10166,Rattus norvegicus,CHEMBL622400,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10167,Rattus norvegicus,CHEMBL628428,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10168,Rattus norvegicus,CHEMBL628590,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10169,Rattus norvegicus,CHEMBL628591,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10170,Rattus norvegicus,CHEMBL628592,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10171,Rattus norvegicus,CHEMBL628593,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10172,Rattus norvegicus,CHEMBL875333,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10173,Rattus norvegicus,CHEMBL628594,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10174,Rattus norvegicus,CHEMBL628595,Intermediate,Plasma,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,N,10116.0,4969,50597,1,,,BAO_0000218,1969.0,
10175,Rattus norvegicus,CHEMBL628596,Intermediate,Plasma,Stability in rat plasma was determined,,N,10116.0,6737,50597,1,,,BAO_0000218,1969.0,
10176,Rattus norvegicus,CHEMBL628597,Intermediate,Plasma,Stability in rat plasma was determined; ND= no data,,N,10116.0,6737,50597,1,,,BAO_0000218,1969.0,
10177,Rattus norvegicus,CHEMBL628598,Intermediate,Plasma,Tested for plasma half life period in rat (0-8 hr),,N,10116.0,5089,50597,1,,,BAO_0000218,1969.0,
10178,Rattus norvegicus,CHEMBL628599,Intermediate,Plasma,Tested for plasma half life period in rat (0-8 hr); Not determined,,N,10116.0,5089,50597,1,,,BAO_0000218,1969.0,
10179,Rattus norvegicus,CHEMBL628600,Intermediate,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,N,10116.0,1466,50597,1,,,BAO_0000218,,
10180,Rattus norvegicus,CHEMBL628601,Intermediate,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,N,10116.0,1466,50597,1,,,BAO_0000218,,
10181,Rattus norvegicus,CHEMBL628602,Intermediate,,Tested for the half life in rat,,N,10116.0,4950,50597,1,,,BAO_0000218,,
10182,Rattus norvegicus,CHEMBL628603,Intermediate,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,N,10116.0,2412,50597,1,,,BAO_0000218,,
10183,Rattus norvegicus,CHEMBL628604,Intermediate,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,N,10116.0,2412,50597,1,,,BAO_0000218,,
10184,Rattus norvegicus,CHEMBL628605,Intermediate,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,N,10116.0,2412,50597,1,,,BAO_0000218,,
10185,Rattus norvegicus,CHEMBL628606,Intermediate,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,N,10116.0,2412,50597,1,,,BAO_0000218,,
10186,Rattus norvegicus,CHEMBL628607,Intermediate,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,N,10116.0,2412,50597,1,,,BAO_0000218,,
10187,Rattus norvegicus,CHEMBL628608,Intermediate,,The biological half life the compound was measured at the dose of 100 umol/kg,,N,10116.0,15022,50597,1,,,BAO_0000218,,
10188,Rattus norvegicus,CHEMBL628609,Intermediate,,The biological half life the compound was measured at the dose of 30 umol/kg,,N,10116.0,15022,50597,1,,,BAO_0000218,,
10189,Rattus norvegicus,CHEMBL628610,Intermediate,Plasma,The compound was evaluated for plasma half life period in rat,,N,10116.0,406,50597,1,,,BAO_0000218,1969.0,
10190,Rattus norvegicus,CHEMBL873819,Intermediate,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
10191,Rattus norvegicus,CHEMBL628611,Intermediate,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
10192,Rattus norvegicus,CHEMBL628612,Intermediate,,The pharmacokinetic parameter half-life period in vivo in rats,,N,10116.0,5247,50597,1,,,BAO_0000218,,
10193,Rattus norvegicus,CHEMBL628613,Intermediate,,"The pharmacokinetic property, Half-life was determined",,N,10116.0,5041,50597,1,,,BAO_0000218,,
10194,Rattus norvegicus,CHEMBL628614,Intermediate,,"The pharmacokinetic property, Half-life in rat in vivo",,N,10116.0,5041,50597,1,,,BAO_0000218,,
10195,Rattus norvegicus,CHEMBL628615,Intermediate,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,N,10116.0,5041,50597,1,,,BAO_0000218,,
10196,Rattus norvegicus,CHEMBL628616,Intermediate,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,N,10116.0,5041,50597,1,,,BAO_0000218,,
10197,Rattus norvegicus,CHEMBL627924,Intermediate,Plasma,The plasma half life period in rats,,N,10116.0,3918,50597,1,,,BAO_0000218,1969.0,
10198,Rattus norvegicus,CHEMBL627925,Intermediate,Liver,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,N,10116.0,2906,50597,1,,,BAO_0000218,2107.0,
10199,Rattus norvegicus,CHEMBL627926,Intermediate,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,N,10116.0,6467,50597,1,,,BAO_0000218,,
10200,Rattus norvegicus,CHEMBL627927,Intermediate,,t1/2 (apparent elimination)of the compound was determined,,N,10116.0,5510,50597,1,,,BAO_0000218,,
10201,Rattus norvegicus,CHEMBL627928,Intermediate,,t1/2 value in rat,,N,10116.0,3788,50597,1,,,BAO_0000218,,
10202,Rattus norvegicus,CHEMBL627539,Intermediate,,Half life in rat,,N,10116.0,17796,50597,1,,,BAO_0000218,,
10203,Rattus norvegicus,CHEMBL876790,Intermediate,Plasma,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,N,10116.0,12873,50597,1,,,BAO_0000218,1969.0,
10204,Rattus norvegicus,CHEMBL858186,Intermediate,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,N,10116.0,5983,50597,1,,,BAO_0000218,,
10205,Rattus norvegicus,CHEMBL627540,Intermediate,,Half-life period in fasted rats,,N,10116.0,15765,50597,1,,,BAO_0000218,,
10206,Rattus norvegicus,CHEMBL627541,Intermediate,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
10207,Rattus norvegicus,CHEMBL627715,Intermediate,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
10208,Rattus norvegicus,CHEMBL627716,Intermediate,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,N,10116.0,429,50597,1,,,BAO_0000218,,
10209,Rattus norvegicus,CHEMBL627717,Intermediate,,Maximum time required to achieve Cmax was determined in rat,,N,10116.0,17655,50597,1,,,BAO_0000218,,
10210,Rattus norvegicus,CHEMBL627718,Intermediate,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,10116.0,17717,50597,1,,,BAO_0000218,,
10211,Rattus norvegicus,CHEMBL627719,Intermediate,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,10116.0,17717,50597,1,,,BAO_0000218,,
10212,Rattus norvegicus,CHEMBL627720,Intermediate,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,N,10116.0,17717,50597,1,,,BAO_0000218,,
10213,Rattus norvegicus,CHEMBL627721,Intermediate,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,N,10116.0,6570,50597,1,,,BAO_0000218,,
10214,Rattus norvegicus,CHEMBL627722,Intermediate,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,N,10116.0,6570,50597,1,,,BAO_0000218,,
10215,Rattus norvegicus,CHEMBL627723,Intermediate,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
10216,Rattus norvegicus,CHEMBL626058,Intermediate,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
10217,Rattus norvegicus,CHEMBL626059,Intermediate,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
10218,Rattus norvegicus,CHEMBL626060,Intermediate,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
10219,Rattus norvegicus,CHEMBL626061,Intermediate,Plasma,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,10116.0,17720,50597,1,,,BAO_0000218,1969.0,
10220,Rattus norvegicus,CHEMBL876791,Intermediate,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,10116.0,4723,50597,1,,,BAO_0000218,,
10221,Rattus norvegicus,CHEMBL626062,Intermediate,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,10116.0,4723,50597,1,,,BAO_0000218,,
10222,Rattus norvegicus,CHEMBL626063,Intermediate,,Tmax at the dose of 2 mg/Kg administered perorally in rats,,N,10116.0,4756,50597,1,,,BAO_0000218,,
10223,Rattus norvegicus,CHEMBL626064,Intermediate,,Tmax at the dose of 5 mg/Kg administered perorally in rats,,N,10116.0,4756,50597,1,,,BAO_0000218,,
10224,Rattus norvegicus,CHEMBL626065,Intermediate,Plasma,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,N,10116.0,17720,50597,1,,,BAO_0000218,1969.0,
10225,Rattus norvegicus,CHEMBL626066,Intermediate,Plasma,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,N,10116.0,17720,50597,1,,,BAO_0000218,1969.0,
10226,Rattus norvegicus,CHEMBL626067,Intermediate,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,N,10116.0,1466,50597,1,,,BAO_0000218,,
10227,Rattus norvegicus,CHEMBL626068,Intermediate,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,N,10116.0,7449,50597,1,,,BAO_0000218,,
10228,Rattus norvegicus,CHEMBL626069,Intermediate,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,N,10116.0,7449,50597,1,,,BAO_0000218,,
10229,Rattus norvegicus,CHEMBL626070,Intermediate,,Percent total excretion of 3-methoxyacetaminophen glucuronide,,N,10116.0,7449,50597,1,,,BAO_0000218,,
10230,Rattus norvegicus,CHEMBL626071,Intermediate,,Percent total excretion of N-methoxyacetaminophen glucuronide,,N,10116.0,7449,50597,1,,,BAO_0000218,,
10231,Rattus norvegicus,CHEMBL626072,Intermediate,,Percent total excretion of N-methoxyacetaminophen sulfate,,N,10116.0,7449,50597,1,,,BAO_0000218,,
10232,Rattus norvegicus,CHEMBL626073,Intermediate,,Percent total excretion of acetaminophen,,N,10116.0,7449,50597,1,,,BAO_0000218,,
10233,Rattus norvegicus,CHEMBL626741,Intermediate,Thyroid gland,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,N,10116.0,7768,50597,1,,,BAO_0000218,2046.0,
10234,Rattus norvegicus,CHEMBL626742,Intermediate,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,N,10116.0,17655,50597,1,,,BAO_0000218,,
10235,Rattus norvegicus,CHEMBL626743,Intermediate,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,N,10116.0,17735,50597,1,,,BAO_0000218,,
10236,Rattus norvegicus,CHEMBL876792,Intermediate,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,N,10116.0,5960,50597,1,,,BAO_0000218,,
10237,Rattus norvegicus,CHEMBL626744,Intermediate,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,N,10116.0,17735,50597,1,,,BAO_0000218,,
10238,Rattus norvegicus,CHEMBL626745,Intermediate,,Compound was tested for antidiuretic activity in rats,,N,10116.0,7116,50597,1,,,BAO_0000218,,
10239,Rattus norvegicus,CHEMBL626746,Intermediate,Plasma,AUC in rat after 3mg/kg oral dose,,N,10116.0,4878,50597,1,,,BAO_0000218,1969.0,
10240,Rattus norvegicus,CHEMBL626747,Intermediate,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,N,10116.0,5939,50597,1,,,BAO_0000218,,
10241,Rattus norvegicus,CHEMBL626748,Intermediate,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,N,10116.0,5939,50597,1,,,BAO_0000218,,
10242,Rattus norvegicus,CHEMBL626749,Intermediate,,Bioavailability administered orally at a dose of 10 mg/kg to rats,,N,10116.0,16367,50597,1,,,BAO_0000218,,
10243,Rattus norvegicus,CHEMBL626750,Intermediate,,Oral Bioavailability was determined,,N,10116.0,16366,50597,1,,,BAO_0000218,,
10244,Rattus norvegicus,CHEMBL626751,Intermediate,,Oral bioavailability in rat,,N,10116.0,4426,50597,1,,,BAO_0000218,,
10245,Rattus norvegicus,CHEMBL626913,Intermediate,,Oral bioavailability in rat; Not performed.,,N,10116.0,4426,50597,1,,,BAO_0000218,,
10246,Rattus norvegicus,CHEMBL626914,Intermediate,,Bioavailability,,N,10116.0,5041,50597,1,,,BAO_0000218,,
10247,Rattus norvegicus,CHEMBL626915,Intermediate,,Bioavailability was determined; ND denotes no data,,N,10116.0,5041,50597,1,,,BAO_0000218,,
10248,Rattus norvegicus,CHEMBL626916,Intermediate,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,N,10116.0,1500,50597,1,,,BAO_0000218,,
10249,Rattus norvegicus,CHEMBL626917,Intermediate,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,N,10116.0,1500,50597,1,,,BAO_0000218,,
10250,Rattus norvegicus,CHEMBL626918,Intermediate,,Binding towards rat plasma protein at 10 uM,,N,10116.0,17409,50597,1,,,BAO_0000218,,
10251,Rattus norvegicus,CHEMBL626919,Intermediate,,Binding towards rat plasma protein at 100 uM,,N,10116.0,17409,50597,1,,,BAO_0000218,,
10252,Rattus norvegicus,CHEMBL626920,Intermediate,,Bioavailability in rat (dose 20 mg/kg p.o.),,N,10116.0,2959,50597,1,,,BAO_0000218,,
10253,Rattus norvegicus,CHEMBL621976,Intermediate,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,N,10116.0,13501,50597,1,,,BAO_0000218,,
10254,Rattus norvegicus,CHEMBL877599,Intermediate,,Bioavailability in rat after 5 mg/kg oral gavage,,N,10116.0,6567,50597,1,,,BAO_0000218,,
10255,Rattus norvegicus,CHEMBL621977,Intermediate,,Bioavailability in rat,,N,10116.0,6571,50597,1,,,BAO_0000218,,
10256,Rattus norvegicus,CHEMBL621978,Intermediate,,Bioavailability in rat (dose 1 mg/kg i.v.),,N,10116.0,6715,50597,1,,,BAO_0000218,,
10257,Rattus norvegicus,CHEMBL621979,Intermediate,,Bioavailability in rat (dose 3 mg/kg p.o.),,N,10116.0,6715,50597,1,,,BAO_0000218,,
10258,Rattus norvegicus,CHEMBL621980,Intermediate,,Oral bioavailability in rat,,N,10116.0,2932,50597,1,,,BAO_0000218,,
10259,Rattus norvegicus,CHEMBL621981,Intermediate,,Bioavailability of the compound in rats after administration of 30 mg/kg,,N,10116.0,4171,50597,1,,,BAO_0000218,,
10260,Rattus norvegicus,CHEMBL621982,Intermediate,,Bioavailability after administration of 10 mg/kg in rats,,N,10116.0,17509,50597,1,,,BAO_0000218,,
10261,Rattus norvegicus,CHEMBL882953,Intermediate,,Bioavailability after administration of 2 mg/kg in rats,,N,10116.0,17509,50597,1,,,BAO_0000218,,
10262,Rattus norvegicus,CHEMBL621983,Intermediate,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,N,10116.0,4527,50597,1,,,BAO_0000218,,
10263,Rattus norvegicus,CHEMBL621984,Intermediate,,Bioavailability in dogs was determined; high,,N,10116.0,4026,50597,1,,,BAO_0000218,,
10264,Rattus norvegicus,CHEMBL621985,Intermediate,,Bioavailability in monkey after intravenous administration at 1 mpk,,N,10116.0,6659,50597,1,,,BAO_0000218,,
10265,Rattus norvegicus,CHEMBL621986,Intermediate,,Bioavailability in monkey after peroral administration at 10 mpk,,N,10116.0,6659,50597,1,,,BAO_0000218,,
10266,Rattus norvegicus,CHEMBL621987,Intermediate,,Bioavailability in rat after intravenous administration at 1 mpk,,N,10116.0,6659,50597,1,,,BAO_0000218,,
10267,Rattus norvegicus,CHEMBL877600,Intermediate,,Bioavailability in rat after intravenous administration at 2 mpk,,N,10116.0,6659,50597,1,,,BAO_0000218,,
10268,Rattus norvegicus,CHEMBL621988,Intermediate,,Bioavailability in rat after peroral administration at 30 mpk,,N,10116.0,6659,50597,1,,,BAO_0000218,,
10269,Rattus norvegicus,CHEMBL621989,Intermediate,,Bioavailability in rat after peroral administration at at 100 mpk,,N,10116.0,6659,50597,1,,,BAO_0000218,,
10270,Rattus norvegicus,CHEMBL621990,Intermediate,,Bioavailability in rats was evaluated,,N,10116.0,6597,50597,1,,,BAO_0000218,,
10271,Rattus norvegicus,CHEMBL621991,Intermediate,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,N,10116.0,1202,50597,1,,,BAO_0000218,,
10272,Rattus norvegicus,CHEMBL621992,Intermediate,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,N,10116.0,1202,50597,1,,,BAO_0000218,,
10273,Rattus norvegicus,CHEMBL621993,Intermediate,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,N,10116.0,1202,50597,1,,,BAO_0000218,,
10274,Rattus norvegicus,CHEMBL621994,Intermediate,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,N,10116.0,1202,50597,1,,,BAO_0000218,,
10275,Rattus norvegicus,CHEMBL621995,Intermediate,,Bioavailability in rat,,N,10116.0,5207,50597,1,,,BAO_0000218,,
10276,Rattus norvegicus,CHEMBL621996,Intermediate,,Bioavailability in rat,,N,10116.0,5970,50597,1,,,BAO_0000218,,
10277,Rattus norvegicus,CHEMBL621997,Intermediate,,Oral bioavailability in rat (dose 10 mg/kg),,N,10116.0,17538,50597,1,,,BAO_0000218,,
10278,Rattus norvegicus,CHEMBL621998,Intermediate,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,N,10116.0,17538,50597,1,,,BAO_0000218,,
10279,Rattus norvegicus,CHEMBL621999,Intermediate,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,N,10116.0,1466,50597,1,,,BAO_0000218,,
10280,Rattus norvegicus,CHEMBL622000,Intermediate,,Oral bioavailability in rat,,N,10116.0,2879,50597,1,,,BAO_0000218,,
10281,Rattus norvegicus,CHEMBL622001,Intermediate,,Bioavailability was measured in rat after oral administration; 2-4,,N,10116.0,2879,50597,1,,,BAO_0000218,,
10282,Rattus norvegicus,CHEMBL622002,Intermediate,,Bioavailability was measured in rat after oral administration; 3-7,,N,10116.0,2879,50597,1,,,BAO_0000218,,
10283,Rattus norvegicus,CHEMBL622003,Intermediate,,Bioavailability in rat (intraduodenal administration),,N,10116.0,3777,50597,1,,,BAO_0000218,,
10284,Rattus norvegicus,CHEMBL877601,Intermediate,,Bioavailability in rat (intraduodenal administration),,N,10116.0,3777,50597,1,,,BAO_0000218,,
10285,Rattus norvegicus,CHEMBL624871,Intermediate,,Oral bioavailability in rat,,N,10116.0,3777,50597,1,,,BAO_0000218,,
10286,Rattus norvegicus,CHEMBL622004,Intermediate,,Oral bioavailability in rat,,N,10116.0,3777,50597,1,,,BAO_0000218,,
10287,Rattus norvegicus,CHEMBL882954,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,N,10116.0,5423,50597,1,,,BAO_0000218,,
10288,Rattus norvegicus,CHEMBL622005,Intermediate,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,N,10116.0,16365,50597,1,,,BAO_0000218,,
10289,Rattus norvegicus,CHEMBL622006,Intermediate,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,N,10116.0,16365,50597,1,,,BAO_0000218,,
10290,Rattus norvegicus,CHEMBL622007,Intermediate,,Bioavailability was measured in rat,,N,10116.0,4239,50597,1,,,BAO_0000218,,
10291,Rattus norvegicus,CHEMBL622008,Intermediate,,Bioavailability was reported,,N,10116.0,5438,50597,1,,,BAO_0000218,,
10292,Rattus norvegicus,CHEMBL622009,Intermediate,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,10116.0,5334,50597,1,,,BAO_0000218,,
10293,Rattus norvegicus,CHEMBL622010,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,N,10116.0,5334,50597,1,,,BAO_0000218,,
10294,Rattus norvegicus,CHEMBL622011,Intermediate,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,N,10116.0,4199,50597,1,,,BAO_0000218,,
10295,Rattus norvegicus,CHEMBL622012,Intermediate,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,N,10116.0,4199,50597,1,,,BAO_0000218,,
10296,Rattus norvegicus,CHEMBL622013,Intermediate,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,N,10116.0,4199,50597,1,,,BAO_0000218,,
10297,Rattus norvegicus,CHEMBL622014,Intermediate,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,N,10116.0,4890,50597,1,,,BAO_0000218,,
10298,Rattus norvegicus,CHEMBL624749,Intermediate,,Bioavailability was determined at 3 mg/kg po dose in rats,,N,10116.0,2792,50597,1,,,BAO_0000218,,
10299,Rattus norvegicus,CHEMBL624750,Intermediate,,Oral bioavailability in rat (dose 2 mg/kg),,N,10116.0,5529,50597,1,,,BAO_0000218,,
10300,Rattus norvegicus,CHEMBL624751,Intermediate,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,N,10116.0,6685,50597,1,,,BAO_0000218,,
10301,Rattus norvegicus,CHEMBL624752,Intermediate,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,N,10116.0,6685,50597,1,,,BAO_0000218,,
10302,Rattus norvegicus,CHEMBL624753,Intermediate,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,N,10116.0,6685,50597,1,,,BAO_0000218,,
10303,Rattus norvegicus,CHEMBL624754,Intermediate,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,N,10116.0,6005,50597,1,,,BAO_0000218,,
10304,Rattus norvegicus,CHEMBL624755,Intermediate,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,N,10116.0,6410,50597,1,,,BAO_0000218,,
10305,Rattus norvegicus,CHEMBL624756,Intermediate,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,N,10116.0,6410,50597,1,,,BAO_0000218,,
10306,Rattus norvegicus,CHEMBL624757,Intermediate,,Bioavailability in rat,,N,10116.0,6103,50597,1,,,BAO_0000218,,
10307,Rattus norvegicus,CHEMBL624758,Intermediate,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,N,10116.0,6410,50597,1,,,BAO_0000218,,
10308,Rattus norvegicus,CHEMBL622270,Intermediate,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,N,10116.0,6410,50597,1,,,BAO_0000218,,
10309,Rattus norvegicus,CHEMBL622271,Intermediate,,Bioavailability in rat (Sprague-Dawley),,N,10116.0,5353,50597,1,,,BAO_0000218,,
10310,Rattus norvegicus,CHEMBL622272,Intermediate,,Bioavailability in rat at the dose of 2 mg/kg,,N,10116.0,4727,50597,1,,,BAO_0000218,,
10311,Rattus norvegicus,CHEMBL622273,Intermediate,,Oral bioavailability in rat,,N,10116.0,17804,50597,1,,,BAO_0000218,,
10312,Rattus norvegicus,CHEMBL622274,Intermediate,,Bioavailability in rat (cannulated) (dose 2 mg/kg),,N,10116.0,5809,50597,1,,,BAO_0000218,,
10313,Rattus norvegicus,CHEMBL622275,Intermediate,,Bioavailability value of compound in rats was determined after peroral administration,,N,10116.0,17804,50597,1,,,BAO_0000218,,
10314,Rattus norvegicus,CHEMBL622276,Intermediate,,Oral bioavailability in rat (dose 20 mg/kg),,N,10116.0,3634,50597,1,,,BAO_0000218,,
10315,Rattus norvegicus,CHEMBL622277,Intermediate,,Oral bioavailability in rat,,N,10116.0,3341,50597,1,,,BAO_0000218,,
10316,Rattus norvegicus,CHEMBL622278,Intermediate,,Oral bioavailability in rat (dose 5 mg/kg),,N,10116.0,2690,50597,1,,,BAO_0000218,,
10317,Rattus norvegicus,CHEMBL622279,Intermediate,,Oral bioavailability in rat,,N,10116.0,3184,50597,1,,,BAO_0000218,,
10318,Rattus norvegicus,CHEMBL622280,Intermediate,,Oral bioavailability in rat,,N,10116.0,740,50597,1,,,BAO_0000218,,
10319,Rattus norvegicus,CHEMBL624083,Intermediate,,Compound was evaluated for oral bioavailability in rats; 15-27 %,,N,10116.0,1806,50597,1,,,BAO_0000218,,
10320,Rattus norvegicus,CHEMBL624084,Intermediate,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,N,10116.0,4891,50597,1,,,BAO_0000218,,
10321,Rattus norvegicus,CHEMBL624085,Intermediate,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,N,10116.0,3634,50597,1,,,BAO_0000218,,
10322,Rattus norvegicus,CHEMBL624086,Intermediate,,Compound was tested for bioavailability in rats,,N,10116.0,64,50597,1,,,BAO_0000218,,
10323,Rattus norvegicus,CHEMBL624087,Intermediate,,Bioavailability in rat,,N,10116.0,4839,50597,1,,,BAO_0000218,,
10324,Rattus norvegicus,CHEMBL624088,Intermediate,,Oral bioavailability in rat,,N,10116.0,1094,50597,1,,,BAO_0000218,,
10325,Macaca mulatta,CHEMBL624089,Intermediate,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,U,9544.0,5005,22224,1,,,BAO_0000218,,
10326,Rattus norvegicus,CHEMBL624090,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,U,10116.0,5005,22224,1,,,BAO_0000218,,
10327,Rattus norvegicus,CHEMBL624091,Intermediate,,Evaluated for the bioavailability in rat (in vivo),,N,10116.0,4687,50597,1,,,BAO_0000218,,
10328,Rattus norvegicus,CHEMBL624092,Intermediate,,F value of compound in rats was determined after peroral administration,,N,10116.0,17804,50597,1,,,BAO_0000218,,
10329,Rattus norvegicus,CHEMBL624093,Intermediate,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
10330,Rattus norvegicus,CHEMBL624094,Intermediate,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
10331,Rattus norvegicus,CHEMBL624095,Intermediate,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
10332,Rattus norvegicus,CHEMBL624096,Intermediate,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,10116.0,5974,50597,1,,,BAO_0000218,,
10333,Rattus norvegicus,CHEMBL624097,Intermediate,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,N,10116.0,1088,50597,1,,,BAO_0000218,,
10334,Rattus norvegicus,CHEMBL624098,Intermediate,,Maximum fall in carotid flow in rat,,N,10116.0,1742,50597,1,,,BAO_0000218,,
10335,Rattus norvegicus,CHEMBL874392,Intermediate,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,N,10116.0,4689,50597,1,,,BAO_0000218,,
10336,Rattus norvegicus,CHEMBL624099,Intermediate,,Oral bioavailability in rat (dose 5 mg/kg),,N,10116.0,2463,50597,1,,,BAO_0000218,,
10337,Rattus norvegicus,CHEMBL624100,Intermediate,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,N,10116.0,5654,50597,1,,,BAO_0000218,,
10338,Rattus norvegicus,CHEMBL624101,Intermediate,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,N,10116.0,5654,50597,1,,,BAO_0000218,,
10339,Rattus norvegicus,CHEMBL624102,Intermediate,,Oral bioavailability in rat (male Wistar),,N,10116.0,6874,50597,1,,,BAO_0000218,,
10340,Rattus norvegicus,CHEMBL624103,Intermediate,,Oral bioavailability after administration (30 mg/kg) in rat; good,,N,10116.0,5633,50597,1,,,BAO_0000218,,
10341,Rattus norvegicus,CHEMBL624104,Intermediate,,Oral bioavailability at the dose of 2 mg/kg in rat,,N,10116.0,5496,50597,1,,,BAO_0000218,,
10342,Rattus norvegicus,CHEMBL624105,Intermediate,,Oral bioavailability determined in rats,,N,10116.0,2358,50597,1,,,BAO_0000218,,
10343,Rattus norvegicus,CHEMBL624106,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,N,10116.0,16456,50597,1,,,BAO_0000218,,
10344,Rattus norvegicus,CHEMBL624107,Intermediate,,Oral bioavailability in rat (dose single 10 mg/kg),,N,10116.0,5302,50597,1,,,BAO_0000218,,
10345,Rattus norvegicus,CHEMBL623943,Intermediate,,Oral bioavailability in rat (dose single 10 mg/kg),,N,10116.0,5302,50597,1,,,BAO_0000218,,
10346,Rattus norvegicus,CHEMBL623944,Intermediate,,Oral bioavailability in rat (dose 5 mg/kg,,N,10116.0,5302,50597,1,,,BAO_0000218,,
10347,Rattus norvegicus,CHEMBL623945,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10348,Rattus norvegicus,CHEMBL623946,Intermediate,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10349,Rattus norvegicus,CHEMBL623947,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10350,Rattus norvegicus,CHEMBL623948,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10351,Rattus norvegicus,CHEMBL623949,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10352,Rattus norvegicus,CHEMBL623950,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10353,Rattus norvegicus,CHEMBL874398,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10354,Rattus norvegicus,CHEMBL623951,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10355,Rattus norvegicus,CHEMBL623952,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10356,Rattus norvegicus,CHEMBL623953,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10357,Rattus norvegicus,CHEMBL623954,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10358,Rattus norvegicus,CHEMBL623955,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10359,Rattus norvegicus,CHEMBL623956,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10360,Rattus norvegicus,CHEMBL627807,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10361,Rattus norvegicus,CHEMBL627808,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10362,Rattus norvegicus,CHEMBL627809,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10363,Rattus norvegicus,CHEMBL627810,Intermediate,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10364,Rattus norvegicus,CHEMBL627811,Intermediate,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,N,10116.0,11020,50597,1,,,BAO_0000218,,
10365,Rattus norvegicus,CHEMBL627812,Intermediate,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,N,10116.0,11020,50597,1,,,BAO_0000218,,
10366,Rattus norvegicus,CHEMBL627813,Intermediate,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,N,10116.0,11020,50597,1,,,BAO_0000218,,
10367,Rattus norvegicus,CHEMBL627814,Intermediate,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,N,10116.0,11020,50597,1,,,BAO_0000218,,
10368,Rattus norvegicus,CHEMBL875336,Intermediate,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,N,10116.0,11020,50597,1,,,BAO_0000218,,
10369,Rattus norvegicus,CHEMBL627815,Intermediate,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,N,10116.0,11020,50597,1,,,BAO_0000218,,
10370,Rattus norvegicus,CHEMBL627816,Intermediate,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,N,10116.0,11020,50597,1,,,BAO_0000218,,
10371,Rattus norvegicus,CHEMBL627817,Intermediate,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,N,10116.0,11020,50597,1,,,BAO_0000218,,
10372,Rattus norvegicus,CHEMBL627818,Intermediate,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,N,10116.0,11020,50597,1,,,BAO_0000218,,
10373,Rattus norvegicus,CHEMBL627819,Intermediate,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,N,10116.0,11020,50597,1,,,BAO_0000218,,
10374,Rattus norvegicus,CHEMBL627820,Intermediate,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,N,10116.0,11020,50597,1,,,BAO_0000218,,
10375,Rattus norvegicus,CHEMBL627821,Intermediate,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,N,10116.0,11020,50597,1,,,BAO_0000218,,
10376,Rattus norvegicus,CHEMBL628464,Intermediate,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10377,Rattus norvegicus,CHEMBL626239,Intermediate,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10378,Rattus norvegicus,CHEMBL626240,Intermediate,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10379,Rattus norvegicus,CHEMBL626241,Intermediate,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10380,Rattus norvegicus,CHEMBL626242,Intermediate,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10381,Rattus norvegicus,CHEMBL626243,Intermediate,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10382,Rattus norvegicus,CHEMBL626244,Intermediate,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10383,Rattus norvegicus,CHEMBL626907,Intermediate,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10384,Rattus norvegicus,CHEMBL626908,Intermediate,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10385,Rattus norvegicus,CHEMBL626909,Intermediate,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10386,Rattus norvegicus,CHEMBL626910,Intermediate,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10387,Rattus norvegicus,CHEMBL875342,Intermediate,,Percent total excretion of acetaminophen cysteine conjugate,,N,10116.0,7449,50597,1,,,BAO_0000218,,
10388,Rattus norvegicus,CHEMBL626911,Intermediate,,Percent total excretion of acetaminophen glucuronide,,N,10116.0,7449,50597,1,,,BAO_0000218,,
10389,Rattus norvegicus,CHEMBL626912,Intermediate,,Percent total excretion of acetaminophen sulfate,,N,10116.0,7449,50597,1,,,BAO_0000218,,
10390,Rattus norvegicus,CHEMBL627065,Intermediate,,Percent total excretion of acetaminophen-mercapturic acid,,N,10116.0,7449,50597,1,,,BAO_0000218,,
10391,Rattus norvegicus,CHEMBL627066,Intermediate,Urine,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,N,10116.0,3172,50597,1,,,BAO_0000218,1088.0,
10392,Rattus norvegicus,CHEMBL627067,Intermediate,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,N,10116.0,16456,50597,1,,,BAO_0000218,,
10393,ratrat,CHEMBL627068,Autocuration,Muscle tissue,Biodistribution of compound in rat muscle after 5 min of administration,,U,8656.0,10839,22224,1,,,BAO_0000218,2385.0,
10394,ratrat,CHEMBL627069,Autocuration,Muscle tissue,Biodistribution of compound in rat muscle after 5 min of administration.,,U,8656.0,10839,22224,1,,,BAO_0000218,2385.0,
10395,Ovis aries,CHEMBL627070,Autocuration,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,U,9940.0,5334,22224,1,,,BAO_0000218,,
10396,Ovis aries,CHEMBL627071,Autocuration,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,U,9940.0,5334,22224,1,,,BAO_0000218,,
10397,Ovis aries,CHEMBL627072,Autocuration,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,U,9940.0,5334,22224,1,,,BAO_0000218,,
10398,Ovis aries,CHEMBL627073,Autocuration,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,U,9940.0,5334,22224,1,,,BAO_0000218,,
10399,Ovis aries,CHEMBL625387,Autocuration,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,U,9940.0,5334,22224,1,,,BAO_0000218,,
10400,Ovis aries,CHEMBL625388,Autocuration,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,U,9940.0,5334,22224,1,,,BAO_0000218,,
10401,Ovis aries,CHEMBL625389,Autocuration,Plasma,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,U,9940.0,5334,22224,1,,,BAO_0000218,1969.0,
10402,Ovis aries,CHEMBL875343,Autocuration,Plasma,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,U,9940.0,5334,22224,1,,,BAO_0000218,1969.0,
10403,Serpentes,CHEMBL876795,Intermediate,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,N,8570.0,1735,50497,1,,,BAO_0000218,,
10404,Serpentes,CHEMBL626552,Intermediate,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,N,8570.0,1469,50497,1,,,BAO_0000218,,
10405,Serpentes,CHEMBL626553,Intermediate,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,N,8570.0,1336,50497,1,,,BAO_0000218,,
10406,Homo sapiens,CHEMBL626554,Autocuration,Plasma,The human biological plasma half life of the compound,,U,9606.0,12403,22224,1,,,BAO_0000366,1969.0,
10407,Rattus norvegicus,CHEMBL626555,Intermediate,Urine,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,N,10116.0,8151,50597,1,,,BAO_0000218,1088.0,
10408,Rattus norvegicus,CHEMBL626556,Intermediate,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,N,10116.0,8004,50597,1,,,BAO_0000218,,
10409,Rattus norvegicus,CHEMBL626557,Intermediate,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,N,10116.0,8004,50597,1,,,BAO_0000218,,
10410,Rattus norvegicus,CHEMBL626558,Intermediate,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,N,10116.0,8004,50597,1,,,BAO_0000218,,
10411,Rattus norvegicus,CHEMBL626559,Intermediate,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,N,10116.0,8004,50597,1,,,BAO_0000218,,
10412,Rattus norvegicus,CHEMBL626560,Intermediate,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,N,10116.0,8004,50597,1,,,BAO_0000218,,
10413,Rattus norvegicus,CHEMBL876803,Intermediate,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,N,10116.0,8004,50597,1,,,BAO_0000218,,
10414,Rattus norvegicus,CHEMBL627964,Intermediate,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,N,10116.0,8004,50597,1,,,BAO_0000218,,
10415,Rattus norvegicus,CHEMBL627965,Intermediate,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,N,10116.0,8004,50597,1,,,BAO_0000218,,
10416,Rattus norvegicus,CHEMBL627966,Intermediate,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,N,10116.0,8004,50597,1,,,BAO_0000218,,
10417,Rattus norvegicus,CHEMBL627967,Intermediate,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,N,10116.0,8004,50597,1,,,BAO_0000218,,
10418,Rattus norvegicus,CHEMBL627968,Intermediate,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,N,10116.0,8004,50597,1,,,BAO_0000218,,
10419,Rattus norvegicus,CHEMBL627969,Intermediate,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,N,10116.0,8004,50597,1,,,BAO_0000218,,
10420,Rattus norvegicus,CHEMBL627970,Intermediate,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,N,10116.0,8004,50597,1,,,BAO_0000218,,
10421,Rattus norvegicus,CHEMBL627971,Intermediate,Blood,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,N,10116.0,8004,50597,1,,,BAO_0000218,178.0,
10422,Rattus norvegicus,CHEMBL627972,Intermediate,Blood,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,N,10116.0,8004,50597,1,,,BAO_0000218,178.0,
10423,Homo sapiens,CHEMBL856029,Expert,,Dissociation constant against binding to human cyclophilin A,,D,9606.0,15917,180,1,,,BAO_0000357,,
10424,Bos taurus,CHEMBL627973,Expert,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,H,9913.0,12396,11591,1,,,BAO_0000019,,
10425,,CHEMBL627974,Autocuration,,-Log C was determined by performing the electroshock minimum test,,U,,7065,22224,1,,,BAO_0000019,,
10426,,CHEMBL627975,Autocuration,,-Log C was determined by performing the foot shock test,,U,,7065,22224,1,,,BAO_0000019,,
10427,,CHEMBL627976,Autocuration,,-Log C was determined by performing the incl screen test,,U,,7065,22224,1,,,BAO_0000019,,
10428,,CHEMBL627977,Autocuration,,-Log C was determined by performing the maximum electroshock test,,U,,7065,22224,1,,,BAO_0000019,,
10429,,CHEMBL627978,Autocuration,,-Log C was determined by performing the pentylenetetrazole test,,U,,7065,22224,1,,,BAO_0000019,,
10430,,CHEMBL627979,Autocuration,,Tested for experimental arotinoid inhibitory dose,,U,,12415,22224,1,,,BAO_0000019,,
10431,,CHEMBL876804,Autocuration,,Negative log transformed activity,,U,,10256,22224,1,,,BAO_0000019,,
10432,,CHEMBL627980,Autocuration,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,U,,7991,22224,1,,,BAO_0000019,,
10433,Cavia porcellus,CHEMBL627981,Intermediate,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,N,10141.0,14342,50512,1,,,BAO_0000218,,
10434,Cavia porcellus,CHEMBL627982,Intermediate,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,N,10141.0,14342,50512,1,,,BAO_0000218,,
10435,Cavia porcellus,CHEMBL627983,Intermediate,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,N,10141.0,14342,50512,1,,,BAO_0000218,,
10436,Cavia porcellus,CHEMBL627984,Intermediate,Ileum,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,N,10141.0,14342,50512,1,,,BAO_0000218,2116.0,
10437,,CHEMBL627985,Autocuration,,Solubility in water was determined; values expressed as -log,,U,,6047,22229,1,,,BAO_0000100,,
10438,,CHEMBL627986,Autocuration,,Ratio of Kcat to that of Km was determined,,U,,17269,22224,1,,,BAO_0000019,,
10439,,CHEMBL627987,Autocuration,,Observed first order rate constant,,U,,10026,22224,1,,,BAO_0000019,,
10440,,CHEMBL627988,Autocuration,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,U,,14583,22224,1,,,BAO_0000019,,
10441,Rattus norvegicus,CHEMBL627989,Intermediate,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
10442,Rattus norvegicus,CHEMBL627990,Intermediate,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,N,10116.0,2661,50597,1,,,BAO_0000218,,
10443,Rattus norvegicus,CHEMBL876805,Intermediate,,Oral Bioavailability after administration of 10 mg/kg in male rat,,N,10116.0,4029,50597,1,,,BAO_0000218,,
10444,Rattus norvegicus,CHEMBL627991,Intermediate,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,N,10116.0,17735,50597,1,,,BAO_0000218,,
10445,Rattus norvegicus,CHEMBL627992,Intermediate,,Oral bioavailability in rat,,N,10116.0,4576,50597,1,,,BAO_0000218,,
10446,Rattus norvegicus,CHEMBL627993,Intermediate,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,N,10116.0,17582,50597,1,,,BAO_0000218,,
10447,Rattus norvegicus,CHEMBL622817,Intermediate,,Oral bioavailability at 1 mg/kg was determined in rat,,N,10116.0,17651,50597,1,,,BAO_0000218,,
10448,Rattus norvegicus,CHEMBL622818,Intermediate,,Oral bioavailability at 10 mg/kg was determined in rat,,N,10116.0,17651,50597,1,,,BAO_0000218,,
10449,Rattus norvegicus,CHEMBL622819,Intermediate,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,N,10116.0,17670,50597,1,,,BAO_0000218,,
10450,Rattus norvegicus,CHEMBL872267,Intermediate,,Oral bioavailability in rat,,N,10116.0,5045,50597,1,,,BAO_0000218,,
10451,Rattus norvegicus,CHEMBL622820,Intermediate,,Oral bioavailability in rat,,N,10116.0,1696,50597,1,,,BAO_0000218,,
10452,Rattus norvegicus,CHEMBL622821,Intermediate,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,N,10116.0,17764,50597,1,,,BAO_0000218,,
10453,Rattus norvegicus,CHEMBL622822,Intermediate,,Oral bioavailability in rat,,N,10116.0,6448,50597,1,,,BAO_0000218,,
10454,Rattus norvegicus,CHEMBL622823,Intermediate,,Oral bioavailability in rat,,N,10116.0,6596,50597,1,,,BAO_0000218,,
10455,Rattus norvegicus,CHEMBL622824,Intermediate,,Oral bioavailability in rat,,N,10116.0,17547,50597,1,,,BAO_0000218,,
10456,Rattus norvegicus,CHEMBL622825,Intermediate,,Oral bioavailability in rat at a dose of 3 mg/kg,,N,10116.0,17771,50597,1,,,BAO_0000218,,
10457,Rattus norvegicus,CHEMBL622901,Intermediate,,Oral bioavailability in rat after oral administration at 10 mg/kg,,N,10116.0,6495,50597,1,,,BAO_0000218,,
10458,Rattus norvegicus,CHEMBL622902,Intermediate,,Oral bioavailability in rat,,N,10116.0,4558,50597,1,,,BAO_0000218,,
10459,Rattus norvegicus,CHEMBL621844,Intermediate,,Oral bioavailability in rat,,N,10116.0,17596,50597,1,,,BAO_0000218,,
10460,Rattus norvegicus,CHEMBL621845,Intermediate,,Oral bioavailability in Dawley rats,,N,10116.0,6827,50597,1,,,BAO_0000218,,
10461,Rattus norvegicus,CHEMBL621846,Intermediate,,Oral bioavailability,,N,10116.0,4026,50597,1,,,BAO_0000218,,
10462,Rattus norvegicus,CHEMBL621847,Intermediate,,Oral bioavailability in rat (dose 30 mg/kg),,N,10116.0,10,50597,1,,,BAO_0000218,,
10463,Rattus norvegicus,CHEMBL877609,Intermediate,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,N,10116.0,17717,50597,1,,,BAO_0000218,,
10464,Rattus norvegicus,CHEMBL621848,Intermediate,,Bioavailability in rat (dose 3 mg/kg i.v.),,N,10116.0,17717,50597,1,,,BAO_0000218,,
10465,Rattus norvegicus,CHEMBL621849,Intermediate,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,N,10116.0,17717,50597,1,,,BAO_0000218,,
10466,Rattus norvegicus,CHEMBL622030,Intermediate,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,N,10116.0,17717,50597,1,,,BAO_0000218,,
10467,Rattus norvegicus,CHEMBL622031,Intermediate,,Percent oral bioavailability determined in rats,,N,10116.0,4796,50597,1,,,BAO_0000218,,
10468,Rattus norvegicus,CHEMBL622032,Intermediate,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,N,10116.0,4883,50597,1,,,BAO_0000218,,
10469,Rattus norvegicus,CHEMBL622033,Intermediate,,The compound was evaluated for bioavailability in rats; 32-51,,N,10116.0,2137,50597,1,,,BAO_0000218,,
10470,Rattus norvegicus,CHEMBL622034,Intermediate,,Bioavailability in rat (dose 20 mg/kg p.o.),,N,10116.0,2959,50597,1,,,BAO_0000218,,
10471,Rattus norvegicus,CHEMBL622035,Intermediate,,Oral bioavailability in rat,,N,10116.0,1361,50597,1,,,BAO_0000218,,
10472,Rattus norvegicus,CHEMBL882966,Intermediate,,Bioavailability percent in rat at the dose of 2 mg/kg,,N,10116.0,4727,50597,1,,,BAO_0000218,,
10473,Rattus norvegicus,CHEMBL622036,Intermediate,,Bioavailability was evaluated after 20 uM/kg of peroral administration,,N,10116.0,16423,50597,1,,,BAO_0000218,,
10474,Rattus norvegicus,CHEMBL622037,Intermediate,,Oral bioavailability in rat,,N,10116.0,5206,50597,1,,,BAO_0000218,,
10475,Rattus norvegicus,CHEMBL622038,Intermediate,,Oral bioavailability in rat,,N,10116.0,6448,50597,1,,,BAO_0000218,,
10476,Rattus norvegicus,CHEMBL622039,Intermediate,,Bioavailability in rats,,N,10116.0,17723,50597,1,,,BAO_0000218,,
10477,Rattus norvegicus,CHEMBL622040,Intermediate,Blood,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,178.0,
10478,Rattus norvegicus,CHEMBL622041,Intermediate,Blood,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,178.0,
10479,Rattus norvegicus,CHEMBL622042,Intermediate,Blood,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,178.0,
10480,Rattus norvegicus,CHEMBL622043,Intermediate,Blood,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,178.0,
10481,Rattus norvegicus,CHEMBL622044,Intermediate,Blood,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,178.0,
10482,Rattus norvegicus,CHEMBL622045,Intermediate,Bone,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,10000001.0,
10483,Rattus norvegicus,CHEMBL622046,Intermediate,Bone,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,10000001.0,
10484,Rattus norvegicus,CHEMBL622047,Intermediate,Bone,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,10000001.0,
10485,Rattus norvegicus,CHEMBL877610,Intermediate,Bone,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,10000001.0,
10486,Rattus norvegicus,CHEMBL622048,Intermediate,Brain,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,955.0,
10487,Rattus norvegicus,CHEMBL622049,Intermediate,Brain,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,955.0,
10488,Rattus norvegicus,CHEMBL622050,Intermediate,Brain,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,955.0,
10489,Rattus norvegicus,CHEMBL622051,Intermediate,Brain,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,955.0,
10490,Rattus norvegicus,CHEMBL622052,Intermediate,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,,
10491,Rattus norvegicus,CHEMBL622053,Intermediate,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,,
10492,Rattus norvegicus,CHEMBL622054,Intermediate,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,,
10493,Rattus norvegicus,CHEMBL622055,Intermediate,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,,
10494,Rattus norvegicus,CHEMBL622056,Intermediate,,Oral bioavailability in rats was determined; High,,N,10116.0,5237,50597,1,,,BAO_0000218,,
10495,Rattus norvegicus,CHEMBL622057,Intermediate,,Oral bioavailability in the rat was determined,,N,10116.0,5503,50597,1,,,BAO_0000218,,
10496,Rattus norvegicus,CHEMBL628008,Intermediate,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,N,10116.0,15765,50597,1,,,BAO_0000218,,
10497,Rattus norvegicus,CHEMBL622058,Intermediate,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,N,10116.0,15660,50597,1,,,BAO_0000218,,
10498,Rattus norvegicus,CHEMBL622059,Intermediate,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
10499,Rattus norvegicus,CHEMBL622060,Intermediate,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
10500,Rattus norvegicus,CHEMBL622061,Intermediate,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
10501,Rattus norvegicus,CHEMBL622062,Intermediate,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,10116.0,5978,50597,1,,,BAO_0000218,,
10502,Rattus norvegicus,CHEMBL622063,Intermediate,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,N,10116.0,5656,50597,1,,,BAO_0000218,,
10503,Rattus norvegicus,CHEMBL877611,Expert,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,10116.0,3598,50597,1,,,BAO_0000218,,
10504,Rattus norvegicus,CHEMBL622064,Intermediate,,Oral bioavailability of compound in Sprague Dawley rats,,N,10116.0,4216,50597,1,,,BAO_0000218,,
10505,Rattus norvegicus,CHEMBL622065,Intermediate,,Oral bioavailability of compound in rat,,N,10116.0,17839,50597,1,,,BAO_0000218,,
10506,Rattus norvegicus,CHEMBL622066,Intermediate,,Oral bioavailability in rat (dose 2 mg/kg),,N,10116.0,6570,50597,1,,,BAO_0000218,,
10507,Rattus norvegicus,CHEMBL622067,Intermediate,,Oral bioavailability of compound in rat was determined,,N,10116.0,5334,50597,1,,,BAO_0000218,,
10508,Rattus norvegicus,CHEMBL622068,Intermediate,,Oral bioavailability of compound in rats,,N,10116.0,6886,50597,1,,,BAO_0000218,,
10509,Rattus norvegicus,CHEMBL622069,Intermediate,,Oral bioavailability of compound was determined in rats,,N,10116.0,5210,50597,1,,,BAO_0000218,,
10510,Rattus norvegicus,CHEMBL624796,Intermediate,,Oral bioavailability at a dose of 30 mg/kg in rats,,N,10116.0,4170,50597,1,,,BAO_0000218,,
10511,Rattus norvegicus,CHEMBL624797,Intermediate,,Oral bioavailability in rat (dose 10 mg/kg),,N,10116.0,6028,50597,1,,,BAO_0000218,,
10512,Rattus norvegicus,CHEMBL623053,Intermediate,,Oral bioavailability in rat (dose 10 mg/kg),,N,10116.0,6028,50597,1,,,BAO_0000218,,
10513,Rattus norvegicus,CHEMBL623054,Intermediate,,Oral bioavailability evaluated in rat,,N,10116.0,6078,50597,1,,,BAO_0000218,,
10514,Rattus norvegicus,CHEMBL623055,Intermediate,,Oral bioavailability in fasted rat,,N,10116.0,6168,50597,1,,,BAO_0000218,,
10515,Rattus norvegicus,CHEMBL623056,Intermediate,,Oral bioavailability in fed rat,,N,10116.0,6168,50597,1,,,BAO_0000218,,
10516,Rattus norvegicus,CHEMBL623057,Intermediate,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,N,10116.0,5160,50597,1,,,BAO_0000218,,
10517,Rattus norvegicus,CHEMBL623058,Intermediate,,Oral bioavailability in rat,,N,10116.0,6057,50597,1,,,BAO_0000218,,
10518,Rattus norvegicus,CHEMBL623059,Intermediate,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,N,10116.0,6535,50597,1,,,BAO_0000218,,
10519,Rattus norvegicus,CHEMBL623060,Intermediate,,Oral bioavailability in rat after administration of 10 mg/kg po,,N,10116.0,6535,50597,1,,,BAO_0000218,,
10520,Rattus norvegicus,CHEMBL623061,Intermediate,,Oral bioavailability in rat,,N,10116.0,4194,50597,1,,,BAO_0000218,,
10521,Rattus norvegicus,CHEMBL623062,Intermediate,,Oral bioavailability in rat,,N,10116.0,6230,50597,1,,,BAO_0000218,,
10522,Rattus norvegicus,CHEMBL623063,Intermediate,,Oral bioavailability in rat,,N,10116.0,6619,50597,1,,,BAO_0000218,,
10523,Rattus norvegicus,CHEMBL623064,Intermediate,,Oral bioavailability in rat,,N,10116.0,17607,50597,1,,,BAO_0000218,,
10524,Rattus norvegicus,CHEMBL623065,Intermediate,,Oral bioavailability in ratrs,,N,10116.0,4942,50597,1,,,BAO_0000218,,
10525,Rattus norvegicus,CHEMBL623066,Intermediate,,Oral bioavailability in rat,,N,10116.0,4942,50597,1,,,BAO_0000218,,
10526,Rattus norvegicus,CHEMBL623067,Intermediate,,Oral bioavailability in rat,,N,10116.0,6646,50597,1,,,BAO_0000218,,
10527,Rattus norvegicus,CHEMBL623068,Intermediate,,Oral bioavailability in rats was determined; High,,N,10116.0,5237,50597,1,,,BAO_0000218,,
10528,Rattus norvegicus,CHEMBL623069,Intermediate,,Oral bioavailability in rat,,N,10116.0,6646,50597,1,,,BAO_0000218,,
10529,Rattus norvegicus,CHEMBL623070,Intermediate,,Oral bioavailability in rat,,N,10116.0,4449,50597,1,,,BAO_0000218,,
10530,Rattus norvegicus,CHEMBL623071,Intermediate,,Oral bioavailability was calculated in rat,,N,10116.0,6057,50597,1,,,BAO_0000218,,
10531,Rattus norvegicus,CHEMBL623072,Intermediate,,Oral bioavailability,,N,10116.0,2552,50597,1,,,BAO_0000218,,
10532,Rattus norvegicus,CHEMBL623073,Intermediate,,Oral bioavailability,,N,10116.0,5496,50597,1,,,BAO_0000218,,
10533,Rattus norvegicus,CHEMBL623074,Intermediate,,Oral bioavailability,,N,10116.0,6484,50597,1,,,BAO_0000218,,
10534,Rattus norvegicus,CHEMBL623075,Intermediate,,Oral bioavailability,,N,10116.0,6485,50597,1,,,BAO_0000218,,
10535,Rattus norvegicus,CHEMBL623076,Intermediate,,Oral bioavailability after i.v. administration,,N,10116.0,6616,50597,1,,,BAO_0000218,,
10536,Rattus norvegicus,CHEMBL623077,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,10116.0,4969,50597,1,,,BAO_0000218,,
10537,Rattus norvegicus,CHEMBL623078,Intermediate,,Oral bioavailability in rat (Sprague-Dawley),,N,10116.0,5862,50597,1,,,BAO_0000218,,
10538,Rattus norvegicus,CHEMBL623079,Intermediate,,Oral bioavailability in Sprague-Dawley rats,,N,10116.0,4514,50597,1,,,BAO_0000218,,
10539,Rattus norvegicus,CHEMBL623080,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,10116.0,4514,50597,1,,,BAO_0000218,,
10540,Rattus norvegicus,CHEMBL623081,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,N,10116.0,4514,50597,1,,,BAO_0000218,,
10541,Rattus norvegicus,CHEMBL623082,Intermediate,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,N,10116.0,5546,50597,1,,,BAO_0000218,,
10542,Rattus norvegicus,CHEMBL874400,Intermediate,,Oral bioavailability in fasted rat,,N,10116.0,6168,50597,1,,,BAO_0000218,,
10543,Rattus norvegicus,CHEMBL623083,Intermediate,,Oral bioavailability in fed rat,,N,10116.0,6168,50597,1,,,BAO_0000218,,
10544,Rattus norvegicus,CHEMBL623084,Intermediate,,Oral bioavailability in rat,,N,10116.0,3624,50597,1,,,BAO_0000218,,
10545,Rattus norvegicus,CHEMBL623085,Intermediate,,Oral bioavailability in rat,,N,10116.0,5213,50597,1,,,BAO_0000218,,
10546,Rattus norvegicus,CHEMBL623086,Intermediate,,Oral bioavailability in rat,,N,10116.0,5496,50597,1,,,BAO_0000218,,
10547,Rattus norvegicus,CHEMBL623087,Intermediate,,Oral bioavailability in rat,,N,10116.0,5553,50597,1,,,BAO_0000218,,
10548,Rattus norvegicus,CHEMBL623088,Intermediate,,Oral bioavailability in rat,,N,10116.0,5833,50597,1,,,BAO_0000218,,
10549,Rattus norvegicus,CHEMBL623089,Intermediate,,Oral bioavailability in rat,,N,10116.0,5836,50597,1,,,BAO_0000218,,
10550,Rattus norvegicus,CHEMBL623090,Intermediate,,Oral bioavailability in rat,,N,10116.0,5865,50597,1,,,BAO_0000218,,
10551,Rattus norvegicus,CHEMBL623091,Intermediate,,Oral bioavailability in rat,,N,10116.0,5960,50597,1,,,BAO_0000218,,
10552,Rattus norvegicus,CHEMBL623092,Intermediate,,Oral bioavailability in rat,,N,10116.0,6249,50597,1,,,BAO_0000218,,
10553,Rattus norvegicus,CHEMBL623093,Intermediate,,Oral bioavailability in rat,,N,10116.0,6448,50597,1,,,BAO_0000218,,
10554,Rattus norvegicus,CHEMBL874401,Intermediate,,Oral bioavailability in rat,,N,10116.0,6453,50597,1,,,BAO_0000218,,
10555,Rattus norvegicus,CHEMBL623094,Intermediate,,Oral bioavailability in rat,,N,10116.0,6640,50597,1,,,BAO_0000218,,
10556,Rattus norvegicus,CHEMBL623095,Intermediate,,Oral bioavailability in rat,,N,10116.0,17607,50597,1,,,BAO_0000218,,
10557,Rattus norvegicus,CHEMBL623096,Intermediate,,Oral bioavailability in rat after peroral administration at 10 mg/kg,,N,10116.0,5939,50597,1,,,BAO_0000218,,
10558,Rattus norvegicus,CHEMBL624913,Intermediate,,Oral bioavailability in rat after peroral administration at 5 mg/kg,,N,10116.0,5939,50597,1,,,BAO_0000218,,
10559,Rattus norvegicus,CHEMBL624914,Intermediate,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,N,10116.0,6281,50597,1,,,BAO_0000218,,
10560,Rattus norvegicus,CHEMBL624915,Intermediate,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,N,10116.0,5874,50597,1,,,BAO_0000218,,
10561,Rattus norvegicus,CHEMBL624916,Intermediate,,Oral bioavailability in rat; Not measured,,N,10116.0,5213,50597,1,,,BAO_0000218,,
10562,Rattus norvegicus,CHEMBL624917,Intermediate,,Oral bioavailability in rat,,N,10116.0,4964,50597,1,,,BAO_0000218,,
10563,Rattus norvegicus,CHEMBL625157,Intermediate,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,N,10116.0,11020,50597,1,,,BAO_0000218,,
10564,Rattus norvegicus,CHEMBL625158,Intermediate,Liver,In vitro metabolic potential in rat liver microsomes,,N,10116.0,6251,50597,1,,,BAO_0000218,2107.0,
10565,Rattus norvegicus,CHEMBL625159,Intermediate,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,N,10116.0,1568,50597,1,,,BAO_0000218,,
10566,Rattus norvegicus,CHEMBL625160,Intermediate,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,N,10116.0,3032,50597,1,,,BAO_0000218,,
10567,Rattus norvegicus,CHEMBL625161,Intermediate,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,N,10116.0,3748,50597,1,,,BAO_0000218,,
10568,Rattus norvegicus,CHEMBL625162,Intermediate,,Oral bioavailability in rat,,N,10116.0,401,50597,1,,,BAO_0000218,,
10569,Rattus norvegicus,CHEMBL625163,Intermediate,,Oral bioavailability in rat,,N,10116.0,6512,50597,1,,,BAO_0000218,,
10570,Rattus norvegicus,CHEMBL625164,Intermediate,,Oral bioavailability in rats at 10 mg/kg,,N,10116.0,17617,50597,1,,,BAO_0000218,,
10571,Rattus norvegicus,CHEMBL625165,Intermediate,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,N,10116.0,6679,50597,1,,,BAO_0000218,,
10572,Rattus norvegicus,CHEMBL625166,Intermediate,,Oral bioavailability in rat,,N,10116.0,6742,50597,1,,,BAO_0000218,,
10573,Rattus norvegicus,CHEMBL625167,Intermediate,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,N,10116.0,589,50597,1,,,BAO_0000218,,
10574,Rattus norvegicus,CHEMBL625168,Intermediate,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,N,10116.0,589,50597,1,,,BAO_0000218,,
10575,Rattus norvegicus,CHEMBL625169,Intermediate,,Plasma clearance of the compound,,N,10116.0,3185,50597,1,,,BAO_0000218,,
10576,Rattus norvegicus,CHEMBL626264,Intermediate,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,N,10116.0,17596,50597,1,,,BAO_0000218,,
10577,Rattus norvegicus,CHEMBL626265,Intermediate,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,N,10116.0,2713,50597,1,,,BAO_0000218,,
10578,Rattus norvegicus,CHEMBL626266,Intermediate,Plasma,The compound was tested for plasma clearance in rat,,N,10116.0,12500,50597,1,,,BAO_0000218,1969.0,
10579,Rattus norvegicus,CHEMBL626267,Intermediate,Plasma,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,N,10116.0,12500,50597,1,,,BAO_0000218,1969.0,
10580,Rattus norvegicus,CHEMBL626268,Intermediate,,Plasma concentration upon oral administration of 1 mg/Kg in rats,,N,10116.0,2713,50597,1,,,BAO_0000218,,
10581,Rattus norvegicus,CHEMBL626269,Intermediate,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,N,10116.0,1446,50597,1,,,BAO_0000218,,
10582,Rattus norvegicus,CHEMBL626270,Intermediate,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,N,10116.0,6227,50597,1,,,BAO_0000218,,
10583,Rattus norvegicus,CHEMBL626271,Intermediate,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,N,10116.0,4709,50597,1,,,BAO_0000218,,
10584,Rattus norvegicus,CHEMBL626272,Intermediate,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,N,10116.0,5510,50597,1,,,BAO_0000218,,
10585,Rattus norvegicus,CHEMBL626273,Intermediate,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,N,10116.0,5510,50597,1,,,BAO_0000218,,
10586,Rattus norvegicus,CHEMBL875346,Intermediate,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,N,10116.0,5510,50597,1,,,BAO_0000218,,
10587,Rattus norvegicus,CHEMBL626274,Intermediate,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,N,10116.0,5510,50597,1,,,BAO_0000218,,
10588,Rattus norvegicus,CHEMBL626275,Intermediate,,Compound was tested for protein binding in rat plasma,,N,10116.0,4514,50597,1,,,BAO_0000218,,
10589,Rattus norvegicus,CHEMBL624646,Intermediate,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,N,10116.0,2713,50597,1,,,BAO_0000218,,
10590,Rattus norvegicus,CHEMBL624647,Intermediate,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,N,10116.0,2713,50597,1,,,BAO_0000218,,
10591,Rattus norvegicus,CHEMBL624648,Intermediate,Liver,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,N,10116.0,5340,50597,1,,,BAO_0000218,2107.0,
10592,Rattus norvegicus,CHEMBL624649,Intermediate,,Area under curve ratio was determined (po/iv) in rat,,N,10116.0,12058,50597,1,,,BAO_0000218,,
10593,Rattus norvegicus,CHEMBL624650,Intermediate,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,,
10594,Rattus norvegicus,CHEMBL624651,Intermediate,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,,
10595,Rattus norvegicus,CHEMBL624652,Intermediate,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,,
10596,Rattus norvegicus,CHEMBL624653,Intermediate,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,N,10116.0,6495,50597,1,,,BAO_0000218,,
10597,Rattus norvegicus,CHEMBL624654,Intermediate,,Ratio of AUCbrain to AUCplasma,,N,10116.0,6078,50597,1,,,BAO_0000218,,
10598,Rattus norvegicus,CHEMBL624655,Intermediate,,Ratio of brain to plasma,,N,10116.0,5656,50597,1,,,BAO_0000218,,
10599,Rattus norvegicus,CHEMBL624656,Intermediate,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,N,10116.0,4910,50597,1,,,BAO_0000218,,
10600,Rattus norvegicus,CHEMBL624657,Intermediate,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,N,10116.0,4910,50597,1,,,BAO_0000218,,
10601,Rattus norvegicus,CHEMBL624658,Intermediate,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,N,10116.0,4910,50597,1,,,BAO_0000218,,
10602,Rattus norvegicus,CHEMBL624659,Intermediate,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,N,10116.0,10130,50597,1,,,BAO_0000218,,
10603,Rattus norvegicus,CHEMBL624660,Intermediate,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,N,10116.0,10130,50597,1,,,BAO_0000218,,
10604,Rattus norvegicus,CHEMBL624661,Intermediate,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,N,10116.0,10130,50597,1,,,BAO_0000218,,
10605,Rattus norvegicus,CHEMBL624662,Intermediate,,Steady state brain :blood ratio was determined,,N,10116.0,5213,50597,1,,,BAO_0000218,,
10606,Rattus norvegicus,CHEMBL625199,Intermediate,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,,
10607,Rattus norvegicus,CHEMBL625200,Intermediate,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,N,10116.0,4910,50597,1,,,BAO_0000218,,
10608,Rattus norvegicus,CHEMBL625201,Intermediate,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,10116.0,4910,50597,1,,,BAO_0000218,,
10609,Rattus norvegicus,CHEMBL625202,Intermediate,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,N,10116.0,4910,50597,1,,,BAO_0000218,,
10610,Rattus norvegicus,CHEMBL625203,Intermediate,,Percentage recovery after 3h incubation with rat hapatocytes was determined,,N,10116.0,2083,50597,1,,,BAO_0000218,,
10611,Rattus norvegicus,CHEMBL625204,Intermediate,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,N,10116.0,2082,50597,1,,,BAO_0000218,,
10612,Rattus norvegicus,CHEMBL625205,Intermediate,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,N,10116.0,2082,50597,1,,,BAO_0000218,,
10613,Rattus norvegicus,CHEMBL625206,Intermediate,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,N,10116.0,6351,50597,1,,,BAO_0000218,,
10614,,CHEMBL625207,Autocuration,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,U,,14583,22224,1,,,BAO_0000019,,
10615,,CHEMBL625208,Autocuration,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,U,,14583,22224,1,,,BAO_0000019,,
10616,Homo sapiens,CHEMBL625209,Intermediate,,In vivo absorption in Caco-2 cell line monolayers was determined,,N,9606.0,4608,50587,1,,495.0,BAO_0000218,,
10617,,CHEMBL625210,Autocuration,,Calculated partition coefficient (clogP),,U,,13668,22229,1,,,BAO_0000100,,
10618,Rattus norvegicus,CHEMBL625211,Intermediate,,Area under curve was determine after peroral administration at 10 mpk in Rat,,N,10116.0,5669,50597,1,,,BAO_0000218,,
10619,Macaca mulatta,CHEMBL625212,Intermediate,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,N,9544.0,5669,50797,1,,,BAO_0000218,,
10620,Rattus norvegicus,CHEMBL625213,Intermediate,,Area under curve was determine after peroral administration at 160 mpk in Rat,,N,10116.0,5669,50597,1,,,BAO_0000218,,
10621,Rattus norvegicus,CHEMBL625214,Intermediate,,Area under curve was determine after peroral administration at 20 mpk in Rat,,N,10116.0,5669,50597,1,,,BAO_0000218,,
10622,Rattus norvegicus,CHEMBL874542,Intermediate,,Area under curve was determine after peroral administration at 50 mpk in Rat,,N,10116.0,5669,50597,1,,,BAO_0000218,,
10623,,CHEMBL625215,Autocuration,,Calculated partition coefficient (clogP) (AlogP),,U,,6472,22229,1,,,BAO_0000100,,
10624,,CHEMBL625216,Autocuration,,Activated partial thromboplastin time measured,,U,,15106,22224,1,,,BAO_0000019,,
10625,,CHEMBL625217,Autocuration,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,U,,15207,22224,1,,,BAO_0000100,,
10626,,CHEMBL625218,Autocuration,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,U,,15207,22224,1,,,BAO_0000100,,
10627,Canis lupus familiaris,CHEMBL622864,Intermediate,Plasma,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,N,9615.0,13941,50588,1,,,BAO_0000218,1969.0,
10628,Rattus norvegicus,CHEMBL622865,Intermediate,Plasma,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,N,10116.0,13941,50597,1,,,BAO_0000218,1969.0,
10629,Rattus norvegicus,CHEMBL622866,Intermediate,Plasma,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,N,10116.0,13941,50597,1,,,BAO_0000218,1969.0,
10630,Canis lupus familiaris,CHEMBL622867,Intermediate,Plasma,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,N,9615.0,13941,50588,1,,,BAO_0000218,1969.0,
10631,Cavia porcellus,CHEMBL876808,Intermediate,Plasma,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,N,10141.0,15240,50512,1,,,BAO_0000218,1969.0,
10632,,CHEMBL627725,Autocuration,Brain,AUC in brain,,U,,10655,22224,1,,,BAO_0000019,955.0,
10633,,CHEMBL627726,Autocuration,Serum,AUC in serum,,U,,10655,22224,1,,,BAO_0000019,1977.0,
10634,,CHEMBL627727,Autocuration,Plasma,AUC was determined,,U,,6504,22224,1,,,BAO_0000019,1969.0,
10635,,CHEMBL627728,Autocuration,Plasma,AUC of the compound.,,U,,10615,22224,1,,,BAO_0000019,1969.0,
10636,,CHEMBL627729,Autocuration,Plasma,AUC value (0-4 hr),,U,,10353,22224,1,,,BAO_0000019,1969.0,
10637,,CHEMBL627730,Autocuration,Plasma,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,U,,14907,22224,1,,,BAO_0000019,1969.0,
10638,,CHEMBL627731,Autocuration,Plasma,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,U,,14907,22224,1,,,BAO_0000019,1969.0,
10639,,CHEMBL627732,Autocuration,Plasma,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,U,,14907,22224,1,,,BAO_0000019,1969.0,
10640,,CHEMBL627733,Autocuration,Plasma,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,U,,14907,22224,1,,,BAO_0000019,1969.0,
10641,Rattus norvegicus,CHEMBL627734,Intermediate,Plasma,AUC(area under curve) was determined after intravenous administration in rats,,N,10116.0,16359,50597,1,,,BAO_0000218,1969.0,
10642,Rattus norvegicus,CHEMBL627735,Intermediate,Plasma,AUC(area under curve) was determined after oral administration in rats,,N,10116.0,16359,50597,1,,,BAO_0000218,1969.0,
10643,Cavia porcellus,CHEMBL627736,Intermediate,Plasma,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,N,10141.0,15240,50512,1,,,BAO_0000218,1969.0,
10644,Rattus norvegicus,CHEMBL876809,Intermediate,Plasma,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,N,10116.0,15240,50597,1,,,BAO_0000218,1969.0,
10645,,CHEMBL627737,Autocuration,,Area Under Curve after oral dosing of 100 uM/Kg,,U,,15469,22224,1,,,BAO_0000019,,
10646,,CHEMBL627738,Autocuration,,Area Under Curve after oral dosing of 30 uM/Kg,,U,,15469,22224,1,,,BAO_0000019,,
10647,,CHEMBL627739,Autocuration,,Area Under Curve was measured by ploting the graph between concentration verses time,,U,,13520,22224,1,,,BAO_0000019,,
10648,Canis lupus familiaris,CHEMBL626143,Intermediate,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,N,9615.0,17025,50588,1,,,BAO_0000218,,
10649,Simiiformes,CHEMBL626144,Autocuration,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,U,314293.0,17025,22224,1,,,BAO_0000218,,
10650,Oryctolagus cuniculus,CHEMBL626145,Intermediate,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,N,9986.0,17025,50592,1,,,BAO_0000218,,
10651,Rattus norvegicus,CHEMBL626146,Intermediate,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,N,10116.0,17025,50597,1,,,BAO_0000218,,
10652,Rattus norvegicus,CHEMBL626147,Intermediate,Blood,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,N,10116.0,12032,50597,1,,,BAO_0000218,178.0,
10653,,CHEMBL626148,Autocuration,,Area under curve (AUC) was determined,,U,,10291,22224,1,,,BAO_0000019,,
10654,,CHEMBL626149,Autocuration,,Area under curve (AUC) following ip administration at 1 mg/kg,,U,,5767,22224,1,,,BAO_0000218,,
10655,,CHEMBL626150,Autocuration,,Area under curve (AUC) was determined; ND is Not determined,,U,,1434,22224,1,,,BAO_0000019,,
10656,Canis lupus familiaris,CHEMBL626151,Intermediate,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,N,9615.0,14925,50588,1,,,BAO_0000218,,
10657,Canis lupus familiaris,CHEMBL626152,Intermediate,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,N,9615.0,14925,50588,1,,,BAO_0000218,,
10658,Canis lupus familiaris,CHEMBL626153,Intermediate,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,N,9615.0,14925,50588,1,,,BAO_0000218,,
10659,,CHEMBL626154,Autocuration,,Area under curve (AUR) was determined,,U,,1434,22224,1,,,BAO_0000019,,
10660,,CHEMBL626155,Autocuration,,Area under curve at 1 uM/dg administered intravenously,,U,,11883,22224,1,,,BAO_0000019,,
10661,,CHEMBL626156,Autocuration,,Area under curve at 10 uM/dg administered perorally,,U,,11883,22224,1,,,BAO_0000019,,
10662,,CHEMBL626157,Autocuration,,Area under curve at 2 uM/dg administered intravenously,,U,,11883,22224,1,,,BAO_0000019,,
10663,,CHEMBL626158,Autocuration,,Area under curve at 20 uM/dg administered perorally,,U,,11883,22224,1,,,BAO_0000019,,
10664,Canis lupus familiaris,CHEMBL626159,Intermediate,,Area under curve at a peroral dose of 3 mg/kg in dog,,N,9615.0,15233,50588,1,,,BAO_0000218,,
10665,Rattus norvegicus,CHEMBL626160,Intermediate,,Area under curve at a peroral dose of 3 mg/kg in rat,,N,10116.0,15233,50597,1,,,BAO_0000218,,
10666,Canis lupus familiaris,CHEMBL626161,Intermediate,,Area under curve at an iv dose of 1 mg/kg in dog,,N,9615.0,15233,50588,1,,,BAO_0000218,,
10667,Rattus norvegicus,CHEMBL626162,Intermediate,,Area under curve at an iv dose of 1 mg/kg in rat,,N,10116.0,15233,50597,1,,,BAO_0000218,,
10668,,CHEMBL626163,Autocuration,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,U,,12978,22224,1,,,BAO_0000019,,
10669,,CHEMBL626164,Autocuration,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,U,,12978,22224,1,,,BAO_0000019,,
10670,Mus musculus,CHEMBL626165,Intermediate,,Area under curve measured as conc vs time after intravenous administration to mice.,,N,10090.0,11355,50594,1,,,BAO_0000218,,
10671,Mus musculus,CHEMBL626166,Intermediate,,Area under curve measured as conc vs time after peroral administration to mice.,,N,10090.0,11355,50594,1,,,BAO_0000218,,
10672,Canis lupus familiaris,CHEMBL626167,Intermediate,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,N,9615.0,12923,50588,1,,,BAO_0000218,,
10673,Canis lupus familiaris,CHEMBL626168,Intermediate,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,N,9615.0,12923,50588,1,,,BAO_0000218,,
10674,Canis lupus familiaris,CHEMBL877463,Intermediate,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,N,9615.0,12923,50588,1,,,BAO_0000218,,
10675,Canis lupus familiaris,CHEMBL626169,Intermediate,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,N,9615.0,12923,50588,1,,,BAO_0000218,,
10676,Rattus norvegicus,CHEMBL626170,Intermediate,Heart,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,948.0,
10677,Rattus norvegicus,CHEMBL626171,Intermediate,Heart,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,948.0,
10678,Rattus norvegicus,CHEMBL626172,Intermediate,Heart,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,948.0,
10679,Rattus norvegicus,CHEMBL626173,Intermediate,Heart,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,948.0,
10680,Rattus norvegicus,CHEMBL626174,Intermediate,Kidney,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2113.0,
10681,Rattus norvegicus,CHEMBL626175,Intermediate,Kidney,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2113.0,
10682,Rattus norvegicus,CHEMBL626176,Intermediate,Kidney,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2113.0,
10683,Rattus norvegicus,CHEMBL626177,Intermediate,Kidney,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2113.0,
10684,Rattus norvegicus,CHEMBL622499,Intermediate,Kidney,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2113.0,
10685,Rattus norvegicus,CHEMBL622500,Intermediate,Liver,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2107.0,
10686,Rattus norvegicus,CHEMBL622501,Intermediate,Liver,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2107.0,
10687,Rattus norvegicus,CHEMBL622502,Intermediate,Liver,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2107.0,
10688,Rattus norvegicus,CHEMBL622503,Intermediate,Liver,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2107.0,
10689,Rattus norvegicus,CHEMBL877614,Intermediate,Liver,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2107.0,
10690,Rattus norvegicus,CHEMBL624839,Intermediate,Lung,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2048.0,
10691,Rattus norvegicus,CHEMBL624840,Intermediate,Lung,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2048.0,
10692,Rattus norvegicus,CHEMBL624841,Intermediate,Lung,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2048.0,
10693,Rattus norvegicus,CHEMBL624842,Intermediate,Lung,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2048.0,
10694,Rattus norvegicus,CHEMBL624843,Intermediate,Muscle tissue,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2385.0,
10695,Rattus norvegicus,CHEMBL624844,Intermediate,Muscle tissue,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2385.0,
10696,Rattus norvegicus,CHEMBL624845,Intermediate,Muscle tissue,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2385.0,
10697,Rattus norvegicus,CHEMBL621904,Intermediate,Muscle tissue,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,N,10116.0,17738,50597,1,,,BAO_0000218,2385.0,
10698,Rattus norvegicus,CHEMBL621905,Intermediate,Blood,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,178.0,
10699,Rattus norvegicus,CHEMBL874382,Intermediate,Blood,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,178.0,
10700,Rattus norvegicus,CHEMBL621906,Intermediate,Blood,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,178.0,
10701,Rattus norvegicus,CHEMBL621907,Intermediate,Brain,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,955.0,
10702,Rattus norvegicus,CHEMBL622096,Intermediate,Brain,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,955.0,
10703,Rattus norvegicus,CHEMBL622097,Intermediate,Brain,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,955.0,
10704,Rattus norvegicus,CHEMBL622098,Intermediate,Heart,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,948.0,
10705,Rattus norvegicus,CHEMBL622099,Intermediate,Heart,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,948.0,
10706,Rattus norvegicus,CHEMBL622100,Intermediate,Heart,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,948.0,
10707,Rattus norvegicus,CHEMBL622101,Intermediate,Kidney,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2113.0,
10708,Rattus norvegicus,CHEMBL622102,Intermediate,Kidney,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2113.0,
10709,Rattus norvegicus,CHEMBL622103,Intermediate,Kidney,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2113.0,
10710,Rattus norvegicus,CHEMBL622104,Intermediate,Liver,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2107.0,
10711,Rattus norvegicus,CHEMBL622105,Intermediate,Liver,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2107.0,
10712,Rattus norvegicus,CHEMBL622106,Intermediate,Liver,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2107.0,
10713,Rattus norvegicus,CHEMBL622107,Intermediate,Lung,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2048.0,
10714,Rattus norvegicus,CHEMBL622108,Intermediate,Lung,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2048.0,
10715,Rattus norvegicus,CHEMBL622109,Intermediate,Lung,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2048.0,
10716,Rattus norvegicus,CHEMBL622110,Intermediate,Muscle tissue,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2385.0,
10717,Rattus norvegicus,CHEMBL622111,Intermediate,Muscle tissue,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2385.0,
10718,Rattus norvegicus,CHEMBL874383,Intermediate,Muscle tissue,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2385.0,
10719,Rattus norvegicus,CHEMBL622112,Intermediate,Zone of skin,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,14.0,
10720,Rattus norvegicus,CHEMBL622113,Intermediate,Zone of skin,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,14.0,
10721,Rattus norvegicus,CHEMBL622114,Intermediate,Zone of skin,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,14.0,
10722,Rattus norvegicus,CHEMBL622115,Intermediate,Spleen,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2106.0,
10723,Rattus norvegicus,CHEMBL622116,Intermediate,Spleen,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,N,10116.0,11195,50597,1,,,BAO_0000218,2106.0,
10724,Rattus norvegicus,CHEMBL622117,Intermediate,,Oral bioavailability in rat,,N,10116.0,6193,50597,1,,,BAO_0000218,,
10725,Rattus norvegicus,CHEMBL622118,Intermediate,,Oral bioavailability in rat,,N,10116.0,6803,50597,1,,,BAO_0000218,,
10726,Rattus norvegicus,CHEMBL622119,Intermediate,,Oral bioavailability in rats at 6 mg/kg,,N,10116.0,6647,50597,1,,,BAO_0000218,,
10727,Rattus norvegicus,CHEMBL622120,Intermediate,,Oral bioavailability in rat (dose 6 mg/kg),,N,10116.0,6647,50597,1,,,BAO_0000218,,
10728,Rattus norvegicus,CHEMBL622121,Intermediate,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,N,10116.0,6647,50597,1,,,BAO_0000218,,
10729,Rattus norvegicus,CHEMBL622122,Intermediate,,Oral bioavailability in rat,,N,10116.0,6640,50597,1,,,BAO_0000218,,
10730,Rattus norvegicus,CHEMBL622123,Intermediate,,Oral bioavailability in rat,,N,10116.0,6641,50597,1,,,BAO_0000218,,
10731,Rattus norvegicus,CHEMBL622124,Intermediate,,Oral bioavailability in rat,,N,10116.0,6641,50597,1,,,BAO_0000218,,
10732,Rattus norvegicus,CHEMBL622125,Intermediate,,Bioavailability in rat,,N,10116.0,6642,50597,1,,,BAO_0000218,,
10733,Rattus norvegicus,CHEMBL622126,Intermediate,,Oral bioavailability,,N,10116.0,5472,50597,1,,,BAO_0000218,,
10734,Rattus norvegicus,CHEMBL620455,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,N,10116.0,6141,50597,1,,,BAO_0000218,,
10735,Rattus norvegicus,CHEMBL620456,Intermediate,,Oral bioavailability in rat,,N,10116.0,4390,50597,1,,,BAO_0000218,,
10736,Rattus norvegicus,CHEMBL620457,Intermediate,,Oral bioavailability in rat,,N,10116.0,5472,50597,1,,,BAO_0000218,,
10737,Rattus norvegicus,CHEMBL620458,Intermediate,,Oral bioavailability was evaluated; Not tested,,N,10116.0,5472,50597,1,,,BAO_0000218,,
10738,Rattus norvegicus,CHEMBL620459,Intermediate,,Oral bioavailability,,N,10116.0,5438,50597,1,,,BAO_0000218,,
10739,Rattus norvegicus,CHEMBL620460,Intermediate,,Oral bioavailability in rat by oral dosing,,N,10116.0,4883,50597,1,,,BAO_0000218,,
10740,Rattus norvegicus,CHEMBL620461,Intermediate,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,N,10116.0,1908,50597,1,,,BAO_0000218,,
10741,Rattus norvegicus,CHEMBL620462,Intermediate,,Oral bioavailability in rat (Sprague-Dawley),,N,10116.0,4853,50597,1,,,BAO_0000218,,
10742,Rattus norvegicus,CHEMBL620463,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,10116.0,4853,50597,1,,,BAO_0000218,,
10743,Rattus norvegicus,CHEMBL620464,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,10116.0,4853,50597,1,,,BAO_0000218,,
10744,Rattus norvegicus,CHEMBL620465,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,N,10116.0,4853,50597,1,,,BAO_0000218,,
10745,Rattus norvegicus,CHEMBL620466,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,N,10116.0,4853,50597,1,,,BAO_0000218,,
10746,Rattus norvegicus,CHEMBL620467,Intermediate,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,N,10116.0,4853,50597,1,,,BAO_0000218,,
10747,Rattus norvegicus,CHEMBL620468,Intermediate,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,N,10116.0,4853,50597,1,,,BAO_0000218,,
10748,Rattus norvegicus,CHEMBL620469,Intermediate,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,N,10116.0,12873,50597,1,,,BAO_0000218,,
10749,Rattus norvegicus,CHEMBL620470,Intermediate,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,N,10116.0,12873,50597,1,,,BAO_0000218,,
10750,Rattus norvegicus,CHEMBL620471,Intermediate,,Oral bioavailability in rat,,N,10116.0,3169,50597,1,,,BAO_0000218,,
10751,Rattus norvegicus,CHEMBL620472,Intermediate,,Oral bioavailability in rat,,N,10116.0,6305,50597,1,,,BAO_0000218,,
10752,Rattus norvegicus,CHEMBL620473,Intermediate,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,N,10116.0,4762,50597,1,,,BAO_0000218,,
10753,Rattus norvegicus,CHEMBL620474,Intermediate,,Oral bioavailability in rat,,N,10116.0,17847,50597,1,,,BAO_0000218,,
10754,Rattus norvegicus,CHEMBL620475,Intermediate,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,N,10116.0,6211,50597,1,,,BAO_0000218,,
10755,Rattus norvegicus,CHEMBL620476,Intermediate,,Oral bioavailability in rat,,N,10116.0,6011,50597,1,,,BAO_0000218,,
10756,Rattus norvegicus,CHEMBL620477,Intermediate,,Oral bioavailability in rat,,N,10116.0,6317,50597,1,,,BAO_0000218,,
10757,Rattus norvegicus,CHEMBL620478,Intermediate,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,N,10116.0,6644,50597,1,,,BAO_0000218,,
10758,Rattus norvegicus,CHEMBL618768,Intermediate,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,N,10116.0,6644,50597,1,,,BAO_0000218,,
10759,Rattus norvegicus,CHEMBL618769,Intermediate,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,N,10116.0,6644,50597,1,,,BAO_0000218,,
10760,Rattus norvegicus,CHEMBL618770,Intermediate,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,N,10116.0,6644,50597,1,,,BAO_0000218,,
10761,Rattus norvegicus,CHEMBL618771,Intermediate,,Oral bioavailability (dose 20 mg/kg p.o.),,N,10116.0,6113,50597,1,,,BAO_0000218,,
10762,Rattus norvegicus,CHEMBL618772,Intermediate,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,N,10116.0,5937,50597,1,,,BAO_0000218,,
10763,Rattus norvegicus,CHEMBL618773,Intermediate,,Oral bioavailability in rat at 10 mg/kg of the compound,,N,10116.0,5711,50597,1,,,BAO_0000218,,
10764,Rattus norvegicus,CHEMBL875842,Intermediate,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,N,10116.0,17717,50597,1,,,BAO_0000218,,
10765,Rattus norvegicus,CHEMBL618774,Intermediate,,Bioavailability in rat (dose 3 mg/kg i.v.),,N,10116.0,17717,50597,1,,,BAO_0000218,,
10766,Rattus norvegicus,CHEMBL618775,Intermediate,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,N,10116.0,17717,50597,1,,,BAO_0000218,,
10767,Rattus norvegicus,CHEMBL618776,Intermediate,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,N,10116.0,17717,50597,1,,,BAO_0000218,,
10768,Rattus norvegicus,CHEMBL618777,Intermediate,,Percent bioavailability (F) in rats after iv administration,,N,10116.0,4722,50597,1,,,BAO_0000218,,
10769,Rattus norvegicus,CHEMBL618778,Intermediate,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,N,10116.0,4722,50597,1,,,BAO_0000218,,
10770,Rattus norvegicus,CHEMBL618779,Intermediate,,Bioavailability in rat (dose 5 uM/kg p.o.),,N,10116.0,4353,50597,1,,,BAO_0000218,,
10771,Rattus norvegicus,CHEMBL618780,Intermediate,,Oral bioavailability,,N,10116.0,15662,50597,1,,,BAO_0000218,,
10772,Rattus norvegicus,CHEMBL618781,Intermediate,,Bioavailability in rat (dose 2 mg/kg p.o.),,N,10116.0,4756,50597,1,,,BAO_0000218,,
10773,Rattus norvegicus,CHEMBL618782,Intermediate,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,N,10116.0,4756,50597,1,,,BAO_0000218,,
10774,Rattus norvegicus,CHEMBL618783,Intermediate,,Oral bioavailability in rat (dose 20 mg/kg),,N,10116.0,3436,50597,1,,,BAO_0000218,,
10775,Rattus norvegicus,CHEMBL618784,Intermediate,,Oral bioavailability in rat,,N,10116.0,17800,50597,1,,,BAO_0000218,,
10776,Rattus norvegicus,CHEMBL618785,Intermediate,,Percent oral bioavailability evaluated in rat,,N,10116.0,15762,50597,1,,,BAO_0000218,,
10777,Rattus norvegicus,CHEMBL618786,Intermediate,,Oral bioavailability in rat,,N,10116.0,5089,50597,1,,,BAO_0000218,,
10778,Rattus norvegicus,CHEMBL618787,Intermediate,,Percent oral bioavailability in rat; Not determined,,N,10116.0,5089,50597,1,,,BAO_0000218,,
10779,Rattus norvegicus,CHEMBL618788,Intermediate,,Oral bioavailability in rat,,N,10116.0,3185,50597,1,,,BAO_0000218,,
10780,Rattus norvegicus,CHEMBL618789,Intermediate,,Bioavailability in rat,,N,10116.0,5145,50597,1,,,BAO_0000218,,
10781,Rattus norvegicus,CHEMBL618790,Intermediate,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,N,10116.0,3457,50597,1,,,BAO_0000218,,
10782,Rattus norvegicus,CHEMBL618791,Intermediate,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,N,10116.0,3457,50597,1,,,BAO_0000218,,
10783,Rattus norvegicus,CHEMBL875843,Intermediate,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,N,10116.0,5983,50597,1,,,BAO_0000218,,
10784,Rattus norvegicus,CHEMBL618792,Intermediate,,Oral bioavailability in rat (dose 20 mg/kg p.o.),,N,10116.0,5739,50597,1,,,BAO_0000218,,
10785,Rattus norvegicus,CHEMBL623395,Intermediate,,Cmax at a dose of 30 mg/kg in rat,,N,10116.0,3579,50597,1,,,BAO_0000218,,
10786,Simiiformes,CHEMBL623396,Autocuration,,Cmax in monkeys at a dose of 1 mg/kg,,U,314293.0,17788,22224,1,,,BAO_0000218,,
10787,Rattus norvegicus,CHEMBL623397,Intermediate,,Cmax in rat,,N,10116.0,14956,50597,1,,,BAO_0000218,,
10788,Rattus norvegicus,CHEMBL623398,Intermediate,,Cmax in rats at a dose of 1 mg/kg,,N,10116.0,17788,50597,1,,,BAO_0000218,,
10789,Mus musculus,CHEMBL623399,Intermediate,,Cmax was measured in mice after an oral dose of 50 mg/kg.,,N,10090.0,9750,50594,1,,,BAO_0000218,,
10790,,CHEMBL623400,Autocuration,,"Cmax value at a dose of 12.7 uM/kg, po",,U,,12767,22224,1,,,BAO_0000218,,
10791,,CHEMBL623401,Autocuration,,"Cmax value at a dose of 6.3 uM/kg, iv",,U,,12767,22224,1,,,BAO_0000218,,
10792,,CHEMBL623402,Autocuration,,"Cmax value at a dose of 7.1 uM/kg, iv",,U,,12767,22224,1,,,BAO_0000218,,
10793,,CHEMBL623403,Autocuration,,Cmax value of compound was determined after 1 hr,,U,,12703,22224,1,,,BAO_0000218,,
10794,,CHEMBL623404,Autocuration,,Cmax value of the compound,,U,,15778,22224,1,,,BAO_0000218,,
10795,Rattus norvegicus,CHEMBL625997,Intermediate,,Cmax value administered intraintestinal in rats.,,N,10116.0,12818,50597,1,,,BAO_0000218,,
10796,Rattus norvegicus,CHEMBL625998,Intermediate,,Cmax value administered perorally was determined in rat; Not determined,,N,10116.0,14964,50597,1,,,BAO_0000218,,
10797,,CHEMBL625999,Autocuration,,Cmax value at the dose of 2.3 mg/kg,,U,,15808,22224,1,,,BAO_0000218,,
10798,,CHEMBL626000,Autocuration,,Cmax value at the dose of 5 mg/kg,,U,,15808,22224,1,,,BAO_0000218,,
10799,,CHEMBL626001,Autocuration,,Cmax value in the period of 8 hr after dosing. ,,U,,15778,22224,1,,,BAO_0000218,,
10800,,CHEMBL626002,Autocuration,,Cmax value at a oral dose of 20 mg/kg; Not tested,,U,,3715,22224,1,,,BAO_0000218,,
10801,,CHEMBL626003,Autocuration,,Cmax value at a oral dose of 20 mg/kg,,U,,3715,22224,1,,,BAO_0000218,,
10802,Rattus norvegicus,CHEMBL626004,Intermediate,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,N,10116.0,1446,50597,1,,,BAO_0000218,,
10803,Cavia porcellus,CHEMBL626005,Intermediate,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,N,10141.0,15240,50512,1,,,BAO_0000218,,
10804,Rattus norvegicus,CHEMBL626006,Intermediate,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,N,10116.0,15240,50597,1,,,BAO_0000218,,
10805,Rattus norvegicus,CHEMBL626007,Intermediate,Plasma,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,N,10116.0,14810,50597,1,,,BAO_0000218,1969.0,
10806,Mus musculus,CHEMBL626008,Intermediate,Plasma,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,N,10090.0,14239,50594,1,,,BAO_0000218,1969.0,
10807,Canis lupus familiaris,CHEMBL626009,Intermediate,Liver,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,N,9615.0,12555,50588,1,,,BAO_0000218,2107.0,
10808,Canis lupus familiaris,CHEMBL626010,Intermediate,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,N,9615.0,10754,50588,1,,,BAO_0000218,,
10809,Mus musculus,CHEMBL626011,Intermediate,Blood,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,N,10090.0,10754,50594,1,,,BAO_0000218,178.0,
10810,Mus musculus,CHEMBL626012,Intermediate,Blood,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,N,10090.0,10754,50594,1,,,BAO_0000218,178.0,
10811,Mus musculus,CHEMBL626013,Intermediate,Blood,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,N,10090.0,10754,50594,1,,,BAO_0000218,178.0,
10812,Mus musculus,CHEMBL626014,Intermediate,Blood,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,N,10090.0,10754,50594,1,,,BAO_0000218,178.0,
10813,Mus musculus,CHEMBL877496,Intermediate,Blood,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,N,10090.0,10754,50594,1,,,BAO_0000218,178.0,
10814,Canis lupus familiaris,CHEMBL626015,Intermediate,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,N,9615.0,14600,50588,1,,,BAO_0000218,,
10815,Canis lupus familiaris,CHEMBL626016,Intermediate,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,N,9615.0,14600,50588,1,,,BAO_0000218,,
10816,Canis lupus familiaris,CHEMBL626017,Intermediate,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,N,9615.0,14600,50588,1,,,BAO_0000218,,
10817,Canis lupus familiaris,CHEMBL626018,Intermediate,Plasma,Bioavailability as maximal plasma concentration in dogs,,N,9615.0,13543,50588,1,,,BAO_0000218,1969.0,
10818,Canis lupus familiaris,CHEMBL626692,Intermediate,Plasma,Bioavailability as maximal plasma concentration in dogs,,N,9615.0,13543,50588,1,,,BAO_0000218,1969.0,
10819,Rattus norvegicus,CHEMBL626693,Intermediate,Plasma,Bioavailability as maximal plasma concentration in rats,,N,10116.0,13543,50597,1,,,BAO_0000218,1969.0,
10820,Rattus norvegicus,CHEMBL626694,Autocuration,Plasma,Bioavailability as maximal plasma concentration in rats,,U,10116.0,13543,22224,1,,,BAO_0000218,1969.0,
10821,Canis lupus familiaris,CHEMBL626695,Intermediate,Blood,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,9615.0,14600,50588,1,,,BAO_0000218,178.0,
10822,Canis lupus familiaris,CHEMBL626696,Intermediate,Blood,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,9615.0,14600,50588,1,,,BAO_0000218,178.0,
10823,Canis lupus familiaris,CHEMBL626697,Intermediate,Blood,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,9615.0,14600,50588,1,,,BAO_0000218,178.0,
10824,Canis lupus familiaris,CHEMBL626859,Intermediate,Blood,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,N,9615.0,14600,50588,1,,,BAO_0000218,178.0,
10825,Canis lupus familiaris,CHEMBL626860,Intermediate,Blood,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,9615.0,14600,50588,1,,,BAO_0000218,178.0,
10826,Canis lupus familiaris,CHEMBL626861,Intermediate,Blood,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,9615.0,14600,50588,1,,,BAO_0000218,178.0,
10827,Rattus norvegicus,CHEMBL626296,Intermediate,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,N,10116.0,14681,50597,1,,,BAO_0000218,,
10828,,CHEMBL626297,Autocuration,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,U,,15905,22224,1,,,BAO_0000218,,
10829,,CHEMBL626298,Autocuration,Plasma,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,U,,15905,22224,1,,,BAO_0000218,1969.0,
10830,Rattus norvegicus,CHEMBL626299,Intermediate,Plasma,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,N,10116.0,13304,50597,1,,,BAO_0000218,1969.0,
10831,Rattus norvegicus,CHEMBL626300,Intermediate,Plasma,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,N,10116.0,15137,50597,1,,,BAO_0000218,1969.0,
10832,Rattus norvegicus,CHEMBL626301,Intermediate,Plasma,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,N,10116.0,15137,50597,1,,,BAO_0000218,1969.0,
10833,Rattus norvegicus,CHEMBL626962,Intermediate,Plasma,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,N,10116.0,15137,50597,1,,,BAO_0000218,1969.0,
10834,Rattus norvegicus,CHEMBL626963,Intermediate,Plasma,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,N,10116.0,15137,50597,1,,,BAO_0000218,1969.0,
10835,Rattus norvegicus,CHEMBL626964,Intermediate,Plasma,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,N,10116.0,15137,50597,1,,,BAO_0000218,1969.0,
10836,Macaca fascicularis,CHEMBL626965,Intermediate,Plasma,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,N,9541.0,14839,100710,1,,,BAO_0000218,1969.0,
10837,Mus musculus,CHEMBL626966,Intermediate,Plasma,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,10090.0,14839,50594,1,,,BAO_0000218,1969.0,
10838,Mus musculus,CHEMBL626967,Intermediate,Plasma,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,10090.0,14839,50594,1,,,BAO_0000218,1969.0,
10839,Macaca fascicularis,CHEMBL626968,Intermediate,Plasma,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,N,9541.0,14839,100710,1,,,BAO_0000218,1969.0,
10840,Rattus norvegicus,CHEMBL626969,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10841,Rattus norvegicus,CHEMBL627126,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10842,Rattus norvegicus,CHEMBL631276,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10843,Rattus norvegicus,CHEMBL631277,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10844,Rattus norvegicus,CHEMBL631278,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10845,Rattus norvegicus,CHEMBL874457,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10846,Rattus norvegicus,CHEMBL631279,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10847,Rattus norvegicus,CHEMBL631280,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10848,Rattus norvegicus,CHEMBL631281,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10849,Rattus norvegicus,CHEMBL631968,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10850,Rattus norvegicus,CHEMBL631969,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10851,Rattus norvegicus,CHEMBL631970,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10852,Rattus norvegicus,CHEMBL631971,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10853,Rattus norvegicus,CHEMBL631972,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10854,Rattus norvegicus,CHEMBL630435,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10855,Rattus norvegicus,CHEMBL630436,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10856,Rattus norvegicus,CHEMBL630437,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10857,Rattus norvegicus,CHEMBL630438,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10858,Rattus norvegicus,CHEMBL630439,Intermediate,Heart,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,N,10116.0,8418,50597,1,,,BAO_0000218,948.0,
10859,Rattus norvegicus,CHEMBL630440,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10860,Rattus norvegicus,CHEMBL630441,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10861,Rattus norvegicus,CHEMBL630442,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10862,Rattus norvegicus,CHEMBL625234,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10863,Rattus norvegicus,CHEMBL625235,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10864,Rattus norvegicus,CHEMBL625236,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10865,Rattus norvegicus,CHEMBL625237,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10866,Rattus norvegicus,CHEMBL626125,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10867,Rattus norvegicus,CHEMBL626126,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10868,Rattus norvegicus,CHEMBL626127,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10869,Rattus norvegicus,CHEMBL626128,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10870,Rattus norvegicus,CHEMBL626129,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10871,Rattus norvegicus,CHEMBL626130,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10872,Rattus norvegicus,CHEMBL626131,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10873,Rattus norvegicus,CHEMBL626132,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10874,Rattus norvegicus,CHEMBL626752,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10875,Rattus norvegicus,CHEMBL626753,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10876,Rattus norvegicus,CHEMBL626754,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10877,Rattus norvegicus,CHEMBL626755,Intermediate,Kidney,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,N,10116.0,8418,50597,1,,,BAO_0000218,2113.0,
10878,Rattus norvegicus,CHEMBL626756,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
10879,Rattus norvegicus,CHEMBL626757,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
10880,Rattus norvegicus,CHEMBL626758,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
10881,Rattus norvegicus,CHEMBL626759,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
10882,Rattus norvegicus,CHEMBL626760,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
10883,Canis lupus familiaris,CHEMBL626394,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10884,Canis lupus familiaris,CHEMBL626395,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,N,9615.0,6996,50588,1,,,BAO_0000218,,
10885,Canis lupus familiaris,CHEMBL626396,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10886,Canis lupus familiaris,CHEMBL626397,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10887,Canis lupus familiaris,CHEMBL626398,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10888,Canis lupus familiaris,CHEMBL626399,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10889,Rattus norvegicus,CHEMBL874653,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,N,10116.0,6996,50597,1,,,BAO_0000218,,
10890,Rattus norvegicus,CHEMBL626400,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10891,Rattus norvegicus,CHEMBL626401,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10892,Rattus norvegicus,CHEMBL626402,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10893,Rattus norvegicus,CHEMBL626403,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10894,Rattus norvegicus,CHEMBL626404,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10895,Rattus norvegicus,CHEMBL626405,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,N,10116.0,6996,50597,1,,,BAO_0000218,,
10896,Rattus norvegicus,CHEMBL625529,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10897,Rattus norvegicus,CHEMBL625530,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10898,Rattus norvegicus,CHEMBL625531,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10899,Rattus norvegicus,CHEMBL625532,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10900,Rattus norvegicus,CHEMBL625533,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10901,Rattus norvegicus,CHEMBL875474,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,N,10116.0,6996,50597,1,,,BAO_0000218,,
10902,Rattus norvegicus,CHEMBL625534,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10903,Rattus norvegicus,CHEMBL625535,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10904,Rattus norvegicus,CHEMBL625536,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10905,Rattus norvegicus,CHEMBL625537,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10906,Rattus norvegicus,CHEMBL625538,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10907,Rattus norvegicus,CHEMBL625539,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,N,10116.0,6996,50597,1,,,BAO_0000218,,
10908,Rattus norvegicus,CHEMBL625540,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10909,Rattus norvegicus,CHEMBL625541,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10910,Rattus norvegicus,CHEMBL625542,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10911,Rattus norvegicus,CHEMBL625543,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10912,Rattus norvegicus,CHEMBL625544,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
10913,Canis lupus familiaris,CHEMBL625545,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,N,9615.0,6996,50588,1,,,BAO_0000218,,
10914,Canis lupus familiaris,CHEMBL625546,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10915,Canis lupus familiaris,CHEMBL625547,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,N,9615.0,6996,50588,1,,,BAO_0000218,,
10916,Canis lupus familiaris,CHEMBL625548,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10917,Canis lupus familiaris,CHEMBL625549,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10918,Canis lupus familiaris,CHEMBL625550,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10919,Canis lupus familiaris,CHEMBL625551,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10920,Canis lupus familiaris,CHEMBL875475,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10921,Canis lupus familiaris,CHEMBL625552,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10922,Canis lupus familiaris,CHEMBL625553,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10923,Canis lupus familiaris,CHEMBL625554,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10924,Canis lupus familiaris,CHEMBL625555,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10925,Canis lupus familiaris,CHEMBL625556,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10926,Canis lupus familiaris,CHEMBL624986,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,N,9615.0,6996,50588,1,,,BAO_0000218,,
10927,Canis lupus familiaris,CHEMBL624987,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10928,Canis lupus familiaris,CHEMBL624988,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
10929,Canis lupus familiaris,CHEMBL624989,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10930,Canis lupus familiaris,CHEMBL624990,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10931,Canis lupus familiaris,CHEMBL874391,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10932,Canis lupus familiaris,CHEMBL624991,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10933,Canis lupus familiaris,CHEMBL624992,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10934,Canis lupus familiaris,CHEMBL624993,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10935,Canis lupus familiaris,CHEMBL624994,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10936,Canis lupus familiaris,CHEMBL624995,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10937,Canis lupus familiaris,CHEMBL624996,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10938,Canis lupus familiaris,CHEMBL624997,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10939,Canis lupus familiaris,CHEMBL624998,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10940,Canis lupus familiaris,CHEMBL624999,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10941,Canis lupus familiaris,CHEMBL882955,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10942,Canis lupus familiaris,CHEMBL625000,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10943,Canis lupus familiaris,CHEMBL625001,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10944,Canis lupus familiaris,CHEMBL625089,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10945,Canis lupus familiaris,CHEMBL625090,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10946,Canis lupus familiaris,CHEMBL625091,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10947,Canis lupus familiaris,CHEMBL625092,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10948,Canis lupus familiaris,CHEMBL625093,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10949,Canis lupus familiaris,CHEMBL625094,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10950,Canis lupus familiaris,CHEMBL625095,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
10951,Canis lupus familiaris,CHEMBL625096,Intermediate,,Compound was evaluated for its bioavailability in the dogs,,N,9615.0,2249,50588,1,,,BAO_0000218,,
10952,Rattus norvegicus,CHEMBL625097,Intermediate,,Compound was evaluated for its bioavailability in the rats,,N,10116.0,2249,50597,1,,,BAO_0000218,,
10953,,CHEMBL882956,Autocuration,,Compound was evaluated for oral bioavailability,,U,,17515,22224,1,,,BAO_0000218,,
10954,Rattus norvegicus,CHEMBL625098,Intermediate,,Compound was evaluated for percentage of Oral bioavailability in rats,,N,10116.0,14541,50597,1,,,BAO_0000218,,
10955,Cavia porcellus,CHEMBL625099,Autocuration,,Bioavailability in guinea pig,,U,10141.0,12797,22224,1,,,BAO_0000218,,
10956,Rattus norvegicus,CHEMBL625100,Intermediate,,Compound was evaluated for the oral bioavailability in rat,,N,10116.0,12797,50597,1,,,BAO_0000218,,
10957,Canis lupus familiaris,CHEMBL625101,Intermediate,,Compound was evaluated for the oral bioavailability in dog,,N,9615.0,12797,50588,1,,,BAO_0000218,,
10958,Rattus norvegicus,CHEMBL874396,Intermediate,,Compound was evaluated for the oral bioavailability in rat,,N,10116.0,12797,50597,1,,,BAO_0000218,,
10959,Canis lupus familiaris,CHEMBL625102,Autocuration,,Bioavailability in dog (dosed i.v.),,U,9615.0,11727,22224,1,,,BAO_0000218,,
10960,Canis lupus familiaris,CHEMBL625103,Intermediate,,Compound was tested for in vivo bioavailability in dog,,N,9615.0,13249,50588,1,,,BAO_0000218,,
10961,Cricetinae,CHEMBL625104,Intermediate,,Compound was tested for in vivo bioavailability in hamsters,,N,10026.0,13249,100712,1,,,BAO_0000218,,
10962,Simiiformes,CHEMBL625105,Autocuration,,Compound was tested for in vivo bioavailability in monkey,,U,314293.0,13249,22224,1,,,BAO_0000218,,
10963,Rattus norvegicus,CHEMBL625106,Intermediate,,Compound was tested for in vivo bioavailability in rat,,N,10116.0,13249,50597,1,,,BAO_0000218,,
10964,Mus musculus,CHEMBL625107,Autocuration,,Oral bioavailability in mouse,,U,10090.0,9552,22224,1,,,BAO_0000218,,
10965,Mus musculus,CHEMBL625108,Intermediate,,Compound was tested for percent of oral bioavailability in mice; 56-74,,N,10090.0,9552,50594,1,,,BAO_0000218,,
10966,Mus musculus,CHEMBL625109,Autocuration,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,U,10090.0,14839,22224,1,,,BAO_0000218,,
10967,Macaca fascicularis,CHEMBL625110,Autocuration,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,U,9541.0,14839,22224,1,,,BAO_0000218,,
10968,Macaca fascicularis,CHEMBL625111,Autocuration,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,U,9541.0,14839,22224,1,,,BAO_0000218,,
10969,Mus musculus,CHEMBL625112,Intermediate,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,N,10090.0,14839,50594,1,,,BAO_0000218,,
10970,Mus musculus,CHEMBL875334,Intermediate,,Oral bioavailability in nude mice,,N,10090.0,14839,50594,1,,,BAO_0000218,,
10971,Primates,CHEMBL628617,Autocuration,,Bioavailability in monkey (i.d. dosing),,U,9443.0,11219,22224,1,,,BAO_0000218,,
10972,Rattus norvegicus,CHEMBL628618,Autocuration,,Bioavailability in rat,,U,10116.0,9552,22224,1,,,BAO_0000218,,
10973,,CHEMBL628619,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,U,,11732,22224,1,,,BAO_0000218,,
10974,,CHEMBL628620,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,U,,11732,22224,1,,,BAO_0000218,,
10975,Macaca fascicularis,CHEMBL628621,Intermediate,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,N,9541.0,14839,100710,1,,,BAO_0000218,,
10976,Macaca fascicularis,CHEMBL628622,Intermediate,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,N,9541.0,14839,100710,1,,,BAO_0000218,,
10977,Macaca fascicularis,CHEMBL628623,Intermediate,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,N,9541.0,14839,100710,1,,,BAO_0000218,,
10978,Macaca fascicularis,CHEMBL628624,Intermediate,Plasma,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,N,9541.0,14839,100710,1,,,BAO_0000218,1969.0,
10979,Mus musculus,CHEMBL628625,Intermediate,Plasma,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,10090.0,14839,50594,1,,,BAO_0000218,1969.0,
10980,Macaca fascicularis,CHEMBL628626,Intermediate,Plasma,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,N,9541.0,14839,100710,1,,,BAO_0000218,1969.0,
10981,Mus musculus,CHEMBL627041,Intermediate,Plasma,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,10090.0,14839,50594,1,,,BAO_0000218,1969.0,
10982,Mus musculus,CHEMBL627042,Intermediate,Plasma,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,10090.0,14839,50594,1,,,BAO_0000218,1969.0,
10983,Mus musculus,CHEMBL627043,Intermediate,Plasma,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,10090.0,14839,50594,1,,,BAO_0000218,1969.0,
10984,,CHEMBL627044,Autocuration,Plasma,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,U,,13932,22224,1,,,BAO_0000218,1969.0,
10985,Mus musculus,CHEMBL627045,Intermediate,Plasma,Cmax in mouse plasma,,N,10090.0,11637,50594,1,,,BAO_0000218,1969.0,
10986,,CHEMBL627046,Autocuration,Plasma,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,U,,11637,22224,1,,,BAO_0000218,1969.0,
10987,Rattus norvegicus,CHEMBL627047,Intermediate,Plasma,Maximal plasma concentration in rat,,N,10116.0,13960,50597,1,,,BAO_0000218,1969.0,
10988,Rattus norvegicus,CHEMBL627048,Intermediate,Plasma,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,N,10116.0,15905,50597,1,,,BAO_0000218,1969.0,
10989,Rattus norvegicus,CHEMBL627049,Intermediate,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,N,10116.0,14062,50597,1,,,BAO_0000218,,
10990,Rattus norvegicus,CHEMBL627050,Intermediate,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,N,10116.0,14062,50597,1,,,BAO_0000218,,
10991,Rattus norvegicus,CHEMBL627051,Intermediate,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,N,10116.0,14062,50597,1,,,BAO_0000218,,
10992,Rattus norvegicus,CHEMBL627052,Intermediate,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,N,10116.0,14062,50597,1,,,BAO_0000218,,
10993,Rattus norvegicus,CHEMBL627053,Intermediate,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,N,10116.0,14062,50597,1,,,BAO_0000218,,
10994,Rattus norvegicus,CHEMBL627054,Intermediate,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,N,10116.0,14062,50597,1,,,BAO_0000218,,
10995,Mus musculus,CHEMBL627055,Intermediate,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,10090.0,15011,50594,1,,,BAO_0000218,,
10996,Mus musculus,CHEMBL627056,Intermediate,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,N,10090.0,15011,50594,1,,,BAO_0000218,,
10997,Mus musculus,CHEMBL627057,Intermediate,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,N,10090.0,15011,50594,1,,,BAO_0000218,,
10998,Mus musculus,CHEMBL627058,Intermediate,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,10090.0,15011,50594,1,,,BAO_0000218,,
10999,Mus musculus,CHEMBL626211,Intermediate,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,N,10090.0,15011,50594,1,,,BAO_0000218,,
11000,,CHEMBL626212,Autocuration,,Maximum Concentration of the compound.,,U,,10291,22224,1,,,BAO_0000218,,
11001,Canis lupus familiaris,CHEMBL626213,Intermediate,,Maximum Concentration was measured after iv administration into Beagle dog,,N,9615.0,14599,50588,1,,,BAO_0000218,,
11002,Canis lupus familiaris,CHEMBL626214,Intermediate,,Maximum Concentration was measured after iv administration into Beagle dog.,,N,9615.0,14599,50588,1,,,BAO_0000218,,
11003,Canis lupus familiaris,CHEMBL626215,Intermediate,,Maximum Concentration was measured after po administration into Beagle dog,,N,9615.0,14599,50588,1,,,BAO_0000218,,
11004,Canis lupus familiaris,CHEMBL626216,Intermediate,,Maximum Concentration was measured after po administration into Beagle dog.,,N,9615.0,14599,50588,1,,,BAO_0000218,,
11005,,CHEMBL626217,Autocuration,Blood,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,U,,12767,22224,1,,,BAO_0000218,178.0,
11006,,CHEMBL626218,Autocuration,Blood,Maximum blood level reached after an iv dose of 12.2 uM/kg,,U,,12767,22224,1,,,BAO_0000218,178.0,
11007,,CHEMBL626219,Autocuration,Blood,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,U,,12767,22224,1,,,BAO_0000218,178.0,
11008,,CHEMBL626220,Autocuration,Blood,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,U,,12767,22224,1,,,BAO_0000218,178.0,
11009,,CHEMBL626221,Autocuration,Blood,Maximum blood level reached after an oral dose of 5.0 mg/kg,,U,,12767,22224,1,,,BAO_0000218,178.0,
11010,,CHEMBL626222,Autocuration,Blood,Maximum blood level reached at dose of 10.6 uM/kg orally,,U,,12767,22224,1,,,BAO_0000218,178.0,
11011,Cavia porcellus,CHEMBL626223,Intermediate,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,N,10141.0,14706,50512,1,,,BAO_0000218,,
11012,Cavia porcellus,CHEMBL626224,Intermediate,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,N,10141.0,14706,50512,1,,,BAO_0000218,,
11013,Rattus norvegicus,CHEMBL626225,Intermediate,Brain,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,N,10116.0,14793,50597,1,,,BAO_0000218,955.0,
11014,Rattus norvegicus,CHEMBL626226,Intermediate,Brain,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,N,10116.0,14793,50597,1,,,BAO_0000218,955.0,
11015,Rattus norvegicus,CHEMBL626227,Intermediate,Brain,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,N,10116.0,14793,50597,1,,,BAO_0000218,955.0,
11016,Rattus norvegicus,CHEMBL626228,Intermediate,Brain,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,N,10116.0,14793,50597,1,,,BAO_0000218,955.0,
11017,Rattus norvegicus,CHEMBL626229,Intermediate,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,N,10116.0,14793,50597,1,,,BAO_0000218,,
11018,Rattus norvegicus,CHEMBL626921,Intermediate,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,N,10116.0,14793,50597,1,,,BAO_0000218,,
11019,Rattus norvegicus,CHEMBL876793,Intermediate,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,N,10116.0,14793,50597,1,,,BAO_0000218,,
11020,Rattus norvegicus,CHEMBL625309,Intermediate,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,N,10116.0,14793,50597,1,,,BAO_0000218,,
11021,Bacillus subtilis,CHEMBL625310,Intermediate,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,N,1423.0,10524,50278,1,,,BAO_0000218,,
11022,Simiiformes,CHEMBL625311,Autocuration,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,U,314293.0,11871,22224,1,,,BAO_0000218,,
11023,Rattus norvegicus,CHEMBL625312,Intermediate,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,N,10116.0,11871,50597,1,,,BAO_0000218,,
11024,,CHEMBL625313,Autocuration,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,U,,3437,22224,1,,,BAO_0000218,,
11025,Mus musculus,CHEMBL625314,Intermediate,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,N,10090.0,12038,50594,1,,,BAO_0000218,,
11026,Rattus norvegicus,CHEMBL625315,Intermediate,,Maximum concentration in male rats after iv administration of 20 mg/kg,,N,10116.0,12038,50597,1,,,BAO_0000218,,
11027,Rattus norvegicus,CHEMBL625316,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11028,Rattus norvegicus,CHEMBL625317,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11029,Rattus norvegicus,CHEMBL625318,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11030,Rattus norvegicus,CHEMBL625319,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11031,Rattus norvegicus,CHEMBL625320,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11032,Rattus norvegicus,CHEMBL625321,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11033,Rattus norvegicus,CHEMBL625322,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11034,Rattus norvegicus,CHEMBL876801,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11035,Rattus norvegicus,CHEMBL625323,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11036,Rattus norvegicus,CHEMBL625324,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11037,Rattus norvegicus,CHEMBL625325,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11038,Rattus norvegicus,CHEMBL625326,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11039,Rattus norvegicus,CHEMBL625327,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11040,Rattus norvegicus,CHEMBL625328,Intermediate,Liver,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,N,10116.0,8418,50597,1,,,BAO_0000218,2107.0,
11041,Rattus norvegicus,CHEMBL625329,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11042,Rattus norvegicus,CHEMBL625330,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11043,Rattus norvegicus,CHEMBL627774,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11044,Rattus norvegicus,CHEMBL627775,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11045,Rattus norvegicus,CHEMBL627949,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11046,Rattus norvegicus,CHEMBL627950,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11047,Rattus norvegicus,CHEMBL627951,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11048,Rattus norvegicus,CHEMBL627952,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11049,Rattus norvegicus,CHEMBL627953,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11050,Rattus norvegicus,CHEMBL627954,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11051,Rattus norvegicus,CHEMBL627955,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11052,Rattus norvegicus,CHEMBL627956,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11053,Rattus norvegicus,CHEMBL876802,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11054,Rattus norvegicus,CHEMBL627957,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11055,Rattus norvegicus,CHEMBL627958,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11056,Rattus norvegicus,CHEMBL627959,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11057,Rattus norvegicus,CHEMBL627960,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11058,Rattus norvegicus,CHEMBL627961,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11059,Rattus norvegicus,CHEMBL627962,Intermediate,Lung,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,N,10116.0,8418,50597,1,,,BAO_0000218,2048.0,
11060,Rattus norvegicus,CHEMBL627963,Intermediate,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,,
11061,Rattus norvegicus,CHEMBL624759,Intermediate,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,,
11062,Rattus norvegicus,CHEMBL624760,Intermediate,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,,
11063,Rattus norvegicus,CHEMBL624761,Intermediate,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,,
11064,Rattus norvegicus,CHEMBL877607,Intermediate,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,,
11065,Rattus norvegicus,CHEMBL624762,Intermediate,Liver,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,2107.0,
11066,Rattus norvegicus,CHEMBL624763,Intermediate,Liver,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,2107.0,
11067,Rattus norvegicus,CHEMBL624764,Intermediate,Liver,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,2107.0,
11068,Rattus norvegicus,CHEMBL624765,Intermediate,Liver,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,2107.0,
11069,Rattus norvegicus,CHEMBL624766,Intermediate,Liver,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,2107.0,
11070,Canis lupus familiaris,CHEMBL624767,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11071,Canis lupus familiaris,CHEMBL624768,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,N,9615.0,6996,50588,1,,,BAO_0000218,,
11072,Canis lupus familiaris,CHEMBL624769,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11073,Canis lupus familiaris,CHEMBL624770,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11074,Canis lupus familiaris,CHEMBL624771,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11075,Canis lupus familiaris,CHEMBL624772,Intermediate,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11076,Rattus norvegicus,CHEMBL624773,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,N,10116.0,6996,50597,1,,,BAO_0000218,,
11077,Rattus norvegicus,CHEMBL624774,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11078,Rattus norvegicus,CHEMBL624775,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11079,Rattus norvegicus,CHEMBL624776,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11080,Rattus norvegicus,CHEMBL624777,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11081,Rattus norvegicus,CHEMBL624778,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11082,Rattus norvegicus,CHEMBL624779,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,N,10116.0,6996,50597,1,,,BAO_0000218,,
11083,Rattus norvegicus,CHEMBL624780,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11084,Rattus norvegicus,CHEMBL624781,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11085,Rattus norvegicus,CHEMBL877608,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11086,Rattus norvegicus,CHEMBL624782,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11087,Rattus norvegicus,CHEMBL624783,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11088,Rattus norvegicus,CHEMBL624784,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,N,10116.0,6996,50597,1,,,BAO_0000218,,
11089,Rattus norvegicus,CHEMBL624785,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11090,Rattus norvegicus,CHEMBL624786,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11091,Rattus norvegicus,CHEMBL624787,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11092,Rattus norvegicus,CHEMBL628676,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11093,Rattus norvegicus,CHEMBL621842,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,N,10116.0,6996,50597,1,,,BAO_0000218,,
11094,Rattus norvegicus,CHEMBL621843,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11095,Rattus norvegicus,CHEMBL623873,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11096,Rattus norvegicus,CHEMBL623874,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11097,Rattus norvegicus,CHEMBL623875,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11098,Rattus norvegicus,CHEMBL623876,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
11099,Canis lupus familiaris,CHEMBL623877,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,N,9615.0,6996,50588,1,,,BAO_0000218,,
11100,Canis lupus familiaris,CHEMBL623878,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11101,Canis lupus familiaris,CHEMBL623879,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,N,9615.0,6996,50588,1,,,BAO_0000218,,
11102,Canis lupus familiaris,CHEMBL623880,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11103,Canis lupus familiaris,CHEMBL623881,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11104,Canis lupus familiaris,CHEMBL623957,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11105,Canis lupus familiaris,CHEMBL623958,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11106,Canis lupus familiaris,CHEMBL623959,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11107,Canis lupus familiaris,CHEMBL623960,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11108,Canis lupus familiaris,CHEMBL623961,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11109,Canis lupus familiaris,CHEMBL623962,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11110,Canis lupus familiaris,CHEMBL624676,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11111,Canis lupus familiaris,CHEMBL624677,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11112,Canis lupus familiaris,CHEMBL624678,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,N,9615.0,6996,50588,1,,,BAO_0000218,,
11113,Canis lupus familiaris,CHEMBL624679,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11114,Canis lupus familiaris,CHEMBL624680,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11115,,CHEMBL624849,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,U,,11732,22224,1,,,BAO_0000218,,
11116,,CHEMBL624850,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,U,,11732,22224,1,,,BAO_0000218,,
11117,,CHEMBL874399,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,U,,11732,22224,1,,,BAO_0000218,,
11118,,CHEMBL624851,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,U,,11732,22224,1,,,BAO_0000218,,
11119,,CHEMBL624852,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,U,,11732,22224,1,,,BAO_0000218,,
11120,Rattus norvegicus,CHEMBL624853,Autocuration,,Oral bioavailability in rat (dose 10 mg/kg),,U,10116.0,13359,22224,1,,,BAO_0000218,,
11121,Rattus norvegicus,CHEMBL624854,Autocuration,,Oral bioavailability in rat (Sprague-Dawley),,U,10116.0,16618,22224,1,,,BAO_0000218,,
11122,Rattus norvegicus,CHEMBL624855,Autocuration,,Oral bioavailability in rat,,U,10116.0,13960,22224,1,,,BAO_0000218,,
11123,Rattus norvegicus,CHEMBL624856,Autocuration,,Oral bioavailability in rats was determined in vivo,,U,10116.0,13917,22224,1,,,BAO_0000218,,
11124,Canis lupus familiaris,CHEMBL882957,Autocuration,,Oral bioavailability in dog,,U,9615.0,14266,22224,1,,,BAO_0000218,,
11125,Simiiformes,CHEMBL624857,Autocuration,,Oral bioavailability of compound in monkey,,U,314293.0,12359,22224,1,,,BAO_0000218,,
11126,Rattus norvegicus,CHEMBL622202,Intermediate,,Oral bioavailability of compound in rat,,N,10116.0,12359,50597,1,,,BAO_0000218,,
11127,Rattus norvegicus,CHEMBL622203,Autocuration,,Bioavailability in rat of PMEA prodrug,,U,10116.0,12359,22224,1,,,BAO_0000218,,
11128,Rattus norvegicus,CHEMBL625522,Intermediate,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,N,10116.0,12359,50597,1,,,BAO_0000218,,
11129,Macaca mulatta,CHEMBL622868,Autocuration,,Serum conc at 3 hours following 25 mg/kg dose,,U,9544.0,10791,22224,1,,,BAO_0000218,,
11130,Macaca mulatta,CHEMBL622869,Autocuration,Urine,Urine conc 0-5 hours following 25 mg/kg dose,,U,9544.0,10791,22224,1,,,BAO_0000218,1088.0,
11131,Macaca mulatta,CHEMBL622870,Autocuration,Urine,Urine conc 0-24 hours following 25 mg/kg dose,,U,9544.0,10791,22224,1,,,BAO_0000218,1088.0,
11132,Chlorocebus aethiops,CHEMBL622871,Autocuration,,Oral bioavailability in African green monkeys; 20-25,,U,9534.0,138,22224,1,,,BAO_0000218,,
11133,Macaca fascicularis,CHEMBL620560,Intermediate,,Oral bioavailability in cynomolgus monkey.,,N,9541.0,14521,100710,1,,,BAO_0000218,,
11134,Canis lupus familiaris,CHEMBL620561,Autocuration,,Oral bioavailability in dog,,U,9615.0,13953,22224,1,,,BAO_0000218,,
11135,Canis lupus familiaris,CHEMBL620562,Intermediate,,Oral bioavailability in dog at 10 mg/kg oral dose,,N,9615.0,12836,50588,1,,,BAO_0000218,,
11136,Cricetinae,CHEMBL620563,Intermediate,,Oral bioavailability in hamster at 10 mg/kg oral dose,,N,10026.0,12836,100712,1,,,BAO_0000218,,
11137,Rattus norvegicus,CHEMBL620564,Intermediate,,Oral bioavailability in rat at 10 mg/kg oral dose,,N,10116.0,12836,50597,1,,,BAO_0000218,,
11138,Rattus norvegicus,CHEMBL872265,Autocuration,,Oral bioavailability in rat,,U,10116.0,14521,22224,1,,,BAO_0000218,,
11139,Rattus norvegicus,CHEMBL620565,Autocuration,,Oral bioavailability in rat,,U,10116.0,13953,22224,1,,,BAO_0000218,,
11140,Eutheria,CHEMBL620566,Autocuration,,Oral bioavailability,,U,9347.0,6799,22224,1,,,BAO_0000218,,
11141,,CHEMBL620567,Autocuration,,Oral bioavailability was determined; range 49-102%,,U,,11311,22224,1,,,BAO_0000218,,
11142,Canis lupus familiaris,CHEMBL620568,Intermediate,,Oral bioavailability was determined in dogs,,N,9615.0,4013,50588,1,,,BAO_0000218,,
11143,Rattus norvegicus,CHEMBL620569,Autocuration,,Oral bioavailability in rat,,U,10116.0,4013,22224,1,,,BAO_0000218,,
11144,Eutheria,CHEMBL620570,Autocuration,,Oral bioavailability,,U,9347.0,17591,22224,1,,,BAO_0000218,,
11145,,CHEMBL620571,Autocuration,,Oral bioavailability was determined; Not orally available,,U,,17591,22224,1,,,BAO_0000218,,
11146,Mus musculus,CHEMBL620572,Intermediate,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,N,10090.0,15011,50594,1,,,BAO_0000218,,
11147,Mus musculus,CHEMBL620573,Autocuration,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,U,10090.0,15011,22224,1,,,BAO_0000218,,
11148,Mus musculus,CHEMBL620574,Autocuration,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,U,10090.0,15011,22224,1,,,BAO_0000218,,
11149,Macaca mulatta,CHEMBL620575,Autocuration,,Oral bioavailability in Rhesus monkey,,U,9544.0,9552,22224,1,,,BAO_0000218,,
11150,Canis lupus familiaris,CHEMBL620576,Autocuration,,Oral bioavailability in dog (female mongrel),,U,9615.0,9552,22224,1,,,BAO_0000218,,
11151,,CHEMBL875846,Autocuration,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,U,,3639,22224,1,,,BAO_0000218,,
11152,Canis lupus familiaris,CHEMBL620577,Autocuration,,Oral bioavailability in dog,,U,9615.0,13397,22224,1,,,BAO_0000218,,
11153,,CHEMBL620578,Autocuration,,Percentage Bioavailability was evaluated.,,U,,3031,22224,1,,,BAO_0000218,,
11154,Rattus norvegicus,CHEMBL620579,Autocuration,,Bioavailability in rat administered i.d.,,U,10116.0,12818,22224,1,,,BAO_0000218,,
11155,Eutheria,CHEMBL621248,Autocuration,,Bioavailability,,U,9347.0,4847,22224,1,,,BAO_0000218,,
11156,Canis lupus familiaris,CHEMBL625390,Autocuration,,Bioavailability in dog (male Beagle) i.v. administration,,U,9615.0,12421,22224,1,,,BAO_0000218,,
11157,Rattus norvegicus,CHEMBL625391,Autocuration,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,U,10116.0,11966,22224,1,,,BAO_0000218,,
11158,Primates,CHEMBL872266,Autocuration,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,U,9443.0,11218,22224,1,,,BAO_0000218,,
11159,Rattus norvegicus,CHEMBL625392,Autocuration,,Oral bioavailability in rat (Sprague-Dawley) (male),,U,10116.0,13129,22224,1,,,BAO_0000218,,
11160,Rattus norvegicus,CHEMBL625393,Intermediate,,The oral bioavailability was measured on rats after oral administration,,N,10116.0,12350,50597,1,,,BAO_0000218,,
11161,Rattus norvegicus,CHEMBL625394,Intermediate,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,N,10116.0,2231,50597,1,,,BAO_0000218,,
11162,Macaca mulatta,CHEMBL625395,Intermediate,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,N,9544.0,2231,50797,1,,,BAO_0000218,,
11163,Rattus norvegicus,CHEMBL625396,Autocuration,,Bioavailability in rat (dose 10 mg/kg i.d.),,U,10116.0,12187,22224,1,,,BAO_0000218,,
11164,Canis lupus familiaris,CHEMBL625397,Autocuration,,Bioavailability in dog (male Beagle) i.v. administration,,U,9615.0,12421,22224,1,,,BAO_0000218,,
11165,Mus musculus,CHEMBL625398,Intermediate,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11166,Mus musculus,CHEMBL625399,Intermediate,Blood,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,178.0,
11167,Mus musculus,CHEMBL626074,Intermediate,Cerebellum,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,2037.0,
11168,Mus musculus,CHEMBL626075,Intermediate,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11169,Rattus norvegicus,CHEMBL626076,Intermediate,Plasma,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,N,10116.0,2231,50597,1,,,BAO_0000218,1969.0,
11170,Macaca mulatta,CHEMBL626077,Intermediate,Plasma,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,N,9544.0,2231,50797,1,,,BAO_0000218,1969.0,
11171,Rattus norvegicus,CHEMBL626078,Intermediate,Blood,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,N,10116.0,12178,50597,1,,,BAO_0000218,178.0,
11172,,CHEMBL625846,Autocuration,Blood,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,U,,12178,22224,1,,,BAO_0000218,178.0,
11173,,CHEMBL625847,Autocuration,Blood,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,U,,12178,22224,1,,,BAO_0000218,178.0,
11174,Rattus norvegicus,CHEMBL625848,Expert,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,N,10116.0,15633,50597,1,,,BAO_0000218,,
11175,Rattus norvegicus,CHEMBL625849,Intermediate,Plasma,Maximum concentration of compound in plasma administered orally to rats,,N,10116.0,14258,50597,1,,,BAO_0000218,1969.0,
11176,Canis lupus familiaris,CHEMBL626023,Intermediate,Plasma,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,N,9615.0,14224,50588,1,,,BAO_0000218,1969.0,
11177,Canis lupus familiaris,CHEMBL626024,Intermediate,Plasma,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,N,9615.0,14224,50588,1,,,BAO_0000218,1969.0,
11178,Canis lupus familiaris,CHEMBL626025,Intermediate,Plasma,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,N,9615.0,14224,50588,1,,,BAO_0000218,1969.0,
11179,,CHEMBL626026,Autocuration,,Maximum concentration after 10 mg/kg by oral administration,,U,,5566,22224,1,,,BAO_0000218,,
11180,,CHEMBL626027,Autocuration,,Maximum concentration at a dose of 1.5 mg/kg,,U,,16935,22224,1,,,BAO_0000218,,
11181,,CHEMBL626028,Autocuration,,Maximum concentration at a dose of 2.0 mg/kg,,U,,16935,22224,1,,,BAO_0000218,,
11182,Canis lupus familiaris,CHEMBL626029,Intermediate,Plasma,Maximum concentration in dog plasma,,N,9615.0,14224,50588,1,,,BAO_0000218,1969.0,
11183,,CHEMBL626030,Autocuration,Plasma,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,U,,12536,22224,1,,,BAO_0000218,1969.0,
11184,,CHEMBL626031,Autocuration,Plasma,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,U,,12536,22224,1,,,BAO_0000218,1969.0,
11185,,CHEMBL626032,Autocuration,Plasma,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,U,,12536,22224,1,,,BAO_0000218,1969.0,
11186,,CHEMBL626033,Autocuration,Plasma,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,U,,12536,22224,1,,,BAO_0000218,1969.0,
11187,,CHEMBL626034,Autocuration,Plasma,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,U,,12536,22224,1,,,BAO_0000218,1969.0,
11188,Canis lupus familiaris,CHEMBL626035,Intermediate,Plasma,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,N,9615.0,9994,50588,1,,,BAO_0000218,1969.0,
11189,,CHEMBL626036,Autocuration,Plasma,Maximum concentration in plasma at Tmax,,U,,1434,22224,1,,,BAO_0000218,1969.0,
11190,Canis lupus familiaris,CHEMBL626037,Expert,Plasma,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,N,9615.0,12836,50588,1,,,BAO_0000218,1969.0,
11191,Cricetinae,CHEMBL626038,Intermediate,Plasma,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,N,10026.0,12836,100712,1,,,BAO_0000218,1969.0,
11192,Rattus norvegicus,CHEMBL626039,Intermediate,Plasma,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,N,10116.0,12836,50597,1,,,BAO_0000218,1969.0,
11193,Rattus norvegicus,CHEMBL626040,Intermediate,Plasma,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,N,10116.0,12545,50597,1,,,BAO_0000218,1969.0,
11194,Oryctolagus cuniculus,CHEMBL626041,Intermediate,Plasma,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,N,9986.0,13856,50592,1,,,BAO_0000218,1969.0,
11195,,CHEMBL626042,Autocuration,,Maximum concentration was calculated,,U,,3550,22224,1,,,BAO_0000218,,
11196,,CHEMBL626043,Autocuration,,Maximum concentration was calculated.,,U,,2632,22224,1,,,BAO_0000218,,
11197,,CHEMBL626044,Autocuration,,Maximum concentration at a peroral dose of 10 mg/kg,,U,,5566,22224,1,,,BAO_0000218,,
11198,,CHEMBL626045,Autocuration,,Maximum concentration of the drug at 10 uM/dg administered perorally,,U,,11883,22224,1,,,BAO_0000218,,
11199,,CHEMBL626046,Autocuration,,Maximum concentration of the drug at 2 uM/dg administered intravenously,,U,,11883,22224,1,,,BAO_0000218,,
11200,Canis lupus familiaris,CHEMBL626047,Intermediate,Plasma,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,N,9615.0,14122,50588,1,,,BAO_0000218,1969.0,
11201,Cricetinae,CHEMBL626048,Intermediate,Plasma,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,N,10026.0,14122,100712,1,,,BAO_0000218,1969.0,
11202,Rattus norvegicus,CHEMBL626049,Intermediate,Plasma,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,N,10116.0,14122,50597,1,,,BAO_0000218,1969.0,
11203,Rattus norvegicus,CHEMBL626050,Intermediate,Plasma,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,N,10116.0,12542,50597,1,,,BAO_0000218,1969.0,
11204,Canis lupus familiaris,CHEMBL874541,Intermediate,Plasma,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,N,9615.0,12542,50588,1,,,BAO_0000218,1969.0,
11205,Cricetinae,CHEMBL622826,Intermediate,Plasma,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,N,10026.0,12542,100712,1,,,BAO_0000218,1969.0,
11206,Cricetinae,CHEMBL622827,Intermediate,Plasma,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,N,10026.0,12542,100712,1,,,BAO_0000218,1969.0,
11207,Rattus norvegicus,CHEMBL622828,Intermediate,Plasma,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,N,10116.0,12542,50597,1,,,BAO_0000218,1969.0,
11208,Rattus norvegicus,CHEMBL622829,Intermediate,Plasma,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,N,10116.0,14080,50597,1,,,BAO_0000218,1969.0,
11209,Rattus norvegicus,CHEMBL876806,Intermediate,,Maximum concentration reached following intravenous administration in male rat,,N,10116.0,11911,50597,1,,,BAO_0000218,,
11210,Canis lupus familiaris,CHEMBL622830,Intermediate,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,N,9615.0,13204,50588,1,,,BAO_0000218,,
11211,Rattus norvegicus,CHEMBL622831,Intermediate,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,N,10116.0,13204,50597,1,,,BAO_0000218,,
11212,Canis lupus familiaris,CHEMBL626794,Intermediate,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,N,9615.0,14346,50588,1,,,BAO_0000218,,
11213,Rattus norvegicus,CHEMBL626795,Intermediate,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,,
11214,Rattus norvegicus,CHEMBL626796,Intermediate,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,,
11215,Rattus norvegicus,CHEMBL626797,Intermediate,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,,
11216,Rattus norvegicus,CHEMBL626798,Intermediate,,Maximum drug concentration is determined after oral dosing in rats.,,N,10116.0,14127,50597,1,,,BAO_0000218,,
11217,Canis lupus familiaris,CHEMBL626799,Intermediate,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,N,9615.0,14339,50588,1,,,BAO_0000218,,
11218,Canis lupus familiaris,CHEMBL626800,Intermediate,,Maximum observed concentration in oral (5 mg/kg) fed dogs,,N,9615.0,14339,50588,1,,,BAO_0000218,,
11219,,CHEMBL626801,Autocuration,Plasma,Maximum plasma concentration,,U,,13494,22224,1,,,BAO_0000218,1969.0,
11220,Rattus norvegicus,CHEMBL876816,Intermediate,Plasma,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,N,10116.0,14925,50597,1,,,BAO_0000218,1969.0,
11221,Rattus norvegicus,CHEMBL626802,Intermediate,Plasma,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,N,10116.0,14474,50597,1,,,BAO_0000218,1969.0,
11222,Canis lupus familiaris,CHEMBL626803,Intermediate,Plasma,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,N,9615.0,14474,50588,1,,,BAO_0000218,1969.0,
11223,,CHEMBL626804,Autocuration,Plasma,Maximum plasma concentration following oral administration of 30 umol/kg,,U,,13917,22224,1,,,BAO_0000218,1969.0,
11224,Rattus norvegicus,CHEMBL626805,Intermediate,Plasma,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,N,10116.0,9796,50597,1,,,BAO_0000218,1969.0,
11225,Rattus norvegicus,CHEMBL626309,Intermediate,Plasma,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,1969.0,
11226,Rattus norvegicus,CHEMBL626310,Intermediate,Plasma,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,1969.0,
11227,Rattus norvegicus,CHEMBL626311,Intermediate,Plasma,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,1969.0,
11228,Rattus norvegicus,CHEMBL626312,Intermediate,Plasma,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,1969.0,
11229,Rattus norvegicus,CHEMBL626313,Intermediate,Uterus,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,995.0,
11230,Rattus norvegicus,CHEMBL626314,Intermediate,Uterus,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,995.0,
11231,Rattus norvegicus,CHEMBL626315,Intermediate,Uterus,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,995.0,
11232,Rattus norvegicus,CHEMBL626316,Intermediate,Uterus,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,995.0,
11233,Rattus norvegicus,CHEMBL626317,Intermediate,Uterus,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,10116.0,9796,50597,1,,,BAO_0000218,995.0,
11234,Rattus norvegicus,CHEMBL626318,Intermediate,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,N,10116.0,8363,50597,1,,,BAO_0000218,,
11235,Rattus norvegicus,CHEMBL626319,Intermediate,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,N,10116.0,8363,50597,1,,,BAO_0000218,,
11236,Rattus norvegicus,CHEMBL626320,Intermediate,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,N,10116.0,8363,50597,1,,,BAO_0000218,,
11237,Rattus norvegicus,CHEMBL875053,Intermediate,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,N,10116.0,8363,50597,1,,,BAO_0000218,,
11238,Rattus norvegicus,CHEMBL626321,Intermediate,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,N,10116.0,8363,50597,1,,,BAO_0000218,,
11239,Rattus norvegicus,CHEMBL626322,Intermediate,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,N,10116.0,8363,50597,1,,,BAO_0000218,,
11240,Rattus norvegicus,CHEMBL626323,Intermediate,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,N,10116.0,8363,50597,1,,,BAO_0000218,,
11241,Rattus norvegicus,CHEMBL626324,Intermediate,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,N,10116.0,8363,50597,1,,,BAO_0000218,,
11242,Rattus norvegicus,CHEMBL626325,Intermediate,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,N,10116.0,8363,50597,1,,,BAO_0000218,,
11243,Rattus norvegicus,CHEMBL626326,Intermediate,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,N,10116.0,8363,50597,1,,,BAO_0000218,,
11244,Rattus norvegicus,CHEMBL626327,Intermediate,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,N,10116.0,8363,50597,1,,,BAO_0000218,,
11245,Rattus norvegicus,CHEMBL626328,Intermediate,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,N,10116.0,8363,50597,1,,,BAO_0000218,,
11246,Rattus norvegicus,CHEMBL626329,Intermediate,Blood,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,178.0,
11247,Rattus norvegicus,CHEMBL626330,Intermediate,Blood,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,178.0,
11248,Rattus norvegicus,CHEMBL626331,Intermediate,Blood,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,178.0,
11249,Rattus norvegicus,CHEMBL626332,Intermediate,Blood,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,178.0,
11250,Rattus norvegicus,CHEMBL626333,Intermediate,Blood,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,178.0,
11251,Rattus norvegicus,CHEMBL626334,Intermediate,Blood,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,178.0,
11252,Rattus norvegicus,CHEMBL626335,Intermediate,Blood,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,178.0,
11253,Rattus norvegicus,CHEMBL624798,Intermediate,Blood,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,178.0,
11254,Rattus norvegicus,CHEMBL624799,Intermediate,Brain,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,955.0,
11255,Rattus norvegicus,CHEMBL624800,Intermediate,Brain,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,955.0,
11256,Rattus norvegicus,CHEMBL624801,Intermediate,Brain,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,955.0,
11257,Rattus norvegicus,CHEMBL624802,Intermediate,Brain,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,955.0,
11258,Rattus norvegicus,CHEMBL624803,Intermediate,Brain,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,955.0,
11259,Rattus norvegicus,CHEMBL624804,Intermediate,Brain,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,955.0,
11260,Rattus norvegicus,CHEMBL624805,Intermediate,Brain,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,955.0,
11261,Rattus norvegicus,CHEMBL624806,Intermediate,Brain,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,955.0,
11262,Rattus norvegicus,CHEMBL624807,Intermediate,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11263,Rattus norvegicus,CHEMBL624808,Intermediate,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11264,Rattus norvegicus,CHEMBL624809,Intermediate,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11265,Rattus norvegicus,CHEMBL624810,Intermediate,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11266,Rattus norvegicus,CHEMBL877618,Intermediate,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11267,Rattus norvegicus,CHEMBL624811,Intermediate,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11268,Rattus norvegicus,CHEMBL624812,Intermediate,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11269,Rattus norvegicus,CHEMBL624813,Intermediate,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11270,Rattus norvegicus,CHEMBL624814,Intermediate,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11271,Rattus norvegicus,CHEMBL624815,Intermediate,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11272,Rattus norvegicus,CHEMBL624816,Intermediate,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11273,Rattus norvegicus,CHEMBL624817,Intermediate,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11274,Canis lupus familiaris,CHEMBL624818,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11275,Canis lupus familiaris,CHEMBL624819,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,N,9615.0,6996,50588,1,,,BAO_0000218,,
11276,Canis lupus familiaris,CHEMBL624820,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11277,Canis lupus familiaris,CHEMBL624821,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11278,Canis lupus familiaris,CHEMBL624822,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11279,Canis lupus familiaris,CHEMBL624823,Intermediate,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
11280,Escherichia coli,CHEMBL624824,Intermediate,,Observed diffusion coefficient in organic solvent for Escherichia coli,,N,562.0,15599,50212,1,,,BAO_0000218,,
11281,Rattus norvegicus,CHEMBL624825,Intermediate,Blood,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,10116.0,9614,50597,1,,,BAO_0000218,178.0,
11282,Rattus norvegicus,CHEMBL624826,Intermediate,Blood,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,10116.0,9614,50597,1,,,BAO_0000218,178.0,
11283,Rattus norvegicus,CHEMBL876817,Intermediate,Cardiac atrium,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,10116.0,9614,50597,1,,,BAO_0000218,2081.0,
11284,Rattus norvegicus,CHEMBL624827,Intermediate,Cardiac atrium,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,10116.0,9614,50597,1,,,BAO_0000218,2081.0,
11285,Rattus norvegicus,CHEMBL624828,Intermediate,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,10116.0,9614,50597,1,,,BAO_0000218,,
11286,Rattus norvegicus,CHEMBL624829,Intermediate,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,10116.0,9614,50597,1,,,BAO_0000218,,
11287,Rattus norvegicus,CHEMBL624830,Intermediate,Liver,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,10116.0,9614,50597,1,,,BAO_0000218,2107.0,
11288,Rattus norvegicus,CHEMBL624831,Intermediate,Liver,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,10116.0,9614,50597,1,,,BAO_0000218,2107.0,
11289,Rattus norvegicus,CHEMBL624832,Intermediate,Cardiac atrium,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,10116.0,9614,50597,1,,,BAO_0000218,2081.0,
11290,Rattus norvegicus,CHEMBL624833,Intermediate,Cardiac atrium,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,10116.0,9614,50597,1,,,BAO_0000218,2081.0,
11291,Rattus norvegicus,CHEMBL624834,Intermediate,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,10116.0,9614,50597,1,,,BAO_0000218,,
11292,Rattus norvegicus,CHEMBL624835,Intermediate,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,10116.0,9614,50597,1,,,BAO_0000218,,
11293,Rattus norvegicus,CHEMBL624836,Intermediate,Spleen,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,10116.0,9614,50597,1,,,BAO_0000218,2106.0,
11294,Rattus norvegicus,CHEMBL624837,Intermediate,Spleen,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,10116.0,9614,50597,1,,,BAO_0000218,2106.0,
11295,Rattus norvegicus,CHEMBL624838,Intermediate,Blood,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,N,10116.0,9071,50597,1,,,BAO_0000218,178.0,
11296,Rattus norvegicus,CHEMBL622188,Intermediate,Blood,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,N,10116.0,9071,50597,1,,,BAO_0000218,178.0,
11297,Rattus norvegicus,CHEMBL622189,Intermediate,Heart,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,N,10116.0,9071,50597,1,,,BAO_0000218,948.0,
11298,Rattus norvegicus,CHEMBL622190,Intermediate,Heart,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,N,10116.0,9071,50597,1,,,BAO_0000218,948.0,
11299,Rattus norvegicus,CHEMBL625170,Intermediate,Heart,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,N,10116.0,9071,50597,1,,,BAO_0000218,948.0,
11300,Rattus norvegicus,CHEMBL625171,Intermediate,Kidney,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,N,10116.0,9071,50597,1,,,BAO_0000218,2113.0,
11301,Rattus norvegicus,CHEMBL625172,Intermediate,Kidney,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,N,10116.0,9071,50597,1,,,BAO_0000218,2113.0,
11302,Rattus norvegicus,CHEMBL625173,Intermediate,Kidney,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,N,10116.0,9071,50597,1,,,BAO_0000218,2113.0,
11303,Rattus norvegicus,CHEMBL625174,Intermediate,Liver,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,N,10116.0,9071,50597,1,,,BAO_0000218,2107.0,
11304,Rattus norvegicus,CHEMBL625175,Intermediate,Liver,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,N,10116.0,9071,50597,1,,,BAO_0000218,2107.0,
11305,Rattus norvegicus,CHEMBL625176,Intermediate,Liver,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,N,10116.0,9071,50597,1,,,BAO_0000218,2107.0,
11306,Rattus norvegicus,CHEMBL625177,Intermediate,Lung,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,N,10116.0,9071,50597,1,,,BAO_0000218,2048.0,
11307,Rattus norvegicus,CHEMBL625178,Intermediate,Lung,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,N,10116.0,9071,50597,1,,,BAO_0000218,2048.0,
11308,Rattus norvegicus,CHEMBL625179,Intermediate,Lung,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,N,10116.0,9071,50597,1,,,BAO_0000218,2048.0,
11309,Rattus norvegicus,CHEMBL625180,Intermediate,Lung,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,N,10116.0,9071,50597,1,,,BAO_0000218,2048.0,
11310,,CHEMBL625181,Autocuration,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,U,,10677,22224,1,,,BAO_0000218,,
11311,Mus musculus,CHEMBL625182,Intermediate,Urine,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,N,10090.0,9750,50594,1,,,BAO_0000218,1088.0,
11312,Rattus norvegicus,CHEMBL625183,Intermediate,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11313,Rattus norvegicus,CHEMBL875848,Intermediate,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11314,Rattus norvegicus,CHEMBL622260,Intermediate,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11315,Rattus norvegicus,CHEMBL622261,Intermediate,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11316,Rattus norvegicus,CHEMBL622262,Intermediate,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11317,Rattus norvegicus,CHEMBL622263,Intermediate,Kidney,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,2113.0,
11318,Rattus norvegicus,CHEMBL622418,Intermediate,Kidney,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,2113.0,
11319,Rattus norvegicus,CHEMBL622419,Intermediate,Liver,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,2107.0,
11320,Mus musculus,CHEMBL623388,Intermediate,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11321,Mus musculus,CHEMBL623389,Intermediate,Liver,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,2107.0,
11322,Mus musculus,CHEMBL623390,Intermediate,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11323,Mus musculus,CHEMBL623391,Intermediate,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11324,Mus musculus,CHEMBL623392,Intermediate,Blood,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,178.0,
11325,Mus musculus,CHEMBL623393,Intermediate,Cerebellum,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,2037.0,
11326,Mus musculus,CHEMBL623394,Intermediate,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11327,Mus musculus,CHEMBL618885,Intermediate,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11328,Mus musculus,CHEMBL618886,Intermediate,Liver,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,2107.0,
11329,Mus musculus,CHEMBL618887,Intermediate,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11330,Mus musculus,CHEMBL619535,Intermediate,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11331,Mus musculus,CHEMBL619536,Intermediate,Blood,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,178.0,
11332,Mus musculus,CHEMBL619537,Intermediate,Cerebellum,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,2037.0,
11333,Mus musculus,CHEMBL619705,Intermediate,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11334,Mus musculus,CHEMBL619706,Intermediate,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11335,Mus musculus,CHEMBL619707,Intermediate,Liver,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,2107.0,
11336,Mus musculus,CHEMBL619708,Intermediate,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11337,Mus musculus,CHEMBL625219,Intermediate,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11338,Mus musculus,CHEMBL625220,Intermediate,Blood,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,178.0,
11339,Mus musculus,CHEMBL625221,Intermediate,Cerebellum,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,2037.0,
11340,Mus musculus,CHEMBL625222,Intermediate,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11341,Mus musculus,CHEMBL625223,Intermediate,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11342,Mus musculus,CHEMBL625224,Intermediate,Liver,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,2107.0,
11343,Mus musculus,CHEMBL625225,Intermediate,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,10090.0,13256,50594,1,,,BAO_0000218,,
11344,Rattus norvegicus,CHEMBL625226,Intermediate,Blood,Biodistribution in Rat blood after 24 hours of iv administration,,N,10116.0,8829,50597,1,,,BAO_0000218,178.0,
11345,Rattus norvegicus,CHEMBL625227,Intermediate,Blood,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,N,10116.0,8829,50597,1,,,BAO_0000218,178.0,
11346,Rattus norvegicus,CHEMBL625228,Intermediate,Blood,Biodistribution in Rat blood after 30 minutes of iv administration,,N,10116.0,8829,50597,1,,,BAO_0000218,178.0,
11347,Rattus norvegicus,CHEMBL875354,Intermediate,Blood,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,N,10116.0,8829,50597,1,,,BAO_0000218,178.0,
11348,Rattus norvegicus,CHEMBL625229,Intermediate,Blood,Biodistribution in Rat blood after 5 minutes of iv administration,,N,10116.0,8829,50597,1,,,BAO_0000218,178.0,
11349,Rattus norvegicus,CHEMBL625230,Intermediate,Blood,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,N,10116.0,8829,50597,1,,,BAO_0000218,178.0,
11350,Rattus norvegicus,CHEMBL625231,Intermediate,Heart,Biodistribution in Rat heart after 24 hours of iv administration,,N,10116.0,8829,50597,1,,,BAO_0000218,948.0,
11351,Rattus norvegicus,CHEMBL625900,Intermediate,Heart,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,N,10116.0,8829,50597,1,,,BAO_0000218,948.0,
11352,Rattus norvegicus,CHEMBL625901,Intermediate,Heart,Biodistribution in Rat heart after 30 minutes of iv administration,,N,10116.0,8829,50597,1,,,BAO_0000218,948.0,
11353,Rattus norvegicus,CHEMBL625902,Intermediate,Heart,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,N,10116.0,8829,50597,1,,,BAO_0000218,948.0,
11354,Rattus norvegicus,CHEMBL625903,Intermediate,Heart,Biodistribution in Rat heart after 5 minutes of iv administration,,N,10116.0,8829,50597,1,,,BAO_0000218,948.0,
11355,Rattus norvegicus,CHEMBL625904,Intermediate,Heart,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,N,10116.0,8829,50597,1,,,BAO_0000218,948.0,
11356,Rattus norvegicus,CHEMBL625905,Intermediate,Liver,Biodistribution in Rat liver after 24 hours of iv administration,,N,10116.0,8829,50597,1,,,BAO_0000218,2107.0,
11357,Rattus norvegicus,CHEMBL627861,Intermediate,Liver,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,N,10116.0,8829,50597,1,,,BAO_0000218,2107.0,
11358,Rattus norvegicus,CHEMBL627862,Intermediate,Liver,Biodistribution in Rat liver after 30 minutes of iv administration,,N,10116.0,8829,50597,1,,,BAO_0000218,2107.0,
11359,Rattus norvegicus,CHEMBL627863,Intermediate,Liver,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,N,10116.0,8829,50597,1,,,BAO_0000218,2107.0,
11360,Rattus norvegicus,CHEMBL627769,Intermediate,Liver,Biodistribution in Rat liver after 30 minutes of iv administration,,N,10116.0,8829,50597,1,,,BAO_0000218,2107.0,
11361,Canis lupus familiaris,CHEMBL627770,Intermediate,Plasma,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,N,9615.0,13249,50588,1,,,BAO_0000218,1969.0,
11362,Macaca fascicularis,CHEMBL627771,Intermediate,,Cmax in cynomolgus monkey (PO dose),,N,9541.0,13622,100710,1,,,BAO_0000218,,
11363,Rattus norvegicus,CHEMBL627772,Intermediate,,Cmax in rat (PO dose),,N,10116.0,13622,50597,1,,,BAO_0000218,,
11364,Rattus norvegicus,CHEMBL627773,Intermediate,,Cmax in rat (PO dose),,N,10116.0,13622,50597,1,,,BAO_0000218,,
11365,Rattus norvegicus,CHEMBL621922,Intermediate,Plasma,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,N,10116.0,13494,50597,1,,,BAO_0000218,1969.0,
11366,Rattus norvegicus,CHEMBL621923,Intermediate,Plasma,Cmax in rat plasma after oral dose (10 mg/kg),,N,10116.0,12170,50597,1,,,BAO_0000218,1969.0,
11367,,CHEMBL621924,Autocuration,Plasma,Cmax in plasma after oral dose (10 mg/kg),,U,,12170,22224,1,,,BAO_0000218,1969.0,
11368,Canis lupus familiaris,CHEMBL621925,Intermediate,Plasma,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,N,9615.0,17025,50588,1,,,BAO_0000218,1969.0,
11369,Simiiformes,CHEMBL621926,Autocuration,Plasma,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,U,314293.0,17025,22224,1,,,BAO_0000218,1969.0,
11370,Oryctolagus cuniculus,CHEMBL621927,Intermediate,Plasma,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,N,9986.0,17025,50592,1,,,BAO_0000218,1969.0,
11371,Rattus norvegicus,CHEMBL621928,Intermediate,Plasma,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,N,10116.0,17025,50597,1,,,BAO_0000218,1969.0,
11372,Rattus norvegicus,CHEMBL621929,Intermediate,Plasma,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,N,10116.0,14187,50597,1,,,BAO_0000218,1969.0,
11373,Mus musculus,CHEMBL621930,Intermediate,Plasma,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,N,10090.0,14816,50594,1,,,BAO_0000218,1969.0,
11374,Rattus norvegicus,CHEMBL621931,Intermediate,Plasma,Maximum plasma concentration after oral dosing in rat,,N,10116.0,17820,50597,1,,,BAO_0000218,1969.0,
11375,,CHEMBL621932,Autocuration,Plasma,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,1969.0,
11376,,CHEMBL621933,Autocuration,Plasma,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,1969.0,
11377,Canis lupus familiaris,CHEMBL621934,Intermediate,Plasma,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,N,9615.0,14691,50588,1,,,BAO_0000218,1969.0,
11378,Canis lupus familiaris,CHEMBL621935,Intermediate,Plasma,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,N,9615.0,14691,50588,1,,,BAO_0000218,1969.0,
11379,Rattus norvegicus,CHEMBL621936,Intermediate,Plasma,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,N,10116.0,13375,50597,1,,,BAO_0000218,1969.0,
11380,,CHEMBL621937,Autocuration,Plasma,Maximum plasma concentration was determined,,U,,6236,22224,1,,,BAO_0000218,1969.0,
11381,,CHEMBL621938,Autocuration,Plasma,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,1969.0,
11382,,CHEMBL621939,Autocuration,Plasma,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,1969.0,
11383,,CHEMBL621940,Autocuration,Plasma,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,1969.0,
11384,,CHEMBL621941,Autocuration,Plasma,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,1969.0,
11385,,CHEMBL621942,Autocuration,Plasma,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,1969.0,
11386,,CHEMBL626178,Autocuration,Plasma,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,1969.0,
11387,,CHEMBL626179,Autocuration,Plasma,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,1969.0,
11388,,CHEMBL626180,Autocuration,Plasma,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,1969.0,
11389,Rattus norvegicus,CHEMBL626181,Intermediate,Plasma,Plasma Cmax in rat (PO dose),,N,10116.0,13622,50597,1,,,BAO_0000218,1969.0,
11390,Rattus norvegicus,CHEMBL626182,Intermediate,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,,
11391,Rattus norvegicus,CHEMBL626183,Intermediate,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,,
11392,Rattus norvegicus,CHEMBL626184,Intermediate,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,,
11393,Rattus norvegicus,CHEMBL626185,Intermediate,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,,
11394,Canis lupus familiaris,CHEMBL626186,Intermediate,Plasma,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,N,9615.0,14925,50588,1,,,BAO_0000218,1969.0,
11395,Canis lupus familiaris,CHEMBL877589,Intermediate,Plasma,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,N,9615.0,14925,50588,1,,,BAO_0000218,1969.0,
11396,,CHEMBL626187,Autocuration,,Maximum concentration of the drug at 1 uM/dg administered intravenously,,U,,11883,22224,1,,,BAO_0000218,,
11397,,CHEMBL626188,Autocuration,,Maximum concentration of the drug at 20 uM/dg administered perorally,,U,,11883,22224,1,,,BAO_0000218,,
11398,,CHEMBL626189,Autocuration,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,U,,13391,22224,1,,,BAO_0000218,,
11399,,CHEMBL626855,Autocuration,Blood,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,U,,13391,22224,1,,,BAO_0000218,178.0,
11400,,CHEMBL623781,Autocuration,Blood,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,U,,13391,22224,1,,,BAO_0000218,178.0,
11401,,CHEMBL623782,Autocuration,Blood,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,U,,13391,22224,1,,,BAO_0000218,178.0,
11402,Rattus norvegicus,CHEMBL623783,Intermediate,Plasma,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,N,10116.0,16360,50597,1,,,BAO_0000218,1969.0,
11403,Canis lupus familiaris,CHEMBL623784,Intermediate,Plasma,Cmax in dog plasma after 1mg/kg oral dose,,N,9615.0,3673,50588,1,,,BAO_0000218,1969.0,
11404,Canis lupus familiaris,CHEMBL623785,Intermediate,Plasma,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,N,9615.0,14431,50588,1,,,BAO_0000218,1969.0,
11405,Rattus norvegicus,CHEMBL623786,Intermediate,Plasma,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,N,10116.0,14431,50597,1,,,BAO_0000218,1969.0,
11406,Rattus norvegicus,CHEMBL623787,Intermediate,,Oral maximum concentration in rat,,N,10116.0,14964,50597,1,,,BAO_0000218,,
11407,Rattus norvegicus,CHEMBL623788,Intermediate,,Oral maximum concentration in rat,,N,10116.0,14964,50597,1,,,BAO_0000218,,
11408,Mus musculus,CHEMBL623789,Intermediate,Plasma,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,N,10090.0,14209,50594,1,,,BAO_0000218,1969.0,
11409,Mus musculus,CHEMBL623790,Intermediate,Blood,Peak concentration in blood after intravenous administration to mice,,N,10090.0,11355,50594,1,,,BAO_0000218,178.0,
11410,Mus musculus,CHEMBL623791,Intermediate,Blood,Peak concentration in blood after peroral administration to mice,,N,10090.0,11355,50594,1,,,BAO_0000218,178.0,
11411,Rattus norvegicus,CHEMBL623792,Intermediate,Plasma,Peak concentration in rat plasma was determined,,N,10116.0,11966,50597,1,,,BAO_0000218,1969.0,
11412,Simiiformes,CHEMBL623793,Autocuration,Plasma,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,U,314293.0,8918,22224,1,,,BAO_0000218,1969.0,
11413,Mus musculus,CHEMBL623794,Intermediate,Plasma,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,N,10090.0,8918,50594,1,,,BAO_0000218,1969.0,
11414,Rattus norvegicus,CHEMBL623795,Intermediate,Plasma,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,N,10116.0,8918,50597,1,,,BAO_0000218,1969.0,
11415,Rattus norvegicus,CHEMBL623796,Intermediate,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11416,Rattus norvegicus,CHEMBL623797,Intermediate,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11417,Rattus norvegicus,CHEMBL623798,Intermediate,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11418,Rattus norvegicus,CHEMBL623799,Intermediate,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11419,Rattus norvegicus,CHEMBL624490,Intermediate,Intestine,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,160.0,
11420,Rattus norvegicus,CHEMBL624491,Intermediate,Intestine,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,160.0,
11421,Rattus norvegicus,CHEMBL624492,Intermediate,Intestine,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,160.0,
11422,Rattus norvegicus,CHEMBL624493,Intermediate,Intestine,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,160.0,
11423,Rattus norvegicus,CHEMBL877595,Intermediate,Intestine,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,160.0,
11424,Rattus norvegicus,CHEMBL624494,Intermediate,Intestine,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,160.0,
11425,Rattus norvegicus,CHEMBL624495,Intermediate,Intestine,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,160.0,
11426,Rattus norvegicus,CHEMBL624681,Intermediate,Intestine,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,160.0,
11427,Rattus norvegicus,CHEMBL624682,Intermediate,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11428,Rattus norvegicus,CHEMBL624683,Intermediate,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11429,Rattus norvegicus,CHEMBL624684,Intermediate,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11430,Rattus norvegicus,CHEMBL624685,Intermediate,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11431,Rattus norvegicus,CHEMBL624686,Intermediate,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11432,Rattus norvegicus,CHEMBL624687,Intermediate,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11433,Rattus norvegicus,CHEMBL624688,Intermediate,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11434,Rattus norvegicus,CHEMBL627161,Intermediate,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11435,Rattus norvegicus,CHEMBL622127,Intermediate,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11436,Rattus norvegicus,CHEMBL622128,Intermediate,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11437,Rattus norvegicus,CHEMBL874384,Intermediate,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11438,Rattus norvegicus,CHEMBL624898,Intermediate,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11439,Rattus norvegicus,CHEMBL624899,Intermediate,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11440,Rattus norvegicus,CHEMBL624900,Intermediate,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11441,Rattus norvegicus,CHEMBL624901,Intermediate,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11442,Rattus norvegicus,CHEMBL624902,Intermediate,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11443,Rattus norvegicus,CHEMBL624903,Intermediate,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11444,Rattus norvegicus,CHEMBL624904,Intermediate,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11445,Rattus norvegicus,CHEMBL624905,Intermediate,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11446,Rattus norvegicus,CHEMBL624906,Intermediate,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11447,Rattus norvegicus,CHEMBL624907,Intermediate,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11448,Rattus norvegicus,CHEMBL624908,Intermediate,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11449,Rattus norvegicus,CHEMBL624909,Intermediate,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11450,Rattus norvegicus,CHEMBL624910,Intermediate,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11451,Rattus norvegicus,CHEMBL624911,Intermediate,Muscle tissue,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2385.0,
11452,Rattus norvegicus,CHEMBL874388,Intermediate,Muscle tissue,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2385.0,
11453,Rattus norvegicus,CHEMBL624912,Intermediate,Muscle tissue,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2385.0,
11454,Rattus norvegicus,CHEMBL622930,Intermediate,Muscle tissue,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2385.0,
11455,Rattus norvegicus,CHEMBL623121,Intermediate,Muscle tissue,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2385.0,
11456,Rattus norvegicus,CHEMBL623122,Intermediate,Muscle tissue,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2385.0,
11457,Rattus norvegicus,CHEMBL623123,Intermediate,Muscle tissue,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2385.0,
11458,Rattus norvegicus,CHEMBL623124,Intermediate,Muscle tissue,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2385.0,
11459,Rattus norvegicus,CHEMBL623125,Intermediate,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11460,Rattus norvegicus,CHEMBL623126,Intermediate,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11461,Rattus norvegicus,CHEMBL623127,Intermediate,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11462,Rattus norvegicus,CHEMBL623128,Intermediate,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11463,Rattus norvegicus,CHEMBL623129,Intermediate,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11464,Rattus norvegicus,CHEMBL623130,Intermediate,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11465,Rattus norvegicus,CHEMBL623131,Intermediate,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11466,Rattus norvegicus,CHEMBL623132,Intermediate,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11467,Rattus norvegicus,CHEMBL623133,Intermediate,Liver,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,2107.0,
11468,Rattus norvegicus,CHEMBL623134,Intermediate,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11469,Rattus norvegicus,CHEMBL874389,Intermediate,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11470,Rattus norvegicus,CHEMBL623135,Intermediate,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11471,Rattus norvegicus,CHEMBL623136,Intermediate,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11472,Rattus norvegicus,CHEMBL623137,Intermediate,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11473,Rattus norvegicus,CHEMBL623138,Intermediate,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11474,Rattus norvegicus,CHEMBL623139,Intermediate,Kidney,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,2113.0,
11475,Rattus norvegicus,CHEMBL623140,Intermediate,Kidney,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,2113.0,
11476,Rattus norvegicus,CHEMBL623141,Intermediate,Liver,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,2107.0,
11477,Rattus norvegicus,CHEMBL623142,Intermediate,Liver,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,2107.0,
11478,Rattus norvegicus,CHEMBL623143,Intermediate,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11479,Mus musculus,CHEMBL623144,Intermediate,Urine,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,N,10090.0,14571,50594,1,,,BAO_0000218,1088.0,
11480,Rattus norvegicus,CHEMBL623405,Intermediate,Urine,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,N,10116.0,14571,50597,1,,,BAO_0000218,1088.0,
11481,Rattus norvegicus,CHEMBL624074,Intermediate,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11482,Rattus norvegicus,CHEMBL624075,Intermediate,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11483,Rattus norvegicus,CHEMBL624076,Intermediate,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11484,Rattus norvegicus,CHEMBL624077,Intermediate,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11485,Rattus norvegicus,CHEMBL624078,Intermediate,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11486,Rattus norvegicus,CHEMBL624079,Intermediate,Kidney,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,2113.0,
11487,Rattus norvegicus,CHEMBL624261,Intermediate,Kidney,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,2113.0,
11488,Rattus norvegicus,CHEMBL624262,Intermediate,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11489,Rattus norvegicus,CHEMBL624263,Intermediate,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11490,Rattus norvegicus,CHEMBL624264,Intermediate,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11491,Rattus norvegicus,CHEMBL624265,Intermediate,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11492,Rattus norvegicus,CHEMBL624266,Intermediate,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11493,Rattus norvegicus,CHEMBL624267,Intermediate,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11494,Rattus norvegicus,CHEMBL624268,Intermediate,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11495,Rattus norvegicus,CHEMBL875227,Intermediate,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11496,Rattus norvegicus,CHEMBL624269,Intermediate,Kidney,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,2113.0,
11497,Rattus norvegicus,CHEMBL624270,Intermediate,Kidney,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,2113.0,
11498,Rattus norvegicus,CHEMBL624271,Intermediate,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11499,Rattus norvegicus,CHEMBL624272,Intermediate,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11500,Rattus norvegicus,CHEMBL624273,Intermediate,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,10116.0,8319,50597,1,,,BAO_0000218,,
11501,Rattus norvegicus,CHEMBL624274,Intermediate,Urine,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,N,10116.0,12064,50597,1,,,BAO_0000218,1088.0,
11502,Rattus norvegicus,CHEMBL624275,Intermediate,Urine,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,N,10116.0,12064,50597,1,,,BAO_0000218,1088.0,
11503,Rattus norvegicus,CHEMBL624276,Intermediate,Urine,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,N,10116.0,12064,50597,1,,,BAO_0000218,1088.0,
11504,Rattus norvegicus,CHEMBL624277,Intermediate,Urine,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,N,10116.0,12038,50597,1,,,BAO_0000218,1088.0,
11505,,CHEMBL624278,Autocuration,,% dose converted to 2-amino-5-chlorophenyl sulfate,,U,,14314,22224,1,,,BAO_0000019,,
11506,,CHEMBL624279,Autocuration,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,U,,14314,22224,1,,,BAO_0000019,,
11507,Rattus norvegicus,CHEMBL624280,Intermediate,Feces,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,N,10116.0,11488,50597,1,,,BAO_0000218,1988.0,
11508,Rattus norvegicus,CHEMBL624281,Intermediate,Feces,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,N,10116.0,11488,50597,1,,,BAO_0000218,1988.0,
11509,Rattus norvegicus,CHEMBL622933,Intermediate,Feces,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,N,10116.0,11488,50597,1,,,BAO_0000218,1988.0,
11510,Rattus norvegicus,CHEMBL622934,Intermediate,Feces,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,N,10116.0,11488,50597,1,,,BAO_0000218,1988.0,
11511,Rattus norvegicus,CHEMBL622935,Intermediate,Liver,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,N,10116.0,8829,50597,1,,,BAO_0000218,2107.0,
11512,Rattus norvegicus,CHEMBL622936,Intermediate,Liver,Biodistribution in Rat liver after 5 minutes of iv administration,,N,10116.0,8829,50597,1,,,BAO_0000218,2107.0,
11513,Rattus norvegicus,CHEMBL875228,Intermediate,Liver,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,N,10116.0,8829,50597,1,,,BAO_0000218,2107.0,
11514,Rattus norvegicus,CHEMBL622937,Intermediate,Lung,Biodistribution in Rat lung after 24 hours of iv administration,,N,10116.0,8829,50597,1,,,BAO_0000218,2048.0,
11515,Rattus norvegicus,CHEMBL622938,Intermediate,Lung,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,N,10116.0,8829,50597,1,,,BAO_0000218,2048.0,
11516,Rattus norvegicus,CHEMBL619736,Intermediate,Lung,Biodistribution in Rat lung after 30 minutes of iv administration,,N,10116.0,8829,50597,1,,,BAO_0000218,2048.0,
11517,Rattus norvegicus,CHEMBL625117,Intermediate,Lung,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,N,10116.0,8829,50597,1,,,BAO_0000218,2048.0,
11518,Rattus norvegicus,CHEMBL625118,Intermediate,Lung,Biodistribution in Rat lung after 5 minutes of iv administration,,N,10116.0,8829,50597,1,,,BAO_0000218,2048.0,
11519,Rattus norvegicus,CHEMBL625119,Intermediate,Lung,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,N,10116.0,8829,50597,1,,,BAO_0000218,2048.0,
11520,Rattus norvegicus,CHEMBL625120,Intermediate,Cerebellum,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,N,10116.0,14972,50597,1,,,BAO_0000218,2037.0,
11521,Rattus norvegicus,CHEMBL625121,Intermediate,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,N,10116.0,14972,50597,1,,,BAO_0000218,,
11522,Rattus norvegicus,CHEMBL625122,Intermediate,Thalamus,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,N,10116.0,14972,50597,1,,,BAO_0000218,10000006.0,
11523,Rattus norvegicus,CHEMBL622204,Intermediate,Blood,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10116.0,14608,50597,1,,,BAO_0000218,178.0,
11524,Rattus norvegicus,CHEMBL877503,Intermediate,Blood,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,178.0,
11525,Rattus norvegicus,CHEMBL627127,Intermediate,Blood,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,178.0,
11526,,CHEMBL627128,Autocuration,Hippocampus,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,U,,14608,22224,1,,,BAO_0000218,10000000.0,
11527,,CHEMBL627129,Autocuration,Hippocampus,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,U,,14608,22224,1,,,BAO_0000218,10000000.0,
11528,,CHEMBL627130,Autocuration,Hippocampus,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,U,,14608,22224,1,,,BAO_0000218,10000000.0,
11529,Rattus norvegicus,CHEMBL627131,Intermediate,Brain,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10116.0,14608,50597,1,,,BAO_0000218,955.0,
11530,Rattus norvegicus,CHEMBL627132,Intermediate,Brain,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,955.0,
11531,Rattus norvegicus,CHEMBL627133,Intermediate,Brain,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,955.0,
11532,Rattus norvegicus,CHEMBL627134,Intermediate,Cerebellum,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2037.0,
11533,Rattus norvegicus,CHEMBL627135,Intermediate,Cerebellum,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2037.0,
11534,Rattus norvegicus,CHEMBL627136,Intermediate,Cerebellum,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2037.0,
11535,Rattus norvegicus,CHEMBL628435,Intermediate,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10116.0,14608,50597,1,,,BAO_0000218,,
11536,Rattus norvegicus,CHEMBL628436,Intermediate,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,,
11537,Rattus norvegicus,CHEMBL628437,Intermediate,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,,
11538,Rattus norvegicus,CHEMBL628438,Intermediate,Heart,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10116.0,14608,50597,1,,,BAO_0000218,948.0,
11539,Rattus norvegicus,CHEMBL628439,Intermediate,Heart,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,948.0,
11540,Rattus norvegicus,CHEMBL628440,Intermediate,Heart,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,948.0,
11541,Rattus norvegicus,CHEMBL628441,Intermediate,Hippocampus,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10116.0,14608,50597,1,,,BAO_0000218,10000000.0,
11542,Rattus norvegicus,CHEMBL628442,Intermediate,Hippocampus,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,10000000.0,
11543,Rattus norvegicus,CHEMBL628443,Intermediate,Hippocampus,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,10000000.0,
11544,Rattus norvegicus,CHEMBL628444,Intermediate,Kidney,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2113.0,
11545,Rattus norvegicus,CHEMBL628445,Intermediate,Kidney,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2113.0,
11546,Rattus norvegicus,CHEMBL877504,Intermediate,Kidney,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2113.0,
11547,Rattus norvegicus,CHEMBL628446,Intermediate,Liver,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2107.0,
11548,Rattus norvegicus,CHEMBL626874,Intermediate,Liver,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2107.0,
11549,Rattus norvegicus,CHEMBL626875,Intermediate,Liver,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2107.0,
11550,Rattus norvegicus,CHEMBL626876,Intermediate,Lung,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2048.0,
11551,Rattus norvegicus,CHEMBL626877,Intermediate,Lung,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2048.0,
11552,Rattus norvegicus,CHEMBL626878,Intermediate,Lung,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2048.0,
11553,Rattus norvegicus,CHEMBL626879,Intermediate,Muscle tissue,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2385.0,
11554,Simiiformes,CHEMBL626880,Autocuration,Plasma,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,U,314293.0,8918,22224,1,,,BAO_0000218,1969.0,
11555,Mus musculus,CHEMBL626881,Intermediate,Plasma,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,N,10090.0,8918,50594,1,,,BAO_0000218,1969.0,
11556,Rattus norvegicus,CHEMBL626882,Intermediate,Plasma,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,N,10116.0,8918,50597,1,,,BAO_0000218,1969.0,
11557,Canis lupus familiaris,CHEMBL626883,Intermediate,Plasma,Peak plasma concentration was measured in dogs,,N,9615.0,14470,50588,1,,,BAO_0000218,1969.0,
11558,Rattus norvegicus,CHEMBL626884,Intermediate,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,10116.0,14393,50597,1,,,BAO_0000218,,
11559,Rattus norvegicus,CHEMBL626885,Intermediate,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,N,10116.0,14886,50597,1,,,BAO_0000218,,
11560,Rattus norvegicus,CHEMBL626886,Intermediate,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,N,10116.0,14886,50597,1,,,BAO_0000218,,
11561,Rattus norvegicus,CHEMBL626887,Intermediate,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,N,10116.0,14886,50597,1,,,BAO_0000218,,
11562,Rattus norvegicus,CHEMBL626888,Intermediate,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,10116.0,14393,50597,1,,,BAO_0000218,,
11563,Canis lupus familiaris,CHEMBL626889,Intermediate,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,N,9615.0,13465,50588,1,,,BAO_0000218,,
11564,Simiiformes,CHEMBL626761,Autocuration,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,U,314293.0,13465,22224,1,,,BAO_0000218,,
11565,Canis lupus familiaris,CHEMBL626762,Intermediate,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,N,9615.0,13465,50588,1,,,BAO_0000218,,
11566,Canis lupus familiaris,CHEMBL626763,Intermediate,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,N,9615.0,13465,50588,1,,,BAO_0000218,,
11567,Rattus norvegicus,CHEMBL626764,Intermediate,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,N,10116.0,13465,50597,1,,,BAO_0000218,,
11568,Rattus norvegicus,CHEMBL626765,Intermediate,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,N,10116.0,13465,50597,1,,,BAO_0000218,,
11569,Canis lupus familiaris,CHEMBL626766,Intermediate,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,N,9615.0,13465,50588,1,,,BAO_0000218,,
11570,Rattus norvegicus,CHEMBL626767,Intermediate,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,N,10116.0,13465,50597,1,,,BAO_0000218,,
11571,Rattus norvegicus,CHEMBL626768,Intermediate,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,N,10116.0,13465,50597,1,,,BAO_0000218,,
11572,Canis lupus familiaris,CHEMBL626769,Intermediate,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,N,9615.0,13465,50588,1,,,BAO_0000218,,
11573,Canis lupus familiaris,CHEMBL874463,Intermediate,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,N,9615.0,13465,50588,1,,,BAO_0000218,,
11574,Simiiformes,CHEMBL626770,Autocuration,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,U,314293.0,13465,22224,1,,,BAO_0000218,,
11575,Simiiformes,CHEMBL626771,Autocuration,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,U,314293.0,13465,22224,1,,,BAO_0000218,,
11576,Rattus norvegicus,CHEMBL626772,Intermediate,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,N,10116.0,13465,50597,1,,,BAO_0000218,,
11577,Macaca fascicularis,CHEMBL626773,Intermediate,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,N,9541.0,14731,100710,1,,,BAO_0000218,,
11578,Mus musculus,CHEMBL626774,Intermediate,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,N,10090.0,14731,50594,1,,,BAO_0000218,,
11579,Canis lupus familiaris,CHEMBL626775,Intermediate,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,N,9615.0,13376,50588,1,,,BAO_0000218,,
11580,Canis lupus familiaris,CHEMBL626776,Intermediate,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,N,9615.0,13376,50588,1,,,BAO_0000218,,
11581,Rattus norvegicus,CHEMBL626777,Intermediate,,Maximum concentration (Cmax) in rat when administered orally,,N,10116.0,14443,50597,1,,,BAO_0000218,,
11582,Simiiformes,CHEMBL626778,Autocuration,Plasma,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,U,314293.0,13465,22224,1,,,BAO_0000218,1969.0,
11583,Rattus norvegicus,CHEMBL626779,Autocuration,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,U,10116.0,16359,22224,1,,,BAO_0000218,,
11584,Rattus norvegicus,CHEMBL626780,Autocuration,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,U,10116.0,16359,22224,1,,,BAO_0000218,,
11585,,CHEMBL626781,Autocuration,Plasma,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,U,,15618,22224,1,,,BAO_0000218,1969.0,
11586,Rattus norvegicus,CHEMBL632164,Intermediate,,Pharmacokinetic profile Cmax was evaluated in rats,,N,10116.0,14554,50597,1,,,BAO_0000218,,
11587,Canis lupus familiaris,CHEMBL632165,Intermediate,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,N,9615.0,11537,50588,1,,,BAO_0000218,,
11588,Mus musculus,CHEMBL632166,Intermediate,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,N,10090.0,11537,50594,1,,,BAO_0000218,,
11589,Canis lupus familiaris,CHEMBL632167,Intermediate,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,N,9615.0,11537,50588,1,,,BAO_0000218,,
11590,Mus musculus,CHEMBL632168,Intermediate,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,N,10090.0,11537,50594,1,,,BAO_0000218,,
11591,Rattus norvegicus,CHEMBL632169,Autocuration,Plasma,Cmax in rat plasma,,U,10116.0,2021,22224,1,,,BAO_0000218,1969.0,
11592,Canis lupus familiaris,CHEMBL632170,Intermediate,Plasma,Cmax in dog plasma after 30mg/kg oral dose,,N,9615.0,5932,50588,1,,,BAO_0000218,1969.0,
11593,Rattus norvegicus,CHEMBL632171,Intermediate,Plasma,Cmax in rat plasma after 30mg/kg oral dose,,N,10116.0,5932,50597,1,,,BAO_0000218,1969.0,
11594,Rattus norvegicus,CHEMBL632172,Intermediate,Plasma,Plasma level in rats at 30 mg/kg,,N,10116.0,17320,50597,1,,,BAO_0000218,1969.0,
11595,Mus musculus,CHEMBL632173,Intermediate,Plasma,Tested for maximum plasma concentration in mice,,N,10090.0,15831,50594,1,,,BAO_0000218,1969.0,
11596,Rattus norvegicus,CHEMBL632174,Intermediate,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
11597,Rattus norvegicus,CHEMBL632175,Intermediate,,The Cmax values in female wistar rats.,,N,10116.0,14941,50597,1,,,BAO_0000218,,
11598,Canis lupus familiaris,CHEMBL632176,Intermediate,Plasma,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,N,9615.0,15343,50588,1,,,BAO_0000218,1969.0,
11599,Rattus norvegicus,CHEMBL632177,Intermediate,Plasma,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,N,10116.0,15343,50597,1,,,BAO_0000218,1969.0,
11600,Rattus norvegicus,CHEMBL632178,Intermediate,Plasma,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,N,10116.0,14856,50597,1,,,BAO_0000218,1969.0,
11601,Rattus norvegicus,CHEMBL632179,Intermediate,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,N,10116.0,13129,50597,1,,,BAO_0000218,,
11602,Rattus norvegicus,CHEMBL632180,Intermediate,Blood,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,N,10116.0,13098,50597,1,,,BAO_0000218,178.0,
11603,Rattus norvegicus,CHEMBL632181,Intermediate,Blood,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,N,10116.0,13098,50597,1,,,BAO_0000218,178.0,
11604,Rattus norvegicus,CHEMBL632182,Intermediate,Blood,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,N,10116.0,13098,50597,1,,,BAO_0000218,178.0,
11605,Mus musculus,CHEMBL632183,Autocuration,Blood,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,U,10090.0,15478,22224,1,,,BAO_0000218,178.0,
11606,Canis lupus familiaris,CHEMBL632184,Intermediate,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,N,9615.0,15341,50588,1,,,BAO_0000218,,
11607,Rattus norvegicus,CHEMBL874470,Intermediate,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,N,10116.0,15341,50597,1,,,BAO_0000218,,
11608,Rattus norvegicus,CHEMBL631302,Intermediate,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11609,Rattus norvegicus,CHEMBL631303,Intermediate,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11610,Rattus norvegicus,CHEMBL631304,Intermediate,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11611,Rattus norvegicus,CHEMBL631305,Intermediate,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11612,Rattus norvegicus,CHEMBL631306,Intermediate,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11613,Rattus norvegicus,CHEMBL631307,Intermediate,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11614,Rattus norvegicus,CHEMBL631308,Intermediate,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11615,Rattus norvegicus,CHEMBL625557,Intermediate,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,,
11616,Rattus norvegicus,CHEMBL625558,Intermediate,Spleen,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2106.0,
11617,Rattus norvegicus,CHEMBL625559,Intermediate,Spleen,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2106.0,
11618,Rattus norvegicus,CHEMBL625560,Intermediate,Spleen,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2106.0,
11619,Rattus norvegicus,CHEMBL625561,Intermediate,Spleen,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2106.0,
11620,Rattus norvegicus,CHEMBL625562,Intermediate,Spleen,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2106.0,
11621,Rattus norvegicus,CHEMBL875320,Intermediate,Spleen,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2106.0,
11622,Rattus norvegicus,CHEMBL625563,Intermediate,Spleen,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2106.0,
11623,Rattus norvegicus,CHEMBL625564,Intermediate,Spleen,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,2106.0,
11624,Rattus norvegicus,CHEMBL625565,Intermediate,Uterus,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,995.0,
11625,Rattus norvegicus,CHEMBL625566,Intermediate,Uterus,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,995.0,
11626,Rattus norvegicus,CHEMBL625567,Intermediate,Uterus,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,995.0,
11627,Rattus norvegicus,CHEMBL625568,Intermediate,Uterus,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,995.0,
11628,Rattus norvegicus,CHEMBL628217,Intermediate,Uterus,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,995.0,
11629,Rattus norvegicus,CHEMBL628218,Intermediate,Uterus,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,995.0,
11630,Rattus norvegicus,CHEMBL628219,Intermediate,Uterus,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,995.0,
11631,Rattus norvegicus,CHEMBL628220,Intermediate,Uterus,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,N,10116.0,8684,50597,1,,,BAO_0000218,995.0,
11632,,CHEMBL628221,Autocuration,,Distribution in the blood after 120 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11633,,CHEMBL628222,Autocuration,,Distribution in the blood after 15 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11634,,CHEMBL628223,Autocuration,,Distribution in the blood after 30 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11635,,CHEMBL628224,Autocuration,,Distribution in the blood after 5 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11636,,CHEMBL628225,Autocuration,,Distribution in the blood after 60 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11637,,CHEMBL628226,Autocuration,,Distribution in the blood after 90 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11638,,CHEMBL628227,Autocuration,,Distribution in the bone after 120 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11639,,CHEMBL875481,Autocuration,,Distribution in the bone after 15 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11640,,CHEMBL628228,Autocuration,,Distribution in the bone after 30 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11641,,CHEMBL628229,Autocuration,,Distribution in the bone after 5 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11642,,CHEMBL628230,Autocuration,,Distribution in the bone after 60 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11643,,CHEMBL628231,Autocuration,,Distribution in the bone after 90 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11644,,CHEMBL628232,Autocuration,,Distribution in the heart after 120 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11645,,CHEMBL628233,Autocuration,,Distribution in the heart after 15 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11646,,CHEMBL628234,Autocuration,,Distribution in the heart after 30 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11647,,CHEMBL628235,Autocuration,,Distribution in the heart after 5 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11648,,CHEMBL628236,Autocuration,,Distribution in the heart after 60 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11649,,CHEMBL628237,Autocuration,,Distribution in the heart after 90 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11650,,CHEMBL628238,Autocuration,,Distribution in the kidneys after 120 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11651,,CHEMBL628239,Autocuration,,Distribution in the kidneys after 15 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11652,,CHEMBL628240,Autocuration,,Distribution in the kidneys after 30 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11653,,CHEMBL628241,Autocuration,,Distribution in the kidneys after 5 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11654,,CHEMBL628242,Autocuration,,Distribution in the kidneys after 60 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11655,,CHEMBL875482,Autocuration,,Distribution in the kidneys after 90 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11656,,CHEMBL628243,Autocuration,,Distribution in the liver after 120 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11657,,CHEMBL628244,Autocuration,,Distribution in the liver after 15 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11658,,CHEMBL628245,Autocuration,,Distribution in the liver after 30 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11659,,CHEMBL628246,Autocuration,,Distribution in the liver after 5 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11660,,CHEMBL628247,Autocuration,,Distribution in the liver after 60 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11661,,CHEMBL628248,Autocuration,,Distribution in the liver after 90 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11662,,CHEMBL628249,Autocuration,,Distribution in the lung after 120 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11663,Mus musculus,CHEMBL625452,Intermediate,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,N,10090.0,14839,50594,1,,,BAO_0000218,,
11664,Mus musculus,CHEMBL625453,Intermediate,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,N,10090.0,14839,50594,1,,,BAO_0000218,,
11665,Mus musculus,CHEMBL625454,Intermediate,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,N,10090.0,14839,50594,1,,,BAO_0000218,,
11666,Mus musculus,CHEMBL623844,Intermediate,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,N,10090.0,14839,50594,1,,,BAO_0000218,,
11667,Rattus norvegicus,CHEMBL623845,Intermediate,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,N,10116.0,12178,50597,1,,,BAO_0000218,,
11668,Rattus norvegicus,CHEMBL623846,Intermediate,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,N,10116.0,12178,50597,1,,,BAO_0000218,,
11669,,CHEMBL623847,Autocuration,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,U,,12178,22224,1,,,BAO_0000218,,
11670,Macaca fascicularis,CHEMBL623848,Intermediate,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,9541.0,12186,100710,1,,,BAO_0000218,,
11671,Macaca fascicularis,CHEMBL623849,Intermediate,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,N,9541.0,12186,100710,1,,,BAO_0000218,,
11672,Macaca fascicularis,CHEMBL623850,Intermediate,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,9541.0,12186,100710,1,,,BAO_0000218,,
11673,Macaca fascicularis,CHEMBL623851,Intermediate,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,N,9541.0,12186,100710,1,,,BAO_0000218,,
11674,Simiiformes,CHEMBL623852,Autocuration,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,U,314293.0,12187,22224,1,,,BAO_0000218,,
11675,Mustela putorius furo,CHEMBL624551,Intermediate,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,N,9669.0,12187,50506,1,,,BAO_0000218,,
11676,Mustela putorius furo,CHEMBL624552,Intermediate,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,N,9669.0,12187,50506,1,,,BAO_0000218,,
11677,Simiiformes,CHEMBL624553,Autocuration,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,U,314293.0,12187,22224,1,,,BAO_0000218,,
11678,Simiiformes,CHEMBL624554,Autocuration,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,U,314293.0,12187,22224,1,,,BAO_0000218,,
11679,Rattus norvegicus,CHEMBL624555,Intermediate,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,N,10116.0,12187,50597,1,,,BAO_0000218,,
11680,Rattus norvegicus,CHEMBL624741,Intermediate,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,N,10116.0,12187,50597,1,,,BAO_0000218,,
11681,Canis lupus familiaris,CHEMBL624742,Intermediate,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,N,9615.0,14122,50588,1,,,BAO_0000218,,
11682,Cricetinae,CHEMBL624743,Intermediate,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,N,10026.0,14122,100712,1,,,BAO_0000218,,
11683,Rattus norvegicus,CHEMBL877606,Intermediate,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,N,10116.0,14122,50597,1,,,BAO_0000218,,
11684,,CHEMBL624744,Autocuration,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,U,,13391,22224,1,,,BAO_0000218,,
11685,,CHEMBL624745,Autocuration,Blood,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,U,,13391,22224,1,,,BAO_0000218,178.0,
11686,,CHEMBL624746,Autocuration,Blood,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,U,,13391,22224,1,,,BAO_0000218,178.0,
11687,,CHEMBL624747,Autocuration,Blood,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,U,,13391,22224,1,,,BAO_0000218,178.0,
11688,,CHEMBL624748,Autocuration,,Oral absorption expressed as Area under curve was determined,,U,,16360,22224,1,,,BAO_0000019,,
11689,Canis lupus familiaris,CHEMBL622504,Intermediate,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,N,9615.0,3673,50588,1,,,BAO_0000218,,
11690,Canis lupus familiaris,CHEMBL622505,Intermediate,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,N,9615.0,14122,50588,1,,,BAO_0000218,,
11691,Cricetinae,CHEMBL622506,Intermediate,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,N,10026.0,14122,100712,1,,,BAO_0000218,,
11692,Cricetinae,CHEMBL622507,Intermediate,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,N,10026.0,14122,100712,1,,,BAO_0000218,,
11693,Rattus norvegicus,CHEMBL622508,Intermediate,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,N,10116.0,14122,50597,1,,,BAO_0000218,,
11694,,CHEMBL622509,Autocuration,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,U,,13889,22224,1,,,BAO_0000019,,
11695,Rattus norvegicus,CHEMBL622510,Intermediate,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,10116.0,14393,50597,1,,,BAO_0000218,,
11696,Rattus norvegicus,CHEMBL622511,Intermediate,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,N,10116.0,17279,50597,1,,,BAO_0000218,,
11697,Macaca fascicularis,CHEMBL622512,Intermediate,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,N,9541.0,14548,100710,1,,,BAO_0000218,,
11698,Macaca fascicularis,CHEMBL622513,Intermediate,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,N,9541.0,14548,100710,1,,,BAO_0000218,,
11699,Macaca fascicularis,CHEMBL622514,Intermediate,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,N,9541.0,14548,100710,1,,,BAO_0000218,,
11700,Canis lupus familiaris,CHEMBL622515,Intermediate,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,N,9615.0,14548,50588,1,,,BAO_0000218,,
11701,Canis lupus familiaris,CHEMBL622516,Intermediate,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,N,9615.0,14548,50588,1,,,BAO_0000218,,
11702,Rattus norvegicus,CHEMBL622517,Intermediate,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,N,10116.0,14548,50597,1,,,BAO_0000218,,
11703,Rattus norvegicus,CHEMBL622518,Intermediate,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,N,10116.0,14548,50597,1,,,BAO_0000218,,
11704,Rattus norvegicus,CHEMBL622519,Intermediate,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,N,10116.0,14548,50597,1,,,BAO_0000218,,
11705,Rattus norvegicus,CHEMBL622520,Intermediate,Muscle tissue,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2385.0,
11706,Rattus norvegicus,CHEMBL622521,Intermediate,Muscle tissue,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2385.0,
11707,Mus musculus,CHEMBL625113,Intermediate,Zone of skin,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10090.0,14608,50594,1,,,BAO_0000218,14.0,
11708,Rattus norvegicus,CHEMBL625114,Intermediate,Zone of skin,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,14.0,
11709,Rattus norvegicus,CHEMBL874397,Intermediate,Zone of skin,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,14.0,
11710,Rattus norvegicus,CHEMBL625115,Intermediate,Spleen,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2106.0,
11711,Rattus norvegicus,CHEMBL625116,Intermediate,Spleen,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2106.0,
11712,Rattus norvegicus,CHEMBL623932,Intermediate,Spleen,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2106.0,
11713,Rattus norvegicus,CHEMBL623933,Intermediate,Striatum,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2435.0,
11714,Rattus norvegicus,CHEMBL623934,Intermediate,Striatum,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2435.0,
11715,Rattus norvegicus,CHEMBL623935,Intermediate,Striatum,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2435.0,
11716,Rattus norvegicus,CHEMBL623936,Intermediate,Thyroid gland,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2046.0,
11717,Rattus norvegicus,CHEMBL623937,Intermediate,Thyroid gland,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2046.0,
11718,Rattus norvegicus,CHEMBL623938,Intermediate,Thyroid gland,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,10116.0,14608,50597,1,,,BAO_0000218,2046.0,
11719,Mus musculus,CHEMBL623939,Intermediate,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11720,Mus musculus,CHEMBL623940,Intermediate,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11721,Mus musculus,CHEMBL623941,Intermediate,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11722,Mus musculus,CHEMBL627216,Intermediate,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11723,Mus musculus,CHEMBL623942,Intermediate,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11724,Mus musculus,CHEMBL618793,Intermediate,Brain,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,10090.0,15383,50594,1,,,BAO_0000218,955.0,
11725,Mus musculus,CHEMBL618794,Intermediate,Brain,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,955.0,
11726,Mus musculus,CHEMBL618795,Intermediate,Brain,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,955.0,
11727,Mus musculus,CHEMBL618796,Intermediate,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11728,Mus musculus,CHEMBL618797,Intermediate,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11729,Mus musculus,CHEMBL618798,Intermediate,Kidney,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,N,10090.0,15383,50594,1,,,BAO_0000218,2113.0,
11730,Mus musculus,CHEMBL618799,Intermediate,Kidney,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,10090.0,15383,50594,1,,,BAO_0000218,2113.0,
11731,Mus musculus,CHEMBL618800,Intermediate,Kidney,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2113.0,
11732,Mus musculus,CHEMBL618801,Intermediate,Kidney,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2113.0,
11733,Mus musculus,CHEMBL618802,Intermediate,Kidney,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2113.0,
11734,Mus musculus,CHEMBL618803,Intermediate,Kidney,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2113.0,
11735,Mus musculus,CHEMBL618804,Intermediate,Liver,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,N,10090.0,15383,50594,1,,,BAO_0000218,2107.0,
11736,Mus musculus,CHEMBL618805,Intermediate,Liver,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,10090.0,15383,50594,1,,,BAO_0000218,2107.0,
11737,Mus musculus,CHEMBL618806,Intermediate,Liver,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2107.0,
11738,Mus musculus,CHEMBL618807,Intermediate,Liver,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2107.0,
11739,Mus musculus,CHEMBL618808,Intermediate,Liver,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2107.0,
11740,Mus musculus,CHEMBL618809,Intermediate,Liver,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2107.0,
11741,Mus musculus,CHEMBL618810,Intermediate,Muscle tissue,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,10090.0,15383,50594,1,,,BAO_0000218,2385.0,
11742,Mus musculus,CHEMBL618811,Intermediate,Muscle tissue,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2385.0,
11743,Mus musculus,CHEMBL875844,Intermediate,Muscle tissue,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2385.0,
11744,Mus musculus,CHEMBL618812,Intermediate,Muscle tissue,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2385.0,
11745,Mus musculus,CHEMBL618813,Intermediate,Muscle tissue,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2385.0,
11746,Mus musculus,CHEMBL618814,Intermediate,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11747,Mus musculus,CHEMBL618815,Intermediate,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11748,Mus musculus,CHEMBL618816,Intermediate,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11749,Mus musculus,CHEMBL618817,Intermediate,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11750,Mus musculus,CHEMBL620544,Intermediate,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11751,Rattus norvegicus,CHEMBL626230,Intermediate,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,N,10116.0,15341,50597,1,,,BAO_0000218,,
11752,Rattus norvegicus,CHEMBL626231,Intermediate,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,N,10116.0,15341,50597,1,,,BAO_0000218,,
11753,Rattus norvegicus,CHEMBL626232,Intermediate,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,N,10116.0,15341,50597,1,,,BAO_0000218,,
11754,Canis lupus familiaris,CHEMBL626233,Intermediate,Plasma,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,N,9615.0,14906,50588,1,,,BAO_0000218,1969.0,
11755,Rattus norvegicus,CHEMBL626234,Intermediate,Plasma,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,N,10116.0,14906,50597,1,,,BAO_0000218,1969.0,
11756,Rattus norvegicus,CHEMBL875341,Intermediate,Plasma,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,N,10116.0,14906,50597,1,,,BAO_0000218,1969.0,
11757,Homo sapiens,CHEMBL626235,Intermediate,Plasma,The maximum plasma concentration (100 mg/kg) administered orally in human,,N,9606.0,14215,50587,1,,,BAO_0000218,1969.0,
11758,Callithrix,CHEMBL626236,Autocuration,Plasma,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,U,9481.0,14215,22224,1,,,BAO_0000218,1969.0,
11759,Simiiformes,CHEMBL626237,Autocuration,Plasma,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,U,314293.0,14215,22224,1,,,BAO_0000218,1969.0,
11760,Canis lupus familiaris,CHEMBL626238,Intermediate,Plasma,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,N,9615.0,14215,50588,1,,,BAO_0000218,1969.0,
11761,Homo sapiens,CHEMBL622412,Intermediate,Plasma,The maximum plasma concentration (200 mg/kg) administered orally in human,,N,9606.0,14215,50587,1,,,BAO_0000218,1969.0,
11762,Rattus norvegicus,CHEMBL623114,Intermediate,Plasma,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,N,10116.0,14215,50597,1,,,BAO_0000218,1969.0,
11763,Callithrix,CHEMBL623115,Autocuration,Plasma,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,U,9481.0,14215,22224,1,,,BAO_0000218,1969.0,
11764,Simiiformes,CHEMBL623116,Autocuration,Plasma,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,U,314293.0,14215,22224,1,,,BAO_0000218,1969.0,
11765,Canis lupus familiaris,CHEMBL623117,Autocuration,Plasma,The maximum plasma concentration (30 mg/kg) administered orally in dog,,U,9615.0,14215,22224,1,,,BAO_0000218,1969.0,
11766,Homo sapiens,CHEMBL623118,Intermediate,Plasma,The maximum plasma concentration (400 mg/kg) administered orally in human,,N,9606.0,14215,50587,1,,,BAO_0000218,1969.0,
11767,Rattus norvegicus,CHEMBL623119,Intermediate,Plasma,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,N,10116.0,14215,50597,1,,,BAO_0000218,1969.0,
11768,Rattus norvegicus,CHEMBL623120,Intermediate,Plasma,The maximum plasma concentration (50 mg/kg) administered orally in rat,,N,10116.0,14215,50597,1,,,BAO_0000218,1969.0,
11769,Homo sapiens,CHEMBL623286,Intermediate,Plasma,The maximum plasma concentration (800 mg/kg) administered orally in human,,N,9606.0,14215,50587,1,,,BAO_0000218,1969.0,
11770,Rattus norvegicus,CHEMBL623287,Intermediate,Plasma,The maximum plasma concentration was measured on rats,,N,10116.0,14067,50597,1,,,BAO_0000218,1969.0,
11771,Rattus norvegicus,CHEMBL623288,Intermediate,Plasma,The maximum plasma concentration was measured on rats after oral administration,,N,10116.0,12350,50597,1,,,BAO_0000218,1969.0,
11772,Rattus norvegicus,CHEMBL623289,Intermediate,Plasma,Plasma drug Cmax in rat (PO dose),,N,10116.0,14813,50597,1,,,BAO_0000218,1969.0,
11773,,CHEMBL623290,Autocuration,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,U,,12536,22224,1,,,BAO_0000218,,
11774,Canis lupus familiaris,CHEMBL623291,Intermediate,Plasma,maximum Plasma concentration in Dog was determined after Peroral administration,,N,9615.0,14169,50588,1,,,BAO_0000218,1969.0,
11775,Rattus norvegicus,CHEMBL623292,Intermediate,Plasma,maximum Plasma concentration in Rats was determined after Peroral administration,,N,10116.0,14169,50597,1,,,BAO_0000218,1969.0,
11776,Canis lupus familiaris,CHEMBL623293,Intermediate,Plasma,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,N,9615.0,15604,50588,1,,,BAO_0000218,1969.0,
11777,Simiiformes,CHEMBL623294,Autocuration,Plasma,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,U,314293.0,15604,22224,1,,,BAO_0000218,1969.0,
11778,Rattus norvegicus,CHEMBL623295,Intermediate,Plasma,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,N,10116.0,15604,50597,1,,,BAO_0000218,1969.0,
11779,Mus musculus,CHEMBL623296,Intermediate,,maximum concentration was measured when administered through oral route in mice,,N,10090.0,14387,50594,1,,,BAO_0000218,,
11780,Mus musculus,CHEMBL875349,Intermediate,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,N,10090.0,15115,50594,1,,,BAO_0000218,,
11781,Simiiformes,CHEMBL623297,Autocuration,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,U,314293.0,15115,22224,1,,,BAO_0000019,,
11782,Simiiformes,CHEMBL623298,Autocuration,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,U,314293.0,15115,22224,1,,,BAO_0000019,,
11783,Simiiformes,CHEMBL623299,Autocuration,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,U,314293.0,15115,22224,1,,,BAO_0000019,,
11784,Rattus norvegicus,CHEMBL623300,Intermediate,,Pharmacokinetic parameter was evaluated in rats,,N,10116.0,16359,50597,1,,,BAO_0000218,,
11785,Mus musculus,CHEMBL623301,Intermediate,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,N,10090.0,12829,50594,1,,,BAO_0000218,,
11786,Mus musculus,CHEMBL623302,Intermediate,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,N,10090.0,12829,50594,1,,,BAO_0000218,,
11787,Mus musculus,CHEMBL623303,Intermediate,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,N,10090.0,12829,50594,1,,,BAO_0000218,,
11788,Mus musculus,CHEMBL623304,Intermediate,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,N,10090.0,12829,50594,1,,,BAO_0000218,,
11789,Mus musculus,CHEMBL623305,Intermediate,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,N,10090.0,12829,50594,1,,,BAO_0000218,,
11790,Rattus norvegicus,CHEMBL623306,Intermediate,Plasma,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,N,10116.0,15137,50597,1,,,BAO_0000218,1969.0,
11791,Rattus norvegicus,CHEMBL623307,Intermediate,Plasma,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,N,10116.0,15137,50597,1,,,BAO_0000218,1969.0,
11792,Rattus norvegicus,CHEMBL623308,Intermediate,Plasma,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,N,10116.0,15137,50597,1,,,BAO_0000218,1969.0,
11793,Mus musculus,CHEMBL623309,Intermediate,Plasma,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,N,10090.0,15137,50594,1,,,BAO_0000218,1969.0,
11794,Mus musculus,CHEMBL623310,Intermediate,,Plasma Concentration after 120 min of oral administration to mice,,N,10090.0,13509,50594,1,,,BAO_0000218,,
11795,Mus musculus,CHEMBL623311,Intermediate,,Plasma Concentration after 30 min of oral administration to mice,,N,10090.0,13509,50594,1,,,BAO_0000218,,
11796,Macaca fascicularis,CHEMBL623312,Intermediate,,Plasma Concentration after 60 min of oral administration to mice,,N,9541.0,13509,100710,1,,,BAO_0000218,,
11797,Mus musculus,CHEMBL875350,Intermediate,,Plasma Concentration after 60 min of oral administration to mice; Not determined,,N,10090.0,13509,50594,1,,,BAO_0000218,,
11798,Mus musculus,CHEMBL628635,Intermediate,,Plasma Concentration after 90 min of oral administration to mice,,N,10090.0,13509,50594,1,,,BAO_0000218,,
11799,Rattus norvegicus,CHEMBL628636,Intermediate,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,N,10116.0,12064,50597,1,,,BAO_0000218,,
11800,Rattus norvegicus,CHEMBL628637,Intermediate,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,N,10116.0,12064,50597,1,,,BAO_0000218,,
11801,Rattus norvegicus,CHEMBL628058,Intermediate,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,N,10116.0,12064,50597,1,,,BAO_0000218,,
11802,Rattus norvegicus,CHEMBL628059,Intermediate,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,N,10116.0,10677,50597,1,,,BAO_0000218,,
11803,Rattus norvegicus,CHEMBL628060,Intermediate,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,N,10116.0,10677,50597,1,,,BAO_0000218,,
11804,,CHEMBL628061,Autocuration,,Distribution in the lung after 15 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11805,,CHEMBL628062,Autocuration,,Distribution in the lung after 30 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11806,,CHEMBL628063,Autocuration,,Distribution in the lung after 5 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11807,,CHEMBL628064,Autocuration,,Distribution in the lung after 60 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11808,,CHEMBL628065,Autocuration,,Distribution in the lung after 90 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,,
11809,,CHEMBL628066,Autocuration,Muscle tissue,Distribution in the muscle after 120 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,2385.0,
11810,,CHEMBL628067,Autocuration,Muscle tissue,Distribution in the muscle after 15 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,2385.0,
11811,Mus musculus,CHEMBL874646,Intermediate,Muscle tissue,Distribution in the muscle after 30 min of intravenous administration,,N,10090.0,8926,50594,1,,,BAO_0000218,2385.0,
11812,,CHEMBL628068,Autocuration,Muscle tissue,Distribution in the muscle after 5 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,2385.0,
11813,,CHEMBL628069,Autocuration,Muscle tissue,Distribution in the muscle after 60 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,2385.0,
11814,,CHEMBL628070,Autocuration,Muscle tissue,Distribution in the muscle after 90 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,2385.0,
11815,,CHEMBL628071,Autocuration,Spleen,Distribution in the spleen after 120 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,2106.0,
11816,,CHEMBL628072,Autocuration,Spleen,Distribution in the spleen after 15 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,2106.0,
11817,,CHEMBL628073,Autocuration,Spleen,Distribution in the spleen after 30 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,2106.0,
11818,,CHEMBL628074,Autocuration,Spleen,Distribution in the spleen after 5 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,2106.0,
11819,,CHEMBL628075,Autocuration,Spleen,Distribution in the spleen after 60 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,2106.0,
11820,,CHEMBL628076,Autocuration,Spleen,Distribution in the spleen after 90 min of intravenous administration,,U,,8926,22224,1,,,BAO_0000019,2106.0,
11821,Rattus norvegicus,CHEMBL628077,Intermediate,Adrenal cortex,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,N,10116.0,7570,50597,1,,,BAO_0000218,1235.0,
11822,Rattus norvegicus,CHEMBL628078,Intermediate,Blood,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,N,10116.0,7570,50597,1,,,BAO_0000218,178.0,
11823,Rattus norvegicus,CHEMBL628079,Intermediate,Liver,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,N,10116.0,7570,50597,1,,,BAO_0000218,2107.0,
11824,Rattus norvegicus,CHEMBL628080,Intermediate,Female gonad,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,N,10116.0,7570,50597,1,,,BAO_0000218,992.0,
11825,Rattus norvegicus,CHEMBL628081,Intermediate,Thyroid gland,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,N,10116.0,7570,50597,1,,,BAO_0000218,2046.0,
11826,Rattus norvegicus,CHEMBL628082,Intermediate,Adrenal cortex,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,N,10116.0,7570,50597,1,,,BAO_0000218,1235.0,
11827,Rattus norvegicus,CHEMBL874647,Intermediate,Blood,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,N,10116.0,7570,50597,1,,,BAO_0000218,178.0,
11828,Rattus norvegicus,CHEMBL626406,Intermediate,Liver,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,N,10116.0,7570,50597,1,,,BAO_0000218,2107.0,
11829,Rattus norvegicus,CHEMBL626407,Intermediate,Female gonad,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,N,10116.0,7570,50597,1,,,BAO_0000218,992.0,
11830,Rattus norvegicus,CHEMBL626408,Intermediate,Thyroid gland,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,N,10116.0,7570,50597,1,,,BAO_0000218,2046.0,
11831,Rattus norvegicus,CHEMBL626409,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11832,Rattus norvegicus,CHEMBL626410,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11833,Rattus norvegicus,CHEMBL626411,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11834,Rattus norvegicus,CHEMBL626412,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11835,Rattus norvegicus,CHEMBL626413,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11836,Rattus norvegicus,CHEMBL626414,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11837,Rattus norvegicus,CHEMBL626415,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11838,Rattus norvegicus,CHEMBL626416,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11839,Rattus norvegicus,CHEMBL627062,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11840,Rattus norvegicus,CHEMBL627063,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11841,Rattus norvegicus,CHEMBL627064,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11842,Rattus norvegicus,CHEMBL627227,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11843,Rattus norvegicus,CHEMBL627228,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11844,Rattus norvegicus,CHEMBL627229,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11845,Rattus norvegicus,CHEMBL625792,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11846,Rattus norvegicus,CHEMBL625793,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11847,Rattus norvegicus,CHEMBL625794,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11848,Rattus norvegicus,CHEMBL625795,Intermediate,Blood,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,N,10116.0,8608,50597,1,,,BAO_0000218,178.0,
11849,Mus musculus,CHEMBL625796,Intermediate,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,N,10090.0,13792,50594,1,,,BAO_0000218,,
11850,Canis lupus familiaris,CHEMBL625797,Intermediate,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,N,9615.0,13376,50588,1,,,BAO_0000218,,
11851,Canis lupus familiaris,CHEMBL625798,Intermediate,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,N,9615.0,13376,50588,1,,,BAO_0000218,,
11852,,CHEMBL875613,Autocuration,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,,
11853,,CHEMBL625799,Autocuration,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,,
11854,,CHEMBL625800,Autocuration,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,,
11855,,CHEMBL625801,Autocuration,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,,
11856,,CHEMBL625802,Autocuration,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,,
11857,,CHEMBL625803,Autocuration,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,,
11858,,CHEMBL625804,Autocuration,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,U,,14380,22224,1,,,BAO_0000019,,
11859,,CHEMBL622530,Autocuration,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,U,,14380,22224,1,,,BAO_0000218,,
11860,Mus musculus,CHEMBL622531,Intermediate,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,N,10090.0,13701,50594,1,,,BAO_0000218,,
11861,Mus musculus,CHEMBL622532,Intermediate,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11862,Mus musculus,CHEMBL623176,Intermediate,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11863,Mus musculus,CHEMBL623177,Intermediate,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11864,Mus musculus,CHEMBL623178,Intermediate,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11865,Mus musculus,CHEMBL623179,Intermediate,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,N,10090.0,13701,50594,1,,,BAO_0000218,,
11866,Mus musculus,CHEMBL623180,Intermediate,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11867,Mus musculus,CHEMBL623181,Intermediate,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11868,Mus musculus,CHEMBL624131,Intermediate,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11869,Mus musculus,CHEMBL624132,Intermediate,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11870,Mus musculus,CHEMBL624133,Intermediate,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11871,Mus musculus,CHEMBL624846,Intermediate,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,N,10090.0,13701,50594,1,,,BAO_0000218,,
11872,Mus musculus,CHEMBL624847,Intermediate,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11873,Mus musculus,CHEMBL624848,Intermediate,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11874,Mus musculus,CHEMBL625012,Intermediate,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11875,Mus musculus,CHEMBL625013,Intermediate,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11876,Mus musculus,CHEMBL625014,Intermediate,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,N,10090.0,13701,50594,1,,,BAO_0000218,,
11877,Mus musculus,CHEMBL625015,Intermediate,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11878,Mus musculus,CHEMBL625016,Intermediate,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11879,Mus musculus,CHEMBL625017,Intermediate,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,N,10090.0,13701,50594,1,,,BAO_0000218,,
11880,Mus musculus,CHEMBL625018,Intermediate,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11881,Mus musculus,CHEMBL625019,Intermediate,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11882,Mus musculus,CHEMBL625020,Intermediate,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
11883,Mus musculus,CHEMBL625021,Intermediate,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,N,10090.0,13701,50594,1,,,BAO_0000218,,
11884,Rattus norvegicus,CHEMBL625022,Intermediate,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,10116.0,14393,50597,1,,,BAO_0000218,,
11885,Mus musculus,CHEMBL625023,Intermediate,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,N,10090.0,14731,50594,1,,,BAO_0000218,,
11886,Macaca fascicularis,CHEMBL625024,Intermediate,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,N,9541.0,14731,100710,1,,,BAO_0000218,,
11887,Macaca fascicularis,CHEMBL627626,Intermediate,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,N,9541.0,14731,100710,1,,,BAO_0000218,,
11888,,CHEMBL627627,Autocuration,Brain,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,U,,13758,22224,1,,,BAO_0000218,955.0,
11889,,CHEMBL627628,Autocuration,Serum,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,U,,13758,22224,1,,,BAO_0000218,1977.0,
11890,,CHEMBL627629,Autocuration,Brain,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,U,,13758,22224,1,,,BAO_0000218,955.0,
11891,,CHEMBL627630,Autocuration,Serum,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,U,,13758,22224,1,,,BAO_0000218,1977.0,
11892,,CHEMBL627631,Autocuration,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,U,,16359,22224,1,,,BAO_0000019,,
11893,,CHEMBL629515,Autocuration,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,U,,16359,22224,1,,,BAO_0000218,,
11894,Mus musculus,CHEMBL629516,Intermediate,Spleen,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,10090.0,15383,50594,1,,,BAO_0000218,2106.0,
11895,Mus musculus,CHEMBL629517,Intermediate,Spleen,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2106.0,
11896,Mus musculus,CHEMBL629518,Intermediate,Spleen,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,2106.0,
11897,Mus musculus,CHEMBL877499,Intermediate,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11898,Mus musculus,CHEMBL629519,Intermediate,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11899,Mus musculus,CHEMBL629520,Intermediate,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11900,Mus musculus,CHEMBL629521,Intermediate,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,10090.0,15383,50594,1,,,BAO_0000218,,
11901,Mus musculus,CHEMBL629522,Intermediate,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,N,10090.0,14439,50594,1,,,BAO_0000218,,
11902,Mus musculus,CHEMBL629523,Intermediate,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,N,10090.0,14439,50594,1,,,BAO_0000218,,
11903,Mus musculus,CHEMBL629524,Intermediate,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,N,10090.0,14439,50594,1,,,BAO_0000218,,
11904,Mus musculus,CHEMBL629525,Intermediate,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,N,10090.0,14439,50594,1,,,BAO_0000218,,
11905,Mus musculus,CHEMBL629526,Intermediate,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,N,10090.0,14439,50594,1,,,BAO_0000218,,
11906,Mus musculus,CHEMBL629527,Intermediate,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,N,10090.0,14439,50594,1,,,BAO_0000218,,
11907,Mus musculus,CHEMBL629528,Intermediate,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,N,10090.0,14439,50594,1,,,BAO_0000218,,
11908,Mus musculus,CHEMBL629529,Intermediate,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,N,10090.0,14439,50594,1,,,BAO_0000218,,
11909,Mus musculus,CHEMBL629530,Intermediate,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,N,10090.0,14439,50594,1,,,BAO_0000218,,
11910,Mus musculus,CHEMBL629531,Intermediate,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,N,10090.0,14439,50594,1,,,BAO_0000218,,
11911,Mus musculus,CHEMBL628656,Intermediate,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,N,10090.0,14439,50594,1,,,BAO_0000218,,
11912,Mus musculus,CHEMBL628657,Intermediate,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,N,10090.0,14439,50594,1,,,BAO_0000218,,
11913,Rattus norvegicus,CHEMBL628658,Intermediate,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
11914,Rattus norvegicus,CHEMBL628659,Intermediate,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
11915,Rattus norvegicus,CHEMBL877500,Intermediate,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
11916,Rattus norvegicus,CHEMBL628660,Intermediate,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
11917,Rattus norvegicus,CHEMBL628661,Intermediate,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
11918,Rattus norvegicus,CHEMBL628662,Intermediate,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
11919,Rattus norvegicus,CHEMBL628663,Intermediate,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
11920,Rattus norvegicus,CHEMBL628664,Intermediate,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
11921,Rattus norvegicus,CHEMBL628665,Intermediate,Blood,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,178.0,
11922,Rattus norvegicus,CHEMBL628666,Intermediate,Blood,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,178.0,
11923,Rattus norvegicus,CHEMBL628667,Intermediate,Blood,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,178.0,
11924,Rattus norvegicus,CHEMBL628668,Intermediate,Blood,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,178.0,
11925,Rattus norvegicus,CHEMBL628669,Intermediate,Blood,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,178.0,
11926,Rattus norvegicus,CHEMBL628670,Intermediate,Blood,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,178.0,
11927,Rattus norvegicus,CHEMBL628671,Intermediate,Blood,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,178.0,
11928,Rattus norvegicus,CHEMBL628672,Intermediate,Bone,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,10000001.0,
11929,Rattus norvegicus,CHEMBL630300,Intermediate,Bone,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,10000001.0,
11930,Rattus norvegicus,CHEMBL629787,Intermediate,Bone,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,10000001.0,
11931,Rattus norvegicus,CHEMBL629788,Intermediate,Bone,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,10000001.0,
11932,Rattus norvegicus,CHEMBL629789,Intermediate,Brain,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,955.0,
11933,Rattus norvegicus,CHEMBL629790,Intermediate,Brain,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,955.0,
11934,Rattus norvegicus,CHEMBL629791,Intermediate,Brain,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,955.0,
11935,Rattus norvegicus,CHEMBL629792,Intermediate,Brain,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,955.0,
11936,Rattus norvegicus,CHEMBL629793,Intermediate,Brain,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,955.0,
11937,Rattus norvegicus,CHEMBL629794,Intermediate,Brain,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,955.0,
11938,Rattus norvegicus,CHEMBL874459,Intermediate,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,N,10116.0,10677,50597,1,,,BAO_0000218,,
11939,Rattus norvegicus,CHEMBL629795,Intermediate,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,N,10116.0,10677,50597,1,,,BAO_0000218,,
11940,Rattus norvegicus,CHEMBL629796,Intermediate,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,N,10116.0,10677,50597,1,,,BAO_0000218,,
11941,Rattus norvegicus,CHEMBL629797,Intermediate,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,N,10116.0,10677,50597,1,,,BAO_0000218,,
11942,Rattus norvegicus,CHEMBL629798,Intermediate,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,N,10116.0,10677,50597,1,,,BAO_0000218,,
11943,Rattus norvegicus,CHEMBL629799,Intermediate,Adrenal gland,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2369.0,
11944,Rattus norvegicus,CHEMBL629800,Intermediate,Adrenal gland,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2369.0,
11945,Rattus norvegicus,CHEMBL629801,Intermediate,Adrenal gland,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2369.0,
11946,Rattus norvegicus,CHEMBL629802,Intermediate,Adrenal gland,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,N,10116.0,10911,50597,1,,,BAO_0000218,2369.0,
11947,Rattus norvegicus,CHEMBL629803,Intermediate,Adrenal gland,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2369.0,
11948,Rattus norvegicus,CHEMBL629804,Intermediate,Blood,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,178.0,
11949,Rattus norvegicus,CHEMBL629805,Intermediate,Blood,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,178.0,
11950,Rattus norvegicus,CHEMBL629806,Intermediate,Blood,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,178.0,
11951,Rattus norvegicus,CHEMBL629807,Intermediate,Blood,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,178.0,
11952,Rattus norvegicus,CHEMBL629808,Intermediate,Blood,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,178.0,
11953,Rattus norvegicus,CHEMBL629809,Intermediate,Brain,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,955.0,
11954,Rattus norvegicus,CHEMBL629810,Intermediate,Brain,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,955.0,
11955,Rattus norvegicus,CHEMBL629811,Intermediate,Brain,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,955.0,
11956,Rattus norvegicus,CHEMBL629812,Intermediate,Brain,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,955.0,
11957,Rattus norvegicus,CHEMBL629813,Intermediate,Brain,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,955.0,
11958,Rattus norvegicus,CHEMBL874460,Intermediate,Brain,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,955.0,
11959,Rattus norvegicus,CHEMBL629814,Intermediate,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,,
11960,Rattus norvegicus,CHEMBL629815,Intermediate,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,,
11961,Rattus norvegicus,CHEMBL629816,Intermediate,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,,
11962,Rattus norvegicus,CHEMBL629817,Intermediate,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,,
11963,Rattus norvegicus,CHEMBL626643,Intermediate,Kidney,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2113.0,
11964,Rattus norvegicus,CHEMBL626644,Intermediate,Kidney,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2113.0,
11965,Rattus norvegicus,CHEMBL626806,Intermediate,Kidney,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2113.0,
11966,Rattus norvegicus,CHEMBL626807,Intermediate,Kidney,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2113.0,
11967,Rattus norvegicus,CHEMBL627261,Intermediate,Liver,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2107.0,
11968,Rattus norvegicus,CHEMBL627262,Intermediate,Liver,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2107.0,
11969,Rattus norvegicus,CHEMBL627263,Intermediate,Liver,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2107.0,
11970,Rattus norvegicus,CHEMBL627264,Intermediate,Liver,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2107.0,
11971,Rattus norvegicus,CHEMBL627265,Intermediate,Lung,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2048.0,
11972,Rattus norvegicus,CHEMBL627266,Intermediate,Lung,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2048.0,
11973,Rattus norvegicus,CHEMBL627267,Intermediate,Lung,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2048.0,
11974,Rattus norvegicus,CHEMBL627268,Intermediate,Lung,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2048.0,
11975,Rattus norvegicus,CHEMBL627269,Intermediate,Muscle tissue,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2385.0,
11976,Rattus norvegicus,CHEMBL627270,Intermediate,Muscle tissue,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2385.0,
11977,Rattus norvegicus,CHEMBL627271,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11978,Rattus norvegicus,CHEMBL627946,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11979,Rattus norvegicus,CHEMBL875472,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11980,Rattus norvegicus,CHEMBL627947,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11981,Rattus norvegicus,CHEMBL627948,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11982,Rattus norvegicus,CHEMBL628113,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11983,Rattus norvegicus,CHEMBL628114,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11984,Rattus norvegicus,CHEMBL628115,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11985,Rattus norvegicus,CHEMBL628116,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11986,Rattus norvegicus,CHEMBL628117,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11987,Rattus norvegicus,CHEMBL628118,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11988,Rattus norvegicus,CHEMBL628119,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11989,Rattus norvegicus,CHEMBL628120,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11990,Rattus norvegicus,CHEMBL628121,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11991,Rattus norvegicus,CHEMBL628122,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11992,Rattus norvegicus,CHEMBL627297,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11993,Rattus norvegicus,CHEMBL627298,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11994,Rattus norvegicus,CHEMBL627299,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11995,Rattus norvegicus,CHEMBL627300,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11996,Rattus norvegicus,CHEMBL627301,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11997,Rattus norvegicus,CHEMBL627302,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11998,Rattus norvegicus,CHEMBL627303,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,N,10116.0,8608,50597,1,,,BAO_0000218,,
11999,Rattus norvegicus,CHEMBL627304,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12000,Rattus norvegicus,CHEMBL627305,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12001,Rattus norvegicus,CHEMBL627306,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12002,Rattus norvegicus,CHEMBL623982,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12003,Rattus norvegicus,CHEMBL623983,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12004,Rattus norvegicus,CHEMBL623984,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12005,Rattus norvegicus,CHEMBL623985,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12006,Rattus norvegicus,CHEMBL623986,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12007,Rattus norvegicus,CHEMBL623987,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12008,Rattus norvegicus,CHEMBL623988,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12009,Rattus norvegicus,CHEMBL623989,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12010,Rattus norvegicus,CHEMBL622215,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12011,Rattus norvegicus,CHEMBL622216,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12012,Rattus norvegicus,CHEMBL877481,Intermediate,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,N,10116.0,8608,50597,1,,,BAO_0000218,,
12013,,CHEMBL622217,Autocuration,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,U,,16359,22224,1,,,BAO_0000218,,
12014,Mus musculus,CHEMBL622218,Intermediate,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,N,10090.0,13701,50594,1,,,BAO_0000218,,
12015,Rattus norvegicus,CHEMBL622219,Intermediate,,Pharmacokinetic profile AUC was evaluated in rats,,N,10116.0,14554,50597,1,,,BAO_0000218,,
12016,,CHEMBL622220,Autocuration,,Pharmacokinetic property (Area under curve),,U,,6241,22224,1,,,BAO_0000019,,
12017,Canis lupus familiaris,CHEMBL622221,Intermediate,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,N,9615.0,11537,50588,1,,,BAO_0000218,,
12018,Mus musculus,CHEMBL622222,Intermediate,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,N,10090.0,11537,50594,1,,,BAO_0000218,,
12019,Canis lupus familiaris,CHEMBL622223,Intermediate,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,N,9615.0,11537,50588,1,,,BAO_0000218,,
12020,Mus musculus,CHEMBL622224,Intermediate,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,N,10090.0,11537,50594,1,,,BAO_0000218,,
12021,,CHEMBL622225,Autocuration,,Plasma concentration (AUC) was determined,,U,,13118,22224,1,,,BAO_0000019,,
12022,,CHEMBL622226,Autocuration,,Plasma concentration (AUC) was determined; Not detectable,,U,,13118,22224,1,,,BAO_0000019,,
12023,Cavia porcellus,CHEMBL624154,Intermediate,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,N,10141.0,9562,50512,1,,,BAO_0000218,,
12024,Rattus norvegicus,CHEMBL624155,Intermediate,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,N,10116.0,10363,50597,1,,,BAO_0000218,,
12025,Rattus norvegicus,CHEMBL624156,Intermediate,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,N,10116.0,10363,50597,1,,,BAO_0000218,,
12026,Rattus norvegicus,CHEMBL624157,Intermediate,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,N,10116.0,10363,50597,1,,,BAO_0000218,,
12027,Rattus norvegicus,CHEMBL624158,Intermediate,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,N,10116.0,10363,50597,1,,,BAO_0000218,,
12028,Rattus norvegicus,CHEMBL624159,Intermediate,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,N,10116.0,12504,50597,1,,,BAO_0000218,,
12029,Rattus norvegicus,CHEMBL624160,Intermediate,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,N,10116.0,12504,50597,1,,,BAO_0000218,,
12030,Rattus norvegicus,CHEMBL624161,Intermediate,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,N,10116.0,12504,50597,1,,,BAO_0000218,,
12031,Rattus norvegicus,CHEMBL624162,Intermediate,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,N,10116.0,12504,50597,1,,,BAO_0000218,,
12032,Canis lupus familiaris,CHEMBL624163,Intermediate,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,N,9615.0,13317,50588,1,,,BAO_0000218,,
12033,Rattus norvegicus,CHEMBL624164,Intermediate,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
12034,Rattus norvegicus,CHEMBL624165,Intermediate,,The AUC(0-infinity) values in female wistar rats.,,N,10116.0,14941,50597,1,,,BAO_0000218,,
12035,Rattus norvegicus,CHEMBL624166,Intermediate,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
12036,Rattus norvegicus,CHEMBL624167,Intermediate,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,N,10116.0,15078,50597,1,,,BAO_0000218,,
12037,Rattus norvegicus,CHEMBL624168,Intermediate,,The AUC(0-t)values in female wistar rats.,,N,10116.0,14941,50597,1,,,BAO_0000218,,
12038,Rattus norvegicus,CHEMBL624169,Intermediate,,The Area under the concentration time curve of compound was measured on rats,,N,10116.0,14067,50597,1,,,BAO_0000218,,
12039,Homo sapiens,CHEMBL624170,Intermediate,,The area under curve (100 mg/kg) administered orally in humans,,N,9606.0,14215,50587,1,,,BAO_0000218,,
12040,Callithrix,CHEMBL624171,Autocuration,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,U,9481.0,14215,22224,1,,,BAO_0000218,,
12041,Simiiformes,CHEMBL624172,Autocuration,,The area under curve (12.5 mg/kg) administered intravenously in monkey,,U,314293.0,14215,22224,1,,,BAO_0000218,,
12042,Canis lupus familiaris,CHEMBL624173,Intermediate,,The area under curve (15 mg/kg) administered intravenously in dog,,N,9615.0,14215,50588,1,,,BAO_0000218,,
12043,Homo sapiens,CHEMBL877488,Intermediate,,The area under curve (200 mg/kg) administered orally in humans,,N,9606.0,14215,50587,1,,,BAO_0000218,,
12044,Rattus norvegicus,CHEMBL624174,Intermediate,,The area under curve (25 mg/kg) administered intravenously in rat,,N,10116.0,14215,50597,1,,,BAO_0000218,,
12045,Callithrix,CHEMBL624175,Autocuration,,The area under curve (25 mg/kg) administered orally in marmoset,,U,9481.0,14215,22224,1,,,BAO_0000218,,
12046,Simiiformes,CHEMBL624176,Autocuration,,The area under curve (25 mg/kg) administered orally in monkey,,U,314293.0,14215,22224,1,,,BAO_0000218,,
12047,Canis lupus familiaris,CHEMBL624177,Intermediate,,The area under curve (30 mg/kg) administered orally in dog,,N,9615.0,14215,50588,1,,,BAO_0000218,,
12048,Homo sapiens,CHEMBL624178,Intermediate,,The area under curve (400 mg/kg) administered orally in humans,,N,9606.0,14215,50587,1,,,BAO_0000218,,
12049,Rattus norvegicus,CHEMBL624179,Intermediate,,The area under curve (50 mg/kg) administered orally in fasted rat,,N,10116.0,14215,50597,1,,,BAO_0000218,,
12050,Rattus norvegicus,CHEMBL627689,Intermediate,,The area under curve (50 mg/kg) administered orally in rat,,N,10116.0,14215,50597,1,,,BAO_0000218,,
12051,Homo sapiens,CHEMBL627690,Intermediate,,The area under curve (800 mg/kg) administered orally in humans,,N,9606.0,14215,50587,1,,,BAO_0000218,,
12052,,CHEMBL627691,Autocuration,,The compound was evaluated for area under the curve,,U,,11324,22224,1,,,BAO_0000019,,
12053,Callithrix,CHEMBL627692,Autocuration,,The compound was evaluated for area under the curve in marmosets,,U,9481.0,11324,22224,1,,,BAO_0000019,,
12054,Callithrix,CHEMBL627693,Autocuration,,The compound was evaluated for area under the curve in marmosets,,U,9481.0,11324,22224,1,,,BAO_0000019,,
12055,Rattus norvegicus,CHEMBL627694,Intermediate,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,N,10116.0,13875,50597,1,,,BAO_0000218,,
12056,Rattus norvegicus,CHEMBL627695,Intermediate,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,N,10116.0,13875,50597,1,,,BAO_0000218,,
12057,,CHEMBL627696,Autocuration,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,U,,13875,22224,1,,,BAO_0000218,,
12058,Rattus norvegicus,CHEMBL627697,Intermediate,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,N,10116.0,13875,50597,1,,,BAO_0000218,,
12059,Rattus norvegicus,CHEMBL627698,Intermediate,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,N,10116.0,13875,50597,1,,,BAO_0000218,,
12060,Rattus norvegicus,CHEMBL627699,Intermediate,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,N,10116.0,13875,50597,1,,,BAO_0000218,,
12061,Rattus norvegicus,CHEMBL627700,Intermediate,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,N,10116.0,13807,50597,1,,,BAO_0000218,,
12062,Rattus norvegicus,CHEMBL627701,Intermediate,,Total drug exposure is determined after oral dosing in rats.,,N,10116.0,14127,50597,1,,,BAO_0000218,,
12063,,CHEMBL627702,Autocuration,,Total drug exposure (5 mg/kg) when administered intravenously,,U,,15116,22224,1,,,BAO_0000218,,
12064,,CHEMBL627703,Autocuration,,Total drug exposure (5 mg/kg) when administered orally,,U,,15116,22224,1,,,BAO_0000218,,
12065,Simiiformes,CHEMBL626873,Autocuration,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,U,314293.0,15604,22224,1,,,BAO_0000218,,
12066,Rattus norvegicus,CHEMBL629583,Intermediate,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,N,10116.0,15604,50597,1,,,BAO_0000218,,
12067,Canis lupus familiaris,CHEMBL629584,Intermediate,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,N,9615.0,15604,50588,1,,,BAO_0000218,,
12068,Canis lupus familiaris,CHEMBL629585,Intermediate,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,N,9615.0,15604,50588,1,,,BAO_0000218,,
12069,Rattus norvegicus,CHEMBL629586,Intermediate,Brain,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,955.0,
12070,Rattus norvegicus,CHEMBL629587,Intermediate,Brain,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,955.0,
12071,Rattus norvegicus,CHEMBL629588,Intermediate,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
12072,Rattus norvegicus,CHEMBL629589,Intermediate,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
12073,Rattus norvegicus,CHEMBL629590,Intermediate,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
12074,Rattus norvegicus,CHEMBL629591,Intermediate,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
12075,Rattus norvegicus,CHEMBL629592,Intermediate,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
12076,Rattus norvegicus,CHEMBL629593,Intermediate,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
12077,Rattus norvegicus,CHEMBL629594,Intermediate,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
12078,Rattus norvegicus,CHEMBL629595,Intermediate,Heart,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,948.0,
12079,Rattus norvegicus,CHEMBL630290,Intermediate,Heart,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,948.0,
12080,Rattus norvegicus,CHEMBL627137,Intermediate,Heart,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,948.0,
12081,Rattus norvegicus,CHEMBL627138,Intermediate,Heart,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,948.0,
12082,Rattus norvegicus,CHEMBL627139,Intermediate,Heart,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,948.0,
12083,Rattus norvegicus,CHEMBL627140,Intermediate,Heart,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,948.0,
12084,Rattus norvegicus,CHEMBL627141,Intermediate,Heart,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,948.0,
12085,Rattus norvegicus,CHEMBL627142,Intermediate,Kidney,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2113.0,
12086,Rattus norvegicus,CHEMBL627143,Intermediate,Kidney,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2113.0,
12087,Rattus norvegicus,CHEMBL874449,Intermediate,Kidney,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2113.0,
12088,Rattus norvegicus,CHEMBL627144,Intermediate,Kidney,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2113.0,
12089,Rattus norvegicus,CHEMBL627145,Intermediate,Kidney,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2113.0,
12090,Rattus norvegicus,CHEMBL627146,Intermediate,Kidney,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2113.0,
12091,Rattus norvegicus,CHEMBL627147,Intermediate,Kidney,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2113.0,
12092,Rattus norvegicus,CHEMBL627148,Intermediate,Liver,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2107.0,
12093,Rattus norvegicus,CHEMBL627149,Intermediate,Lung,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2048.0,
12094,Rattus norvegicus,CHEMBL632160,Intermediate,Lung,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2048.0,
12095,Rattus norvegicus,CHEMBL632161,Intermediate,Lung,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2048.0,
12096,Rattus norvegicus,CHEMBL632162,Intermediate,Lung,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2048.0,
12097,Rattus norvegicus,CHEMBL632163,Intermediate,Lung,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2048.0,
12098,Rattus norvegicus,CHEMBL874469,Intermediate,Lung,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2048.0,
12099,Rattus norvegicus,CHEMBL627182,Intermediate,Lung,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2048.0,
12100,Rattus norvegicus,CHEMBL627183,Intermediate,Muscle tissue,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2385.0,
12101,Rattus norvegicus,CHEMBL627184,Intermediate,Muscle tissue,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2385.0,
12102,Rattus norvegicus,CHEMBL627185,Intermediate,Muscle tissue,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2385.0,
12103,Rattus norvegicus,CHEMBL627186,Intermediate,Muscle tissue,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2385.0,
12104,Rattus norvegicus,CHEMBL627187,Intermediate,Muscle tissue,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2385.0,
12105,Rattus norvegicus,CHEMBL627188,Intermediate,Muscle tissue,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2385.0,
12106,Rattus norvegicus,CHEMBL627189,Intermediate,Muscle tissue,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2385.0,
12107,Rattus norvegicus,CHEMBL627190,Intermediate,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,,
12108,Rattus norvegicus,CHEMBL627191,Intermediate,Liver,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2107.0,
12109,Rattus norvegicus,CHEMBL627192,Intermediate,Liver,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2107.0,
12110,Rattus norvegicus,CHEMBL627193,Intermediate,Liver,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2107.0,
12111,Rattus norvegicus,CHEMBL874590,Intermediate,Muscle tissue,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2385.0,
12112,Rattus norvegicus,CHEMBL627194,Intermediate,Muscle tissue,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2385.0,
12113,Rattus norvegicus,CHEMBL627195,Intermediate,Muscle tissue,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2385.0,
12114,Rattus norvegicus,CHEMBL627196,Intermediate,Female gonad,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,992.0,
12115,Rattus norvegicus,CHEMBL627197,Intermediate,Female gonad,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,992.0,
12116,Rattus norvegicus,CHEMBL627198,Intermediate,Female gonad,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,992.0,
12117,Rattus norvegicus,CHEMBL627199,Intermediate,Female gonad,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,N,10116.0,10911,50597,1,,,BAO_0000218,992.0,
12118,Rattus norvegicus,CHEMBL627200,Intermediate,Female gonad,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,992.0,
12119,Rattus norvegicus,CHEMBL627201,Intermediate,Plasma,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,1969.0,
12120,Rattus norvegicus,CHEMBL627202,Intermediate,Plasma,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,1969.0,
12121,Rattus norvegicus,CHEMBL627203,Intermediate,Plasma,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,1969.0,
12122,Rattus norvegicus,CHEMBL627204,Intermediate,Plasma,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,1969.0,
12123,Rattus norvegicus,CHEMBL627205,Intermediate,Spleen,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2106.0,
12124,Rattus norvegicus,CHEMBL627206,Intermediate,Spleen,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2106.0,
12125,Rattus norvegicus,CHEMBL627207,Intermediate,Spleen,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2106.0,
12126,Rattus norvegicus,CHEMBL627208,Intermediate,Spleen,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2106.0,
12127,Rattus norvegicus,CHEMBL627209,Intermediate,Thyroid gland,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2046.0,
12128,Rattus norvegicus,CHEMBL627210,Intermediate,Thyroid gland,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2046.0,
12129,Rattus norvegicus,CHEMBL627211,Intermediate,Thyroid gland,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2046.0,
12130,Rattus norvegicus,CHEMBL627212,Intermediate,Thyroid gland,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,2046.0,
12131,Rattus norvegicus,CHEMBL627213,Intermediate,Uterus,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,995.0,
12132,Rattus norvegicus,CHEMBL626599,Intermediate,Uterus,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,995.0,
12133,Rattus norvegicus,CHEMBL626600,Intermediate,Uterus,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,995.0,
12134,Rattus norvegicus,CHEMBL626601,Intermediate,Uterus,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,10116.0,10911,50597,1,,,BAO_0000218,995.0,
12135,,CHEMBL627484,Autocuration,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,U,,8081,22224,1,,,BAO_0000019,,
12136,Macaca fascicularis,CHEMBL627485,Intermediate,Plasma,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,N,9541.0,17248,100710,1,,,BAO_0000218,1969.0,
12137,Macaca fascicularis,CHEMBL628147,Intermediate,Plasma,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,N,9541.0,17248,100710,1,,,BAO_0000218,1969.0,
12138,Macaca fascicularis,CHEMBL628148,Intermediate,Plasma,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,N,9541.0,17248,100710,1,,,BAO_0000218,1969.0,
12139,Canis lupus familiaris,CHEMBL628149,Intermediate,Plasma,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,N,9615.0,17248,50588,1,,,BAO_0000218,1969.0,
12140,Canis lupus familiaris,CHEMBL628150,Intermediate,Plasma,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,N,9615.0,17248,50588,1,,,BAO_0000218,1969.0,
12141,Canis lupus familiaris,CHEMBL628318,Intermediate,Plasma,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,N,9615.0,17248,50588,1,,,BAO_0000218,1969.0,
12142,Canis lupus familiaris,CHEMBL628319,Intermediate,Plasma,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,N,9615.0,17248,50588,1,,,BAO_0000218,1969.0,
12143,Canis lupus familiaris,CHEMBL875609,Intermediate,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,N,9615.0,15592,50588,1,,,BAO_0000218,,
12144,,CHEMBL628320,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,U,,7040,22224,1,,,BAO_0000019,,
12145,,CHEMBL628321,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,U,,7040,22224,1,,,BAO_0000019,,
12146,,CHEMBL628322,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,U,,7040,22224,1,,,BAO_0000019,,
12147,,CHEMBL628323,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,U,,7040,22224,1,,,BAO_0000019,,
12148,,CHEMBL628324,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,U,,7040,22224,1,,,BAO_0000019,,
12149,,CHEMBL628325,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,U,,7040,22224,1,,,BAO_0000019,,
12150,,CHEMBL628326,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,U,,7040,22224,1,,,BAO_0000019,,
12151,Canis lupus familiaris,CHEMBL628327,Intermediate,Adrenal medulla,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,1236.0,
12152,Canis lupus familiaris,CHEMBL628328,Intermediate,Adrenal medulla,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,1236.0,
12153,Canis lupus familiaris,CHEMBL628329,Intermediate,Blood,"Concentration of compound in blood of dog 1, after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,178.0,
12154,Rattus norvegicus,CHEMBL628330,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12155,Rattus norvegicus,CHEMBL628331,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12156,Rattus norvegicus,CHEMBL628332,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12157,Rattus norvegicus,CHEMBL628333,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12158,Rattus norvegicus,CHEMBL628334,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12159,Rattus norvegicus,CHEMBL628335,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12160,Rattus norvegicus,CHEMBL628336,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12161,Rattus norvegicus,CHEMBL628337,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12162,Rattus norvegicus,CHEMBL628338,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12163,Rattus norvegicus,CHEMBL875610,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12164,Rattus norvegicus,CHEMBL628339,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12165,Rattus norvegicus,CHEMBL628340,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12166,Rattus norvegicus,CHEMBL628341,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12167,Rattus norvegicus,CHEMBL622214,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12168,Rattus norvegicus,CHEMBL623167,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12169,Rattus norvegicus,CHEMBL623168,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12170,Rattus norvegicus,CHEMBL623169,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12171,Rattus norvegicus,CHEMBL623170,Intermediate,Liver,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,N,10116.0,8608,50597,1,,,BAO_0000218,2107.0,
12172,Rattus norvegicus,CHEMBL627224,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12173,Rattus norvegicus,CHEMBL875634,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12174,Rattus norvegicus,CHEMBL627225,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12175,Rattus norvegicus,CHEMBL627226,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12176,Rattus norvegicus,CHEMBL626083,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12177,Rattus norvegicus,CHEMBL626084,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12178,Rattus norvegicus,CHEMBL626085,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12179,Rattus norvegicus,CHEMBL626086,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12180,Rattus norvegicus,CHEMBL626087,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12181,Rattus norvegicus,CHEMBL626088,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12182,Rattus norvegicus,CHEMBL626089,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12183,Rattus norvegicus,CHEMBL626090,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12184,Rattus norvegicus,CHEMBL626091,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12185,Rattus norvegicus,CHEMBL626092,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12186,Rattus norvegicus,CHEMBL626093,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12187,Rattus norvegicus,CHEMBL626094,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12188,Rattus norvegicus,CHEMBL626095,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12189,Rattus norvegicus,CHEMBL626096,Intermediate,Lung,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,N,10116.0,8608,50597,1,,,BAO_0000218,2048.0,
12190,Simiiformes,CHEMBL626097,Autocuration,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,U,314293.0,15604,22224,1,,,BAO_0000218,,
12191,Rattus norvegicus,CHEMBL626098,Intermediate,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,N,10116.0,15604,50597,1,,,BAO_0000218,,
12192,,CHEMBL626099,Autocuration,Plasma,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,U,,1806,22224,1,,,BAO_0000218,1969.0,
12193,,CHEMBL626100,Autocuration,Plasma,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,U,,1806,22224,1,,,BAO_0000218,1969.0,
12194,Canis lupus familiaris,CHEMBL626101,Intermediate,Plasma,AUC 0-inf in dog,,N,9615.0,17237,50588,1,,,BAO_0000218,1969.0,
12195,Cavia porcellus,CHEMBL626102,Intermediate,Plasma,AUC 0-inf in guinea pig,,N,10141.0,17237,50512,1,,,BAO_0000218,1969.0,
12196,Canis lupus familiaris,CHEMBL626103,Intermediate,Plasma,AUC 0-t in dog,,N,9615.0,17237,50588,1,,,BAO_0000218,1969.0,
12197,Cavia porcellus,CHEMBL628391,Intermediate,Plasma,AUC 0-t in guinea pig,,N,10141.0,17237,50512,1,,,BAO_0000218,1969.0,
12198,Rattus norvegicus,CHEMBL628392,Intermediate,,The compound was tested for brain to plasma partition in rat,,N,10116.0,15194,50597,1,,,BAO_0000218,,
12199,Rattus norvegicus,CHEMBL628393,Intermediate,,The compound was tested for brain to plasma partition in rat.,,N,10116.0,15194,50597,1,,,BAO_0000218,,
12200,,CHEMBL628394,Autocuration,Blood,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,U,,8787,22224,1,,,BAO_0000019,178.0,
12201,Canis lupus familiaris,CHEMBL628395,Intermediate,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,N,9615.0,17025,50588,1,,,BAO_0000218,,
12202,Simiiformes,CHEMBL628396,Autocuration,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,U,314293.0,17025,22224,1,,,BAO_0000218,,
12203,Oryctolagus cuniculus,CHEMBL628397,Intermediate,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,N,9986.0,17025,50592,1,,,BAO_0000218,,
12204,Rattus norvegicus,CHEMBL628398,Intermediate,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,N,10116.0,17025,50597,1,,,BAO_0000218,,
12205,Macaca mulatta,CHEMBL628399,Intermediate,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,N,9544.0,4236,50797,1,,,BAO_0000218,,
12206,Canis lupus familiaris,CHEMBL628400,Intermediate,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,N,9615.0,15343,50588,1,,,BAO_0000218,,
12207,Rattus norvegicus,CHEMBL874907,Intermediate,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,N,10116.0,15343,50597,1,,,BAO_0000218,,
12208,,CHEMBL628401,Autocuration,,Area under curve of the compound was determined,,U,,17720,22224,1,,,BAO_0000019,,
12209,Simiiformes,CHEMBL628402,Autocuration,Plasma,AUC in monkeys at a dose of 1 mg/kg,,U,314293.0,17788,22224,1,,,BAO_0000218,1969.0,
12210,Rattus norvegicus,CHEMBL628403,Intermediate,Plasma,AUC in rats at a dose of 1 mg/kg,,N,10116.0,17788,50597,1,,,BAO_0000218,1969.0,
12211,,CHEMBL628404,Autocuration,,Compound was evaluated for the overall absorbance loss at pH of 2,,U,,8778,22224,1,,,BAO_0000019,,
12212,,CHEMBL628405,Autocuration,,Compound was evaluated for the overall absorbance loss at pH of 4,,U,,8778,22224,1,,,BAO_0000019,,
12213,,CHEMBL628406,Autocuration,,Compound was evaluated for the overall absorbance loss at pH of 7,,U,,8778,22224,1,,,BAO_0000019,,
12214,Rattus norvegicus,CHEMBL628407,Intermediate,,Compound was evaluated for its absorption in the rats,,N,10116.0,2249,50597,1,,,BAO_0000218,,
12215,Rattus norvegicus,CHEMBL628408,Intermediate,Urine,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,N,10116.0,8881,50597,1,,,BAO_0000218,1088.0,
12216,Rattus norvegicus,CHEMBL629171,Intermediate,Urine,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,N,10116.0,8881,50597,1,,,BAO_0000218,1088.0,
12217,Rattus norvegicus,CHEMBL629172,Intermediate,Urine,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,N,10116.0,8881,50597,1,,,BAO_0000218,1088.0,
12218,Rattus norvegicus,CHEMBL629173,Intermediate,Urine,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,N,10116.0,8881,50597,1,,,BAO_0000218,1088.0,
12219,Rattus norvegicus,CHEMBL629174,Intermediate,,In vitro percent permeability into rat ileum,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12220,Rattus norvegicus,CHEMBL629175,Intermediate,,In vitro percent permeability into rat ileum; Range is 10-17,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12221,Rattus norvegicus,CHEMBL629176,Intermediate,,In vitro percent permeability into rat ileum; Range is 10-18,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12222,Rattus norvegicus,CHEMBL629177,Intermediate,,In vitro percent permeability into rat ileum; Range is 10-19,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12223,Rattus norvegicus,CHEMBL629178,Intermediate,,In vitro percent permeability into rat ileum; Range is 12-15,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12224,Rattus norvegicus,CHEMBL631869,Intermediate,,In vitro percent permeability into rat ileum; Range is 13-19,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12225,Rattus norvegicus,CHEMBL631870,Intermediate,,In vitro percent permeability into rat ileum; Range is 14-17,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12226,Rattus norvegicus,CHEMBL631871,Intermediate,,In vitro percent permeability into rat ileum; Range is 15-18,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12227,Rattus norvegicus,CHEMBL631872,Intermediate,,In vitro percent permeability into rat ileum; Range is 2-5,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12228,,CHEMBL875775,Autocuration,Ileum,In vitro percent permeability into rat ileum; Range is 23-42,,U,,15286,22224,1,,,BAO_0000221,2116.0,
12229,Rattus norvegicus,CHEMBL631873,Intermediate,,In vitro percent permeability into rat ileum; Range is 28-36,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12230,Rattus norvegicus,CHEMBL631874,Intermediate,,In vitro percent permeability into rat ileum; Range is 29-35,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12231,Rattus norvegicus,CHEMBL631875,Intermediate,,In vitro percent permeability into rat ileum; Range is 46-66,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12232,Rattus norvegicus,CHEMBL631876,Intermediate,,In vitro percent permeability into rat ileum; Range is 50-68,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12233,Rattus norvegicus,CHEMBL631877,Intermediate,,In vitro percent permeability into rat ileum; Range is 78-81,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12234,Rattus norvegicus,CHEMBL631878,Intermediate,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12235,Rattus norvegicus,CHEMBL631879,Intermediate,,In vitro percent permeability into rat ileum; nd indicates not detected,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12236,Rattus norvegicus,CHEMBL631880,Intermediate,,In vitro percent permeability into rat ileum; nt indicates not detected,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12237,Rattus norvegicus,CHEMBL631881,Intermediate,,In vitro percent permeability into rat ileum; nt indicates not tested,,N,10116.0,15286,50597,1,,,BAO_0000218,,
12238,Rattus norvegicus,CHEMBL631882,Intermediate,,Compound was tested for oral absorption in bile-duct cannulated rats,,N,10116.0,13770,50597,1,,,BAO_0000218,,
12239,Rattus norvegicus,CHEMBL630749,Intermediate,,Compound was tested for oral absorption in bile-duct cannulated rats.,,N,10116.0,13770,50597,1,,,BAO_0000218,,
12240,Homo sapiens,CHEMBL630750,Intermediate,,Oral absorption using Caco-2 cell monolayers.,,N,9606.0,5202,50587,1,,,BAO_0000218,,
12241,Homo sapiens,CHEMBL630253,Intermediate,,Percent of the drug absorbed after administration to humans was determined,,N,9606.0,14920,50587,1,,,BAO_0000218,,
12242,Rattus norvegicus,CHEMBL630254,Intermediate,Plasma,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12243,Rattus norvegicus,CHEMBL630255,Intermediate,Plasma,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12244,Rattus norvegicus,CHEMBL630256,Intermediate,Plasma,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12245,Rattus norvegicus,CHEMBL875781,Intermediate,Liver,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2107.0,
12246,Rattus norvegicus,CHEMBL630257,Intermediate,Liver,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2107.0,
12247,Rattus norvegicus,CHEMBL630258,Intermediate,Liver,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,10116.0,13751,50597,1,,,BAO_0000218,2107.0,
12248,Rattus norvegicus,CHEMBL630259,Intermediate,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,N,10116.0,15807,50597,1,,,BAO_0000218,,
12249,Rattus norvegicus,CHEMBL630260,Intermediate,Striatum,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,N,10116.0,15807,50597,1,,,BAO_0000218,2435.0,
12250,Rattus norvegicus,CHEMBL630261,Intermediate,Striatum,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,N,10116.0,15807,50597,1,,,BAO_0000218,2435.0,
12251,Rattus norvegicus,CHEMBL630262,Intermediate,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,N,10116.0,14950,50597,1,,,BAO_0000218,,
12252,Rattus norvegicus,CHEMBL630263,Intermediate,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,N,10116.0,14950,50597,1,,,BAO_0000218,,
12253,Rattus norvegicus,CHEMBL630264,Intermediate,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,,
12254,Rattus norvegicus,CHEMBL630265,Intermediate,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,,
12255,Rattus norvegicus,CHEMBL630266,Intermediate,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,,
12256,Rattus norvegicus,CHEMBL630267,Intermediate,Kidney,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,2113.0,
12257,Rattus norvegicus,CHEMBL630268,Intermediate,Kidney,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,2113.0,
12258,Rattus norvegicus,CHEMBL630269,Intermediate,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,N,10116.0,14950,50597,1,,,BAO_0000218,,
12259,Rattus norvegicus,CHEMBL630270,Intermediate,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,,
12260,Rattus norvegicus,CHEMBL630141,Intermediate,Lung,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,N,10116.0,14950,50597,1,,,BAO_0000218,2048.0,
12261,Rattus norvegicus,CHEMBL630142,Intermediate,Lung,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,2048.0,
12262,Rattus norvegicus,CHEMBL630143,Intermediate,Muscle tissue,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,2385.0,
12263,Rattus norvegicus,CHEMBL630144,Intermediate,Muscle tissue,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,2385.0,
12264,Rattus norvegicus,CHEMBL630145,Intermediate,Prostate gland,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,2367.0,
12265,Rattus norvegicus,CHEMBL630146,Intermediate,Prostate gland,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,2367.0,
12266,Rattus norvegicus,CHEMBL630147,Intermediate,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,N,10116.0,14950,50597,1,,,BAO_0000218,,
12267,Rattus norvegicus,CHEMBL630148,Intermediate,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,,
12268,Rattus norvegicus,CHEMBL630149,Intermediate,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,,
12269,Rattus norvegicus,CHEMBL630150,Intermediate,Spleen,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,N,10116.0,14950,50597,1,,,BAO_0000218,2106.0,
12270,Rattus norvegicus,CHEMBL630151,Intermediate,Spleen,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,2106.0,
12271,Rattus norvegicus,CHEMBL632031,Intermediate,Thyroid gland,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,2046.0,
12272,Rattus norvegicus,CHEMBL632032,Intermediate,Thyroid gland,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,N,10116.0,14950,50597,1,,,BAO_0000218,2046.0,
12273,Rattus norvegicus,CHEMBL632033,Intermediate,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,N,10116.0,14950,50597,1,,,BAO_0000218,,
12274,Rattus norvegicus,CHEMBL632034,Intermediate,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,N,10116.0,14950,50597,1,,,BAO_0000218,,
12275,Rattus norvegicus,CHEMBL632035,Intermediate,Muscle tissue,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,N,10116.0,14950,50597,1,,,BAO_0000218,2385.0,
12276,Rattus norvegicus,CHEMBL632036,Intermediate,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,N,10116.0,14950,50597,1,,,BAO_0000218,,
12277,Rattus norvegicus,CHEMBL632037,Intermediate,Thyroid gland,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,N,10116.0,14950,50597,1,,,BAO_0000218,2046.0,
12278,Rattus norvegicus,CHEMBL632038,Intermediate,Blood,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12279,Rattus norvegicus,CHEMBL632039,Intermediate,Blood,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12280,Rattus norvegicus,CHEMBL632040,Intermediate,Blood,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12281,Rattus norvegicus,CHEMBL632041,Intermediate,Blood,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12282,Canis lupus familiaris,CHEMBL632042,Intermediate,Blood,"Concentration of compound in blood of dog 2, after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,178.0,
12283,Canis lupus familiaris,CHEMBL632043,Intermediate,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,,
12284,Canis lupus familiaris,CHEMBL632044,Intermediate,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,,
12285,Canis lupus familiaris,CHEMBL632045,Intermediate,Liver,"Concentration of compound in liver of dog 1, after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,2107.0,
12286,Canis lupus familiaris,CHEMBL632046,Intermediate,Liver,"Concentration of compound in liver of dog 2, after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,2107.0,
12287,Canis lupus familiaris,CHEMBL632047,Intermediate,Lung,"Concentration of compound in lung of dog 1, after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,2048.0,
12288,Canis lupus familiaris,CHEMBL632048,Intermediate,Lung,"Concentration of compound in lung of dog 2, after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,2048.0,
12289,Canis lupus familiaris,CHEMBL632049,Intermediate,Muscle tissue,"Concentration of compound in muscle of dog 1, after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,2385.0,
12290,Canis lupus familiaris,CHEMBL876418,Intermediate,Muscle tissue,"Concentration of compound in muscle of dog 2, after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,2385.0,
12291,Canis lupus familiaris,CHEMBL632050,Intermediate,Spleen,"Concentration of compound in spleen of dog 1,after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,2106.0,
12292,Canis lupus familiaris,CHEMBL632051,Intermediate,Spleen,"Concentration of compound in spleen of dog 2, after administering intravenously",,N,9615.0,9614,50588,1,,,BAO_0000218,2106.0,
12293,,CHEMBL632052,Autocuration,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,U,,10353,22224,1,,,BAO_0000218,,
12294,,CHEMBL632053,Autocuration,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,U,,10353,22224,1,,,BAO_0000218,,
12295,,CHEMBL632054,Autocuration,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,U,,10353,22224,1,,,BAO_0000218,,
12296,,CHEMBL632055,Autocuration,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,U,,10353,22224,1,,,BAO_0000218,,
12297,,CHEMBL631181,Autocuration,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,U,,10353,22224,1,,,BAO_0000218,,
12298,,CHEMBL631182,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12299,,CHEMBL631183,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12300,,CHEMBL631184,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12301,,CHEMBL629774,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12302,,CHEMBL629775,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12303,,CHEMBL876549,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12304,,CHEMBL628172,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12305,,CHEMBL628173,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12306,,CHEMBL628174,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12307,,CHEMBL628175,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12308,,CHEMBL628176,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12309,,CHEMBL628177,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12310,,CHEMBL628178,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12311,,CHEMBL628179,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12312,,CHEMBL628180,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,U,,9196,22224,1,,,BAO_0000218,,
12313,,CHEMBL628181,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12314,,CHEMBL628182,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12315,,CHEMBL628183,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12316,,CHEMBL628184,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,U,,9196,22224,1,,,BAO_0000218,,
12317,,CHEMBL628185,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12318,,CHEMBL875617,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12319,,CHEMBL628186,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,U,,9196,22224,1,,,BAO_0000218,,
12320,,CHEMBL628187,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12321,,CHEMBL628188,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12322,,CHEMBL628189,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12323,,CHEMBL628190,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,U,,9196,22224,1,,,BAO_0000218,,
12324,,CHEMBL628191,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12325,,CHEMBL626513,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,U,,9196,22224,1,,,BAO_0000218,,
12326,Rattus norvegicus,CHEMBL626514,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12327,Rattus norvegicus,CHEMBL626515,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12328,Rattus norvegicus,CHEMBL626516,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12329,Rattus norvegicus,CHEMBL626517,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12330,Rattus norvegicus,CHEMBL626518,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12331,Rattus norvegicus,CHEMBL626519,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12332,Rattus norvegicus,CHEMBL626520,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12333,Rattus norvegicus,CHEMBL626521,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12334,Rattus norvegicus,CHEMBL626522,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12335,Rattus norvegicus,CHEMBL626523,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12336,Rattus norvegicus,CHEMBL626524,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12337,Rattus norvegicus,CHEMBL626688,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12338,Rattus norvegicus,CHEMBL626689,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12339,Rattus norvegicus,CHEMBL626690,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12340,Rattus norvegicus,CHEMBL626691,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12341,Rattus norvegicus,CHEMBL627319,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12342,Rattus norvegicus,CHEMBL624052,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12343,Rattus norvegicus,CHEMBL624053,Intermediate,Thyroid gland,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,N,10116.0,8608,50597,1,,,BAO_0000218,2046.0,
12344,Rattus norvegicus,CHEMBL624054,Intermediate,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,10116.0,8085,50597,1,,,BAO_0000218,,
12345,Rattus norvegicus,CHEMBL624055,Intermediate,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,10116.0,8085,50597,1,,,BAO_0000218,,
12346,Rattus norvegicus,CHEMBL624056,Intermediate,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,10116.0,8085,50597,1,,,BAO_0000218,,
12347,Rattus norvegicus,CHEMBL624057,Intermediate,Uterus,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,10116.0,8085,50597,1,,,BAO_0000218,995.0,
12348,Rattus norvegicus,CHEMBL622281,Intermediate,Uterus,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,10116.0,8085,50597,1,,,BAO_0000218,995.0,
12349,Rattus norvegicus,CHEMBL622282,Intermediate,Uterus,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,10116.0,8085,50597,1,,,BAO_0000218,995.0,
12350,Rattus norvegicus,CHEMBL622283,Intermediate,Uterus,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,10116.0,8085,50597,1,,,BAO_0000218,995.0,
12351,Rattus norvegicus,CHEMBL622284,Intermediate,Uterus,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,10116.0,8085,50597,1,,,BAO_0000218,995.0,
12352,Rattus norvegicus,CHEMBL622285,Intermediate,Uterus,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,10116.0,8085,50597,1,,,BAO_0000218,995.0,
12353,Rattus norvegicus,CHEMBL622286,Intermediate,Uterus,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,10116.0,8085,50597,1,,,BAO_0000218,995.0,
12354,,CHEMBL622287,Autocuration,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,U,,7657,22224,1,,,BAO_0000100,,
12355,Mus musculus,CHEMBL622288,Intermediate,,Partition coefficient (logD7.4),,N,10090.0,8935,50594,1,,,BAO_0000218,,
12356,Mus musculus,CHEMBL622289,Intermediate,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,N,10090.0,13792,50594,1,,,BAO_0000218,,
12357,Mus musculus,CHEMBL622290,Intermediate,Brain,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,N,10090.0,13792,50594,1,,,BAO_0000218,955.0,
12358,Mus musculus,CHEMBL622291,Intermediate,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,N,10090.0,13792,50594,1,,,BAO_0000218,,
12359,Mus musculus,CHEMBL622292,Intermediate,Brain,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,N,10090.0,13792,50594,1,,,BAO_0000218,955.0,
12360,Mus musculus,CHEMBL622293,Intermediate,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,N,10090.0,13792,50594,1,,,BAO_0000218,,
12361,Mus musculus,CHEMBL622294,Intermediate,Brain,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,N,10090.0,13792,50594,1,,,BAO_0000218,955.0,
12362,Mus musculus,CHEMBL622295,Intermediate,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,N,10090.0,13792,50594,1,,,BAO_0000218,,
12363,Rattus norvegicus,CHEMBL622296,Intermediate,Brain,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,N,10116.0,13792,50597,1,,,BAO_0000218,955.0,
12364,Rattus norvegicus,CHEMBL874409,Intermediate,Plasma,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12365,Rattus norvegicus,CHEMBL622297,Intermediate,Plasma,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12366,Rattus norvegicus,CHEMBL622298,Intermediate,Plasma,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12367,Rattus norvegicus,CHEMBL622299,Intermediate,Plasma,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12368,Rattus norvegicus,CHEMBL622300,Intermediate,Plasma,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12369,Rattus norvegicus,CHEMBL622301,Intermediate,Plasma,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12370,Rattus norvegicus,CHEMBL622302,Intermediate,Plasma,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12371,Rattus norvegicus,CHEMBL622303,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12372,Rattus norvegicus,CHEMBL622304,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12373,Rattus norvegicus,CHEMBL622305,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12374,Rattus norvegicus,CHEMBL622306,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12375,Rattus norvegicus,CHEMBL626864,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12376,Rattus norvegicus,CHEMBL626865,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12377,Rattus norvegicus,CHEMBL626866,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12378,Rattus norvegicus,CHEMBL626867,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12379,Rattus norvegicus,CHEMBL626868,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12380,Rattus norvegicus,CHEMBL626869,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12381,Rattus norvegicus,CHEMBL626870,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12382,Rattus norvegicus,CHEMBL626871,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12383,Rattus norvegicus,CHEMBL626872,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12384,Rattus norvegicus,CHEMBL632185,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12385,Rattus norvegicus,CHEMBL632186,Intermediate,Plasma,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,N,10116.0,14103,50597,1,,,BAO_0000218,1969.0,
12386,,CHEMBL629310,Autocuration,,Amount of acetic acid produced by the compound,,U,,12904,22224,1,,,BAO_0000019,,
12387,,CHEMBL629311,Autocuration,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,U,,12904,22224,1,,,BAO_0000019,,
12388,Rattus norvegicus,CHEMBL629312,Intermediate,,Log of (Cbrain/Cblood) in rats,,N,10116.0,9663,50597,1,,,BAO_0000218,,
12389,,CHEMBL629313,Autocuration,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000221,,
12390,,CHEMBL629314,Autocuration,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000221,,
12391,,CHEMBL629315,Autocuration,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000221,,
12392,,CHEMBL629316,Autocuration,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000219,,
12393,,CHEMBL629317,Autocuration,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000221,,
12394,,CHEMBL629318,Autocuration,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000019,,
12395,,CHEMBL877497,Autocuration,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000019,,
12396,,CHEMBL629319,Autocuration,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000019,,
12397,,CHEMBL629320,Autocuration,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000019,,
12398,,CHEMBL629496,Autocuration,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000019,,
12399,,CHEMBL629497,Autocuration,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000019,,
12400,,CHEMBL629498,Autocuration,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000019,,
12401,,CHEMBL629499,Autocuration,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000019,,
12402,,CHEMBL629500,Autocuration,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000019,,
12403,,CHEMBL629501,Autocuration,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000019,,
12404,,CHEMBL629502,Autocuration,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,U,,7652,22224,1,,,BAO_0000019,,
12405,,CHEMBL629503,Autocuration,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,U,,8267,22224,1,,,BAO_0000218,,
12406,Canis lupus familiaris,CHEMBL629504,Intermediate,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,N,9615.0,8267,50588,1,,,BAO_0000218,,
12407,,CHEMBL629505,Autocuration,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,U,,14479,22224,1,,,BAO_0000019,,
12408,,CHEMBL629506,Autocuration,,Compound was evaluated for total body clearance,,U,,17515,22224,1,,,BAO_0000019,,
12409,,CHEMBL629507,Autocuration,,Compound was evaluated for volume of distribution at steady state,,U,,17515,22224,1,,,BAO_0000019,,
12410,,CHEMBL877498,Autocuration,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,U,,8142,22224,1,,,BAO_0000019,,
12411,,CHEMBL629508,Autocuration,,Percentage of the diamine which is monoprotonated at pH 7.4,,U,,14849,22224,1,,,BAO_0000019,,
12412,,CHEMBL629509,Autocuration,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,U,,7653,22224,1,,,BAO_0000019,,
12413,Rattus norvegicus,CHEMBL629510,Intermediate,Blood,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12414,Rattus norvegicus,CHEMBL629511,Intermediate,Blood,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12415,Rattus norvegicus,CHEMBL629512,Intermediate,Blood,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12416,Rattus norvegicus,CHEMBL629513,Intermediate,Blood,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12417,Rattus norvegicus,CHEMBL629514,Intermediate,Blood,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12418,Rattus norvegicus,CHEMBL628447,Intermediate,Blood,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12419,Rattus norvegicus,CHEMBL628448,Intermediate,Blood,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12420,Rattus norvegicus,CHEMBL628449,Intermediate,Blood,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12421,Rattus norvegicus,CHEMBL631119,Intermediate,Blood,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12422,Rattus norvegicus,CHEMBL631120,Intermediate,Blood,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12423,Rattus norvegicus,CHEMBL631121,Intermediate,Blood,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12424,Rattus norvegicus,CHEMBL874458,Intermediate,Blood,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12425,Rattus norvegicus,CHEMBL631122,Intermediate,Blood,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12426,Rattus norvegicus,CHEMBL631123,Intermediate,Blood,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12427,Rattus norvegicus,CHEMBL631124,Intermediate,Blood,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12428,Rattus norvegicus,CHEMBL631125,Intermediate,Blood,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12429,Rattus norvegicus,CHEMBL631290,Intermediate,Blood,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12430,Rattus norvegicus,CHEMBL631291,Intermediate,Blood,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12431,Rattus norvegicus,CHEMBL631292,Intermediate,Blood,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12432,Rattus norvegicus,CHEMBL631293,Intermediate,Blood,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12433,Rattus norvegicus,CHEMBL631294,Intermediate,Blood,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12434,Rattus norvegicus,CHEMBL631295,Intermediate,Blood,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12435,Rattus norvegicus,CHEMBL631296,Intermediate,Blood,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12436,Rattus norvegicus,CHEMBL631297,Intermediate,Blood,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,10116.0,8631,50597,1,,,BAO_0000218,178.0,
12437,,CHEMBL631298,Autocuration,,Maximum biodistribution (Bmax) was determined.,,U,,10263,22224,1,,,BAO_0000218,,
12438,Mus musculus,CHEMBL631299,Intermediate,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,N,10090.0,12364,50594,1,,,BAO_0000218,,
12439,Mus musculus,CHEMBL631300,Intermediate,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,N,10090.0,12364,50594,1,,,BAO_0000218,,
12440,Mus musculus,CHEMBL631301,Intermediate,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,N,10090.0,12364,50594,1,,,BAO_0000218,,
12441,Mus musculus,CHEMBL630291,Intermediate,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,N,10090.0,12364,50594,1,,,BAO_0000218,,
12442,,CHEMBL630292,Autocuration,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,,14793,22224,1,,,BAO_0000218,,
12443,,CHEMBL630293,Autocuration,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,U,,14793,22224,1,,,BAO_0000218,,
12444,,CHEMBL630294,Autocuration,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,U,,14793,22224,1,,,BAO_0000218,,
12445,,CHEMBL630295,Autocuration,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,U,,14793,22224,1,,,BAO_0000218,,
12446,,CHEMBL630296,Autocuration,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,U,,14793,22224,1,,,BAO_0000218,,
12447,,CHEMBL626782,Autocuration,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,U,,14793,22224,1,,,BAO_0000218,,
12448,,CHEMBL626783,Autocuration,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,U,,14793,22224,1,,,BAO_0000218,,
12449,,CHEMBL626784,Autocuration,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,,14793,22224,1,,,BAO_0000218,,
12450,,CHEMBL626785,Autocuration,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,U,,14793,22224,1,,,BAO_0000218,,
12451,,CHEMBL626786,Autocuration,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,U,,14793,22224,1,,,BAO_0000218,,
12452,,CHEMBL626787,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12453,,CHEMBL626788,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,U,,9196,22224,1,,,BAO_0000218,,
12454,,CHEMBL625927,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12455,Rattus norvegicus,CHEMBL625928,Intermediate,Blood,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12456,Rattus norvegicus,CHEMBL625929,Intermediate,Blood,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12457,Rattus norvegicus,CHEMBL625930,Intermediate,Blood,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12458,Rattus norvegicus,CHEMBL625931,Intermediate,Blood,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12459,Rattus norvegicus,CHEMBL627230,Intermediate,Blood,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12460,Rattus norvegicus,CHEMBL627231,Intermediate,Blood,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12461,Rattus norvegicus,CHEMBL627232,Intermediate,Blood,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12462,Rattus norvegicus,CHEMBL627233,Intermediate,Blood,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12463,Rattus norvegicus,CHEMBL875470,Intermediate,Blood,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12464,Rattus norvegicus,CHEMBL627234,Intermediate,Blood,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12465,Rattus norvegicus,CHEMBL627235,Intermediate,Blood,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12466,Rattus norvegicus,CHEMBL627236,Intermediate,Blood,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12467,Rattus norvegicus,CHEMBL627237,Intermediate,Blood,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12468,Rattus norvegicus,CHEMBL627238,Intermediate,Blood,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12469,Rattus norvegicus,CHEMBL627239,Intermediate,Blood,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12470,Rattus norvegicus,CHEMBL627240,Intermediate,Blood,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12471,Rattus norvegicus,CHEMBL627241,Intermediate,Blood,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12472,Rattus norvegicus,CHEMBL627242,Intermediate,Blood,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12473,Rattus norvegicus,CHEMBL627243,Intermediate,Blood,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12474,Rattus norvegicus,CHEMBL627244,Intermediate,Blood,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12475,Rattus norvegicus,CHEMBL627245,Intermediate,Blood,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12476,Rattus norvegicus,CHEMBL627246,Intermediate,Blood,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12477,Rattus norvegicus,CHEMBL627247,Intermediate,Blood,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12478,Rattus norvegicus,CHEMBL627248,Intermediate,Blood,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12479,Rattus norvegicus,CHEMBL627249,Intermediate,Blood,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12480,Rattus norvegicus,CHEMBL625569,Intermediate,Blood,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12481,Rattus norvegicus,CHEMBL625570,Intermediate,Blood,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12482,Rattus norvegicus,CHEMBL625571,Intermediate,Blood,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12483,Rattus norvegicus,CHEMBL625572,Intermediate,Blood,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12484,Rattus norvegicus,CHEMBL625573,Intermediate,Blood,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12485,Rattus norvegicus,CHEMBL625574,Intermediate,Blood,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12486,Rattus norvegicus,CHEMBL626245,Intermediate,Blood,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12487,Rattus norvegicus,CHEMBL626246,Intermediate,Blood,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12488,,CHEMBL626247,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12489,,CHEMBL626248,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12490,,CHEMBL626249,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12491,,CHEMBL626420,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12492,,CHEMBL626421,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12493,,CHEMBL626422,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12494,,CHEMBL626423,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12495,,CHEMBL626424,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12496,Canis lupus familiaris,CHEMBL626425,Intermediate,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,N,9615.0,12023,50588,1,,,BAO_0000218,,
12497,Rattus norvegicus,CHEMBL875476,Intermediate,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,N,10116.0,12023,50597,1,,,BAO_0000218,,
12498,Macaca fascicularis,CHEMBL626426,Intermediate,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,N,9541.0,12023,100710,1,,,BAO_0000218,,
12499,,CHEMBL626427,Autocuration,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,U,,10580,22224,1,,,BAO_0000100,,
12500,,CHEMBL626428,Autocuration,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,U,,10580,22224,1,,,BAO_0000100,,
12501,,CHEMBL626429,Autocuration,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,U,,16032,22224,1,,,BAO_0000019,,
12502,,CHEMBL625025,Autocuration,Urine,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,U,,16032,22224,1,,,BAO_0000019,1088.0,
12503,Rattus norvegicus,CHEMBL625026,Intermediate,Blood,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12504,Rattus norvegicus,CHEMBL625027,Intermediate,Blood,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12505,Rattus norvegicus,CHEMBL874410,Intermediate,Blood,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12506,Rattus norvegicus,CHEMBL625028,Intermediate,Blood,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12507,Rattus norvegicus,CHEMBL625029,Intermediate,Blood,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12508,Rattus norvegicus,CHEMBL625030,Intermediate,Blood,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12509,Rattus norvegicus,CHEMBL625031,Intermediate,Blood,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12510,Rattus norvegicus,CHEMBL625032,Intermediate,Blood,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12511,Rattus norvegicus,CHEMBL625033,Intermediate,Blood,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12512,Rattus norvegicus,CHEMBL625034,Intermediate,Blood,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12513,Rattus norvegicus,CHEMBL624872,Intermediate,Heart,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12514,Rattus norvegicus,CHEMBL624873,Intermediate,Heart,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12515,Rattus norvegicus,CHEMBL624874,Intermediate,Heart,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12516,Rattus norvegicus,CHEMBL624875,Intermediate,Heart,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12517,Rattus norvegicus,CHEMBL624876,Intermediate,Heart,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12518,Rattus norvegicus,CHEMBL624877,Intermediate,Heart,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12519,Rattus norvegicus,CHEMBL624878,Intermediate,Heart,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12520,Rattus norvegicus,CHEMBL624879,Intermediate,Heart,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12521,Rattus norvegicus,CHEMBL624880,Intermediate,Heart,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12522,Rattus norvegicus,CHEMBL624881,Intermediate,Heart,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12523,Rattus norvegicus,CHEMBL624882,Intermediate,Heart,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12524,Rattus norvegicus,CHEMBL624883,Intermediate,Kidney,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12525,Rattus norvegicus,CHEMBL624884,Intermediate,Kidney,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12526,Rattus norvegicus,CHEMBL624885,Intermediate,Kidney,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12527,Rattus norvegicus,CHEMBL624886,Intermediate,Kidney,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12528,Rattus norvegicus,CHEMBL624887,Intermediate,Kidney,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12529,Rattus norvegicus,CHEMBL624888,Intermediate,Kidney,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12530,Rattus norvegicus,CHEMBL624889,Intermediate,Kidney,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12531,Rattus norvegicus,CHEMBL624890,Intermediate,Kidney,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12532,Rattus norvegicus,CHEMBL621964,Intermediate,Kidney,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12533,Rattus norvegicus,CHEMBL621965,Intermediate,Kidney,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12534,Rattus norvegicus,CHEMBL621966,Intermediate,Liver,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12535,Rattus norvegicus,CHEMBL621967,Intermediate,Liver,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12536,Rattus norvegicus,CHEMBL622164,Intermediate,Liver,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12537,,CHEMBL623097,Autocuration,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,U,,7653,22224,1,,,BAO_0000019,,
12538,,CHEMBL623098,Autocuration,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,U,,7653,22224,1,,,BAO_0000019,,
12539,,CHEMBL623099,Autocuration,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,U,,7653,22224,1,,,BAO_0000019,,
12540,,CHEMBL623100,Autocuration,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,U,,7653,22224,1,,,BAO_0000019,,
12541,Rattus norvegicus,CHEMBL628673,Intermediate,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,N,10116.0,9104,50597,1,,,BAO_0000218,,
12542,Rattus norvegicus,CHEMBL628674,Intermediate,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,N,10116.0,9104,50597,1,,,BAO_0000218,,
12543,Rattus norvegicus,CHEMBL628675,Intermediate,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,N,10116.0,9104,50597,1,,,BAO_0000218,,
12544,Rattus norvegicus,CHEMBL627644,Intermediate,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,N,10116.0,9104,50597,1,,,BAO_0000218,,
12545,Rattus norvegicus,CHEMBL627645,Intermediate,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,N,10116.0,9104,50597,1,,,BAO_0000218,,
12546,Rattus norvegicus,CHEMBL627646,Intermediate,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,N,10116.0,9104,50597,1,,,BAO_0000218,,
12547,Rattus norvegicus,CHEMBL627647,Intermediate,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,N,10116.0,9104,50597,1,,,BAO_0000218,,
12548,Rattus norvegicus,CHEMBL627648,Intermediate,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,N,10116.0,9104,50597,1,,,BAO_0000218,,
12549,Rattus norvegicus,CHEMBL627649,Intermediate,,Free level in rat plasma,,N,10116.0,12902,50597,1,,,BAO_0000218,,
12550,,CHEMBL628313,Autocuration,,Level reaching in blood plasma of rat or human was determined,,U,,6614,22224,1,,,BAO_0000019,,
12551,Rattus norvegicus,CHEMBL628314,Intermediate,,Log (Cbrain/Cblood) in rats,,N,10116.0,9663,50597,1,,,BAO_0000218,,
12552,,CHEMBL628315,Autocuration,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,U,,17658,22224,1,,,BAO_0000019,,
12553,,CHEMBL628316,Autocuration,,Mean percentage of compound transport through membrane; expressed as membrane transport,,U,,17658,22224,1,,,BAO_0000019,,
12554,,CHEMBL628317,Autocuration,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,U,,14314,22224,1,,,BAO_0000218,,
12555,,CHEMBL628473,Autocuration,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,U,,7385,22224,1,,,BAO_0000019,,
12556,,CHEMBL628474,Autocuration,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,U,,7385,22224,1,,,BAO_0000019,,
12557,,CHEMBL628475,Autocuration,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,U,,7385,22224,1,,,BAO_0000019,,
12558,,CHEMBL628476,Autocuration,,Net water uptake by a carrier mediated transport (%cm) mechanism,,U,,1329,22224,1,,,BAO_0000019,,
12559,Simiiformes,CHEMBL628477,Autocuration,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,U,314293.0,12187,22224,1,,,BAO_0000218,,
12560,Mustela putorius furo,CHEMBL628478,Intermediate,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,N,9669.0,12187,50506,1,,,BAO_0000218,,
12561,Mustela putorius furo,CHEMBL628479,Intermediate,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,N,9669.0,12187,50506,1,,,BAO_0000218,,
12562,Simiiformes,CHEMBL628480,Autocuration,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,U,314293.0,12187,22224,1,,,BAO_0000218,,
12563,Simiiformes,CHEMBL628481,Autocuration,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,U,314293.0,12187,22224,1,,,BAO_0000218,,
12564,Rattus norvegicus,CHEMBL628482,Intermediate,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,N,10116.0,12187,50597,1,,,BAO_0000218,,
12565,Rattus norvegicus,CHEMBL628483,Intermediate,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,N,10116.0,12187,50597,1,,,BAO_0000218,,
12566,Rattus norvegicus,CHEMBL628484,Intermediate,Plasma,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,N,10116.0,9278,50597,1,,,BAO_0000218,1969.0,
12567,Rattus norvegicus,CHEMBL628485,Intermediate,Plasma,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,N,10116.0,9278,50597,1,,,BAO_0000218,1969.0,
12568,Macaca fascicularis,CHEMBL628486,Intermediate,Plasma,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,N,9541.0,9278,100710,1,,,BAO_0000218,1969.0,
12569,Homo sapiens,CHEMBL628487,Intermediate,Plasma,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,N,9606.0,9278,50587,1,,,BAO_0000218,1969.0,
12570,Rattus norvegicus,CHEMBL628488,Intermediate,Plasma,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,N,10116.0,9278,50597,1,,,BAO_0000218,1969.0,
12571,Rattus norvegicus,CHEMBL628489,Intermediate,Plasma,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,N,10116.0,9278,50597,1,,,BAO_0000218,1969.0,
12572,Rattus norvegicus,CHEMBL628490,Intermediate,Plasma,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,N,10116.0,9278,50597,1,,,BAO_0000218,1969.0,
12573,Macaca fascicularis,CHEMBL628491,Intermediate,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,9541.0,12186,100710,1,,,BAO_0000218,,
12574,Macaca fascicularis,CHEMBL877507,Intermediate,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,9541.0,12186,100710,1,,,BAO_0000218,,
12575,,CHEMBL628492,Autocuration,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,U,,12186,22224,1,,,BAO_0000218,,
12576,Simiiformes,CHEMBL628493,Autocuration,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,U,314293.0,12041,22224,1,,,BAO_0000019,,
12577,Simiiformes,CHEMBL628494,Autocuration,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,U,314293.0,12041,22224,1,,,BAO_0000019,,
12578,Simiiformes,CHEMBL628495,Autocuration,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,U,314293.0,12041,22224,1,,,BAO_0000019,,
12579,Homo sapiens,CHEMBL628496,Intermediate,,Permeability in Caco-2 assay at 10E-6,,N,9606.0,6737,50587,1,,,BAO_0000218,,
12580,,CHEMBL628497,Autocuration,Brain,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,U,,13758,22224,1,,,BAO_0000218,955.0,
12581,,CHEMBL628498,Autocuration,Brain,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,U,,13758,22224,1,,,BAO_0000218,955.0,
12582,,CHEMBL628499,Autocuration,,Plasma protein binding was determined,,U,,5676,22224,1,,,BAO_0000019,,
12583,,CHEMBL627656,Autocuration,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,U,,14793,22224,1,,,BAO_0000218,,
12584,,CHEMBL627657,Autocuration,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,,14793,22224,1,,,BAO_0000218,,
12585,,CHEMBL626808,Autocuration,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,U,,14793,22224,1,,,BAO_0000218,,
12586,,CHEMBL626809,Autocuration,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,U,,14793,22224,1,,,BAO_0000218,,
12587,,CHEMBL626810,Autocuration,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,U,,14793,22224,1,,,BAO_0000218,,
12588,,CHEMBL626811,Autocuration,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,,14793,22224,1,,,BAO_0000218,,
12589,,CHEMBL874465,Autocuration,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,U,,14793,22224,1,,,BAO_0000218,,
12590,,CHEMBL626812,Autocuration,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,U,,14793,22224,1,,,BAO_0000218,,
12591,,CHEMBL626813,Autocuration,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,U,,14793,22224,1,,,BAO_0000218,,
12592,,CHEMBL626814,Autocuration,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,U,,14793,22224,1,,,BAO_0000218,,
12593,,CHEMBL626815,Autocuration,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,U,,14000,22224,1,,,BAO_0000019,,
12594,,CHEMBL628566,Autocuration,,Partition coefficient (logP),,U,,5948,22224,1,,,BAO_0000019,,
12595,,CHEMBL628567,Autocuration,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,U,,13824,22229,1,,,BAO_0000100,,
12596,,CHEMBL628568,Autocuration,,Calculated partition coefficient (clogP),,U,,10778,22229,1,,,BAO_0000100,,
12597,Canis lupus familiaris,CHEMBL628569,Intermediate,,C max in dog,,N,9615.0,17237,50588,1,,,BAO_0000218,,
12598,Cavia porcellus,CHEMBL628570,Intermediate,,C max in guinea pig,,N,10141.0,17237,50512,1,,,BAO_0000218,,
12599,,CHEMBL628571,Autocuration,,C max value was evaluated,,U,,2809,22224,1,,,BAO_0000218,,
12600,,CHEMBL628572,Autocuration,,Cmax value after oral dose of 0.1 mg//kg,,U,,11954,22224,1,,,BAO_0000218,,
12601,,CHEMBL628573,Autocuration,,Cmax value after oral dose of 0.3 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
12602,,CHEMBL628574,Autocuration,,Cmax value after oral dose of 1 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
12603,,CHEMBL628575,Autocuration,,Cmax value after oral dose of 10 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
12604,,CHEMBL628576,Autocuration,,Cmax value after oral dose of 23.4 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
12605,,CHEMBL628577,Autocuration,,Cmax value after oral dose of 3 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
12606,,CHEMBL628578,Autocuration,,Cmax value after oral dose of 3.87 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
12607,Canis lupus familiaris,CHEMBL874466,Intermediate,,Cmax value in female Beagle dogs,,N,9615.0,12768,50588,1,,,BAO_0000218,,
12608,Rattus norvegicus,CHEMBL628579,Intermediate,,Cmax value in male rats,,N,10116.0,12768,50597,1,,,BAO_0000218,,
12609,Rattus norvegicus,CHEMBL628580,Intermediate,Plasma,Cmax value in rat plasma when administered 20 mg/kg perorally,,N,10116.0,12780,50597,1,,,BAO_0000218,1969.0,
12610,Canis lupus familiaris,CHEMBL628581,Intermediate,Plasma,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,N,9615.0,15592,50588,1,,,BAO_0000218,1969.0,
12611,Canis lupus familiaris,CHEMBL628582,Intermediate,Plasma,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,N,9615.0,15592,50588,1,,,BAO_0000218,1969.0,
12612,Canis lupus familiaris,CHEMBL628583,Intermediate,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,N,9615.0,17025,50588,1,,,BAO_0000218,,
12613,Simiiformes,CHEMBL625782,Autocuration,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,U,314293.0,17025,22224,1,,,BAO_0000218,,
12614,Oryctolagus cuniculus,CHEMBL625783,Intermediate,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,N,9986.0,17025,50592,1,,,BAO_0000218,,
12615,Rattus norvegicus,CHEMBL625784,Intermediate,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,N,10116.0,17025,50597,1,,,BAO_0000218,,
12616,Macaca mulatta,CHEMBL625785,Intermediate,Plasma,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,N,9544.0,4236,50797,1,,,BAO_0000218,1969.0,
12617,Rattus norvegicus,CHEMBL625786,Intermediate,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,N,10116.0,15791,50597,1,,,BAO_0000218,,
12618,,CHEMBL874467,Autocuration,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,U,,11149,22224,1,,,BAO_0000019,,
12619,Canis lupus familiaris,CHEMBL625787,Intermediate,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,N,9615.0,15592,50588,1,,,BAO_0000218,,
12620,Human immunodeficiency virus,CHEMBL625964,Intermediate,,cytotoxicity against HIV protease enzyme.,,N,12721.0,15778,50677,1,,,BAO_0000218,,
12621,Mus musculus,CHEMBL625965,Intermediate,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,N,10090.0,12745,50594,1,,,BAO_0000218,,
12622,Mus musculus,CHEMBL625966,Intermediate,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,N,10090.0,12745,50594,1,,,BAO_0000218,,
12623,Canis lupus familiaris,CHEMBL625967,Intermediate,Plasma,The plasma clearance in dog.,,N,9615.0,13941,50588,1,,,BAO_0000218,1969.0,
12624,Rattus norvegicus,CHEMBL625968,Intermediate,Plasma,The plasma clearance in rat.,,N,10116.0,13941,50597,1,,,BAO_0000218,1969.0,
12625,Rattus norvegicus,CHEMBL625969,Intermediate,Plasma,Clearance from plasma in male Sprague-Dawley rats,,N,10116.0,16449,50597,1,,,BAO_0000218,1969.0,
12626,Macaca fascicularis,CHEMBL625970,Intermediate,Plasma,Clearance from plasma in male cynomolgus monkeys,,N,9541.0,16449,100710,1,,,BAO_0000218,1969.0,
12627,Canis lupus familiaris,CHEMBL625971,Intermediate,Plasma,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,N,9615.0,14224,50588,1,,,BAO_0000218,1969.0,
12628,Canis lupus familiaris,CHEMBL625972,Intermediate,Plasma,Clearance of compound in dog plasma,,N,9615.0,14224,50588,1,,,BAO_0000218,1969.0,
12629,Homo sapiens,CHEMBL625973,Intermediate,Plasma,Clearance of compound in human plasma,,N,9606.0,14224,50587,1,,,BAO_0000218,1969.0,
12630,Canis lupus familiaris,CHEMBL625974,Intermediate,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,N,9615.0,14317,50588,1,,,BAO_0000218,,
12631,Canis lupus familiaris,CHEMBL625975,Intermediate,,Clearance of compound when administered intravenously as an individual dose to a single dog.,,N,9615.0,14317,50588,1,,,BAO_0000218,,
12632,Canis lupus familiaris,CHEMBL625976,Intermediate,Plasma,"Clearance (10 mg/kg, intravenously) in dog plasma",,N,9615.0,14224,50588,1,,,BAO_0000218,1969.0,
12633,Canis lupus familiaris,CHEMBL625977,Intermediate,,Clearance value in dog,,N,9615.0,17237,50588,1,,,BAO_0000218,,
12634,Cavia porcellus,CHEMBL625978,Intermediate,,Clearance value in guinea pig,,N,10141.0,17237,50512,1,,,BAO_0000218,,
12635,Rattus norvegicus,CHEMBL874468,Intermediate,,Clearance values in rats after iv administration.,,N,10116.0,14187,50597,1,,,BAO_0000218,,
12636,,CHEMBL625421,Autocuration,Plasma,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,U,,4806,22224,1,,,BAO_0000218,1969.0,
12637,Oryctolagus cuniculus,CHEMBL625422,Intermediate,,In vivo clearance (5 mg/kg) was determined in rabbits,,N,9986.0,15025,50592,1,,,BAO_0000218,,
12638,Rattus norvegicus,CHEMBL625423,Intermediate,,Plasma Clearance rate was determined for the compound in rats,,N,10116.0,13197,50597,1,,,BAO_0000218,,
12639,Saimiri,CHEMBL625424,Autocuration,,Plasma Clearance rate was determined for the compound in squirrel monkeys,,U,9520.0,13197,22224,1,,,BAO_0000218,,
12640,Rattus norvegicus,CHEMBL625425,Intermediate,,Plasma clearance in rat,,N,10116.0,13960,50597,1,,,BAO_0000218,,
12641,,CHEMBL625426,Autocuration,,Plasma clearance of the compound,,U,,17820,22224,1,,,BAO_0000218,,
12642,Cavia porcellus,CHEMBL625427,Intermediate,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,N,10141.0,14706,50512,1,,,BAO_0000218,,
12643,Cavia porcellus,CHEMBL625428,Intermediate,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,N,10141.0,14706,50512,1,,,BAO_0000218,,
12644,,CHEMBL625429,Autocuration,,Plasma clearance was determined,,U,,6504,22224,1,,,BAO_0000218,,
12645,Canis lupus familiaris,CHEMBL625430,Intermediate,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,N,9615.0,14925,50588,1,,,BAO_0000218,,
12646,Rattus norvegicus,CHEMBL625431,Intermediate,,Plasma clearance rate was determined for the compound in rats,,N,10116.0,13197,50597,1,,,BAO_0000218,,
12647,Saimiri,CHEMBL627307,Autocuration,,Plasma clearance rate was determined for the compound in squirrel monkeys,,U,9520.0,13197,22224,1,,,BAO_0000218,,
12648,,CHEMBL627308,Autocuration,,Slow clearance (CL) was determined,,U,,3437,22224,1,,,BAO_0000218,,
12649,,CHEMBL627309,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12650,,CHEMBL627310,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,U,,9196,22224,1,,,BAO_0000218,,
12651,,CHEMBL627311,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12652,,CHEMBL627312,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12653,,CHEMBL627313,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12654,,CHEMBL627314,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12655,,CHEMBL627315,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12656,,CHEMBL627316,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12657,,CHEMBL627317,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12658,,CHEMBL627318,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12659,,CHEMBL627999,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12660,,CHEMBL628000,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12661,,CHEMBL628001,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12662,,CHEMBL628002,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12663,,CHEMBL625610,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12664,,CHEMBL625611,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12665,,CHEMBL625612,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12666,,CHEMBL625613,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12667,,CHEMBL875479,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12668,,CHEMBL625614,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12669,,CHEMBL625615,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,U,,9196,22224,1,,,BAO_0000218,,
12670,,CHEMBL626302,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,U,,9196,22224,1,,,BAO_0000218,,
12671,Rattus norvegicus,CHEMBL626303,Intermediate,Blood,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12672,Rattus norvegicus,CHEMBL627420,Intermediate,Blood,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,10116.0,8374,50597,1,,,BAO_0000218,178.0,
12673,Rattus norvegicus,CHEMBL627421,Intermediate,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12674,Rattus norvegicus,CHEMBL625695,Intermediate,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12675,Rattus norvegicus,CHEMBL625696,Intermediate,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12676,Mus musculus,CHEMBL875606,Intermediate,Brain,Distribution of compound in mice brain was measured after 1 hr,,N,10090.0,10009,50594,1,,,BAO_0000218,955.0,
12677,Mus musculus,CHEMBL625697,Intermediate,Brain,Distribution of compound in mice brain was measured after 24 hr r,,N,10090.0,10009,50594,1,,,BAO_0000218,955.0,
12678,Mus musculus,CHEMBL625698,Intermediate,Brain,Distribution of compound in mice brain was measured after 2 hr,,N,10090.0,10009,50594,1,,,BAO_0000218,955.0,
12679,Mus musculus,CHEMBL625699,Intermediate,Brain,Distribution of compound in mice brain was measured after 3 hr,,N,10090.0,10009,50594,1,,,BAO_0000218,955.0,
12680,Mus musculus,CHEMBL625700,Intermediate,Brain,Distribution of compound in mice brain was measured after 6 hr,,N,10090.0,10009,50594,1,,,BAO_0000218,955.0,
12681,Mus musculus,CHEMBL625701,Intermediate,,Distribution of compound in mice liver was measured after 1 hr,,N,10090.0,10009,50594,1,,,BAO_0000218,,
12682,Mus musculus,CHEMBL625702,Intermediate,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,N,10090.0,10009,50594,1,,,BAO_0000218,,
12683,Mus musculus,CHEMBL625703,Intermediate,,Distribution of compound in mice liver was measured after 2 hr,,N,10090.0,10009,50594,1,,,BAO_0000218,,
12684,Mus musculus,CHEMBL625704,Intermediate,,Distribution of compound in mice liver was measured after 3 hr,,N,10090.0,10009,50594,1,,,BAO_0000218,,
12685,Mus musculus,CHEMBL625705,Intermediate,,Distribution of compound in mice liver was measured after 6 hr,,N,10090.0,10009,50594,1,,,BAO_0000218,,
12686,Canis lupus familiaris,CHEMBL625706,Intermediate,Adrenal medulla,Distribution in dog adrenal medulla 30 min after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,1236.0,
12687,Canis lupus familiaris,CHEMBL625707,Intermediate,Adrenal medulla,Distribution in dog adrenal medulla 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,1236.0,
12688,Canis lupus familiaris,CHEMBL625708,Intermediate,,Distribution in female dog Ovary 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12689,Canis lupus familiaris,CHEMBL625709,Intermediate,,Distribution in female dog Ovary 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12690,Canis lupus familiaris,CHEMBL624180,Intermediate,,Distribution in female dog adipose 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12691,Canis lupus familiaris,CHEMBL624181,Intermediate,,Distribution in female dog adipose 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12692,Canis lupus familiaris,CHEMBL624182,Intermediate,Adrenal cortex,Distribution in female dog adrenal cortex 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,1235.0,
12693,Canis lupus familiaris,CHEMBL624183,Intermediate,Adrenal cortex,Distribution in female dog adrenal cortex 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,1235.0,
12694,Rattus norvegicus,CHEMBL624184,Intermediate,Liver,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12695,Rattus norvegicus,CHEMBL877489,Intermediate,Liver,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12696,Rattus norvegicus,CHEMBL624185,Intermediate,Liver,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12697,Rattus norvegicus,CHEMBL624186,Intermediate,Liver,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12698,Rattus norvegicus,CHEMBL624187,Intermediate,Liver,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12699,Rattus norvegicus,CHEMBL624188,Intermediate,Liver,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12700,Rattus norvegicus,CHEMBL624189,Intermediate,Lung,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12701,Rattus norvegicus,CHEMBL624190,Intermediate,Lung,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12702,Rattus norvegicus,CHEMBL624191,Intermediate,Lung,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12703,Rattus norvegicus,CHEMBL624192,Intermediate,Lung,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12704,Rattus norvegicus,CHEMBL624193,Intermediate,Lung,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12705,Rattus norvegicus,CHEMBL624194,Intermediate,Lung,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12706,Rattus norvegicus,CHEMBL624891,Intermediate,Lung,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12707,Rattus norvegicus,CHEMBL624892,Intermediate,Lung,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12708,Rattus norvegicus,CHEMBL624893,Intermediate,Lung,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12709,Rattus norvegicus,CHEMBL627632,Intermediate,Lung,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12710,Rattus norvegicus,CHEMBL627633,Intermediate,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12711,Rattus norvegicus,CHEMBL627634,Intermediate,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12712,Rattus norvegicus,CHEMBL627635,Intermediate,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12713,Rattus norvegicus,CHEMBL627636,Intermediate,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12714,Rattus norvegicus,CHEMBL626816,Intermediate,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12715,Rattus norvegicus,CHEMBL626817,Intermediate,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12716,Rattus norvegicus,CHEMBL626818,Intermediate,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12717,Rattus norvegicus,CHEMBL626819,Intermediate,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12718,Rattus norvegicus,CHEMBL626820,Intermediate,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12719,Rattus norvegicus,CHEMBL626821,Intermediate,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12720,Rattus norvegicus,CHEMBL626822,Intermediate,Thyroid gland,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12721,Rattus norvegicus,CHEMBL626823,Intermediate,Thyroid gland,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12722,Rattus norvegicus,CHEMBL626824,Intermediate,Thyroid gland,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12723,Rattus norvegicus,CHEMBL626825,Intermediate,Thyroid gland,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12724,Rattus norvegicus,CHEMBL626826,Intermediate,Thyroid gland,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12725,Rattus norvegicus,CHEMBL626827,Intermediate,Thyroid gland,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12726,Rattus norvegicus,CHEMBL626828,Intermediate,Thyroid gland,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12727,Rattus norvegicus,CHEMBL626829,Intermediate,Thyroid gland,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12728,Rattus norvegicus,CHEMBL626830,Intermediate,Thyroid gland,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12729,Rattus norvegicus,CHEMBL627150,Intermediate,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12730,Rattus norvegicus,CHEMBL627151,Intermediate,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12731,Rattus norvegicus,CHEMBL627152,Intermediate,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12732,Rattus norvegicus,CHEMBL627153,Intermediate,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12733,,CHEMBL627154,Autocuration,,Rate of acetate production by the compound was determined,,U,,12904,22224,1,,,BAO_0000019,,
12734,,CHEMBL627155,Autocuration,,Rate of acetate production by the compound was determined; Not determined,,U,,12904,22224,1,,,BAO_0000019,,
12735,,CHEMBL627156,Autocuration,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,U,,3730,22224,1,,,BAO_0000019,,
12736,,CHEMBL627157,Autocuration,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,U,,3627,22224,1,,,BAO_0000019,,
12737,Oryctolagus cuniculus,CHEMBL627158,Intermediate,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,N,9986.0,13799,50592,1,,,BAO_0000218,,
12738,Oryctolagus cuniculus,CHEMBL627159,Intermediate,Plasma,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,N,9986.0,13799,50592,1,,,BAO_0000218,1969.0,
12739,Mus musculus,CHEMBL627160,Intermediate,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,N,10090.0,13799,50594,1,,,BAO_0000218,,
12740,Rattus norvegicus,CHEMBL628540,Intermediate,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,N,10116.0,13799,50597,1,,,BAO_0000218,,
12741,Rattus norvegicus,CHEMBL628541,Intermediate,Plasma,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,N,10116.0,13799,50597,1,,,BAO_0000218,1969.0,
12742,Rattus norvegicus,CHEMBL628542,Intermediate,Plasma,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,N,10116.0,13799,50597,1,,,BAO_0000218,1969.0,
12743,,CHEMBL628543,Autocuration,,Solubility after at a pH 1.2,,U,,6629,22229,1,,,BAO_0000100,,
12744,,CHEMBL628544,Autocuration,,Solubility after at pH 1.2,,U,,6629,22229,1,,,BAO_0000100,,
12745,,CHEMBL628545,Autocuration,,Solubility after injection of water,,U,,6629,22229,1,,,BAO_0000100,,
12746,,CHEMBL628546,Autocuration,,Statistical significance of IC 50 values; Expressed as R value,,U,,14000,22224,1,,,BAO_0000019,,
12747,,CHEMBL874455,Autocuration,,Systemic availability with respect to methyldopa was determined,,U,,8267,22224,1,,,BAO_0000019,,
12748,Rattus norvegicus,CHEMBL628547,Intermediate,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,N,10116.0,13799,50597,1,,,BAO_0000218,,
12749,Rattus norvegicus,CHEMBL628548,Intermediate,Plasma,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,N,10116.0,13799,50597,1,,,BAO_0000218,1969.0,
12750,Oryctolagus cuniculus,CHEMBL628549,Intermediate,Feces,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
12751,Oryctolagus cuniculus,CHEMBL628550,Intermediate,Feces,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
12752,Oryctolagus cuniculus,CHEMBL628551,Intermediate,Feces,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
12753,Oryctolagus cuniculus,CHEMBL628552,Intermediate,Urine,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
12754,Oryctolagus cuniculus,CHEMBL628553,Intermediate,Urine,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
12755,Oryctolagus cuniculus,CHEMBL628554,Intermediate,Urine,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
12756,Oryctolagus cuniculus,CHEMBL628555,Intermediate,Urine,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
12757,Oryctolagus cuniculus,CHEMBL628556,Intermediate,Urine,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
12758,Oryctolagus cuniculus,CHEMBL628557,Intermediate,Kidney,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,N,9986.0,7132,50592,1,,,BAO_0000218,2113.0,
12759,Oryctolagus cuniculus,CHEMBL628558,Intermediate,Feces,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
12760,Oryctolagus cuniculus,CHEMBL628559,Intermediate,Feces,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
12761,Oryctolagus cuniculus,CHEMBL628560,Intermediate,Feces,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
12762,Oryctolagus cuniculus,CHEMBL874456,Intermediate,Urine,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
12763,Oryctolagus cuniculus,CHEMBL628561,Intermediate,Feces,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
12764,Oryctolagus cuniculus,CHEMBL628562,Intermediate,Feces,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
12765,Oryctolagus cuniculus,CHEMBL628563,Intermediate,Urine,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
12766,Oryctolagus cuniculus,CHEMBL628564,Intermediate,Urine,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
12767,Oryctolagus cuniculus,CHEMBL628565,Intermediate,Urine,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
12768,Oryctolagus cuniculus,CHEMBL631248,Intermediate,Urine,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
12769,Oryctolagus cuniculus,CHEMBL631249,Intermediate,Urine,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
12770,Oryctolagus cuniculus,CHEMBL627214,Intermediate,Kidney,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,N,9986.0,7132,50592,1,,,BAO_0000218,2113.0,
12771,Oryctolagus cuniculus,CHEMBL874591,Intermediate,Feces,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
12772,Oryctolagus cuniculus,CHEMBL627215,Intermediate,Feces,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
12773,Oryctolagus cuniculus,CHEMBL625471,Intermediate,Feces,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
12774,Oryctolagus cuniculus,CHEMBL625472,Intermediate,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,N,9986.0,7132,50592,1,,,BAO_0000218,,
12775,Oryctolagus cuniculus,CHEMBL625473,Intermediate,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,N,9986.0,7132,50592,1,,,BAO_0000218,,
12776,Canis lupus familiaris,CHEMBL625474,Intermediate,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,N,9615.0,13317,50588,1,,,BAO_0000218,,
12777,Canis lupus familiaris,CHEMBL625475,Intermediate,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,N,9615.0,15341,50588,1,,,BAO_0000218,,
12778,Rattus norvegicus,CHEMBL625476,Intermediate,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,N,10116.0,15341,50597,1,,,BAO_0000218,,
12779,Rattus norvegicus,CHEMBL625477,Intermediate,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,N,10116.0,15341,50597,1,,,BAO_0000218,,
12780,Rattus norvegicus,CHEMBL625478,Intermediate,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,N,10116.0,15341,50597,1,,,BAO_0000218,,
12781,Rattus norvegicus,CHEMBL625479,Intermediate,esophageal tunica muscularis mucosae,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,N,10116.0,12801,50597,1,,,BAO_0000218,,
12782,Rattus norvegicus,CHEMBL625480,Intermediate,esophageal tunica muscularis mucosae,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,N,10116.0,12801,50597,1,,,BAO_0000218,,
12783,Rattus norvegicus,CHEMBL625481,Intermediate,Plasma,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,N,10116.0,14856,50597,1,,,BAO_0000218,1969.0,
12784,Rattus norvegicus,CHEMBL625482,Intermediate,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,N,10116.0,14062,50597,1,,,BAO_0000218,,
12785,Rattus norvegicus,CHEMBL625483,Intermediate,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,N,10116.0,14062,50597,1,,,BAO_0000218,,
12786,Rattus norvegicus,CHEMBL625484,Intermediate,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,N,10116.0,14062,50597,1,,,BAO_0000218,,
12787,Rattus norvegicus,CHEMBL625485,Intermediate,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,N,10116.0,14062,50597,1,,,BAO_0000218,,
12788,Canis lupus familiaris,CHEMBL625486,Intermediate,Plasma,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,N,9615.0,14346,50588,1,,,BAO_0000218,1969.0,
12789,Rattus norvegicus,CHEMBL625487,Intermediate,Plasma,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,1969.0,
12790,Rattus norvegicus,CHEMBL625488,Intermediate,Plasma,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,1969.0,
12791,Rattus norvegicus,CHEMBL625489,Intermediate,Plasma,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,1969.0,
12792,Rattus norvegicus,CHEMBL625490,Intermediate,Plasma,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,1969.0,
12793,Canis lupus familiaris,CHEMBL625491,Intermediate,Plasma,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,N,9615.0,14346,50588,1,,,BAO_0000218,1969.0,
12794,Rattus norvegicus,CHEMBL625492,Intermediate,Plasma,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,N,10116.0,14346,50597,1,,,BAO_0000218,1969.0,
12795,Homo sapiens,CHEMBL625493,Intermediate,Plasma,plasma clearance in human,,N,9606.0,15711,50587,1,,,BAO_0000218,1969.0,
12796,Rattus norvegicus,CHEMBL625494,Intermediate,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,N,10116.0,14886,50597,1,,,BAO_0000218,,
12797,Rattus norvegicus,CHEMBL625495,Intermediate,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,N,10116.0,14886,50597,1,,,BAO_0000218,,
12798,Rattus norvegicus,CHEMBL625496,Intermediate,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,N,10116.0,14886,50597,1,,,BAO_0000218,,
12799,,CHEMBL625497,Autocuration,,1-Octanol/water partition coefficient measured at 7.4,,U,,4115,22229,1,,,BAO_0000100,,
12800,,CHEMBL625498,Autocuration,,Calculated partition coefficient (clogP),,U,,13733,22229,1,,,BAO_0000100,,
12801,,CHEMBL625499,Autocuration,,Partition coefficient (logP),,U,,12102,22224,1,,,BAO_0000019,,
12802,,CHEMBL625500,Autocuration,,Calculated partition coefficient (clogP),,U,,12676,22229,1,,,BAO_0000100,,
12803,,CHEMBL625501,Autocuration,,Calculated partition coefficient (clogP),,U,,13733,22229,1,,,BAO_0000100,,
12804,,CHEMBL625502,Autocuration,,Calculated partition coefficient (clogP),,U,,13740,22229,1,,,BAO_0000100,,
12805,,CHEMBL625503,Autocuration,,Calculated partition coefficient (clogP) (relative to BAY K 8644),,U,,12766,22229,1,,,BAO_0000100,,
12806,,CHEMBL625504,Autocuration,,Calculated partition coefficient (clogP),,U,,2764,22229,1,,,BAO_0000100,,
12807,,CHEMBL625505,Autocuration,,Calculated partition coefficient (clogP),,U,,12355,22229,1,,,BAO_0000100,,
12808,,CHEMBL625506,Autocuration,,Calculated partition coefficient of the compound,,U,,11314,22229,1,,,BAO_0000100,,
12809,,CHEMBL625507,Autocuration,,Partition coefficient (logP),,U,,12706,22224,1,,,BAO_0000019,,
12810,,CHEMBL625508,Autocuration,,Calculated partition coefficient (clogP),,U,,12645,22229,1,,,BAO_0000100,,
12811,,CHEMBL625509,Autocuration,,Calculated partition coefficient (clogP),,U,,13668,22229,1,,,BAO_0000100,,
12812,,CHEMBL625510,Autocuration,,Calculated partition coefficient (clogP),,U,,12819,22229,1,,,BAO_0000100,,
12813,,CHEMBL883125,Autocuration,,Calculated partition coefficient (clogP),,U,,13668,22229,1,,,BAO_0000100,,
12814,,CHEMBL625511,Autocuration,,Calculated partition coefficient (clogP),,U,,13017,22229,1,,,BAO_0000100,,
12815,,CHEMBL874650,Autocuration,,Partition coefficient of the compound,,U,,2448,22224,1,,,BAO_0000019,,
12816,,CHEMBL625512,Autocuration,,Partition coefficient of the compound,,U,,11526,22224,1,,,BAO_0000019,,
12817,,CHEMBL625513,Autocuration,,Partition coefficient of compound was determined,,U,,12426,22224,1,,,BAO_0000019,,
12818,,CHEMBL625514,Autocuration,,Partition coefficient was determined,,U,,2448,22224,1,,,BAO_0000019,,
12819,,CHEMBL625515,Autocuration,,Calculated partition coefficient (clogP),,U,,12001,22229,1,,,BAO_0000100,,
12820,,CHEMBL625516,Autocuration,,partition coefficient of compound was determined,,U,,12426,22229,1,,,BAO_0000100,,
12821,Canis lupus familiaris,CHEMBL625517,Intermediate,,The total body administered intravenously in dog,,N,9615.0,13204,50588,1,,,BAO_0000218,,
12822,Rattus norvegicus,CHEMBL625518,Intermediate,,The total body administered intravenously in rats,,N,10116.0,13204,50597,1,,,BAO_0000218,,
12823,Mus musculus,CHEMBL625519,Intermediate,,Time taken for the administration to female NIH mice weighing 25-30 g.,,N,10090.0,13889,50594,1,,,BAO_0000218,,
12824,,CHEMBL625520,Autocuration,,Time taken for the administration,,U,,13889,22224,1,,,BAO_0000019,,
12825,Canis lupus familiaris,CHEMBL874651,Intermediate,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,N,9615.0,17025,50588,1,,,BAO_0000218,,
12826,Simiiformes,CHEMBL625521,Autocuration,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,U,314293.0,17025,22224,1,,,BAO_0000218,,
12827,Oryctolagus cuniculus,CHEMBL623171,Intermediate,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,N,9986.0,17025,50592,1,,,BAO_0000218,,
12828,Rattus norvegicus,CHEMBL623853,Intermediate,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,N,10116.0,17025,50597,1,,,BAO_0000218,,
12829,,CHEMBL623854,Autocuration,,Plasma clearance for the compound was determined.,,U,,15067,22224,1,,,BAO_0000019,,
12830,,CHEMBL874405,Autocuration,,CLog P value of the compound,,U,,3091,22224,1,,,BAO_0000100,,
12831,,CHEMBL623855,Autocuration,,Calculated partition coefficient (clogP),,U,,15592,22229,1,,,BAO_0000100,,
12832,,CHEMBL623856,Autocuration,,Calculated partition coefficient (clogP),,U,,14738,22229,1,,,BAO_0000100,,
12833,,CHEMBL623857,Autocuration,,ClogP value of the compound; nd ='no data',,U,,14738,22224,1,,,BAO_0000100,,
12834,,CHEMBL623858,Autocuration,,ClogP value of the compound; nd ='not determined',,U,,14738,22224,1,,,BAO_0000100,,
12835,,CHEMBL623859,Autocuration,,CLog P was determined,,U,,6076,22224,1,,,BAO_0000100,,
12836,,CHEMBL839829,Autocuration,,Calculated partition coefficient (clogP),,U,,17840,22229,1,,,BAO_0000100,,
12837,,CHEMBL623860,Autocuration,,CLogP was calculated,,U,,13589,22224,1,,,BAO_0000019,,
12838,,CHEMBL623861,Autocuration,,CLogP value was determined,,U,,17655,22224,1,,,BAO_0000019,,
12839,,CHEMBL623862,Autocuration,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,U,,5867,22224,1,,,BAO_0000019,,
12840,,CHEMBL874406,Autocuration,,Calculated partition coefficient (clogP),,U,,5867,22229,1,,,BAO_0000100,,
12841,,CHEMBL623863,Autocuration,,Calculated partition coefficient (clogP),,U,,10783,22229,1,,,BAO_0000100,,
12842,,CHEMBL624021,Autocuration,,Calculated partition coefficient (clogP),,U,,14849,22229,1,,,BAO_0000100,,
12843,Canis lupus familiaris,CHEMBL624022,Intermediate,Adrenal medulla,Distribution in female dog adrenal medulla 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,1236.0,
12844,Canis lupus familiaris,CHEMBL624023,Intermediate,Adrenal medulla,Distribution in female dog adrenal medulla 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,1236.0,
12845,Canis lupus familiaris,CHEMBL624024,Intermediate,,Distribution in female dog bile 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12846,Canis lupus familiaris,CHEMBL624025,Intermediate,,Distribution in female dog bile 72 hr after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12847,Canis lupus familiaris,CHEMBL624026,Intermediate,,Distribution in female dog blood 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12848,Canis lupus familiaris,CHEMBL624027,Intermediate,,Distribution in female dog blood 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12849,Canis lupus familiaris,CHEMBL624028,Intermediate,,Distribution in female dog heart 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12850,Canis lupus familiaris,CHEMBL624029,Intermediate,,Distribution in female dog heart 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12851,Canis lupus familiaris,CHEMBL624030,Intermediate,,Distribution in female dog kidney 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12852,Canis lupus familiaris,CHEMBL624031,Intermediate,,Distribution in female dog kidney 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12853,Canis lupus familiaris,CHEMBL624032,Intermediate,Intestine,Distribution in female dog large intestine 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,160.0,
12854,Canis lupus familiaris,CHEMBL874407,Intermediate,Intestine,Distribution in female dog large intestine 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,160.0,
12855,Canis lupus familiaris,CHEMBL624033,Intermediate,,Distribution in female dog liver 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12856,Canis lupus familiaris,CHEMBL624034,Intermediate,,Distribution in female dog liver 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12857,Canis lupus familiaris,CHEMBL624035,Intermediate,,Distribution in female dog lung 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12858,Canis lupus familiaris,CHEMBL624036,Intermediate,,Distribution in female dog lung 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12859,Canis lupus familiaris,CHEMBL624037,Intermediate,Muscle tissue,Distribution in female dog muscle 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,2385.0,
12860,Canis lupus familiaris,CHEMBL624038,Intermediate,Muscle tissue,Distribution in female dog muscle 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,2385.0,
12861,Canis lupus familiaris,CHEMBL624039,Intermediate,,Distribution in female dog pancreas 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12862,Canis lupus familiaris,CHEMBL624040,Intermediate,,Distribution in female dog pancreas 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,,
12863,Canis lupus familiaris,CHEMBL624041,Intermediate,Intestine,Distribution in female dog small intestine 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,160.0,
12864,Canis lupus familiaris,CHEMBL624042,Intermediate,Intestine,Distribution in female dog small intestine 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,160.0,
12865,Canis lupus familiaris,CHEMBL624043,Intermediate,Spleen,Distribution in female dog spleen 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,2106.0,
12866,Canis lupus familiaris,CHEMBL624044,Intermediate,Spleen,Distribution in female dog spleen 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,2106.0,
12867,Canis lupus familiaris,CHEMBL624045,Intermediate,Stomach,Distribution in female dog stomach 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,945.0,
12868,Canis lupus familiaris,CHEMBL624046,Intermediate,Stomach,Distribution in female dog stomach 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,945.0,
12869,Canis lupus familiaris,CHEMBL624047,Intermediate,Thyroid gland,Distribution in female dog thyroid 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,2046.0,
12870,Canis lupus familiaris,CHEMBL624048,Intermediate,Thyroid gland,Distribution in female dog thyroid 72 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,2046.0,
12871,Canis lupus familiaris,CHEMBL874408,Intermediate,Urine,Distribution in female dog urine 24 hours after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,1088.0,
12872,Canis lupus familiaris,CHEMBL624049,Intermediate,Urine,Distribution in female dog urine 72 hr after administration.,,N,9615.0,8170,50588,1,,,BAO_0000218,1088.0,
12873,,CHEMBL624050,Autocuration,Plasma,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,U,,14283,22224,1,,,BAO_0000218,1969.0,
12874,,CHEMBL624051,Autocuration,,Plasma concentration at 7 hr after intravenous dosing,,U,,5623,22224,1,,,BAO_0000019,,
12875,Rattus norvegicus,CHEMBL623278,Intermediate,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12876,Rattus norvegicus,CHEMBL623279,Intermediate,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12877,Rattus norvegicus,CHEMBL623280,Intermediate,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12878,Rattus norvegicus,CHEMBL623963,Intermediate,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12879,Rattus norvegicus,CHEMBL623964,Intermediate,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12880,Rattus norvegicus,CHEMBL623965,Intermediate,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12881,Rattus norvegicus,CHEMBL623966,Intermediate,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12882,Rattus norvegicus,CHEMBL874415,Intermediate,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12883,Rattus norvegicus,CHEMBL623967,Intermediate,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12884,Rattus norvegicus,CHEMBL623968,Intermediate,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12885,Rattus norvegicus,CHEMBL623969,Intermediate,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12886,Rattus norvegicus,CHEMBL628409,Intermediate,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12887,Rattus norvegicus,CHEMBL628410,Intermediate,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12888,Rattus norvegicus,CHEMBL628411,Intermediate,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12889,Rattus norvegicus,CHEMBL628412,Intermediate,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,N,10116.0,13477,50597,1,,,BAO_0000218,,
12890,,CHEMBL628413,Autocuration,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,U,,12553,22224,1,,,BAO_0000019,,
12891,,CHEMBL628414,Autocuration,Plasma,The concentration in plasmat; Not determined,,U,,14548,22224,1,,,BAO_0000019,1969.0,
12892,Rattus norvegicus,CHEMBL628415,Intermediate,,Tissue level at 10 mg/kg/po in wistar rats in blood,,N,10116.0,14393,50597,1,,,BAO_0000218,,
12893,Rattus norvegicus,CHEMBL628416,Intermediate,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,N,10116.0,14393,50597,1,,,BAO_0000218,,
12894,Rattus norvegicus,CHEMBL628417,Intermediate,,Tissue level at 10 mg/kg/po in wistar rats in heart,,N,10116.0,14393,50597,1,,,BAO_0000218,,
12895,Rattus norvegicus,CHEMBL874908,Intermediate,Liver,Tissue level at 10 mg/kg/po in wistar rats in liver,,N,10116.0,14393,50597,1,,,BAO_0000218,2107.0,
12896,Rattus norvegicus,CHEMBL628418,Intermediate,,Tissue level at 10 mg/kg/po in wistar rats in plasma,,N,10116.0,14393,50597,1,,,BAO_0000218,,
12897,Rattus norvegicus,CHEMBL628419,Intermediate,Muscle tissue,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,N,10116.0,14393,50597,1,,,BAO_0000218,2385.0,
12898,Rattus norvegicus,CHEMBL628420,Intermediate,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,N,10116.0,14393,50597,1,,,BAO_0000218,,
12899,,CHEMBL628421,Autocuration,,Water solubility at 37 degree C.,,U,,1629,22224,1,,,BAO_0000019,,
12900,,CHEMBL626726,Autocuration,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,U,,8194,22229,1,,,BAO_0000100,,
12901,,CHEMBL626727,Autocuration,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,U,,8194,22229,1,,,BAO_0000100,,
12902,Rattus norvegicus,CHEMBL626728,Intermediate,Blood,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12903,Rattus norvegicus,CHEMBL626729,Intermediate,Blood,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12904,Rattus norvegicus,CHEMBL626730,Intermediate,Blood,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12905,Rattus norvegicus,CHEMBL626731,Intermediate,Blood,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12906,Rattus norvegicus,CHEMBL626732,Intermediate,Blood,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,178.0,
12907,Rattus norvegicus,CHEMBL626733,Intermediate,Heart,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12908,Rattus norvegicus,CHEMBL626734,Intermediate,Heart,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12909,Rattus norvegicus,CHEMBL626735,Intermediate,Heart,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12910,Rattus norvegicus,CHEMBL874909,Intermediate,Heart,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12911,Rattus norvegicus,CHEMBL626736,Intermediate,Heart,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,948.0,
12912,Rattus norvegicus,CHEMBL626737,Intermediate,Kidney,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12913,Rattus norvegicus,CHEMBL630999,Intermediate,Kidney,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12914,Rattus norvegicus,CHEMBL631000,Intermediate,Kidney,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12915,Rattus norvegicus,CHEMBL631001,Intermediate,Kidney,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12916,Rattus norvegicus,CHEMBL631002,Intermediate,Kidney,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2113.0,
12917,Rattus norvegicus,CHEMBL631003,Intermediate,Liver,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12918,Rattus norvegicus,CHEMBL631004,Intermediate,Liver,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12919,Rattus norvegicus,CHEMBL631005,Intermediate,Liver,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12920,Rattus norvegicus,CHEMBL631006,Intermediate,Liver,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12921,Rattus norvegicus,CHEMBL631007,Intermediate,Liver,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2107.0,
12922,Rattus norvegicus,CHEMBL631008,Intermediate,Lung,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12923,Rattus norvegicus,CHEMBL631009,Intermediate,Lung,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12924,Rattus norvegicus,CHEMBL631010,Intermediate,Lung,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12925,Rattus norvegicus,CHEMBL631011,Intermediate,Lung,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12926,Rattus norvegicus,CHEMBL631012,Intermediate,Lung,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2048.0,
12927,Rattus norvegicus,CHEMBL630271,Intermediate,Thyroid gland,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12928,Rattus norvegicus,CHEMBL630272,Intermediate,Thyroid gland,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12929,Rattus norvegicus,CHEMBL630273,Intermediate,Thyroid gland,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12930,Rattus norvegicus,CHEMBL630274,Intermediate,Thyroid gland,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12931,Rattus norvegicus,CHEMBL630275,Intermediate,Thyroid gland,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,2046.0,
12932,Rattus norvegicus,CHEMBL875782,Intermediate,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12933,Rattus norvegicus,CHEMBL630276,Intermediate,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12934,Rattus norvegicus,CHEMBL630277,Intermediate,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12935,Rattus norvegicus,CHEMBL630278,Intermediate,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12936,Rattus norvegicus,CHEMBL630279,Intermediate,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,N,10116.0,8594,50597,1,,,BAO_0000218,,
12937,,CHEMBL630280,Autocuration,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,U,,8151,22224,1,,,BAO_0000019,,
12938,,CHEMBL630281,Autocuration,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,U,,8151,22224,1,,,BAO_0000019,,
12939,Oryctolagus cuniculus,CHEMBL630282,Intermediate,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,N,9986.0,7132,50592,1,,,BAO_0000218,,
12940,Oryctolagus cuniculus,CHEMBL630283,Intermediate,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,N,9986.0,7132,50592,1,,,BAO_0000218,,
12941,,CHEMBL630284,Autocuration,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,U,,5797,22224,1,,,BAO_0000019,,
12942,,CHEMBL630285,Autocuration,,Alkylating activity was determined,,U,,7849,22224,1,,,BAO_0000019,,
12943,,CHEMBL630286,Autocuration,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,U,,14220,22224,1,,,BAO_0000251,,
12944,Oryctolagus cuniculus,CHEMBL630069,Intermediate,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,N,9986.0,8650,50592,1,,,BAO_0000218,,
12945,Oryctolagus cuniculus,CHEMBL630070,Intermediate,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,N,9986.0,8650,50592,1,,,BAO_0000218,,
12946,Oryctolagus cuniculus,CHEMBL630071,Intermediate,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,N,9986.0,8650,50592,1,,,BAO_0000218,,
12947,Oryctolagus cuniculus,CHEMBL630072,Intermediate,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,N,9986.0,8650,50592,1,,,BAO_0000218,,
12948,Oryctolagus cuniculus,CHEMBL875110,Intermediate,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,N,9986.0,8650,50592,1,,,BAO_0000218,,
12949,Rattus norvegicus,CHEMBL630073,Intermediate,,Compound was tested for antidiuretic activity in rats,,N,10116.0,7116,50597,1,,,BAO_0000218,,
12950,,CHEMBL630074,Autocuration,,Compound was tested for inactivation kinetic values,,U,,14131,22224,1,,,BAO_0000019,,
12951,,CHEMBL630075,Autocuration,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,U,,7415,22224,1,,,BAO_0000218,,
12952,,CHEMBL630076,Autocuration,,Dissociation rate calculated from the first-order equation using the t1/2 value,,U,,13178,22224,1,,,BAO_0000019,,
12953,,CHEMBL630077,Autocuration,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,U,,8815,22229,1,,,BAO_0000100,,
12954,,CHEMBL630078,Autocuration,,Aqueous solubility was measured,,U,,1450,22229,1,,,BAO_0000100,,
12955,,CHEMBL630079,Autocuration,,Aqueous solubility was measured at a pH 4,,U,,1450,22229,1,,,BAO_0000100,,
12956,,CHEMBL630080,Autocuration,,Aqueous solubility (pH 7),,U,,1450,22229,1,,,BAO_0000100,,
12957,,CHEMBL630081,Autocuration,,Aqueous solubility was measured at a pH 9,,U,,1450,22229,1,,,BAO_0000100,,
12958,,CHEMBL630082,Autocuration,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,U,,12711,22224,1,,,BAO_0000019,,
12959,,CHEMBL630083,Autocuration,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,U,,12711,22224,1,,,BAO_0000019,,
12960,,CHEMBL630084,Autocuration,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,U,,12711,22224,1,,,BAO_0000019,,
12961,,CHEMBL629198,Autocuration,,Aqueous solubility of the compound,,U,,15032,22229,1,,,BAO_0000100,,
12962,,CHEMBL629199,Autocuration,,Aqueous solubility at 37 degree Celsius at pH 7.38,,U,,9964,22229,1,,,BAO_0000100,,
12963,,CHEMBL629200,Autocuration,,Aqueous solubility in pH 7.4 phosphate buffer,,U,,14962,22229,1,,,BAO_0000100,,
12964,Canis lupus familiaris,CHEMBL629201,Intermediate,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,N,9615.0,12487,50588,1,,,BAO_0000218,,
12965,Canis lupus familiaris,CHEMBL629202,Intermediate,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,N,9615.0,12487,50588,1,,,BAO_0000218,,
12966,Homo sapiens,CHEMBL875111,Intermediate,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,N,9606.0,10026,50587,1,,,BAO_0000218,,
12967,Homo sapiens,CHEMBL629203,Intermediate,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,N,9606.0,10026,50587,1,,,BAO_0000218,,
12968,Homo sapiens,CHEMBL629204,Intermediate,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,N,9606.0,10026,50587,1,,,BAO_0000218,,
12969,Homo sapiens,CHEMBL629205,Intermediate,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,N,9606.0,10026,50587,1,,,BAO_0000218,,
12970,Homo sapiens,CHEMBL629206,Intermediate,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,N,9606.0,10026,50587,1,,,BAO_0000218,,
12971,,CHEMBL631185,Autocuration,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,U,,10026,22224,1,,,BAO_0000019,,
12972,Rattus norvegicus,CHEMBL631186,Intermediate,,Compound was evaluated for the average bile flow rat in rats,,N,10116.0,7415,50597,1,,,BAO_0000218,,
12973,Oryctolagus cuniculus,CHEMBL631187,Intermediate,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,N,9986.0,17025,50592,1,,,BAO_0000218,,
12974,Oryctolagus cuniculus,CHEMBL631188,Intermediate,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,N,9986.0,17025,50592,1,,,BAO_0000218,,
12975,,CHEMBL876419,Autocuration,,Average half life period was determined,,U,,10184,22224,1,,,BAO_0000019,,
12976,,CHEMBL631189,Autocuration,,Average half life period was determined,,U,,10184,22224,1,,,BAO_0000019,,
12977,Human herpesvirus 1,CHEMBL631190,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
12978,Human herpesvirus 1,CHEMBL631191,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
12979,Human herpesvirus 1,CHEMBL631192,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
12980,Human herpesvirus 1,CHEMBL632400,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
12981,Human herpesvirus 1,CHEMBL630564,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
12982,Human herpesvirus 1,CHEMBL630565,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
12983,Human herpesvirus 1,CHEMBL630566,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
12984,Human herpesvirus 1,CHEMBL631229,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
12985,Human herpesvirus 1,CHEMBL631230,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
12986,,CHEMBL876428,Autocuration,,Calculated partition coefficient (clogP),,U,,6030,22229,1,,,BAO_0000100,,
12987,,CHEMBL631231,Autocuration,,Calculated partition coefficient (clogP),,U,,6147,22229,1,,,BAO_0000100,,
12988,,CHEMBL631232,Autocuration,,Calculated partition coefficient (clogP) (MacLogP),,U,,14556,22229,1,,,BAO_0000100,,
12989,,CHEMBL631233,Autocuration,,Hydrophilicity was determined,,U,,768,22224,1,,,BAO_0000019,,
12990,,CHEMBL631234,Autocuration,,Calculated partition coefficient (clogP),,U,,14452,22229,1,,,BAO_0000100,,
12991,,CHEMBL883126,Autocuration,,Increased absorption was determined,,U,,5237,22224,1,,,BAO_0000019,,
12992,,CHEMBL631235,Autocuration,,Lipophilicity value was evaluated,,U,,14378,22224,1,,,BAO_0000100,,
12993,,CHEMBL631236,Autocuration,,Log P value of the compound.,,U,,14418,22224,1,,,BAO_0000100,,
12994,,CHEMBL631237,Autocuration,,Partition coefficient of compound was determined,,U,,5249,22224,1,,,BAO_0000019,,
12995,,CHEMBL631238,Autocuration,,Calculated partition coefficient (clogP),,U,,14621,22229,1,,,BAO_0000100,,
12996,,CHEMBL876429,Autocuration,,Calculated partition coefficient (clogP),,U,,12542,22229,1,,,BAO_0000100,,
12997,,CHEMBL631414,Autocuration,,Partition coefficient was measured by medchem software; Not calculated,,U,,12542,22224,1,,,BAO_0000019,,
12998,,CHEMBL631415,Autocuration,,Partition coefficient was measured by octanol-water using standard shake-flask method,,U,,12542,22224,1,,,BAO_0000100,,
12999,,CHEMBL631416,Autocuration,,Calculated partition coefficient (clogP),,U,,15462,22229,1,,,BAO_0000100,,
13000,,CHEMBL631417,Autocuration,,Partition coefficient (logP),,U,,14884,22224,1,,,BAO_0000019,,
13001,,CHEMBL631418,Autocuration,,Calculated partition coefficient (clogP),,U,,16526,22229,1,,,BAO_0000100,,
13002,,CHEMBL631419,Autocuration,,The Octanol/Water partition coefficient CLogP,,U,,13693,22229,1,,,BAO_0000100,,
13003,,CHEMBL631420,Autocuration,,The pharmacokinetic parameter C Log p was reported,,U,,13693,22224,1,,,BAO_0000019,,
13004,,CHEMBL631421,Autocuration,,Calculated partition coefficient (clogP),,U,,13779,22229,1,,,BAO_0000100,,
13005,,CHEMBL631422,Autocuration,,Calculated partition coefficient (clogP),,U,,14772,22229,1,,,BAO_0000100,,
13006,,CHEMBL631423,Autocuration,,Calculated partition coefficient (clogP),,U,,14393,22229,1,,,BAO_0000100,,
13007,Rattus norvegicus,CHEMBL876430,Intermediate,Plasma,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,N,10116.0,14793,50597,1,,,BAO_0000218,1969.0,
13008,Rattus norvegicus,CHEMBL631424,Intermediate,Plasma,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,N,10116.0,14793,50597,1,,,BAO_0000218,1969.0,
13009,Canis lupus familiaris,CHEMBL631425,Intermediate,Plasma,Compound was administered intravenously in dog to evaluate plasma clearance values,,N,9615.0,13744,50588,1,,,BAO_0000218,1969.0,
13010,Simiiformes,CHEMBL631426,Autocuration,Plasma,Compound was administered intravenously in monkey to evaluate plasma clearance values,,U,314293.0,13744,22224,1,,,BAO_0000218,1969.0,
13011,Mus musculus,CHEMBL631427,Intermediate,Plasma,Compound was administered intravenously in mouse to evaluate plasma clearance values,,N,10090.0,13744,50594,1,,,BAO_0000218,1969.0,
13012,Canis lupus familiaris,CHEMBL631428,Intermediate,Plasma,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,N,9615.0,13207,50588,1,,,BAO_0000218,1969.0,
13013,Macaca mulatta,CHEMBL631429,Intermediate,Liver,Intrinsic clearance in Rhesus liver microsome,,N,9544.0,5669,50797,1,,,BAO_0000218,2107.0,
13014,Canis lupus familiaris,CHEMBL631430,Intermediate,Liver,Intrinsic clearance in dog liver microsome,,N,9615.0,5669,50588,1,,,BAO_0000218,2107.0,
13015,Rattus norvegicus,CHEMBL631431,Intermediate,Liver,Intrinsic clearance in rat liver microsome,,N,10116.0,5669,50597,1,,,BAO_0000218,2107.0,
13016,Macaca mulatta,CHEMBL631432,Intermediate,Plasma,Low plasma clearance was calculated in rhesus monkey,,N,9544.0,4853,50797,1,,,BAO_0000218,1969.0,
13017,Canis lupus familiaris,CHEMBL631433,Intermediate,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,N,9615.0,16452,50588,1,,,BAO_0000218,,
13018,,CHEMBL631434,Autocuration,,Plasma clearance after intravenous dose of 0.3 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
13019,,CHEMBL631435,Autocuration,,Plasma clearance after intravenous dose of 1 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
13020,,CHEMBL631436,Autocuration,,Plasma clearance after intravenous dose of 3 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
13021,,CHEMBL631437,Autocuration,,Plasma clearance after intravenous dose of 3.87 mg/kg,,U,,11954,22224,1,,,BAO_0000218,,
13022,Rattus norvegicus,CHEMBL631438,Intermediate,,Plasma clearance after peroral administration at 10 mpk in Rat,,N,10116.0,5669,50597,1,,,BAO_0000218,,
13023,Macaca mulatta,CHEMBL876431,Intermediate,,Plasma clearance after peroral administration at 10 mpk in Rhesus,,N,9544.0,5669,50797,1,,,BAO_0000218,,
13024,Canis lupus familiaris,CHEMBL631439,Intermediate,,Plasma clearance after peroral administration at 10 mpk in dog,,N,9615.0,5669,50588,1,,,BAO_0000218,,
13025,Rattus norvegicus,CHEMBL631440,Intermediate,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,N,10116.0,13662,50597,1,,,BAO_0000218,,
13026,,CHEMBL631441,Autocuration,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,U,,8272,22224,1,,,BAO_0000019,,
13027,,CHEMBL631442,Autocuration,,Critical Micellar concentration was determined,,U,,13410,22224,1,,,BAO_0000019,,
13028,,CHEMBL626525,Autocuration,,Critical Micellar concentration of the compound. was determined,,U,,13410,22224,1,,,BAO_0000019,,
13029,,CHEMBL627168,Autocuration,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,U,,12628,22224,1,,,BAO_0000019,,
13030,,CHEMBL875618,Autocuration,,Critical micellar concentration was measured in water by the dye solubilization method,,U,,9675,22224,1,,,BAO_0000019,,
13031,,CHEMBL626612,Autocuration,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,U,,12628,22224,1,,,BAO_0000019,,
13032,,CHEMBL626613,Autocuration,,CMR value (relative to BAY K 8644),,U,,12766,22224,1,,,BAO_0000019,,
13033,,CHEMBL626614,Autocuration,,Carbamoylating activity was determined,,U,,7849,22224,1,,,BAO_0000019,,
13034,Simiiformes,CHEMBL626615,Autocuration,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,U,314293.0,12187,22224,1,,,BAO_0000218,,
13035,,CHEMBL626616,Autocuration,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,U,,2040,22224,1,,,BAO_0000019,,
13036,,CHEMBL626617,Autocuration,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,U,,2040,22224,1,,,BAO_0000019,,
13037,Canis lupus familiaris,CHEMBL626618,Intermediate,Plasma,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,N,9615.0,14180,50588,1,,,BAO_0000218,1969.0,
13038,Rattus norvegicus,CHEMBL626619,Intermediate,Plasma,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,N,10116.0,14180,50597,1,,,BAO_0000218,1969.0,
13039,Canis lupus familiaris,CHEMBL626620,Intermediate,,"Clearance rate at 0.46 mg/kg, iv, in dogs",,N,9615.0,14474,50588,1,,,BAO_0000218,,
13040,Rattus norvegicus,CHEMBL626621,Intermediate,,"Clearance rate at 5.5 mg/kg, iv, in rat",,N,10116.0,14474,50597,1,,,BAO_0000218,,
13041,Macaca fascicularis,CHEMBL626622,Intermediate,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,N,9541.0,14548,100710,1,,,BAO_0000218,,
13042,Macaca fascicularis,CHEMBL626623,Intermediate,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,N,9541.0,14548,100710,1,,,BAO_0000218,,
13043,Canis lupus familiaris,CHEMBL626624,Intermediate,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,N,9615.0,14548,50588,1,,,BAO_0000218,,
13044,Rattus norvegicus,CHEMBL626625,Intermediate,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,N,10116.0,14548,50597,1,,,BAO_0000218,,
13045,Rattus norvegicus,CHEMBL626626,Intermediate,Liver,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,N,10116.0,6125,50597,1,,,BAO_0000218,2107.0,
13046,,CHEMBL626627,Autocuration,,Tested for the total clearance of the compound,,U,,6874,22224,1,,,BAO_0000218,,
13047,Canis lupus familiaris,CHEMBL626628,Intermediate,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,N,9615.0,15343,50588,1,,,BAO_0000218,,
13048,,CHEMBL626629,Autocuration,,Total body clearance was determined,,U,,6236,22224,1,,,BAO_0000218,,
13049,Rattus norvegicus,CHEMBL626630,Intermediate,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13050,Rattus norvegicus,CHEMBL626631,Intermediate,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13051,,CHEMBL626632,Autocuration,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,U,,8194,22229,1,,,BAO_0000100,,
13052,,CHEMBL626633,Autocuration,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,U,,8194,22229,1,,,BAO_0000100,,
13053,,CHEMBL626634,Autocuration,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,U,,8194,22229,1,,,BAO_0000100,,
13054,,CHEMBL626635,Autocuration,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,U,,8194,22229,1,,,BAO_0000100,,
13055,,CHEMBL626636,Autocuration,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,U,,8194,22229,1,,,BAO_0000100,,
13056,,CHEMBL626637,Autocuration,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,U,,8194,22229,1,,,BAO_0000100,,
13057,Pneumocystis carinii,CHEMBL626638,Intermediate,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,N,4754.0,13273,50339,1,,,BAO_0000218,,
13058,Pneumocystis carinii,CHEMBL626639,Intermediate,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,N,4754.0,13273,50339,1,,,BAO_0000218,,
13059,Pneumocystis carinii,CHEMBL626640,Intermediate,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,N,4754.0,13273,50339,1,,,BAO_0000218,,
13060,Pneumocystis carinii,CHEMBL626641,Intermediate,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,N,4754.0,13273,50339,1,,,BAO_0000218,,
13061,Pneumocystis carinii,CHEMBL627272,Intermediate,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,N,4754.0,13273,50339,1,,,BAO_0000218,,
13062,Pneumocystis carinii,CHEMBL627273,Intermediate,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,N,4754.0,13273,50339,1,,,BAO_0000218,,
13063,Pneumocystis carinii,CHEMBL627441,Intermediate,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,N,4754.0,13273,50339,1,,,BAO_0000218,,
13064,Pneumocystis carinii,CHEMBL628355,Intermediate,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,N,4754.0,13273,50339,1,,,BAO_0000218,,
13065,Pneumocystis carinii,CHEMBL628356,Intermediate,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,N,4754.0,13273,50339,1,,,BAO_0000218,,
13066,Pneumocystis carinii,CHEMBL628357,Intermediate,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,N,4754.0,13273,50339,1,,,BAO_0000218,,
13067,Pneumocystis carinii,CHEMBL628358,Intermediate,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,N,4754.0,13273,50339,1,,,BAO_0000218,,
13068,Pneumocystis carinii,CHEMBL622307,Intermediate,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,N,4754.0,13273,50339,1,,,BAO_0000218,,
13069,,CHEMBL622527,Autocuration,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,U,,13118,22224,1,,,BAO_0000019,,
13070,,CHEMBL622528,Autocuration,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,U,,13118,22224,1,,,BAO_0000019,,
13071,,CHEMBL622529,Autocuration,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,U,,13118,22224,1,,,BAO_0000019,,
13072,,CHEMBL622992,Autocuration,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,U,,13118,22224,1,,,BAO_0000019,,
13073,,CHEMBL622993,Autocuration,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,U,,13118,22224,1,,,BAO_0000019,,
13074,,CHEMBL622994,Autocuration,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,U,,13118,22224,1,,,BAO_0000019,,
13075,Rattus norvegicus,CHEMBL622995,Intermediate,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,N,10116.0,10633,50597,1,,,BAO_0000218,,
13076,Rattus norvegicus,CHEMBL622996,Intermediate,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,N,10116.0,10633,50597,1,,,BAO_0000218,,
13077,Rattus norvegicus,CHEMBL622997,Intermediate,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,N,10116.0,10633,50597,1,,,BAO_0000218,,
13078,Rattus norvegicus,CHEMBL622998,Intermediate,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,N,10116.0,10633,50597,1,,,BAO_0000218,,
13079,,CHEMBL622999,Autocuration,,Cp max following ip administration at 1 mg/kg,,U,,5767,22224,1,,,BAO_0000218,,
13080,,CHEMBL623000,Autocuration,Plasma,Maximum concentration in plasma was reported at 0.5 hour,,U,,3302,22224,1,,,BAO_0000218,1969.0,
13081,,CHEMBL623001,Autocuration,Plasma,Maximum concentration in plasma was reported at 2 hour,,U,,3302,22224,1,,,BAO_0000218,1969.0,
13082,Mus musculus,CHEMBL623002,Intermediate,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,N,10090.0,12467,50594,1,,,BAO_0000218,,
13083,,CHEMBL623003,Autocuration,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,U,,11778,22229,1,,,BAO_0000100,,
13084,,CHEMBL623004,Autocuration,,Steady state concentration was evaluated,,U,,4321,22224,1,,,BAO_0000019,,
13085,,CHEMBL623005,Autocuration,,Partition coefficient (logP),,U,,14884,22224,1,,,BAO_0000019,,
13086,,CHEMBL623006,Autocuration,,Partition coefficient (logD7.4),,U,,15234,22224,1,,,BAO_0000019,,
13087,Rattus norvegicus,CHEMBL623007,Intermediate,Liver,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2107.0,
13088,Rattus norvegicus,CHEMBL623008,Intermediate,Bone,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,10000001.0,
13089,Rattus norvegicus,CHEMBL876654,Intermediate,Cerebellum,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2037.0,
13090,Rattus norvegicus,CHEMBL623009,Intermediate,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,,
13091,Rattus norvegicus,CHEMBL623010,Intermediate,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,,
13092,Rattus norvegicus,CHEMBL623011,Intermediate,Heart,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,948.0,
13093,Rattus norvegicus,CHEMBL623012,Intermediate,Intestine,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,160.0,
13094,,CHEMBL623013,Autocuration,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,U,,8151,22224,1,,,BAO_0000019,,
13095,,CHEMBL623014,Autocuration,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,U,,8151,22224,1,,,BAO_0000019,,
13096,,CHEMBL623015,Autocuration,Urine,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,U,,8151,22224,1,,,BAO_0000019,1088.0,
13097,,CHEMBL623016,Autocuration,Urine,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,U,,8151,22224,1,,,BAO_0000019,1088.0,
13098,,CHEMBL624858,Autocuration,Urine,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,U,,8151,22224,1,,,BAO_0000019,1088.0,
13099,Rattus norvegicus,CHEMBL624859,Intermediate,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,N,10116.0,8151,50597,1,,,BAO_0000218,,
13100,Rattus norvegicus,CHEMBL624860,Intermediate,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,N,10116.0,8151,50597,1,,,BAO_0000218,,
13101,Rattus norvegicus,CHEMBL624861,Intermediate,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,N,10116.0,8151,50597,1,,,BAO_0000218,,
13102,Rattus norvegicus,CHEMBL624862,Intermediate,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,N,10116.0,8151,50597,1,,,BAO_0000218,,
13103,Rattus norvegicus,CHEMBL624863,Intermediate,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,N,10116.0,8151,50597,1,,,BAO_0000218,,
13104,Rattus norvegicus,CHEMBL876655,Intermediate,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,N,10116.0,8151,50597,1,,,BAO_0000218,,
13105,Canis lupus familiaris,CHEMBL624864,Intermediate,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13106,Canis lupus familiaris,CHEMBL624865,Intermediate,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13107,Canis lupus familiaris,CHEMBL624866,Intermediate,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13108,Canis lupus familiaris,CHEMBL624867,Expert,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13109,Canis lupus familiaris,CHEMBL624868,Intermediate,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13110,Canis lupus familiaris,CHEMBL628450,Intermediate,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13111,Canis lupus familiaris,CHEMBL628451,Intermediate,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13112,Canis lupus familiaris,CHEMBL628452,Intermediate,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13113,Canis lupus familiaris,CHEMBL628453,Intermediate,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13114,Canis lupus familiaris,CHEMBL628454,Intermediate,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13115,Canis lupus familiaris,CHEMBL628455,Intermediate,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13116,Canis lupus familiaris,CHEMBL628456,Intermediate,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13117,Canis lupus familiaris,CHEMBL628457,Intermediate,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13118,Canis lupus familiaris,CHEMBL877505,Intermediate,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13119,Canis lupus familiaris,CHEMBL628458,Intermediate,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13120,Canis lupus familiaris,CHEMBL628459,Intermediate,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13121,Canis lupus familiaris,CHEMBL628460,Intermediate,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13122,Canis lupus familiaris,CHEMBL628461,Intermediate,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13123,,CHEMBL628462,Autocuration,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,U,,6996,22224,1,,,BAO_0000218,,
13124,Canis lupus familiaris,CHEMBL628463,Intermediate,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13125,Rattus norvegicus,CHEMBL625666,Expert,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,N,10116.0,6996,50597,1,,,BAO_0000218,,
13126,,CHEMBL625667,Autocuration,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,U,,6996,22224,1,,,BAO_0000218,,
13127,Rattus norvegicus,CHEMBL625668,Expert,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,N,10116.0,6996,50597,1,,,BAO_0000218,,
13128,Rattus norvegicus,CHEMBL625669,Intermediate,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,N,10116.0,6996,50597,1,,,BAO_0000218,,
13129,,CHEMBL625670,Autocuration,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,U,,7114,22224,1,,,BAO_0000019,,
13130,Rattus norvegicus,CHEMBL625671,Intermediate,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,N,10116.0,7114,50597,1,,,BAO_0000218,,
13131,Human herpesvirus 1,CHEMBL625672,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
13132,Human herpesvirus 1,CHEMBL625673,Intermediate,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,N,10298.0,8613,50602,1,,,BAO_0000218,,
13133,Human herpesvirus 1,CHEMBL625674,Intermediate,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
13134,Human herpesvirus 1,CHEMBL625675,Intermediate,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,N,10298.0,8613,50602,1,,,BAO_0000218,,
13135,Human herpesvirus 1,CHEMBL627637,Intermediate,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
13136,Human herpesvirus 1,CHEMBL627638,Intermediate,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
13137,Human herpesvirus 1,CHEMBL627639,Intermediate,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,N,10298.0,8613,50602,1,,,BAO_0000218,,
13138,Human herpesvirus 1,CHEMBL627640,Intermediate,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
13139,Human herpesvirus 1,CHEMBL627641,Intermediate,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
13140,Human herpesvirus 1,CHEMBL627642,Intermediate,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
13141,Human herpesvirus 1,CHEMBL877506,Intermediate,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,N,10298.0,8613,50602,1,,,BAO_0000218,,
13142,Mus musculus,CHEMBL627275,Intermediate,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,N,10090.0,8613,50594,1,,,BAO_0000218,,
13143,Mustela putorius furo,CHEMBL627643,Intermediate,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,N,9669.0,11219,50506,1,,,BAO_0000218,,
13144,Mustela putorius furo,CHEMBL631246,Intermediate,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,N,9669.0,11219,50506,1,,,BAO_0000218,,
13145,Mustela putorius furo,CHEMBL631247,Intermediate,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,N,9669.0,11219,50506,1,,,BAO_0000218,,
13146,Mustela putorius furo,CHEMBL629532,Intermediate,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,N,9669.0,11219,50506,1,,,BAO_0000218,,
13147,Mustela putorius furo,CHEMBL629533,Intermediate,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,N,9669.0,11219,50506,1,,,BAO_0000218,,
13148,Mustela putorius furo,CHEMBL629534,Intermediate,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,N,9669.0,11219,50506,1,,,BAO_0000218,,
13149,Mustela putorius furo,CHEMBL629535,Intermediate,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,N,9669.0,11219,50506,1,,,BAO_0000218,,
13150,,CHEMBL625932,Autocuration,,Pharmacokinetic parameter :drug bound to plasma was reported,,U,,14837,22224,1,,,BAO_0000019,,
13151,,CHEMBL625933,Autocuration,,compound was evaluated for drug bound in plasma,,U,,14837,22224,1,,,BAO_0000019,,
13152,Rattus norvegicus,CHEMBL625934,Intermediate,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,N,10116.0,15343,50597,1,,,BAO_0000218,,
13153,Eutheria,CHEMBL625935,Autocuration,,Bioavailability,,U,9347.0,13761,22224,1,,,BAO_0000218,,
13154,Rattus norvegicus,CHEMBL625936,Intermediate,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,N,10116.0,14810,50597,1,,,BAO_0000218,,
13155,Rattus norvegicus,CHEMBL625937,Intermediate,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,N,10116.0,14810,50597,1,,,BAO_0000218,,
13156,Canis lupus familiaris,CHEMBL625938,Intermediate,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,N,9615.0,13249,50588,1,,,BAO_0000218,,
13157,Rattus norvegicus,CHEMBL625939,Intermediate,Bile,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,N,10116.0,9267,50597,1,,,BAO_0000218,1970.0,
13158,Rattus norvegicus,CHEMBL625940,Intermediate,Bile,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,N,10116.0,9267,50597,1,,,BAO_0000218,1970.0,
13159,Rattus norvegicus,CHEMBL874464,Intermediate,Bile,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,N,10116.0,9267,50597,1,,,BAO_0000218,1970.0,
13160,Rattus norvegicus,CHEMBL625941,Intermediate,Bile,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,N,10116.0,9267,50597,1,,,BAO_0000218,1970.0,
13161,Rattus norvegicus,CHEMBL625942,Intermediate,Bile,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,N,10116.0,9267,50597,1,,,BAO_0000218,1970.0,
13162,Rattus norvegicus,CHEMBL625943,Intermediate,Bile,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,N,10116.0,9267,50597,1,,,BAO_0000218,1970.0,
13163,Homo sapiens,CHEMBL625944,Intermediate,Serum,In vitro protein binding in human serum at 5 ug/ml,,N,9606.0,15549,50587,1,,,BAO_0000218,1977.0,
13164,,CHEMBL625945,Autocuration,,Serum protein binding ability was measured,,U,,10929,22224,1,,,BAO_0000019,,
13165,,CHEMBL625946,Autocuration,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,U,,15444,22224,1,,,BAO_0000019,,
13166,Canis lupus familiaris,CHEMBL625947,Autocuration,,Oral bioavailability in dog,,U,9615.0,12860,22224,1,,,BAO_0000218,,
13167,Rattus norvegicus,CHEMBL625948,Intermediate,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,N,10116.0,12170,50597,1,,,BAO_0000218,,
13168,,CHEMBL625949,Autocuration,,Absolute oral bioavailability at an iv dose of 14 mg/kg,,U,,15173,22224,1,,,BAO_0000218,,
13169,,CHEMBL625950,Autocuration,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,U,,15173,22224,1,,,BAO_0000218,,
13170,Eutheria,CHEMBL625951,Autocuration,,Oral bioavailability (dose 15 mg/kg i.v.),,U,9347.0,15173,22224,1,,,BAO_0000218,,
13171,,CHEMBL625952,Autocuration,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,U,,15173,22224,1,,,BAO_0000218,,
13172,,CHEMBL625953,Autocuration,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,U,,15173,22224,1,,,BAO_0000218,,
13173,,CHEMBL625954,Autocuration,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,U,,15173,22224,1,,,BAO_0000218,,
13174,,CHEMBL882959,Autocuration,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,U,,15173,22224,1,,,BAO_0000218,,
13175,Canis lupus familiaris,CHEMBL625955,Intermediate,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,N,9615.0,11767,50588,1,,,BAO_0000218,,
13176,Mustela putorius furo,CHEMBL625956,Autocuration,,Bioavailability in ferret,,U,9669.0,11219,22224,1,,,BAO_0000218,,
13177,Macaca fascicularis,CHEMBL625957,Intermediate,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,N,9541.0,12186,100710,1,,,BAO_0000218,,
13178,Rattus norvegicus,CHEMBL625958,Intermediate,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13179,Rattus norvegicus,CHEMBL625959,Intermediate,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13180,Rattus norvegicus,CHEMBL626642,Intermediate,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13181,Rattus norvegicus,CHEMBL631330,Intermediate,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13182,Rattus norvegicus,CHEMBL631331,Intermediate,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13183,Rattus norvegicus,CHEMBL631332,Intermediate,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13184,Rattus norvegicus,CHEMBL631333,Intermediate,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13185,Rattus norvegicus,CHEMBL632018,Intermediate,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13186,Rattus norvegicus,CHEMBL632019,Intermediate,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13187,Rattus norvegicus,CHEMBL632020,Intermediate,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13188,Rattus norvegicus,CHEMBL632021,Intermediate,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13189,Rattus norvegicus,CHEMBL632022,Intermediate,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13190,Rattus norvegicus,CHEMBL632023,Intermediate,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13191,Rattus norvegicus,CHEMBL632024,Intermediate,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13192,Rattus norvegicus,CHEMBL874472,Intermediate,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13193,Rattus norvegicus,CHEMBL632025,Intermediate,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13194,Rattus norvegicus,CHEMBL632026,Intermediate,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13195,Rattus norvegicus,CHEMBL632027,Intermediate,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13196,Rattus norvegicus,CHEMBL632028,Intermediate,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13197,Rattus norvegicus,CHEMBL626430,Intermediate,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13198,Rattus norvegicus,CHEMBL626431,Intermediate,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13199,Rattus norvegicus,CHEMBL626432,Intermediate,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13200,Rattus norvegicus,CHEMBL626433,Intermediate,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13201,Rattus norvegicus,CHEMBL626434,Intermediate,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13202,Rattus norvegicus,CHEMBL627280,Intermediate,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13203,Rattus norvegicus,CHEMBL627281,Intermediate,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13204,Rattus norvegicus,CHEMBL627282,Intermediate,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13205,,CHEMBL627283,Autocuration,,Total body clearance was measured at given dose,,U,,7199,22224,1,,,BAO_0000019,,
13206,,CHEMBL627284,Autocuration,,Total body clearance was measured at given dose.,,U,,7199,22224,1,,,BAO_0000218,,
13207,Rattus norvegicus,CHEMBL627285,Intermediate,,Metabolic clearance from the body in rat,,N,10116.0,7095,50597,1,,,BAO_0000218,,
13208,,CHEMBL627286,Autocuration,,Renal clearance from the body,,U,,7095,22224,1,,,BAO_0000218,,
13209,Rattus norvegicus,CHEMBL875477,Intermediate,,Renal clearance from the body in rat,,N,10116.0,7095,50597,1,,,BAO_0000218,,
13210,Rattus norvegicus,CHEMBL627287,Intermediate,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,N,10116.0,12528,50597,1,,,BAO_0000218,,
13211,Canis lupus familiaris,CHEMBL627288,Intermediate,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,N,9615.0,12528,50588,1,,,BAO_0000218,,
13212,Rattus norvegicus,CHEMBL627289,Intermediate,,Total clearance from the body in rat,,N,10116.0,7095,50597,1,,,BAO_0000218,,
13213,Rattus norvegicus,CHEMBL627290,Intermediate,Plasma,Clearance into cortex from rat plasma or PBS,,N,10116.0,14223,50597,1,,,BAO_0000218,1969.0,
13214,,CHEMBL627291,Autocuration,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,U,,13569,22224,1,,,BAO_0000218,,
13215,,CHEMBL627292,Autocuration,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,U,,13569,22224,1,,,BAO_0000218,,
13216,,CHEMBL627293,Autocuration,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,U,,13569,22224,1,,,BAO_0000218,,
13217,,CHEMBL627294,Autocuration,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,U,,13569,22224,1,,,BAO_0000218,,
13218,,CHEMBL875478,Autocuration,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,U,,13569,22224,1,,,BAO_0000218,,
13219,,CHEMBL627295,Autocuration,,Clearance was determined,,U,,13979,22224,1,,,BAO_0000218,,
13220,Mus musculus,CHEMBL627296,Intermediate,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,N,10090.0,14315,50594,1,,,BAO_0000218,,
13221,Oryctolagus cuniculus,CHEMBL626119,Intermediate,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,N,9986.0,14315,50592,1,,,BAO_0000218,,
13222,Rattus norvegicus,CHEMBL626120,Intermediate,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,N,10116.0,14315,50597,1,,,BAO_0000218,,
13223,Rattus norvegicus,CHEMBL626121,Intermediate,,Clearance in rat after iv dose (100 ug/kg),,N,10116.0,12174,50597,1,,,BAO_0000218,,
13224,Cavia porcellus,CHEMBL626122,Autocuration,,Clearance in guinea pig,,U,10141.0,12797,22224,1,,,BAO_0000218,,
13225,Rattus norvegicus,CHEMBL626123,Intermediate,,Compound was evaluated for clearance in rat,,N,10116.0,12797,50597,1,,,BAO_0000218,,
13226,Canis lupus familiaris,CHEMBL623456,Intermediate,,Compound was evaluated for the clearance in dog,,N,9615.0,12797,50588,1,,,BAO_0000218,,
13227,Rattus norvegicus,CHEMBL623457,Intermediate,,Compound was evaluated for the clearance in rat,,N,10116.0,12797,50597,1,,,BAO_0000218,,
13228,Rattus norvegicus,CHEMBL623458,Intermediate,,Compound was tested in vivo for clearance after iv administration in the rat,,N,10116.0,11500,50597,1,,,BAO_0000218,,
13229,,CHEMBL623459,Autocuration,,IV clearance determined at an iv dose of 14 mg/kg,,U,,15173,22224,1,,,BAO_0000218,,
13230,,CHEMBL875484,Autocuration,,IV clearance determined at an iv dose of 15.2 mg/kg,,U,,15173,22224,1,,,BAO_0000218,,
13231,,CHEMBL623460,Autocuration,,IV clearance determined at an iv dose of 15 mg/kg,,U,,15173,22224,1,,,BAO_0000218,,
13232,,CHEMBL623461,Autocuration,,IV clearance determined at an peroral dose of 30 mg/kg.,,U,,15173,22224,1,,,BAO_0000218,,
13233,,CHEMBL623462,Autocuration,,IV clearance determined at an peroral dose of 30.2 mg/kg.,,U,,15173,22224,1,,,BAO_0000218,,
13234,,CHEMBL627386,Autocuration,,IV clearance determined at an peroral dose of 30.3 mg/kg.,,U,,15173,22224,1,,,BAO_0000218,,
13235,Rattus norvegicus,CHEMBL627387,Intermediate,Kidney,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2113.0,
13236,Rattus norvegicus,CHEMBL627388,Intermediate,Liver,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2107.0,
13237,Rattus norvegicus,CHEMBL627389,Intermediate,Lung,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2048.0,
13238,Rattus norvegicus,CHEMBL627390,Intermediate,Muscle tissue,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2385.0,
13239,Rattus norvegicus,CHEMBL627391,Intermediate,Plasma,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,1969.0,
13240,Rattus norvegicus,CHEMBL627392,Intermediate,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,,
13241,Rattus norvegicus,CHEMBL627393,Intermediate,Spleen,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2106.0,
13242,Rattus norvegicus,CHEMBL627394,Intermediate,Trachea,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,3126.0,
13243,Rattus norvegicus,CHEMBL627395,Intermediate,Bone,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,10000001.0,
13244,Rattus norvegicus,CHEMBL875485,Intermediate,Cerebellum,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2037.0,
13245,Rattus norvegicus,CHEMBL627396,Intermediate,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,,
13246,Rattus norvegicus,CHEMBL627397,Intermediate,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,,
13247,Rattus norvegicus,CHEMBL627398,Intermediate,Heart,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,948.0,
13248,Rattus norvegicus,CHEMBL627399,Intermediate,Bone,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,10000001.0,
13249,Rattus norvegicus,CHEMBL627400,Intermediate,Kidney,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2113.0,
13250,Rattus norvegicus,CHEMBL627401,Intermediate,Liver,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2107.0,
13251,Rattus norvegicus,CHEMBL627402,Intermediate,Lung,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2048.0,
13252,Rattus norvegicus,CHEMBL627403,Intermediate,Muscle tissue,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2385.0,
13253,Rattus norvegicus,CHEMBL627404,Intermediate,Plasma,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,1969.0,
13254,Rattus norvegicus,CHEMBL623101,Intermediate,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,,
13255,Rattus norvegicus,CHEMBL877480,Intermediate,Spleen,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2106.0,
13256,Rattus norvegicus,CHEMBL623102,Intermediate,Trachea,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,3126.0,
13257,Rattus norvegicus,CHEMBL623103,Intermediate,Bone,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,10000001.0,
13258,Rattus norvegicus,CHEMBL623104,Intermediate,Cerebellum,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2037.0,
13259,Rattus norvegicus,CHEMBL623105,Intermediate,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,,
13260,Rattus norvegicus,CHEMBL623106,Intermediate,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,,
13261,Rattus norvegicus,CHEMBL623107,Intermediate,Heart,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,948.0,
13262,Rattus norvegicus,CHEMBL623108,Intermediate,Intestine,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,160.0,
13263,Rattus norvegicus,CHEMBL623109,Intermediate,Kidney,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2113.0,
13264,Rattus norvegicus,CHEMBL623110,Intermediate,Liver,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2107.0,
13265,Rattus norvegicus,CHEMBL623111,Intermediate,Lung,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2048.0,
13266,Rattus norvegicus,CHEMBL625060,Intermediate,Muscle tissue,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2385.0,
13267,Rattus norvegicus,CHEMBL625061,Intermediate,Plasma,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,1969.0,
13268,Rattus norvegicus,CHEMBL625062,Intermediate,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,,
13269,Rattus norvegicus,CHEMBL625063,Intermediate,Spleen,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2106.0,
13270,Rattus norvegicus,CHEMBL625064,Intermediate,Trachea,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,3126.0,
13271,Rattus norvegicus,CHEMBL625065,Intermediate,Bone,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,10000001.0,
13272,Rattus norvegicus,CHEMBL625066,Intermediate,Cerebellum,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2037.0,
13273,Rattus norvegicus,CHEMBL625067,Intermediate,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,,
13274,Rattus norvegicus,CHEMBL625068,Intermediate,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,,
13275,Rattus norvegicus,CHEMBL622159,Intermediate,Heart,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,948.0,
13276,Rattus norvegicus,CHEMBL622160,Intermediate,Intestine,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,160.0,
13277,Rattus norvegicus,CHEMBL622161,Intermediate,Kidney,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2113.0,
13278,Rattus norvegicus,CHEMBL622162,Intermediate,Lung,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2048.0,
13279,Rattus norvegicus,CHEMBL622163,Intermediate,Muscle tissue,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2385.0,
13280,Rattus norvegicus,CHEMBL622313,Intermediate,Plasma,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,1969.0,
13281,Rattus norvegicus,CHEMBL622314,Intermediate,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,,
13282,Rattus norvegicus,CHEMBL622315,Intermediate,Spleen,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,2106.0,
13283,Rattus norvegicus,CHEMBL622316,Intermediate,Trachea,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,N,10116.0,14198,50597,1,,,BAO_0000218,3126.0,
13284,Escherichia coli,CHEMBL877486,Intermediate,,Normal diffusion coefficient in water for Escherichia coli,,N,562.0,15599,50212,1,,,BAO_0000218,,
13285,,CHEMBL622317,Autocuration,,Average max percent decrease in RVR (renal vascular resistance) was determined,,U,,8204,22224,1,,,BAO_0000019,,
13286,,CHEMBL622318,Autocuration,,Average max percent decrease in RVR (renal vascular resistance) was determined.,,U,,8204,22224,1,,,BAO_0000019,,
13287,,CHEMBL622319,Autocuration,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,U,,6154,22224,1,,,BAO_0000019,,
13288,,CHEMBL622320,Autocuration,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,U,,6154,22224,1,,,BAO_0000019,,
13289,,CHEMBL622321,Autocuration,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,U,,6154,22224,1,,,BAO_0000019,,
13290,,CHEMBL622322,Autocuration,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,U,,6154,22224,1,,,BAO_0000019,,
13291,,CHEMBL622323,Autocuration,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,U,,7114,22224,1,,,BAO_0000019,,
13292,Rattus norvegicus,CHEMBL622324,Intermediate,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,N,10116.0,7114,50597,1,,,BAO_0000218,,
13293,Canis lupus familiaris,CHEMBL622325,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13294,Canis lupus familiaris,CHEMBL622326,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13295,Canis lupus familiaris,CHEMBL877487,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13296,Canis lupus familiaris,CHEMBL622327,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13297,Canis lupus familiaris,CHEMBL622328,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13298,Canis lupus familiaris,CHEMBL622329,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13299,Canis lupus familiaris,CHEMBL622330,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13300,Canis lupus familiaris,CHEMBL622331,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13301,Canis lupus familiaris,CHEMBL622332,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13302,Canis lupus familiaris,CHEMBL622333,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13303,Simiiformes,CHEMBL627658,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13304,Simiiformes,CHEMBL630428,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13305,Simiiformes,CHEMBL630429,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13306,Simiiformes,CHEMBL630430,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13307,Simiiformes,CHEMBL630431,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13308,Rattus norvegicus,CHEMBL630432,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13309,Rattus norvegicus,CHEMBL630433,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13310,Rattus norvegicus,CHEMBL630434,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13311,Rattus norvegicus,CHEMBL629372,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13312,Rattus norvegicus,CHEMBL629553,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13313,Rattus norvegicus,CHEMBL629554,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13314,Rattus norvegicus,CHEMBL874447,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13315,Rattus norvegicus,CHEMBL629555,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13316,Rattus norvegicus,CHEMBL629556,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13317,Rattus norvegicus,CHEMBL629557,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13318,Rattus norvegicus,CHEMBL629558,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13319,Rattus norvegicus,CHEMBL629559,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13320,Rattus norvegicus,CHEMBL629560,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13321,Canis lupus familiaris,CHEMBL629561,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13322,Canis lupus familiaris,CHEMBL629562,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13323,Canis lupus familiaris,CHEMBL629563,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13324,Canis lupus familiaris,CHEMBL629564,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13325,Canis lupus familiaris,CHEMBL629565,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13326,Canis lupus familiaris,CHEMBL629566,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13327,Canis lupus familiaris,CHEMBL629567,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13328,Canis lupus familiaris,CHEMBL629568,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13329,Canis lupus familiaris,CHEMBL629569,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13330,Canis lupus familiaris,CHEMBL629570,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13331,Simiiformes,CHEMBL629571,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13332,Rattus norvegicus,CHEMBL629572,Autocuration,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,U,10116.0,12170,22224,1,,,BAO_0000218,,
13333,Rattus norvegicus,CHEMBL629573,Autocuration,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,U,10116.0,12170,22224,1,,,BAO_0000218,,
13334,Eutheria,CHEMBL629574,Autocuration,,Bioavailability (dose 20 mg/kg),,U,9347.0,4985,22224,1,,,BAO_0000218,,
13335,Canis lupus familiaris,CHEMBL629575,Autocuration,,Bioavailability in dog,,U,9615.0,15145,22224,1,,,BAO_0000218,,
13336,Rattus norvegicus,CHEMBL874448,Autocuration,,Bioavailability in rat (Sprague-Dawley) (male),,U,10116.0,14080,22224,1,,,BAO_0000218,,
13337,Primates,CHEMBL629576,Autocuration,,Bioavailability in monkey (dose 10 mg/kg i.d.),,U,9443.0,11219,22224,1,,,BAO_0000218,,
13338,Rattus norvegicus,CHEMBL629577,Autocuration,,Bioavailability in rat,,U,10116.0,15145,22224,1,,,BAO_0000218,,
13339,Rattus norvegicus,CHEMBL629578,Autocuration,,Bioavailability in rat,,U,10116.0,15145,22224,1,,,BAO_0000218,,
13340,Canis lupus familiaris,CHEMBL629579,Autocuration,,Bioavailability in dog (dose 3.0 mg/kg p.o.),,U,9615.0,1202,22224,1,,,BAO_0000218,,
13341,Canis lupus familiaris,CHEMBL882958,Autocuration,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,U,9615.0,1202,22224,1,,,BAO_0000218,,
13342,Pan troglodytes,CHEMBL629580,Intermediate,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,N,9598.0,1202,50505,1,,,BAO_0000218,,
13343,Eutheria,CHEMBL629581,Autocuration,,Bioavailability,,U,9347.0,4026,22224,1,,,BAO_0000218,,
13344,Saimiri,CHEMBL629582,Autocuration,,Bioavailability in squirrel monkey,,U,9520.0,1492,22224,1,,,BAO_0000218,,
13345,Canis lupus familiaris,CHEMBL628522,Intermediate,,Bioavailability was evaluated in dog,,N,9615.0,12793,50588,1,,,BAO_0000218,,
13346,Cricetinae,CHEMBL625432,Intermediate,,Bioavailability was evaluated in hamster,,N,10026.0,12793,100712,1,,,BAO_0000218,,
13347,Rattus norvegicus,CHEMBL625433,Autocuration,,Bioavailability in rat,,U,10116.0,12793,22224,1,,,BAO_0000218,,
13348,Rattus norvegicus,CHEMBL625434,Intermediate,Plasma,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,N,10116.0,14793,50597,1,,,BAO_0000218,1969.0,
13349,Rattus norvegicus,CHEMBL625435,Intermediate,Plasma,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,N,10116.0,14793,50597,1,,,BAO_0000218,1969.0,
13350,Rattus norvegicus,CHEMBL625436,Autocuration,,Bioavailability in rat (dose 10 mg/kg p.o.),,U,10116.0,14793,22224,1,,,BAO_0000218,,
13351,Macaca fascicularis,CHEMBL874588,Intermediate,,Bioavailability was measured in cynomolgus monkeys.,,N,9541.0,14731,100710,1,,,BAO_0000218,,
13352,Mus musculus,CHEMBL625437,Intermediate,,Bioavailability was measured in nude mice.,,N,10090.0,14731,50594,1,,,BAO_0000218,,
13353,Mustela putorius furo,CHEMBL625438,Autocuration,,Bioavailability in ferret (dose 10 mg/kg i.d.),,U,9669.0,12187,22224,1,,,BAO_0000218,,
13354,Simiiformes,CHEMBL625439,Autocuration,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,U,314293.0,12187,22224,1,,,BAO_0000218,,
13355,Simiiformes,CHEMBL625440,Autocuration,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,U,314293.0,12187,22224,1,,,BAO_0000218,,
13356,Simiiformes,CHEMBL625441,Autocuration,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,U,314293.0,12187,22224,1,,,BAO_0000218,,
13357,Rattus norvegicus,CHEMBL625442,Autocuration,,Bioavailability in rat (dose 10 mg/kg i.d.),,U,10116.0,12187,22224,1,,,BAO_0000218,,
13358,Rattus norvegicus,CHEMBL625443,Intermediate,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,N,10116.0,12187,50597,1,,,BAO_0000218,,
13359,,CHEMBL625444,Autocuration,,Bioavailability was determined; extremely poor,,U,,17431,22224,1,,,BAO_0000218,,
13360,Mus musculus,CHEMBL625445,Intermediate,,% bioavailability in mice after oral administration of prodrug,,N,10090.0,13318,50594,1,,,BAO_0000218,,
13361,Canis lupus familiaris,CHEMBL625446,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13362,Canis lupus familiaris,CHEMBL882960,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13363,Canis lupus familiaris,CHEMBL625447,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13364,Canis lupus familiaris,CHEMBL625448,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13365,Canis lupus familiaris,CHEMBL625449,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13366,Canis lupus familiaris,CHEMBL874589,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,N,9615.0,9025,50588,1,,,BAO_0000218,,
13367,Canis lupus familiaris,CHEMBL625450,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13368,Canis lupus familiaris,CHEMBL625451,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13369,Canis lupus familiaris,CHEMBL626584,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13370,Canis lupus familiaris,CHEMBL626585,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13371,Canis lupus familiaris,CHEMBL626586,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13372,Canis lupus familiaris,CHEMBL626587,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13373,Canis lupus familiaris,CHEMBL626588,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13374,Canis lupus familiaris,CHEMBL626589,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13375,Canis lupus familiaris,CHEMBL626590,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13376,Canis lupus familiaris,CHEMBL626591,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13377,Canis lupus familiaris,CHEMBL627181,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13378,Canis lupus familiaris,CHEMBL628083,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13379,,CHEMBL628084,Autocuration,,IV clearance determined at an peroral dose of 15 mg/kg.,,U,,15173,22224,1,,,BAO_0000218,,
13380,Hymenolepis nana,CHEMBL628085,Expert,,Mouse oral clearance was measured against Hymenolepiasis nana.,,N,102285.0,7732,50064,1,,,BAO_0000218,,
13381,Heligmosomoides polygyrus,CHEMBL628086,Expert,,Mouse oral clearance was measured against Nematospiroides dubius,,N,6339.0,7732,50545,1,,,BAO_0000218,,
13382,,CHEMBL628087,Autocuration,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,U,,7732,22224,1,,,BAO_0000218,,
13383,Mus musculus,CHEMBL628088,Intermediate,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,N,10090.0,7732,50594,1,,,BAO_0000218,,
13384,,CHEMBL628089,Autocuration,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,U,,7732,22224,1,,,BAO_0000218,,
13385,,CHEMBL628090,Autocuration,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,U,,8328,22224,1,,,BAO_0000218,,
13386,,CHEMBL628091,Autocuration,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,U,,8328,22224,1,,,BAO_0000218,,
13387,,CHEMBL628092,Autocuration,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,U,,8328,22224,1,,,BAO_0000218,,
13388,,CHEMBL628093,Autocuration,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,U,,8328,22224,1,,,BAO_0000218,,
13389,,CHEMBL875607,Autocuration,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,U,,8328,22224,1,,,BAO_0000218,,
13390,,CHEMBL625710,Autocuration,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,U,,8328,22224,1,,,BAO_0000218,,
13391,,CHEMBL625711,Autocuration,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,U,,8328,22224,1,,,BAO_0000218,,
13392,,CHEMBL625712,Autocuration,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,U,,8328,22224,1,,,BAO_0000218,,
13393,,CHEMBL625713,Autocuration,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,U,,8328,22224,1,,,BAO_0000218,,
13394,Canis lupus familiaris,CHEMBL625714,Intermediate,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,N,9615.0,13376,50588,1,,,BAO_0000218,,
13395,Macaca mulatta,CHEMBL625715,Intermediate,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,N,9544.0,13477,50797,1,,,BAO_0000218,,
13396,Rattus norvegicus,CHEMBL625716,Intermediate,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,N,10116.0,13477,50597,1,,,BAO_0000218,,
13397,Rattus norvegicus,CHEMBL625717,Intermediate,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,N,10116.0,13477,50597,1,,,BAO_0000218,,
13398,Rattus norvegicus,CHEMBL625718,Intermediate,,Plasma clearance was determined for the compound in rats,,N,10116.0,13313,50597,1,,,BAO_0000218,,
13399,Rattus norvegicus,CHEMBL625719,Intermediate,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,N,10116.0,12504,50597,1,,,BAO_0000218,,
13400,Rattus norvegicus,CHEMBL625720,Intermediate,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,N,10116.0,12504,50597,1,,,BAO_0000218,,
13401,Rattus norvegicus,CHEMBL625721,Intermediate,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,N,10116.0,12504,50597,1,,,BAO_0000218,,
13402,Rattus norvegicus,CHEMBL625722,Intermediate,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,N,10116.0,12504,50597,1,,,BAO_0000218,,
13403,Rattus norvegicus,CHEMBL625723,Intermediate,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,N,10116.0,13129,50597,1,,,BAO_0000218,,
13404,Heligmosomoides polygyrus,CHEMBL625724,Intermediate,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,N,6339.0,7732,50545,1,,,BAO_0000218,,
13405,Heligmosomoides polygyrus,CHEMBL625725,Intermediate,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,N,6339.0,7732,50545,1,,,BAO_0000218,,
13406,Heligmosomoides polygyrus,CHEMBL625726,Intermediate,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,N,6339.0,7732,50545,1,,,BAO_0000218,,
13407,Heligmosomoides polygyrus,CHEMBL875608,Intermediate,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,N,6339.0,7732,50545,1,,,BAO_0000218,,
13408,Heligmosomoides polygyrus,CHEMBL625727,Intermediate,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,N,6339.0,7732,50545,1,,,BAO_0000218,,
13409,Rattus norvegicus,CHEMBL625728,Autocuration,Urine,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,U,10116.0,9278,22224,1,,,BAO_0000218,1088.0,
13410,Rattus norvegicus,CHEMBL625729,Autocuration,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,U,10116.0,9278,22224,1,,,BAO_0000218,,
13411,Rattus norvegicus,CHEMBL625730,Autocuration,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,U,10116.0,9278,22224,1,,,BAO_0000218,,
13412,Rattus norvegicus,CHEMBL625731,Autocuration,Urine,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,U,10116.0,9278,22224,1,,,BAO_0000218,1088.0,
13413,Rattus norvegicus,CHEMBL626417,Autocuration,Urine,Urinary clearance was determined in rat at 25 mg/kg os dosage,,U,10116.0,9278,22224,1,,,BAO_0000218,1088.0,
13414,Homo sapiens,CHEMBL626418,Intermediate,Urine,Urinary clearance was determined at 100 mg/kg oral dosage in human,,N,9606.0,9278,50587,1,,,BAO_0000218,1088.0,
13415,Canis lupus familiaris,CHEMBL626419,Intermediate,Urine,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,N,9615.0,9278,50588,1,,,BAO_0000218,1088.0,
13416,Canis lupus familiaris,CHEMBL626592,Intermediate,Plasma,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,N,9615.0,5932,50588,1,,,BAO_0000218,1969.0,
13417,Rattus norvegicus,CHEMBL626593,Intermediate,Plasma,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,N,10116.0,5932,50597,1,,,BAO_0000218,1969.0,
13418,Rattus norvegicus,CHEMBL626594,Intermediate,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,N,10116.0,5182,50597,1,,,BAO_0000218,,
13419,Canis lupus familiaris,CHEMBL625035,Intermediate,,Clearance rate in dogs,,N,9615.0,10499,50588,1,,,BAO_0000218,,
13420,,CHEMBL625036,Autocuration,,Compound was measured for intrinsic clearance,,U,,6051,22224,1,,,BAO_0000019,,
13421,,CHEMBL625037,Autocuration,,Calculated partition coefficient (clogP),,U,,17508,22229,1,,,BAO_0000100,,
13422,,CHEMBL625038,Autocuration,,Calculated partition coefficient (clogP),,U,,6228,22229,1,,,BAO_0000100,,
13423,,CHEMBL625039,Autocuration,,Calculated partition coefficient (clogP),,U,,6231,22229,1,,,BAO_0000100,,
13424,,CHEMBL625040,Autocuration,,Calculated partition coefficient (clogP),,U,,17740,22229,1,,,BAO_0000100,,
13425,,CHEMBL625041,Autocuration,,Calculated partition coefficient (clogP),,U,,6495,22229,1,,,BAO_0000100,,
13426,,CHEMBL625042,Autocuration,,Calculated partition coefficient (clogP),,U,,2171,22229,1,,,BAO_0000100,,
13427,,CHEMBL874411,Autocuration,,Partition coefficient of the compound,,U,,3255,22224,1,,,BAO_0000019,,
13428,,CHEMBL625043,Autocuration,,Permeability,,U,,6821,22224,1,,,BAO_0000019,,
13429,,CHEMBL625044,Autocuration,,Calculated partition coefficient (clogP),,U,,2685,22229,1,,,BAO_0000100,,
13430,,CHEMBL625045,Autocuration,,Partition coefficient (logD),,U,,17584,22224,1,,,BAO_0000019,,
13431,,CHEMBL625046,Autocuration,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,U,,13824,22229,1,,,BAO_0000100,,
13432,,CHEMBL625047,Autocuration,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,U,,13824,22229,1,,,BAO_0000100,,
13433,,CHEMBL625048,Autocuration,,Calculated partition coefficient (clogP),,U,,16479,22229,1,,,BAO_0000100,,
13434,,CHEMBL625049,Autocuration,,Calculated partition coefficient (clogP),,U,,11997,22229,1,,,BAO_0000100,,
13435,,CHEMBL625050,Autocuration,,Calculated logarithm of partition coefficient (P) was determined,,U,,2988,22229,1,,,BAO_0000100,,
13436,,CHEMBL625051,Autocuration,,Calculated partition coefficient (clogP),,U,,931,22229,1,,,BAO_0000100,,
13437,,CHEMBL874412,Autocuration,,Calculated partition coefficient (clogP),,U,,4381,22229,1,,,BAO_0000100,,
13438,,CHEMBL625052,Autocuration,,Calculated partition coefficient (clogP),,U,,4397,22229,1,,,BAO_0000100,,
13439,,CHEMBL625053,Autocuration,,Calculated partition coefficient (clogP),,U,,5889,22229,1,,,BAO_0000100,,
13440,,CHEMBL623250,Autocuration,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,U,,6154,22224,1,,,BAO_0000019,,
13441,,CHEMBL623251,Autocuration,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,U,,6154,22224,1,,,BAO_0000019,,
13442,,CHEMBL623252,Autocuration,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,U,,6154,22224,1,,,BAO_0000019,,
13443,,CHEMBL623253,Autocuration,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,U,,6154,22224,1,,,BAO_0000019,,
13444,,CHEMBL623254,Autocuration,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,U,,6154,22224,1,,,BAO_0000019,,
13445,,CHEMBL623255,Autocuration,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,U,,6154,22224,1,,,BAO_0000019,,
13446,,CHEMBL626831,Autocuration,,Percent degradation of compound at a pH of 1 over a 18 hr period,,U,,6887,22224,1,,,BAO_0000019,,
13447,,CHEMBL877494,Autocuration,,Percent degradation of compound at pH of 1 over an 18 hr period,,U,,6887,22224,1,,,BAO_0000019,,
13448,,CHEMBL626832,Autocuration,,Delta Logarithm of Partition Coefficient value was determined.,,U,,14116,22224,1,,,BAO_0000019,,
13449,,CHEMBL626833,Autocuration,,Delta logPoct-cyc,,U,,11137,22224,1,,,BAO_0000019,,
13450,,CHEMBL626834,Autocuration,,Lipophilicity estimated on reversed phase TLC,,U,,7230,22224,1,,,BAO_0000100,,
13451,,CHEMBL626835,Autocuration,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,U,,15741,22224,1,,,BAO_0000019,,
13452,,CHEMBL626836,Autocuration,,Delta logPoct-cyc,,U,,9663,22224,1,,,BAO_0000019,,
13453,,CHEMBL626837,Autocuration,,Change in logarithm of partition coefficient of the compound,,U,,9663,22229,1,,,BAO_0000100,,
13454,,CHEMBL626838,Autocuration,,Delta logD (pH 6.5),,U,,13807,22224,1,,,BAO_0000019,,
13455,,CHEMBL626839,Autocuration,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,U,,13807,22224,1,,,BAO_0000100,,
13456,,CHEMBL626840,Autocuration,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,U,,17425,22224,1,,,BAO_0000019,,
13457,,CHEMBL626841,Autocuration,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,U,,12143,22224,1,,,BAO_0000019,,
13458,,CHEMBL626842,Autocuration,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,U,,12608,22224,1,,,BAO_0000219,,
13459,,CHEMBL626843,Autocuration,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,U,,12608,22224,1,,,BAO_0000219,,
13460,Rattus norvegicus,CHEMBL626844,Intermediate,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,N,10116.0,8649,50597,1,,,BAO_0000218,,
13461,Rattus norvegicus,CHEMBL877495,Intermediate,,Amount of deuterium retained was reported after normal workup in rats,,N,10116.0,8649,50597,1,,,BAO_0000218,,
13462,Rattus norvegicus,CHEMBL626845,Intermediate,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,N,10116.0,8649,50597,1,,,BAO_0000218,,
13463,Rattus norvegicus,CHEMBL626846,Intermediate,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,N,10116.0,8649,50597,1,,,BAO_0000218,,
13464,Rattus norvegicus,CHEMBL626847,Intermediate,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,N,10116.0,8649,50597,1,,,BAO_0000218,,
13465,Rattus norvegicus,CHEMBL628677,Intermediate,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,N,10116.0,8649,50597,1,,,BAO_0000218,,
13466,Rattus norvegicus,CHEMBL628678,Intermediate,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,N,10116.0,8649,50597,1,,,BAO_0000218,,
13467,,CHEMBL628679,Autocuration,,Compound was subjected to electrochemical oxidation,,U,,9659,22224,1,,,BAO_0000019,,
13468,,CHEMBL628680,Autocuration,,Compound was subjected to photochemical oxidation,,U,,9659,22224,1,,,BAO_0000019,,
13469,,CHEMBL628681,Autocuration,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,U,,9659,22224,1,,,BAO_0000019,,
13470,,CHEMBL628682,Autocuration,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,U,,9659,22224,1,,,BAO_0000019,,
13471,,CHEMBL628683,Autocuration,,Oxidation of compound by methemoglobin in presence of hydroperoxide,,U,,9659,22224,1,,,BAO_0000019,,
13472,Rattus norvegicus,CHEMBL628684,Intermediate,,Percent diffusion through fuzzy rat skin after 48 h of incubation,,N,10116.0,9607,50597,1,,,BAO_0000218,,
13473,,CHEMBL877501,Autocuration,,Dissociation constant (pKa),,U,,7057,22229,1,,,BAO_0000100,,
13474,,CHEMBL628685,Autocuration,,Dissociation constant value of the compound; ND means not determined.,,U,,7057,22224,1,,,BAO_0000100,,
13475,Rattus norvegicus,CHEMBL628686,Intermediate,Blood,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,N,10116.0,7911,50597,1,,,BAO_0000218,178.0,
13476,Rattus norvegicus,CHEMBL628687,Intermediate,Blood,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,10116.0,7911,50597,1,,,BAO_0000218,178.0,
13477,Rattus norvegicus,CHEMBL628688,Intermediate,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,N,10116.0,7911,50597,1,,,BAO_0000218,,
13478,Rattus norvegicus,CHEMBL628689,Intermediate,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,10116.0,7911,50597,1,,,BAO_0000218,,
13479,Rattus norvegicus,CHEMBL628690,Intermediate,Liver,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,N,10116.0,7911,50597,1,,,BAO_0000218,2107.0,
13480,Rattus norvegicus,CHEMBL629363,Intermediate,Liver,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,N,10116.0,7911,50597,1,,,BAO_0000218,2107.0,
13481,Rattus norvegicus,CHEMBL629364,Intermediate,Spleen,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,N,10116.0,7911,50597,1,,,BAO_0000218,2106.0,
13482,Rattus norvegicus,CHEMBL629365,Intermediate,Spleen,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,10116.0,7911,50597,1,,,BAO_0000218,2106.0,
13483,Rattus norvegicus,CHEMBL629366,Intermediate,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,N,10116.0,7911,50597,1,,,BAO_0000218,,
13484,Rattus norvegicus,CHEMBL629367,Intermediate,Urine,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,N,10116.0,7911,50597,1,,,BAO_0000218,1088.0,
13485,Rattus norvegicus,CHEMBL629368,Intermediate,Feces,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,10116.0,7911,50597,1,,,BAO_0000218,1988.0,
13486,Rattus norvegicus,CHEMBL877502,Intermediate,Urine,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,N,10116.0,7911,50597,1,,,BAO_0000218,1088.0,
13487,Mus musculus,CHEMBL629369,Intermediate,Cerebellum,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,N,10090.0,13792,50594,1,,,BAO_0000218,2037.0,
13488,Mus musculus,CHEMBL629370,Intermediate,Brain,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,N,10090.0,13792,50594,1,,,BAO_0000218,955.0,
13489,Simiiformes,CHEMBL629371,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13490,Simiiformes,CHEMBL626276,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13491,Simiiformes,CHEMBL626277,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13492,Simiiformes,CHEMBL631250,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13493,Rattus norvegicus,CHEMBL631251,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13494,Rattus norvegicus,CHEMBL631252,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13495,Rattus norvegicus,CHEMBL631253,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13496,Rattus norvegicus,CHEMBL631254,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13497,Rattus norvegicus,CHEMBL631255,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13498,Rattus norvegicus,CHEMBL631256,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13499,Rattus norvegicus,CHEMBL631257,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13500,Rattus norvegicus,CHEMBL628009,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13501,Rattus norvegicus,CHEMBL628010,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13502,Rattus norvegicus,CHEMBL628011,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13503,Rattus norvegicus,CHEMBL628012,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13504,Rattus norvegicus,CHEMBL628013,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13505,Rattus norvegicus,CHEMBL628014,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13506,Canis lupus familiaris,CHEMBL628015,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13507,Canis lupus familiaris,CHEMBL628016,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13508,Canis lupus familiaris,CHEMBL874461,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13509,Canis lupus familiaris,CHEMBL628017,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13510,Canis lupus familiaris,CHEMBL628018,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13511,Canis lupus familiaris,CHEMBL628019,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13512,Canis lupus familiaris,CHEMBL628020,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13513,Canis lupus familiaris,CHEMBL628021,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13514,Canis lupus familiaris,CHEMBL628022,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13515,Canis lupus familiaris,CHEMBL628023,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,N,9615.0,8133,50588,1,,,BAO_0000218,1088.0,
13516,Simiiformes,CHEMBL628024,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13517,Simiiformes,CHEMBL628025,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13518,Simiiformes,CHEMBL628026,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13519,Simiiformes,CHEMBL628027,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13520,Simiiformes,CHEMBL628028,Autocuration,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,U,314293.0,8133,22224,1,,,BAO_0000218,1088.0,
13521,Rattus norvegicus,CHEMBL628029,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13522,Rattus norvegicus,CHEMBL628030,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13523,Rattus norvegicus,CHEMBL628031,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13524,Rattus norvegicus,CHEMBL628032,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13525,Rattus norvegicus,CHEMBL628033,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13526,Rattus norvegicus,CHEMBL628034,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13527,Rattus norvegicus,CHEMBL628035,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13528,Rattus norvegicus,CHEMBL628036,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13529,Rattus norvegicus,CHEMBL874462,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13530,Canis lupus familiaris,CHEMBL628037,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13531,Canis lupus familiaris,CHEMBL628123,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13532,Canis lupus familiaris,CHEMBL628124,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13533,Canis lupus familiaris,CHEMBL628125,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13534,Canis lupus familiaris,CHEMBL628126,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13535,Canis lupus familiaris,CHEMBL628127,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,N,9615.0,9025,50588,1,,,BAO_0000218,,
13536,Canis lupus familiaris,CHEMBL628128,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13537,Canis lupus familiaris,CHEMBL628129,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13538,Canis lupus familiaris,CHEMBL628130,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13539,Canis lupus familiaris,CHEMBL628131,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13540,Canis lupus familiaris,CHEMBL628132,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13541,Canis lupus familiaris,CHEMBL628133,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13542,Canis lupus familiaris,CHEMBL628134,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13543,Canis lupus familiaris,CHEMBL628135,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13544,Canis lupus familiaris,CHEMBL628136,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13545,Canis lupus familiaris,CHEMBL628137,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13546,Canis lupus familiaris,CHEMBL628138,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13547,Canis lupus familiaris,CHEMBL628139,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13548,Canis lupus familiaris,CHEMBL628140,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13549,Canis lupus familiaris,CHEMBL628141,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13550,Canis lupus familiaris,CHEMBL628142,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13551,Canis lupus familiaris,CHEMBL628143,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13552,Canis lupus familiaris,CHEMBL628144,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13553,Canis lupus familiaris,CHEMBL628145,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13554,Canis lupus familiaris,CHEMBL628146,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13555,Canis lupus familiaris,CHEMBL625355,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13556,Canis lupus familiaris,CHEMBL625356,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13557,Canis lupus familiaris,CHEMBL625357,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13558,Canis lupus familiaris,CHEMBL625527,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13559,Canis lupus familiaris,CHEMBL875473,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,N,9615.0,9025,50588,1,,,BAO_0000218,,
13560,Canis lupus familiaris,CHEMBL625528,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,N,9615.0,9025,50588,1,,,BAO_0000218,,
13561,Rattus norvegicus,CHEMBL626304,Intermediate,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,N,10116.0,9025,50597,1,,,BAO_0000218,,
13562,Canis lupus familiaris,CHEMBL624138,Intermediate,Artery,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,N,9615.0,9025,50588,1,,,BAO_0000218,1637.0,
13563,,CHEMBL624139,Autocuration,,Calculated partition coefficient (clogP),,U,,6448,22229,1,,,BAO_0000100,,
13564,,CHEMBL624140,Autocuration,,Calculated partition coefficient (clogP),,U,,17221,22229,1,,,BAO_0000100,,
13565,,CHEMBL624141,Autocuration,,Calculated partition coefficient (clogP),,U,,6545,22229,1,,,BAO_0000100,,
13566,,CHEMBL624142,Autocuration,,Calculated partition coefficient (clogP),,U,,577,22229,1,,,BAO_0000100,,
13567,,CHEMBL624143,Autocuration,,Calculated partition coefficient (clogP),,U,,6285,22229,1,,,BAO_0000100,,
13568,,CHEMBL624144,Autocuration,,Calculated partition coefficient (clogP),,U,,6500,22229,1,,,BAO_0000100,,
13569,,CHEMBL624145,Autocuration,,Calculated partition coefficient (clogP),,U,,6716,22229,1,,,BAO_0000100,,
13570,,CHEMBL624146,Autocuration,,Calculated partition coefficient (clogP),,U,,13658,22229,1,,,BAO_0000100,,
13571,,CHEMBL624147,Autocuration,,Calculated partition coefficient (clogP),,U,,6549,22229,1,,,BAO_0000100,,
13572,,CHEMBL883123,Autocuration,,Calculated partition coefficient (clogP) (MacLogP),,U,,14685,22229,1,,,BAO_0000100,,
13573,,CHEMBL624148,Autocuration,,Partition coefficient (logP),,U,,6893,22224,1,,,BAO_0000019,,
13574,,CHEMBL874416,Autocuration,,Kinetic parameter was determined,,U,,3687,22224,1,,,BAO_0000019,,
13575,,CHEMBL624149,Autocuration,,Calculated partition coefficient (clogP),,U,,4207,22229,1,,,BAO_0000100,,
13576,,CHEMBL624150,Autocuration,,Calculated partition coefficient (clogP),,U,,4626,22229,1,,,BAO_0000100,,
13577,,CHEMBL624151,Autocuration,,Lipophilicity was determined,,U,,1021,22224,1,,,BAO_0000100,,
13578,,CHEMBL624152,Autocuration,,Lipophilicity was determined,,U,,3777,22224,1,,,BAO_0000100,,
13579,,CHEMBL622139,Autocuration,,Lipophilicity was determined,,U,,17533,22224,1,,,BAO_0000100,,
13580,,CHEMBL622140,Autocuration,,Calculated partition coefficient (clogP),,U,,6524,22229,1,,,BAO_0000100,,
13581,,CHEMBL622141,Autocuration,,Lipophilicity was determined,,U,,17533,22224,1,,,BAO_0000100,,
13582,,CHEMBL622142,Autocuration,,Lipophilicity in octanol-water,,U,,6480,22224,1,,,BAO_0000100,,
13583,,CHEMBL622143,Autocuration,,Calculated partition coefficient (clogP),,U,,17606,22229,1,,,BAO_0000100,,
13584,,CHEMBL622144,Autocuration,,Octanol-water partition coefficient was determined,,U,,6863,22229,1,,,BAO_0000100,,
13585,,CHEMBL877473,Autocuration,,Partition coefficient (logP),,U,,1356,22224,1,,,BAO_0000019,,
13586,,CHEMBL622145,Autocuration,,Calculated partition coefficient (clogP),,U,,3326,22229,1,,,BAO_0000100,,
13587,,CHEMBL622146,Autocuration,,Partition coefficient was determined; ND means not determined,,U,,1356,22224,1,,,BAO_0000019,,
13588,,CHEMBL622147,Autocuration,,Calculated partition coefficient (clogP),,U,,12984,22229,1,,,BAO_0000100,,
13589,,CHEMBL622148,Autocuration,,Partition coefficient of the compound,,U,,17363,22224,1,,,BAO_0000019,,
13590,,CHEMBL883124,Autocuration,,Permeability was determined,,U,,6827,22224,1,,,BAO_0000019,,
13591,,CHEMBL622149,Autocuration,,The compound was evaluated for the partition coefficient,,U,,261,22229,1,,,BAO_0000100,,
13592,,CHEMBL622150,Autocuration,,Partition coefficient (logP),,U,,2685,22224,1,,,BAO_0000019,,
13593,,CHEMBL622151,Autocuration,,The lipophilicity was reported,,U,,414,22224,1,,,BAO_0000100,,
13594,,CHEMBL622152,Autocuration,,logarithm of the octanol-water partition coefficient for the compound,,U,,15769,22229,1,,,BAO_0000100,,
13595,,CHEMBL622153,Autocuration,,Clogp value was determined,,U,,17248,22224,1,,,BAO_0000019,,
13596,,CHEMBL877474,Autocuration,,Clp at a dose of 1.5 mg/kg,,U,,16935,22224,1,,,BAO_0000218,,
13597,,CHEMBL622154,Autocuration,,Clp at a dose of 2.0 mg/kg,,U,,16935,22224,1,,,BAO_0000218,,
13598,,CHEMBL622155,Autocuration,Plasma,"Clp, plasma clearance at a dose of 10 mg/kg",,U,,14832,22224,1,,,BAO_0000218,1969.0,
13599,,CHEMBL622156,Autocuration,Plasma,"Clp, plasma clearance at a dose of 50 mg/kg",,U,,14832,22224,1,,,BAO_0000218,1969.0,
13600,Rattus norvegicus,CHEMBL622157,Intermediate,Plasma,Compound was tested for plasma clearance in rat,,N,10116.0,2399,50597,1,,,BAO_0000218,1969.0,
13601,Rattus norvegicus,CHEMBL622158,Intermediate,Plasma,Compound was tested for plasma clearance in rat; Not determined,,N,10116.0,2399,50597,1,,,BAO_0000218,1969.0,
13602,Rattus norvegicus,CHEMBL622807,Intermediate,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,N,10116.0,6227,50597,1,,,BAO_0000218,,
13603,Macaca mulatta,CHEMBL622808,Intermediate,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,N,9544.0,6227,50797,1,,,BAO_0000218,,
13604,,CHEMBL622809,Autocuration,,Plasma clearance by iv administration at a dose 0.003 ug/mL,,U,,5623,22224,1,,,BAO_0000218,,
13605,,CHEMBL622810,Autocuration,,Plasma clearance determined,,U,,4854,22224,1,,,BAO_0000218,,
13606,Cricetinae,CHEMBL876653,Intermediate,,Plasma clearance after iv administration at 3 mg/kg in hamster,,N,10026.0,4493,100712,1,,,BAO_0000218,,
13607,Cricetinae,CHEMBL622811,Intermediate,,Plasma clearance after iv administration at 4 mg/kg in hamster,,N,10026.0,4493,100712,1,,,BAO_0000218,,
13608,Rattus norvegicus,CHEMBL622986,Intermediate,,Rate of clearance in rat was determined,,N,10116.0,14956,50597,1,,,BAO_0000218,,
13609,Rattus norvegicus,CHEMBL622987,Intermediate,Plasma,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,1969.0,
13610,Rattus norvegicus,CHEMBL622988,Intermediate,Plasma,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,1969.0,
13611,Rattus norvegicus,CHEMBL622989,Intermediate,Plasma,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,1969.0,
13612,Rattus norvegicus,CHEMBL622990,Intermediate,Plasma,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,N,10116.0,15372,50597,1,,,BAO_0000218,1969.0,
13613,Simiiformes,CHEMBL622991,Autocuration,Plasma,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,U,314293.0,15604,22224,1,,,BAO_0000218,1969.0,
13614,Rattus norvegicus,CHEMBL622227,Intermediate,Plasma,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,N,10116.0,15604,50597,1,,,BAO_0000218,1969.0,
13615,Canis lupus familiaris,CHEMBL622228,Intermediate,Plasma,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,N,9615.0,15604,50588,1,,,BAO_0000218,1969.0,
13616,Rattus norvegicus,CHEMBL622229,Intermediate,,Clpl value in rat,,N,10116.0,14964,50597,1,,,BAO_0000218,,
13617,Cavia porcellus,CHEMBL622230,Intermediate,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,N,10141.0,15240,50512,1,,,BAO_0000218,,
13618,Rattus norvegicus,CHEMBL622231,Intermediate,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,N,10116.0,16449,50597,1,,,BAO_0000218,,
13619,Macaca fascicularis,CHEMBL622232,Intermediate,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,N,9541.0,16449,100710,1,,,BAO_0000218,,
13620,,CHEMBL622233,Autocuration,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,U,,12902,22224,1,,,BAO_0000218,,
13621,,CHEMBL622234,Autocuration,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,U,,12902,22224,1,,,BAO_0000218,,
13622,,CHEMBL622235,Autocuration,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,U,,12902,22224,1,,,BAO_0000218,,
13623,,CHEMBL622236,Autocuration,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,U,,12902,22224,1,,,BAO_0000218,,
13624,,CHEMBL622237,Autocuration,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,U,,12902,22224,1,,,BAO_0000218,,
13625,,CHEMBL877482,Autocuration,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,U,,12902,22224,1,,,BAO_0000218,,
13626,,CHEMBL622238,Autocuration,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,U,,12902,22224,1,,,BAO_0000218,,
13627,,CHEMBL622239,Autocuration,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,U,,12902,22224,1,,,BAO_0000218,,
13628,,CHEMBL622240,Autocuration,Blood,Cmax was calculated as maximum concentration reached in the blood,,U,,11149,22224,1,,,BAO_0000218,178.0,
13629,,CHEMBL622241,Autocuration,Blood,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,U,,11149,22224,1,,,BAO_0000218,178.0,
13630,Rattus norvegicus,CHEMBL631013,Intermediate,,Cmax was determine after peroral administration at 10 mpk in Rat,,N,10116.0,5669,50597,1,,,BAO_0000218,,
13631,Macaca mulatta,CHEMBL631014,Intermediate,,Cmax was determine after peroral administration at 10 mpk in Rhesus,,N,9544.0,5669,50797,1,,,BAO_0000218,,
13632,Canis lupus familiaris,CHEMBL631015,Intermediate,,Cmax was determine after peroral administration at 10 mpk in dog,,N,9615.0,5669,50588,1,,,BAO_0000218,,
13633,Rattus norvegicus,CHEMBL631016,Intermediate,,Cmax was determine after peroral administration at 160 mpk in Rat,,N,10116.0,5669,50597,1,,,BAO_0000218,,
13634,Rattus norvegicus,CHEMBL631017,Intermediate,,Cmax was determine after peroral administration at 20 mpk in Rat,,N,10116.0,5669,50597,1,,,BAO_0000218,,
13635,Rattus norvegicus,CHEMBL631018,Intermediate,,Cmax was determine after peroral administration at 50 mpk in Rat,,N,10116.0,5669,50597,1,,,BAO_0000218,,
13636,,CHEMBL631019,Autocuration,,Cmax was determined,,U,,4236,22224,1,,,BAO_0000218,,
13637,Mus musculus,CHEMBL875761,Intermediate,Brain,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,N,10090.0,13792,50594,1,,,BAO_0000218,955.0,
13638,Mus musculus,CHEMBL631020,Intermediate,Brain,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,N,10090.0,13792,50594,1,,,BAO_0000218,955.0,
13639,Mus musculus,CHEMBL631669,Intermediate,Brain,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,N,10090.0,13792,50594,1,,,BAO_0000218,955.0,
13640,Mus musculus,CHEMBL631670,Intermediate,Brain,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,N,10090.0,13792,50594,1,,,BAO_0000218,955.0,
13641,Mus musculus,CHEMBL631671,Intermediate,Striatum,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,N,10090.0,13792,50594,1,,,BAO_0000218,2435.0,
13642,Rattus norvegicus,CHEMBL631672,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13643,Rattus norvegicus,CHEMBL631673,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13644,Rattus norvegicus,CHEMBL631856,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13645,Rattus norvegicus,CHEMBL631857,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13646,Rattus norvegicus,CHEMBL631858,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13647,Rattus norvegicus,CHEMBL631859,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13648,Rattus norvegicus,CHEMBL631860,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13649,Rattus norvegicus,CHEMBL631861,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13650,Rattus norvegicus,CHEMBL631862,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13651,Rattus norvegicus,CHEMBL631863,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13652,Rattus norvegicus,CHEMBL631864,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13653,Rattus norvegicus,CHEMBL631865,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13654,Rattus norvegicus,CHEMBL631866,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13655,Rattus norvegicus,CHEMBL629360,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13656,Rattus norvegicus,CHEMBL629361,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13657,Rattus norvegicus,CHEMBL629362,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13658,Rattus norvegicus,CHEMBL630740,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13659,Rattus norvegicus,CHEMBL630741,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13660,Rattus norvegicus,CHEMBL630742,Intermediate,Blood,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,N,10116.0,8418,50597,1,,,BAO_0000218,178.0,
13661,Rattus norvegicus,CHEMBL630743,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13662,Rattus norvegicus,CHEMBL630744,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13663,Rattus norvegicus,CHEMBL630745,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13664,Rattus norvegicus,CHEMBL630746,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13665,Rattus norvegicus,CHEMBL630747,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13666,Rattus norvegicus,CHEMBL630748,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13667,Rattus norvegicus,CHEMBL632056,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13668,Rattus norvegicus,CHEMBL632057,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13669,Rattus norvegicus,CHEMBL632058,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13670,Rattus norvegicus,CHEMBL632059,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13671,Rattus norvegicus,CHEMBL632060,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13672,Rattus norvegicus,CHEMBL632061,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13673,Rattus norvegicus,CHEMBL629207,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13674,Rattus norvegicus,CHEMBL629208,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13675,Rattus norvegicus,CHEMBL629209,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13676,Rattus norvegicus,CHEMBL629210,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13677,Rattus norvegicus,CHEMBL629211,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13678,Rattus norvegicus,CHEMBL629212,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13679,Rattus norvegicus,CHEMBL629213,Intermediate,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,N,10116.0,8418,50597,1,,,BAO_0000218,,
13680,Rattus norvegicus,CHEMBL629214,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13681,Rattus norvegicus,CHEMBL629215,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13682,Rattus norvegicus,CHEMBL635154,Intermediate,Urine,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,N,10116.0,8133,50597,1,,,BAO_0000218,1088.0,
13683,Rattus norvegicus,CHEMBL629216,Intermediate,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13684,Rattus norvegicus,CHEMBL629217,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,N,10116.0,6996,50597,1,,,BAO_0000218,,
13685,Rattus norvegicus,CHEMBL629218,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13686,Rattus norvegicus,CHEMBL629219,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13687,Rattus norvegicus,CHEMBL629220,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13688,Rattus norvegicus,CHEMBL629221,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13689,Rattus norvegicus,CHEMBL631127,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13690,Rattus norvegicus,CHEMBL631128,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,N,10116.0,6996,50597,1,,,BAO_0000218,,
13691,Rattus norvegicus,CHEMBL631129,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13692,Rattus norvegicus,CHEMBL631130,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13693,Rattus norvegicus,CHEMBL631131,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13694,Rattus norvegicus,CHEMBL631132,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13695,Rattus norvegicus,CHEMBL631133,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13696,Rattus norvegicus,CHEMBL631134,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,N,10116.0,6996,50597,1,,,BAO_0000218,,
13697,Rattus norvegicus,CHEMBL875120,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13698,Rattus norvegicus,CHEMBL631135,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13699,Rattus norvegicus,CHEMBL631136,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13700,Rattus norvegicus,CHEMBL631137,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13701,Rattus norvegicus,CHEMBL631138,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13702,Rattus norvegicus,CHEMBL631139,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,N,10116.0,6996,50597,1,,,BAO_0000218,,
13703,Rattus norvegicus,CHEMBL631140,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13704,Rattus norvegicus,CHEMBL631141,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13705,Rattus norvegicus,CHEMBL631142,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13706,Rattus norvegicus,CHEMBL631143,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13707,Rattus norvegicus,CHEMBL631144,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,10116.0,6996,50597,1,,,BAO_0000218,,
13708,Canis lupus familiaris,CHEMBL631145,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13709,Canis lupus familiaris,CHEMBL631146,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13710,Canis lupus familiaris,CHEMBL631147,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13711,Canis lupus familiaris,CHEMBL631148,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13712,Canis lupus familiaris,CHEMBL631149,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13713,Canis lupus familiaris,CHEMBL631150,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13714,Canis lupus familiaris,CHEMBL631151,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13715,Canis lupus familiaris,CHEMBL631152,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13716,Canis lupus familiaris,CHEMBL631443,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13717,Canis lupus familiaris,CHEMBL631444,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13718,Canis lupus familiaris,CHEMBL631445,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13719,Canis lupus familiaris,CHEMBL631446,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13720,Canis lupus familiaris,CHEMBL631447,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13721,Canis lupus familiaris,CHEMBL631448,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13722,Canis lupus familiaris,CHEMBL631449,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,N,9615.0,6996,50588,1,,,BAO_0000218,,
13723,Canis lupus familiaris,CHEMBL631450,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13724,Canis lupus familiaris,CHEMBL629724,Intermediate,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,N,9615.0,6996,50588,1,,,BAO_0000218,,
13725,Mus musculus,CHEMBL629725,Intermediate,Zone of skin,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,14.0,
13726,Mus musculus,CHEMBL629726,Intermediate,Zone of skin,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,14.0,
13727,Mus musculus,CHEMBL629727,Intermediate,Spleen,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,2106.0,
13728,Mus musculus,CHEMBL630404,Intermediate,Spleen,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,2106.0,
13729,Mus musculus,CHEMBL630405,Intermediate,Spleen,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,2106.0,
13730,Mus musculus,CHEMBL630406,Intermediate,Spleen,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,2106.0,
13731,Mus musculus,CHEMBL630407,Intermediate,Stomach,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,945.0,
13732,Mus musculus,CHEMBL630573,Intermediate,Stomach,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,945.0,
13733,Mus musculus,CHEMBL630574,Intermediate,Stomach,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,945.0,
13734,Mus musculus,CHEMBL630575,Intermediate,Stomach,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,945.0,
13735,Mus musculus,CHEMBL630576,Intermediate,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,,
13736,Mus musculus,CHEMBL630577,Intermediate,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,,
13737,Mus musculus,CHEMBL630578,Intermediate,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,,
13738,Mus musculus,CHEMBL630579,Intermediate,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,10090.0,9716,50594,1,,,BAO_0000218,,
13739,Mus musculus,CHEMBL630580,Intermediate,Kidney,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,N,10090.0,12192,50594,1,,,BAO_0000218,2113.0,
13740,Mus musculus,CHEMBL630581,Intermediate,Kidney,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,N,10090.0,12192,50594,1,,,BAO_0000218,2113.0,
13741,Mus musculus,CHEMBL630582,Intermediate,Kidney,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,N,10090.0,12192,50594,1,,,BAO_0000218,2113.0,
13742,Mus musculus,CHEMBL630583,Intermediate,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,N,10090.0,12192,50594,1,,,BAO_0000218,,
13743,Mus musculus,CHEMBL630584,Intermediate,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,N,10090.0,12192,50594,1,,,BAO_0000218,,
13744,Mus musculus,CHEMBL630585,Intermediate,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,N,10090.0,12192,50594,1,,,BAO_0000218,,
13745,Mus musculus,CHEMBL630586,Intermediate,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,N,10090.0,12192,50594,1,,,BAO_0000218,,
13746,Mus musculus,CHEMBL630587,Intermediate,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,N,10090.0,12192,50594,1,,,BAO_0000218,,
13747,Mus musculus,CHEMBL630588,Intermediate,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,N,10090.0,12192,50594,1,,,BAO_0000218,,
13748,Mus musculus,CHEMBL630589,Intermediate,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,N,10090.0,12192,50594,1,,,BAO_0000218,,
13749,Mus musculus,CHEMBL630590,Intermediate,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,N,10090.0,12192,50594,1,,,BAO_0000218,,
13750,,CHEMBL630591,Autocuration,Feces,Removal of 238-Plutonium(IV) in feces at 24 h,,U,,12192,22224,1,,,BAO_0000019,1988.0,
13751,,CHEMBL630592,Autocuration,Feces,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,U,,12192,22224,1,,,BAO_0000019,1988.0,
13752,,CHEMBL630593,Autocuration,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,U,,12192,22224,1,,,BAO_0000019,,
13753,,CHEMBL630594,Autocuration,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,U,,12192,22224,1,,,BAO_0000019,,
13754,,CHEMBL630595,Autocuration,Urine,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,U,,12192,22224,1,,,BAO_0000019,1088.0,
13755,,CHEMBL630596,Autocuration,Urine,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,U,,12192,22224,1,,,BAO_0000019,1088.0,
13756,,CHEMBL630597,Autocuration,Urine,Removal of 238-Plutonium(IV) in urine after 0-24 h,,U,,12192,22224,1,,,BAO_0000019,1088.0,
13757,,CHEMBL630598,Autocuration,Urine,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,U,,12192,22224,1,,,BAO_0000019,1088.0,
13758,,CHEMBL630599,Autocuration,Urine,Removal of 238-Plutonium(IV) in urine after 0-4 h,,U,,12192,22224,1,,,BAO_0000019,1088.0,
13759,,CHEMBL630600,Autocuration,Urine,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,U,,12192,22224,1,,,BAO_0000019,1088.0,
13760,,CHEMBL630601,Autocuration,Urine,Removal of 238-Plutonium(IV) in urine after 4-24 h,,U,,12192,22224,1,,,BAO_0000019,1088.0,
13761,,CHEMBL630602,Autocuration,Urine,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,U,,12192,22224,1,,,BAO_0000019,1088.0,
13762,,CHEMBL630603,Autocuration,Urine,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,U,,12192,22224,1,,,BAO_0000019,1088.0,
13763,,CHEMBL630604,Autocuration,Urine,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,U,,12192,22224,1,,,BAO_0000019,1088.0,
13764,Rattus norvegicus,CHEMBL624869,Intermediate,Blood,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
13765,Rattus norvegicus,CHEMBL624870,Intermediate,Blood,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
13766,Rattus norvegicus,CHEMBL623189,Intermediate,Blood,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
13767,Rattus norvegicus,CHEMBL623190,Intermediate,Blood,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
13768,Rattus norvegicus,CHEMBL623191,Intermediate,Blood,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
13769,Rattus norvegicus,CHEMBL623192,Intermediate,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
13770,Rattus norvegicus,CHEMBL623193,Intermediate,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
13771,Rattus norvegicus,CHEMBL623194,Intermediate,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,,
13772,Rattus norvegicus,CHEMBL623195,Intermediate,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
13773,Rattus norvegicus,CHEMBL623196,Intermediate,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
13774,Rattus norvegicus,CHEMBL623197,Intermediate,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,N,10116.0,11836,50597,1,,,BAO_0000218,,
13775,Rattus norvegicus,CHEMBL623198,Intermediate,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,10116.0,11836,50597,1,,,BAO_0000218,,
13776,Rattus norvegicus,CHEMBL623199,Intermediate,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,N,10116.0,11836,50597,1,,,BAO_0000218,,
13777,Rattus norvegicus,CHEMBL623200,Intermediate,Muscle tissue,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,N,10116.0,11836,50597,1,,,BAO_0000218,2385.0,
13778,Rattus norvegicus,CHEMBL623201,Intermediate,Muscle tissue,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,N,10116.0,11836,50597,1,,,BAO_0000218,2385.0,
13779,Rattus norvegicus,CHEMBL623202,Intermediate,Muscle tissue,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,N,10116.0,11836,50597,1,,,BAO_0000218,2385.0,
13780,Rattus norvegicus,CHEMBL623203,Intermediate,Muscle tissue,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,10116.0,11836,50597,1,,,BAO_0000218,2385.0,
13781,Rattus norvegicus,CHEMBL623204,Intermediate,Muscle tissue,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,N,10116.0,11836,50597,1,,,BAO_0000218,2385.0,
13782,Rattus norvegicus,CHEMBL623205,Intermediate,Muscle tissue,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,N,10116.0,11836,50597,1,,,BAO_0000218,2385.0,
13783,Rattus norvegicus,CHEMBL623206,Intermediate,Muscle tissue,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,N,10116.0,11836,50597,1,,,BAO_0000218,2385.0,
13784,Rattus norvegicus,CHEMBL623207,Intermediate,Muscle tissue,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,N,10116.0,11836,50597,1,,,BAO_0000218,2385.0,
13785,Rattus norvegicus,CHEMBL623208,Intermediate,Muscle tissue,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,N,10116.0,11836,50597,1,,,BAO_0000218,2385.0,
13786,Rattus norvegicus,CHEMBL623209,Intermediate,Muscle tissue,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,10116.0,11836,50597,1,,,BAO_0000218,2385.0,
13787,Rattus norvegicus,CHEMBL623210,Intermediate,Muscle tissue,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,N,10116.0,11836,50597,1,,,BAO_0000218,2385.0,
13788,Rattus norvegicus,CHEMBL623211,Intermediate,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,10116.0,11836,50597,1,,,BAO_0000218,,
13789,Rattus norvegicus,CHEMBL623212,Intermediate,Uterus,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,N,10116.0,11836,50597,1,,,BAO_0000218,995.0,
13790,,CHEMBL623213,Autocuration,,Tested in vitro for intrinsic activity relative to quinpirole,,U,,12640,22224,1,,,BAO_0000019,,
13791,,CHEMBL623214,Autocuration,,"Relative ion enhancement, determined in pulsed ultrafiltration",,U,,14218,22224,1,,,BAO_0000019,,
13792,,CHEMBL623215,Autocuration,,% ionization at the pH 7.4 at 37 degree Centigrade,,U,,11296,22224,1,,,BAO_0000019,,
13793,,CHEMBL623216,Autocuration,,Percentage ionization was measured,,U,,10929,22224,1,,,BAO_0000019,,
13794,Bos taurus,CHEMBL623217,Intermediate,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,N,9913.0,13841,50591,1,,,BAO_0000218,,
13795,,CHEMBL623218,Autocuration,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,U,,10431,22224,1,,,BAO_0000019,,
13796,,CHEMBL623913,Autocuration,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,U,,10431,22224,1,,,BAO_0000019,,
13797,,CHEMBL623914,Autocuration,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,U,,10431,22224,1,,,BAO_0000019,,
13798,,CHEMBL623915,Autocuration,,Compound was evaluated for the partition coefficient in octanol/water,,U,,8826,22229,1,,,BAO_0000100,,
13799,,CHEMBL624080,Autocuration,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,U,,8826,22229,1,,,BAO_0000100,,
13800,,CHEMBL624081,Autocuration,,Equilibrium constant measured by the pulse radiolysis at pH 7,,U,,9884,22224,1,,,BAO_0000019,,
13801,Homo sapiens,CHEMBL624082,Intermediate,,In vitro hydrolytic rate constant determined in human blood,,N,9606.0,9827,50587,1,,,BAO_0000218,,
13802,Homo sapiens,CHEMBL625054,Intermediate,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,N,9606.0,10009,50587,1,,,BAO_0000218,,
13803,,CHEMBL877485,Autocuration,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,U,,10009,22224,1,,,BAO_0000019,,
13804,Mus musculus,CHEMBL625055,Intermediate,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,N,10090.0,10009,50594,1,,,BAO_0000218,,
13805,Mus musculus,CHEMBL625056,Intermediate,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,N,10090.0,10009,50594,1,,,BAO_0000218,,
13806,Homo sapiens,CHEMBL625057,Intermediate,,In vitro oxidation of compound in presence of human plasma,,N,9606.0,10009,50587,1,,,BAO_0000218,,
13807,,CHEMBL625058,Autocuration,,In vitro oxidation of compound in presence of hydrogen peroxide,,U,,10009,22224,1,,,BAO_0000019,,
13808,Mus musculus,CHEMBL625059,Intermediate,,In vitro oxidation of compound in presence of mouse brain homogenate,,N,10090.0,10009,50594,1,,,BAO_0000218,,
13809,Mus musculus,CHEMBL629536,Intermediate,,In vitro oxidation of compound in presence of mouse liver homogenate,,N,10090.0,10009,50594,1,,,BAO_0000218,,
13810,Rattus norvegicus,CHEMBL629537,Intermediate,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13811,Rattus norvegicus,CHEMBL629538,Intermediate,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13812,Rattus norvegicus,CHEMBL629539,Intermediate,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13813,Rattus norvegicus,CHEMBL874445,Intermediate,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13814,Rattus norvegicus,CHEMBL629540,Intermediate,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13815,Rattus norvegicus,CHEMBL629541,Intermediate,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13816,Rattus norvegicus,CHEMBL629542,Intermediate,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13817,Rattus norvegicus,CHEMBL630243,Intermediate,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13818,Rattus norvegicus,CHEMBL630244,Intermediate,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13819,Rattus norvegicus,CHEMBL630245,Intermediate,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13820,Rattus norvegicus,CHEMBL630246,Intermediate,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13821,Rattus norvegicus,CHEMBL630247,Intermediate,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13822,Rattus norvegicus,CHEMBL630248,Intermediate,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13823,Rattus norvegicus,CHEMBL630249,Intermediate,Blood,Biodistribution in rat blood at 240 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,178.0,
13824,Rattus norvegicus,CHEMBL630250,Intermediate,Blood,Biodistribution in rat blood at 30 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,178.0,
13825,Rattus norvegicus,CHEMBL630251,Intermediate,Blood,Biodistribution in rat blood at 360 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,178.0,
13826,Rattus norvegicus,CHEMBL630252,Intermediate,Blood,Biodistribution in rat blood at 3 hr after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,178.0,
13827,Rattus norvegicus,CHEMBL630408,Intermediate,Blood,Biodistribution in rat blood at 60 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,178.0,
13828,Rattus norvegicus,CHEMBL630409,Intermediate,Cerebellum,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2037.0,
13829,Rattus norvegicus,CHEMBL874446,Intermediate,Cerebellum,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2037.0,
13830,Rattus norvegicus,CHEMBL630410,Intermediate,Cerebellum,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2037.0,
13831,Rattus norvegicus,CHEMBL630411,Intermediate,Cerebellum,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2037.0,
13832,Rattus norvegicus,CHEMBL630412,Intermediate,Cerebellum,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2037.0,
13833,Rattus norvegicus,CHEMBL630413,Intermediate,Cerebellum,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2037.0,
13834,Rattus norvegicus,CHEMBL630414,Intermediate,Cerebellum,Biodistribution in rat cerebellum at 3 hr after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2037.0,
13835,Rattus norvegicus,CHEMBL630415,Intermediate,Cerebellum,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2037.0,
13836,Rattus norvegicus,CHEMBL630416,Intermediate,,Biodistribution in rat cortex at 120 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
13837,Rattus norvegicus,CHEMBL630417,Intermediate,,Biodistribution in rat cortex at 1440 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
13838,Rattus norvegicus,CHEMBL630418,Intermediate,,Biodistribution in rat cortex at 15 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
13839,Rattus norvegicus,CHEMBL630419,Intermediate,,Biodistribution in rat cortex at 240 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
13840,Rattus norvegicus,CHEMBL630420,Intermediate,,Biodistribution in rat cortex at 30 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
13841,Rattus norvegicus,CHEMBL630421,Intermediate,,Biodistribution in rat cortex at 360 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
13842,Rattus norvegicus,CHEMBL630422,Intermediate,,Biodistribution in rat cortex at 3 hr after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
13843,Rattus norvegicus,CHEMBL630423,Intermediate,,Biodistribution in rat cortex at 60 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
13844,Rattus norvegicus,CHEMBL630424,Intermediate,Heart,Biodistribution in rat heart at 120 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,948.0,
13845,Rattus norvegicus,CHEMBL630425,Intermediate,Heart,Biodistribution in rat heart at 15 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,948.0,
13846,Rattus norvegicus,CHEMBL629462,Intermediate,Heart,Biodistribution in rat heart at 240 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,948.0,
13847,Rattus norvegicus,CHEMBL630426,Intermediate,Heart,Biodistribution in rat heart at 30 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,948.0,
13848,Rattus norvegicus,CHEMBL630427,Intermediate,Heart,Biodistribution in rat heart at 360 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,948.0,
13849,Rattus norvegicus,CHEMBL625877,Intermediate,Heart,Biodistribution in rat heart at 3 hr after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,948.0,
13850,Rattus norvegicus,CHEMBL625878,Intermediate,Heart,Biodistribution in rat heart at 60 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,948.0,
13851,Rattus norvegicus,CHEMBL625879,Intermediate,Hippocampus,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,10000000.0,
13852,Rattus norvegicus,CHEMBL625880,Intermediate,Hippocampus,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,10000000.0,
13853,Rattus norvegicus,CHEMBL625881,Intermediate,Hippocampus,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,10000000.0,
13854,Rattus norvegicus,CHEMBL625882,Intermediate,Hippocampus,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,10000000.0,
13855,Rattus norvegicus,CHEMBL625883,Intermediate,Hippocampus,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,10000000.0,
13856,Rattus norvegicus,CHEMBL625884,Intermediate,Kidney,Biodistribution in rat kidney at 120 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2113.0,
13857,Rattus norvegicus,CHEMBL625885,Intermediate,Kidney,Biodistribution in rat kidney at 1440 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2113.0,
13858,Rattus norvegicus,CHEMBL628649,Intermediate,Kidney,Biodistribution in rat kidney at 15 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2113.0,
13859,Rattus norvegicus,CHEMBL628650,Intermediate,Kidney,Biodistribution in rat kidney at 240 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2113.0,
13860,Rattus norvegicus,CHEMBL628651,Intermediate,Kidney,Biodistribution in rat kidney at 30 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2113.0,
13861,Rattus norvegicus,CHEMBL628652,Intermediate,Kidney,Biodistribution in rat kidney at 360 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2113.0,
13862,Rattus norvegicus,CHEMBL628653,Intermediate,Kidney,Biodistribution in rat kidney at 60 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2113.0,
13863,Rattus norvegicus,CHEMBL628654,Intermediate,Liver,Biodistribution in rat liver at 120 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2107.0,
13864,Rattus norvegicus,CHEMBL628655,Intermediate,Liver,Biodistribution in rat liver at 1440 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2107.0,
13865,Rattus norvegicus,CHEMBL625238,Intermediate,Liver,Biodistribution in rat liver at 15 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2107.0,
13866,Rattus norvegicus,CHEMBL625239,Intermediate,Liver,Biodistribution in rat liver at 240 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2107.0,
13867,Rattus norvegicus,CHEMBL625240,Intermediate,Liver,Biodistribution in rat liver at 30 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2107.0,
13868,Rattus norvegicus,CHEMBL625241,Intermediate,Liver,Biodistribution in rat liver at 360 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2107.0,
13869,Rattus norvegicus,CHEMBL625242,Intermediate,Liver,Biodistribution in rat liver at 60 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2107.0,
13870,Rattus norvegicus,CHEMBL874587,Intermediate,Lung,Biodistribution in rat lung at 120 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2048.0,
13871,Rattus norvegicus,CHEMBL625405,Intermediate,Lung,Biodistribution in rat lung at 1440 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2048.0,
13872,Rattus norvegicus,CHEMBL625406,Intermediate,Lung,Biodistribution in rat lung at 15 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2048.0,
13873,Rattus norvegicus,CHEMBL625407,Intermediate,Lung,Biodistribution in rat lung at 240 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2048.0,
13874,Rattus norvegicus,CHEMBL625408,Intermediate,Lung,Biodistribution in rat lung at 30 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2048.0,
13875,Rattus norvegicus,CHEMBL625409,Intermediate,Lung,Biodistribution in rat lung at 360 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2048.0,
13876,Rattus norvegicus,CHEMBL625410,Intermediate,Thoracic aorta,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,N,10116.0,12361,50597,1,,,BAO_0000218,1515.0,
13877,Rattus norvegicus,CHEMBL625411,Intermediate,Thoracic aorta,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,N,10116.0,12361,50597,1,,,BAO_0000218,1515.0,
13878,Rattus norvegicus,CHEMBL625412,Intermediate,Thoracic aorta,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,N,10116.0,12361,50597,1,,,BAO_0000218,1515.0,
13879,Rattus norvegicus,CHEMBL625413,Intermediate,Thoracic aorta,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,N,10116.0,12361,50597,1,,,BAO_0000218,1515.0,
13880,Rattus norvegicus,CHEMBL625414,Intermediate,Thoracic aorta,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,N,10116.0,12361,50597,1,,,BAO_0000218,1515.0,
13881,Rattus norvegicus,CHEMBL625415,Intermediate,Thoracic aorta,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,N,10116.0,12361,50597,1,,,BAO_0000218,1515.0,
13882,Rattus norvegicus,CHEMBL625416,Intermediate,Thoracic aorta,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,N,10116.0,12361,50597,1,,,BAO_0000218,1515.0,
13883,Rattus norvegicus,CHEMBL625417,Intermediate,Urine,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,N,10116.0,12712,50597,1,,,BAO_0000218,1088.0,
13884,Rattus norvegicus,CHEMBL625418,Intermediate,Feces,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,N,10116.0,7415,50597,1,,,BAO_0000218,1988.0,
13885,Rattus norvegicus,CHEMBL625419,Intermediate,Urine,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,N,10116.0,7415,50597,1,,,BAO_0000218,1088.0,
13886,Rattus norvegicus,CHEMBL625420,Intermediate,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,N,10116.0,7415,50597,1,,,BAO_0000218,,
13887,Rattus norvegicus,CHEMBL626996,Intermediate,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,N,10116.0,7415,50597,1,,,BAO_0000218,,
13888,Rattus norvegicus,CHEMBL626997,Intermediate,Feces,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,N,10116.0,7415,50597,1,,,BAO_0000218,1988.0,
13889,Rattus norvegicus,CHEMBL626998,Intermediate,Urine,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,N,10116.0,7415,50597,1,,,BAO_0000218,1088.0,
13890,Rattus norvegicus,CHEMBL626999,Intermediate,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,N,10116.0,7415,50597,1,,,BAO_0000218,,
13891,Mus musculus,CHEMBL627000,Intermediate,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,N,10090.0,8050,50594,1,,,BAO_0000218,,
13892,Mus musculus,CHEMBL627001,Intermediate,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,N,10090.0,8050,50594,1,,,BAO_0000218,,
13893,Mus musculus,CHEMBL627002,Intermediate,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,N,10090.0,8050,50594,1,,,BAO_0000218,,
13894,Mus musculus,CHEMBL627003,Intermediate,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,N,10090.0,8050,50594,1,,,BAO_0000218,,
13895,Mus musculus,CHEMBL627004,Intermediate,Urine,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,N,10090.0,8050,50594,1,,,BAO_0000218,1088.0,
13896,Mus musculus,CHEMBL627005,Intermediate,Urine,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,N,10090.0,8050,50594,1,,,BAO_0000218,1088.0,
13897,Mus musculus,CHEMBL874594,Intermediate,Urine,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,N,10090.0,8050,50594,1,,,BAO_0000218,1088.0,
13898,Mus musculus,CHEMBL627006,Intermediate,Urine,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,N,10090.0,8050,50594,1,,,BAO_0000218,1088.0,
13899,Mus musculus,CHEMBL627007,Intermediate,Urine,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,N,10090.0,8050,50594,1,,,BAO_0000218,1088.0,
13900,Mus musculus,CHEMBL627884,Intermediate,Urine,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,N,10090.0,8050,50594,1,,,BAO_0000218,1088.0,
13901,Mus musculus,CHEMBL627885,Intermediate,Urine,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,N,10090.0,8050,50594,1,,,BAO_0000218,1088.0,
13902,Mus musculus,CHEMBL627886,Intermediate,Urine,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,N,10090.0,8050,50594,1,,,BAO_0000218,1088.0,
13903,Mus musculus,CHEMBL627887,Intermediate,Urine,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,N,10090.0,8050,50594,1,,,BAO_0000218,1088.0,
13904,Mus musculus,CHEMBL627888,Intermediate,Urine,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,N,10090.0,8050,50594,1,,,BAO_0000218,1088.0,
13905,Mus musculus,CHEMBL628057,Intermediate,Urine,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,N,10090.0,8050,50594,1,,,BAO_0000218,1088.0,
13906,Mus musculus,CHEMBL627405,Intermediate,Urine,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,N,10090.0,8050,50594,1,,,BAO_0000218,1088.0,
13907,Canis lupus familiaris,CHEMBL627406,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13908,Canis lupus familiaris,CHEMBL627407,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13909,Canis lupus familiaris,CHEMBL627408,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13910,Canis lupus familiaris,CHEMBL627409,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13911,Canis lupus familiaris,CHEMBL875486,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13912,Canis lupus familiaris,CHEMBL627410,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13913,Canis lupus familiaris,CHEMBL627411,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13914,Canis lupus familiaris,CHEMBL627412,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13915,Canis lupus familiaris,CHEMBL627413,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13916,Canis lupus familiaris,CHEMBL627414,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13917,Canis lupus familiaris,CHEMBL627415,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13918,Canis lupus familiaris,CHEMBL627416,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13919,Canis lupus familiaris,CHEMBL627417,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13920,Canis lupus familiaris,CHEMBL627418,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13921,Canis lupus familiaris,CHEMBL627419,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13922,Canis lupus familiaris,CHEMBL627320,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13923,Canis lupus familiaris,CHEMBL627321,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
13924,Rattus norvegicus,CHEMBL627322,Intermediate,Kidney,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
13925,Rattus norvegicus,CHEMBL627323,Intermediate,Kidney,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
13926,Rattus norvegicus,CHEMBL627491,Intermediate,Kidney,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
13927,Rattus norvegicus,CHEMBL627492,Intermediate,Kidney,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
13928,Rattus norvegicus,CHEMBL627493,Intermediate,Kidney,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
13929,Rattus norvegicus,CHEMBL627494,Intermediate,Liver,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
13930,Rattus norvegicus,CHEMBL627495,Intermediate,Liver,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
13931,Rattus norvegicus,CHEMBL627496,Intermediate,Liver,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
13932,Rattus norvegicus,CHEMBL627497,Intermediate,Liver,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
13933,Rattus norvegicus,CHEMBL627498,Intermediate,Liver,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
13934,Rattus norvegicus,CHEMBL627499,Intermediate,Lung,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
13935,Rattus norvegicus,CHEMBL627500,Intermediate,Lung,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
13936,Rattus norvegicus,CHEMBL627501,Intermediate,Lung,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
13937,Rattus norvegicus,CHEMBL625616,Intermediate,Lung,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
13938,Rattus norvegicus,CHEMBL625617,Intermediate,Lung,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
13939,Rattus norvegicus,CHEMBL625618,Intermediate,Muscle tissue,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
13940,Rattus norvegicus,CHEMBL625619,Intermediate,Muscle tissue,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
13941,Rattus norvegicus,CHEMBL625620,Intermediate,Muscle tissue,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
13942,Rattus norvegicus,CHEMBL625621,Intermediate,Muscle tissue,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
13943,Rattus norvegicus,CHEMBL625622,Intermediate,Muscle tissue,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
13944,Rattus norvegicus,CHEMBL625788,Intermediate,Spleen,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
13945,Rattus norvegicus,CHEMBL625789,Intermediate,Spleen,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
13946,Rattus norvegicus,CHEMBL625790,Intermediate,Spleen,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
13947,Rattus norvegicus,CHEMBL625791,Intermediate,Spleen,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
13948,Rattus norvegicus,CHEMBL622334,Intermediate,Spleen,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
13949,Rattus norvegicus,CHEMBL622335,Intermediate,Thyroid gland,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2046.0,
13950,Rattus norvegicus,CHEMBL622336,Intermediate,Thyroid gland,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2046.0,
13951,Rattus norvegicus,CHEMBL622337,Intermediate,Thyroid gland,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2046.0,
13952,Rattus norvegicus,CHEMBL622338,Intermediate,Thyroid gland,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2046.0,
13953,Rattus norvegicus,CHEMBL622339,Intermediate,Thyroid gland,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2046.0,
13954,Rattus norvegicus,CHEMBL624153,Intermediate,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
13955,Rattus norvegicus,CHEMBL628430,Intermediate,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
13956,Rattus norvegicus,CHEMBL628431,Intermediate,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,,
13957,Rattus norvegicus,CHEMBL628432,Intermediate,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
13958,Rattus norvegicus,CHEMBL628433,Intermediate,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
13959,Rattus norvegicus,CHEMBL628434,Intermediate,Spleen,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
13960,Rattus norvegicus,CHEMBL626789,Intermediate,Spleen,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
13961,Rattus norvegicus,CHEMBL626790,Intermediate,Spleen,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
13962,Rattus norvegicus,CHEMBL626791,Intermediate,Spleen,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
13963,Rattus norvegicus,CHEMBL626792,Intermediate,Spleen,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
13964,Rattus norvegicus,CHEMBL626793,Intermediate,Spleen,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
13965,Rattus norvegicus,CHEMBL627436,Intermediate,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13966,Rattus norvegicus,CHEMBL627437,Intermediate,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13967,Rattus norvegicus,CHEMBL627438,Intermediate,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13968,Rattus norvegicus,CHEMBL627439,Intermediate,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13969,Rattus norvegicus,CHEMBL627440,Intermediate,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13970,Rattus norvegicus,CHEMBL627602,Intermediate,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13971,Rattus norvegicus,CHEMBL627603,Intermediate,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13972,Rattus norvegicus,CHEMBL627604,Intermediate,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13973,Rattus norvegicus,CHEMBL627605,Intermediate,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13974,Rattus norvegicus,CHEMBL627606,Intermediate,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13975,Rattus norvegicus,CHEMBL627607,Intermediate,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13976,Rattus norvegicus,CHEMBL627608,Intermediate,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13977,Rattus norvegicus,CHEMBL627609,Intermediate,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13978,Rattus norvegicus,CHEMBL627610,Intermediate,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13979,Rattus norvegicus,CHEMBL627611,Intermediate,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13980,Rattus norvegicus,CHEMBL627612,Intermediate,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
13981,,CHEMBL627613,Autocuration,,Octanol:water partition coefficient is evaluated,,U,,8362,22229,1,,,BAO_0000100,,
13982,,CHEMBL627614,Autocuration,,Partition coefficient in 1-octanol/water system,,U,,8257,22224,1,,,BAO_0000100,,
13983,,CHEMBL627615,Autocuration,,Partition coefficient in 1-octanol/water system measured using radio active compounds,,U,,8257,22224,1,,,BAO_0000100,,
13984,,CHEMBL627616,Autocuration,,Partition coefficient in octanol/water system was determined,,U,,9468,22224,1,,,BAO_0000100,,
13985,,CHEMBL627617,Autocuration,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,U,,9468,22224,1,,,BAO_0000100,,
13986,,CHEMBL627618,Autocuration,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,U,,10568,22224,1,,,BAO_0000019,,
13987,,CHEMBL627619,Autocuration,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,U,,10568,22224,1,,,BAO_0000019,,
13988,,CHEMBL627620,Autocuration,,Pseudo-first-order rate constant of the compound,,U,,15359,22224,1,,,BAO_0000019,,
13989,,CHEMBL627621,Autocuration,,Pseudo-first-order rate constant with 1-min time point,,U,,15359,22224,1,,,BAO_0000019,,
13990,,CHEMBL627622,Autocuration,,Pseudo-first-order rate constant without 1-min time point,,U,,15359,22224,1,,,BAO_0000019,,
13991,,CHEMBL627623,Autocuration,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,U,,10431,22224,1,,,BAO_0000019,,
13992,,CHEMBL627624,Autocuration,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,U,,10431,22224,1,,,BAO_0000019,,
13993,,CHEMBL627625,Autocuration,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,U,,10431,22224,1,,,BAO_0000019,,
13994,,CHEMBL628523,Autocuration,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,U,,15704,22224,1,,,BAO_0000019,,
13995,,CHEMBL628524,Autocuration,,The alkaline hydrolysis second order rate constant(K OH) of the compound,,U,,15287,22224,1,,,BAO_0000019,,
13996,,CHEMBL628525,Autocuration,,The efflux rate constant of the compound,,U,,7516,22224,1,,,BAO_0000019,,
13997,,CHEMBL625732,Autocuration,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,U,,12973,22224,1,,,BAO_0000019,,
13998,,CHEMBL625733,Autocuration,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,U,,12973,22224,1,,,BAO_0000019,,
13999,,CHEMBL625734,Autocuration,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,U,,12973,22224,1,,,BAO_0000019,,
14000,,CHEMBL625913,Autocuration,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,U,,12973,22224,1,,,BAO_0000019,,
14001,,CHEMBL625914,Autocuration,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,U,,8696,22224,1,,,BAO_0000019,,
14002,,CHEMBL625915,Autocuration,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,U,,15052,22224,1,,,BAO_0000019,,
14003,,CHEMBL625916,Autocuration,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,U,,15052,22224,1,,,BAO_0000019,,
14004,,CHEMBL625917,Autocuration,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,U,,10503,22224,1,,,BAO_0000019,,
14005,,CHEMBL625918,Autocuration,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
14006,,CHEMBL625919,Autocuration,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
14007,,CHEMBL625920,Autocuration,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
14008,,CHEMBL874453,Autocuration,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
14009,,CHEMBL625921,Autocuration,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
14010,,CHEMBL625922,Autocuration,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,U,,10503,22224,1,,,BAO_0000019,,
14011,,CHEMBL625923,Autocuration,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
14012,,CHEMBL625924,Autocuration,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
14013,,CHEMBL625925,Autocuration,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
14014,,CHEMBL625926,Autocuration,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
14015,Rattus norvegicus,CHEMBL627704,Intermediate,Lung,Biodistribution in rat lung at 60 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2048.0,
14016,Rattus norvegicus,CHEMBL627705,Intermediate,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
14017,Rattus norvegicus,CHEMBL627706,Intermediate,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
14018,Rattus norvegicus,CHEMBL627707,Intermediate,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
14019,Rattus norvegicus,CHEMBL627708,Intermediate,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
14020,Rattus norvegicus,CHEMBL628361,Intermediate,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
14021,Rattus norvegicus,CHEMBL628362,Intermediate,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,,
14022,Rattus norvegicus,CHEMBL628363,Intermediate,Striatum,Biodistribution in rat striatum at 120 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2435.0,
14023,Rattus norvegicus,CHEMBL628364,Intermediate,Striatum,Biodistribution in rat striatum at 1440 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2435.0,
14024,Rattus norvegicus,CHEMBL628365,Intermediate,Striatum,Biodistribution in rat striatum at 15 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2435.0,
14025,Rattus norvegicus,CHEMBL874454,Intermediate,Striatum,Biodistribution in rat striatum at 240 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2435.0,
14026,Rattus norvegicus,CHEMBL628531,Intermediate,Striatum,Biodistribution in rat striatum at 30 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2435.0,
14027,Rattus norvegicus,CHEMBL628532,Intermediate,Striatum,Biodistribution in rat striatum at 360 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2435.0,
14028,Rattus norvegicus,CHEMBL628533,Intermediate,Striatum,Biodistribution in rat striatum at 3 hr after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2435.0,
14029,Rattus norvegicus,CHEMBL628534,Intermediate,Striatum,Biodistribution in rat striatum at 60 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2435.0,
14030,Rattus norvegicus,CHEMBL628535,Intermediate,Thyroid gland,Biodistribution in rat thyroid at 120 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2046.0,
14031,Rattus norvegicus,CHEMBL628536,Intermediate,Thyroid gland,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2046.0,
14032,Rattus norvegicus,CHEMBL628537,Intermediate,Thyroid gland,Biodistribution in rat thyroid at 15 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2046.0,
14033,Rattus norvegicus,CHEMBL628538,Intermediate,Thyroid gland,Biodistribution in rat thyroid at 240 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2046.0,
14034,Rattus norvegicus,CHEMBL628539,Intermediate,Thyroid gland,Biodistribution in rat thyroid at 30 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2046.0,
14035,Rattus norvegicus,CHEMBL630297,Intermediate,Thyroid gland,Biodistribution in rat thyroid at 360 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2046.0,
14036,Rattus norvegicus,CHEMBL630298,Intermediate,Thyroid gland,Biodistribution in rat thyroid at 60 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,2046.0,
14037,Rattus norvegicus,CHEMBL630299,Intermediate,Brain,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,955.0,
14038,Rattus norvegicus,CHEMBL628094,Intermediate,Brain,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,955.0,
14039,Rattus norvegicus,CHEMBL628095,Intermediate,Brain,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,955.0,
14040,Rattus norvegicus,CHEMBL874648,Intermediate,Brain,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,955.0,
14041,Rattus norvegicus,CHEMBL628096,Intermediate,Brain,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,955.0,
14042,Rattus norvegicus,CHEMBL628097,Intermediate,Brain,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,955.0,
14043,Rattus norvegicus,CHEMBL628098,Intermediate,Brain,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,N,10116.0,13100,50597,1,,,BAO_0000218,955.0,
14044,,CHEMBL628099,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,U,,13331,22224,1,,,BAO_0000019,,
14045,,CHEMBL628100,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,U,,13331,22224,1,,,BAO_0000019,,
14046,,CHEMBL628101,Autocuration,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,U,,13331,22224,1,,,BAO_0000019,,
14047,,CHEMBL628102,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,U,,13331,22224,1,,,BAO_0000019,,
14048,,CHEMBL628103,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,U,,13331,22224,1,,,BAO_0000019,,
14049,,CHEMBL628104,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,U,,13331,22224,1,,,BAO_0000019,,
14050,,CHEMBL628105,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,U,,13331,22224,1,,,BAO_0000019,,
14051,,CHEMBL628106,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,U,,13331,22224,1,,,BAO_0000019,,
14052,Rattus norvegicus,CHEMBL628107,Intermediate,Urine,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,N,10116.0,10086,50597,1,,,BAO_0000218,1088.0,
14053,,CHEMBL628108,Autocuration,Urine,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,U,,10086,22224,1,,,BAO_0000218,1088.0,
14054,Rattus norvegicus,CHEMBL628109,Intermediate,Urine,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,N,10116.0,10086,50597,1,,,BAO_0000218,1088.0,
14055,,CHEMBL625299,Autocuration,Urine,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,U,,10086,22224,1,,,BAO_0000218,1088.0,
14056,Rattus norvegicus,CHEMBL625300,Intermediate,Urine,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,N,10116.0,10086,50597,1,,,BAO_0000218,1088.0,
14057,Rattus norvegicus,CHEMBL625301,Intermediate,Urine,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,N,10116.0,10086,50597,1,,,BAO_0000218,1088.0,
14058,Rattus norvegicus,CHEMBL625302,Intermediate,Urine,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,N,10116.0,10086,50597,1,,,BAO_0000218,1088.0,
14059,Rattus norvegicus,CHEMBL874649,Intermediate,Urine,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,N,10116.0,10086,50597,1,,,BAO_0000218,1088.0,
14060,Rattus norvegicus,CHEMBL625303,Intermediate,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,N,10116.0,13248,50597,1,,,BAO_0000218,,
14061,Rattus norvegicus,CHEMBL625463,Intermediate,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,N,10116.0,13248,50597,1,,,BAO_0000218,,
14062,Homo sapiens,CHEMBL625464,Intermediate,Liver,In vitro metabolism in human liver microsomes,,N,9606.0,14527,50587,1,,,BAO_0000218,2107.0,
14063,Homo sapiens,CHEMBL625465,Intermediate,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,N,9606.0,3008,50587,1,,,BAO_0000218,,
14064,Canis lupus familiaris,CHEMBL625466,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14065,Canis lupus familiaris,CHEMBL625467,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14066,Rattus norvegicus,CHEMBL625468,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14067,Rattus norvegicus,CHEMBL625469,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14068,Rattus norvegicus,CHEMBL625470,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14069,Rattus norvegicus,CHEMBL632418,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14070,Rattus norvegicus,CHEMBL627250,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14071,Rattus norvegicus,CHEMBL627251,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14072,Rattus norvegicus,CHEMBL627252,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14073,Rattus norvegicus,CHEMBL627253,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14074,Rattus norvegicus,CHEMBL627254,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14075,Rattus norvegicus,CHEMBL875471,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14076,Rattus norvegicus,CHEMBL627255,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14077,Rattus norvegicus,CHEMBL627256,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14078,Rattus norvegicus,CHEMBL627257,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14079,Rattus norvegicus,CHEMBL627258,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14080,Rattus norvegicus,CHEMBL627259,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14081,Rattus norvegicus,CHEMBL627260,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14082,Rattus norvegicus,CHEMBL623256,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14083,Rattus norvegicus,CHEMBL874413,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14084,Rattus norvegicus,CHEMBL623257,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14085,Rattus norvegicus,CHEMBL623258,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14086,Rattus norvegicus,CHEMBL623259,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14087,Rattus norvegicus,CHEMBL623260,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14088,Rattus norvegicus,CHEMBL623261,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14089,Rattus norvegicus,CHEMBL623262,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14090,Rattus norvegicus,CHEMBL623263,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14091,Rattus norvegicus,CHEMBL623264,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14092,Rattus norvegicus,CHEMBL623265,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14093,Rattus norvegicus,CHEMBL623266,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14094,Rattus norvegicus,CHEMBL623267,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14095,Rattus norvegicus,CHEMBL623268,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14096,Rattus norvegicus,CHEMBL623269,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14097,Rattus norvegicus,CHEMBL623270,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14098,Rattus norvegicus,CHEMBL623271,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14099,Rattus norvegicus,CHEMBL623272,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14100,Rattus norvegicus,CHEMBL623273,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14101,Rattus norvegicus,CHEMBL623274,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14102,Rattus norvegicus,CHEMBL874414,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14103,Rattus norvegicus,CHEMBL623275,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14104,Rattus norvegicus,CHEMBL629150,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14105,Rattus norvegicus,CHEMBL623276,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14106,Rattus norvegicus,CHEMBL623277,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14107,Rattus norvegicus,CHEMBL623112,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14108,Rattus norvegicus,CHEMBL623113,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14109,Rattus norvegicus,CHEMBL623800,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14110,Rattus norvegicus,CHEMBL623801,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14111,Rattus norvegicus,CHEMBL623802,Intermediate,Spleen,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
14112,Rattus norvegicus,CHEMBL623803,Intermediate,Uterus,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,995.0,
14113,Rattus norvegicus,CHEMBL623970,Intermediate,Uterus,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,995.0,
14114,Rattus norvegicus,CHEMBL623971,Intermediate,Uterus,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,995.0,
14115,Rattus norvegicus,CHEMBL623972,Intermediate,Blood,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,N,10116.0,14045,50597,1,,,BAO_0000218,178.0,
14116,Rattus norvegicus,CHEMBL623973,Intermediate,Blood,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,N,10116.0,14045,50597,1,,,BAO_0000218,178.0,
14117,Rattus norvegicus,CHEMBL623974,Intermediate,Blood,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,N,10116.0,14045,50597,1,,,BAO_0000218,178.0,
14118,Rattus norvegicus,CHEMBL623975,Intermediate,Blood,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,N,10116.0,14045,50597,1,,,BAO_0000218,178.0,
14119,Rattus norvegicus,CHEMBL623976,Intermediate,Brain,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,N,10116.0,14045,50597,1,,,BAO_0000218,955.0,
14120,Rattus norvegicus,CHEMBL623977,Intermediate,Brain,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,N,10116.0,14045,50597,1,,,BAO_0000218,955.0,
14121,Rattus norvegicus,CHEMBL623978,Intermediate,Brain,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,N,10116.0,14045,50597,1,,,BAO_0000218,955.0,
14122,Rattus norvegicus,CHEMBL623979,Intermediate,Brain,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,N,10116.0,14045,50597,1,,,BAO_0000218,955.0,
14123,Rattus norvegicus,CHEMBL623980,Intermediate,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,N,10116.0,14045,50597,1,,,BAO_0000218,,
14124,Rattus norvegicus,CHEMBL623981,Intermediate,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,N,10116.0,14045,50597,1,,,BAO_0000218,,
14125,Rattus norvegicus,CHEMBL626278,Intermediate,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,N,10116.0,14045,50597,1,,,BAO_0000218,,
14126,Rattus norvegicus,CHEMBL626279,Intermediate,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,N,10116.0,14045,50597,1,,,BAO_0000218,,
14127,Mus musculus,CHEMBL626280,Intermediate,,Biodistribution in mice bladder plus excreted urine was determined,,N,10090.0,14045,50594,1,,,BAO_0000218,,
14128,Mus musculus,CHEMBL626281,Intermediate,,"Percentage biodistribution in mouse blood, 10 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,,
14129,Mus musculus,CHEMBL626282,Intermediate,,"Percentage biodistribution in mouse blood, 30 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,,
14130,Mus musculus,CHEMBL626283,Intermediate,,"Percentage biodistribution in mouse blood, 5 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,,
14131,Mus musculus,CHEMBL626284,Intermediate,,"Percentage biodistribution in mouse blood, 60 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,,
14132,Mus musculus,CHEMBL626285,Intermediate,Brain,"Percentage biodistribution in mouse brain, 10 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,955.0,
14133,Mus musculus,CHEMBL626286,Intermediate,Brain,"Percentage biodistribution in mouse brain, 30 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,955.0,
14134,Mus musculus,CHEMBL626287,Intermediate,Brain,"Percentage biodistribution in mouse brain, 5 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,955.0,
14135,Mus musculus,CHEMBL626288,Intermediate,Brain,"Percentage biodistribution in mouse brain, 60 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,955.0,
14136,Mus musculus,CHEMBL626289,Intermediate,,"Percentage biodistribution in mouse heart, 10 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,,
14137,Mus musculus,CHEMBL626290,Intermediate,,"Percentage biodistribution in mouse heart, 30 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,,
14138,Mus musculus,CHEMBL626291,Intermediate,,"Percentage biodistribution in mouse heart, 5 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,,
14139,Mus musculus,CHEMBL839888,Intermediate,,"Percentage biodistribution in mouse heart, 60 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,,
14140,Mus musculus,CHEMBL626292,Intermediate,Intestine,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,160.0,
14141,Mus musculus,CHEMBL626293,Intermediate,Intestine,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,160.0,
14142,Mus musculus,CHEMBL626294,Intermediate,Intestine,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,160.0,
14143,Mus musculus,CHEMBL626295,Intermediate,Intestine,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,160.0,
14144,Mus musculus,CHEMBL627659,Intermediate,Liver,"Percentage biodistribution in mouse liver, 10 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,2107.0,
14145,Mus musculus,CHEMBL627660,Intermediate,Liver,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,2107.0,
14146,Mus musculus,CHEMBL627661,Intermediate,Liver,"Percentage biodistribution in mouse liver, 5 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,2107.0,
14147,Mus musculus,CHEMBL627662,Intermediate,Liver,Biodistribution in mice liver at 60 minutes of post injection,,N,10090.0,14045,50594,1,,,BAO_0000218,2107.0,
14148,Mus musculus,CHEMBL627663,Intermediate,Lung,Biodistribution in mice lungs at 10 min of post injection,,N,10090.0,14045,50594,1,,,BAO_0000218,2048.0,
14149,Mus musculus,CHEMBL627664,Intermediate,,"Percentage biodistribution in mouse lung, 30 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,,
14150,Mus musculus,CHEMBL627665,Intermediate,,"Percentage biodistribution in mousee lung, 5 minutes post injection",,N,10090.0,14045,50594,1,,,BAO_0000218,,
14151,Mus musculus,CHEMBL627666,Intermediate,Lung,Biodistribution in mice lungs at 60 min of post injection,,N,10090.0,14045,50594,1,,,BAO_0000218,2048.0,
14152,Mus musculus,CHEMBL627667,Intermediate,Spleen,Percentage biodistribution in mouse spleen,,N,10090.0,14045,50594,1,,,BAO_0000218,2106.0,
14153,Mus musculus,CHEMBL627668,Intermediate,Stomach,Percentage biodistribution in mouse stomach,,N,10090.0,14045,50594,1,,,BAO_0000218,945.0,
14154,Mus musculus,CHEMBL627669,Intermediate,Urine,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,N,10090.0,11745,50594,1,,,BAO_0000218,1088.0,
14155,,CHEMBL627670,Autocuration,Urinary bladder,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,U,,13257,22224,1,,,BAO_0000218,1255.0,
14156,,CHEMBL627671,Autocuration,Blood,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,U,,13257,22224,1,,,BAO_0000218,178.0,
14157,,CHEMBL627672,Autocuration,Bone element,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,U,,13257,22224,1,,,BAO_0000218,1474.0,
14158,,CHEMBL627673,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,U,,13257,22224,1,,,BAO_0000218,,
14159,,CHEMBL627674,Autocuration,Kidney,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,U,,13257,22224,1,,,BAO_0000218,2113.0,
14160,,CHEMBL627675,Autocuration,Liver,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,U,,13257,22224,1,,,BAO_0000218,2107.0,
14161,,CHEMBL627676,Autocuration,Lung,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,U,,13257,22224,1,,,BAO_0000218,2048.0,
14162,,CHEMBL627677,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14163,,CHEMBL627678,Autocuration,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
14164,Rattus norvegicus,CHEMBL627679,Intermediate,Serum,Affinity for protein binding expressed as association constant in fresh rat serum,,N,10116.0,7095,50597,1,,,BAO_0000218,1977.0,
14165,,CHEMBL627680,Autocuration,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,U,,12185,22224,1,,,BAO_0000019,,
14166,,CHEMBL627681,Autocuration,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,U,,12185,22224,1,,,BAO_0000019,,
14167,,CHEMBL627682,Autocuration,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,U,,12185,22224,1,,,BAO_0000019,,
14168,,CHEMBL627683,Autocuration,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,U,,12185,22224,1,,,BAO_0000019,,
14169,,CHEMBL627684,Autocuration,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,U,,12686,22224,1,,,BAO_0000019,,
14170,,CHEMBL874441,Autocuration,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,U,,12686,22224,1,,,BAO_0000019,,
14171,,CHEMBL627685,Autocuration,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,U,,12686,22224,1,,,BAO_0000019,,
14172,,CHEMBL627686,Autocuration,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,U,,12686,22224,1,,,BAO_0000019,,
14173,,CHEMBL627687,Autocuration,,Apparent rate constant Koff for inactivation of dTMP synthase.,,U,,8057,22224,1,,,BAO_0000019,,
14174,,CHEMBL627688,Autocuration,,The irreversible inhibitor activity by second order rate equation.,,U,,15778,22224,1,,,BAO_0000019,,
14175,Rattus norvegicus,CHEMBL628038,Intermediate,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,N,10116.0,12375,50597,1,,,BAO_0000218,,
14176,Rattus norvegicus,CHEMBL628039,Intermediate,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,N,10116.0,12375,50597,1,,,BAO_0000218,,
14177,Rattus norvegicus,CHEMBL628040,Intermediate,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,N,10116.0,12375,50597,1,,,BAO_0000218,,
14178,,CHEMBL628041,Autocuration,,Dissociation rate calculated from the first-order equation using t1/2 value,,U,,13588,22224,1,,,BAO_0000019,,
14179,,CHEMBL630226,Autocuration,,The compound was tested for Binding constant against DNA,,U,,15039,22224,1,,,BAO_0000019,,
14180,,CHEMBL628042,Autocuration,,First order rate constant for cyclization of the compound,,U,,9500,22224,1,,,BAO_0000019,,
14181,,CHEMBL625232,Autocuration,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,U,,10014,22224,1,,,BAO_0000019,,
14182,,CHEMBL625233,Autocuration,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,U,,10014,22224,1,,,BAO_0000019,,
14183,,CHEMBL625979,Autocuration,,Hydrolysis rate constant was determined,,U,,568,22224,1,,,BAO_0000019,,
14184,,CHEMBL625980,Autocuration,,Observed first order rate constant,,U,,10026,22224,1,,,BAO_0000019,,
14185,,CHEMBL625981,Autocuration,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,U,,10281,22224,1,,,BAO_0000019,,
14186,,CHEMBL625982,Autocuration,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,U,,10281,22224,1,,,BAO_0000019,,
14187,,CHEMBL625983,Autocuration,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,U,,9680,22224,1,,,BAO_0000019,,
14188,,CHEMBL625984,Autocuration,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14189,,CHEMBL625985,Autocuration,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14190,,CHEMBL625986,Autocuration,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14191,,CHEMBL625987,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14192,,CHEMBL625988,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14193,,CHEMBL625989,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14194,,CHEMBL625990,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14195,,CHEMBL625991,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14196,,CHEMBL625992,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14197,,CHEMBL625993,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14198,,CHEMBL631973,Autocuration,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14199,,CHEMBL632143,Autocuration,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14200,,CHEMBL632144,Autocuration,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14201,,CHEMBL632145,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14202,,CHEMBL632146,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14203,,CHEMBL632147,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14204,,CHEMBL632148,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14205,,CHEMBL632149,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14206,,CHEMBL632150,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14207,,CHEMBL632151,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14208,Homo sapiens,CHEMBL632152,Intermediate,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,N,9606.0,3008,50587,1,,,BAO_0000218,,
14209,Homo sapiens,CHEMBL632153,Intermediate,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,N,9606.0,4509,50587,1,,,BAO_0000218,,
14210,Homo sapiens,CHEMBL632154,Intermediate,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,N,9606.0,4509,50587,1,,,BAO_0000218,,
14211,Human herpesvirus 1,CHEMBL632155,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,N,10298.0,8613,50602,1,,,BAO_0000218,,
14212,Human herpesvirus 1,CHEMBL632156,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,N,10298.0,8613,50602,1,,,BAO_0000218,,
14213,Human herpesvirus 1,CHEMBL632157,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,N,10298.0,8613,50602,1,,,BAO_0000218,,
14214,Human herpesvirus 1,CHEMBL632158,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,N,10298.0,8613,50602,1,,,BAO_0000218,,
14215,Human herpesvirus 1,CHEMBL632159,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,N,10298.0,8613,50602,1,,,BAO_0000218,,
14216,Human herpesvirus 1,CHEMBL626305,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,N,10298.0,8613,50602,1,,,BAO_0000218,,
14217,Human herpesvirus 1,CHEMBL626306,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,N,10298.0,8613,50602,1,,,BAO_0000218,,
14218,Human herpesvirus 1,CHEMBL626307,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,N,10298.0,8613,50602,1,,,BAO_0000218,,
14219,Human herpesvirus 1,CHEMBL626308,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,N,10298.0,8613,50602,1,,,BAO_0000218,,
14220,Human herpesvirus 1,CHEMBL626479,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,N,10298.0,8613,50602,1,,,BAO_0000218,,
14221,Human herpesvirus 1,CHEMBL626480,Intermediate,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,N,10298.0,8613,50602,1,,,BAO_0000218,,
14222,,CHEMBL626481,Autocuration,,Calculated partition coefficient (clogP) (MlogP),,U,,6021,22229,1,,,BAO_0000100,,
14223,,CHEMBL626482,Autocuration,,Equipotent potent ratio relative to carbachol (nicotinic activity),,U,,9348,22224,1,,,BAO_0000019,,
14224,Canis lupus familiaris,CHEMBL626483,Intermediate,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,N,9615.0,15592,50588,1,,,BAO_0000218,,
14225,Canis lupus familiaris,CHEMBL626484,Intermediate,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,N,9615.0,15592,50588,1,,,BAO_0000218,,
14226,,CHEMBL626485,Autocuration,,Solubility at pH 7.4 in micro g/mL;NA denotes available,,U,,15592,22229,1,,,BAO_0000100,,
14227,,CHEMBL626486,Autocuration,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,U,,15592,22229,1,,,BAO_0000100,,
14228,,CHEMBL626487,Autocuration,,Solubility at pH 7.4 in ug/mL;NA denotes not available,,U,,15592,22229,1,,,BAO_0000100,,
14229,Canis lupus familiaris,CHEMBL626488,Intermediate,Plasma,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,N,9615.0,15592,50588,1,,,BAO_0000218,1969.0,
14230,Rattus norvegicus,CHEMBL626489,Intermediate,Serum,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,N,10116.0,7095,50597,1,,,BAO_0000218,1977.0,
14231,,CHEMBL626490,Autocuration,,Area under the MAP curve measured over 5 min; ND means Not determined,,U,,16618,22224,1,,,BAO_0000019,,
14232,,CHEMBL626491,Autocuration,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,U,,16835,22224,1,,,BAO_0000100,,
14233,,CHEMBL626492,Autocuration,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,U,,15284,22229,1,,,BAO_0000100,,
14234,,CHEMBL626493,Autocuration,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,U,,15750,22224,1,,,BAO_0000019,,
14235,Rattus norvegicus,CHEMBL626494,Intermediate,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,N,10116.0,16618,50597,1,,,BAO_0000218,,
14236,,CHEMBL626495,Autocuration,,Half life after oral tested,,U,,16618,22224,1,,,BAO_0000218,,
14237,Rattus norvegicus,CHEMBL626496,Intermediate,Plasma,Half life was determined in plasma of rat; NT indicates not tested,,N,10116.0,15812,50597,1,,,BAO_0000218,1969.0,
14238,Rattus norvegicus,CHEMBL626497,Intermediate,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,N,10116.0,16618,50597,1,,,BAO_0000218,,
14239,,CHEMBL626498,Autocuration,,Oral bioavailability after oral tested,,U,,16618,22224,1,,,BAO_0000218,,
14240,Rattus norvegicus,CHEMBL626499,Intermediate,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,N,10116.0,13098,50597,1,,,BAO_0000218,,
14241,Rattus norvegicus,CHEMBL626500,Intermediate,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,N,10116.0,13098,50597,1,,,BAO_0000218,,
14242,Rattus norvegicus,CHEMBL626501,Intermediate,Plasma,half life was determined in plasma of rat; NT indicates not tested,,N,10116.0,15812,50597,1,,,BAO_0000218,1969.0,
14243,Rattus norvegicus,CHEMBL626502,Intermediate,Plasma,half life was determined in plasma of rat; NT means not tested,,N,10116.0,15812,50597,1,,,BAO_0000218,1969.0,
14244,Rattus norvegicus,CHEMBL626503,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14245,Rattus norvegicus,CHEMBL626504,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14246,Rattus norvegicus,CHEMBL626505,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14247,Rattus norvegicus,CHEMBL626506,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14248,Rattus norvegicus,CHEMBL626507,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14249,Rattus norvegicus,CHEMBL626508,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14250,Rattus norvegicus,CHEMBL626509,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14251,Rattus norvegicus,CHEMBL875480,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14252,Rattus norvegicus,CHEMBL626510,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14253,Rattus norvegicus,CHEMBL626511,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14254,Rattus norvegicus,CHEMBL626512,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14255,Rattus norvegicus,CHEMBL628208,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14256,Rattus norvegicus,CHEMBL628209,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14257,Rattus norvegicus,CHEMBL628210,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14258,Rattus norvegicus,CHEMBL628211,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14259,Rattus norvegicus,CHEMBL628212,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14260,Rattus norvegicus,CHEMBL628213,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14261,Rattus norvegicus,CHEMBL628214,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14262,Rattus norvegicus,CHEMBL628215,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14263,Rattus norvegicus,CHEMBL628216,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14264,Rattus norvegicus,CHEMBL626595,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14265,Rattus norvegicus,CHEMBL626596,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14266,Rattus norvegicus,CHEMBL626597,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14267,Rattus norvegicus,CHEMBL626598,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14268,Rattus norvegicus,CHEMBL622242,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14269,Rattus norvegicus,CHEMBL622243,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14270,Rattus norvegicus,CHEMBL622244,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14271,Rattus norvegicus,CHEMBL622245,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14272,Rattus norvegicus,CHEMBL622246,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14273,Rattus norvegicus,CHEMBL622247,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14274,Rattus norvegicus,CHEMBL622248,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14275,Rattus norvegicus,CHEMBL877483,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14276,Rattus norvegicus,CHEMBL622249,Intermediate,Urine,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14277,Canis lupus familiaris,CHEMBL622250,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14278,Canis lupus familiaris,CHEMBL622251,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14279,Canis lupus familiaris,CHEMBL622252,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14280,Canis lupus familiaris,CHEMBL622253,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14281,Canis lupus familiaris,CHEMBL622254,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14282,Canis lupus familiaris,CHEMBL622255,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14283,Canis lupus familiaris,CHEMBL622256,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14284,Canis lupus familiaris,CHEMBL622257,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14285,Canis lupus familiaris,CHEMBL622258,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14286,Canis lupus familiaris,CHEMBL622259,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14287,Canis lupus familiaris,CHEMBL622927,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14288,Canis lupus familiaris,CHEMBL622928,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14289,Canis lupus familiaris,CHEMBL622929,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14290,Canis lupus familiaris,CHEMBL623182,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14291,Canis lupus familiaris,CHEMBL623183,Intermediate,Urine,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14292,Rattus norvegicus,CHEMBL623184,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14293,Rattus norvegicus,CHEMBL623185,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14294,Rattus norvegicus,CHEMBL877484,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14295,Rattus norvegicus,CHEMBL627274,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14296,Rattus norvegicus,CHEMBL623186,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14297,Rattus norvegicus,CHEMBL623187,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14298,Rattus norvegicus,CHEMBL623188,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14299,Rattus norvegicus,CHEMBL628055,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14300,Rattus norvegicus,CHEMBL628056,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14301,Rattus norvegicus,CHEMBL628200,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14302,Rattus norvegicus,CHEMBL628201,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14303,Rattus norvegicus,CHEMBL628202,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14304,Rattus norvegicus,CHEMBL628203,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14305,Rattus norvegicus,CHEMBL628204,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14306,Rattus norvegicus,CHEMBL628205,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14307,Rattus norvegicus,CHEMBL628206,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14308,,CHEMBL628207,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,U,,13257,22224,1,,,BAO_0000218,2367.0,
14309,,CHEMBL627220,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,U,,13257,22224,1,,,BAO_0000218,2367.0,
14310,,CHEMBL627221,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14311,,CHEMBL627222,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,U,,13257,22224,1,,,BAO_0000218,2367.0,
14312,,CHEMBL627223,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,U,,13257,22224,1,,,BAO_0000218,,
14313,,CHEMBL632062,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14314,,CHEMBL632063,Autocuration,Spleen,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,U,,13257,22224,1,,,BAO_0000218,2106.0,
14315,,CHEMBL632064,Autocuration,Urinary bladder,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,U,,13257,22224,1,,,BAO_0000218,1255.0,
14316,,CHEMBL632065,Autocuration,Blood,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,U,,13257,22224,1,,,BAO_0000218,178.0,
14317,,CHEMBL632066,Autocuration,Bone element,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,U,,13257,22224,1,,,BAO_0000218,1474.0,
14318,,CHEMBL632067,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,U,,13257,22224,1,,,BAO_0000218,,
14319,,CHEMBL629188,Autocuration,Kidney,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,U,,13257,22224,1,,,BAO_0000218,2113.0,
14320,,CHEMBL629189,Autocuration,Liver,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,U,,13257,22224,1,,,BAO_0000218,2107.0,
14321,,CHEMBL629190,Autocuration,Lung,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,U,,13257,22224,1,,,BAO_0000218,2048.0,
14322,,CHEMBL629191,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14323,,CHEMBL629192,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,U,,13257,22224,1,,,BAO_0000218,2367.0,
14324,,CHEMBL629193,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14325,,CHEMBL629194,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,U,,13257,22224,1,,,BAO_0000218,2367.0,
14326,,CHEMBL629195,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,U,,13257,22224,1,,,BAO_0000218,,
14327,,CHEMBL629373,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14328,,CHEMBL629374,Autocuration,Spleen,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,U,,13257,22224,1,,,BAO_0000218,2106.0,
14329,,CHEMBL629375,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,U,,13257,22224,1,,,BAO_0000218,2367.0,
14330,,CHEMBL629376,Autocuration,Urinary bladder,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,U,,13257,22224,1,,,BAO_0000218,1255.0,
14331,,CHEMBL629377,Autocuration,Blood,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,U,,13257,22224,1,,,BAO_0000218,178.0,
14332,,CHEMBL629378,Autocuration,Bone element,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,U,,13257,22224,1,,,BAO_0000218,1474.0,
14333,,CHEMBL629379,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,U,,13257,22224,1,,,BAO_0000218,,
14334,,CHEMBL629151,Autocuration,Kidney,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,U,,13257,22224,1,,,BAO_0000218,2113.0,
14335,,CHEMBL629152,Autocuration,Liver,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,U,,13257,22224,1,,,BAO_0000218,2107.0,
14336,,CHEMBL629153,Autocuration,Lung,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,U,,13257,22224,1,,,BAO_0000218,2048.0,
14337,,CHEMBL629154,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14338,,CHEMBL629155,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,U,,13257,22224,1,,,BAO_0000218,2367.0,
14339,,CHEMBL629156,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,U,,13257,22224,1,,,BAO_0000218,2367.0,
14340,,CHEMBL629157,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14341,,CHEMBL629158,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,U,,13257,22224,1,,,BAO_0000218,2367.0,
14342,,CHEMBL629159,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,U,,13257,22224,1,,,BAO_0000218,,
14343,,CHEMBL629160,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14344,,CHEMBL629161,Autocuration,Spleen,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,U,,13257,22224,1,,,BAO_0000218,2106.0,
14345,,CHEMBL629162,Autocuration,Urinary bladder,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,U,,13257,22224,1,,,BAO_0000218,1255.0,
14346,,CHEMBL629163,Autocuration,Blood,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,U,,13257,22224,1,,,BAO_0000218,178.0,
14347,,CHEMBL629164,Autocuration,Bone element,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,U,,13257,22224,1,,,BAO_0000218,1474.0,
14348,,CHEMBL629165,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,U,,13257,22224,1,,,BAO_0000218,,
14349,,CHEMBL629166,Autocuration,Liver,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,U,,13257,22224,1,,,BAO_0000218,2107.0,
14350,,CHEMBL629167,Autocuration,Lung,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,U,,13257,22224,1,,,BAO_0000218,2048.0,
14351,,CHEMBL629168,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14352,,CHEMBL629169,Autocuration,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,U,,2193,22224,1,,,BAO_0000019,,
14353,,CHEMBL629170,Autocuration,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,U,,2193,22224,1,,,BAO_0000019,,
14354,,CHEMBL631153,Autocuration,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,U,,2193,22224,1,,,BAO_0000019,,
14355,,CHEMBL875121,Autocuration,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,U,,2193,22224,1,,,BAO_0000019,,
14356,,CHEMBL631154,Autocuration,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,U,,2193,22224,1,,,BAO_0000019,,
14357,,CHEMBL631155,Autocuration,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,U,,2193,22224,1,,,BAO_0000019,,
14358,,CHEMBL631156,Autocuration,,Hydrolysis rate constant was determined,,U,,568,22224,1,,,BAO_0000019,,
14359,,CHEMBL631157,Autocuration,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,U,,9680,22224,1,,,BAO_0000019,,
14360,,CHEMBL631158,Autocuration,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,U,,9680,22224,1,,,BAO_0000019,,
14361,,CHEMBL631159,Autocuration,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,U,,9680,22224,1,,,BAO_0000019,,
14362,,CHEMBL631160,Autocuration,,Observed second order rate constant,,U,,10026,22224,1,,,BAO_0000019,,
14363,,CHEMBL631161,Autocuration,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,U,,10281,22224,1,,,BAO_0000019,,
14364,,CHEMBL631162,Autocuration,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,U,,10014,22224,1,,,BAO_0000019,,
14365,,CHEMBL630313,Autocuration,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,U,,10014,22224,1,,,BAO_0000019,,
14366,,CHEMBL630314,Autocuration,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,U,,9680,22224,1,,,BAO_0000019,,
14367,,CHEMBL630315,Autocuration,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,U,,9680,22224,1,,,BAO_0000019,,
14368,,CHEMBL630316,Autocuration,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14369,,CHEMBL630986,Autocuration,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14370,,CHEMBL630987,Autocuration,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14371,,CHEMBL630988,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14372,,CHEMBL630989,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14373,,CHEMBL630990,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14374,,CHEMBL630991,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14375,,CHEMBL630992,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14376,,CHEMBL630993,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14377,,CHEMBL630994,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,13028,22224,1,,,BAO_0000019,,
14378,Rattus norvegicus,CHEMBL630995,Intermediate,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,N,10116.0,10014,50597,1,,,BAO_0000218,,
14379,,CHEMBL629252,Autocuration,,Association constant for compound at 31 degree C was determined,,U,,9962,22224,1,,,BAO_0000019,,
14380,,CHEMBL629253,Autocuration,,Calculated antagonist equilibrium dissociation constant of the compound,,U,,12029,22224,1,,,BAO_0000019,,
14381,,CHEMBL629944,Autocuration,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,U,,12029,22224,1,,,BAO_0000019,,
14382,Cavia porcellus,CHEMBL629945,Intermediate,Trachea,Dissociation constants vs LTE4 on guinea pig trachea,,N,10141.0,10583,50512,1,,,BAO_0000218,3126.0,
14383,,CHEMBL629946,Autocuration,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,U,,568,22224,1,,,BAO_0000019,,
14384,,CHEMBL629947,Autocuration,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,U,,568,22224,1,,,BAO_0000019,,
14385,,CHEMBL629948,Autocuration,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,U,,568,22224,1,,,BAO_0000019,,
14386,,CHEMBL856024,Autocuration,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,U,,568,22224,1,,,BAO_0000019,,
14387,,CHEMBL629949,Autocuration,,Affinity constant KD value was derived from TMP,,U,,7493,22224,1,,,BAO_0000019,,
14388,,CHEMBL629950,Autocuration,,Apparent dissociation (binding) rate constant was evaluated,,U,,8371,22224,1,,,BAO_0000019,,
14389,,CHEMBL630127,Autocuration,,Dissociation constant (KD) of the compound,,U,,13114,22224,1,,,BAO_0000100,,
14390,,CHEMBL630128,Autocuration,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,U,,15515,22224,1,,,BAO_0000100,,
14391,,CHEMBL630129,Autocuration,,Dissociation constant from ESR titration experiments,,U,,522,22224,1,,,BAO_0000100,,
14392,,CHEMBL630130,Autocuration,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,U,,13888,22224,1,,,BAO_0000019,,
14393,,CHEMBL875234,Autocuration,,Dissociation constant was evaluated.,,U,,2616,22224,1,,,BAO_0000100,,
14394,,CHEMBL630131,Autocuration,,Dissociation constant was reported,,U,,3798,22224,1,,,BAO_0000100,,
14395,Rattus norvegicus,CHEMBL630132,Intermediate,,Dissociation constant was determined in rat pituitary cells.,,N,10116.0,8731,50597,1,,,BAO_0000218,,
14396,,CHEMBL630133,Autocuration,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,U,,11892,22224,1,,,BAO_0000019,,
14397,,CHEMBL630134,Autocuration,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,U,,11892,22224,1,,,BAO_0000019,,
14398,,CHEMBL630135,Autocuration,,Equilibrium dissociation constant of the compound,,U,,2582,22224,1,,,BAO_0000019,,
14399,,CHEMBL630136,Autocuration,,Equilibrium dissociation constant was determined,,U,,11892,22224,1,,,BAO_0000019,,
14400,,CHEMBL630137,Autocuration,,Kinetic constant KD was evaluated,,U,,13396,22224,1,,,BAO_0000019,,
14401,,CHEMBL630138,Autocuration,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,U,,603,22224,1,,,BAO_0000019,,
14402,,CHEMBL630139,Autocuration,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,U,,15673,22224,1,,,BAO_0000019,,
14403,,CHEMBL630140,Autocuration,,Rate constant for hydrolysis in aqueous acetone.,,U,,10368,22224,1,,,BAO_0000019,,
14404,,CHEMBL875235,Autocuration,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,U,,14228,22224,1,,,BAO_0000019,,
14405,Rattus norvegicus,CHEMBL876439,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14406,Rattus norvegicus,CHEMBL630605,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14407,Rattus norvegicus,CHEMBL630606,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14408,Rattus norvegicus,CHEMBL630607,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14409,Rattus norvegicus,CHEMBL630608,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14410,Rattus norvegicus,CHEMBL630609,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14411,Rattus norvegicus,CHEMBL630610,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14412,Rattus norvegicus,CHEMBL630611,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14413,Rattus norvegicus,CHEMBL629552,Intermediate,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14414,Rattus norvegicus,CHEMBL629733,Intermediate,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14415,Rattus norvegicus,CHEMBL629734,Intermediate,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14416,Rattus norvegicus,CHEMBL629735,Intermediate,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14417,Rattus norvegicus,CHEMBL629736,Intermediate,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14418,Rattus norvegicus,CHEMBL629737,Intermediate,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14419,Rattus norvegicus,CHEMBL629738,Intermediate,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14420,Rattus norvegicus,CHEMBL629739,Intermediate,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14421,Rattus norvegicus,CHEMBL629740,Intermediate,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14422,Rattus norvegicus,CHEMBL629741,Intermediate,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14423,Rattus norvegicus,CHEMBL629742,Intermediate,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14424,Rattus norvegicus,CHEMBL629743,Intermediate,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14425,Rattus norvegicus,CHEMBL629744,Intermediate,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14426,Rattus norvegicus,CHEMBL629745,Intermediate,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14427,Rattus norvegicus,CHEMBL629746,Intermediate,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14428,Rattus norvegicus,CHEMBL629747,Intermediate,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14429,Rattus norvegicus,CHEMBL629748,Intermediate,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14430,Rattus norvegicus,CHEMBL629749,Intermediate,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14431,Rattus norvegicus,CHEMBL629750,Intermediate,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14432,Rattus norvegicus,CHEMBL629751,Intermediate,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14433,Rattus norvegicus,CHEMBL629752,Intermediate,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14434,Rattus norvegicus,CHEMBL629753,Intermediate,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14435,Rattus norvegicus,CHEMBL629754,Intermediate,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14436,Rattus norvegicus,CHEMBL629755,Intermediate,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14437,Rattus norvegicus,CHEMBL629756,Intermediate,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14438,Rattus norvegicus,CHEMBL629757,Intermediate,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14439,Rattus norvegicus,CHEMBL629758,Intermediate,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14440,Rattus norvegicus,CHEMBL629759,Intermediate,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14441,Rattus norvegicus,CHEMBL629760,Intermediate,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14442,Rattus norvegicus,CHEMBL876443,Intermediate,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,N,10116.0,11510,50597,1,,,BAO_0000218,,
14443,Canis lupus familiaris,CHEMBL629761,Intermediate,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,N,9615.0,8310,50588,1,,,BAO_0000218,,
14444,Canis lupus familiaris,CHEMBL629762,Intermediate,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,N,9615.0,8310,50588,1,,,BAO_0000218,,
14445,Mus musculus,CHEMBL629763,Intermediate,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,10090.0,8310,50594,1,,,BAO_0000218,,
14446,Mus musculus,CHEMBL629764,Intermediate,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,N,10090.0,8310,50594,1,,,BAO_0000218,,
14447,Mus musculus,CHEMBL629765,Intermediate,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,N,10090.0,8310,50594,1,,,BAO_0000218,,
14448,Mus musculus,CHEMBL629766,Intermediate,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,N,10090.0,8310,50594,1,,,BAO_0000218,,
14449,Mus musculus,CHEMBL629767,Intermediate,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,10090.0,8310,50594,1,,,BAO_0000218,,
14450,Canis lupus familiaris,CHEMBL629768,Intermediate,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,N,9615.0,8310,50588,1,,,BAO_0000218,,
14451,Mus musculus,CHEMBL629769,Intermediate,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,N,10090.0,8310,50594,1,,,BAO_0000218,,
14452,Canis lupus familiaris,CHEMBL629770,Intermediate,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,N,9615.0,8310,50588,1,,,BAO_0000218,,
14453,Canis lupus familiaris,CHEMBL629771,Intermediate,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,N,9615.0,8310,50588,1,,,BAO_0000218,,
14454,Mus musculus,CHEMBL629772,Intermediate,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,10090.0,8310,50594,1,,,BAO_0000218,,
14455,Mus musculus,CHEMBL629773,Intermediate,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,10090.0,8310,50594,1,,,BAO_0000218,,
14456,Mus musculus,CHEMBL625455,Intermediate,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,N,10090.0,8310,50594,1,,,BAO_0000218,,
14457,Mus musculus,CHEMBL625456,Intermediate,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,N,10090.0,8310,50594,1,,,BAO_0000218,,
14458,Mus musculus,CHEMBL625457,Intermediate,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,N,10090.0,8310,50594,1,,,BAO_0000218,,
14459,Rattus norvegicus,CHEMBL625458,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14460,Rattus norvegicus,CHEMBL625459,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14461,Rattus norvegicus,CHEMBL875483,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14462,Rattus norvegicus,CHEMBL634779,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14463,Rattus norvegicus,CHEMBL625460,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14464,Rattus norvegicus,CHEMBL626117,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14465,Rattus norvegicus,CHEMBL626118,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14466,Rattus norvegicus,CHEMBL628342,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14467,Rattus norvegicus,CHEMBL628343,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14468,Rattus norvegicus,CHEMBL628344,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14469,Rattus norvegicus,CHEMBL628345,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14470,Rattus norvegicus,CHEMBL628346,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14471,Rattus norvegicus,CHEMBL628347,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14472,Rattus norvegicus,CHEMBL628348,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14473,Rattus norvegicus,CHEMBL628349,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14474,Rattus norvegicus,CHEMBL875611,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14475,Rattus norvegicus,CHEMBL628350,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14476,Rattus norvegicus,CHEMBL628351,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14477,Rattus norvegicus,CHEMBL628352,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14478,Rattus norvegicus,CHEMBL628353,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14479,Rattus norvegicus,CHEMBL628354,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14480,Rattus norvegicus,CHEMBL626667,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14481,Rattus norvegicus,CHEMBL626668,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14482,Rattus norvegicus,CHEMBL626669,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14483,Rattus norvegicus,CHEMBL626670,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14484,Rattus norvegicus,CHEMBL626671,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14485,Rattus norvegicus,CHEMBL626672,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14486,Rattus norvegicus,CHEMBL626673,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14487,Rattus norvegicus,CHEMBL626674,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14488,Rattus norvegicus,CHEMBL626675,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14489,Rattus norvegicus,CHEMBL626676,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14490,Rattus norvegicus,CHEMBL626677,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14491,Rattus norvegicus,CHEMBL626678,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14492,Rattus norvegicus,CHEMBL626679,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14493,Rattus norvegicus,CHEMBL875612,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14494,Rattus norvegicus,CHEMBL626680,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14495,Rattus norvegicus,CHEMBL626681,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14496,Rattus norvegicus,CHEMBL626682,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14497,Rattus norvegicus,CHEMBL626683,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14498,Rattus norvegicus,CHEMBL626684,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14499,Rattus norvegicus,CHEMBL626685,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14500,Rattus norvegicus,CHEMBL626686,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14501,Rattus norvegicus,CHEMBL626687,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14502,Rattus norvegicus,CHEMBL624978,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14503,Rattus norvegicus,CHEMBL624979,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14504,Rattus norvegicus,CHEMBL624980,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14505,Rattus norvegicus,CHEMBL624981,Intermediate,Urine,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14506,Canis lupus familiaris,CHEMBL624982,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14507,,CHEMBL627564,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,U,,13257,22224,1,,,BAO_0000218,2367.0,
14508,,CHEMBL627565,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,U,,13257,22224,1,,,BAO_0000218,2367.0,
14509,,CHEMBL627566,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,U,,13257,22224,1,,,BAO_0000218,,
14510,,CHEMBL627567,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14511,,CHEMBL627568,Autocuration,Spleen,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,U,,13257,22224,1,,,BAO_0000218,2106.0,
14512,,CHEMBL627569,Autocuration,Kidney,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,U,,13257,22224,1,,,BAO_0000218,2113.0,
14513,,CHEMBL627570,Autocuration,Urinary bladder,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,U,,13257,22224,1,,,BAO_0000218,1255.0,
14514,,CHEMBL627571,Autocuration,Blood,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,U,,13257,22224,1,,,BAO_0000218,178.0,
14515,,CHEMBL627572,Autocuration,Bone element,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,U,,13257,22224,1,,,BAO_0000218,1474.0,
14516,,CHEMBL627573,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,U,,13257,22224,1,,,BAO_0000218,,
14517,,CHEMBL627574,Autocuration,Kidney,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,U,,13257,22224,1,,,BAO_0000218,2113.0,
14518,,CHEMBL627575,Autocuration,Liver,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,U,,13257,22224,1,,,BAO_0000218,2107.0,
14519,,CHEMBL627576,Autocuration,Lung,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,U,,13257,22224,1,,,BAO_0000218,2048.0,
14520,,CHEMBL627577,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14521,,CHEMBL627578,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,U,,13257,22224,1,,,BAO_0000218,2367.0,
14522,,CHEMBL627579,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,U,,13257,22224,1,,,BAO_0000218,2367.0,
14523,,CHEMBL627580,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14524,,CHEMBL627581,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,U,,13257,22224,1,,,BAO_0000218,2367.0,
14525,,CHEMBL627582,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,U,,13257,22224,1,,,BAO_0000218,,
14526,,CHEMBL627583,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14527,,CHEMBL627584,Autocuration,Spleen,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,U,,13257,22224,1,,,BAO_0000218,2106.0,
14528,,CHEMBL627585,Autocuration,Prostate gland,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,U,,13257,22224,1,,,BAO_0000218,2367.0,
14529,,CHEMBL627586,Autocuration,Muscle tissue,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,U,,13257,22224,1,,,BAO_0000218,2385.0,
14530,Rattus norvegicus,CHEMBL627587,Intermediate,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,,
14531,Rattus norvegicus,CHEMBL627588,Intermediate,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,,
14532,Rattus norvegicus,CHEMBL628250,Intermediate,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,,
14533,Rattus norvegicus,CHEMBL628251,Intermediate,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,,
14534,Rattus norvegicus,CHEMBL628252,Intermediate,Hippocampus,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,10000000.0,
14535,Rattus norvegicus,CHEMBL628253,Intermediate,Hippocampus,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,10000000.0,
14536,Rattus norvegicus,CHEMBL628254,Intermediate,Hypothalamus,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,1898.0,
14537,Rattus norvegicus,CHEMBL877493,Intermediate,Hypothalamus,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,1898.0,
14538,Rattus norvegicus,CHEMBL628255,Intermediate,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,,
14539,Rattus norvegicus,CHEMBL628256,Intermediate,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,,
14540,Rattus norvegicus,CHEMBL628257,Intermediate,Hippocampus,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,10000000.0,
14541,Rattus norvegicus,CHEMBL628258,Intermediate,Hypothalamus,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,1898.0,
14542,Rattus norvegicus,CHEMBL628259,Intermediate,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,,
14543,Rattus norvegicus,CHEMBL628429,Intermediate,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,,
14544,Rattus norvegicus,CHEMBL626862,Intermediate,Hippocampus,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,N,10116.0,15413,50597,1,,,BAO_0000218,10000000.0,
14545,Rattus norvegicus,CHEMBL626863,Intermediate,Hypothalamus,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,N,10116.0,15413,50597,1,,,BAO_0000218,1898.0,
14546,Rattus norvegicus,CHEMBL625886,Intermediate,Cerebellum,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,N,10116.0,15413,50597,1,,,BAO_0000218,2037.0,
14547,Rattus norvegicus,CHEMBL625887,Intermediate,Cerebellum,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,N,10116.0,15413,50597,1,,,BAO_0000218,2037.0,
14548,Rattus norvegicus,CHEMBL625888,Intermediate,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,N,10116.0,15413,50597,1,,,BAO_0000218,,
14549,Rattus norvegicus,CHEMBL625889,Intermediate,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,N,10116.0,15413,50597,1,,,BAO_0000218,,
14550,Rattus norvegicus,CHEMBL625890,Intermediate,Hippocampus,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,N,10116.0,15413,50597,1,,,BAO_0000218,10000000.0,
14551,Rattus norvegicus,CHEMBL625891,Intermediate,Hippocampus,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,N,10116.0,15413,50597,1,,,BAO_0000218,10000000.0,
14552,Rattus norvegicus,CHEMBL625892,Intermediate,Hypothalamus,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,N,10116.0,15413,50597,1,,,BAO_0000218,1898.0,
14553,Rattus norvegicus,CHEMBL625893,Intermediate,Hypothalamus,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,N,10116.0,15413,50597,1,,,BAO_0000218,1898.0,
14554,Rattus norvegicus,CHEMBL625894,Intermediate,Cerebellum,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,N,10116.0,15413,50597,1,,,BAO_0000218,2037.0,
14555,Rattus norvegicus,CHEMBL625895,Intermediate,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,N,10116.0,15413,50597,1,,,BAO_0000218,,
14556,,CHEMBL625896,Autocuration,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,U,,12404,22224,1,,,BAO_0000019,,
14557,,CHEMBL625897,Autocuration,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,U,,568,22224,1,,,BAO_0000019,,
14558,,CHEMBL625898,Autocuration,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,U,,568,22224,1,,,BAO_0000019,,
14559,,CHEMBL625899,Autocuration,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,U,,568,22224,1,,,BAO_0000019,,
14560,,CHEMBL626124,Autocuration,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,U,,12404,22224,1,,,BAO_0000019,,
14561,Escherichia coli,CHEMBL628500,Intermediate,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,N,562.0,7624,50212,1,,,BAO_0000218,,
14562,Rattus norvegicus,CHEMBL857856,Intermediate,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,N,10116.0,7624,50597,1,,,BAO_0000218,,
14563,Rattus norvegicus,CHEMBL628501,Intermediate,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,N,10116.0,7624,50597,1,,,BAO_0000218,,
14564,,CHEMBL628502,Autocuration,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,U,,4643,22224,1,,,BAO_0000019,,
14565,,CHEMBL628503,Autocuration,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,U,,11532,22224,1,,,BAO_0000019,,
14566,,CHEMBL628504,Autocuration,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,U,,11018,22224,1,,,BAO_0000019,,
14567,,CHEMBL628505,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,U,,2276,22224,1,,,BAO_0000019,,
14568,,CHEMBL874452,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,U,,2276,22224,1,,,BAO_0000019,,
14569,,CHEMBL628506,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,U,,2276,22224,1,,,BAO_0000019,,
14570,,CHEMBL628507,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,U,,2276,22224,1,,,BAO_0000019,,
14571,,CHEMBL628508,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,U,,2276,22224,1,,,BAO_0000019,,
14572,,CHEMBL628509,Autocuration,,Michaelis constant (KM) was evaluated,,U,,8949,22224,1,,,BAO_0000019,,
14573,,CHEMBL628510,Autocuration,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,U,,12404,22224,1,,,BAO_0000019,,
14574,,CHEMBL628511,Autocuration,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,U,,7625,22224,1,,,BAO_0000019,,
14575,,CHEMBL628512,Autocuration,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,U,,7625,22224,1,,,BAO_0000019,,
14576,,CHEMBL628513,Autocuration,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,U,,7625,22224,1,,,BAO_0000019,,
14577,,CHEMBL628514,Autocuration,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,U,,7625,22224,1,,,BAO_0000019,,
14578,,CHEMBL628515,Autocuration,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,U,,12908,22224,1,,,BAO_0000019,,
14579,,CHEMBL628516,Autocuration,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,U,,10368,22224,1,,,BAO_0000019,,
14580,,CHEMBL628517,Autocuration,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,U,,13108,22224,1,,,BAO_0000019,,
14581,,CHEMBL628518,Autocuration,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,U,,13108,22224,1,,,BAO_0000019,,
14582,,CHEMBL628519,Autocuration,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,U,,15217,22224,1,,,BAO_0000019,,
14583,,CHEMBL628520,Autocuration,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,U,,15217,22224,1,,,BAO_0000019,,
14584,,CHEMBL628521,Autocuration,,Binding constant was determined,,U,,10933,22224,1,,,BAO_0000019,,
14585,,CHEMBL630443,Autocuration,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,U,,2363,22224,1,,,BAO_0000019,,
14586,,CHEMBL630444,Autocuration,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,U,,2363,22224,1,,,BAO_0000019,,
14587,,CHEMBL857732,Autocuration,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,U,,2276,22224,1,,,BAO_0000019,,
14588,,CHEMBL630445,Autocuration,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,U,,14915,22224,1,,,BAO_0000100,,
14589,,CHEMBL630446,Autocuration,,Catalytic rate constant of the compound,,U,,8847,22224,1,,,BAO_0000019,,
14590,,CHEMBL630447,Autocuration,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,U,,15357,22224,1,,,BAO_0000019,,
14591,,CHEMBL630448,Autocuration,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,U,,2869,22224,1,,,BAO_0000019,,
14592,,CHEMBL630449,Autocuration,,Catalytic rate constant against phospholipase A2 was determined,,U,,3484,22224,1,,,BAO_0000019,,
14593,,CHEMBL630450,Autocuration,,"Compound was evaluated for catalytic constant, Kcat",,U,,1373,22224,1,,,BAO_0000019,,
14594,,CHEMBL630451,Autocuration,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,U,,8142,22224,1,,,BAO_0000019,,
14595,,CHEMBL630452,Autocuration,,Kcat calculated from 0.693/T1/2,,U,,14131,22224,1,,,BAO_0000019,,
14596,,CHEMBL630453,Autocuration,,Kcat was determined,,U,,17269,22224,1,,,BAO_0000019,,
14597,,CHEMBL630454,Autocuration,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,U,,3485,22224,1,,,BAO_0000019,,
14598,,CHEMBL630455,Autocuration,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,U,,3485,22224,1,,,BAO_0000019,,
14599,,CHEMBL631487,Autocuration,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,U,,3485,22224,1,,,BAO_0000019,,
14600,,CHEMBL631488,Autocuration,,Kcat value was determined,,U,,5962,22224,1,,,BAO_0000019,,
14601,,CHEMBL876440,Autocuration,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,U,,3133,22224,1,,,BAO_0000019,,
14602,,CHEMBL631489,Autocuration,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,U,,3133,22224,1,,,BAO_0000019,,
14603,,CHEMBL857742,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,U,,2276,22224,1,,,BAO_0000019,,
14604,,CHEMBL631490,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,U,,2276,22224,1,,,BAO_0000019,,
14605,,CHEMBL631491,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,U,,2276,22224,1,,,BAO_0000019,,
14606,,CHEMBL631492,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,U,,2276,22224,1,,,BAO_0000019,,
14607,,CHEMBL631493,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,U,,2276,22224,1,,,BAO_0000019,,
14608,,CHEMBL631494,Autocuration,,Kinetic parameter for rate of conversion to PABA was determined,,U,,4892,22224,1,,,BAO_0000019,,
14609,,CHEMBL631495,Autocuration,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,U,,3133,22224,1,,,BAO_0000019,,
14610,Rattus norvegicus,CHEMBL631496,Intermediate,Feces,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,N,10116.0,11488,50597,1,,,BAO_0000218,1988.0,
14611,Rattus norvegicus,CHEMBL631497,Intermediate,Urine,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,N,10116.0,11488,50597,1,,,BAO_0000218,1088.0,
14612,Rattus norvegicus,CHEMBL631498,Intermediate,Urine,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,N,10116.0,11488,50597,1,,,BAO_0000218,1088.0,
14613,Rattus norvegicus,CHEMBL629776,Intermediate,Urine,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,N,10116.0,11488,50597,1,,,BAO_0000218,1088.0,
14614,Rattus norvegicus,CHEMBL629777,Intermediate,Urine,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,N,10116.0,11488,50597,1,,,BAO_0000218,1088.0,
14615,Rattus norvegicus,CHEMBL629778,Intermediate,Urine,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,N,10116.0,11488,50597,1,,,BAO_0000218,1088.0,
14616,Rattus norvegicus,CHEMBL630456,Intermediate,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14617,Rattus norvegicus,CHEMBL630457,Intermediate,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14618,Rattus norvegicus,CHEMBL630458,Intermediate,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14619,Rattus norvegicus,CHEMBL630459,Intermediate,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14620,Rattus norvegicus,CHEMBL630460,Intermediate,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14621,Rattus norvegicus,CHEMBL876550,Intermediate,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14622,Rattus norvegicus,CHEMBL630461,Intermediate,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14623,Rattus norvegicus,CHEMBL630462,Intermediate,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14624,Rattus norvegicus,CHEMBL630463,Intermediate,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14625,Rattus norvegicus,CHEMBL630464,Intermediate,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14626,Rattus norvegicus,CHEMBL630465,Intermediate,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14627,Rattus norvegicus,CHEMBL630466,Intermediate,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14628,Rattus norvegicus,CHEMBL630467,Intermediate,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14629,Rattus norvegicus,CHEMBL630633,Intermediate,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14630,Rattus norvegicus,CHEMBL630634,Intermediate,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14631,Rattus norvegicus,CHEMBL630635,Intermediate,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14632,Rattus norvegicus,CHEMBL630636,Intermediate,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14633,Rattus norvegicus,CHEMBL630637,Intermediate,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,N,10116.0,11488,50597,1,,,BAO_0000218,,
14634,Oryctolagus cuniculus,CHEMBL630638,Intermediate,Feces,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
14635,Oryctolagus cuniculus,CHEMBL630639,Intermediate,Feces,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
14636,Oryctolagus cuniculus,CHEMBL630640,Intermediate,Feces,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
14637,Oryctolagus cuniculus,CHEMBL876551,Intermediate,Feces,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
14638,Oryctolagus cuniculus,CHEMBL630641,Intermediate,Urine,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
14639,Oryctolagus cuniculus,CHEMBL630642,Intermediate,Urine,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
14640,Oryctolagus cuniculus,CHEMBL630643,Intermediate,Urine,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
14641,Oryctolagus cuniculus,CHEMBL630644,Intermediate,Urine,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
14642,Oryctolagus cuniculus,CHEMBL630645,Intermediate,Urine,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
14643,Oryctolagus cuniculus,CHEMBL625599,Intermediate,Feces,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
14644,Oryctolagus cuniculus,CHEMBL625600,Intermediate,Feces,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
14645,Oryctolagus cuniculus,CHEMBL625601,Intermediate,Feces,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
14646,Oryctolagus cuniculus,CHEMBL625602,Intermediate,Feces,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1988.0,
14647,Oryctolagus cuniculus,CHEMBL627470,Intermediate,Urine,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
14648,Oryctolagus cuniculus,CHEMBL627471,Intermediate,Urine,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
14649,Oryctolagus cuniculus,CHEMBL627472,Intermediate,Urine,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
14650,Oryctolagus cuniculus,CHEMBL627473,Intermediate,Urine,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
14651,Oryctolagus cuniculus,CHEMBL627474,Intermediate,Urine,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,N,9986.0,7132,50592,1,,,BAO_0000218,1088.0,
14652,Rattus norvegicus,CHEMBL627475,Intermediate,Blood,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,178.0,
14653,Rattus norvegicus,CHEMBL627476,Intermediate,Blood,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,178.0,
14654,Canis lupus familiaris,CHEMBL627477,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14655,Canis lupus familiaris,CHEMBL627478,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14656,Canis lupus familiaris,CHEMBL627479,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14657,Canis lupus familiaris,CHEMBL627480,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14658,Canis lupus familiaris,CHEMBL627481,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14659,Canis lupus familiaris,CHEMBL627482,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14660,Canis lupus familiaris,CHEMBL627483,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14661,Canis lupus familiaris,CHEMBL875636,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14662,Canis lupus familiaris,CHEMBL625764,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14663,Canis lupus familiaris,CHEMBL625765,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14664,Canis lupus familiaris,CHEMBL625766,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14665,Canis lupus familiaris,CHEMBL625767,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14666,Canis lupus familiaris,CHEMBL625768,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14667,Canis lupus familiaris,CHEMBL625769,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14668,Canis lupus familiaris,CHEMBL625770,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14669,Canis lupus familiaris,CHEMBL625771,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14670,Canis lupus familiaris,CHEMBL625772,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14671,Canis lupus familiaris,CHEMBL625773,Intermediate,Urine,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,N,9615.0,12582,50588,1,,,BAO_0000218,1088.0,
14672,Rattus norvegicus,CHEMBL625774,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14673,Rattus norvegicus,CHEMBL625775,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14674,Rattus norvegicus,CHEMBL625776,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14675,Rattus norvegicus,CHEMBL625777,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14676,Rattus norvegicus,CHEMBL625778,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14677,Rattus norvegicus,CHEMBL625779,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14678,Rattus norvegicus,CHEMBL625780,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14679,Rattus norvegicus,CHEMBL625781,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14680,Rattus norvegicus,CHEMBL875637,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14681,Rattus norvegicus,CHEMBL626473,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14682,Rattus norvegicus,CHEMBL626474,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14683,Rattus norvegicus,CHEMBL626475,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14684,Rattus norvegicus,CHEMBL626476,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14685,Rattus norvegicus,CHEMBL634397,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14686,Rattus norvegicus,CHEMBL626477,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14687,Rattus norvegicus,CHEMBL631069,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14688,Rattus norvegicus,CHEMBL631070,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14689,Rattus norvegicus,CHEMBL631071,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14690,Rattus norvegicus,CHEMBL631072,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14691,Rattus norvegicus,CHEMBL631073,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14692,Rattus norvegicus,CHEMBL631074,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14693,Rattus norvegicus,CHEMBL631075,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14694,Rattus norvegicus,CHEMBL631725,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14695,Rattus norvegicus,CHEMBL631726,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14696,Rattus norvegicus,CHEMBL631727,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14697,Rattus norvegicus,CHEMBL631728,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14698,Rattus norvegicus,CHEMBL631729,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14699,Rattus norvegicus,CHEMBL631730,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14700,Rattus norvegicus,CHEMBL631731,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14701,Rattus norvegicus,CHEMBL631910,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14702,Rattus norvegicus,CHEMBL631911,Intermediate,Hippocampus,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,N,10116.0,15413,50597,1,,,BAO_0000218,10000000.0,
14703,Rattus norvegicus,CHEMBL631912,Intermediate,Hypothalamus,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,N,10116.0,15413,50597,1,,,BAO_0000218,1898.0,
14704,Rattus norvegicus,CHEMBL631913,Intermediate,Hypothalamus,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,N,10116.0,15413,50597,1,,,BAO_0000218,1898.0,
14705,Rattus norvegicus,CHEMBL631914,Intermediate,Blood,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
14706,Rattus norvegicus,CHEMBL631915,Intermediate,Blood,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
14707,Rattus norvegicus,CHEMBL875778,Intermediate,Blood,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
14708,Rattus norvegicus,CHEMBL631916,Intermediate,Blood,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
14709,Rattus norvegicus,CHEMBL631917,Intermediate,Blood,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
14710,Rattus norvegicus,CHEMBL631918,Intermediate,Blood,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
14711,Rattus norvegicus,CHEMBL631919,Intermediate,Blood,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
14712,Rattus norvegicus,CHEMBL631920,Intermediate,Blood,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
14713,Rattus norvegicus,CHEMBL631921,Intermediate,Blood,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
14714,Rattus norvegicus,CHEMBL631922,Intermediate,Blood,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
14715,Rattus norvegicus,CHEMBL631923,Intermediate,Blood,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,178.0,
14716,Rattus norvegicus,CHEMBL631924,Intermediate,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
14717,Rattus norvegicus,CHEMBL630234,Intermediate,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
14718,Rattus norvegicus,CHEMBL630235,Intermediate,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,,
14719,Rattus norvegicus,CHEMBL630236,Intermediate,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
14720,Rattus norvegicus,CHEMBL630237,Intermediate,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
14721,Rattus norvegicus,CHEMBL630238,Intermediate,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
14722,Rattus norvegicus,CHEMBL630239,Intermediate,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
14723,Rattus norvegicus,CHEMBL630303,Intermediate,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,,
14724,Rattus norvegicus,CHEMBL630304,Intermediate,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
14725,Rattus norvegicus,CHEMBL630305,Intermediate,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,,
14726,Rattus norvegicus,CHEMBL630306,Intermediate,Kidney,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
14727,Rattus norvegicus,CHEMBL630307,Intermediate,Kidney,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
14728,Rattus norvegicus,CHEMBL630308,Intermediate,Kidney,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
14729,Rattus norvegicus,CHEMBL630309,Intermediate,Kidney,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
14730,Rattus norvegicus,CHEMBL629309,Intermediate,Kidney,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
14731,Rattus norvegicus,CHEMBL629993,Intermediate,Kidney,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
14732,Rattus norvegicus,CHEMBL629994,Intermediate,Kidney,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
14733,Rattus norvegicus,CHEMBL629995,Intermediate,Kidney,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
14734,Rattus norvegicus,CHEMBL631993,Intermediate,Kidney,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
14735,Rattus norvegicus,CHEMBL631994,Intermediate,Kidney,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
14736,Rattus norvegicus,CHEMBL631995,Intermediate,Kidney,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2113.0,
14737,Rattus norvegicus,CHEMBL631996,Intermediate,Liver,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
14738,Rattus norvegicus,CHEMBL631997,Intermediate,Liver,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
14739,Rattus norvegicus,CHEMBL631998,Intermediate,Liver,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
14740,Rattus norvegicus,CHEMBL631999,Intermediate,Liver,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
14741,Rattus norvegicus,CHEMBL632000,Intermediate,Liver,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
14742,Rattus norvegicus,CHEMBL632001,Intermediate,Liver,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
14743,Rattus norvegicus,CHEMBL874424,Intermediate,Liver,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
14744,Rattus norvegicus,CHEMBL632002,Intermediate,Liver,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
14745,Rattus norvegicus,CHEMBL632003,Intermediate,Liver,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
14746,,CHEMBL632004,Autocuration,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,U,,3133,22224,1,,,BAO_0000019,,
14747,,CHEMBL632005,Autocuration,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,U,,2742,22224,1,,,BAO_0000019,,
14748,,CHEMBL632006,Autocuration,,Compound was tested for amidase rate in the presence of N62C screen enzyme,,U,,2742,22224,1,,,BAO_0000019,,
14749,,CHEMBL632007,Autocuration,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,U,,2742,22224,1,,,BAO_0000019,,
14750,,CHEMBL632008,Autocuration,,Compound was tested for amidase rate in the presence of S166C screen enzyme,,U,,2742,22224,1,,,BAO_0000019,,
14751,,CHEMBL632009,Autocuration,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,U,,2742,22224,1,,,BAO_0000019,,
14752,,CHEMBL632010,Autocuration,,Compound was tested for esterase rate in the presence of N62C screen enzyme,,U,,2742,22224,1,,,BAO_0000019,,
14753,,CHEMBL857750,Autocuration,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,U,,2742,22224,1,,,BAO_0000019,,
14754,,CHEMBL632011,Autocuration,,Compound was tested for esterase rate in the presence of S166C screen enzyme,,U,,2742,22224,1,,,BAO_0000019,,
14755,,CHEMBL632012,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,,2276,22224,1,,,BAO_0000019,,
14756,,CHEMBL632013,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,,2276,22224,1,,,BAO_0000019,,
14757,,CHEMBL632014,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,U,,2276,22224,1,,,BAO_0000019,,
14758,,CHEMBL629622,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,,2276,22224,1,,,BAO_0000019,,
14759,,CHEMBL629623,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,,2276,22224,1,,,BAO_0000019,,
14760,,CHEMBL629624,Autocuration,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,U,,2276,22224,1,,,BAO_0000019,,
14761,,CHEMBL629625,Autocuration,,Ratio of Kcat to that of Km was determined,,U,,17269,22224,1,,,BAO_0000019,,
14762,,CHEMBL629626,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,U,,2276,22224,1,,,BAO_0000019,,
14763,,CHEMBL629627,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,U,,2276,22224,1,,,BAO_0000019,,
14764,,CHEMBL629628,Autocuration,,"Compound was evaluated for constant, Kd",,U,,15917,22224,1,,,BAO_0000019,,
14765,,CHEMBL629629,Autocuration,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,U,,10933,22224,1,,,BAO_0000019,,
14766,,CHEMBL629630,Autocuration,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,U,,10933,22224,1,,,BAO_0000019,,
14767,,CHEMBL856030,Autocuration,,Dissociation Constant of compound determined,,U,,14293,22224,1,,,BAO_0000019,,
14768,,CHEMBL629631,Autocuration,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,U,,6698,22224,1,,,BAO_0000019,,
14769,,CHEMBL629632,Autocuration,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,U,,6698,22224,1,,,BAO_0000019,,
14770,,CHEMBL629633,Autocuration,,Dissociation constant of compound with Fructose was determined,,U,,4318,22224,1,,,BAO_0000100,,
14771,,CHEMBL629634,Autocuration,,Dissociation constant of compound with Fructose was determined; Not determined,,U,,4318,22224,1,,,BAO_0000100,,
14772,,CHEMBL629635,Autocuration,,Dissociation constant of compound with Lactulose was determined,,U,,4318,22224,1,,,BAO_0000100,,
14773,,CHEMBL629636,Autocuration,,Dissociation constant of compound with Lactulose was determined; Not determined,,U,,4318,22224,1,,,BAO_0000100,,
14774,,CHEMBL629637,Autocuration,,Dissociation constant of the Compound,,U,,14959,22224,1,,,BAO_0000100,,
14775,,CHEMBL629638,Autocuration,,Dissociation constant by non-linear regression analysis,,U,,5913,22224,1,,,BAO_0000100,,
14776,,CHEMBL629639,Autocuration,,Dissociation constant was determined,,U,,14218,22224,1,,,BAO_0000100,,
14777,,CHEMBL629640,Autocuration,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,U,,10689,22224,1,,,BAO_0000100,,
14778,,CHEMBL629641,Autocuration,,Dissociation constant was determined,,U,,13925,22224,1,,,BAO_0000100,,
14779,,CHEMBL631344,Autocuration,,Dissociation constant was determined,,U,,16359,22224,1,,,BAO_0000100,,
14780,Rattus norvegicus,CHEMBL631345,Intermediate,Muscle tissue,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,N,10116.0,10944,50597,1,,,BAO_0000218,2385.0,
14781,,CHEMBL631346,Autocuration,,The dissociation constant determined by fluorescence displacement assay,,U,,11080,22224,1,,,BAO_0000019,,
14782,,CHEMBL631524,Autocuration,,kd value surface plasmon resonance (SPR) method,,U,,17805,22224,1,,,BAO_0000019,,
14783,Rattus norvegicus,CHEMBL631525,Intermediate,Muscle tissue,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,N,10116.0,10944,50597,1,,,BAO_0000218,2385.0,
14784,,CHEMBL631526,Autocuration,,First dissociation constant of the binding of compound to V30M TTR,,U,,16645,22224,1,,,BAO_0000019,,
14785,,CHEMBL631527,Autocuration,,Second dissociation constant of the binding of compound to V30M TTR,,U,,16645,22224,1,,,BAO_0000019,,
14786,,CHEMBL631528,Autocuration,,"Compound was evaluated for equilibrium constant, Ke",,U,,7793,22224,1,,,BAO_0000019,,
14787,,CHEMBL631529,Autocuration,Hypothalamus,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,U,,12199,22224,1,,,BAO_0000019,1898.0,
14788,,CHEMBL631530,Autocuration,Hypothalamus,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,U,,12199,22224,1,,,BAO_0000019,1898.0,
14789,,CHEMBL631531,Autocuration,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,U,,9680,22224,1,,,BAO_0000019,,
14790,,CHEMBL631532,Autocuration,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,U,,9680,22224,1,,,BAO_0000019,,
14791,,CHEMBL631533,Autocuration,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,U,,9680,22224,1,,,BAO_0000019,,
14792,Mus musculus,CHEMBL876552,Intermediate,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,10090.0,13758,50594,1,,,BAO_0000218,,
14793,Mus musculus,CHEMBL631534,Intermediate,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,N,10090.0,13758,50594,1,,,BAO_0000218,,
14794,Mus musculus,CHEMBL631535,Intermediate,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,10090.0,13758,50594,1,,,BAO_0000218,,
14795,Mus musculus,CHEMBL631536,Intermediate,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,10090.0,13758,50594,1,,,BAO_0000218,,
14796,Mus musculus,CHEMBL631537,Intermediate,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,N,10090.0,13758,50594,1,,,BAO_0000218,,
14797,Mus musculus,CHEMBL631538,Intermediate,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,N,10090.0,13758,50594,1,,,BAO_0000218,,
14798,Mus musculus,CHEMBL631539,Intermediate,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,N,10090.0,13758,50594,1,,,BAO_0000218,,
14799,Mus musculus,CHEMBL631540,Intermediate,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,10090.0,13758,50594,1,,,BAO_0000218,,
14800,Rattus norvegicus,CHEMBL625637,Intermediate,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,10116.0,14393,50597,1,,,BAO_0000218,,
14801,Rattus norvegicus,CHEMBL625638,Intermediate,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,10116.0,14393,50597,1,,,BAO_0000218,,
14802,Rattus norvegicus,CHEMBL625639,Intermediate,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,N,10116.0,15078,50597,1,,,BAO_0000218,,
14803,Rattus norvegicus,CHEMBL625640,Intermediate,Brain,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,955.0,
14804,Rattus norvegicus,CHEMBL625641,Intermediate,Brain,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,955.0,
14805,Rattus norvegicus,CHEMBL625642,Intermediate,Heart,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,948.0,
14806,Rattus norvegicus,CHEMBL625643,Intermediate,Heart,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,948.0,
14807,Rattus norvegicus,CHEMBL625644,Intermediate,Kidney,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,2113.0,
14808,Rattus norvegicus,CHEMBL625645,Intermediate,Kidney,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,2113.0,
14809,Rattus norvegicus,CHEMBL625646,Intermediate,Liver,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,2107.0,
14810,Rattus norvegicus,CHEMBL625647,Intermediate,Liver,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,2107.0,
14811,Rattus norvegicus,CHEMBL625648,Intermediate,Lung,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,2048.0,
14812,Rattus norvegicus,CHEMBL625649,Intermediate,Lung,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,2048.0,
14813,Rattus norvegicus,CHEMBL625650,Intermediate,Muscle tissue,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,2385.0,
14814,Rattus norvegicus,CHEMBL625651,Intermediate,Muscle tissue,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,2385.0,
14815,Rattus norvegicus,CHEMBL625652,Intermediate,Zone of skin,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,14.0,
14816,Rattus norvegicus,CHEMBL625653,Intermediate,Zone of skin,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,14.0,
14817,Rattus norvegicus,CHEMBL625654,Intermediate,Spleen,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,2106.0,
14818,Rattus norvegicus,CHEMBL625655,Intermediate,Spleen,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,10116.0,13925,50597,1,,,BAO_0000218,2106.0,
14819,Rattus norvegicus,CHEMBL625656,Intermediate,Blood,Biodistribution of Compound in rat blood after 15 minutes of administration,,N,10116.0,9712,50597,1,,,BAO_0000218,178.0,
14820,Rattus norvegicus,CHEMBL625657,Intermediate,Blood,Biodistribution of Compound in rat blood after 2 minutes of administration,,N,10116.0,9712,50597,1,,,BAO_0000218,178.0,
14821,Rattus norvegicus,CHEMBL625658,Intermediate,Brain,Biodistribution of Compound in rat brain after 15 minutes of administration,,N,10116.0,9712,50597,1,,,BAO_0000218,955.0,
14822,Rattus norvegicus,CHEMBL625659,Intermediate,Brain,Biodistribution of Compound in rat brain after 2 minutes of administration,,N,10116.0,9712,50597,1,,,BAO_0000218,955.0,
14823,Rattus norvegicus,CHEMBL625660,Intermediate,Heart,Biodistribution of Compound in rat heart after 15 minutes of administration,,N,10116.0,9712,50597,1,,,BAO_0000218,948.0,
14824,Rattus norvegicus,CHEMBL625661,Intermediate,Heart,Biodistribution of Compound in rat heart after 2 minutes of administration,,N,10116.0,9712,50597,1,,,BAO_0000218,948.0,
14825,Rattus norvegicus,CHEMBL625662,Intermediate,Liver,Biodistribution of Compound in rat liver after 15 minutes of administration,,N,10116.0,9712,50597,1,,,BAO_0000218,2107.0,
14826,Rattus norvegicus,CHEMBL625663,Intermediate,Liver,Biodistribution of Compound in rat liver after 2 minutes of administration,,N,10116.0,9712,50597,1,,,BAO_0000218,2107.0,
14827,Rattus norvegicus,CHEMBL875621,Intermediate,Lung,Biodistribution of Compound in rat lung after 15 minutes of administration,,N,10116.0,9712,50597,1,,,BAO_0000218,2048.0,
14828,Rattus norvegicus,CHEMBL628382,Intermediate,Lung,Biodistribution of Compound in rat lung after 2 minutes of administration,,N,10116.0,9712,50597,1,,,BAO_0000218,2048.0,
14829,Rattus norvegicus,CHEMBL628383,Intermediate,Muscle tissue,Biodistribution of Compound in rat muscle after 15 minutes of administration,,N,10116.0,9712,50597,1,,,BAO_0000218,2385.0,
14830,Rattus norvegicus,CHEMBL628384,Intermediate,Muscle tissue,Biodistribution of Compound in rat muscle after 2 minutes of administration,,N,10116.0,9712,50597,1,,,BAO_0000218,2385.0,
14831,Rattus norvegicus,CHEMBL628385,Intermediate,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,N,10116.0,13925,50597,1,,,BAO_0000218,,
14832,Rattus norvegicus,CHEMBL875753,Intermediate,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,N,10116.0,13925,50597,1,,,BAO_0000218,,
14833,Rattus norvegicus,CHEMBL628386,Intermediate,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,N,10116.0,13925,50597,1,,,BAO_0000218,,
14834,Rattus norvegicus,CHEMBL628387,Intermediate,,Organ distribution in rat blood 2 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14835,Rattus norvegicus,CHEMBL628388,Intermediate,,Organ distribution in rat blood 2 hr after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14836,Rattus norvegicus,CHEMBL628389,Intermediate,,Organ distribution in rat blood 30 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14837,Rattus norvegicus,CHEMBL632756,Intermediate,,Organ distribution in rat blood 30 min after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14838,Rattus norvegicus,CHEMBL628390,Intermediate,,Organ distribution in rat brain 2 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14839,Rattus norvegicus,CHEMBL631811,Intermediate,,Organ distribution in rat brain 2 hr after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14840,Rattus norvegicus,CHEMBL631812,Intermediate,,Organ distribution in rat brain 30 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14841,Rattus norvegicus,CHEMBL631813,Intermediate,,Organ distribution in rat heart 2 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14842,Rattus norvegicus,CHEMBL631814,Intermediate,,Organ distribution in rat heart 2 hr after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14843,Rattus norvegicus,CHEMBL631815,Intermediate,,Organ distribution in rat heart 30 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14844,Rattus norvegicus,CHEMBL631816,Intermediate,,Organ distribution in rat kidney 2 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14845,Rattus norvegicus,CHEMBL875758,Intermediate,,Organ distribution in rat kidney 2 hr after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14846,Rattus norvegicus,CHEMBL631817,Intermediate,,Organ distribution in rat kidney 30 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14847,Rattus norvegicus,CHEMBL631818,Intermediate,Liver,Organ distribution in rat liver 2 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,2107.0,
14848,Rattus norvegicus,CHEMBL631819,Intermediate,Liver,Organ distribution in rat liver 2 hr after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,2107.0,
14849,Rattus norvegicus,CHEMBL631820,Intermediate,Liver,Organ distribution in rat liver 30 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,2107.0,
14850,Rattus norvegicus,CHEMBL631821,Intermediate,,Organ distribution in rat lung 2 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14851,Rattus norvegicus,CHEMBL631822,Intermediate,,Organ distribution in rat lung 2 hr after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14852,Rattus norvegicus,CHEMBL631823,Intermediate,,Organ distribution in rat lung 30 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,,
14853,Rattus norvegicus,CHEMBL631824,Intermediate,Muscle tissue,Organ distribution in rat muscle 2 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,2385.0,
14854,Rattus norvegicus,CHEMBL631825,Intermediate,Muscle tissue,Organ distribution in rat muscle 2 hr after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,2385.0,
14855,Rattus norvegicus,CHEMBL631826,Intermediate,Muscle tissue,Organ distribution in rat muscle 30 minutes after intravenous injection,,N,10116.0,6941,50597,1,,,BAO_0000218,2385.0,
14856,Mus musculus,CHEMBL631827,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,N,10090.0,14439,50594,1,,,BAO_0000218,,
14857,Mus musculus,CHEMBL631828,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,N,10090.0,14439,50594,1,,,BAO_0000218,,
14858,Mus musculus,CHEMBL631829,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,N,10090.0,14439,50594,1,,,BAO_0000218,,
14859,Rattus norvegicus,CHEMBL875759,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14860,Rattus norvegicus,CHEMBL631830,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14861,Rattus norvegicus,CHEMBL631831,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14862,Rattus norvegicus,CHEMBL631832,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14863,Rattus norvegicus,CHEMBL631833,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14864,Rattus norvegicus,CHEMBL631834,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14865,Rattus norvegicus,CHEMBL631835,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14866,Rattus norvegicus,CHEMBL631836,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14867,Rattus norvegicus,CHEMBL631837,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14868,Rattus norvegicus,CHEMBL631838,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14869,Rattus norvegicus,CHEMBL631839,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14870,Rattus norvegicus,CHEMBL631840,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14871,Rattus norvegicus,CHEMBL631841,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14872,Rattus norvegicus,CHEMBL631842,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14873,Rattus norvegicus,CHEMBL631843,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14874,Rattus norvegicus,CHEMBL631844,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14875,Rattus norvegicus,CHEMBL631845,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14876,Rattus norvegicus,CHEMBL631846,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14877,Rattus norvegicus,CHEMBL875760,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14878,Rattus norvegicus,CHEMBL632199,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14879,Rattus norvegicus,CHEMBL631847,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14880,Rattus norvegicus,CHEMBL631848,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14881,Rattus norvegicus,CHEMBL628707,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14882,Rattus norvegicus,CHEMBL628708,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14883,Rattus norvegicus,CHEMBL628709,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14884,Rattus norvegicus,CHEMBL628710,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14885,Rattus norvegicus,CHEMBL628711,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14886,Rattus norvegicus,CHEMBL628712,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14887,Rattus norvegicus,CHEMBL628713,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14888,Rattus norvegicus,CHEMBL628714,Intermediate,Urine,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,N,10116.0,12582,50597,1,,,BAO_0000218,1088.0,
14889,Rattus norvegicus,CHEMBL628715,Intermediate,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,N,10116.0,7415,50597,1,,,BAO_0000218,,
14890,,CHEMBL629179,Autocuration,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,U,,7313,22224,1,,,BAO_0000019,,
14891,,CHEMBL629180,Autocuration,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,U,,7313,22224,1,,,BAO_0000019,,
14892,,CHEMBL875108,Autocuration,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,U,,7313,22224,1,,,BAO_0000019,,
14893,,CHEMBL629181,Autocuration,Adrenal cortex,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,1235.0,
14894,,CHEMBL629182,Autocuration,Adrenal cortex,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,1235.0,
14895,,CHEMBL629183,Autocuration,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,,
14896,,CHEMBL629184,Autocuration,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,,
14897,,CHEMBL629185,Autocuration,Adrenal cortex,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,1235.0,
14898,,CHEMBL629186,Autocuration,Adrenal cortex,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,1235.0,
14899,,CHEMBL629187,Autocuration,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,,
14900,,CHEMBL629887,Autocuration,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,,
14901,,CHEMBL629888,Autocuration,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,,
14902,,CHEMBL629889,Autocuration,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,,
14903,,CHEMBL629890,Autocuration,Adrenal cortex,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,1235.0,
14904,,CHEMBL629891,Autocuration,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,,
14905,,CHEMBL629892,Autocuration,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,,
14906,,CHEMBL629893,Autocuration,Adrenal cortex,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,1235.0,
14907,,CHEMBL629894,Autocuration,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,,
14908,,CHEMBL629895,Autocuration,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,U,,7570,22224,1,,,BAO_0000019,,
14909,Canis lupus familiaris,CHEMBL875109,Autocuration,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,U,9615.0,14122,22224,1,,,BAO_0000218,,
14910,Macaca fascicularis,CHEMBL629896,Autocuration,,Absolute bioavailability in male cynomolgus monkeys,,U,9541.0,16449,22224,1,,,BAO_0000218,,
14911,Rattus norvegicus,CHEMBL629897,Autocuration,,Absolute bioavailability in maleSprague-Dawley rats,,U,10116.0,16449,22224,1,,,BAO_0000218,,
14912,Rattus norvegicus,CHEMBL629898,Intermediate,Liver,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
14913,Rattus norvegicus,CHEMBL630057,Intermediate,Liver,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
14914,Rattus norvegicus,CHEMBL630058,Intermediate,Liver,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2107.0,
14915,Rattus norvegicus,CHEMBL630059,Intermediate,Lung,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
14916,Rattus norvegicus,CHEMBL630060,Intermediate,Lung,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
14917,Rattus norvegicus,CHEMBL630061,Intermediate,Lung,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
14918,Rattus norvegicus,CHEMBL630062,Intermediate,Lung,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
14919,Rattus norvegicus,CHEMBL630063,Intermediate,Lung,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
14920,Rattus norvegicus,CHEMBL630064,Intermediate,Lung,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
14921,Rattus norvegicus,CHEMBL630065,Intermediate,Lung,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
14922,Rattus norvegicus,CHEMBL630066,Intermediate,Lung,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
14923,Rattus norvegicus,CHEMBL630067,Intermediate,Lung,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
14924,Rattus norvegicus,CHEMBL630068,Intermediate,Lung,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2048.0,
14925,Rattus norvegicus,CHEMBL631113,Intermediate,Muscle tissue,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
14926,Rattus norvegicus,CHEMBL631114,Intermediate,Muscle tissue,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
14927,Rattus norvegicus,CHEMBL631115,Intermediate,Muscle tissue,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
14928,Rattus norvegicus,CHEMBL631116,Intermediate,Muscle tissue,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
14929,Rattus norvegicus,CHEMBL630528,Intermediate,Muscle tissue,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
14930,Rattus norvegicus,CHEMBL630529,Intermediate,Muscle tissue,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
14931,Rattus norvegicus,CHEMBL630530,Intermediate,Muscle tissue,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
14932,Rattus norvegicus,CHEMBL630531,Intermediate,Muscle tissue,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
14933,Rattus norvegicus,CHEMBL630532,Intermediate,Muscle tissue,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
14934,Rattus norvegicus,CHEMBL630533,Intermediate,Muscle tissue,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2385.0,
14935,Mus musculus,CHEMBL630534,Intermediate,Blood,Biodistribution in normal mice blood after 120 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,178.0,
14936,Mus musculus,CHEMBL630535,Intermediate,Blood,Biodistribution in normal mice blood after 24 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,178.0,
14937,Mus musculus,CHEMBL630536,Intermediate,Blood,Biodistribution in normal mice blood after 4 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,178.0,
14938,Mus musculus,CHEMBL630537,Intermediate,Bone,Biodistribution in normal mice bone after 120 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,10000001.0,
14939,Mus musculus,CHEMBL630538,Intermediate,Bone,Biodistribution in normal mice bone after 24 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,10000001.0,
14940,Mus musculus,CHEMBL630539,Intermediate,Bone,Biodistribution in normal mice bone after 4 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,10000001.0,
14941,Mus musculus,CHEMBL630540,Intermediate,Heart,Biodistribution in normal mice heart after 120 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,948.0,
14942,Mus musculus,CHEMBL630541,Intermediate,Heart,Biodistribution in normal mice heart after 24 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,948.0,
14943,Mus musculus,CHEMBL630542,Intermediate,Heart,Biodistribution in normal mice heart after 4 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,948.0,
14944,Mus musculus,CHEMBL630543,Intermediate,Kidney,Biodistribution in normal mice kidney after 120 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,2113.0,
14945,Mus musculus,CHEMBL630544,Intermediate,Kidney,Biodistribution in normal mice kidney after 24 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,2113.0,
14946,Mus musculus,CHEMBL630545,Intermediate,Kidney,Biodistribution in normal mice kidney after 4 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,2113.0,
14947,Mus musculus,CHEMBL630546,Intermediate,Liver,Biodistribution in normal mice liver after 120 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,2107.0,
14948,Mus musculus,CHEMBL630547,Intermediate,Liver,Biodistribution in normal mice liver after 24 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,2107.0,
14949,Mus musculus,CHEMBL630548,Intermediate,Liver,Biodistribution in normal mice liver after 4 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,2107.0,
14950,Mus musculus,CHEMBL630549,Intermediate,Spleen,Biodistribution in normal mice spleen after 120 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,2106.0,
14951,Mus musculus,CHEMBL630550,Intermediate,Spleen,Biodistribution in normal mice spleen after 24 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,2106.0,
14952,Mus musculus,CHEMBL876426,Intermediate,Spleen,Biodistribution in normal mice spleen after 4 hr,,N,10090.0,15045,50594,1,,,BAO_0000218,2106.0,
14953,Rattus norvegicus,CHEMBL630551,Intermediate,Spleen,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
14954,Rattus norvegicus,CHEMBL630552,Intermediate,Spleen,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
14955,Rattus norvegicus,CHEMBL630553,Intermediate,Spleen,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
14956,Rattus norvegicus,CHEMBL630554,Intermediate,Spleen,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
14957,Rattus norvegicus,CHEMBL630555,Intermediate,Spleen,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
14958,Rattus norvegicus,CHEMBL630556,Intermediate,Spleen,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
14959,Rattus norvegicus,CHEMBL630557,Intermediate,Spleen,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
14960,Rattus norvegicus,CHEMBL630558,Intermediate,Spleen,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
14961,Rattus norvegicus,CHEMBL630559,Intermediate,Spleen,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
14962,Rattus norvegicus,CHEMBL630560,Intermediate,Spleen,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2106.0,
14963,Rattus norvegicus,CHEMBL876427,Intermediate,Thyroid gland,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,10116.0,12017,50597,1,,,BAO_0000218,2046.0,
14964,Rattus norvegicus,CHEMBL630561,Intermediate,,The Kel values in female wistar rats.,,N,10116.0,14941,50597,1,,,BAO_0000218,,
14965,,CHEMBL630562,Autocuration,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,U,,4646,22224,1,,,BAO_0000019,,
14966,,CHEMBL630563,Autocuration,,Hydrolysis rate constant of the compound,,U,,8847,22224,1,,,BAO_0000019,,
14967,,CHEMBL629673,Autocuration,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,U,,11778,22229,1,,,BAO_0000100,,
14968,,CHEMBL629674,Autocuration,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,U,,2363,22224,1,,,BAO_0000019,,
14969,,CHEMBL629675,Autocuration,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,U,,2363,22224,1,,,BAO_0000019,,
14970,,CHEMBL629676,Autocuration,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,U,,2363,22224,1,,,BAO_0000019,,
14971,,CHEMBL629677,Autocuration,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,U,,2363,22224,1,,,BAO_0000019,,
14972,,CHEMBL629678,Autocuration,,Apparent inactivation rate constant was evaluated,,U,,8371,22224,1,,,BAO_0000019,,
14973,,CHEMBL629679,Autocuration,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,U,,14883,22224,1,,,BAO_0000019,,
14974,,CHEMBL629680,Autocuration,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,U,,14883,22224,1,,,BAO_0000019,,
14975,,CHEMBL629681,Autocuration,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,U,,4643,22224,1,,,BAO_0000019,,
14976,,CHEMBL629682,Autocuration,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,U,,3519,22224,1,,,BAO_0000019,,
14977,,CHEMBL629683,Autocuration,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,U,,10600,22224,1,,,BAO_0000019,,
14978,,CHEMBL629684,Autocuration,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,U,,8501,22224,1,,,BAO_0000019,,
14979,,CHEMBL629685,Autocuration,,Dissociation constant was determined,,U,,8505,22224,1,,,BAO_0000100,,
14980,,CHEMBL629686,Autocuration,,Dissociation constant was determined,,U,,9778,22224,1,,,BAO_0000100,,
14981,,CHEMBL872932,Autocuration,,Dissociation constant at pH 7.4,,U,,9778,22224,1,,,BAO_0000100,,
14982,,CHEMBL629687,Autocuration,,Dissociation constant in presence of 1 mM dithiothreitol,,U,,9778,22224,1,,,BAO_0000100,,
14983,,CHEMBL872931,Autocuration,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,U,,13007,22224,1,,,BAO_0000019,,
14984,,CHEMBL628151,Autocuration,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,U,,13007,22224,1,,,BAO_0000019,,
14985,,CHEMBL628152,Autocuration,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,U,,13007,22224,1,,,BAO_0000019,,
14986,,CHEMBL628153,Autocuration,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,U,,13007,22224,1,,,BAO_0000019,,
14987,,CHEMBL628154,Autocuration,,Kinetic constant for aromatization of androstenedione,,U,,11482,22224,1,,,BAO_0000019,,
14988,,CHEMBL628155,Autocuration,,Kinetic constant for aromatization of testosterone,,U,,11482,22224,1,,,BAO_0000019,,
14989,,CHEMBL628156,Autocuration,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,U,,2303,22224,1,,,BAO_0000019,,
14990,,CHEMBL628157,Autocuration,,Local inhibition constant was determined,,U,,11964,22224,1,,,BAO_0000019,,
14991,Saccharomyces cerevisiae,CHEMBL857533,Intermediate,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,N,4932.0,3140,50347,1,,,BAO_0000218,,
14992,,CHEMBL628158,Autocuration,,Dissociation constant value of the compound,,U,,10650,22224,1,,,BAO_0000100,,
14993,,CHEMBL628159,Autocuration,Cornea,In vitro permeability through cornea without epithelium,,U,,4667,22224,1,,,BAO_0000019,964.0,
14994,,CHEMBL875616,Autocuration,Cornea,In vitro permeability through intact cornea,,U,,4667,22224,1,,,BAO_0000019,964.0,
14995,Oryctolagus cuniculus,CHEMBL628160,Intermediate,Cornea,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,N,9986.0,9199,50592,1,,,BAO_0000218,964.0,
14996,,CHEMBL628161,Autocuration,,Rate of enzyme inactivation for the compound was determined,,U,,11966,22224,1,,,BAO_0000019,,
14997,,CHEMBL628162,Autocuration,Cornea,In vitro permeability through cornea without epithelium,,U,,4667,22224,1,,,BAO_0000019,964.0,
14998,,CHEMBL628163,Autocuration,Cornea,In vitro permeability through intact cornea,,U,,4667,22224,1,,,BAO_0000019,964.0,
14999,,CHEMBL628164,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15000,,CHEMBL628165,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15001,,CHEMBL628166,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15002,,CHEMBL628167,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15003,,CHEMBL628168,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15004,,CHEMBL628169,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15005,,CHEMBL628170,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15006,,CHEMBL628171,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15007,,CHEMBL627434,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15008,,CHEMBL627435,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15009,,CHEMBL628110,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15010,,CHEMBL628111,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15011,,CHEMBL628112,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15012,,CHEMBL628260,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15013,,CHEMBL628261,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,8354,22224,1,,,BAO_0000019,,
15014,Mus musculus,CHEMBL628262,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,N,10090.0,14439,50594,1,,,BAO_0000218,,
15015,Homo sapiens,CHEMBL628263,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,N,9606.0,14439,50587,1,,,BAO_0000218,,
15016,Mus musculus,CHEMBL628264,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,N,10090.0,14439,50594,1,,,BAO_0000218,,
15017,Mus musculus,CHEMBL628265,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,N,10090.0,14439,50594,1,,,BAO_0000218,,
15018,Mus musculus,CHEMBL628266,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,N,10090.0,14439,50594,1,,,BAO_0000218,,
15019,Mus musculus,CHEMBL628267,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,N,10090.0,14439,50594,1,,,BAO_0000218,,
15020,Mus musculus,CHEMBL628268,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,N,10090.0,14439,50594,1,,,BAO_0000218,,
15021,Mus musculus,CHEMBL628269,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,N,10090.0,14439,50594,1,,,BAO_0000218,,
15022,Mus musculus,CHEMBL628270,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,N,10090.0,14439,50594,1,,,BAO_0000218,,
15023,Mus musculus,CHEMBL628271,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,N,10090.0,14439,50594,1,,,BAO_0000218,,
15024,Mus musculus,CHEMBL628272,Intermediate,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,N,10090.0,14439,50594,1,,,BAO_0000218,,
